Form 1-A Issuer Information
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1-A
REGULATION A OFFERING STATEMENT
UNDER THE SECURITIES ACT OF 1933
|
OMB APPROVAL
|
FORM 1-A
|
OMB Number:
3235-0286
Estimated average burden hours per response:
608.0
|
1-A: Filer Information
Issuer CIK | 0001644903 |
Issuer CCC | XXXXXXXX |
DOS File Number | |
Offering File Number | |
Is this a LIVE or TEST Filing?
| ☒
LIVE
☐
TEST
|
Would you like a Return Copy?
| ☐ |
Notify via Filing Website only?
| ☐ |
Since Last Filing?
| ☐ |
Submission Contact Information
1-A: Item 1. Issuer Information
Issuer Infomation
Exact name of issuer as specified in the issuer's
charter
| Level Brands, Inc. |
Jurisdiction of Incorporation / Organization |
NORTH CAROLINA
|
Year of Incorporation | 2015 |
CIK | 0001644903 |
Primary Standard Industrial Classification Code | PERFUMES COSMETICS & OTHER TOILET PREPARATIONS |
I.R.S. Employer Identification Number | 47-3414576 |
Total number of full-time employees | 9 |
Total number of part-time employees | 0 |
Contact Infomation
Address of Principal Executive Offices
|
Address 1 | 4521 SHARON ROAD |
Address 2 | SUITE 407 |
City | CHARLOTTE |
State/Country |
NORTH CAROLINA
|
Mailing Zip/ Postal Code | 28211 |
Phone | 704-445-5800 |
Provide the following information for the person the
Securities
and Exchange Commission's staff should call in
connection with any
pre-qualification review of the offering
statement.
|
Name | BRIAN A. PEARLMAN, ESQ. |
Address 1 | |
Address 2 | |
City | |
State/Country | |
Mailing Zip/ Postal Code | |
Phone | |
Provide up to two e-mail addresses to which
the
Securities and
Exchange Commission's staff may send any comment
letters relating to
the offering statement. After qualification of
the offering
statement, such e-mail addresses are not required to
remain active.
Financial Statements
Industry Group (select one)
| ☐
Banking
☐
Insurance
☒
Other
|
Use the financial statements for the most recent period
contained in
this offering statement to provide the following
information about
the issuer. The following table does not include
all of the line
items from the financial statements. Long Term Debt
would include
notes payable, bonds, mortgages, and similar
obligations. To
determine "Total Revenues" for all companies
selecting "Other" for
their industry group, refer to Article
5-03(b)(1) of Regulation
S-X. For companies selecting "Insurance",
refer to Article 7-04 of
Regulation S-X for calculation of "Total
Revenues" and paragraphs 5
and 7 of Article 7-04 for "Costs and
Expenses Applicable to
Revenues".
Balance Sheet Information
|
Cash and Cash Equivalents |
$
398350.00 |
Investment Securities |
$
1387000.00 |
Total Investments |
$
|
Accounts and Notes Receivable |
$
432719.00 |
Loans |
$
|
Property, Plant and Equipment (PP&E): |
$
149148.00 |
Property and Equipment |
$
|
Total Assets |
$
5097622.00 |
Accounts Payable and Accrued Liabilities |
$
556272.00 |
Policy Liabilities and Accruals |
$
|
Deposits |
$
|
Long Term Debt |
$
0.00 |
Total Liabilities |
$
657855.00 |
Total Stockholders' Equity |
$
4439767.00 |
Total Liabilities and Equity |
$
5097622.00 |
Statement of Comprehensive Income Information
|
Total Revenues |
$
3395387.00 |
Total Interest Income |
$
|
Costs and Expenses Applicable to Revenues |
$
822556.00 |
Total Interest Expenses |
$
|
Depreciation and Amortization |
$
0.00 |
Net Income |
$
-1127608.00 |
Earnings Per Share - Basic |
$
-0.34 |
Earnings Per Share - Diluted |
$
-0.34 |
Name of Auditor (if any) | CHERRY BEKAERT LLP |
Outstanding Securities
Common Equity
|
Name of Class (if any) Common Equity
| Common Stock |
Common Equity Units Outstanding
| 5764668 |
Common Equity CUSIP (if any):
| 52730Q209 |
Common Equity Units Name of Trading Center or Quotation Medium (if any)
| N/A |
Preferred Equity
Preferred Equity Name of Class (if any)
| N/A |
Preferred Equity Units Outstanding
| 0 |
Preferred Equity CUSIP (if any)
| 000000000 |
Preferred Equity Name of Trading Center or Quotation Medium (if any)
| N/A |
Debt Securities
Debt Securities Name of Class (if any)
| N/A |
Debt Securities Units Outstanding
| 0 |
Debt Securities CUSIP (if any):
| 000000000 |
Debt Securities Name of Trading Center or Quotation Medium (if any)
| N/A |
1-A: Item 2. Issuer Eligibility
Issuer Eligibility
Check this box to certify that all of the following statements
are true for the issuer(s)
☒
-
Organized under the laws of the United States or Canada, or any
State, Province, Territory or possession thereof, or the District
of Columbia.
- Principal place of business is in the United States or Canada.
-
Not subject to section 13 or 15(d) of the Securities Exchange
Act of 1934.
-
Not a development stage company that either (a) has no specific
business plan or purpose, or (b) has indicated that its business
plan is to merge with an unidentified company or companies.
-
Not an investment company registered or required to be
registered under the Investment Company Act of 1940.
-
Not issuing fractional undivided interests in oil or gas rights,
or a similar interest in other mineral rights.
-
Not issuing asset-backed securities as defined in Item 1101 (c)
of Regulation AB.
-
Not, and has not been, subject to any order of the Commission
entered pursuant to Section 12(j) of the Exchange Act (15 U.S.C.
78l(j)) within five years before the filing of this offering
statement.
-
Has filed with the Commission all the reports it was required to
file, if any, pursuant to Rule 257 during the two years immediately
before the filing of the offering statement (or for such shorter
period that the issuer was required to file such reports).
1-A: Item 3. Application of Rule 262
Application Rule 262
Check this box to certify that, as of the time of this filing,
each person described in Rule 262 of Regulation A is either not
disqualified under that rule or is disqualified but has received a
waiver of such disqualification.
☒
Check this box if "bad actor" disclosure under Rule 262(d) is
provided in Part II of the offering statement.
☐
1-A: Item 4. Summary Information Regarding the Offering and Other
Current or Proposed Offerings
Summary Infomation
Check the appropriate box to indicate whether you are
conducting
a Tier 1 or Tier 2 offering
| ☐
Tier1
☒
Tier2
|
Check the appropriate box to indicate whether the
financial statements
have been audited
| ☐
Unaudited
☒
Audited
|
Types of Securities Offered in this Offering Statement
(select
all that apply)
| |
☒Equity (common or preferred stock) |
Does the issuer intend to offer the securities on a
delayed or continuous basis pursuant to Rule 251(d)(3)?
| ☒
Yes
☐
No
|
Does the issuer intend this offering to last more than
one year?
| ☐
Yes
☒
No
|
Does the issuer intend to price this offering after
qualification
pursuant to Rule 253(b)?
| ☐
Yes
☒
No
|
Will the issuer be conducting a best efforts offering?
| ☒
Yes
☐
No
|
Has the issuer used solicitation of interest
communications in
connection with the proposed offering?
| ☐
Yes
☒
No
|
Does the proposed offering involve the resale of
securities by
affiliates of the issuer?
| ☐
Yes
☒
No
|
Number of securities offered
| 1769235 |
Number of securities of that class outstanding
| 5764668 |
The information called for by this item below may be omitted if
undetermined at the time of filing or submission, except that if a
price range has been included in the offering statement, the midpoint
of that range must be used to respond. Please refer to Rule 251(a)
for the definition of "aggregate offering price" or "aggregate sales"
as used in this item. Please leave the field blank if undetermined at
this time and include a zero if a particular item is not applicable
to the offering.
Price per security
|
$
|
The portion of the aggregate offering price
attributable to securities being offered on behalf of the issuer
|
$
15000000.00 |
The portion of the aggregate offering price
attributable to securities being offered on behalf of selling
securityholders
|
$
0.00 |
The portion of the aggregate offering price
attributable to all the securities of the issuer sold pursuant to a
qualified offering statement within the 12 months before the
qualification of this offering statement
|
$
0.00 |
The estimated portion of aggregate sales attributable
to securities that may be sold pursuant to any other qualified
offering statement concurrently with securities being sold under
this offering statement
|
$
0.00 |
Total (the sum of the aggregate offering price and
aggregate sales in the four preceding paragraphs)
|
$
15000000.00 |
Anticipated fees in connection with this offering and names of
service providers
Underwriters - Name of Service Provider
| |
Underwriters - Fees
|
$
|
Sales Commissions - Name of Service Provider
| Joseph Gunnar and Co. and TriPoint Global Equities LLC |
Sales Commissions - Fee
|
$
1050000.00 |
Finders' Fees - Name of Service Provider
| |
Finders' Fees - Fees
|
$
|
Audit - Name of Service Provider
| Cherry Bekaert LLP |
Audit - Fees
|
$
100000.00 |
Legal - Name of Service Provider
| Pearlman Law Group LLP |
Legal - Fees
|
$
200000.00 |
Promoters - Name of Service Provider
| |
Promoters - Fees
|
$
|
Blue Sky Compliance - Name of Service Provider
| |
Blue Sky Compliance - Fees
|
$
|
CRD Number of any broker or dealer listed:
| |
Estimated net proceeds to the issuer
|
$
13650000.00 |
Clarification of responses (if necessary)
| Assumes sale of $15,000,000 of shares. Joseph Gunnar and Co. CRD Number is 24795 and TriPoint Global Equities LLC CRD Number is 143174. |
1-A: Item 5. Jurisdictions in Which Securities are to be Offered
Jurisdictions in Which Securities are to be Offered
Using the list below, select the jurisdictions in which
the
issuer intends to offer the securities
Selected States and Jurisdictions
|
ALABAMA
ALASKA
ARIZONA
ARKANSAS
CALIFORNIA
COLORADO
CONNECTICUT
DELAWARE
FLORIDA
GEORGIA
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MAINE
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
MONTANA
NEBRASKA
NEVADA
NEW HAMPSHIRE
NEW JERSEY
NEW MEXICO
NEW YORK
NORTH CAROLINA
NORTH DAKOTA
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
TEXAS
UTAH
VERMONT
VIRGINIA
WASHINGTON
WEST VIRGINIA
WISCONSIN
WYOMING
PUERTO RICO
DISTRICT OF COLUMBIA
|
Using the list below, select the jurisdictions in which the
securities are to be offered by underwriters, dealers or sales
persons or check the appropriate box
None
| ☐ |
Same as the jurisdictions in which the issuer intends
to offer the securities
| ☒ |
Selected States and Jurisdictions
|
ALABAMA
ALASKA
ARIZONA
ARKANSAS
CALIFORNIA
COLORADO
CONNECTICUT
DELAWARE
FLORIDA
GEORGIA
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MAINE
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
MONTANA
NEBRASKA
NEVADA
NEW HAMPSHIRE
NEW JERSEY
NEW MEXICO
NEW YORK
NORTH CAROLINA
NORTH DAKOTA
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
TEXAS
UTAH
VERMONT
VIRGINIA
WASHINGTON
WEST VIRGINIA
WISCONSIN
WYOMING
PUERTO RICO
DISTRICT OF COLUMBIA
|
1-A: Item 6. Unregistered Securities Issued or Sold Within One
Year
Unregistered Securities Issued or Sold Within One Year
None
☐
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Units consisting of convertible promissory notes and warrants |
(2) Total Amount of such securities issued | 2125000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| 2,125,000 in cash proceeds |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 14667 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| purchase of minority membership interests in majority owned subsidiary valued at $12,467 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 38358 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| 0 cashless exercise of warrants |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Stock Options |
(2) Total Amount of such securities issued | 185800 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| issued as additional compensation for services to the issuer rendered by the optionees valued at $24,639 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 14000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| compensation for valued at $105,000 for renewal of credit line |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 76000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| compensation for services to issuer valued at $570,000 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 20000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| charitable contribution valued at $17,000 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 26667 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| compensation for services to issuer by employees valued at $22,667 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 283000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| purchase of membership interests valued at $240,550 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 583000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| purchase of membership interests valued at $495,550 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 114745 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| purchase of minority interests in majority owned subsidiary valued at $97,533 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 100000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| issued as additional compensation for services to the issuer rendered by the optionees valued at $21,500 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 155294 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| purchase of minority interest in majority owned subsidiary valued at $132,000 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 195740 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| satisfaction of $593,797 of principal and accrued interest due by the issuer under a revolving credit line |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 570254 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| conversion of $2,125,000 due under convertible notes into equity |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 5000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| compensation for services to the issuer valued at $19,750 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 77000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| private placement of common stock |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 133000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| private placement of common stock |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 19100 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| compensation for services valued at $75,445 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 25000 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| compensation for services valued at $98,750 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | Common Stock |
(2) Total Amount of such securities issued | 45500 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| compensation for services valued at $179,725 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Issued
As to any unregistered securities issued by the issuer of any of
its predecessors or affiliated issuers within one year before the
filing of this Form 1-A, state:
(a)Name of such issuer | Level Brands, Inc. |
(b)(1) Title of securities issued | options to purchase common stock |
(2) Total Amount of such securities issued | 7500 |
(3) Amount of such securities sold by or for the
account of any person who at the time was a director, officer,
promoter or principal securityholder of the issuer of such
securities, or was an underwriter of any securities of such issuer.
| 0 |
(c)(1) Aggregate consideration for which the securities
were issued and basis for computing the amount thereof.
| compensation for services valued at $10,770 |
(2) Aggregate consideration for which the securities
listed in (b)(3) of this item (if any) were issued and the basis
for computing the amount thereof (if different from the basis
described in (c)(1)).
| |
Unregistered Securities Act
(e) Indicate the section of the Securities Act or
Commission rule or regulation relied upon for exemption from the
registration requirements of such Act and state briefly the facts
relied upon for such exemption
| private transaction exempt from registration in reliance on Section 4(a)(2) |
PART II — INFORMATION REQUIRED IN OFFERING
CIRCULAR
An offering statement pursuant to Regulation A relating to these
securities has been filed with the United States Securities and
Exchange Commission. Information contained in this Preliminary
Offering Circular is subject to completion or amendment. These
securities may not be sold nor may offers to buy be accepted before
the offering statement filed with the United States Securities and
Exchange Commission is qualified. This Preliminary Offering
Circular shall not constitute an offer to sell or the solicitation
of an offer to buy nor may there be any sales of these securities
in any state in which such offer, solicitation or sale would be
unlawful before registration or qualification under the laws of any
such state. We may elect to satisfy our obligation to deliver a
Final Offering Circular by sending you a notice within two business
days after the completion of our sale to you that contains the URL
where the Final Offering Circular or the offering statement in
which such Final Offering Circular was filed may be
obtained.
PRELIMINARY OFFERING CIRCULAR
|
SUBJECT TO COMPLETION
|
DATED
SEPTEMBER 18, 2017
|
_________ Shares of Common
Stock
Level Brands,
Inc.
|
|
This is
the initial public offering of securities of Level Brands, Inc. We
are offering up to _________ shares of our common stock. The
initial public offering price is expected to be $____ for an
offering amount of up to $10,000,000. We and the representative of
the selling agents may, in our mutual discretion, determine to
offer and sell up to an additional ___________ shares of our common
stock for gross proceeds of $5,000,000. The offering will terminate
at the earlier of the date at which $15,000,000 of shares of our
common stock have been sold, the date which is __ days after this
offering is qualified by the U.S. Securities and Exchange
Commission, or the "SEC," or the date on which we terminate this
offering in our sole discretion, or the “Termination
Date”.
This offering is
being conducted on a “best efforts” basis without any
minimum offering amount pursuant to Regulation A of Section 3(6) of
the Securities Act of 1933, as amended, or the “Securities
Act”, for Tier 2 offerings. Until we complete an initial
closing, the proceeds for the offering raised through the efforts
of the selling agents will be kept in an escrow account, except
with respect to those investors using a BANQ online brokerage
account. We will hold an initial closing on any number of shares of
common stock at any time during the offering period after we have
received notification of approval, or "Notification of Approval,"
to list our common stock on the NYSE American LLC, or the "NYSE
American," subject to meeting all of the requirements of the NYSE
American listing standards and official notice of issuance.
Thereafter, we may hold one or more additional closings until we
determine to cease having any additional closings during the
offering period. At a closing, the proceeds will be distributed to
us and the associated shares of our common stock will be issued to
the investors in such shares. _____________ will serve as the
escrow agent. Additionally, we may offer shares through other
selected dealers after receipt of Notification of Approval. If
there are no closings or if funds remain in the escrow account on
the Termination Date without any corresponding closing, the
investments for this offering will be promptly returned to
investors, without deduction and without interest. The minimum
purchase requirement per investor is 100 shares of our common stock
($________); however, we can waive the minimum purchase requirement
on a case-by-case basis in our sole
discretion.
We have
engaged Joseph Gunnar & Co., LLC as sole book-running manager
and lead selling agent to offer the shares of our common stock to
prospective investors on a best efforts basis. TriPoint Global
Equities, LLC is acting as co-manager and selling agent for the
offering. Joseph Gunnar & Co., LLC and TriPoint Global
Equities, LLC are referred to herin as the "selling agents". These
selling agents will have the right to engage such other
broker-dealers or agents as they may determine to assist in such
offering. The selling agents are not purchasing the shares of our
common stock, and are not required to sell any specific number or
dollar amount of the shares in the offering.
We have
also engaged WhoYouKnow LLC which does business as CrowdfundX to
assist in the planning, public relations and promotion of this
offering, utilizing the BANQ website, which is provided by TriPoint
Global Equities LLC as an offering platform.
We
expect to commence the offer and sale of the shares of our common
stock as of the date on which the offering statement of which this
Offering Circular is a part, or the “Offering
Statement”, is qualified by the SEC. Prior to this offering,
there has been no public market for our common stock. We intend to
apply to list our common stock on the NYSE American under the
symbol “LEVB.”
We
are an “emerging growth company” as defined in the
Jumpstart Our Business Startups Act of 2012, or “JOBS
Act,” and, as such, we have elected to comply with certain
reduced public company reporting requirements for this Offering
Circular and future filings.
Investing in our common stock involves a high degree of risk. See
“Risk Factors” beginning on page 14 of this Offering
Circular for a discussion of information that should be considered
in connection with an investment in our common stock.
|
|
Selling Agent
Commissions (1)
|
|
Per
Share
|
$
|
$
|
$
|
Maximum Offering
Amount
|
$
|
$
|
|
(1)
|
Does not include a non-accountable expense allowance equal of 1% of
the gross proceeds of this offering payable to the lead selling
agent. In addition, we will issue to the lead selling agent
warrants, or the "selling agents' warrants," to purchase ________
shares of our common stock at an exercise price of $_______ per
share as additional compensation. See “Plan of
Distribution” on page [64] for a description of additional
compensation payable to the selling agents.
|
(2)
|
We
estimate that our total expenses for the offering will be
approximately $_____ along with selling agents commissions of
$_________, assuming the maximum offering, including the Additional
Shares are sold.
|
(3)
|
We and the selling agents intend to sell the shares of our common
stock for aggregate gross proceeds of $10,000,000. In addition, we
have granted a 45-day option to the lead selling agent to sell up
to an additional $5,000,000 of shares of common stock, or the
"Additional Shares."
|
THE SEC DOES NOT PASS UPON THE MERITS OF OR
GIVE ITS APPROVAL TO ANY SECURITIES OFFERED OR THE TERMS OF THE
OFFERING, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF ANY
OFFERING CIRCULAR OR OTHER SOLICITATION MATERIALS. THESE SECURITIES
ARE OFFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE
COMMISSION; HOWEVER, THE SEC HAS NOT MADE AN INDEPENDENT
DETERMINATION THAT THE SECURITIES OFFERED ARE EXEMPT FROM
REGISTRATION.
This Offering Circular is following the disclosure format of Part I
of SEC Form S-1.
Sole Book Running Manager
Joseph Gunnar & Co.
Co-Manager
TriPoint Global Equities, LLC
|
The date of this Offering Circular
is
, 2017
We
are offering to sell, and seeking offers to buy, shares of common
stock only in jurisdictions where such offers and sales are
permitted. You should rely only on the information contained in
this Offering Circular. We have not authorized anyone to provide
you with any information other than the information contained in
this Offering Circular. The information contained in this Offering
Circular is accurate only as of its date, regardless of the time of
its delivery or of any sale or delivery of our securities. Neither
the delivery of this Offering Circular nor any sale or delivery of
our securities shall, under any circumstances, imply that there has
been no change in our affairs since the date of this Offering
Circular. This Offering Circular will be updated and made available
for delivery to the extent required by the federal securities
laws.
TABLE OF
CONTENTS
OFFERING CIRCULAR SUMMARY
|
5
|
THE OFFERING
|
9
|
RISK FACTORS
|
11
|
USE OF PROCEEDS
|
24
|
DIVIDEND POLICY
|
25
|
CAPITALIZATION
|
25
|
DILUTION
|
26
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF
OPERATIONS
|
28
|
OUR BUSINESS
|
38
|
MANAGEMENT
|
57
|
EXECUTIVE COMPENSATION
|
68
|
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
|
71
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
|
73
|
DESCRIPTION OF SECURITIES
|
77
|
SHARES ELIGIBLE FOR FUTURE SALE
|
78
|
PLAN OF DISTRIBUTION
|
79
|
LEGAL MATTERS
|
83
|
EXPERTS
|
83
|
WHERE YOU CAN FIND ADDITIONAL INFORMATION
|
84
|
INDEX
TO FINANCIAL STATEMENTS
|
F-1
|
Unless
the context otherwise indicates, when used in this Offering
Circular, the terms Level Brands,” “we,”
“us, “our” and similar terms refer to Level
Brands, Inc., a North Carolina corporation formerly known as Level
Beauty Group, Inc., and our majority owned subsidiaries Beauty and
Pinups, LLC, a North Carolina limited liability company which we
refer to as “Beauty & Pin-Ups”, I | M 1, LLC, a
California limited liability company, which we refer to as
“I’M1” and Encore Endeavor 1 LLC, a California
limited liability company which we refer to as “EE1.”
In addition, “fiscal 2015” refers to the period from
inception (March 17, 2015) to September 30, 2015, “fiscal
2016” refers to the year ended September 30, 2016 and "fiscal
2017" refers to the year ending September 30, 2017.
Unless otherwise indicated, all share and per
share information contained herein gives pro forma effect to the
1:5 reverse stock split of our common stock, which was effective
December 5, 2016. The information contained on our websites
at www.levelbrands.com
and www.beautyandpinups.com
are not part of this Offering
Circular.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION
This
Offering Circular contains statements that express our opinions,
expectations, beliefs, plans, objectives, assumptions or
projections regarding future events or future results, in contrast
with statements that reflect historical facts. Many of these
statements are contained under the headings “Offering
Circular Summary,” “Management’s Discussion and
Analysis of Financial Condition and Results of Operations”
and “Business.” In some cases, we have identified such
forward-looking statements with typical conditional words such as
“anticipate,” “intend,”
“believe,” “estimate,” “plan,”
“seek,” “project” or “expect,”
“may,” “will,” “would,”
“could” or “should,” the negative of these
terms or other comparable terminology. Important factors related to
forward-looking statements may include, among others, assumptions
regarding:
●
our limited operating history;
●
our history of losses;
●
our material dependence on our chief executive officer and managing
directors at certain of our subsidiaries who do not devote their
full time to our company;
●
our material dependence on our relationship with kathy
ireland® Worldwide, and the ability of kathy ireland®
Worldwide to terminate those agreements;
●
our material dependence on our managing directors and other
personnel that are affiliates of kathy ireland®
Worldwide;
●
our non-exclusive relationship with kathy ireland® Worldwide
and its affiliates;
●
the impact of consumer spending patterns on our business and the
need to continually market and promote our company;
●
the historic reliance on a limited number of customers and the lack
of long term sales contracts;
●
lack of long-term manufacturing and distribution
agreements;
●
our dependence on revenues from Beauty & Pin-Ups
products;
●
our ability to execute the I’M1 and EE1 business
plans;
●
the highly competitive nature of our business and our lack of an
established name recognition and brands
●
potential conflicts of interest involving kathy ireland®
Worldwide affiliates;
●
risks associated with the protection of our intellectual property
rights, including licensing relationships;
●
dependence on third party manufacturers, product developers and
distributors;
●
our ability to successfully develop new products, launch our new
brands and enter into licensing agreements with third
parties;
●
risks
associated with possible litigation;
●
our ability to acquire additional brands;
●
risks associated with the development of an active trading market
for our common stock;
●
the impact of dilution to purchasers in this offering;
●
risks associated with a "best efforts" offering;
●
the ability to satisfy the initial listing and continued listing
standards of NYSE American;
●
volatility in the price of our common stock;
●
risks
associated with accepting securities as partial
compensation;
●
our status as an emerging growth company;
●
market overhang;
●
control by our executive officers, directors and principal
shareholders;
●
management’s discretion regarding the use of proceeds from
this offering;
●
future development of a following by securities or industry
analysts for our company;
●
the impact of public company reporting requirements on our
company;
●
our ability to maintain effective internal controls;
●
expected lack of dividends on our common stock;
●
the impact of securities litigation on our company;
●
potential impact of anti-takeover measures under our articles of
incorporation, bylaws and North Carolina law; and
●
the potential impact of the penny stock rules on our common
stock.
You
should read thoroughly this Offering Circular and the documents
that we refer to herein with the understanding that our actual
future results may be materially different from and/or worse than
what we expect. We qualify all of our forward-looking statements by
these cautionary statements including those made in Risk Factors
appearing elsewhere in this Offering Circular. Other sections of
this Offering Circular include additional factors which could
adversely impact our business and financial performance. New risk
factors emerge from time to time and it is not possible for our
management to predict all risk factors, nor can we assess the
impact of all factors on our business or the extent to which any
factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements. Except for our ongoing obligations to disclose material
information under the Federal securities laws, we undertake no
obligation to release publicly any revisions to any forward-looking
statements, to report events or to report the occurrence of
unanticipated events. These forward-looking statements speak only
as of the date of this Offering Circular, and you should not rely
on these statements without also considering the risks and
uncertainties associated with these statements and our
business.
MARKET DATA AND FORECASTS
Unless
otherwise indicated, information in this Offering Circular
concerning economic conditions, our industry, our markets and our
competitive position is based on a variety of sources, including
information from independent industry analysts and publications, as
well as our own estimates and research. Our estimates are derived
from industry and general publications, studies and surveys
conducted by third-parties, as well as data from our own internal
research. Industry publications, studies and surveys generally
state that they have been obtained from sources believed to be
reliable.
OFFERING
CIRCULAR SUMMARY
This summary highlights certain information about us and this
offering contained elsewhere in this Offering Circular. Because it
is only a summary, it does not contain all the information that you
should consider before investing in shares of our common stock and
it is qualified in its entirety by, and should be read in
conjunction with, the more detailed information appearing elsewhere
in this Offering Circular. Before you decide to invest in our
common stock, you should read the entire Offering Circular
carefully, including “Risk Factors” beginning on page
14 and our financial statements and the accompanying notes included
in this Offering Circular.
Level
Brands strives to be an innovative branding and marketing company
and, through our subsidiaries, we focus our efforts on
lifestyle-based brands. Our goal is to create a bold,
unconventional and socially responsible image and consciousness for
our company and our brands. Working closely with our Chairman
Emeritus and Chief Brand Strategist, Kathy Ireland, the Chairman,
CEO and Chief Designer of kathy ireland® Worldwide, or "kiWW,"
we seek to secure strategic licenses and joint venture partnerships
for our brands, as well as to grow the portfolio of brands through
strategic acquisitions.
Currently, we operate our business in three
segments:
|
●
|
Professional products division. Currently, the operations of our Beauty &
Pin-Ups subsidiary comprise the operations of this division. Beauty
& Pin-Ups, our first brand, offers quality hair care and other
beauty products including, a hair styling tool, shampoos,
conditioners, treatments and styling products to salons. We have
expanded distribution to an online retail outlet in the second
quarter of fiscal 2017 and expect to expand distribution to
additional beauty-centric, and specialty outlets during 2017. Sales
from our professional products division represented all of our
historic revenues during fiscal 2016 and fiscal 2015 and 25.5%
of our net sales for the first nine months of fiscal
2017;
|
|
|
●
|
Licensing division. The
operations of I’M1 – Ireland Men One, a newly created
company and brand inspired by Kathy Ireland, comprise the
operations of this division. I’M1 intends to provide
millennial-inspired lifestyle products under the I’M1 brand.
Sales from our licensing division, which began reporting revenues
in the second quarter of fiscal 2017, represented 51.1% of our net
sales for the first nine months of fiscal 2017;
and
|
|
|
●
|
Entertainment division. The
operations of EE1, another newly created company, comprise the
operations of this division. EE1 seeks to be an "omni-entertainment
experience and brand management company" serving as a producer and
marketer of multiple entertainment distribution platforms as well
as assisting companies with brand strategies. Sales from our
entertainment division represented 23.4% of our net sales for the
first nine months of fiscal 2017.
|
Affiliates
of kathy ireland® Worldwide are the co-managing directors and
minority owners of both I’M1 and EE1.
Best Buddies International, an organization
founded by Anthony K. Shriver, a member of our board of directors,
which supports the inclusion of individuals with intellectual and
developmental disabilities is the exclusive charity partner for
Beauty & Pin-Ups. Under ourcommitment to Best Buddies
International, we make a mandatory annual contribution of 0.5% of
Beauty & Pin-Up's net sales to support this cause, which we
believe drives the message of Beauty & Pin-Ups - beauty belongs
to everyone. In fiscal 2016 this contribution totaled $10,157 and
we have accrued $5,339 in fiscal 2017 for a contribution. Kathy
Ireland also serves as a Global Ambassador for Best Buddies
International and she was instrumental in developing
Fearless
with Katie Meade, the first model with
Down Syndrome to be the face of a beauty campaign. Fearless Hair
Rescue Treatment is part of the Beauty & Pin-Ups product
line.
Our
business model is designed with the goal of maximizing the value of
our brands through entry into license agreements with partners that
are responsible for the design, manufacturing and distributing our
licensed products.
|
We expect to promote our brands across multiple
channels, including print, television and social media.
We have allocated up to $5.9 million
of the proceeds from this offering for brand development and
marketing. We believe that this
“omnichannel” (or multi-channel) approach, which we
expect will allow our customers to interact with each of our
brands, in addition to the products themselves, will be critical to
our success. Leveraging our relationship with kathy ireland®
Worldwide, we will seek to maximize the value of our brands by
promoting, marketing and licensing our brands to various
distribution channels for different customer segments. As a
branding and marketing company, our goal is to create brand
names which are recognized by consumers and then utilize that name
recognition to maximize the value of our brands by marketing the
branded products through the licensing agreements with our current
and future partners who will be responsible for the design,
manufacturing and marketing of the licensed products. Our current
licensing agreements provide that the manufacturing, development,
distribution costs and operating costs and expenses of products are
borne by our licensee, and we expect that licensing agreements we
enter into with future partners will be similarly structured. We
believe this business model will enable us to grow our revenues
without significant increases in our operating expenses. In
addition, we are seeking to expand our revenue sources through the
provision of strategic advisory and promotional services leveraging
the experience of the managing directors of our licensing and
entertainment divisions. In furtherance of this goal, between March
2017 and August 2017 we have entered into agreements with several
third parties to provide strategic advisory and promotional
services.
We
will further build and maintain our brand portfolio by acquiring
additional brands directly or through joint ventures or as a
licensee under license agreements, as opportunities arise that we
believe are in our best interests. In assessing potential
acquisitions or investments, we expect to primarily evaluate the
strength of the target brand as well as the expected viability and
sustainability of future royalty streams and its fit within its
targeted segments. We believe that this focused approach will allow
us to effectively screen a wide pool of consumer brand candidates
and strategically evaluate acquisition targets and efficiently
complete due diligence for potential acquisitions. We are not,
however, a party to any agreements or understandings regarding the
acquisition of additional brands or companies and there are no
assurances we will be successful in expanding our brand
portfolio.
We
began our operations in 2015 following our acquisition of certain
assets which comprise our Beauty & Pin-Ups brand. Following the
acquisitions of the membership interests in I'M1 and EE1 in January
2017, we have reorganized our operational structure into our three
current divisions: professional products; licensing; and
entertainment. We reported net sales of $3,395,387 for the nine
months ended June 30, 2017, and net sales of $2,031,562 and $12,542
for fiscal 2016 and fiscal 2015, respectively, and net
losses attributable to common shareholders of $1,400,406,
$3,356,489 and $1,130,847, respectively, for the same
periods.
Market Opportunity
We
seek to establish market opportunities with significant growth
potential as well as those that include industries which have
favorable indicators for customer appeal. Examples of the
industries which we are initially focusing our efforts include
beauty, entertainment experiences and products, pet products,
culinary arts, fitness, nutraceuticals, health and lifestyle
management and baby product offerings.
Our Products and Brands
Professional products division - Beauty & Pin-Ups
Beauty & Pin-Ups was founded in 2015 when we
acquired certain assets related to this brand. The Beauty &
Pin-Ups line currently includes a hair iron and 11 different
products, including shampoos, conditioners, styling and treatment
products. We launched two new products during the first nine months
of fiscal 2017, and we expect to launch an additional three
products during the balance of 2017. Since our launch of the
products, Beauty & Pin-Ups products have been sold principally
through our distribution arrangement with Beauty Systems Group,
which has approximately 1,265 stores, including over 150 franchise
stores, and is one of the largest networks of professional
distributor sales consultants in North America with almost 1,000
consultants. We utilize Beauty Systems Group’s distribution
channel by focusing on marketing and sales to the professional
salon industry. We also distribute Beauty & Pin-Ups through
Paramount Beauty Distributing Associates, Inc. and Ricky’s
NYC. In an effort to expand our distribution, in August 2017 Beauty
& Pin-Ups entered into a distribution agreement with East Coast
Enterprises, Inc., a professional beauty supply product
distributor. By the end of the calendar year 2017, our goal is to
expand to multi channels of beauty distribution, including
wholesale and professional salon distribution, retail, as well as
e-commerce including through our website and customer
websites.
|
|
Licensing division - I’M1
I’M1
is designed to be a lifestyle brand targeted to millennials with a
focus on addressing the needs of the men who take pride in their
appearance. Our goal with this brand is to enter and become a
leader in multiple categories including grooming, personal care,
cologne, accessories, jewelry and apparel. Under the terms of our
Wholesale License Agreement with kathy ireland® Worldwide, we
expect I’M1 to be developed under a broad brand capability
which is aimed at targeting the millennials.
I’M1
was formed in September 2016. Since March 2017 I'M1 has
entered into licensing agreements for the I'M1 mark with several
clients, consulting agreements with several clients for marketing
and branding advisory services, as well as agreements with
additional clients for which brand advisory services are being
provided jointly by I'M1 and EE1.
Mr. Stephen Roseberry, President and a member of
the board of directors of kathy ireland ® Worldwide, and Mr.
Tommy Meharey, Vice President and a member of the board of
directors of kathy
ireland ® Worldwide, are
co-Managing Directors of I’M1. In these roles, Mr. Roseberry is
responsible for developing and executing sales and business
strategies and Mr. Meharey, the “face of I’M1” is
responsible for marketing and brand development. Mr. Jon Carrasco,
Global Creative Director for kathy ireland® Worldwide, also
serves at Global Creative Director for I’M1, and is
responsible for developing and facilitating creative strategies for
I’M1.
Entertainment division - EE1 – Encore Endeavor
One
EE1’s goal is to become a producer and
marketer of multiple entertainment distribution platforms. Our
initial focus is on the production of songbooks/albums, a movie
concept in development stage, and a charter service partnership to
assist in providing a full entertainment experience- travel,
concierge services, tickets and extras for various events,such as
shows, concerts and sporting events. EE1 intends to seek to
cultivate a relationship with its customers and address their needs
and wants by conceptualizing and marketing entertainment related
events and experiences that are in demand, while partnering with
larger companies with expertise in the particular event or
experience that will be responsible for the execution of the
project. We expect to generate revenues from royalty fees with our
partners being responsible for the costs of the project.
Mr. Stephen Roseberry, President and a
member of the board of directors of kathy ireland ® Worldwide,
and Mr. Nic Mendoza, Vice President of kathy ireland ®
Worldwide, are co-Managing
Directors of EE1. In these
roles, Mr. Roseberry is responsible for developing and executing
sales and business strategies and Mr. Mendoza is responsible for
production, marketing and brand development. These individuals enjoy key strategic
relationships with many of the people involved in successful firms
in the live entertainment, publishing, music, film, and television
industries which we expect to leverage to implement EE1’s
business model. Mr. Jon Carrasco, Global Creative Director for
kathy ireland® Worldwide, also serves as Global Creative
Director for EE1 and is responsible for developing and facilitating
creative strategies for EE1.
EE1 seeks to be an “omni-entertainment
experience and brand management” company serving as a
producer and marketer of multiple
entertainment distribution platforms as well as assisting clients
with brand strategies. Our initial focus is on the production of
songbooks/albums, a movie concept in development stage, and a
charter service partnership to help in providing a full
entertainment experience- travel, concierge services, tickets and
extras for various events, such as shows, concerts and sporting
events. EE1 recently coordinated its first travel related event
which involved charter flights and concierge
services.
EE1
provides input, strategies and an architecture for corporate
brands, including:
●
content creation and promotion through social and traditional
media;
●
marketing input;
●
assisting with influencer marketing
programs, a form of marketing in which focus is placed on
influential people rather than the target market as a
whole;
●
providing production capability for video and photo support for
brand advertising; and
●
assisting with brand extension through licensing
opportunities.
|
|
Emerging
Growth Company Status
We are an “emerging growth company” as
defined in the JOBS Act, which permits us to elect not to be
subject to certain disclosure and other requirements that otherwise
would have been applicable to us had we not been an “emerging
growth company.” These provisions include:
|
●
|
reduced disclosure about our executive compensation
arrangements;
|
|
|
●
|
no non-binding advisory votes on executive compensation or golden
parachute arrangements; and
|
|
|
●
|
exemption from the auditor attestation requirement in the
assessment of our internal control over financial
reporting.
|
We may take advantage of these exemptions for up
to five years or such earlier time as we are no longer an
“emerging growth company.” We will qualify as an
“emerging growth company” until the earliest
of:
|
|
●
|
the last day of our fiscal year following the fifth anniversary of
the date of completion of this offering;
|
|
|
●
|
the last day of our fiscal year in which we have annual gross
revenue of $1.0 billion or more;
|
|
|
●
|
the date on which we have, during the previous three-year period,
issued more than $1.0 billion in non-convertible debt;
or
|
|
|
●
|
the last day of the fiscal year in which we become a “large
accelerated filer” as defined in Rule 12b-2 under the
Securities Exchange Act of 1934, as amended, or the “Exchange
Act.”
|
Under this definition, we will be
an “emerging growth company” upon completion of this
offering and could remain an “emerging growth company”
until as late as ____________, 2022.
In
addition, the JOBS Act provides that an emerging growth company can
take advantage of an extended transition period for complying with
new or revised accounting standards. This allows an emerging growth
company to delay the adoption of certain accounting standards until
those standards would otherwise apply to private companies. We have
irrevocably elected not to avail ourselves of this exemption from
new or revised accounting standards and, therefore, we will be
subject to the same new or revised accounting standards as other
public companies that are not emerging growth
companies.
Corporate Information
Our principal executive offices are located at
4521 Sharon Road, Suite 407, Charlotte, NC 28211, and our telephone
number is (704) 445-5800. Our fiscal year end is September 30. The
information which appears on our websites at
www.levelbrands.com and www.beautyandpinups.com are not part of this Offering
Circular.
|
|
Common Stock Offered By Us
|
|
_________ shares.
|
|
|
|
Common Stock Outstanding After This Offering
|
|
_________ shares (or _________ shares if all of the Additional
Shares are sold).
|
|
|
|
Additional Shares
|
|
We have granted the lead selling agent the option, exercisable for
45 days from the date of this Offering Circular, to sell the
Additional Shares.
|
|
|
|
Use of Proceeds
|
|
We plan to use the net proceeds for brand development and
expansion, sales and marketing, and general working capital
including for costs and expenses associated with being a public
company. See “Use of Proceeds.”
|
|
|
|
Risk Factors
|
|
Investing in our securities involves substantial risks. You should
carefully review and consider the “Risk Factors”
section of this Offering Circular beginning on page 14 and the
other information in this Offering Circular for a discussion of the
factors you should consider before you decide to invest in this
offering.
|
|
|
|
Proposed NYSE American Listing
|
|
We
intend to apply to list our common stock on the NYSE American under
the symbol “LEVB.” Our common stock will not commence
trading on the NYSE American until all of the following conditions
are met: (i) the offering is completed; and (ii) we have filed a
post-qualification amendment to the Offering Statement and a
registration statement on Form 8-A under the Exchange Act, and such
post-qualification amendment is qualified by the SEC and the Form
8-A has become effective. Pursuant to applicable rules under
Regulation A, the Form 8-A will not become effective until the SEC
qualifies the post-qualification amendment. We intend to file the
post-qualification amendment and request its qualification
immediately prior to the termination of the offering in order that
the Form 8-A may become effective as soon as practicable. Even if
we meet the minimum requirements for listing on the NYSE American,
we may wait before terminating the offering and commencing the
trading of our common stock on the NYSE American in order to raise
additional proceeds. As a result, you may experience a delay
between the closing of your purchase of shares of our common stock
and the commencement of exchange trading of our common stock on the
NYSE American.
|
The number of
shares of our common stock to be outstanding after this offering is
based on 5,764,668 shares outstanding as of September 14, 2017
and excludes:
●
the sale of up to _______ Additional Shares;
●
the exercise of the selling agents’ warrants to be issued to
the lead selling agents, or its designees;
●
the possible issuance of up to 949,200 shares of our common stock
reserved for issuance under our 2015 Equity Compensation
Plan;
●
the future issuance of 6,667 shares to an employee upon vesting of
an award and the exercise of outstanding options and warrants to
purchase up to 545,476 shares of our common stock; and
●
the vesting of restricted stock awards granted totaling 230,000
shares of our common stock.
|
Summary Historical
Financial Data
The tables below summarize our
financial information for the periods indicated. We derived the
financial information for the nine months ended June 30, 2017 from
our unaudited consolidated financial statements and the financial
information for fiscal 2016 and fiscal 2015 from our audited
consolidated financial statements, both as included elsewhere in
this Offering Circular. You should read the following information
together with the more detailed information contained in
“Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and our financial
statements and the accompanying notes. Our historical results are
not necessarily indicative of the results to be expected in any
future period.
|
|
Nine
months ended
June 30,
2017
|
Fiscal year ended
September 30, 2016
|
Period of inception (March 17,
2015) to September 30, 2015
|
|
|
|
|
Sales
|
$4,199,412
|
$2,631,125
|
$12,542
|
Allowances
|
(804,025)
|
(599,563)
|
0
|
Net
sales
|
3,395,387
|
2,031,562
|
12,542
|
Cost
of goods
|
822,556
|
1,618,432
|
7,618
|
Gross
profit
|
2,572,831
|
413,130
|
4,924
|
Operating
expenses
|
2,536,586
|
4,146,423
|
1,304,109
|
Income
(loss) from operations
|
36,245
|
(3,733,293)
|
(1,299,185)
|
Debt
conversion expense
|
446,250
|
0
|
0
|
Other
than temporary impairment on marketable securities
|
175,000
|
0
|
0
|
Interest
expense
|
500,353
|
154,977
|
14,546
|
Loss before provision for income taxes
|
$(1,085,358)
|
$(3,888,270)
|
$(1,313,731)
|
Provision for income taxes
|
42,250
|
8,000
|
4,000
|
Net
loss
|
$(1,127,608)
|
$(3,896,270)
|
$(1,317,731)
|
Net
gain (loss) attributable to non-controlling interest
|
272,798
|
539,781
|
186,884
|
Net
loss attributable to Level Brands, Inc. common
shareholders
|
$(1,400,406)
|
$(3,356,489)
|
$(1,130,847)
|
Net
loss per share, basic and diluted
|
$(0.34)
|
$(1.13)
|
$(0.59)
|
Weighted
average shares outstanding
|
4,128,541
|
2,980,223
|
1,911,768
|
|
June 30, 2017
(Unaudited)
|
Balance sheet data
|
|
|
Cash
and cash equivalents
|
$398,350
|
$
|
Working
capital
|
$2,414,775
|
$
|
Total
current assets
|
$3,018,380
|
$
|
Total
assets
|
$5,097,622
|
|
Total
current liabilities
|
$603,605
|
$
|
Total
liabilities
|
$657,855
|
|
Accumulated
deficit
|
$(5,949,627)
|
$
|
Total
shareholders’ equity
|
$4,439,767
|
$
|
|
(1)
|
Pro forma information discussed above is unaudited and illustrative
only. Pro forma as adjusted gives effect to (i) the issuance
of ______ shares of common stock since June 30, 2017; and (ii)
the sale of _______ shares of our common stock in this offering at
an initial public offering price of $______ per share, after
deducting the estimated selling agents' commissions and estimated
offering expenses payable by us and the application of the proceeds
therefrom, but giving no effect to the sale of the Additional
Shares.
|
RISK FACTORS
Investing in our common stock involves risks. In addition to the
other information contained in this Offering Circular, you should
carefully consider the following risks before deciding to purchase
shares of our common stock in this offering. The occurrence of any
of the following risks might cause you to lose all or a part of
your investment. Some statements in this Offering Circular,
including statements in the following risk factors, constitute
forward-looking statements. Please refer to “Cautionary
Statement Regarding Forward-Looking Statements” for more
information regarding forward-looking statements.
Risks Related To Our Business
Our limited operating history does not afford investors a
sufficient history on which to base an investment
decision.
Level Brands was formed in March 2015. During
fiscal 2016 and fiscal 2015 our net sales were solely from our
professional products division. We began reporting revenues from
our licensing division and our entertainment division during
the second quarter of fiscal 2017. In September 2018, we entered
into wholesale license agreements for three new brands, including
kathy ireland® Health & Wellness, a newly created brand.
While we are allocating a portion of the proceeds from this
offering for fees and costs associated with these new agreements,
there are no assurances we will be successful in generating net
sales in future periods based upon these new agreements. Our
operations are subject to all the risks inherent in the
establishment of a new business enterprise. The likelihood of
success must be considered in light of the problems, expenses,
difficulties, complications and delays that are frequently
encountered in a newly-formed
company. There can be no assurance that at this time that we will
successfully implement our business plan, operate profitably or
will have adequate working capital to meet our obligations as they
become due. Prospective investors must consider the risks and
difficulties frequently encountered by early stage companies,
particularly in rapidly evolving markets. We cannot be certain that
our business strategy will be successful or that we will
successfully address these risks. In the event that we do not
successfully address these risks, our business, prospects,
financial condition, and results of operations could be materially
and adversely affected and we may not have the resources to
continue or expand our business operations.
We have a history of losses and there are no assurances we will
report profitable operations in future periods.
We
reported net losses to common shareholders of $3,356,489 and
$1,130,847 for fiscal 2016 and fiscal 2015, respectively, and a net
loss to common shareholders of $1,400,406 for the nine
months ended June 30, 2017. Until such time, if ever, that we are
successful in generating profits which are sufficient to pay our
operating expenses it is likely we will continue to report losses
in future periods. Further, historically our revenues have
been attributable to sales from our professional products
division and we did not begin reporting revenues from either our
licensing division or our entertainment division until the second
quarter of fiscal 2017. There are no assurances we will generate
substantial revenues from the new businesses or that we will ever
generate sufficient revenues to report profitable operations or a
net profit.
Our chief executive officer was recently appointed to his
position.
Mr.
Martin A. Sumichrast, chairman of the board, has served as our
chief executive officer and president since September 2016. Mr.
Sumichrast has been a member of our board of directors since
shortly after our formation and has been an active participant in
advising on our business model and operational strategies. Mr.
Sumichrast’s decades long personal relationships with both
Kathy Ireland and Anthony K. Shriver have been instrumental in the
development of our company to date. While Mr. Sumichrast has
significant business management experience, he has limited
operational experience in our particular industry. It is possible
that our expected future growth may be adversely impacted by Mr.
Sumichrast's lack of operating experience in our particular
business segment.
Kathy Ireland is not an officer or director of our company. We are
materially dependent upon our relationships with kathy
ireland® Worldwide and certain of its affiliates. If these
advisory agreements should be terminated or expire, we would be
deprived of the services and our business could be materially
adversely impacted.
While
affiliates of kathy ireland® Worldwide are minority owners of
both I’M1 and EE1, the terms of the operating agreements for
those subsidiaries do not require them to provide any services to
us and our advisory agreement with kathy ireland® Worldwide
expires in February 2018. We have entered into a non exclusive
advisory agreement with kathy ireland® Worldwide, as amended,
which expires in February 2025 under which we engaged it provide
various consulting and advisory services to us. Ms. Ireland serves
in the non-executive role of Chairman Emeritus and Chief Brand
Strategist to us under this agreement. Ms. Ireland is not a member
of our management or board of directors, the title Chairman
Emeritus is an honorary title and she is not a founder or
co-founder of our company. Ms. Ireland provides services to us
solely under the terms of the non exclusive advisory agreement. We
have also entered into advisory agreements with additional
affiliates of kathy ireland® Worldwide, including Messrs.
Roseberry, Carrasco, Meharey and Mendoza, pursuant to which they
provide various management and advisory services to us, including
key operational roles at I’M1 and EE1. None of these services
are provided on an exclusive basis, each of these individuals may
have a conflict of interest in that they have a long term
relationship with Kathy Ireland and have derived substantial income
from kathy ireland® Worldwide and there is no minimum number
of hours which are required to be devoted to us. Our business model
is materially dependent upon our continued relationship with kathy
ireland® Worldwide, Ms. Ireland and her affiliates, including
Messrs. Roseberry, Carrasco, Meharey and Mendoza. If we should lose
access to those relationships or if the reputation of Ms. Ireland
and/or kathy ireland® Worldwide were to be damaged, our
results would suffer and there are no assurances we would be able
to continue to operate our company and develop our brands as
presently planned.
The terms of the various agreements between our company and kathy
ireland® Worldwide contain termination provisions which may
impact on our management's ability to make certain decisions
regarding the operation of our company.
The
master advisory and consulting agreement with kathy ireland®
Worldwide on which we are materially dependent provides that the
agreement is immediately terminable by
kathy ireland® Worldwide if any officers are terminated or
resign, including Mr. Roseberry in his role as President and
co-Managing Director of I'M1 and EE1, or if additional officers are
appointed for each I'M1 and EE1 without the consent of kathy
ireland® Worldwide. The wholesale license agreement for kathy
ireland® Health & Wellness™ contains the right of
kathy ireland® Worldwide to immediately terminate it if
any officers are terminated or removed or additional officers are
appointed with respect to either I'M1 or EE1, or if we compete with
or invest in business that compete with kathy ireland®
Worldwide. We believe our relationship with kathy ireland®
Worldwide and its affiliates is good. It is possible, however, that
our management's ability to make certain operational decisions
which it believes are otherwise in the best interests of our
company could be restricted in future periods if these decisions
could result in triggering the rights of kathy ireland®
Worldwide to terminate any agreement.
Our business
depends on consumer spending patterns.
Our
business is sensitive to a number of factors that influence the
levels of consumer spending, including political and economic
conditions such as recessionary environments, the levels of
disposable consumer income, consumer debt, interest rates and
consumer confidence. Reduced consumer spending on beauty products
could have an adverse effect on our operating results in future
periods.
Substantially all of our net sales have been to a limited
number of customers, the loss of any of which would be materially
adverse to our company.
Substantially
all of our net sales in fiscal 2015, fiscal 2016 and for the first
nine months of fiscal 2017 were attributable to sales to a limited
number of customers. There are no assurances sales to these
customers will continue. While we expect to add additional
customers to our distribution network in the future for our
professional products division, and expand our licensing and
consulting clients in our other divisions, until such time as we
are successful in these efforts, of which there is no assurance,
any significant decrease in sales to any of our customers would
have a material adverse financial effect on our
company.
The majority of our net sales to date in our professional products
division are generated on the basis of purchase orders, rather than
long term purchase commitments; which could adversely affect our
financial position and results of operations.
Our
operating history is not long enough to evaluate the likelihood of
future cancellations or deferments of customer orders related to
product sales in our professional products division. Manufacturers
and distributors are currently contracted on a per order basis. The
lack of long-term purchase commitments creates a risk that product
demand may be reduced if orders are canceled or deferred or, in the
event of unanticipated demand, an inability to timely produce and
deliver our products. We do not have long-term agreements with our
distributors, manufacturers or suppliers and these parties may
disrupt or cancel a purchase order or defer or delay shipments of
our products at any time. Furthermore, because of our inability to
rely on enforceable purchase contracts, and our limited visibility
into future customer demand, actual net sales may be different from
our forecasts, which could adversely affect our financial position
and results of operations.
If we fail to promote and maintain our brands in the market, our
businesses, operating results, financial condition, and our ability
to attract customers will be materially adversely
affected.
Our
success depends on our ability to create and maintain brand
awareness for our product offerings. This may require a significant
amount of capital to allow us to market our products and establish
brand recognition and customer loyalty. Additionally, many of the
companies offering similar products have already established their
brand identity within the marketplace. We can offer no assurances
that we will be successful in establishing awareness of our brands
allowing us to compete in this market. The importance of brand
recognition will continue to increase because low barriers of entry
to the industries in which we operate may result in an increased
number of direct competitors. To promote our brands, we may be
required to continue to increase our financial commitment to
creating and maintaining brand awareness. We may not generate a
corresponding increase in revenue to justify these
costs.
Each of our
I'M1 and EE1 subsidiaries are governed by operating agreements that
require us to distribute amounts to minority members in certain
circumstances. These distributions could reduce the amount of
operating capital we have in future periods.
Under
the terms of the operating agreements for each of Beauty &
Pin-Ups, I’M1 and EE1, Level Brands as the manager of these
entities is responsible for the operations, including the payment
of the operating costs. These costs are then deducted from the
“profits” of the entity and a portion of those amounts,
as determined by the particular operating agreement, will then be
distributed to the members. We own 100% of Beauty &
Pin-Ups and all of the voting interests in I'M1 and EE1. During the
second and third quarters of fiscal 2017 EE1 made a distribution to
its members. Distributions to the members of I'M1 and EE1 will
reduce the amount of working capital available to us and could
adversely impact our liquidity in future periods.
We may never generate any significant royalties under the terms of
the wholesale license agreements with either Nicholas Walker or
Andre Carthen.
In
September 2017, we entered into non-exclusive wholesale license
agreements with two parties, each of which have a preexisting
relationship with kathy ireland® Worldwide. We have agreed to
pay each of the licensors certain amounts as consideration for
these agreements in the form of cash and equity. We will incur
certain additional costs in our efforts to attract and secure
additional licensed products for each of these licensors. Our
future compensation, if any, will be in the form of royalties. In
order for these non-exclusive wholesale license agreements to
provide an economic benefit to our company, we will need to
generate consistent, meaningful royalties from products sold or
manufactured using the marks of these licensors. There are no
assurances we will be successful in our efforts to attract
sub-licensees or that the costs incurred in these efforts will not
exceed our costs in securing these agreements.
Risks Related to Beauty & Pin-Ups and our professional products
division
A decline in the price of, or demand for, any of our business
services or products, would seriously harm our revenues and
operating margins.
Beauty
& Pin-Ups accounted for all of our net sales in fiscal 2015 and
fiscal 2016 and 25.5% of our net sales in the first nine months of
fiscal 2017. We expect to be reliant on revenues from this division
until we are able to begin generating significant revenues and cash
flows from our licensing division and/or our entertainment
division. Consequently, a decline in the sales of price of, or
demand for the Beauty & Pin-Ups product line would seriously
harm our business.
The beauty business is highly competitive, and if we are unable to
compete effectively our results will suffer.
We
face vigorous competition from companies much larger than ours
throughout the world, including multinational consumer product
companies. Almost all of these competitors have much greater
resources than we do and may be able to respond to changing
business and economic conditions more quickly than us. Competition
in the beauty business is based on pricing of products, innovation,
perceived value, service to the consumer, promotional activities,
advertising, special events, new product introductions, e-commerce
and m-commerce initiatives and other activities. It is difficult
for us to predict the timing and scale of our competitors’
actions in these areas. Our ability to compete also depends on the
continued strength of our brands, our ability to attract and retain
key talent and other personnel, the efficiency of our manufacturing
facilities and distribution network, and our ability to maintain
and protect our intellectual property and those other rights used
in our business. As a new company with limited brand recognition,
there are no assurances we will ever be able to effectively compete
in our target markets.
We may be unable to protect our intellectual property rights and/or
intellectual property rights licensed to us, and may be subject to
intellectual property litigation and infringement claims by third
parties.
We
intend to protect our intellectual property through limited patents
and our unpatented trade secrets and know-how through
confidentiality or license agreements with third parties, employees
and consultants, and by controlling access to and distribution of
our proprietary information. However, this method may not afford
complete protection, particularly in foreign countries where the
laws may not protect our proprietary rights as fully as in the
United States and unauthorized parties may copy or otherwise obtain
and use our products, processes or technology. Additionally, there
can be no assurance that others will not independently develop
similar know-how and trade secrets. We are also dependent upon the
owners of intellectual property rights licensed to us under various
wholesale license agreements to protect and defend those rights
against third party claims. If third parties take actions that
affect our rights, the value of our intellectual property, similar
proprietary rights or reputation or the licensors who have granted
us certain rights under wholesale license agreements, or we are
unable to protect the intellectual property from infringement or
misappropriation, other companies may be able to offer competitive
products at lower prices, and we may not be able to effectively
compete against these companies. We also face the risk of claims
that we have infringed third parties’ intellectual property
rights. Any claims of intellectual property infringement, even
those without merit, may require us to:
●
defend against infringement claims which are expensive and time
consuming;
●
cease making, licensing or using products that incorporate the
challenged intellectual property;
●
re-design, re-engineer or re-brand our products or packaging;
or
●
enter into royalty or licensing agreements in order to obtain the
right to use a third party’s intellectual
property.
In the
event of claims by third parties for infringement of intellectual
property rights we license from third parties under wholesale
license agreements, we could be liable for costs of defending
allegations of infringement and there are no assurances the
licensors will either adequately defend the licensed intellectual
property rights or that they would prevail in the related
litigation. In that event, we would incur additional costs and may
deprived from generating royalties from these
agreements.
A disruption in operations or our supply chain could adversely
affect our business and financial results.
We
are subject to the risks inherent in manufacturing our products,
including industrial accidents, environmental events, strikes and
other labor disputes, disruptions in supply chain or information
systems, loss or impairment of key manufacturing sites or
suppliers, product quality control, safety, increase in commodity
prices and energy costs, licensing requirements and other
regulatory issues, as well as natural disasters and other external
factors over which we have no control. If such an event were to
occur, it could have an adverse effect on our business and
financial results.
We are dependent upon suppliers for our raw materials which we
purchase on a per order basis without long term contracts and our
suppliers are dependent on the continued availability and pricing
of raw materials, either of which could negatively affect our
ability to manage costs and maintain profitable operating
margins.
We
currently purchase our raw materials from suppliers with whom we
have no written purchase contracts. Any supplier and any order may
be terminated or rejected by any supplier at any time. Our reliance
on open orders, no preference or assurances from suppliers, and our
reliance on these suppliers, creates a risk that our supply of raw
materials may be interrupted at any time. We may not be able to
timely source another supplier, resulting in delays and decreased
sales. There are no assurances that we will be able to maintain
adequate stockpiles or that we will be able to acquire and
stockpile raw materials at reasonable costs. Our failure to ensure
a steady supply of raw material or any significant interruption in
the supply of raw materials could have a material adverse effect on
our operations and ability to timely fulfill orders, resulting in
lost orders and revenue.
We rely on third-parties to manufacture and to compound our
products, and we have no control over these manufactures and may
not be able to obtain quality products on a timely basis or in
sufficient quantity.
All
of our products are manufactured or compounded by unaffiliated
third parties. We do not have any long-term contracts with any of
these third parties, and we expect to compete with other companies
for raw materials, production and import capacity. If we experience
significant increased demand, or need to replace an existing
manufacturer, there can be no assurance that additional
manufacturing capacity will be available when required on terms
that are acceptable to us, or at all, or that any manufacturer or
compounder would allocate sufficient capacityto us in order to meet
our requirements. In addition, even if we are able to expand
existing or find new sources, we may encounter delays in production
and added costs as a result of the time it takes to engage third
parties. Any delays, interruption or increased costs in the
manufacturing or compounding of our products could have an adverse
effect on our ability to meet retail customer and consumer demand
for our products and result in lower revenues and net income both
in the short and long-term.
Adverse changes in political and economic policies of the PRC
government could negatively affect the production and cost of
certain of our products and damage our business.
Certain
of our products are currently manufactured in China. Accordingly,
our business, financial condition, results of operations and
prospects are affected significantly by economic, political and
legal developments in China and relationships with the United
States. The PRC economy differs from the economies of most
developed countries in many respects, including:
●
the higher level of government involvement and
regulation;
●
the early stage of development of the market-oriented sector of the
economy;
●
the higher rate of inflation;
●
tariffs and the higher level of control over foreign exchange;
and
●
government control over the allocation of many
resources.
Although
the PRC government has in recent years implemented measures
emphasizing the utilization of market forces for economic reform,
the PRC government continues to exercise significant control over
economic growth in China through the allocation of resources,
controlling payment of foreign currency-denominated obligations,
setting monetary policy and imposing policies that impact
particular industries or companies in different ways. Any adverse
change in the economic conditions or government policies in China
or relationship with the United States could have a material
adverse effect on tariffs and the cost or availability of our
products and consequently have a material adverse effect on our
business and prospects.
Like other distributors and manufacturers of beauty products, we
face an inherent risk of exposure to product liability claims in
the event that the use of the products that we sell results in
injury.
While
we believe we are currently materially compliant with regulations
covering our products, we may be subjected to various product
liability claims, including claims that the products we sell
contain contaminants, are improperly labeled or include inadequate
instructions as to use or inadequate warnings concerning side
effects and interactions with other substances. In addition, we may
be forced to defend lawsuits. While to date we have never been
subject to any product liability claim, given our limited operating
history we cannot predict whether product liability claims will be
brought against us in the future or predict the effect of any
resulting adverse publicity on our business. Moreover, we may not
have adequate resources in the event of a successful claim against
us. If our insurance protection is inadequate and our third-party
vendors do not indemnify us, the successful assertion of product
liability claims against us could result in potentially significant
monetary damages. In addition, interactions of our products with
other similar products, prescription medicines and over-the-counter
drugs have not been fully explored. We may also be exposed to
claims relating to product advertising or product quality. People
may purchase our products expecting certain physical results,
unique to beauty products. If they do not perceive expected results
to occur, such individuals may seek monetary
retribution.
Our business may be adversely affected by unfavorable publicity
within the beauty products market.
We
believe that the beauty products market is significantly affected
by national media attention. As with any retail provider, future
scientific research or publicity may not be favorable to the
industry or to any particular product, and may not be consistent
with earlier favorable research or publicity. Because of our
dependence on consumers’ perceptions, adverse publicity
associated with illness or other adverse effects resulting from the
use of our products or any similar products distributed by other
companies and future reports of research that are perceived as less
favorable or that question earlier research, could have a material
adverse effect on our business, financial condition and results of
operations. We are highly dependent upon consumers’
perceptions of the safety and quality of our products as well as
similar products distributed by other companies. Thus, the mere
publication of reports asserting that beauty products may be
harmful or questioning their efficacy could have a material adverse
effect on our business, financial condition and results of
operations, regardless of whether such reports are scientifically
supported or whether the claimed harmful effects would be present
at the dosages recommended for such products.
Our success is dependent upon the successful introduction of our
new products and success in expanding the demand for existing
brands.
We
believe the growth of our net sales is substantially dependent upon
our ability to introduce our products to the public. Our ability to
meet future obligations is dependent in large measure on the
success of our product sales. Subject to the availability of
sufficient capital and the further establishment of effective
distribution channels, we expect to introduce additional products.
The success of new products is dependent upon a number of factors,
including our ability to formulate products that will appeal to
consumers and respond to market trends in a timely manner. There
can be no assurance that our efforts to formulate new products will
be successful or that consumers will accept our new products. In
addition, products experiencing strong popularity and rapid growth
may not maintain their sales volumes over time.
Risks Related to our Subsidiaries, I’M1 and EE1, our
licensing and entertainment divisions
Our subsidiaries I’M1 and EE1 are new entities with a limited
operating history, which does not afford investors a sufficient
history on which to base an investment decision.
I’M1
and EE1 are entities formed in September 2016 and March 2016,
respectively. We acquired membership interests in each of these
entities in January 2017. Both entities are in the early stages of
their businesses and we began reporting revenues from each of these
subsidiaries operations in the second quarter of fiscal 2017. Our
operations are subject to all the risks inherent in the
establishment of a new business enterprise. The likelihood of
success must be considered in light of the problems, expenses,
difficulties, complications and delays that are frequently
encountered in a newly-formed company. There can be no assurance
that at this time that we will operate profitably or will have
adequate working capital to meet our obligations as they become
due. Prospective investors must consider the risks and difficulties
frequently encountered by early stage companies, particularly in
rapidly evolving markets. We cannot be certain that our business
strategy will be successful or that we will successfully address
these risks. In the event that we do not successfully address these
risks, our business, prospects, financial condition, and results of
operations could be materially and adversely affected and we may
not have the resources to continue or expand our business
operations.
We are materially dependent upon the wholesale license agreement
with kathy ireland® Worldwide. If this agreement were to be
terminated, we would be unable to continue to operate
I’M1.
In
January 2017, I’M1 entered into a 10 year wholesale license
agreement with kathy ireland® Worldwide under which we were
granted exclusive royalty free rights to certain marks and
tradenames associated with the I’M1 brand. This agreement may
be immediately terminated upon notice to us if I’M1
terminates, removes or replaces officers, if we cease to be the
manager of I’M1 or if we compete with or invest in a business
that competes with kathy ireland® Worldwide. The restriction
on competition against kathy ireland® Worldwide may limit our
ability to enter into licensing agreements in the future for
products which could impact our revenues in future periods. If
kathy ireland® Worldwide should terminate this wholesale
license agreement, our ability to operate I’M1 under that
brand name would cease and, depending upon the amount of revenues
we are then recognizing from that brand, our results of operations
and liquidity in future periods could be materially adversely
impacted.
The failure of our licensees to adequately produce, market, import
and sell products bearing our brand names in their license
categories, continue their operations, renew their license
agreements or pay their obligations under their license agreements
could result in a decline in our results of
operations.
Our
future revenues from our licensing division will be substantially
dependent on royalty payments made to us under our license
agreements, in addition to compensation under any consulting
agreements we may enter into with the third parties for services by
either our licensing division, our entertainment division, or both.
The failure of our licensees to satisfy their obligations under
these agreements, or their inability to operate successfully or at
all, could result in their breach and/or the early termination of
such agreements, their non-renewal of such agreements or our
decision to amend such, thereby eliminating some or all of that
stream of revenue. It is possible that the milestones to be met
under the terms of licensing agreements may never be achieved which
also could deprive us of additional revenues. There can be no
assurances that we will not lose the licensees under our license
agreements due to their failure to exercise the option to renew or
extend the term of those agreements or the cessation of their
business operations (as a result of their financial difficulties or
otherwise) without equivalent options for replacement. Any of such
failures could reduce the anticipated revenue stream to be
generated by the license agreements. In addition, the failure of
our licensees to meet their production, manufacturing and
distribution requirements, or to be able to continue to import
goods (including, without limitation, as a result of labor strikes
or unrest), could cause a decline in their sales and potentially
decrease the amount of royalty payments (over and above any
guaranteed minimums) due to us. Further, the failure of
our licensees and/or their third party manufacturers, which we do
not control, to adhere to local laws, industry standards and
practices generally accepted in the United States in areas of
worker safety, worker rights of association, social compliance, and
general health and welfare, could result in accidents and practices
that cause disruptions or delays in production and/or substantial
harm to the reputation of our brands, any of which could have a
material adverse effect on our business, financial position,
results of operations and cash flows. A weak economy or
softness in certain sectors including apparel, consumer products,
retail and entertainment could exacerbate this risk. This, in turn,
could decrease our potential revenues and cash
flows.
From time to time we may compete with kathy ireland Worldwide®
in securing advisory or representation agreements with potential
clients for EE1 which may create a conflict of interests for the
managers directors of EE1.
kathy
ireland Worldwide® is an established company which has
significant experience in assisting companies in the promotion and
management of their brands through licensing and advisory
agreements. Affiliates of kathy ireland Worldwide are responsible
for the day to day operations of EE1 and kathy ireland®
Worldwide. Part of EE1's business competes with kathy ireland
Worldwide® in identifying and securing clients for its
advisory services. For example, both EE1 and kathy ireland
Worldwide® are parties to substantial identical representation
agreements with Dada Media, Inc. and David Tutera. These affiliates
will be able to determine which entity, either kathy ireland
Worldwide® or EE1, is referred to the potential client. kathy
ireland Worldwide® has more experience and resources and there
are no assurances that conflicts of interest which may arise will
be resolved in our favor. As a result, it is possible that we may
lose out on potential business opportunities.
We could become a party to litigation involving our licensed
products which could result in additional costs to us. Certain
licensed products may be more likely to lead to product liability
lawsuits than others, which could expose us to additional unknown
risks.
Although
we are not responsible for the manufacturing, sale or distribution
of licensed products, it is possible our company could be named as
a defendant in litigation related to licensed products. Certain
licensed products may, by virtue of the industry in which they are
sold and the governmental regulations to which they are subject,
such as vaping products, could be more likely to be the subject of
litigation than others. Notwithstanding that our standard form of
license agreements requires the licensee to indemnify us against
ligation involving the licensed products and to maintain product
liability insurance policies, it is possible that a licensee may
fail to maintain this coverage during the term of the license
agreement. While we would then have a right to terminate the
license agreement as a result of this breach of its terms, there
are no assurances we would not be required to expend significant
funds and management time defending our company in any potential
product liability insurance claim. There are no assurances that we
would prevail in any such litigation, which could subject us to
judgments and costs of settlements which could adversely impact our
liquidity and results of operations in future periods.
As a result of the intense competition within our targeted
licensees’ markets and the strength of some of their
competitors, we and our licensees may not be able to compete
successfully.
Many
of our targeted trademark licenses are for products in the apparel,
fashion accessories, footwear, beauty and fragrance, home products
and décor, consumer electronics and entertainment industries
in which licensees face intense competition from third party brands
and licensees. In general, competitive factors include quality,
price, style, name recognition and service. In addition, various
fads and the limited availability of shelf space could affect
competition for our licensees’ products. Many of our
licensees’ competitors have greater financial, importation,
distribution, marketing and other resources than our licensees and
have achieved significant name recognition for their brand names.
Our licensees may be unable to compete successfully in the markets
for their products, and we may not be able to compete successfully
with respect to our licensing arrangements.
Our business is dependent on market acceptance of our brands and
the potential future products of our licensees bearing these
brands.
Although
some of our targeted licensees might have guaranteed minimum net
sales and minimum royalties to us, a failure of our brands or of
products bearing our brands to achieve or maintain market
acceptance could cause a reduction of our licensing revenue and
could further cause existing licensees not to renew their
agreements. Such failure could also cause the devaluation of our
trademarks, which are our primary intellectual property, or
“IP”, assets, making it more difficult for us to renew
our current licenses upon their expiration or enter into new or
additional licenses for our trademarks. In addition, if such
devaluation of our trademarks were to occur, a material impairment
in the carrying value of one or more of our trademarks could also
occur and be charged as an expense to our operating
results.
The
industries in which we target to compete, including the apparel
industry, are subject to rapidly evolving trends and competition.
In addition, consumer tastes change rapidly. The licensees under
our licensing agreements may not be able to anticipate, gauge or
respond to such changes in a timely manner. Failure of our
licensees to anticipate, identify and capitalize on evolving trends
could result in declining sales of our brands and devaluation of
our trademarks. Continued and substantial marketing efforts, which
may, from time to time, also include our expenditure of significant
additional funds to keep pace with changing consumer demands, are
required to maintain market acceptance of the licensees’
products and to create market acceptance of new products and
categories of products bearing our trademarks; however, these
expenditures may not result in either increased market acceptance
of, or licenses for, our trademarks or increased market acceptance,
or sales, of our licensees’ products. Furthermore, while we
believe that we currently maintain sufficient control over the
products our licensees’ produce under our brand names through
the provision of trend direction and our right to preview and
approve a majority of such products, including their presentation
and packaging, we do not actually design or manufacture products
bearing our marks, and therefore, have more limited control over
such products’ quality and design than a traditional product
manufacturer might have.
If we are unable to identify and successfully acquire additional
brands and trademarks, our growth may be limited, and, even if
additional trademarks are acquired, we may not realize anticipated
benefits due to integration or licensing difficulties.
A
component of our growth strategy is the acquisition of additional
brands and trademarks. We generally compete with traditional
apparel and consumer brand companies, other brand management
companies and private equity groups for brand acquisitions.
However, as more of our competitors continue to pursue our brand
management model, competition for specific acquisition targets may
become more acute, acquisitions may become more expensive and
suitable acquisition candidates could become more difficult to
find. In addition, even if we successfully acquire additional
trademarks or the rights to use additional trademarks, we may not
be able to achieve or maintain profitability levels that justify
our investment in, or realize planned benefits with respect to,
those additional brands.
Although
we seek to temper our acquisition risks by following acquisition
guidelines relating to the existing strength of the brand, its
diversification benefits to us, its potential licensing scale and
credit worthiness of the licensee base, acquisitions, whether they
be of additional IP assets or of the companies that own them,
entail numerous risks, any of which could detrimentally affect our
results of operations.
Acquisition
of brands or trademarks transactions involve a number of risks and
present financial, managerial and operational challenges,
including: diversion of management’s attention from running
our existing business; unanticipated costs associated with the
target acquisition, appropriately valuing the target acquisition
and analyzing its marketability, increased expenses, including
legal and administrative expenses; integration costs related to the
customer base and business practices of the acquired company with
our own; and adverse effects on our reported operating results due
to possible write-down of goodwill associated with
acquisitions.
When
we acquire IP assets or the companies that own them, our due
diligence reviews are subject to inherent uncertainties and may not
reveal all potential risks. Although we generally attempt to
seek contractual protections through representations, warranties
and indemnities, we cannot be sure that we will obtain such
provisions in our acquisitions or that such provisions will fully
protect us from all unknown, contingent or other liabilities or
costs. Finally, claims against us relating to any acquisition
may necessitate our seeking claims against the seller for which the
seller may not, or may not be able to, indemnify us or that
may exceed the scope, duration or amount of the seller’s
indemnification obligations.
No
assurance can be given with respect to the timing, likelihood or
financial or business effect of any possible transaction. As a
result, there is no guarantee that our shareholders will achieve
greater returns as a result of any future acquisitions we
complete.
We may require additional capital to finance the acquisition of
additional brands and our inability to raise such capital on
beneficial terms or at all could restrict our growth.
We
may, in the future, require additional capital to help fund all or
part of potential acquisitions. If, at the time required, we do not
have sufficient cash to finance those additional capital needs, we
will need to raise additional funds through equity and/or debt
financing. We cannot guarantee that, if and when needed, additional
financing will be available to us on acceptable terms or at all.
Further, if additional capital is needed and is either unavailable
or cost prohibitive, our growth may be limited as we may need to
change our business strategy to slow the rate of our expansion
plans. In addition, any additional financing we undertake could
impose additional covenants upon us that restrict our operating
flexibility, and, if we issue equity securities to raise capital or
as acquisition consideration, our existing shareholders may
experience dilution or the new securities may have rights senior to
those of our common stock.
Risks Related to this Offering and Ownership of Our Common
Stock
There has been no public market for our common stock prior to this
offering, and an active trading market for our common stock may not
develop after this offering. As a result, you may be unable to
resell your common stock at or above the price paid under this
offering, or at all.
Prior
to this offering, there has been no public market for our common
stock, and an active trading market for our common stock may not
develop or be sustained after this offering. Also, the initial
public offering price for our common stock will be determined by
negotiations between us and the representative of the selling
agents and may bear no relationship to the market price for our
common stock after the offering. Furthermore, the market price of
our common stock may decline below the initial public offering
price. As a result of any of the foregoing, you may be unable to
resell your common stock at or above the price you paid under this
offering, or at all, and you may lose part or all of your
investment in our common stock.
Our offering is being conducted on a “best efforts”
basis and does not require a minimum amount to be raised. As a
result, we may not be able to raise enough funds to fully implement
our business plan and our investors may lose their entire
investment.
This
offering is on a “best efforts” basis and does not
require a minimum amount to be raised, excluding any amounts
required for NYSE American initial listing requirements. If we are
not able to raise sufficient funds, we may not be able to fund our
operations as planned, and our growth opportunities may be
materially adversely affected. This could increase the likelihood
that an investor may lose their entire investment.
Until we complete a closing or the offering is terminated, the
proceeds for this offering will be kept in a non interest bearing
escrow and you will not have access to your investment funds or
receive shares of Level Brands common stock.
Although there is
no minimum amount to be raised, we will not hold an initial closing
until such time as we meet the initial listing requirements of the
NYSE American and our common stock is approved for listing on the
NYSE American. Until we complete a closing, the proceeds for the
offering will be kept in an escrow account, except with respect to
those investors using a BANQ online brokerage account. At a
closing, the proceeds will be distributed to us and the associated
shares of our common stock will be issued to the investors in such
shares. If there are no closings or if funds remain in the escrow
account on the Termination Date without any corresponding closing,
the investments for this offering will be promptly returned to
investors, without deduction and generally without interest.
Investors will not have access to their funds held in escrow which
may be for an indeterminable period of time. Furthermore, funds
will be held in a non interest bearing escrow account.
We may not be able to satisfy continued listing requirements of the
NYSE American to maintain a listing of our common
stock.
We must
meet certain financial and liquidity criteria to maintain listing
on the NYSE American. If we fail to meet any of the NYSE
American’s continued listing standards, our common stock may
be delisted. In addition, our board may determine that the cost of
maintaining our listing on a national securities exchange outweighs
the benefits of such listing. A delisting of our common stock from
the NYSE American may materially impair our shareholders’
ability to buy and sell our common stock and could have an adverse
effect on the market price of, and the efficiency of the trading
market for, our common stock. In addition, in order to list, we
will be required to, among other things, file with the SEC a
post-qualification amendment to the offering statement, and then
file an Form 8-A in order to register our shares of common stock
under the Exchange Act. The post-qualification amendment of the
offering statement is subject to review by the SEC, and there is no
guarantee that such amendment will be qualified promptly after
filing. Any delay in the qualification of the post-qualification
amendment may cause a delay in the initial trading of our common
stock on the NYSE American. For all of the foregoing reasons, you
may experience a delay between the closing of your purchase of
shares of our common stock and the commencement of exchange trading
of our common stock. In addition, the delisting of our common stock
could significantly impair our ability to raise
capital.
Investors in this offering will experience immediate and
substantial dilution in the book value of their
investment.
The
initial public offering price of our common stock will be
substantially higher than the net tangible book value per share of
our outstanding common stock immediately prior to this offering.
Therefore, if you purchase our common stock in this offering, you
will incur an immediate dilution of $_____ in net tangible book
value per share from the price you paid, based on an initial public
offering price of $_____ per share. In addition, purchasers who
bought shares from us in this offering will have contributed _____%
of the total consideration paid to us by our shareholders to
purchase shares of our common stock, in exchange for acquiring
approximately _____% of the outstanding shares of our capital stock
as of June 30, 2017 after giving effect to this offering. The
exercise of outstanding options and warrants and the issuance of
additional securities by us will result in further dilution. For a
further description of the dilution that you will experience
immediately after this offering, see the section titled
“Dilution.”
The issuance of shares upon exercise of our outstanding options or,
warrants may cause immediate and substantial dilution to our
existing shareholders.
We
presently have options and warrants that if exercised would result
in the issuance of an additional 467,476 shares of our common
stock. The issuance of shares upon exercise of warrants and options
may result in dilution to the interests of other
shareholders.
The price of our common stock may be volatile, and you could lose
all or part of your investment.
Stock
markets have experienced extreme volatility that has often been
unrelated to the operating performance of particular companies.
These broad market fluctuations may adversely affect the trading
price of our common stock. In addition, limited trading volume of
our stock may contribute to its future volatility. Price declines
in our common stock could result from general market and economic
conditions, some of which are beyond our control, and a variety of
other factors, including any of the risk factors described in this
Offering Circular. These broad market and industry factors may harm
the market price of our common stock, regardless of our operating
performance, and could cause you to lose all or part of your
investment in our common stock since you might be unable to sell
your shares at or above the price you paid in this offering.
Factors that could cause fluctuations in the market price of our
common stock include the following:
●
price and volume fluctuations in the overall stock market from time
to time;
●
volatility in the market prices and trading volumes of hair care
products;
●
changes in operating performance and stock market valuations of
other hair care products companies generally;
●
sales of shares of our common stock by us or our
shareholders;
●
failure of securities analysts to initiate or maintain coverage of
us, changes in financial estimates by securities analysts who
follow our company, or our failure to meet these estimates or the
expectations of investors;
●
the financial projections we may provide to the public, any changes
in those projections or our failure to meet those
projections;
●
rumors and market speculation involving us or other companies in
our industry;
●
actual or anticipated changes in our results of operations or
fluctuations in our results of operations;
●
actual or anticipated developments in our business, our
competitors’ businesses or the competitive landscape
generally;
●
litigation involving us, our industry or both, or investigations by
regulators into our operations or those of our
competitors;
●
developments or disputes concerning our intellectual property or
other proprietary rights;
●
announced or completed acquisitions of businesses or brands by us
or our competitors;
●
new laws or regulations or new interpretations of existing laws or
regulations applicable to our business;
●
changes in accounting standards, policies, guidelines,
interpretations or principles;
●
any significant change in our management; and
●
general economic conditions and slow or negative growth of our
markets.
In
addition, in the past, following periods of volatility in the
overall market and the market price of a particular company’s
securities, securities class action litigation has often been
instituted against these companies. This litigation, if instituted
against us, could result in substantial costs and a diversion of
our management’s attention and resources.
The value of the equity securities we may accept as partial
compensation under consulting agreements will be subject to
adjustment which could result in losses to us in future periods. By
accepting equity securities as partial compensation for our
services, we may be adversely impacting our working capital in
future periods.
As
described elsewhere herein, in March 2017 I'M1 entered into a
consulting agreement with a third party under which we accepted
shares of its common stock as partial compensation for the services
to be provided. In May 2017 as compensation under the terms of an
advisory agreement I'M1 and EE1 received a warrant to purchase
shares of the third party’s stock which was exercised in June
2017. Since then we have entered into similar agreements with
additional clients and it is possible we may enter into similar
arrangements with other third parties. By accepting equity
securities as partial compensation for our services in lieu of
cash, we will be incurring expenses to deliver the services without
the corresponding cash payments from our clients. As such, we will
be utilizing a greater portion of our working capital to provide
services with the hope that we may benefit from an increase in the
market value of the equity securities we have received in future
periods. In addition, these securities will be reflected on our
balance sheets in future periods as “marketable
securities”. At the end of each quarter, we will evaluate the
carrying value of the marketable securities for a decrease in
value. We will evaluate the company underlying these marketable
securities to determine whether a decline in fair value below the
amortized cost basis is other than temporary. If the decline in
fair value is judged to be “other- than- temporary”,
the cost basis of the individual security will be written down to
fair value as a new cost basis and the amount of the write-down is
charged to earnings. As a result of these policies, it is possible
that we may recognize impairments on the carrying value of these
securities in future periods. Any future impairments would
adversely affect our operating results for the corresponding
periods in that we would be required to reduce the carrying value
of these investments.
We may be unable to liquidate securities we accept as partial
compensation under consulting agreements which could adversely
impact our liquidity in future periods.
Our
ability to sell any securities we accept as partial compensation
under consulting agreements is dependent upon a number of factors,
including the existence of a liquid market for the securities and
our compliance with the resale provisions of Federal securities
laws which require us to hold the shares for at least six months,
among other factors. While we expect to generally accept securities
from issuers who are publicly traded or who are expecting to become
a publicly traded company, there are no assurances a liquid market
will exist in such securities at such time as we are able to resell
the shares, or that the price we may receive will be commensurate
with the value of the services we are providing. In that event, we
would not benefit from the expected rise in the market price of the
securities we own as a result of our efforts on behalf of the
client company. In addition, depending upon the terms of our
business relationship with the issuer of the securities, it is
possible that from time to time we could be in possession of
non-public information regarding the issuer which could prohibit us
from disposing of the shares at a time when it is advantageous to
us to do so. If we are unable to readily liquidate any securities
we accept as compensation, we would be deprived of the cash value
of those services and we would be required to write-off the
carrying value of the securities which could adversely impact our
results of operations in future periods.
The Investment Company Act of 1940 will limit the value of
securities we can accept as payment for our business consulting
services which may limit our future revenues.
We
recently accepted securities as partial payment for consulting
services to be rendered by I'M1 and may do so again in the future,
but only to the extent that it does not cause us to become
classified as an investment company under the Investment Company
Act 1940. Although we do not believe we are engaged in the business
of investing, reinvesting or trading in securities, and we do not
currently hold ourselves out to the public as being engaged in
those activities, it is possible that we may be deemed to be an
“inadvertent investment company” under Section
3(a)(1)(C) of the Investment Company Act of 1940, as amended, or
the “ICA”, if more than 40% of our future income and/or
more than 40% of our assets are derived from “investment
securities” (as defined in the ICA), and if we are deemed to
be, or perceived to be, primarily engaged in the business of
investing, reinvesting or trading in securities. If we were deemed
or found to be an investment company by the SEC or a court of law,
then we would face significant consequences and additional
regulatory obligations. For example, registered investment
companies are subject to extensive, restrictive and potentially
adverse regulation relating to, among other things, operating
methods, management, capital structure, dividends and transactions
with affiliates. If it were established that we are an unregistered
investment company, there would be a risk, among other material
adverse consequences, that we could become subject to monetary
penalties or injunctive relief, or both, in an action by the SEC,
that we would be unable to enforce contracts with third parties or
that third parties with whom we have contracts could seek to obtain
rescission of transactions with us undertaken during the period it
was established that we were an unregistered investment company. To
the extent that we are required to reduce the amount of securities
we may accept as payment for consulting services to avoid becoming
an investment company, our ability to maximum our future revenues
from consulting arrangements with potential licensees may be
adversely impacted.
We are an “emerging growth company,” and the reduced
reporting requirements applicable to emerging growth companies may
make our common stock less attractive to investors.
We
are an “emerging growth company,” as defined in the
JOBS Act. For as long as we continue to be an emerging growth
company, we may take advantage of exemptions from various reporting
requirements that are applicable to other public companies but not
to “emerging growth companies,” including, but not
limited to:
●
being permitted to provide only two years of audited financial
statements, in addition to any required unaudited interim financial
statements, with correspondingly reduced “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations” disclosure;
●
not being required to comply with the auditor attestation
requirements in the assessment of our internal control over
financial reporting under Section 404 of the Sarbanes-Oxley Act of
2002, or “Sarbanes-Oxley Act”;
●
not being required to comply with any requirement that may be
adopted by the Public Company Accounting Oversight Board regarding
mandatory audit firm rotation or a supplement to the
auditor’s report providing additional information about the
audit and the financial statements;
●
reduced disclosure obligations regarding executive compensation in
our periodic reports and proxy statements; and
●
exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved.
Investors may find our common stock less
attractive if we choose to rely on these exemptions. If some
investors find our common stock less attractive as a result of any
choices to reduce future disclosure, there may be a less active
trading market for our common stock and the price of our common
stock may be more volatile.
Substantial future sales of our common stock in the public market,
or the perception that these sales may occur, could cause the price
of our common stock to decline, even if our business is doing
well.
Sales
of our common stock in the public market after this offering, or
the perception that these sales may occur, could cause the market
price of our common stock to decline, even if our business is doing
well. All common stock sold in this offering, other than shares
acquired by our affiliates, will be freely transferable without
restriction or additional registration under the Securities Act.
All of the remaining common stock outstanding after this offering
will be available for sale upon the expiration of the 12 month
period following the date of this offering. See “Shares
Eligible For Future Sale” and “Plan of
Distribution” for a detailed description of the lock-up and
Securities Act restrictions. Any or all of our common stock may be
released prior to expiration of the lock-up period at the
discretion of the underwriter. To the extent this common stock is
released before the expiration of the lock-up period and sold into
the market, the market price of our common stock could
decline.
Our executive officers, directors and principal shareholders may
exert control over us and may exercise influence over matters
subject to shareholder approval.
Our
executive officers and directors, together with their respective
affiliates, beneficially owned approximately 36% of our outstanding
common stock as of September 14, 2017, and upon consummation of
this offering, that same group will beneficially own approximately
______% of our outstanding common stock. Accordingly, these
shareholders, if they act together, may exercise substantial
influence over matters requiring shareholder approval, including
the election of directors and approval of corporate transactions,
such as a merger. This concentration of ownership could have the
effect of delaying or preventing a change in control or otherwise
discourage a potential acquirer from attempting to obtain control
over us, which in turn could have a material adverse effect on the
market value of our common stock. For information regarding the
ownership of our common stock by our executive officers and
directors and their affiliates, please see the section entitled
“Security Ownership of Certain Beneficial Owners and
Management.”
Our management will have broad discretion over the use and
investment of the net proceeds received in this offering and might
not apply the proceeds in ways that increase the value of your
investment in our common stock.
Our
management will have broad discretion over the use and investment
of the net proceeds received from this offering, and you will be
relying on, and may not agree with, the judgment of management
regarding the application of these net proceeds. Management intends
to use the net proceeds received from this offering as described in
the section entitled “Use of Proceeds.” The failure by
management to apply these funds effectively may result in financial
losses that could have a material adverse effect on our business
and cause the price of our common stock to decline. Management may
invest the net proceeds received from this offering in a manner
that does not produce income or increase value, which could have a
material adverse effect on our business and cause the price of our
common stock to decline.
If securities or industry analysts do not publish research or
publish unfavorable or inaccurate research about our business, our
common stock share price and trading volume could
decline.
The
trading market for our common stock will depend, in part, on the
research and reports that securities or industry analysts publish
about us or our business. We may be unable to attract or sustain
coverage by well-regarded securities and industry analysts. If
either none or only a limited number of securities or industry
analysts cover us orour business, or if these securities or
industry analysts are not widely respected within the general
investment community, the trading price for our common stock would
be materially and negatively impacted. In the event we obtain
securities or industry analyst coverage, if one or more of the
analysts who cover us or our business downgrade our common stock or
publish inaccurate or unfavorable research about us or our
business, the price of our common stock would likely decline. If
one or more of these analysts cease coverage of us or our business,
or fail to publish reports on us or our business regularly, demand
for our common stock could decrease, which might cause the price of
our common stock and trading volume to decline.
Public company requirements may strain our resources and divert
management’s attention, which could adversely impact our
ability to execute our strategy and harm operating
results.
As
a public company, we will be subject to the reporting requirements
of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall
Street Reform and Consumer Protection Act, which we refer to as
“Dodd-Frank,” the listing requirements of the NYSE
American and other applicable securities rules and regulations.
Despite recent reforms made possible by the JOBS Act, compliance
with these rules and regulations will nonetheless increase our
legal and financial compliance costs, make some activities more
difficult, time-consuming or costly and increase demand on our
systems and resources, particularly after we are no longer an
“emerging growth company.” The Exchange Act requires,
among other things, that we file annual, quarterly, and current
reports with respect to our business and operating results. While
the members of our board of directors have substantial experience
relevant to our business, they have limited experience with
operations as a public company upon which you can base your
prediction of our future success or failure in complying with
public company requirements. Our management may fail to comply with
public company requirements, or may fail to do so effectively and
efficiently, each would materially and adversely harm our ability
to execute our strategy and, consequently, our operating
results.
Furthermore,
as a result of disclosure of information in this Offering Circular
and in filings required of a public company, our business and
financial condition will become more visible, which may result in
threatened or actual litigation, including by competitors and other
third parties. If these claims are successful, our business and
operating results could be harmed, and even if the claims do not
result in litigation or are resolved in our favor, these claims,
and the time and resources necessary to resolve them, could divert
the resources of management and adversely affect our business,
brand and reputation and results of operations. Our new public
company status and these new rules and regulations will make it
more expensive for us to obtain director and officer liability
insurance, and we may be required to accept reduced coverage or
incur substantially higher costs to obtain coverage. These factors
could also make it more difficult for us to attract and retain
qualified members of the board of directors, particularly to serve
on the audit committee and compensation committee, and qualified
executive officers.
If we fail to maintain proper and effective internal controls, our
ability to produce accurate and timely financial statements could
be impaired and investors’ views of us or our business could
be harmed, resulting in the decrease in value of our common
stock.
As
a public company, we will be required to maintain internal control
over financial reporting and to report any material weaknesses in
our internal controls. We are in the process of designing,
implementing and testing the internal control over financial
reporting required to comply with this obligation, which process is
time-consuming, costly and complicated. Our compliance with Section
404 of the Sarbanes-Oxley Act will require us to incur substantial
accounting expense and expend significant management efforts. If we
are unable to comply with the requirements of Section 404 in a
timely manner, or we or our independent registered public
accounting firm identify deficiencies in our internal control over
financial reporting that are deemed to be material weaknesses, the
market price of our common stock could decline and we could be
subject to sanctions or investigations by NYSE Regulation, the SEC
or other regulatory authorities, which would require additional
financial and management resources.
Our
ability to implement our business plan successfully and comply with
Section 404 requires us to be able to prepare timely and accurate
financial statements. We expect that we will need to continue to
improve existing, and implement new, operational and financial
systems, procedures and controls to manage our business
effectively. Any delay in the implementation of, or disruption in
the transition to, new or enhanced systems, procedures or controls,
may cause our operations to suffer and we may be unable to conclude
that our internal control over financial reporting is effective and
to obtain an unqualified report on internal controls from our
auditors when required under Section 404 of the Sarbanes-Oxley Act.
Moreover, we may not implement and maintain adequate controls over
our financial processes and reporting in the future. Even if we
were to conclude, and, when required, our auditors were to concur,
that our internal control over financialreporting provided
reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles, because of our inherent limitations, internal control
over financial reporting may not prevent or detect fraud or
misstatements or omissions.
Because we do not anticipate paying any cash dividends on our
capital stock in the foreseeable future, capital appreciation, if
any, will be your sole source of potential gain.
We
have never declared or paid cash dividends on our capital stock. We
currently intend to retain all of our future earnings, if any, to
finance the growth and development of our business. As a result,
capital appreciation, if any, of our shares of common stock will be
your sole source of gain for the foreseeable future.
We may be subject to securities litigation, which is expensive and
could divert management attention.
The
market price of the shares of our common stock may be volatile, and
in the past companies that have experienced volatility in the
market price of their securities have been subject to securities
class action litigation. We may be the target of this type of
litigation in the future. Securities litigation against us could
result in substantial costs and divert our management’s
attention from other business concerns, which could seriously harm
our business. To the extent that any claims or suits are brought
against us and successfully concluded, we could be materially
adversely affected, jeopardizing our ability to operate
successfully. Furthermore, our human and capital resources of could
be adversely affected by the need to defend any such actions, even
if we are ultimately successful in our defense.
Some provisions of our charter documents and North Carolina law may
have anti-takeover effects that could discourage an acquisition of
us by others, even if an acquisition would be beneficial to our
shareholders and may prevent attempts by our shareholders to
replace or remove our current management.
Provisions
in our articles of incorporation and bylaws, as well as provisions
of North Carolina law, could make it more difficult for a third
party to acquire us or increase the cost of acquiring us, even if
doing so would benefit our shareholders, or remove our current
management. These include provisions that:
●
permit our board of directors to issue up to 50,000,000 shares of
preferred stock, with any rights, preferences and privileges as
they may designate;
●
provide that all vacancies on our board of directors, including as
a result of newly created directorships, may, except as otherwise
required by law, be filled by the affirmative vote of a majority of
directors then in office, even if less than a quorum;
and
●
do not provide for cumulative voting rights, thereby allowing the
holders of a majority of the shares of common stock entitled to
vote in any election of directors to elect all of the directors
standing for election.
These
provisions may frustrate or prevent any attempts by our
shareholders to replace or remove our current management by making
it more difficult for shareholders to replace members of our board
of directors, who are responsible for appointing the members of our
management. In addition, North Carolina has two primary
anti-takeover statutes, the Shareholder Protection Act and the
Control Share Acquisition Act, which govern the shareholder
approval required for certain business combinations. As permitted
by North Carolina law, we have opted out of both these provisions.
Accordingly, we are not subject to any anti-takeover effects of the
North Carolina Shareholder Protection Act or Control Share
Acquisition Act. Any provision of our articles of incorporation,
bylaws or North Carolina law that has the effect of delaying or
deterring a change in control could limit the opportunity for our
shareholders to receive a premium for their shares of common stock,
and could also affect the price that some investors are willing to
pay for our shares of common stock.
USE OF PROCEEDS
We
estimate we will receive net proceeds from this offering of
approximately $[______] million (or $[_____] million if the
Additional Shares are sold in full), assuming an initial public
offering price of $______ per share, after deducting estimated
selling agents' commissions and estimated offering expenses payable
by us.
We currently expect to use the net proceeds of
this offering primarily to fund the continued development of our
company as follows:
●
$515,000 for licensing fees which are due
under license agreements with kathy ireland® Worldwide, Andre
Carthen and Nicholas Walker; (1)
●
approximately $5.9 million for brand development and marketing;
and
●
the remainder for working capital and other general corporate
purposes.
(1)
|
Includes
(i) an aggregate of $410,000 payable to kathy ireland®
Worldwide, a related party, $65,000 payable to Andre Carthen and
$40,000 payable to Nicholas Walker. The terms of these license
agreements are described later in this Offering
Statement.
|
A $______ increase (decrease) in the assumed
public offering price of $____ per share would increase (decrease)
the amount of cash, working capital, total assets and total
shareholders’ equity (deficit) by approximately $________,
assuming the number of shares of common stock offered, as set forth on the cover page of this
prospectus, remains the same and after deducting estimated selling
agents' commissions and estimated offering expenses. Similarly,
each increase (decrease) of ______ shares of common stock
offered would increase (decrease) the
amount of cash, working capital, total assets and total
shareholders’ equity (deficit) by approximately $________,
assuming that the assumed public offering price remains the same,
after deducting estimated selling agents' commissions and estimated
offering expenses. The as adjusted information discussed above is
illustrative only and will be adjusted based on the actual public
offering price and the other terms of this offering determined at
pricing.
The
following table sets forth a breakdown of our estimated use of our
net proceeds as we currently expect to use them, assuming the sale
of, respectively, 100%, 75%, 50% and 25% of the shares of our
common stock (based on an offering amount of
$10,000,000).
Assumed
Percentage of Shares Sold
|
100%
|
75%
|
50%
|
25%
|
Price to
public
|
$10,000,000
|
$7,500,000
|
$5,000,000
|
$2,500,000
|
Selling agent
commissions
|
700,000
|
525,000
|
350,000
|
175,000
|
Other offering
expenses
|
|
|
|
|
Net
proceeds
|
$
|
|
|
|
Licensing
fees
|
$515,000
|
$515,000
|
$515,000
|
$515,000
|
Brand development
and marketing
|
|
|
|
|
Working
capital
|
|
|
|
|
Total use of net
proceeds
|
$
|
|
|
|
We will
allocate the net proceeds to us from the sale of any Additional
Shares to working capital. Our
expected use of net proceeds from this offering represents our
current intentions based upon our plans and business condition. As
of the date of this Offering Circular, we cannot predict with
certainty all of the particular uses for the net proceeds to be
received upon the completion of this offering or the amounts that
we will actually spend on the uses set forth above. The amounts and
timing of our actual use of the net proceeds will vary depending on
numerous factors, including the factors described under the heading
“Risk Factors” in this Offering Circular. As a result,
management will have broad discretion in its application of the net
proceeds, and investors will be relying on our judgment in such
application.
In the event we do not sell all of the shares of common stock
offered hereby, we may seek additional financing from other sources
in order to support the intended use of proceeds indicated above.
If we secure additional equity funding, investors in this offering
would be diluted. In all events, there can be no assurance that
additional financing would be available to us when desired or
needed and, if available, on terms acceptable to
us.
Pending
use of the net proceeds from this offering, we may invest in short-
and intermediate-term interest-bearing obligations,
investment-grade instruments, certificates of deposit or direct or
guaranteed obligations of the U.S. government will adjust based on
the actual initial public offering price and other terms of this
offering determined at pricing.
DIVIDEND POLICY
We
do not currently intend to pay dividends on our common stock. The
declaration, amount and payment of any future dividends on shares
of our common stock, if any, will be at the sole discretion of our
Board, which may take into account general and economic conditions,
our financial condition and results of operations, our available
cash and current and anticipated cash needs, capital requirements,
contractual, legal, tax and regulatory restrictions, the
implications of the payment of dividends by us to our shareholders
or by our subsidiaries to us, and any other factors that our Board
may deem relevant.
CAPITALIZATION
The
following table sets forth our capitalization as of June 30,
2017:
●
on a pro forma basis to give effect to the issuance of __________
shares of common stock since June 30, 2017;
●
on a pro forma as adjusted basis to reflect the sale of ________
shares of common stock in this offering at a public offering price
of $______ per share, after deducting estimated selling agents'
commissions and estimated offering expenses.
You
should read the information in this table together with the section
titled “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” and our
consolidated financial statements and related notes included
elsewhere in this Offering Circular. The data presented in the
following table is for illustrative purposes only, does not purport
to reflect what our actual financial position would have been if
this offering (and the use of proceeds contemplated hereby) had
actually taken place on such date and is not necessarily indicative
of our financial position as of the specified date or in the
future.
|
As of June 30, 2017
(unaudited)
|
|
|
|
Pro-Forma as Adjusted(1)(2)
|
Long-term
debt
|
$0
|
$
|
$
|
|
|
|
|
Preferred
stock, par value $0.001 per share, 50,000,000 shares authorized, no
shares issued and outstanding
|
-
|
|
|
Common
stock, $0.001 par value, 150,000,000 shares authorized; 5,529,568
shares issued and outstanding, actual; [ ] shares issued and
outstanding, pro forma; [________] shares issued and outstanding,
pro forma as adjusted
|
5,530
|
|
|
Additional
paid-in capital
|
9,302,974
|
|
|
Accumulated
deficit
|
(5,949,627)
|
|
|
Total
shareholders (deficit) equity
|
$4,439,767
|
|
|
Total
capitalization
|
$4,439,767
|
$
|
$
|
———————
(1)
|
Each $[________] increase (decrease) in the assumed public offering
price of $[_____] per share would increase (decrease) each of cash,
additional paid-in capital, total shareholders’ equity
(deficit) and total capitalization by approximately $[________],
assuming the number of shares of common stock, as set forth on the
cover page of this Offering Circular, remains the same, and after
deducting estimated selling agents' commissions and estimated
offering expenses. Similarly, each increase (decrease) of [_______]
shares in the number of shares of common stock offered would
increase (decrease) cash, additional paid-in capital, total
shareholders’ equity (deficit) and total capitalization by
approximately $[______], assuming the assumed public offering price
remains the same, and after deducting estimated selling agents'
commissions and estimated offering expenses payable by us. The pro
forma as adjusted information discussed above is illustrative only
and will be adjusted based on the actual public offering price and
other terms of this offering determined at pricing.
|
(2)
Such information excludes:
●
333,300 shares of common stock issuable upon the exercise of
options granted under our 2015 Equity Compensation Plan with a
weighted average exercise price of $5.83 per share;
●
approximately 949,200 shares of our common stock available for
future issuance under our 2015 Equity Compensation
Plan;
●
212,176 shares of our common stock issuable upon the exercise of
outstanding warrants with a weighted average exercise price of
$6.54 per share; and
●
________ shares of common stock issuable upon exercise of the
selling agents' warrants, assuming the issuance of _________ shares
of common stock in this offering.
DILUTION
If
you invest in our common stock, your ownership interest will be
diluted to the extent of the difference between the initial public
offering price in this offering per share of our common stock and
the pro forma as adjusted net tangible book value per share of our
common stock after the consummation of this offering. Net tangible
book value per share represents the book value of our total
tangible assets less the book value of our total liabilities
divided by the number of shares of common stock then issued and
outstanding. As of June 30, 2017, our net tangible book value
(unaudited) was $(_________), or $(____) per share of common stock,
which represents the amount of our total tangible assets less total
liabilities, divided by the number of shares outstanding at June
30, 2017.
After
giving effect to (i) on a pro forma basis to give effect to the
issuance of ________ shares of common stock since June 30, 2017 and
(ii) our sale of _______ shares of our common stock in this
offering at the initial public offering price of $________ per
share, and after deducting estimated selling agents' commissions
and estimated offering expenses payable by us, our pro forma as
adjusted net tangible book value as of June 30, 2017 would have
been $[________], or $[____] per share (assuming no sale of any
Additional Shares). This represents an immediate and substantial
dilution of $[_____] per share to new investors purchasing common
stock in this offering. The following table illustrates this
dilution per share:
Assumed initial public offering price per share
|
$
|
|
$
|
|
|
Net tangible book value per share before this offering
|
|
|
|
|
|
$
|
|
|
Increase in net tangible book value per share attributable to this
offering
|
|
|
|
|
|
$
|
|
|
Pro forma net tangible book value per share after giving effect to
this offering
|
|
|
|
|
|
$
|
|
|
Dilution per share to new investors in this offering
|
|
|
|
|
|
$
|
|
|
If
all of the Additional Shares are sold, the pro forma as adjusted
net tangible book value would be $[__________], or $[____] per
share, and the dilution to new investors participating in this
offering would be $[____] per share. The pro forma information
discussed above is illustrative only and will change based on the
actual initial public offering price and other terms of this
offering determined at pricing.
The
following table summarizes, on a pro forma as adjusted basis as of
June 30, 2017, the differences between the number of shares of
common stock purchased from us, the total price and the average
price per share paid by existing shareholders and by the new
investors in this offering, before deducting estimated selling
agents' commissions and estimated offering expenses payable by us,
at an assumed initial public offering price of $______ per
share.
|
|
|
|
Assuming
100% of shares sold:
|
Number
|
|
|
|
|
Existing
shareholders
|
|
|
$
|
|
$
|
New
investors
|
|
|
$
|
|
$
|
Total
|
|
100.0%
|
$
|
100.0%
|
$
|
In
addition, if all of the Additional Shares are sold, the number of
shares held by existing shareholders will be reduced to [_____]% of
the total number of shares of common stock to be outstanding upon
completion of this offering, and the number of shares of common
stock held by new investors participating in this offering will be
further increased to [____]% of the total number of shares of
common stock to be outstanding upon completion of the
offering.
To the extent that options and warrants are exercised or we issue
additional shares of common stock in the future, there will be
further dilution to investors participating in this offering. In
addition, we may choose to raise additional capital because of
market conditions or strategic considerations, even if we believe
that we have sufficient funds for our current or future operating
plans. If we raise additional capital through the sale of equity or
convertible debt securities, the issuance of these securities could
result in further dilution to our shareholders.
MANAGEMENT’S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
The
following discussion of our financial condition and results of
operations should be read in conjunction with the consolidated
financial statements and the notes to those statements that are
included elsewhere in this Offering Circular. Our discussion
includes forward-looking statements based upon current expectations
that involve risks and uncertainties, such as our plans,
objectives, expectations and intentions. Actual results and the
timing of events could differ materially from those anticipated in
these forward-looking statements as a result of a number of
factors, including those set forth under the Risk Factors,
Cautionary Notice Regarding Forward-Looking Statements and Business
sections in this Offering Circular. We use words such as
“anticipate,” “estimate,”
“plan,” “project,”
“continuing,” “ongoing,”
“expect,” “believe,” “intend,”
“may,” “will,” “should,”
“could,” and similar expressions to identify
forward-looking statements. Our future operating results, however,
are impossible to predict and no guaranty or warranty is to be
inferred from those forward-looking statements.
Overview
Formed
in March 2015, we are positioning Level Brands to be an innovative
branding and marketing company. We intend to focus our efforts on
lifestyle-based brands and entertainment experiences. Our goal is
to create a bold, unconventional and socially responsible image and
consciousness for our businesses. Our mission is overseen by our
Chairman Emeritus and Chief Brand Strategist Kathy Ireland. Our
business strategy is to utilize our relationship with kathy
ireland® Worldwide in order to secure strategic licenses and
joint venture partnerships around the world for our brands, as well
as to grow the portfolio of brands through strategic acquisitions
and as a licensee of third party brands. Our ability to
successfully implement our business strategy is dependent on our
ability to leverage our contractual arrangement with Ms. Ireland
and kathy ireland® Worldwide.
Historically
our revenues are attributable to sales of our Beauty & Pin-Ups
brand of products. With the recent acquisitions of membership
interests in I’M1 and EE1 in January 2017 we expanded our
brand portfolio and our revenue sources to include revenues from
licensing fees, consulting fees and royalties. Following these
acquisitions and the continued implementation of our business
model, we now manage our business as three segments,
including:
●
|
the professional products division, which is a producer and
marketer of quality hair care and beauty products. Revenues from
this division are attributable to sales of our Beauty & Pin-Ups
brand of products;
|
|
|
●
|
the licensing division, which is designed to establish a lifestyle
brand through the licensing of select products and categories
targeted primarily to men under the I'M1 brand; and
|
|
|
●
|
the entertainment division, which is focused on producing and
marketing of multiple entertainment distribution platforms under
the EE1 brand.
|
Utilizing
a portion of the proceeds of this offering we expect to devote
significant assets and efforts to the marketing, development and
promotion of our brands. Both our licensing division and our
entertainment division first began generating revenues from
contractual relationships during the second quarter of fiscal 2017.
We expect each of those divisions to continue to expand their
client base during the balance of fiscal 2017 through additional
licensing and consulting engagements. During fiscal 2017 we also
expect to expand our Beauty & Pin-Ups product line with the
introduction of additional hair care and beauty products in an
effort to extend our sales channels.
As
we continue to implement our business strategy, however, we expect
to encounter hurdles typically encountered by new companies,
operating in a highly competitive environment. By the nature of
licensing agreements, the time between the execution of a licensing
agreement and the launch of the licensed products will vary from
client to client, and it may be some time before we begin
generating royalty revenues. The terms of the various consulting
agreements may also result in inconsistent revenues from period to
period based upon the delivery requirements and timelines of the
services. We believe, however, that over time our business model
will enable us to rapidly grow our revenues while enabling us to
control costs and overhead expenses.
Results of Operations
Three and nine months ended June 30, 2017 compared to the three and
nine months ended June 30, 2016
Net sales
The
following tables provide certain selected consolidated financial
information (unaudited) for the periods presented:
|
Three Months Ended June 30,
|
|
|
|
|
|
|
|
|
|
Sales
|
$1,867,590
|
$492,319
|
$1,375,271
|
Allowances
|
(80,581)
|
(106,833)
|
26,252
|
Net
sales
|
$1,787,009
|
$385,486
|
$1,397,012
|
Cost
of goods sold
|
261,420
|
321,341
|
$(59,921)
|
Gross
profit as a percentage of gross sales
|
81.7%
|
13.0%
|
-
|
Operating
expenses
|
853,670
|
1,485,887
|
(42.7)%
|
Net
loss
|
$(141,909)
|
$(1,439,175)
|
$1,297,266
|
Net
loss attributable to Level Brands, Inc. common
shareholders
|
$(210,690)
|
$(1,206,471)
|
$995,781
|
|
Nine Months Ended June 30,
|
|
|
|
|
|
|
|
|
|
Sales
|
$4,199,412
|
$2,043,491
|
$2,155,921
|
Allowances
|
(804,025)
|
(242,137)
|
561,888
|
Net
sales
|
$3,395,387
|
$1,801,354
|
$1,594,033
|
Cost
of sales
|
822,556
|
1,248,984
|
$(426,428)
|
Gross
profit as a percentage of gross sales
|
61.3%
|
27.0%
|
-
|
Operating
expenses
|
2,536,586
|
3,255,901
|
(22.1)%
|
Net
loss
|
$(1,127,608)
|
$(2,776,557)
|
$1,648,949
|
Net
loss attributable to Level Brands, Inc. common
shareholders
|
$(1,400,406)
|
$(2,324,599)
|
$924,193
|
The following table provide net sales information (unaudited) by
our operating segments for the periods presented:
|
Three Months
Ended June 30,
|
Nine
Months Ended June 30,
|
|
|
|
|
|
|
|
|
|
|
Professional
products division
|
$291,342
|
$385,486
|
$865,890
|
$1,801,354
|
Licensing
division
|
870,667
|
0
|
1,635,667
|
0
|
Entertainment
division
|
625,000
|
0
|
893,830
|
0
|
Total net
sales
|
$1,787,009
|
$385,486
|
$3,395,387
|
$1,801,354
|
We
began reporting our revenues by segment during the three months
ended March 31, 2017 following our acquisitions of I'M1 and EE1.
The following table provides information on the contribution of net
sales by segment to our total net sales for the three and nine
months ended June 30, 2017 (unaudited).
|
% of net sales
by segment to total net sales
|
|
Three months
ended June 30, 2017
|
Nine months
ended June 30, 2017
|
|
|
|
Professional
products division
|
16.3%
|
25.5%
|
Licensing
division
|
48.8%
|
48.2%
|
Entertainment
division
|
34.9%
|
26.3%
|
Professional products division
We launched the Beauty & Pin-Ups products in
September 2015 and subsequently obtained a first order with Beauty
Systems Group in October 2015, which accounted for our largest
sales order to date in this division, and all of our sales in the
nine months ended June 30, 2016. Thereafter, our net sales in this
division have been primarily based on refill orders of the Iron,
Flaunt, Luxe, Fearless, Sway, Fever, and Valor products. Our sales
from this division have not met our internal expectations due
primarily to our historic reliance on Beauty Systems Group as a
principal distributor. While Beauty Systems Group has broad
distribution coverage, it represents a large number of companies
such as ours, many with much greater brand recognition than Beauty
& Pin-Ups. In an effort to
expand our distribution, in August 2017 Beauty & Pin-Ups
entered into a distribution agreement with East Coast Enterprises,
Inc., a distributor of beauty supply products covering the
northeast of the United States. We are continuing to solidify the
Beauty Systems Group sales channel and are also assessing other
channels that we believe will increase our overall visibility in
the marketplace, including other distributors, large retail as well
as a more focused strategy for online and mobile channels. We have
delayed the projected launch of three additional products until
such time as we believe the distribution channels for our current
Beauty & Pin-Ups product line have been more fully developed
and our sales in this division are meeting our internal
expectations.
As
is customary in the wholesale distribution of hair care and beauty
products, we provide our distributors an allowance against the
sales price for advertising and distribution, damaged good, product
development allowance, and a discount if paid within a prescribed
time frame, which is now 30 days for Beauty Systems Group. These
allowances were 21.7% of gross sales of our professional products
division for the three months ended June 30, 2017 and 2016,
respectively, and 48.1% and 11.8%, respectively, for the nine
months ended June 30, 2017 and 2016. The large increase in the
fiscal 2017 periods is related to discounting of hair irons to our
distribution channel in an effort to offer incentives to customers
and move historical products as we prepared to launch new products
in 2017 as well as rollout of a discounted sample sized product as
our entrance into a new distribution channel.
Licensing division
This
division enters into various license agreements that can provide
revenues based on minimum royalties and advertising/marketing fees
and additional revenues based on a percentage of defined sales.
Minimum royalty and advertising/marketing revenue is recognized on
a straight-line basis over the term of each contract year, as
defined, in each license agreement. Royalties exceeding the defined
minimum amounts are recognized as income during the period
corresponding to the licensee’s sales. Payments received as
consideration of the grant of a license are recognized ratably as
revenue over the term of the license agreement and are reflected on
our consolidated balance sheets as deferred license revenue at the
time payment is received and recognized ratably as revenue over the
term of the license agreement. Similarly, advanced
royalty payments are recognized ratably over the period indicated
by the terms of the license and are reflected on our consolidated
balance sheet in deferred license revenue at the time the payment
is received. In regard to sales for advisory and promotional
services provided through a consulting agreement, we record revenue
when the services are provided and the customer is invoiced at
agreed upon rates and terms in the agreement. In the three
months ended June 30, 2017, I’M1 recorded $3,000 of licensing
revenue. It has also delivered strategic marketing and branding
services under multiple advisory agreements and recorded $867,667
of revenues during the three months ended June 30, 2017, of which
$11,666 was deferred revenue recognized in the three months ended
June 30, 2017.
Entertainment division
EE1
recorded consulting / advisory revenue of $511,000 for the three
months ended June 30, 2017, encompassing production assistance
related to content development for two television shows, initial
production phase for a music recording project, and brand
development services for a customer. Additional consulting revenue
of $114,000 for the three months ended June 30, 2017 was earned at
the corporate level and is included in the entertainment division
segment. This was revenue earned as a referral fee from kiWW for
business it earned from introductions by us for a business
opportunity.
Cost of sales
Our
cost of sales includes costs associated with distribution, external
fill and labor expense, components, and freight for our
professional products divisions, and includes labor and third party
service providers for our licensing and entertainment divisions.
Cost of sales as a percentage of net sales was 14.6% as compared to
83.4% in the three months ended June 30, 2017 and 2016,
respectively, and was 24.2% and 69.3% for the nine months ended
June 30, 2017 and 2016, respectively. In order to explain the
change in cost of sales we must account for the two new divisions
and look at each division separately to see the cumulative
impact.
In
our professional products division, our cost of sales on this
division’s net sales was 66.7% and 83.4% for the three months
ended June 30, 2017 and 2016 and was 75.6% and 69.3% for the nine
months ended June 30, 2017 and 2016, respectively. Cost of sales
variances are primarily related to two key impacts. First,
allowances from this division have varied significantly based on
the product line being new and various advertising and promotional
packages have been used to promote the products. Second, with the
initial Beauty & Pin-Ups product launch, we had incurred
significantly higher shipping and logistics expenses primarily as
the result of minimum orders required by our vendors for our
initial orders, and we also incurred charges for expedited
processing to meet our first order deadlines. As we continue to
refine our operations, we expect our cost of sales to decrease,
thereby increasing our gross profit, as we expect to be able to not
offer as many promotional packages, manage the production of our
product lines more efficiently procuring various materials used in
our process with better pricing as well as having a more effective
inventory management control process.
In
our licensing division, our cost of sales for the three and nine
months ended June 30, 2017, was 3.5% and 1.7% respectively, of its
net sales. We expect this division to have a low cost of sales as
the business is structured in a manner that the licensee incur the
significant costs and revenues associated with the sale oflicensed
products, we only recognize the associated royalty fees on a net
basis.
In
our entertainment division, our cost of sales for the three and
nine months ended June 30, 2017 was 5.9% and 17.4% respectively, of
its net sales. The cost of sales for this division will vary based
upon the type of projects in which it is involved. For instance,
its cost of sales is expected to be less for advisory services,
which utilize internal resources, as compared to television
production services which require the use of external facilities
and personnel. As a result, our gross margin for the entertainment
division will vary from period to period.
Operating expenses
Our
operating expenses include wages, advertising, travel, rent,
professional service fees, and expenses related to industry
distribution and trade shows. Our operating expenses decreased
42.5% for the three months ended June 30, 2017 from the comparable
period in fiscal 2016, and decreased 22.1% for the first nine
months of fiscal 2017 from the comparable period in fiscal 2016.
During the three months ended June 30, 2017 as compared to the
three months ended June 30, 2016, expenses related to social media,
public relations, advertising and marketing process, tradeshows,
and promotions decreased approximately $46,000, our travel and
entertainment expenses decreased approximately $61,000, our
professional outside services related to product formulation,
design, marketing and tradeshow expenses decreased approximately by
$9,000, our rent expense decreased $70,000, and commissions paid to
an outside sales consultant decreased approximately $53,000. The
decrease during the third quarter of fiscal 2017 was partially
offset by certain increases in operating expenses during such
period, mostly due to costs related to startup of our two new
subsidiaries and accounting and legal costs related to our audits
and the SEC registration process. During the three months ended
June 30, 2017 as compared to the three months ended June 30, 2016
our staff related expenses increased approximately $45,000 as we
added executive management and management over our licensing and
entertainment divisions. In addition, during the three months ended
June 30, 2017, our accounting and legal expenses increased by
approximately $92,000, over the three months ended June 30, 2016,
as we have engaged independent auditors for our fiscal audits and
quarterly reviews as well as counsel for our SEC registration
process. During the three months ended June 30, 2017 we had a
non-cash expense of $56,924 related to the issuance of restricted
stock awards to our board members as well as for options issued to
employees, however in the three months ended June 30, 2016 we had a
non-cash expense of $225,000 related to the issuance of stock to
the designated charity of our professional products
division.
Our
operating expenses for the nine months ended June 30, 2017 from the
comparable period in fiscal 2016 decreased approximately $198,000
for expenses related to social media, public relations, advertising
and marketing process, tradeshows, and promotions, decreased
approximately $153,000 for travel and entertainment expenses,
decreased approximately $102,000 for professional outside services
related to product formulation, design, marketing and tradeshow
expenses, and decreased approximately $136,000 for commissions paid
to an outside sales consultant. During this period we also had a
decrease in outside management fees of $180,000 under two
engagements, one with kathy ireland® Worldwide and one with
Stone Street Partners, LLC, of which both ended in September 2016.
These decreases were offset by our staff related expenses which
increased approximately $169,000 and our accounting and legal
expenses which increased by approximately $411,000. During the nine
months ended June 30, 2017, we had a non-cash expense of
approximately $149,182 related to the issuance of restricted stock
awards to our board members as well as for options issued to
employees. The operating expenses breakout as related to our
divisions are discussed below.
Professional products division
Operating
expenses in the professional products division were approximately
$483,000 and $1,113,000 for the three months ended June 30, 2017
and 2016, respectively, a decrease of 56.6%. Operating expenses for
these periods, respectively, include staff related expenses which
were approximately $125,000 and $72,000, accounting and legal
expenses of approximately $23,000 and $16,000, expenses related to
social media, public relations, advertising, marketing, promotions
and tradeshow of approximately $116,000 and $194,000, travel and
entertainment expenses of approximately $46,000 and $116,000,
professional outside services related to product formulation,
design, and marketing expenses of approximately $20,000 and
$66,000, and commissions paid to an outside sales consultant of
approximately $1,000 and $54,000 respectively. In addition, for the
three months ended June 30, 2016 we had management fees of
approximately $125,000 that we did not have in the comparable
period for 2017.
Operating
expenses in the professional products division were approximately
$1,436,000 and $2,573,000 for the nine months ended June 30, 2017
and 2016, respectively, a decrease of 44.2%. Operating expenses for
these periods respectively, include staff related expenses which
were approximately $428,000 and $188,000, accounting and legal
expenses of approximately $176,000 and $32,000, expenses related to
social media, public relations, advertising, marketing, promotions
and tradeshow of approximately $242,000 and $477,000, travel and
entertainment expenses of approximately $107,000 and $243,000,
professional outside services related to product formulation,
design, and marketing expenses of approximately $133,000 and
$257,000, and commissions paid to an outside sales consultant of
approximately $38,000 and $174,000. In addition, for the nine
months ended June 30, 2016 we had initial product launch expense
with our distributor of approximately $132,000 and management fees
of approximately $382,000, of which we had neither in the
comparable period for 2017.
Licensing division
Operating expenses in the licensing division were
approximately $624,000 in the three months ended June 30, 2017.
There is no comparative 2016 period. Operating expenses
include subcontract fees of $15,000, accounting and legal expenses
of approximately $17,000, expenses related to social media, public
relations, and tradeshow of approximately $11,000. We had referral
fees of $528,000 paid to our corporate entity for two large
contracts and internal management fees also to corporate of
$45,000.
Operating expenses in the licensing division were
approximately $775,000 in the nine months ended June 30, 2017.
There is no comparative 2016 period. Operating expenses include
subcontract fees of $57,000, accounting and legal expenses of
approximately $25,000. Expenses related to social media, public
relations, and tradeshows of approximately $13,000 and division
startup expenses of $100,000. We had referral fees of $528,000 paid
to our corporate entity for two large contracts and internal
management fees also to corporate of $45,000. . We expect to continue to allocate
corporate management fees to this division in future periods,
however, the amount of such fees will vary depending upon the
amount of time devoted by our senior management to this
division.
The
corporate charges eliminate upon consolidation of our financial
statements.
Entertainment division
Operating
expenses in the entertainment division were approximately $339,000
in the three months ended June 30, 2017. There is no comparative
2016 period. Operating expenses include subcontract fees
of $30,000, accounting and legal expenses of approximately $14,000.
Expenses related to social media, public relations, and tradeshows
of approximately $21,000. We had referral fees of $228,000 paid to
our corporate entity for one large contract and internal management
fees also to corporate of $45,000.
Operating expenses in the entertainment division
were approximately $475,000 in the nine months ended June 30, 2017.
There is no comparative 2016 period. Operating expenses include
subcontract fees of $58,000, accounting and legal expenses of
approximately $19,000. Expenses related to social media, public
relations, and tradeshows of approximately $23,000 and division
startup expenses of $100,000. We had referral fees of $228,000 paid
to our corporate entity for one large contract and internal
management fees also to corporate of $45,000 As with our licensing
division, we expect to continue to allocate corporate
management fees to this division in future periods, however, the
amount of such fees will vary depending upon the amount of time
devoted by our senior management to this division.
The
corporate charges eliminate upon consolidation of our financial
statements.
Interest expense and other non-operating expenses
Our
interest expense increased 1,385% for the third quarter of fiscal
2017 from the comparable period in fiscal 2016, and 646% for the
nine months ended June 30, 2017 as compared to the nine months
ended June 30, 2016. The increases in both periods is related to
increased borrowings under the 8% convertible promissory notes
issued and sold in October 2016. The 8% convertible promissory
notes were converted to equity as of June 30, 2017, and upon
conversion we accelerated the unamortized debt discount and debt
issuance fees and have recorded interest expense of $107,457 and
$205,959 for the three and nine months ended June 30, 2017,
respectively, these were non-cash charges.
In
addition, we accounted for a conversion inducement in accordance
with ASC 470-20 on the conversion price reduction from $5.00 to
$3.95 per share and recorded a non-cash debt conversion expense of
$446,250 in the consolidated statement of operations. This is a
one-time non-cash charge. We also sold marketable securities we had
received from a customer for services. In this transaction, we
determined that an other-than-temporary impairment on securities of
$175,000 occurred and recorded the loss in earnings.
Net loss and net loss attributable to our common
shareholders
Our
net loss for the three months ended June 30, 2017 decreased 90.1%
to $(141,909) as compared to a net loss of $(1,439,175) in the
three months ended June 30, 2016. Likewise, our net loss for the
nine months ended June 30, 2017 decreased 59.4% to $(1,127,608) as
compared to $(2,776,557) for the nine months ended June 30,
2016.
Each
of our subsidiaries had minority members as of June 30, 2017 and/or
2016. At June 30, 2017 and 2016, we owned 100% and 78% of the
membership interests of Beauty & Pin-Ups respectively, and at
June 30, 2017 we owned 100% of the voting interests in each of I'M1
and EE1 and 51% membership interest in each of I’M1 and EE1.
As such we account for the noncontrolling interest in each of
I’M1 and EE1 based on their gains or losses. Based on the
noncontrolling interest for these entities, this can have a
negative impact on the gains or losses to our
shareholders.
After
allocating a portion of the net gain to the noncontrolling
interests in accordance with generally accepted accounting
principles, our net loss decreased 82.5% for three months ended
June 30, 2017 from the three months ended June 30, 2016, and
decreased 39.7% for the nine months ended June 30, 2017 from the
comparable period in fiscal 2016.
In
some cases, we may, from time to time, enter into contracts
where all or a portion of the consideration provided by the
customer in exchange for our services is stock, options or
warrants. In accepting equity positions, we have a risk that
the value of the consideration provided could decline and require
an impairment charge to be recorded in non-operating income in the
consolidated statement of operations.
Fiscal 2016 Compared to Fiscal 2015
Our
results of operations described below includes revenues and
expenses associated with our Beauty & Pin-Ups subsidiary, which
now comprises our professional products division, for the entire
fiscal year of 2016 and from March 17, 2015 (date of inception) to
September 30, 2015 as the company started operations in March
2015.
|
|
|
|
Sales
|
$2,631,125
|
$12,542
|
$2,618,583
|
Allowances
|
(599,563)
|
-
|
599,563
|
Net
sales
|
$2,031,562
|
$12,542
|
$2,019,020
|
Gross
profit as a percentage of net sales
|
20.3%
|
39.3%
|
(19.0)%
|
Operating
expenses
|
$4,146,423
|
$1,304,109
|
218%
|
Net
loss
|
$(3,896,270)
|
$(1,317,731)
|
$2,578,539
|
Net
loss attributable to Level Brands, Inc. common
shareholders
|
$(3,356,489)
|
$(1,130,847)
|
$(2,225,642)
|
Following
our formation in March 2015 and the acquisition of the Beauty &
Pin-Ups business described elsewhere in this Offering Circular, our
efforts in fiscal 2015 were devoted to the launch of the new Beauty
& Pin-Ups product line which included branding and packaging,
the establishment of a distribution channel with Beauty Systems
Group, and initial organizational and capital raising activities.
We began generating revenue at the beginning of fiscal 2016.
Substantially all of these sales were made through Beauty Systems
Group and primarily consisted of the following products: The Iron
(approximately 19% of net sales, Fearless (approximately 12% of net
sales), Lavish and Flaunt (each at approximately 8% of net sales),
Fierce (approximately 7% of net sales), Valor, Luxe, Sway, and
Fever (each at approximately 5% of net sales) and approximately 27%
coming from a variety of promotional packages, salon and gift box
sets. Subsequent to the end of fiscal 2016, we have continued to
establish and solidify the Beauty Systems Group sales channel and
are now assessing other channels that we believe will increase our
overall visibility in the marketplace, including large retail and a
more focused strategy for online and mobile channels.
These
allowances to distributors were 22.8% of revenues in 2016. For 2015
we had no allowances as our sales process was not in
place.
Cost
of sales as a percentage of net sales was 79% in fiscal 2016 as
compared to 61% in fiscal 2015. As we continue to scale, we expect
our cost of sales to decrease, thereby increasing our gross profit,
as we expect to be able to manage the production of our product
lines more efficiently procuring various materials used in our
process with better pricing as well as having a more effective
inventory management control.
Our operating expenses were 202% of
net sales in fiscal 2016, and they increased over the 2015 fiscal
year by $2,842,314. For fiscal 2015 we had virtually no sales and
therefore our operating expenses were 10,398% of net sales. Most of
the operating expenses in fiscal 2015 were attributable to
establishment and organization of our company and the initial
staff, costs associated with filing patents for the intellectual
property, establishing the brand, presentation, platform, and
strategy for the future. This included expenses related to
management, creative, and marketing fees, as well as legal and
accounting expenses. In fiscal 2016 we built the infrastructure for
the company by establishing a robust social media, public
relations, advertising and marketing process, and promotions, which
increased our expenses by $243,000. In addition, we added
additional staff to our sales support and marketing team, an
increase in expense of $412,000. During fiscal 2016 our operating
expenses also included costs associated with the full launch of the
Beauty & Pin-Ups brand, setup and attendance at multiple trade
shows, and participation in a one-time beauty television event,
which was an increase in expense over the prior fiscal year by
approximately $737,000. Costs related to our Beauty Supply Group
distribution channel including promotions, commissions, and travel
accounted for an increase in expense of $275,000. Legal and
accounting expenses increased by $71,000. In addition, we incurred
a non-cash expense of $225,000 through the issuance of common
stock, when we made a strategic and social conscious decision to
establish a relationship between Best Buddies International and
Beauty & Pin-Ups. Level Brands as the corporate parent provides
all operational back office support, including human resources,
accounting, and legal, for our subsidiaries, with the goal of
creating efficiencies in process and expenses related to these
areas. Specific expenses related to a specific subsidiary will be
allocated to the subsidiary, and all other general company expenses
at the corporate parent level will be allocated to the subsidiaries
on a pro rata basis based on gross sales.
Our
net loss in fiscal 2016 increased 196% to $(3,896,270) as compared
to our net loss of $(1,317,731) in fiscal 2015. At September 30,
2016 and 2015 we owned 78% of the membership interests of Beauty
& Pin-Ups. After allocating a portion of the net loss to these
noncontrolling interests in accordance with generally accepted
accounting principles, our net loss increased 197% for fiscal 2016
from fiscal 2015.
Liquidity and Capital Resources
We had cash on hand of $398,350 and working
capital of $2,414,775 at June 30, 2017 as compared to cash on hand
of $34,258 and working capital deficit of $947,766 at September 30,
2016. Our current assets increased 215.6% at June 30, 2017 from
September 30, 2016, and is primarily attributable to an increase of
cash, accounts receivable, marketable and other securities and
inventory, offset by a decrease in prepaid expenses. Our
current liabilities decreased 68.3% at June 30, 2017 from September
30, 2016. This decrease is primarily attributable to decreases in a
line of credit, notes payable, and interest payable which were all
converted to equity in June 2017. These were offset by increases in
accounts payable and deferred revenue. Both the changes in our
current assets and current liabilities are also reflective of the
further development of our business during the first nine months of
fiscal 2017. In January 2017, we acquired membership
interests in two new segments, which had an impact on our current
assets as the new segments have generated significant revenue
compared to prior periods, which has increased our accounts
receivables, marketable and other securities (as we have received
from customers their public or private stock as compensation for
services delivered). In addition, during the first quarter of 2017
our liabilities had increased approximately $1.6 million based on
promissory convertible notes sold in October 2016. However, these
notes were converted by the holders into shares of our common stock
during the third quarter of 2017, and we recorded equity and
expenses as required and reflected in our financial statements as
of June 30, 2017.
During
the nine months ended June 30, 2017 we used cash primarily to fund
our operating loss in addition to increases in our inventory,
accounts receivable, marketable and other securities. We offer net
30 day terms and our receivables generally turn every 51
days.
We
do not have any commitments for capital expenditures. We have been
dependent upon sales of our securities and loans from related
parties to provide working capital for our operations. In fiscal
2017, we raised net proceeds of $201,450 from the sale of our
securities. During fiscal 2016 and fiscal 2015 we raised net
proceeds of $1,984,747 and $2,280,066 respectively, from the sale
of our securities.
In
August 2015, we entered into a one year $1,000,000 revolving line
of credit agreement with LBGLOC, LLC, a related party. Under the
terms of the agreement, we pay interest on any amounts advanced at
the rate of 10% per annum. We granted LBGLOC, LLC a blanket
security agreement on our inventory and accounts receivables as
collateral for amounts advanced under the credit line. As
additional consideration for granting the credit line, we issued
the lender 16,000 shares of common stock valued at $32,000. The
agreement was renewed for an additional one year period on August
7, 2016. As additional consideration for renewing the credit line,
we issued the lender 14,000 shares of common stock valued at
$105,000. The outstanding balances due under the credit line was
$593,797 and $893,797 at March 31, 2017 and September 30, 2016,
respectively. In June 2017 the lender converted $773,177 due under
the line of credit, representing outstanding principal and accrued
but unpaid interest, into 195,740 shares of our common stock at a
conversion price of $3.95 per share in full satisfaction of these
obligations. Upon this conversion, the security interest we had
previously granted in our assets was released.
In
October 2016, we issued and sold the aggregate principal amount of
$2,125,000 of our 8% convertible promissory notes to accredited
investors, and in connection with the issuance of the notes issued
warrants to purchase shares of our common stock. After the offering
costs, we used these proceeds for business development and general
working capital. Effective June 30, 2017, the note holders agreed
to convert the principal amount of $2,125,000 and all accrued
interest of $127,500 into 570,254 shares of our common stock at a
conversion price of $3.95 per share.
We
own 51% of the membership interests of each of I'M1 and EE1 and
100% of Beauty & Pin-Ups at June 30, 2017. We acquired the
remaining 12% membership interest in Beauty & Pin-Ups in April
2017. We are the manager, have sole voting interests and fund all
of the operating expenses for each of these entities. Under the
terms of the operating the agreements, the minority owners of each
I'M1 and EE1 are entitled to their pro-rata share of a distribution
of the available cash and adjusted taxable income for each of the
entities. The structure of the operating agreements may increase
our need for cash for operations and could adversely impact our
results of operations in future periods. In fiscal year 2017, EE1
distributed $59,550 to its two members for quarterly tax planning
purposes, of which $30,370 was distributed to us and $29,180 was
distributed to EE1 Holdings. The companies have determined that
going forward, distributions for tax purposes will be assessed on
an annual basis and addressed based on cash flow and the ability to
make these distributions without impacting the
business.
While
we do not have any long-term capital commitments, we do have a
lease commitment which is less than 12 months. We have sufficient
working capital to fund our operations, but need additional working
capital to fund our expected growth. We are dependent upon the
proceeds of this offering to provide sufficient funds for those
purposes. We assume that the proceeds from this offering will
satisfy our working capital needs for the foreseeable
future.
Our goal from a liquidity perspective is to use operating cash
flows to fund day to day operations. To date, we have not met this
goal as cash flow from operations has been a net use of $1,417,352
and $2,897,254 for the nine months ended June 30, 2017 and the year
ended September 30, 2016, respectively. We are dependent upon the
proceeds from this offering to provide sufficient capital to fully
expand our operations to a level which we believe will be able to
fund our operating expenses. In an effort to increase our revenues
pending the completion of this offering, we are focusing on the
areas of the business which we believe have the most opportunity
for revenue growth, including expanding our distribution channels
for Beauty & Pin-Ups. In addition, we continue to assess all
areas of operations for cost improvements and efficiencies and, as
indicated in the results of operations discussed above; we have
decreased many of the day to day business expenses in an effort to
conserve our cash resources. Our accounting and legal expenses have
been a significant area of increase related to the audit of our
financial statements and costs associated with this offering.
Additionally, during the first nine months of fiscal 2017 we
incurred non-cash expenses of $197,420 related to stock
compensation and options, $305,800 for amortization of debt
discounts and debt issuance fees related to financings, a one-time
non-cash charge of $446,250 of debt conversion expense related to
conversion of the convertible promissory notes, and a non-cash
charge of $175,000 as an other than temporary impairment on
securities.
Initially, our
operational focus was limited to product development, re-branding and launching new
products under our Beauty & Pin-Ups line. During fiscal 2016 we
expended significant resources in these efforts for this product
line. While we believe we have experienced certain initial
successes with our Beauty & Pin-Ups line, our competitors in
the hair care and beauty products segment are generally better
capitalized than our company and have far greater brand recognition
with consumers and salons. We believe that as we are able to
execute on the evolution of our business model to a marketing and
branding company, we will be able to
use the brand management expertise at our disposal through our
relationship with kathy ireland® Worldwide to continue to grow
our portfolio of brands and generate new revenue streams without
significantly changing our infrastructure, thereby reducing our
working capital needs in future periods.
Critical Accounting Policies
The preparation of financial statements in
conformity with U.S. GAAP requires management to make estimates and
assumptions that affect the reported amount of assets and
liabilities, the disclosure of contingent assets and liabilities
and the reported amounts of revenue and expenses during the
reported periods. The more critical accounting estimates include
estimates related to doubtful accounts, inventory obsolescence,
depreciation of property and equipment, valuation of intangible
assets, valuation of warrants, options and other complex equity
transactions, and valuation allowance for deferred income tax
assets. We also have other key accounting policies, which involve
the use of estimates, judgments and assumptions that are
significant to understanding our results, which are described in
Note 1 to our audited consolidated financial statements appearing
elsewhere in this Offering Circular. We believe that the following critical accounting
policies involve the more significant judgments and estimates used
in the preparation of our consolidated financial statements and are
the most critical to aid you in fully understanding and evaluating
our reported financial results.
Common Stock
We
are currently a private company and as such there is no market for
shares of our common stock. We value a share of common stock based
on recent financing transactions that include the issuance of
common stock at a specified price. In the event, however, there is
not a recent and significant equity financing transaction or the
nature of the business has significantly changed subsequent to an
equity financing, we will use valuation techniques, which could
include discounted cash flow analysis, comparable company review,
and consultation with third party valuation experts to assist in
estimating the value of our common stock.
Accounts Receivable
Accounts receivable
are stated at cost less an allowance for doubtful accounts, if
applicable. Credit is extended to customers after an evaluation of
customer’s financial condition, and generally collateral is
not required as a condition of credit extension. Management’s
determination of the allowance for doubtful accounts is based on an
evaluation of the receivables, past experience, current economic
conditions, and other risks inherent in the receivables portfolio.
As of June 30, 2017, all receivables were considered by management
to be fully collectible.
In
addition, we may, from time to time, enter into contracts
where a portion of the consideration provided by the customer in
exchange for our services is stock, options or warrants. In
these situations, upon invoicing the customer for the stock or
other equity instruments, we will record the receivable as accounts
receivable other, and use the value of the stock or other equity
instrument upon invoicing to determine the value. Where an accounts
receivable is settled with the receipt of the stock or other equity
instrument, the stock or other equity instrument will be classified
as an asset on the balance sheet as either an investment marketable
security (when the customer is a public entity) or as an investment
other security (when the customer is a private
entity).
Marketable Securities
At the
time of acquisition, the marketable security is designated as
available-for-sale as the intent is to hold for a period of time
before selling. Available-for-sale securities are carried at fair
value on the consolidated statements of financial condition with
changes in fair value recorded in the accumulated other
comprehensive income component of shareholders’ equity in the
period of the change in accordance with ASC 320-10. Upon the
disposition of an available-for-sale security, we reclassify the
gain or loss on the security from accumulated other comprehensive
income to non-operating income on our consolidated statements of
operations.
Investment Other Securities
For
equity investments where weneither control nor have significant
influence over the investee and which are non-marketable, the
investments are accounted for using the cost method of accounting
in accordance with ASC 325-10. Under the cost method, dividends
received from the investment are recorded as dividend income within
non-operating income.
Other-than-Temporary Impairment
Our
management periodically assesses its marketable securities and
investment other securities, for any unrealized losses that may be
other-than-temporary and require recognition of an impairment loss
in the consolidated statement of operations. If the cost of an
investment exceeds its fair value, we evaluate, among other
factors, general market conditions, the length of time the security
has been in a loss position, the extent to which the
security’s market value is less than its cost, the financial
condition and prospects of the security’s issuer and our
ability and intent to hold the security for a length of time
sufficient to allow for recovery. If the impairment is considered
other-than-temporary, an impairment charge is recorded in
non-operating income in the consolidated statements of
operations.
Inventory
Inventory is stated
at the lower of cost or net realizable value with cost being
determined on a weighted average basis. The cost of inventory
includes product cost, and production fill and labor (which we
outsource to third party manufacturers). Write-offs of potentially
slow moving or damaged inventory are recorded based on
management’s analysis of inventory levels, future sales
forecasts and through specific identification of obsolete or
damaged products. Prepaid Inventory represents deposits made with
third party manufacturers in order to begin production of an order
for product. We assess inventory quarterly for slow moving products
and potential impairments and do a physical inventory count
annuallynear fiscal year end.
Intangible Assets
Our
intangible assets consist of trademarks and other intellectual
property. We employ the non-amortization approach to account for
purchased intangible assets having indefinite lives. Under the
non-amortization approach, intangible assets having indefinite
lives are not amortized into the results of operations, but instead
are reviewed annually or more frequently if events or changes in
circumstances indicate that the assets might be impaired, to assess
whether their fair value exceeds their carrying value. We perform
an impairment analysis at August 1 annually on the indefinite-lived
intangible assets following the steps laid out in ASC 350-30-35-18.
Our annual impairment analysis includes a qualitative assessment to
determine if it is necessary to perform the quantitative impairment
test. In performing a qualitative assessment, we review events and
circumstances that could affect the significant inputs used to
determine if the fair value is less than the carrying value of the
intangible assets. Events and circumstances reviewed included:
status of business with our distributors, review and progress of
our sales strategy, impacts of any financings on the business, any
legal, regulatory, political; or general business factors that
could affect significant inputs used to determine the fair value of
the assets. If a quantitative analysis is necessary, we would
analyze various aspects including number of contracts acquired and
retained as well as revenues from those contracts, associated with
the intangible assets. In addition, intangible assets will be
tested on an interim basis if an event or circumstance indicates
that it is more likely than not that an impairment loss has been
incurred. Events or circumstances that are assessed include
contracts acquired and lost that are associated with the intangible
assets, as well as the impact on revenues associated with those
contracts, and relationship changes with our
distributors.
In
conjunction with any acquisitions, we refer to ASC-805 as amended
by ASU 2017-01 in determining if we are acquiring any inputs,
processes or outputs and the impact that such factors would have on
the classification of the acquisition as a business combination or
asset purchase. Additionally, we refer to the aforementioned
guidance in reviewing all potential assets and liabilities for
valuation including the determination of intangible asset values.
There were no impairments during the three and nine months ended
June 30, 2017 and 2016.
Revenue Recognition
We
receive revenue from three different types of arrangements: sale of
products, license and royalty agreements, and sales for services
provided (advisory or consulting agreements).
In
regards to the sale of products, our policy is to recognize revenue
when persuasive evidence of an arrangement exists, shipping has
occurred, the sales price is fixed or determinable and collection
is probable. We record revenue from the sale of our products when
risk of loss and title to the product are transferred to the
customer, which is upon shipping. Net sales are comprised of gross
revenues less expected product returns, trade discounts and
customer allowances, which include costs associated with
off-invoice mark-downs and other price reductions, as well as trade
promotions and coupons. These incentive costs are recognized at the
later of the date on which we recognize the related revenue or the
date on which we offer the incentive. Although, we do not have a
formal return policy, from time to time we will allow customers to
return certain products. A business decision related to
customer returns is made by us and is performed on a case-by-case
basis. We record returns as a reduction in sales and based on
whether we dispose of the returned product adjust inventory and
record expense as appropriate. There were no allowances for sales
returns during the nine months ended June 30, 2017 and
2016.
We also
enter into various license agreements that provide revenues based
on royalties as a percentage of sales and advertising/marketing
fees. The contracts can also have a minimum royalty, with which
this and the advertising/marketing revenue is recognized on a
straight-line basis over the term of each contract year, as
defined, in each license agreement. Royalties exceeding the defined
minimum amounts are recognized as income during the period
corresponding to the licensee’s sales, as are all royalties
that do not have a minimum royalty. Payments received as
consideration of the grant of a license are recognized ratably as
revenue over the term of the license agreement and are reflected on
our consolidated balance sheets as deferred license revenue at the
time payment is received and recognized ratably as revenue over the
term of the license agreement. Similarly, advanced
royalty payments are recognized ratably over the period indicated
by the terms of the license and are reflected in our consolidated
balance sheet in deferred license revenue at the time the payment
is received. Revenue is not recognized unless
collectability is reasonably assured. If licensing arrangements are
terminated prior to the original licensing period, we will
recognize revenue for any contractual termination fees, unless such
amounts are deemed non-recoverable.
In
regard to sales for services provided, we record revenue when
persuasive evidence of any agreement exists, services have been
rendered, and collectability is reasonably assured; therefore,
revenue is recognized when we invoice customers for completed
services at agreed upon rates and terms. Therefore, revenue
recognition may differ from the timing of cash
receipts.
Recent Accounting Pronouncements
The
recent accounting standards that have been issued or proposed by
the FASB or other standards-setting bodies that do not require
adoption until a future date are being assessed by us and at this
time we do not expect them to have a material impact on our
financial statements upon adoption.
Off Balance Sheet Arrangements
As
of the date of this Offering Circular, we do not have any
off-balance sheet arrangements that have or are reasonably likely
to have a current or future effect on our financial condition,
changes in financial condition, revenues or expenses, results of
operations, liquidity, capital expenditures or capital resources
that are material to investors. The term “off-balance sheet
arrangement” generally means any transaction, agreement or
other contractual arrangement to which an entity unconsolidated
with us is a party, under which we have any obligation arising
under a guarantee contract, derivative instrument or variable
interest or a retained or contingent interest in assets transferred
to such entity or similar arrangement that serves as credit,
liquidity or market risk support for such assets.
OUR BUSINESS
Level
Brands strives to be an innovative branding and marketing company
and, through our subsidiaries, has a focus on lifestyle based
products. Our goal is to create a bold, unconventional and socially
responsible image for our company and our brands. Currently we
operate our business in three segments, including:
●
|
Our professional products division. Currently, the operations of our Beauty
& Pin-Ups subsidiary comprise the operations of this division.
Beauty & Pin-Ups, our first brand, offers quality hair care and
other beauty products to salons, with expected distribution
expansion to include beauty-centric, specialty and online retail
outlets. Net sales from Beauty & Pin-Ups represented all of our
revenues in fiscal 2016 and fiscal 2015, and 25.5% of our net sales
for the first nine months of fiscal 2017;
|
|
|
●
|
Our licensing division. The
operations of I’M1 – Ireland Men One, a newly
created company and brand inspired by Kathy Ireland, comprise the
operations of this division. I'M1 intends to provide
millennial-inspired lifestyle products under the I’M1 brand.
I’M1 has entered into an exclusive wholesale license
agreement with kathy ireland® Worldwide in connection with the
use of the intellectual property related to this brand. In March
2017 I'M1 entered into its first licensing agreements and since
March 2017 it has entered into brand consulting agreements with
four clients, two of which include services to be provided jointly
with EE1. Our licensing division, which began reporting revenues in
the second quarter of fiscal 2017, represented 51.1% of our net
sales for the first nine months of fiscal 2017; and
|
|
|
●
|
Our entertainment division. The
operations of EE1, another newly created company and brand
which is designed to serve as a producer and marketer of multiple
entertainment distribution platforms and help companies with brand
strategies, all under the EE1 brand, comprises the operations of
our entertainment division. Our initial focus is on the production
of songbooks/albums, a movie concept in development, and a charter
service partnership to help in providing a full entertainment
experience- travel, concierge services, tickets and extras for
various events, such as shows, concerts and sporting events as well
as assisting companies with brand management. EE1 has coordinated
its first travel related event which involved charter flights and
concierge services, has provided creative and content input and
feedback on two television series featuring Kathy Ireland, assisted
in the promotion of a music festival and has provided brand
strategy services to two clients. In June 2017, EE1 began
production of a music songbook featuring Marilyn McCoo and Billy
Davis, Jr. under the terms of an agreement with the artists and BMG
Rights Management (US) LLC. Our entertainment division, which began
reporting revenues in the second quarter of fiscal 2017,
represented 23.4% of our net sales for the first nine months of
fiscal 2017.
|
Our
mission is to focus on designing and building the brand with
innovation that customers and business partners can use, exceeding
market needs, creating sustainable cost advantages and fighting
commoditization. We expect that this focus will include aspects of
how we brand, promote, access, incorporate and utilize the
products. We have expanded the United Nations "Millennium
Development Goals" which below are part of our
mission:
We must eradiate extreme poverty and hunger;
Achieve universal primary education;
Promote gender equality and empower women;
Reduce child mortality;
Improve maternal health;
Combat HIV/AIDS, Malaria and other diseases;
Ensure environmental sustainability;
Develop a global partnership for development;
Bring opportunities of financial stability and healthcare to
American Veterans and their families; and
Stop Human Trafficking
Master Advisory Agreement with kathy ireland®
Worldwide
In
February 2017 we entered into a master advisory and consulting
agreement with kathy ireland® Worldwide, as amended, pursuant
to which we have engaged the company to provide non-exclusive
strategic advisory services to us under a term expiring in February
2025. Under the terms of this agreement, Ms. Ireland serves in the
non-executive positions as our Chairman Emeritus and Chief Brand
Strategist. The agreement also provides that kathy ireland®
Worldwide will provide input to us on various aspects of our
corporate strategies and branding, provides access to us of its
in-house design team to assist us in developing our brands. As
compensation under the agreement we agreed to pay kathy
ireland® Worldwide a nominal monthly fee. We are also
responsible for the payment of expenses incurred by Ms. Ireland or
kathy ireland® Worldwide in providing these services to us.
The agreement contains customary confidentiality and
indemnification provisions, together with the standard use and
conditions of imposed by kathy ireland® Worldwide on the use
of Ms. Ireland's likeness. Under the September 2017 amendment to
the agreement, the parties also granted each other certain rights
for opportunities introduced by one party to the other, including
rights of first refusal and the payment of referral fees. The
agreement has a 30 day termination clause in the event of breach,
by the non-breaching party, subject to immediate termination by
kathy ireland® Worldwide if any officers are terminated or
resign, including Mr. Roseberry in his role as President and
co-Managing Director of I'M1 and EE1, or if additional officers are
appointed for each I'M1 and EE1 without the consent of kathy
ireland® Worldwide.
We
are also parties to additional agreements with kathy ireland®
Worldwide and its affiliates which are described later in this
Offering Circular.
Strategy
Our
business strategy is to maximize the potential value of our brands
primarily through strategic licenses and joint venture partnerships
around the world, as well as to grow the portfolio of brands
through strategic acquisitions. In the recent past, we have made
two acquisitions which are described later in this offering
circular which we believe will expand the scope of our business and
achieve growth in our revenues and profitability.
We
believe our business model enables us to use the brand management
expertise at our disposal through our relationship with kathy
ireland® Worldwide to continue to grow our portfolio of brands
and generate new revenue streams without significantly changing our
infrastructure. We believe our business model provides numerous
benefits, including:
●
|
potential for financial upside without the investment and
management risks and capital demands associated with traditional
wholesale operating companies;
|
●
|
diversification resulting from both broad demographic appeal and
distribution through a range of distribution channels;
|
●
|
growth opportunity through expansion of existing brands into new
categories, geographic areas and acquisitions; and
|
●
|
reduced operational risks as inventory and other typical wholesale
operating functions are the responsibilities of our
licensees.
|
We
plan to continue to build and maintain our brand portfolio by
developing our existing brands, acquiring additional brands
directly or through joint ventures or partnerships. In assessing
potential acquisitions or joint ventures, we expect to primarily
evaluate the strength of the target brand as well as the expected
viability and sustainability of future royalty streams and its fit
within its targeted segments as well asin segments where we believe
significant opportunity lies. We believe that this focused approach
will allow us to effectively screen a wide pool of consumer brand
candidates and other asset light businesses that meet our criteria,
strategically evaluate targets and efficiently complete due
diligence for potential acquisition. The identification and
evaluation of potential acquisitions or joint ventures will be
conducted under the direction of our chief executive officer, with
expected significant input from Ms. Ireland under the scope of her
role as Chief Brand Strategist.
Professional products division
Beauty & Pin-Ups
Beauty
& Pin-Ups is designed to be an innovative and cutting-edge
producer and marketer of quality hair care and other beauty
products. It has a brand name that we believe lends itself to
various channels of distribution and licensing including swimsuits,
cosmetics, nails, accessories and more.
With
an initial launch in September 2015 of “The Iron”, a
unique styling hair iron tool, and seven products, the Beauty &
Pin-Ups brand currently has 11 products, including:
Flaunt-
Silkening
Shampoo and
Conditioner.
Luxe - Leave-in Spray On
Revitalizing Conditioner.
Lavish - All in 1 Cleansing
and Conditioning.
Sway - Blow Out Styling Primer
Enhanced with Marine Botanicals.
Fever - Thermal Protectant.
Linger - Style and Sculpting Spray Gel.
Fierce - Firm Hold Finishing
Spray.
Fearless Hair Rescue
Treatment.
Valor - Superfine Hair
Spray.
Rewind - Shampoo and Conditioner.
Stay Dirty - Dry
Shampoo.
Beauty & Pin-Ups uses healthy, lavish
ingredients in stylist-tested formulas. All of the products are
cruelty free – (not tested on animals), paraben, phthalate
and sulfate free. We are just as proud of what is
not
in our products as what is in them. We
believe that the result is beautiful, healthy
hair.
We
believe that the brand is unique in its packaging with classic
pin-up imagery on the bottles that are designed to create a feel of
affordable luxury with a vintage, yet modern feel. Our mission of
beauty with a purpose is inspired by the pin-up who was a symbol of
empowerment… women who were comfortable in their own skin and
defined femininity yet had a fierce independence and
confidence.
Brand Management
Our
managing directors at Beauty & Pin-Ups are Beth Pence and Brian
Anderson. Mrs. Pence and Mr. Anderson are former owners and
executives at Columbia Beauty Supply, which sold beauty products in
the Mid-Atlantic region. Their portfolio included REDKEN,
Pureology, L’Oreal Professional, KENRA, Keune, Lanza,
Davines, OPI, Creative Nail, Bioelements, Takara Belmont, and
various other brands. L’Oreal USA acquired Columbia Beauty
Supply in 2008. At the time of the sale, Columbia Beauty Supply
covered 11 states;from Florida up to the Maryland/Delaware market,
and west to Alabama, Tennessee and West Virginia. Columbia Beauty
Supply had over 267 employees, serviced over 30,000 salons, and
their annual sales exceeded $67 million with a growth rate of 9% at
the time of sale in January of 2008. We expect that Mrs. Pence and
Mr. Anderson will use over 30 years of combined knowledge in the
professional beauty industry to fully develop the Beauty &
Pin-Ups brand.
Product Development
Mr.
Maman, formerly the minority owner of Beauty & Pin-Ups, was the
developer of the original Beauty & Pin-Ups product line. In our
acquisition of the assets of Beauty & Pin-Ups in 2015 we
acquired all of the intellectual property associated with those
development efforts. Since that date,we have completed product
development, re-branding and launched eight new products and have
five additional products in final stages of development. Our
products are conceptualized by our in-house team and utilizing the
services of third party contractorsthe product formulas are then
developed, tested and finalized. The research and development
expense portion of the fees included in the amounts paid to third
party contractors were approximately $36,750 and $24,500 in fiscal
2016 and fiscal 2015, respectively. Concurrently a third party
contractor also assists also our in-house team in packaging design
and development and production of marketing materials.
Sales Channels
Beauty
& Pin-Ups products are currently being sold primarily through
Beauty Systems Group under a purchase order arrangement. Beauty
Systems Group has approximately 1,265 stores nationwide, including
over 150 franchise stores, and is one of the largest networks of
professional distributor sales consultants in North America, with
almost 1,000 consultants. We utilize Beauty Systems Group’s
distribution channel by focusing on marketing and sales to the
professional salon industry. We also distribute our products under
purchase order arrangements with Paramount Beauty Distributing
Associates, Inc. AMLP, BSG Canada, and recently online through
JCPenney.com. Historically, we have been materially dependent upon
Beauty Systems Group for sales of our Beauty & Pin-Ups
products.
By
the end of calendar year 2017, our goal is to expand our sale
channels to multiple channels of beauty distribution, including
wholesale and professional chain salon distribution as well as
through additional e-commerce channels including from on our
website. In furtherance of this goal, in August 2017 we entered
into a distribution agreement with East Coast Enterprises, Inc., a
distributor of beauty supply products in the northeast of the
United States. Under the terms of this five year agreement, we
appointed East Coast Distributors, Inc. as Beauty & Pin-Ups
exclusive distributor in Pennsylvania and New Jersey and certain
counties of West Virginia on an exclusive basis, and on a
non-exclusive basis in certain Delaware and West Virginia counties.
The agreement requires East Coast Distributors, Inc. to meet
certain minimum purchase requirements, ranging from approximately
$385,000 in the first year to approximately $568,000 in the fifth
year of the contract. We have the right to terminate the agreement
for cause as described in the agreement, including for failure to
meet the minimum annual purchase requirements.
Beauty
& Pin-Ups is currently developing a North American sales
support team to build sales for the brand with its distribution
partners. This group is expected to cover all regions of the United
States and Canada. In the first quarter of fiscal 2017 we hired our
first regional sales manager, covering the northeast portion of the
United States and we have plans to hire three to four more regional
sales managers in 2017, using proceeds from this offering to
support our sales and marketing efforts.
Through
its relationship with Beauty Systems Group, Beauty & Pin-Ups is
also distributed in Canada. Beauty & Pin-Ups is also in the
process of expanding its international business geographically
through professional distribution channels in Germany and Austria.
While we have already taken initial steps to meet regulatory
requirements in these countries and have been working with
distribution organizations in Europe to define timetables and
launch strategies, we are unable at this time to predict when we
launch this planned expansion. We do not expect funds from this
offering will be needed to support this effort.
Marketing
We
have an internal team that manages and facilitates our social media
presence and strategy which strives to appeal to a wide audience
with positive messaging that embraces inner beauty and
authenticity. Through high quality visual imagery that engages both
the consumer and the stylist, we seek to convey our message that
beauty belongs to everyone. We use a mix of sales messaging,
ingredient stories, giveaways/contests, and images of hairstyles to
engage customers and increase reach. Our marketing messages and
social media messages are complementary to each other; however
social media is used as much more of a story telling platform. We
aim to be a destination for both the consumer and the stylist to
acquire knowledge about the latest styles and trends in the
industry, and to be inspired.
We
desire to be nationally relevant with the marketing and visual
merchandising of our products across an array of markets within the
channels of distribution in which we operate. We will seek to build
our brand through our websites, trade shows, television, digital,
and social media. In addition, we seek editorial coverage for our
brands and products not only in traditional media, but increasingly
in digital and social media, leveraging significant opportunities
for amplification.
Our
marketing planning approach is designed to leverage the talent of
our employees and advisors to optimize the allocation of resources
across different media outlets and retail touch points to resonate
with our consumers most effectively. This includes providing our
products to the salon professionals who use them with their
customers. Most of our creative marketing work is done by an
in-house creative team that design and produce the sales materials,
advertisements and packaging for products.
Beauty & Pin-Ups launched a Fearless campaign
around a product launch and our new model Katie Meade. We engaged a
New York, New York-based public relations firm, BaseBeauty, to
coordinate the process. The campaign included an exclusive story in
the April 1, 2016 edition of People magazine to announce the release of this new
product with Katie Meade, a brand ambassador for Beauty &
Pin-Up's exclusive charitable partner Best Buddies International.
Katie is the first person with Down Syndrome to be on the cover of
a beauty package. She was selected for the package as we believed
she is a perfect representative of the image and personality of
this product and our message -- Katie has overcome many obstacles
and truly lives her life fearlessly.
Following the publication, the story went
“viral” and was picked up by the top beauty
publications, business publications and news outlets both
nationally and internationally. This led to immediate coverage
in Cosmopolitan,
Teen Vogue
and Glamour. Subsequently Katie and Beauty & Pin-Ups were
interviewed by Fox News and as far away as an Australian News
network. We followed this exclusive announcement with an event in
New York where Fearless was presented to 30 New York City beauty
editors who covered the story with their publications and/or social
channels. We shared the article on our social networks, as did Best
Buddies International and kathy ireland ®Worldwide. There was
also a commercial spot that ran during the airing of Global Beauty
Masters on TLC. Based on following of the outlets that were reached
by the story, we had one billion impressions, and
Reuters
informed us we were the top news story
at that time for 10 days.
Katie was recently covered by Refinery29 as
“one of the top five changing the face of beauty,”
by Cosmopolitan
as “one of the top beauty
moments of 2016” and by People as “one of the stories that made us smile in
2016.”
In
September 2015, Beauty & Pin-Ups was invited by TLC television
network to participate in Global Beauty Masters, a television
beauty reality series where hair, makeup and nail artists competed
in a 10 week competition. An entire episode, which aired in early
March 2016, featured Beauty & Pin-Ups and our
products.
Manufacturing, Warehousing and Raw Materials
We manufacture our core products for Beauty &
Pin-Ups through hair care and other third-party manufacturers in
the United States and Canada; our flat iron products, foil pods for
the irons, and promotional items (back packs, zipper bags, and
clutch purses) are manufactured by third parties in China on a
purchase order basis. Terms with our China-based manufacturers
typically require 30% to 50% upon order with payment due when
products are ready to ship. We expect to continue to streamline our
manufacturing processes and identify sourcing opportunities to
improve innovation, increase efficiencies, minimize our impact on
the environment and reduce costs.
The
principal raw materials used in the manufacture of our core
products are essential oils, alcohols and specialty chemicals. We
have engagements with specific organizations that are our
“fillers”; they use the formulas provided to create the
products and fill our packaging so we have a product that can be
distributed to our customers. Our terms typically provide that upon
an order being completed by the filler, balances are due within 30
to 45 days, although in some instances we have been required to
place a deposit of 30% to 50% upon placement of an
order.
We
also purchase packaging components that are manufactured to our
design specifications using our unique brand image. We utilize a
third party firm that specializes in design and rollout of
packaging, labeling, merchandising displays and advertising for our
products.
We
review our supplier base periodically with the specific objectives
of improving quality, increasing innovation and speed-to-market and
reducing costs. In addition, we source within the region of
manufacturing to allow for improved supply chain efficiencies. To
date, we have been able to obtain an adequate supply of essential
raw materials and currently believe we have adequate sources of
supply for virtually all components of our products.
Competition
There
is vigorous competition within each market where our hair care and
other beauty products are sold. Brand recognition, quality,
performance, availability and price are some of the factors that
impact consumers’ choices among competing products and
brands. Advertising, promotion, merchandising and the pace and
timing of new product introductions also have a significant impact
on consumers’ buying decisions. We compete against a number
of national and international companies, most of which have
substantially greater resources than we do.
Our
principal competitors consist of large, well-known, multinational
manufacturers and marketers of hair care and other beauty products,
most of which market and sell their products under multiple brand
names. They include, among others, L’Oreal Professional,
Matrix Essentials, Redken, Paul Mitchell, Sebastian and
Schwartzkopf. We also face competition from a number of independent
brands, as well as some retailers that have developed their own
beauty brands. Certain of our competitors also have ownership
interests in retailers that are customers of ours. There are no
assurances we will ever be able to effectively compete or that we
will develop any widespread brand recognition.
Government Regulation
We
and our products are subject to regulation by the Federal Trade
Commission in the United States, as well as by various other
federal, state, local and international regulatory authorities and,
at such time as we expand our distribution outside the United
States, the regulatory authorities in the countries in which our
products may be sold. Such regulations principally relate to the
ingredients, manufacturing, labeling, packaging, marketing,
advertising, shipment, disposal and safety of our products. We
believe that we are in substantial compliance with such
regulations, as well as with applicable federal, state, local and
international and other countries’ rules and regulations
governing the discharge of materials hazardous to the environment
or that relate to climate change.
We
have engaged a third party that specializes in regulation in our
industry to advise us and provide regulatory consulting services
and regulatory and technical support for our product offering in
the United States, Canada and Europe.
At
such time as we are successful in expanding our distribution
network outside the United States, we will also be subject to the
laws of the countries in which are products are imported and sold.
We expect to expand our engagement of this third party to include
these additional countries.
Licensing division
I’M1
I’M1
is a newly created brand which was first conceptualized by kathy
ireland® Worldwide.
I’M1 strives to become a leader in multiple
categories including grooming, personal care, cologne, accessories,
jewelry and apparel. I’M1 seeks to be a lifestyle brand with
a focus on addressing the needs of the I’M1 man, how he looks
and feels, all with an objective of helping them live better lives.
I’M1 intends to market itself as a lifestyle brand for men,
who are not threatened by change, embrace it willingly and with
gusto. We expect that our marketing will be centered around the
core concept that I’M1 men, and the women who love them, take
pride in their appearance, thrive on quality, and
value what matters in helping them live a better life.
Our target customers are men who enjoy a lifestyle inspired by the
rugged chic of an athletic lifestyle, while giving back to our
communities by supporting our Millennium Development
Goals.
Branding
is one of the most important aspects of any business. Building a
powerful brand is a dynamic way to give companies an edge in
increasingly competitive markets. I’M1’s brand identity
goal will be to seek to construct lasting relationships with men
who wish to elevate their lives, through the purchases they make by
developing quality products that they need as a part of their day
to day lives.
I’M1 plans to be developed under a broad
brand capability which we expect will target and represent
different consumer groups based on specific products and licensing
agreements. I’M1 can also stand for Ireland Men 1, Ireland
Meharey 1, Interested Millennials 1, Intelligent Moms 1, and
Intriguing Men 1.
Under
the terms of our agreement with kathy ireland® Worldwide, its
in-house design team will support the brand and the future
licensing partnerships by providing unified trend direction,
guidance and coordination of the brand image across all product
categories. The design team will be focused on trying to identify
and interpret the most current trends, both domestically and
internationally, and seeking to forecast the future design and
product demands of the brand’s customers.
kathy ireland® Worldwide Licensing Agreement
In
January 2017 I’M1 entered into a wholesale worldwide license
agreement with kathy ireland® Worldwide for an exclusive,
royalty-free 10 year right to use, assign and sublease certain
trademarks, including I’M1, and to allow for the
manufacturing, marketing and sale of products bearing those marks.
Under the license agreement we are also permitted to sublicense
certain of these rights with the prior approval of kathy
ireland® Worldwide. Without kathy ireland ®Worldwide's
prior consent, the wholesale license agreement may be terminated by
kathy ireland ® Worldwide if I’M1 terminates any
officers or appoints additional officers, if we cease to be the
manager of I’M1, or if we compete with or invest in
businesses that compete with kathy ireland®
Worldwide.
License and consulting agreements
We
have developed a standardized form of licensing agreement for use
by I'M1 which contains general terms and conditions under which we
will grant licenses to the I'M1 marks that can be modified to meet
the business terms of each particular product. The standard terms
and conditions include the limitations on the grant of the license
for the marks, use and ownership of our intellectual property and
the ownership of the intellectual property related to the licensed
products, means for conducting brand business and coordinating with
us and other licensees, royalty reporting and accounting
obligations, quality assurance procedures, acceptable display,
labeling and promotional materials, minimum insurance requirements,
termination and confidentiality provisions, a code of conduct for
our licensees and other customary terms and conditions contained in
licensing agreements.
Since March 2017 we entered into licensing
agreements for the I'M1 mark and consulting agreements with several
clients, as well as agreements with several additional clients for
which services are being provided jointly by I'M1 and EE1. The
material terms of these agreements are described below. Our
cost of sales related to our advisory agreements are minimal as the
efforts related to the services are not extensive and costly to
deliver, but more expertise-focused.
Kure Corp.
Under
the terms of a license agreement dated March 29, 2017, we granted
Kure Corp. a non-transferrable license to use the I'M1 marks solely
for the sale, marketing and distribution of vaping liquids and
vaping products through certain specified channels of distribution
in the United States. Kure Corp. is a Charlotte, North
Carolina-based privately held vaping company. Under the terms of
the 10 year license agreement, Kure Corp. is required to begin
shipping the licensed products no later than April 30, 2018. As
compensation we are entitled to a royalty of 5% of the gross sales
of all licensed products. We may internally allocate a portion of
this compensation to EE1 in connection with services related to any
appearances, filming and/or recording by Mr. Tom Meharey to promote
these licensed products. The license agreement may be terminated by
either party upon 30 days notice in the event of a breach of the
agreement by the other party.
On
March 20, 2017 we also entered into a nine month consulting
agreement with Kure Corp. under which we were engaged to provide
assistance in the promotion and advice with respect to the
marketing and branding of the licensed products. As compensation,
Kure Corp. was obligated to pay us a total of $600,000 upon the
completion of various of the contracted services under the terms of
the agreement, including $200,000 which was due by March 31, 2017
in exchange for certain social media promotional services and
marketing services which were delivered by March 31, 2017, with the
balance due upon the provisions of additional marketing and
promotional services. The additional services were provided in the
third quarter of fiscal 2017 and all payment obligations have been
made. Specific services delivered under the agreement
include:
•
|
production of various images promoting Kure;
|
|
|
•
|
social media content and distribution;
|
|
|
•
|
content for press releases as well as coordinating distribution;
and
|
|
|
•
|
production of a marketing video.
|
These
services were delivered in coordination with EE1 as I'M1's service
provider. Our Chief Executive Officer is a former member of the
board of directors of Kure Corp. and he continues to control
approximately 3.3% of its outstanding voting
securities.
NuGene International, Inc.
On March 20, 2017 we entered into a nine month
consulting agreement with NuGene International, Inc., a
publicly-traded company (OTCPink:NUGN), that is principally in the
business of research, development, and sales and marketing
“cosmeceutical” skincare and hair products. In November 2014
NuGene International, Inc. entered into a license agreement
with kathy ireland Worldwide® under
which it licensed the right to utilize the trademarks and rights to
the name, likeness and visual representations of Kathy Ireland in
connection with its cosmeceutical line of products containing adult
human adipose stem cell derived or containing biologically active
or biologically derived ingredients.
Under
the terms of the consulting agreement, I'M1 was engaged to provide
assistance in the promotion of NuGene International, Inc.'s men's
products to create greater public awareness. These services
specifically included:
•
|
assistance for social media content and distribution;
|
|
|
•
|
content for press releases; and
|
|
|
•
|
content for public support statements regarding the product from
brand ambassadors.
|
These services were delivered in coordination with
kiWW under our advisory agreement and with EE1 as I'M1's service
provider, thus keeping our cost of services nominal. As
compensation, NuGene International, Inc. issued us 2,500,000 shares
of its common stock valued at approximately $650,000 to I'M1 upon
the execution of the agreement, and will pay I’M1 an
additional $50,000 in cash upon the earlier of the completion of a
financing by NuGene, or June 30, 2017. We have not yet received
payment of this amount. Based
upon our recent discussions with management of NuGene, we expect
that this amount will be satisfied prior to the end of our current
fiscal year. We will continue to monitor for
collectability.
Effective June 30, 2017 we exchanged the 2,500,000
shares of common stock for 65 shares of NuGene's Series B
Convertible Preferred Stock which has a stated value of $10,000 per
share. Each share of preferred stock is convertible using a
formula, into such number of common shares of NuGene as
equal to the stated value at a price per share of common stock. We
made a business decision that it would be in our best interests to
increase our cash position and sell the preferred stock.
On July 31, 2017, we sold the shares
of Series B Convertible Preferred Stock to Stone Street Partners,
LLC, an affiliate of our Chairman and Chief Executive Officer, for
an aggregate purchase price of $475,000. Based on the market value
of the common shares of NuGene between June 30, 2017 and the time
that the preferred shares were sold to Stone Street Partners, LLC,
and factoring in certain restrictions on the ability to liquidate
the shares, we determined that the consideration paid by the
related party was a reasonable approximation of the fair market
value that would have been commanded in an arms’ length
transaction. The terms of this transaction are described later in
this Offering Circular under "Certain Relationships and Related
Party Transactions." Additional terms of the preferred stock are
included in Notes 3 and 15 to the note to our unaudited
consolidated financial statements for the period ended June 30,
2017 appearing later in this Offering Circular. NuGene is not a
related party.
Andre Phillipe, Inc.
Under the terms of a license agreement dated March
29, 2017, we granted Andre Phillipe, Inc. a non-transferrable
license to use the I'M1 marks solely for the sale, marketing and
distribution of men's suits in the United States through
distribution channels we approve in advance and which specifically
excludes any distribution channel that includes mass market
or lower-tier department stores, including stores that sell
affordably priced products that appeal to a wide variety of
consumers, or club stores, such as Sam's. We also have prior approval rights relating to any
Internet retailers in the approved distribution channel. Andre
Phillipe, Inc. is a Dallas, Texas-based privately held bespoke or
"made to order" menswear company offering custom attire for men.
Under the terms of the five year license agreement, Andre Phillipe,
Inc. paid us a $12,000 licensing fee, which represents the minimum
guarantee royalty for the first year of the agreement, and we are
entitled to a royalty of 4% of the gross sales of all licensed
products, with certain minimum guaranteed monthly royalty payments
ranging from $2,000 to $8,000 during years two through five of the
license agreement. Annual minimum guaranteed royalties will be
accounted for as deferred revenue and recognized as income on a
pro-rata basis over each year of the agreement. In addition, the
creation of any content to be exploited in any media
pursuant to the license agreement will be exclusively provided by
EE1 on a “work for hire” basis with I'M1 as the sole
owner of the results and proceeds of such services. The
license agreement may be terminated by
either party upon 30 days notice in the event of a breach of the
agreement by the other party.
Loose
Leaf Eyewear and Accessories LLC
Under
the terms of a license agreement dated June 27, 2017, we granted
Loose Leaf Eyewear and Accessories LLC a non-transferrable license
to use the I'M1 marks solely for the sale, marketing and
distribution of men's fashion eyewear products of the licensee in
the United States, Mexico and Canada through distribution channels
we approve in advance. The initial term of the license agreement is
for five years and will automatically renew for additional one year
periods unless either party notifies the other of non-renewal at
least 30 days prior to the end of the then period. Loose Leaf
Eyewear and Accessories LLC is obligated to pay us a $15,000 annual
marketing fee and we are entitled to a royalty of 4% of the net
sales (as defined in the agreement) of all licensed products. We
received the first year marketing fee upon execution of the
agreement and are accounting for it as deferred
revenue.
Brand Management
Mr. Stephen Roseberry, President and a member of
the board of directors of kathy ireland ® Worldwide, and Mr.
Tommy Meharey, Vice President and a member of the board of
directors of kathy
ireland® Worldwide, are
co-Managing Directors of I’M1. Mr. Roseberry is responsible for
developing and executing sales and business strategies and Mr.
Meharey is responsible for marketing and brand development. During
February 2017, we have entered into one year advisory agreements
with each of Mr. Roseberry and Mr. Meharey pursuant to which they
provide advisory and consulting services to us, including serving
as co-Managing Directors of I’M1, devoting such time to our
business as we mutually determine. Mr. Jon Carrasco, who is the
Global Creative Director for kathy ireland® Worldwide, also
serves as Global Creative Director for I’M1, and he is
responsible for developing and facilitating creative strategies for
I’M1. In September 2017, we entered into a one year advisory
agreement with Mr. Carrasco for these services. We have agreed to
pay Mr. Meharey a fee of $15,000 per month for his services. Mr.
Roseberry and Mr. Carrasco each receive a nominal monthly fee for
their services.
Marketing
Tommy
Meharey is the “face” of I’M1. He is a father,
corporate vice president, fashion model, and former marine
sergeant. We believe Mr. Meharey embodies the essence of the
targeted I’M1 clientele and his approachable nature, history
of service to the nation, and family values may be an asset to the
brand. As the voice and inspiration of I’M1, we expect to
leverage Mr. Meharey’s ability to communicate the DNA of
I’M1 to the media, retailers, and our consumers. In his role
as co-Managing Director of I’M1, Mr. Meharey will communicate
directly with potential brand partners, and attend events including
the annual Licensing Expo held in Las Vegas, NV in May 2017 to
develop new business relationships.
Competition
We
expect I’M1’s competition will include established,
well-capitalized companies with wide consumer recognition such as
Armani, Ferragamo, Prada, Burberry, and Gucci as well as newer
brands including Gilt, Me Undies, Uniqlo, Concepts, Roden and Grey,
Machus, Far Fetch and The Corner. I’M1 is expected to be a
younger brand, built to address the desires of millennials. While
we expect we will seek to address the aspirations of our customers
at attainable prices points which we believe may give us a
competitive advantage, there are no assurances we will ever be able
to effectively compete with our target customers.
Entertainment division
Encore Endeavor 1 (EE1)
EE1 seeks to be an “omni-entertainment
experience and brand management” company serving as a
producer and marketer of multiple
entertainment distribution platforms as well as assisting clients
with brand strategies. Our initial focus is on the production of
songbooks/albums, a movie concept in development stage, and a
charter service partnership to help in providing a full
entertainment experience- travel, concierge services, tickets and
extras for various events, such as shows, concerts and sporting
events. EE1 recently coordinated its first travel related event
which involved charter flights and concierge
services.
EE1
provides input, strategies and an architecture for corporate
brands, including:
•
|
content creation and promotion through social and standard media
;
|
|
|
•
|
marketing input;
|
|
|
•
|
assisting with influencer marketing programs, a form of
marketing in which focus is placed on influential people rather
than the target market as a whole;
|
|
|
•
|
providing production capability for video and photo support for
brand advertising; and
|
|
|
•
|
assisting with brand extension through licensing
opportunities.
|
EE1
is expected to be able to assess all entertainment distribution
platforms such as recording, film, television, radio, podcasts, web
content, live events including: sports, festivals, fashion shows,
holiday-centric programming, and business-centric programming, to
identify areas of additional opportunity. EE1’s goal is to
provide a variety of “all inclusive” entertainment
experiences targeted to millennials which combine multiple facets
of an entertainment experience into one event.
For
example, EE1 will seek to combine concert promotion with a VIP
experience which would allow concert goers the opportunity to step
behind the proverbial velvet rope, access exclusive artist content
and have once in a lifetime encounters. Fan moments, such as seeing
your name on stage acknowledged by the artist, will provide an
interactive concert performance. Focused on impacting domestic
sales, we believe that this concept will facilitate demand for
recorded physical music in the United States, in contrast to
downloading or streaming and will allow artists to connect with
their fans and market their goods directly to their key
demographic.
Other
planned “omni-entertainment” experiences may include
providing VIP access to entertainment experiences, from private
planes and tickets for events such as the Super Bowl, Fashion Week
and beyond.
EE1
coordinated its first travel related event, arranging for travel
and concierge related services, which generated nominal revenues.
EE1 intends to pursue opportunities to build content in every area
of the entertainment, sports, and travel industries - including
joining artists in the recording studio, participating in an
artist’s sound check, VIP back stage artist meet and greets,
films, broadcast, live events including concerts and musical
theatre, and fashion shows. EE1 is presently in the development
stages of jointly developing with kathy ireland® Worldwide two
projects, "Bad Girlz (Season 1 Queenie)" and a television series
"Model to Mogul".
We
seek to be internationally successful in all areas of the
entertainment industry by developing marketing campaigns that are
individualized to each project and in each of our markets. We
expect that the EE1 brand will be built through a combination of
in-house development, our expected contractual agreements with BMG
Rights Management (US) LLC, a division of Bertelsmann Music Group,
and by yet to be established licensing affiliations with companies
in a variety of sectors including, music, television, travel,
fashion, and sports to name a few.
In
2017 EE1 has begun implementing its business strategy with the
following projects:
●
|
In February 2017 EE1 arranged, coordinated and booked for Sandbox
LLC its first travel related event, arranging for travel and
concierge related services. Under the terms of the oral agreement,
EE1 was paid $68,550 for its services. Sandbox LLC is not a related
party, however, it has a prior business relationship with kathy
ireland® Worldwide;
|
●
|
In March 2017 EE1 agreed to provide creative and content input and
feedback to Multimedia Productions, Inc., the producer of
Worldwide Business with kathy
ireland® and Modern Living with kathy ireland®, on those
series. As compensation EE1 is to receive $50,000 per production
month for an expected minimum of four production months. Through
June 2017 we have provided services for two production months, as
the series are produced at irregular intervals, and have received
an aggregate of $100,000 for our services. Multimedia Productions,
Inc. is not a related party, however it has a prior business
relationship with kathy ireland® Worldwide;
and
|
●
|
In April 2017 EE1 and kathy ireland® Worldwide co-produced the
Winter Music Festivals, LLC (a subsidiary of National Event
Company) 2nd Annual MINUS ZERO Winter Sports and Music Festival
at the Stratton Mountain Resort in South Londonderry, Vermont. The
two-day winter sports and musical festival featured three stages of
music, skiing, snowboarding, Rail Jam & Jump presented by
Monster Energy, lodging onsite and free parking. EE1 assisted in
the promotion of the vent through press releases and social media,
as well as having a team onsite for the event. For its services in
connection with this event, EE1 received $15,000. Winter Music
Festivals, LLC is not a related party.
|
Prior
to our acquisition of EE1, in February
2016 EEI entered into a letter agreement with BMG Rights
Management (US) LLC, a division of
Bertelsmann Music Group which we refer to as
"BMG", which relates to future
projects the parties may undertake concerning three recording
artists that were then signed to Sterling/Winters Company, a
subsidiary of kathy ireland® Worldwide, including Marilyn
McCoo and Billy Davis, Jr. The letter agreement generally
provides that EE1 is to receive advances on each album to be
produced ranging from $50,000 to $100,000, payable 10% on
commencement of the recording, 30% on the delivery of 10 tracks and
the balance, less any costs incurred directly by BMG, to be paid on
delivery of the album.BMG is to have ownership of the albums, and
it will advance all costs for the marketing and promotion of the
albums, up to an aggregate of $50,000 for each album plus
manufacturing and mechanical royalties. Upon release of the albums,
the royalties will be split 50%/50%, subject to a
distribution/administration fee of 18% payable to
BMG.
In May
2017 EE1 entered into an exclusive 12 month recording master
license agreement with McCoo & Davis, Inc. under which the
artists were engaged as recording artists for a to-be newly
recorded musical songbook. The services include performance as a
musician and vocalists, but exclude any services or performance
which are marketed as religious or gospel and substantially all of
which are religious or gospel in nature. Under the terms of the
agreement, EE1 will own all intellectual property rights in the
album, any videos, production elements and the master recordings
and in all other forms of media, with the right to sublicense. We
are responsible for the payment of therecording costs, any advances
or other fees payable to the artists or other third parties and out
of pocket manufacturing costs and mechanical royalties. The artists
are entitled to receive a recording fee in an amount determined by
us in consultation with the artists prior to the commencement of
the studio album, and thereafter is entitled to receive to be
agreed upon royalties. EE1 began production of the album in June
2017.
Representation Agreements
EE1 has
entered into representation agreements with two clients to license
certain products as follows:
Romero Britto and Britto Central, Inc.
In
August 2017 EE1 entered into a representation agreement with Romero
Britto and Britto Central, Inc. under which it was appointed as
exclusive licensing consultant to license certain intellectual
property in entertainment industry category, which includes
theatre, film, art, dance, opera, music, literary, publishing,
television and radio, worldwide except for South America. Mr.
Britto is a Brazilian neo-pop artist, painter, serigrapher, and
sculptor. Under the terms of the agreement, EE1 will:
•
|
identify,
present and introduce the licensor to potential license
opportunities;
|
|
|
•
|
negotiate
and present term sheets and standard terms and condition on the
licensor's behalf;
|
|
|
•
|
negotiate
on the licensor's behalf, implement and administer each eligible
license; and
|
|
|
•
|
use our
reasonable efforts to cause the licensees to pay any amounts due
under the future license agreements into a separate account located
owned, maintained and administered by EE1.
|
As
compensation for our services, EE1 is entitled to receive 35% of
the net proceeds received under any license, and following the
termination or expiration of the agreement, 15% of the net proceeds
of eligible licenses. The term of the exclusive rights granted EE1
under this representation agreement expires on May 1, 2019. The
agreement may be terminated by either party upon 30 days notice in
the event of a breach. The agreement contains confidentiality and
indemnification provisions. Alina Shriver, the wife of a member of
our board of directors, is President of Britto Licensing, an
affiliate of the licensor. See "Certain Relationships and
Related
Party Transactions" appearing later in this Offering
Statement.
David Tutera and Dada Media, Inc.
In
August 2017 EE1 also entered into a five year representation
agreement with David Tutera and Dada Media, Inc. Mr. Tutera is an
American celebrity wedding planner, bridal fashion designer, author
and professional speaker. Under the terms of the representation
agreement, EE1 was appointed as an exclusive consultant to license
certain intellectual property worldwide for use in various products
and merchandise. Under the terms of the agreement, EE1
will:
•
|
identify,
present and introduce the licensor to potential license
opportunities;
|
|
|
•
|
negotiate
and present term sheets and standard terms and condition on the
licensor's behalf;
|
|
|
•
|
negotiate
on the licensor's behalf, implement and administer each eligible
license; and
|
|
|
•
|
use our
reasonable efforts to cause the licensees to pay any amounts due
under the future license agreements into a separate account located
owned, maintained and administered by EE1.
|
As
compensation for our services, EE1 is entitled to receive 12.5% of
the gross proceeds for all new eligible licensees, or any form of
non-cash compensation received by the licensor, EE1 or their
respective affiliates. Following the termination or expiration of
the agreement, we are entitled to receive 6.25% of the gross
proceeds of new eligible licenses. The agreement may be terminated
by either party upon 30 days notice in the event of a breach. The
agreement contains confidentiality and indemnification
provisions.
Brand Management
Our co-managing directors at EE1 are Stephen
Roseberry and Nic Mendoza. Mr. Roseberry, President of kathy
ireland® Worldwide who is
represented by William Morris Endeavor/IMG is expected to leverage
his relationship with his contacts in the entertainment industry to
assist EE1 in implementing its business model. EE1 co-founder Nic
Mendoza, a Vice President at kathy Ireland® Worldwide,
will bring experience in producing
recordings, concerts, theatrical events and national radio
broadcasts for SiriusXM to EE1. We have entered into an advisory agreement with
each of Mr. Roseberry and Mr. Mendoza pursuant to which they
provide advisory and consulting services to us, including serving
as co-Managing Directors of EE1, devoting such time to our business
as we mutually determine. Mr. Jon Carrasco, who is the Global
Creative Director for kathy ireland® Worldwide, also serves as
Global Creative Director of EE1, and he is responsible for the
development and facilitation of creative strategies for EE1. In
September 2017, we entered into a one year advisory agreement with
Mr. Carrasco for these services. We have agreed to pay Mr. Mendoza
a fee of $10,000 per month for his services. Mr. Roseberry and Mr.
Carrasco each receive a nominal monthly fee for their
services.
Competition
Our principal competitors are expected to be
large, established multi-national companies such as The Walt Disney
Company, Bertelsmann Group, Comcast (owners of Universal, NBC, Telemundo), and
20th Century Fox. Additional competitive organizations include
independent studios, though the majority of these agencies do not
address consumers across
multiple platforms. Despite the significant competition in the
entertainment industry from larger, established and
well-capitalized companies, we believe it is a field that welcomes,
and is in fact driven, by disruption and we will seek to leverage
the flexibility of a start-up without a large organizational
structure to our advantage. There are no assurances, however,
that we will ever be successful in effectively competing in this
market segment.
Joint Advisory Agreements with I'M1 and EE1
We may
determine from time to time that the scope of the advisory services
we are asked to provide by a prospective client would span the
services particular to both our licensing division and our
entertainment division.
Advisory
Agreement with Formula Four Beverages Inc.
In May
2017 I'M1 and EE1 entered into a four year advisory agreement with
Formula Four Beverages Inc., a Canadian-based company that supplies
oxygenated beverage products including those under the trade name
OXiGEN. I'M1 and EE1 will jointly advise Formula Four Beverages
Inc. on:
• various
aspects of corporate branding and work with the company, including
coordinating with other services provider in areas related to
influencer marketing programs and advertising;
• assist
on media opportunities;
• production
of a video telling the story and vision of OXiGEN; and
• provide
strategies to increase its distribution network.
As
compensation for the services, Formula Four Beverages Inc. issued a
warrant to purchase 1,600,000 shares of its common stock at an
aggregate purchase price of $400.00 to I’M1 and
EE1. For accounting
purposes, we valued the warrant at $0.57 per share based on Formula
Four Beverages June 2017 financing activities, which at that time
was in process of raising approximately $8 million using a company
valuation of $45 million as performed by Formula Four management
and provided to us, and with 79 million shares outstanding this
provided a value of $0.57 per share. The advisory agreement
provides that the services for which the warrant was issued as
consideration were to be fully performed within 45 days from the
date of the agreement, which services were completed in June 2017
and reflected in our June 30, 2017 unaudited consolidated financial
statements. In June 2017 we exercised this warrant, with 50% of the
shares being issued to I’M1 and 50% of the shares being
issued to EE1. In addition, I'M1 and EE1 are entitled to receive
royalties ranging from $0.40 to $0.60 per case, split evenly, based
upon the number of cases of OXiGEN related products, including
current and future products, sold annually in the U.S. above
750,000 cases, based upon a contract year running from May 9 to May
8 of the following year.
The
royalty payments are due within 45 days after the close of a month.
We are also entitled to be reimbursed for our out of pocket
expenses incurred in performing the services under the advisory
agreement. In the event of a change of control of either Formula
Four Beverages Inc. or its U.S. subsidiary Formula Four Beverages
(USA) Inc. as defined in the advisory agreement, upon notice to us
we have the right to immediately terminate the advisory agreement
and receive a lump sum payment equal to the cumulative royalties
paid to us over the previous trailing 12 month period. The advisory
agreement, which may be terminated by either party upon 30 days
notice in the event of a breach, contains customary mutual
confidentiality provisions. Formula Four Beverages has indemnified
I'M1 and EE1 in certain cases and is required to maintain certain
insurance coverage naming I'M1 and EE1 as covered
parties.
Advisory
Agreement with Damiva Inc.
In
August 2017 I'M1 and EE1 entered into a five year advisory
agreement with Damiva Inc., a Canadian-based company that offers
products for perimenopause, menopause and postmenopause and the
related symptoms. Under the terms of the agreement, we were engaged
to use our best efforts to:
• introduce
Damiva Inc. to potential business customers;
• assist
the company with influencer marketing and advertising programs
;
• when
appropriate, include its story in media opportunities and social
media posts;
• lead
the initiative with other service providers to create a five to six
minute video telling the story of Damiva and related production
activities; and
• seek
to enhance the client's sales and distribution networks, retail
accounts and key product alignments and placements with various
entities.
As
compensation for the services, Damiva Inc. issued a warrant to
purchase 28,276 shares of its common stock, representing 1% of the
then fully diluted common shares outstanding, at an aggregate
purchase price of $0.01 to each of I’M1 and EE1, for an
aggregate of 56,552 shares. The advisory agreement provides that
the services for which the warrant was issued as consideration were
to be fully performed within 45 days from the date of the
agreement. In addition, I'M1 and EE1 are entitled to receive
royalties of 1.5% of Damiva Inc.'s annual revenues of up to $25
million and 2% of its annual revenues in excess of $25 million,
with a minimum annual royalty of $75,000, together with an annual
marketing fee of $75,000. The royalty payments are payable on a
monthly basis during the term for revenues during each calendar
month. The initial year marketing fee is payable in three
installments, with the first due within 30 days of the date of the
agreement, $25,000 on November 30, 2017 and $25,000 on March 31,
2008. Thereafter, the annual marketing fee is due in advance on the
anniversary date of the agreement.
The
advisory agreement, which may be terminated by either party upon 30
days notice in the event of a breach, or upon a change of control
of Damiva Inc., in which event we are entitled to receive a one
time lump sum payment equal to the cumulative royalties paid to us
during the previously 12 month period. We are entitled to
reimbursement for our out of pocket expenses, subject to
preapproval by Damiva Inc. The advisory agreement contains
customary mutual confidentiality provisions, and Damiva Inc. has
indemnified I'M1 and EE1 in certain cases and is required to
maintain certain insurance coverage naming I'M1 and EE1 as covered
parties.
Licensing Relationships
We
plan to license our Beauty & Pin-Ups, I’M1 and EE1 brands
to both manufacturing and direct-to-retail licensees. In a
traditional license, a manufacturer is granted rights, at times on
an exclusive basis, to a single or small group of related product
categories for a particular item for sale to multiple accounts
within an approved channel of distribution and territory. In a
direct-to-retail license, a single retailer is granted the right
(typically on an exclusive basis) to sell branded products in a
broad range of product categories through its brick and mortar
stores and e-commerce sites.
We
expect that our license agreements will typically require a
licensee to pay us royalties based upon net sales. The term of the
licensing agreement will be determined on a case by case basis
based upon negotiations by the parties, and generally will be
terminable by either upon 30 days notice in the event of a breach
or default by the other party, subject to cure during the 30 day
notice period. It is also likely our license agreements will
require licensees to support the marketing and advertising of the
respective licensed brands.
Our
license agreements typically will stipulate specific geographical
territories and distribution channels in which the licensed
products may be sold. As we grow our existing brands and acquire
new brands, we intend to increase the share of our international
revenue, primarily through additional licenses, partnerships, and
other arrangements.
Additional Agreements with kathy ireland®
Worldwide
In
addition to the Master Advisory and Consulting Agreement with kathy
ireland® Worldwide which is described earlier in this Offering
Circular, we have entered into the following additional agreements
with it:
License Agreement related to this
offering
In
September 2017 we entered into a license agreement with kathy
ireland® Worldwide under which it granted us a
non-transferrable license to use the kathy ireland® trademark,
as well as Ms. Ireland's likeness, videos, photographs and other
visual representations in connection with this offering, including
the associated road shows, subject to its prior approval. Under the
terms of the agreement, we agreed to pay kathy ireland®
Worldwide $100,000, of which $50,000 has been paid , and the
balance will be paid from the proceeds of this
offering.
kathy ireland® Health & Wellness Wholesale License
Agreement
In
September 2017 we also entered into a wholesale license agreement
with kathy ireland® Worldwide under which we were granted an
exclusive, royalty free right to license, assign and use the kathy
ireland® Health & Wellness™ trademark, and all trade
names, trademarks and service marks related to the intellectual
property including any derivatives or modifications, goodwill
associated with this intellectual property when used in conjunction
with health and wellness as well as Ms. Ireland's likeness, videos,
photographs and other visual representations connected with kathy
ireland® Health & Wellness™.
As a
result of Ms. Ireland's five best selling fitness programs and her
personal focus on health and wellness, we expect to develop a new
brand utilizing these rights. Through licensing arrangements with
third parties which we will seek to obtain, our goal is to create a
brand which will include a wide variety of licensed products and
services, targeted to both Baby Boomers as well as millennials. We
believe that licensed products and services under this brand can
benefit from a wide distribution path of grocery, drug and mass, as
well as direct response and online sales. Our business plan for
this brand, however, is in its preliminary stages and there are no
assurances we will be successful in developing this brand concept
or entering into agreements for licensed product.
As
compensation under this agreement, we agreed to pay kathy
ireland® Worldwide a marketing fee of $840,000, of which
$360,000 is payable from the proceeds of this offering and the
balance is payable in equal annual installments beginning January
1, 2018, subject to acceleration. Under the terms of this
agreement, we also agreed to pay kathy ireland® Worldwide a
royalty of 33 1/3% of our net proceeds under any sublicense
agreements we may enter into for this intellectual
property.
The
initial term of this wholesale license agreement expires in
September 2024, and we have the right to renew it for an additional
three year period by paying an additional marketing fee of
$360,000. kathy ireland® Worldwide has the right to
immediately terminate the agreement if any officers are terminated
or removed or additional officers are appointed with respect to
either I'M1 or EE1, or if we compete with or invest in businesses
that compete with kathy ireland® Worldwide.
Additional Recent Wholesale License Agreements
In
September 2017 we also entered into non-exclusive wholesale license
agreements with two existing brands introduced to us by kathy
ireland® Worldwide and with which kathy ireland®
Worldwide has pre-existing relationships. While we are utilizing a
portion of the proceeds from this offering to pay the cash portion
of the license fees, we have yet to devote any substantial time to
these new relationships.
Wholesale License Agreement with Andre Carthen
Mr.
Carthen, a chef, has had a relationship with kathy ireland®
Worldwide for over 15 years. He was responsible for the menu and
recipe content of True You, a 2011 #1 New York Times bestselling
book with Janet Jackson. Mr. Carthen has enjoyed licensing success
in dinnerware, home accessories, accent furniture, and as the
costar of five bestselling fitness programs with kathy
ireland® Worldwide. Under the terms of this
nonexclusive agreement, we have the right to use, assign and
sublicense the marks, intellectual property and other rights in
connection with "Chef Andre," "Andre Carthen," ACafe" or "Fit Chef"
and all trade names, trademarks and service marks related to this
intellectual property for the purpose of entering into sublicense
agreements with third parties for the manufacture, marketing and
sale of products utilizing these marks. The terms of these future
sublicense agreement are subject to the prior approval of Mr.
Carthen. As compensation, we issued him 45,500 shares of our common
stock valued at $179,725, a five year warrant to purchase an
additional 45,500 shares of our common stock at a purchase price of
$4.00 per share, and agreed to pay him a cash fee of $65,000 from
the proceeds of this offering. He is also entitled to receive
royalties of 20% of the net proceeds under any sublicense
agreement, with a minimum annual guaranteed royalty of $65,000
beginning in the second contract year. The agreement is subject to
termination upon mutual consent, or if a receiver, trustee or
liquidator is appointed for either party or either party declares
bankruptcy.
Wholesale License Agreement with Nicholas Walker
Mr. Walker has had
a relationship with kathy ireland® Worldwide for over 15
years, During his licensing career with kathy ireland®
Worldwide he has appeared on HGTV and the Oprah Winfrey Show, among
other television projects. His licensing career includes
garden-inspired products from candles and candlesticks, to accent
furniture, and lighting. Under the terms of this nonexclusive
agreement, we have the right to use, assign and sublicense the
marks, intellectual property and other rights in connection with
"Jardin," "Nicholas Walker," "Nicholas Walker Jardin," "Nicholas
Walker Garden Party," "Cultivated by Nicholas Walker," and "Jardin
Du Jour," and all trade names, trademarks and service marks related
to this intellectual property for the purpose of entering into
sublicense agreements with third parties for the manufacture,
marketing and sale of products utilizing these marks. The terms of
these future sublicense agreement are subject to the prior approval
of Mr. Walker. As compensation, we issued him 25,000 shares of our
common stock valued at $98,750, a five year warrant to purchase an
additional 25,000 shares of our common stock at a purchase price of
$4.00 per share, and agreed to pay him a cash fee of $40,000 from
the proceeds of this offering. He is also entitled to receive
royalties of 20% of the net proceeds under any sublicense
agreement, with a minimum annual guaranteed royalty of $40,000
beginning in the second contract year. The agreement is subject to
termination upon mutual consent, or if a receiver, trustee or
liquidator is appointed for either party or either party declares
bankruptcy.
Intellectual Property Rights
In
addition to our license agreement with kathy ireland®
Worldwide described earlier in this Offering Circular, our success
depends, at least in part, on our ability to protect our brand
names. We rely on a combination of trademarks, patents, copyrights,
trade secrets and know-how, intellectual property licenses and
other contractual rights (including confidentiality and invention
assignment agreements) to establish and protect our proprietary
rights. We own the trademark rights used in connection with our
brands in the United States including Beauty & Pin-Ups,
I’M1 and EE1. We have also filed trademark registrations for
an additional approximately twelve trademarks which we may use in
the future as we launch new products under the Beauty & Pin-Ups
product line or enter into licensing agreements for Beauty &
Pin-Ups, I’M1 and EE1. We consider the protection of our
trademarks to be important to our business. We own both U.S.,
European Union and Chinese design patents on our hair iron titled
“hair iron” and have filed application in the U.S.,
Europe and China for design patents for the hair foil, titled
“aluminum foil for hair” under the Chinese application
and “hair foil” under the U.S. and European Union
application. This product is used in conjunction with the hair
iron. Finally, in connection with the recording master license
agreement with McCoo & Davis, Inc. EE1 will own all
intellectual property rights in the album, any videos, production
elements and the master recordings and in all other forms of media,
with the right to sublicense.
Employees
At
September 14, 2017 we had nine full-time employees. There are no
collective bargaining agreements covering any of our
employees.
Legal Proceedings
We
are not a party to any material pending legal proceedings; however
our industry is subject to claims regarding product liability. As a
result, we may be subject to various legal proceedings in the
future.
Our Offices
Our
headquarters are located in approximately 2,400 square feet in a
modern four-story building in Charlotte, North Carolina which we
sub-lease under the terms of an agreement expiring on January 1,
2018. Under the terms of this agreement, we currently pay an annual
base rental of approximately $82,950. We will make a determination
prior to the end of the term of this lease if we intend to renew
this lease or seek alternative space. If we choose to relocate our
principal offices we do not expect any difficulty in finding
suitable alternative office space upon similar terms and
conditions.
In
addition we have warehouse space where we store small amount of
product and related items in Charlotte, North Carolina. This space
totals approximately 500 square feet and is on a month to month
arrangement under an oral agreement. Most of our product is stored
at our manufacturers as a part of their services to us or to a
third party logistics company and is charged based on volume of
space needed. We believe that our existing facilities are adequate
to meet our current needs.
Our History
Our
company was formed under the laws of the state of North Carolina in
March 2015 under the name Level Beauty Group, Inc. In March 2015 we
formed our majority owned subsidiary Beauty & Pin-Ups. In
November 2016 we changed the name of our parent company to Level
Brands, Inc. In December 2016 we effected a 1:5 reverse stock split
of our outstanding common stock.
In
April 2015 we entered into a Contribution Agreement with Beauty
& Pinups, Inc., a New York corporation that we refer to as
"BPUNY" and Priel Maman, pursuant to which BPUNY and Mr. Maman
contributed the business and certain assets, including the
trademark “Beauty & Pin Ups” and its variants,
certain other intellectual property and certain inventory to our
Beauty & Pin-Ups subsidiary in exchange for a 12% membership
interest in our subsidiary for Mr. Maman, a 10% membership interest
in our subsidiary for Sigan Industries Group, and $150,000 in cash.
At closing we assumed approximately $177,000 in BPUNY’s
accounts payable to its product vendor, Sigan Industries Group,
which bore interest at 6% annually. In connection with the
transaction, we entered into a two year exclusive Consulting
Agreement with Mr. Maman pursuant to which he is entitled to a
monthly fee of $12,000. In addition, pursuant to the Operating
Agreement of Beauty & Pin-Ups, we were granted the right to
redeem the 10% membership interest of Sigan Industries Group for
$110,000 at any time before April 13, 2017. In October 2016, as
amended in March 2017, we acquired Sigan Industries’
membership interest in exchange for 129,412 shares of our common
stock valued at $110,000. In April 2017 we acquired the remaining
12% interest in Beauty & Pin-Ups from Mr. Maman in exchange for
155,294 shares of our common stock. Following this transaction, we
now own 100% of Beauty & Pin-Ups.
We
are the manager of Beauty & Pin-Ups. Under the terms of the
operating for Beauty & Pin-Ups entered into in April 2015,
among other terms, any transfer or sale of any membership interests
requires our approval as well as the approval of a majority in
interest of members, subject to certain permitted transfers. There
are no mandatory additional capital contributions, and, after
giving effect to special allocations, the net income and net losses
of the entity will be allocated to members on a pro rata basis. The
operating agreement also requires the annual distribution out of
available cash an amount equal to the annual tax liability for the
fiscal year, less distributions.
I’M1
was formed in California in September 2016. IM1 Holdings, LLC, a
California limited liability company, or “IM1 Holdings“
was the initial member of I'M1. In January 2017, we acquired all of
the Class A voting membership interests in I’M1 from IM1
Holdings in exchange for 583,000 shares of our common stock valued
at $495,550. IM1 Holdings continues to own the Class B non-voting
membership interests of I’M1.
EE1
was formed in California in March 2016. EE1 Holdings, LLC, a
California limited liability company, or “EE1 Holdings" was
the initial member of EE1 Holdings. In January 2017, we acquired
all of the Class A voting membership interests in EE1 from EE1
Holdings in exchange for 283,000 shares of our common stock valued
at $240,550. EE1 Holdings continues to own the Class B non-voting
membership interests of EE1.
Ms.
Ireland, Mr. Sterling, Mr. Jason Winters, Mr. Roseberry and Mr. Jon
Carrasco are members of both IM1 Holdings and EE1
Holdings.
We
are the manager of both I’M1 and EE1. The terms of the
operating agreements for these entities, which are substantially
similar, govern their operations. If, as manager, we determine to
sell any additional interests in the entities, the existing members
have right of first refusal. Within 15 days of the end of each tax
estimation period, we are required to use our commercially
reasonable best efforts to distribute to the members in cash an
amount equal to the entity’s adjusted taxable income
allocated to each member for the period. We may also make
discretionary distributions to the members. Proceeds the entity may
receive from any capital transaction, after adequate provision for
any debts or obligations of the entity, are to be distributed to
the members. The transfer of any membership interests by members,
except for certain permitted transfers, must be pre-approved by the
consent of a majority of the Class B members.
MANAGEMENT
Directors and Executive Officers
The
following table provides information on our current executive
officers and directors:
Name
|
|
Age
|
|
Positions
|
|
|
|
|
|
Martin A. Sumichrast
|
|
50
|
|
Chairman of the Board of Directors, Chief Executive Officer and
President
|
Mark S. Elliott
|
|
56
|
|
Chief Financial Officer and Chief Operating Officer
|
Erik Sterling
|
|
63
|
|
Director
|
Anthony K. Shriver
|
|
52
|
|
Director
|
Seymour G. Siegel
|
|
74
|
|
Director
|
Bakari Sellers
|
|
32
|
|
Director
|
Gregory C. Morris
|
|
56
|
|
Director
|
Martin A.
Sumichrast. Mr. Sumichrast has served as a member of the
board of directors since our inception, and has served as our chief
executive officer and president since September 2016. Since 2012,
Mr. Sumichrast has served as Managing Director of a family office,
managingfamily wealth, which he formed in March 2012 and
subsequently incorporated into Washington Capital, LLC in December
2012. Since September 2013 he has been a Managing Member of Stone
Street Capital, LLC, a Charlotte, North Carolina-based private
investmentcompany. Stone Street Capital, LLC manages specific
purpose investment entities, as well as traditional private equity
funds. Mr. Sumichrast serves as a Trustee and Chairman of the
Nominating and Governance Committees of the Babson Capital Growth
Short Duration High Yield Fund, Inc. (NYSE: BGH) and the Babson
Capital Funds Trust, Inc. From January 2015 until January 2016, he
was also a member of the board of directors of Social Reality, Inc.
(NADASQ:SRAX) and served as a member of the Audit Committee. From
its formation in 2014 until March 1, 2017 he served as Chairman of
the Board of Directors of Kure Corp., a privately-held company. Mr.
Sumichrast also serves as Managing Director of Washington Capital,
LLC, his family office. We selected Mr. Sumichrast's to serve on
our board of directors based upon his significant experience both
as an investor and advisor, as well as his experience as a member
of a board of directors of a listed company.
Mark S.
Elliott. Mr. Elliott has been
our chief financial officer since October 2016 and our chief
operating officer since January 2017. He has over 30 years of
business experience spanning the financial, retail, consulting and
government sectors and includes time at Fortune 500 and regional
firms. Mr. Elliott began his career in the technology arena and
worked with such Fortune 500 companies as JCPenney and First Union
National Bank within their corporate headquarters. Mr. Elliott
moved into the consulting arena as a regional technology specialist
and eventually moved into senior management as a Director for
Contract Data Services (acquired by Inacom Information Systems).
This position involved all aspects of the business including staff
management, business development, strategy, and managing the
profitability of multiple divisions. Mr. Elliott was a founder and
partner of Premier Alliance Group (now named root9B Holdings, Inc.
NASDAQ:RTNB) and was the Chairman and CEO of the company from 2004
to 2013 where he oversaw the strategic direction and operation of
the company.He directed the transformation of the company to a
public market company and successfully oversaw and integrated 6
merger and acquisition transactions that strategically positioned
the company. Mr. Elliott has had compliance, financial reporting,
and strategic responsibilities within the company (serving as the
CFO also from 2004 to 2010 and as the Chief Administrative Officer
of the company from 2014 to 2015). Mr. Elliott is also an
independent advisor for Malidan Capital Group a firm specializing
in business restructuring and turn around management consulting.
Mr. Elliott received a Bachelor of Science degree with a
concentration in Computer Science and Management from Marshall
University.
Erik
Sterling. Mr. Sterling has
served as a member of our board of directors since April 2015. Mr.
Sterling is the founder of Sterling/Winters Company, a brand
building, marketing and management firm established 1978 and now a
wholly-owned subsidiary of kathy ireland Worldwide. Today the
efforts of Sterling/Winters Company encompass branded merchandise
development, licensing and entertainment programming. Mr. Sterling
also serves as Vice Chairman and Chief Financial Officer of kiWW.
Over the past 22 years, the Kathy Ireland brand has included
leading manufacturers of furniture, flooring, lighting, bedding,
decorative accessories, wall art, tabletop, window coverings,
precious jewelry, watches, sewing patterns, fashion accessories,
sportswear, women and girls swimwear, active wear, maternity,
intimate apparel, sleepwear, shoes, golf wear, fitness equipment,
publishing, made-for-television movies and specials. Mr. Sterling
serves on the National board of directors for Project Inform, an
HIV/AIDS treatment advocacy group which provides free treatment
information to its subscribers, and holds memberships in the
American Film Institute, Academy of Television Arts & Sciences
and the Hollywood Radio & Television Society. We selected Mr.
Sterling to serve on our board of directors because he brings to
the board extensive branding and marketing company experience, and
brings to the board significant executive leadership and
operational experience. Mr. Sterling is the father of Mr.
Roseberry.
Anthony K.
Shriver. Mr. Shriver has been a member of our board of
directors since June 2015. Mr. Shriver is the Chairman of Best
Buddies® International, a nonprofit 501(c)(3) organization
he founded in 1989 which is dedicated to establishing a global
volunteer movement that creates opportunities for one-to-one
friendships, integrated employment and leadership development for
people with intellectual and developmental disabilities (IDD). Best
Buddies has grown from one original chapter to almost 1,900 middle
school, high school, and college chapters worldwide, engaging
participants programs in each of the 50 United States, and over 50
countries around the world. Mr. Shriver is a member of the board of
directors of Kure Corp., a privately-held company. Mr. Shriver, who
graduated from Georgetown University, has been recognized for his
work on behalf of Best Buddies with diverse international accolades
and honorary degrees. We
selected Mr. Shriver to serve on our board of directors based upon
his lifelong commitment to charitable efforts and his dedication to
the principles upon which our company seeks to
operate.
Seymour G.
Siegel. Mr. Siegel has been a
member of our board of directors since March 2017. Mr. Siegel, a
certified public accountant, no longer in practice, has over 35
years of experience in public accounting and SEC regulatory matters
and has a strong background in mergers and acquisitions, start-ups,
SEC reporting, cost cutting initiatives, profit enhancements and
business operations. Since 2014 he has been President of Siegel
Rich, Inc., a consulting firm. From April 2000 until July 2014, Mr.
Siegel was a principal emeritus at Rothstein Kass & Company,
P.C. (now KPMG), an international firm of accountants and
consultants. Mr. Siegel was a founder of Siegel Rich & Co.,
CPAs, which eventually merged with what is now known as
WeiserMazars LLP, where he was a senior partner until selling his
interest and co-founding a business advisory firm which later
became a part of Rothstein Kass. He received his Bachelor of
Business Administration from the Baruch School of The City College
of New York. He has been a director and officer of numerous
business, philanthropic and civic organizations. As a professional
director, he has served on the boards of approximately a dozen
public companies over the last 25 years. Since 2005 he has been a
member of the board of directors and chairman of the audit
committees of Air Industries Group, Inc. (NYSE American:AIRI) and
root9B Holdings, Inc. (NASDAQ:RTNB). Mr. Siegel served as a member
of the board of directors of Hauppauge Digital, Inc., from 2003
until 2014, and as a member of the board of directors of Oak Hall
Capital Fund, Prime Motor Inns Limited Partnership, Noise
Cancellation Technologies, Inc., and Emerging Vision, Inc., among
others. We have selected Mr. Siegel as a member of our board of
directors as a result of his extensive experience in mergers and
acquisitions, public companies and boards, financial reporting and
business advisory services.
Bakari
Sellers. Mr. Sellers has been a
member of our board of directors since March 2017. Mr. Sellers, an
attorney, has been a member of the Strom Law Firm, LLC, in
Columbia, South Carolina since 2007. Mr. Sellers is a former member
of the South Carolina House of Representative, where he represented
the 90th District beginning in 2006, making history as the youngest
member of the South Carolina state legislature and the youngest
African American elected official in the nation. In 2014, he became
the Democratic nominee for Lt. Governor of South Carolina. He has
worked for United States Congressman James Clyburn and former
Atlanta Mayor Shirley Franklin. Earning his undergraduate degree
from Morehouse College, where he served as student body president,
and his law degree from the University of South Carolina, Mr.
Sellers has followed in the footsteps of his father, civil rights
leader Cleveland Sellers, in his tireless commitment to service
taking championing progressive policies to address issues ranging
from education and poverty to preventing domestic violence and
childhood obesity. He has served as a featured speaker at events
for the National Education Association, College Democrats of
America National Convention, the 2008 Democratic National
Convention and, in 2007, delivered the opening keynote address to
the AIPAC Policy Conference in Washington, DC. Mr. Sellers is a
political commentator at CNN. We selected Mr. Sellers as a member
of our board of directors as a result of his leadership experience,
commitment to public policy and legal
background.
Gregory C.
Morris. Mr. Morris has been a member of our board of
directors since March 2017. Mr. Morris has worked in positions
involving finance, investments, benefits, risk management, legal
and human resources for more than 30 years. Since June 2016 he has
served as the Vice President of Human Resources for Healthstat,
Inc., a privately held company providing onsite health clinics and
workplace wellness programs. Prior to that, from January 2013 until
June 2015, he was the Vice President of Administration and
Corporate Secretary at Swisher Hygiene (at that time a
NASDAQ-listed company), leading the human resources and legal
functions. He was employed by Snyder’s-Lance, Inc. (NASDAQ:
LNCE) for 15 years prior to joining Swisher Hygine, Inc., holding
the positions of Vice President-Human Resources and Senior Director
– Benefits and Risk Management. At Snyder’s-Lance, Mr.
Morris served as the Chairman of the Risk Management Committee,
chaired the Business Continuity Plan Steering Committee, and was a
member of the Corporate Mergers & Acquisitions team. Prior to
joining Snyder’s-Lance, he held various positions with Belk
Stores, Collins & Aikman and Laporte plc. Mr. Morris has served
as a board member for root9B Holdings, Inc. (NASDAQ:RTNB) since
2008 where he chairs the Compensation Committee and also serves on
the Audit Committee. Mr. Morris also served as a board member for
the Second Harvest Food Bank of Metrolina from 2001 to 2016. Mr.
Morris received a Bachelor of Science degree in Accounting from
West Virginia University. We selected Mr. Morris as a member of our
board of directors as a result of his extensive executive level
experience in public companies regarding human resources,
accounting, compliance and compensation matters as well as public
board experience.
The
term of office of each director is until the next annual election
of directors and until a successor is elected and qualified or
until the director’s earlier death, resignation or removal.
Officers are appointed by the board of directors and serve at the
discretion of the Board. There are no family relationships between
any of the executive officers, directors and director
nominees.
Kathy Ireland – Chairman Emeritus and Chief Brand
Strategist
Under
the terms of the consulting and advisory agreement with kathy
ireland® Worldwide, Ms. Ireland serves in the non-executive,
non-voting roles of our Chairman Emeritus, an honorary title, and
Chief Brand Strategist. She is one of America’s leading
design and marketing executives. Ms. Ireland is the founder of her
own private enterprise, kathy ireland® Worldwide, an entity
that began by selling a single pair of socks and morphed, after
selling 100 million pairs, into what Forbes reports as a licensing
empire. Ms. Ireland is referenced, by Forbes as, “First Lady
of Fly Over Country” and in 2017, as one of the most
successful, self-made women in America. Ms. Ireland is recognized
for utilizing her business platforms to serve global nonprofit
causes. Ms. Ireland is Founding Ambassador for the Dream
Foundation, America’s first wish fulfillment organization for
terminally ill adults. Global Ambassador for the Elizabeth Taylor
AIDS Foundation, Hardwired, Best Buddies International, YWCA GLA
and numerous other causes, including fundraising efforts for
military families, women and children’s health, as well as
the battle against Human Trafficking.
Key Management
The
following table provides information on key management for our
business lines:
Name
|
Positions
|
|
|
Elizabeth Pence
|
Co-Managing Director, Beauty & Pin-Ups
|
Brian Anderson
|
Co-Managing Director, Beauty & Pin-Ups
|
Stephen Roseberry
|
Co-Managing Director, I’M1; President, I'M1; Co-Managing
Director, EE1; President, EE1
|
Jon Carrasco
|
Global Creative Director, I’M1 and EE1
|
Tommy Meharey
|
Co-Managing Director, I’M1
|
Nic Mendoza
|
Co-Managing Director, EE1
|
Elizabeth
Pence. Mrs. Pence, an employee
of our company, is responsible for developing sales partnerships
for Beauty & Pin-Ups within the professional beauty industry
and building a unique marketing and education platform to support
sales. She has spent over 22 years leading sales organizations in
the professional beauty business. As Vice President of Field Sales
for Salon Centric (a division of L’Oreal), she led the sales
integration of various L’Oréal acquisitions of family
owned businesses within the industry, including Columbia Beauty
Supply, which her family owned since 1920.
Brian
Anderson. Mr. Anderson, an
employee of our company, began his career at his family’s
business, Columbia Beauty Supply, where he was instrumental in
growing the company to a $60 million enterprise. During his tenure,
it became the largest family-owned beauty distribution company in
the Southeast and a major distributor of L’Oreal products,
the largest beauty care company in the world. L’Oreal
acquired Columbia Beauty Supply in 2008.
Stephen
Roseberry. Mr. Roseberry is
President, Chief Marketing Officer and member of the board of
directors of kathy ireland® Worldwide and Sterling/ Winters
Company (SWC), and has spent his entire career in service to Kathy
Ireland and her business endeavors. Mr. Roseberry began his career
as an assistant to one of Ms. Ireland’s personal managers
during her modeling and acting career. He quickly rose from an
entry level position to head the talent business unit of Sterling/
Winters Company (SWC), a firm which Ms. Ireland purchased. SWC
clients past and present are Janet Jackson, Dolly Parton, Elizabeth
Taylor, The Pointer Sisters, Kenny Loggins, Steve Guttenberg, and
many other celebrities. Mr.
Roseberry develops all marketing and licensing programs for kathy
ireland® Worldwide and was instrumental in transforming kathy
ireland® Worldwide into a global licensing powerhouse. Mr.
Roseberry is the son of Mr. Sterling and the spouse of Mr.
Carrasco.
Jon Carrasco. Mr.
Carrasco is the Global Creative Director and executive vice present
of kathy ireland® Worldwide where he is responsible for all
creative aspects at kathy ireland® Worldwide. Among his
passions are photography and philanthropy. Mr. Carrasco has
represented and worked with Kathy Ireland® for over 25
years. Mr. Carrasco is the spouse of Mr. Roseberry.
Tommy
Meharey. Mr. Meharey
is a
Marine, a contractor and a model. His advertising campaigns have
taken place globally in Hawaii, New York, California, Thailand,
Japan and Indonesia, including Cartier, Gucci, Louis Vuitton,
Nivea, Zara, Tim Gunn’s Project Runway, Hawaii Five-0, Lost,
and Flirting with Forty. As a Marine, Mr. Meharey was stationed in
Hawaii, Japan, Okinawa, Philippines, Australia and other countries,
which are not at liberty to be discussed. He is a kathy
ireland®
Worldwide
Vice President and serves on
the kathy
ireland®
Worldwide
board of directors. Mr. Meharey is a
curator for weddings, real estate, and financial products, a
contributor to Worldwide Business with kathy ireland and Modern
Living with kathy ireland, which airs globally, in addition to
having produced Janet Jackson’s Unbreakable
tour in Hawaii.
Nic Mendoza. Mr. Mendoza is a Los
Angeles based multimedia producer, the youngest Vice President of
kathy ireland®
Worldwide,
and Executive Assistant to Jason Winters, Vision Strategist for
kathy ireland®
Worldwide.
From 2011 to 2015, he worked as a member of the management team on
Janet Jackson’s Number
1’s Up Close & Personal and Unbreakable
Tours,
respectively. He is also producer of Marilyn McCoo and Billy Davis,
Jr.’s current live tour Up,
Up & Away! a musical fable with The Next
Dimension. Nic recently produced E&M,
an album from Santa Barbara-based duo Erik &
Madeleine.
Leadership Structure and Risk Oversight
Mr.
Martin A. Sumichrast serves as both our chief executive officer and
chairman of our board of directors. Messrs. Shriver, Siegel,
Sellers and Morris are each considered an independent director
within the meaning of Section 803 of the NYSE American LLC Company
Guide. We do not have a “lead” independent
director.
Risk
is inherent with every business, and how well a business manages
risk can ultimately determine its success. We face a number of
risks, including credit risk, interest rate risk, liquidity risk,
operational risk, strategic risk and reputation risk. Management is
responsible for the day-to-day management of risks we face, while
the board, as a whole and through itscommittees, has responsibility
for the oversight of risk management. In its risk oversight role,
the board of directors has the responsibility to satisfy itself
that the risk management process designed and implemented by
management are adequate and functioning as designed. To do this,
the chairman of the board meets regularly with management to
discuss strategy and the risks facing our company. The CFO attends
the board meetings and is available to address any questions or
concerns raised by the board on risk management and any other
matters. The chairman of the board and independent members of the
board work together to provide strong, independent oversight of our
company’s management and affairs through its standing
committees and, when necessary, special meetings of independent
directors.
Board Committees
In
January 2017 our board of directors established standing Audit,
Compensation and Corporate Governance and Nominating Committees.
Each committee has a written charter. The charters are available on
our website at www.levelbrands.com.Information
concerning the current membership and function of each committee is
as follows:
Director
|
|
Audit
Committee
|
|
Compensation
Committee
|
|
Corporate
Governance and
Nominating
Committee
|
Anthony K. Shriver
|
|
|
|
✓
|
|
|
|
|
|
|
|
|
|
Erik Sterling
|
|
|
|
|
|
✓
|
|
|
|
|
|
|
|
Seymour G. Siegel
|
|
✓(C)
|
|
✓
|
|
|
|
|
|
|
|
|
|
Bakari Sellers
|
|
✓
|
|
|
|
✓(C)
|
|
|
|
|
|
|
|
Gregory C. Morris
|
|
✓
|
|
✓(C)
|
|
✓
|
|
|
|
|
|
|
|
C = chairman
Audit Committee
The
Audit Committee assists the board in fulfilling its oversight
responsibility relating to:
|
●
|
the integrity of our financial statements;
|
|
|
|
|
●
|
our compliance with legal and regulatory requirements;
and
|
|
|
|
|
●
|
the qualifications and independence of our independent registered
public accountants.
|
The
Audit Committee has the ultimate authority to select, evaluate and,
where appropriate, replace the independent auditor, approve all
audit engagement fees and terms, and engage outside advisors,
including its own counsel, as it deems necessary to carry out its
duties. The Audit Committee is also be responsible for performing
other related responsibilities set forth in its
charter.
The
Audit Committee is composed of three directors, Messrs. Siegel,
Sellers and Morris, each of whom has been determined by the board
of directors to be independent within the meaning of Section 803 of
the NYSE American LLC Company Guide. In addition, Mr. Siegel meets
the definition of “audit committee financial expert”
under applicable SEC rules.
Compensation Committee
The
Compensation Committee assists the board in:
|
●
|
determining, in executive session at which our chief executive
officer is not present, the compensation for our CEO or president,
if such person is acting as the CEO;
|
|
|
|
|
●
|
discharging its responsibilities for approving and evaluating our
officer compensation plans, policies and programs;
|
|
|
|
|
●
|
reviewing and recommending to the board regarding compensation to
be provided to our employees and directors; and
|
|
|
|
|
●
|
administering our equity compensation plan.
|
The
Compensation Committee is charged with ensuring that our
compensation programs are competitive, designed to attract and
retain highly qualified directors, officers and employees,
encourage high performance, promote accountability and assure that
employee interests are aligned with the interests of our
shareholders. The Compensation Committee is composed of three
directors, Messrs. Morris, Shriver and Siegel, each of whom has
been determined by the board of directors to be independent within
the meaning of Section 803 of the NYSE American LLC Company
Guide.
Corporate Governance and Nominating Committee
The
Corporate Governance and Nominating Committee:
|
●
|
assists the board in selecting nominees for election to the
Board;
|
|
|
|
|
●
|
monitor the composition of the board;
|
|
|
|
|
●
|
develops and recommends to the board, and annually reviews, a set
of effective corporate governance policies and procedures
applicable to our company; and
|
|
|
|
|
●
|
regularly review the overall corporate governance of the
Corporation and recommends improvements to the board as
necessary.
|
The
purpose of the Corporate Governance and Nominating Committee is to
assess the performance of the board and to make recommendations to
the board from time to time, or whenever it shall be called upon to
do so, regarding nominees for the board and to ensure our
compliance with appropriate corporate governance policies and
procedures. The Corporate Governance and Nominating Committee is
composed of three directors, two of whom (Messrs. Sellers and
Morris) have been determined by the board of directors to be
independent within the meaning of Section 803 of the NYSE American
LLC Company Guide.
Shareholder Nominations
Shareholders
who would like to propose a candidate may do so by submitting the
candidate’s name, resume and biographical information to the
attention of our Corporate Secretary. All proposals for nomination
received by the Corporate Secretary will be presented to the
Corporate Governance and Nominating Committee for appropriate
consideration. It is the policy of the Corporate Governance and
Nominating Committee to consider director candidates recommended by
shareholders who appear to be qualified to serve on our board of
directors. The Corporate Governance and Nominating Committee may
choose not to consider an unsolicited recommendation if no vacancy
exists on the board of directors and the committee does not
perceive a need to increase the size of the board of directors. In
order to avoid the unnecessary use of the Corporate Governance and
Nominating Committee’s resources, the committee will consider
only those director candidates recommended in accordance with the
procedures set forth below. To submit a recommendation of a
director candidate to the Corporate Governance and Nominating
Committee, a shareholder should submit the following information in
writing, addressed to the Corporate Secretary of Level Brands at
our main office:
|
●
|
the name and address of the person recommended as a director
candidate;
|
|
|
|
|
●
|
all information relating to such person that is required to be
disclosed in solicitations of proxies for election of directors
pursuant to Regulation 14A under the Exchange Act;
|
|
|
|
|
●
|
the written consent of the person being recommended as a director
candidate to be named in the proxy statement as a nominee and to
serve as a director if elected;
|
|
|
|
|
●
|
as to the person making the recommendation, the name and address,
as they appear on our books, of such person, and number of shares
of our common stock owned by such person; provided,
however, that if the person is
not a registered holder of our common stock, the person should
submit his or her name and address along with a current written
statement from the record holder of the shares that reflects the
recommending person’s beneficial ownership of our common
stock; and
|
|
|
|
|
●
|
a statement disclosing whether the person making the recommendation
is acting with or on behalf of any other person and, if applicable,
the identity of such person.
|
Code of Ethics and Conduct and Insider Trading Policy
In
January 2017 we adopted a Code of Ethics and Conduct which applies
to our board of directors, our executive officers and our
employees. The Code of Ethics and Conduct outlines the broad
principles of ethical business conduct we adopted, covering subject
areas such as:
|
●
|
conflicts of interest;
|
|
|
|
|
●
|
corporate opportunities;
|
|
|
|
|
●
|
public disclosure reporting;
|
|
|
|
|
●
|
confidentiality;
|
|
|
|
|
●
|
protection of company assets;
|
|
|
|
|
●
|
health and safety;
|
|
|
|
|
●
|
conflicts of interest; and
|
|
|
|
|
●
|
compliance with applicable laws.
|
A copy of our Code of Ethics and Conduct is
available on our website at www.levelbrands.com.
Additionally,
all of our directors, officers, employees and consultants are
subject to our Insider Trading Policy. Our Insider Trading Policy
prohibits the purchase, sale or trade of our securities with the
knowledge of material nonpublic information. In addition, our
Insider Trading Policy prohibitsour employees, officers, directors,
and consultants from trading on a short-term basis, engaging in a
short sale of our securities, engaging in transactions in puts,
call or other derivatives tied to our securities, engaging in
hedging transactions, holding any of our securities in a margin
account or otherwise pledging our securities as collateral for a
loan. Any transactions by our directors, officers, employees and
consultants must be first pre-cleared by our chief executive
officer in an effort to assist these individuals from inadvertently
violating our Insider Trading Policy. Our Insider Trading Policy
also fixes certain quarterly and event specific blackout
periods.
Limitation on Liability
Sections
55-8-50 through 55-8-58 of the North Carolina General Statutes
permit a corporation to indemnify its directors, officers,
employees or agents under either or both a statutory or
non-statutory scheme of indemnification. Under the statutory
scheme, a corporation may, with certain exceptions, indemnify a
director, officer, employee or agent of the corporation who was,
is, or is threatened to be made, a party to any threatened, pending
or completed legal action, suit or proceeding, whether civil,
criminal, administrative, or investigative, because of the fact
that such person was a director, officer, agent or employee of the
corporation, or is or was serving at the request of such
corporation as a director, officer, employee or agent of another
corporation or enterprise. This indemnity may include the
obligation to pay any judgment, settlement, penalty, fine
(including an excise tax assessed with respect to an employee
benefit plan) and reasonable expenses incurred in connection with a
proceeding (including counsel fees), but no such indemnification
may be granted unless such director, officer, agent or employee (i)
conducted himself in good faith, (ii) reasonably believed (a) that
any action taken in his official capacity with the corporation was
in the best interest of the corporation or (b) that in all other
cases his conduct at least was not opposed to the
corporation’s best interest, and (iii) in the case of any
criminal proceeding, had no reasonable cause to believe his conduct
was unlawful. Whether a director has met the requisite standard of
conduct for the type of indemnification set forth above is
determined by the board of directors, a committee of directors,
special legal counsel or the shareholders in accordance with
Section 55-8-55. A corporation may not indemnify a director under
the statutory scheme in connection with a proceeding by or in the
right of the corporation in which the director was adjudged liable
to the corporation or in connection with a proceeding in which a
director was adjudged liable on the basis of having received an
improper personal benefit.
In
addition to, and separate and apart from the indemnification
described above under the statutory scheme, Section 55-8-57 of
the North Carolina General Statutes permits a corporation to
indemnify or agree to indemnify any of its directors, officers,
employees or agents against liability and expenses (including
attorney’s fees) in any proceeding (including proceedings
brought by or on behalf of the corporation) arising out of their
status as such or their activities in such capacities, except for
any liabilities or expenses incurred on account of activities that
were, at the time taken, known or believed by the person to be
clearly in conflict with the best interests of the corporation. Our
bylaws provide for indemnification to thefullest extent permitted
by law for persons who serve as a director, officer, agent or
employee of Level Brands or at the request of Level Brands serve as
a director, officer, agent or employee for any other corporation,
partnership, joint venture, trust or other enterprise, or as a
trustee or administrator under an employee benefit plan.
Accordingly, we may indemnify our directors, officers, agents or
employees in accordance with either the statutory or non-statutory
standards.
Sections
55-8-52 and 55-8-56 of the North Carolina General Statutes require
a corporation, unless its articles of incorporation provide
otherwise, to indemnify a director or officer who has been wholly
successful, on the merits or otherwise, in the defense of any
proceeding to which such director or officer was a party. Unless
prohibited by the articles of incorporation, a director or officer
also may make application and obtain court-ordered indemnification
if the court determines that such director or officer is fairly and
reasonably entitled to such indemnification as provided in Sections
55-8-54 and 55-8-56.
Finally,
Section 55-8-57 of the North Carolina General Statutes provides
that a corporation may purchase and maintain insurance on behalf of
an individual who is or was a director, officer, employee or agent
of the corporation against certain liabilities incurred by such
persons, whether or not the corporation is otherwise authorized by
the North Carolina Business Corporation Act to indemnify such
party. We have purchased a standard directors’ and
officers’ liability policy which will, subject to certain
limitations, indemnify us and our officers and directors for
damages they become legally obligated to pay as a result of any
negligent act, error, or omission committed by directors or
officers while acting in their capacity as such.
As
permitted by North Carolina law, Article 6 of our Articles of
Incorporation limits the personal liability of directors for
monetary damages for breaches of duty as a director arising out of
any legal action for breach of duty as a director.
Insofar
as the limitation of, or indemnification for, liabilities arising
under the Securities Act may be permitted to directors, officers,
or persons controlling us pursuant to the foregoing, or otherwise,
we have been advised that, in the opinion of the Securities and
Exchange Commission, such limitation or indemnification is against
public policy as expressed in the Securities Act and is, therefore,
unenforceable.
Director Compensation
Prior
to December 2016, none of our directors received compensation for
services performed as directors. In December 2016, the board of
directors adopted a formal compensation plan for our independent
directors which was amended by the board in January 2017.
Currently, our board compensation plan effective for non-management
directors includes:
●
annual retainer of $10,000;
●
annual retainer for committee chairpersons as follows: $15,000 for
the Audit Committee Chairman; $5,000 for the Compensation Committee
Chairman; and $2,500 for the Corporate Governance and Nominating
Committee Chairman,
●
annual retainer for committee members as follows: $6,000 for
service on the Audit Committee; $2,000 for service on the
Compensation Committee; and $1,000 for service on the Corporate
Governance and Nominating Committee, and
●
$1,500 for each scheduled board meeting attended.
In
addition board members are reimbursed for out-of-pocket expenses
related to participation in board and committee
meetings.
The
following table provides information concerning the compensation
paid to our independent directors for their services as members of
our board of directors for the fiscal year ended September 30,
2016. The information in the following table excludes any
reimbursement of out-of-pocket travel and lodging expenses which we
may have paid:
|
|
Name
|
Fees
earned or
paid in
cash ($)
|
|
|
Non-equity
incentive
plan
compensation
($)
|
Nonqualified
deferred
compensation
earnings
($)
|
All other
compensation
($)
|
|
Erik
Sterling
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Anthony
K. Shriver
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
———————
In
October 2016 the board of directors awarded restricted stock grants
of 40,000 shares of our common stock valued at $34,000 which vest
on January 1, 2018 to each of Messrs. Sterling and Shriver as
compensation for services in fiscal 2017.
EXECUTIVE COMPENSATION
The
following table summarizes all compensation recorded by us in the
past two fiscal years for:
●
our principal executive officer or other individual serving in a
similar capacity;
●
our two most highly compensated executive officers (as that term is
defined under Rule 3b-7 of the Exchange Act) other than our
principal executive officer who were serving as executive officers
at September 30, 2016; and
●
up to two additional individuals for whom disclosure would have
been required but for the fact that the individual was not serving
as an executive officer at September 30, 2016.
For
definitional purposes, these individuals are sometimes referred to
as the “named executive officers.” The amounts included
in the “Option Awards” column represent the aggregate
grant date fair value of the stock options, computed in accordance
with ASC Topic 718. The assumptions made in the valuations of the
option awards are included in Note 8 of the notes to our audited
consolidated financial statements appearing elsewhere in this
Offering Circular.
Summary Compensation Table
Name and principal position
|
|
|
|
|
|
No equity
incentive plan
compensation
($)
|
Non-qualified
deferred
compensation
earnings
($)
|
All
other
compensation
($)
|
|
|
|
|
|
|
|
|
|
|
|
Martin A. Sumichrast (1)
|
2016
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0
|
Chief
Executive Officer
|
2015
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0
|
|
|
|
|
|
|
|
|
|
Kenneth F. Kahn (2)
|
2016
|
150,000
|
-
|
-
|
-
|
-
|
-
|
-
|
150,000
|
Former
Chief Executive Officer
|
2015
|
105,000
|
-
|
-
|
-
|
-
|
-
|
-
|
105,000
|
|
|
|
|
|
|
|
|
|
Brian
Anderson
|
2016
|
150,000
|
-
|
-
|
-
|
-
|
-
|
-
|
150,000
|
Former Executive Vice President
(3)
|
2015
|
105,000
|
-
|
-
|
-
|
-
|
-
|
-
|
105,000
|
———————
(1)
|
Mr. Sumichrast has served as our chief executive officer since
September 2016 and a member of our board of directors since
inception and initially served without compensation. In January
2017 we entered into an employment agreement with Mr. Sumichrast
pursuant to which he receives a base salary of $120,000. The amount
of compensation paid to Mr. Sumichrast excludes amounts paid to
Stone Street Partners, LLP. See “Certain Relationships and
Related Party Transactions” appearing later in this Offering
Circular.
|
|
|
(2)
|
Mr. Kahn served as our chief executive officer and a member of our
board of directors from March 2015 until September
2016.
|
|
|
(3)
|
Mr. Anderson served as Executive Vice President and a member of our
board of directors from March 2015 until September
2016.
|
Executive Compensation Arrangements
During
fiscal 2016 we were not a party to any employment agreements with
any executive. In fiscal 2016 Messrs. Kahn’s and
Anderson’s compensation was determined by the board of
directors of which they were members.
On
October 1, 2016 we entered into a letter agreement with Mr. Elliott
under which we engaged him to serve as our Chief Financial Officer.
Under the terms of the agreement, we paid him initial base monthly
compensation of $6,000. The agreement further provided that on
January 1, 2017 we would issue him 20,000 shares of our common
stock valued at $17,000; and grant him option to purchase an
additional 100,000 shares of our common stock with an exercise
price of $7.50 per share which vests on January 1, 2018. The letter
agreement with Mr. Elliott was superseded by an employment
agreement described below.
In
addition, in October 2016 our board of directors granted Mr.
Sumichrast a restricted stock award of 150,000 shares of our common
stock valued at $127,500 as incentive compensation for his
continued service to our company. The shares vest on the earlier of
January 1, 2018 or his death.
In
January 2017 we entered into employment agreements with each of Mr.
Sumichrast and Mr. Elliott, the terms of which are substantially
similar, including:
●
the
term of each agreement is for one year and it may be extended for
additional one year periods at our option upon 60 days’
notice;
●
the
executive is entitled to an annual base salary of $120,000. The
agreement initially provided that the compensation due Mr.
Sumichrast is would accrue until the completion of this offering,
after which time all accrued compensation will was be paid to him.
In April 2017 the employment agreement with Mr. Sumichrast was
amended to provide that we begin paying Mr. Sumichrast his
compensation on a current basis;
●
the
executive is entitled to a discretion bonus as determined by our
board of directors;
●
the
executive is entitled to participate in all benefit programs we
offer our employees, and such amount of paid vacation as is
consistent with his position and length of service to
us;
●
the
agreement will terminate upon his death or disability, and may be
terminated by us with or without cause, subject to cure periods, or
by the executive at his discretion. The executive is not entitled
to any severance or similar benefits upon a termination of the
agreement; and
●
the
agreement contains customary non-compete, confidentiality and
indemnification provisions.
Outstanding Equity Awards at Fiscal Year-End
The
following table provides information concerning unexercised
options, stock that has not vested and equity incentive plan awards
for each named executive officer outstanding as of September 30,
2016:
|
|
|
Name
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
|
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
|
Equity
Incentive
Plan
Awards: Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)
|
Option
Exercise
Price
($)
|
|
Number of
Shares
or Units of
Stock
That Have Not
Vested
(#)
|
Market
Value
of Shares
or Units of Stock
That
Have Not
Vested
($)
|
Equity
Incentive
Plan
Awards: Number of
Unearned
Shares,
Units or Other
Rights
that Have Not
Vested
(#)
|
Equity (#)
Incentive
Plan Awards: Market or Payout Value of Unearned Shares, Units or
Other Rights That Have Not Vested
|
Martin
A. Sumichrast
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
Kenneth
F. Kahn(1)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|
|
|
|
|
|
|
|
|
|
William
Brian Anderson(2)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1)
Former Chief Executive Officer and Director
(2)
Former Executive Vice President and Director
Indemnification Agreements
Our
articles of incorporation and by-laws provide for the
indemnification of our directors and officers to the fullest extent
permitted by the North Carolina General Statutes. In addition to
the indemnification provided under our certificate of incorporation
and by-laws, we have entered into separate indemnification
agreements with each of our current directors. Under these
agreements, we have agreed to indemnify the director (in excess of
statutory indemnification and subject to limited exceptions) in
connection with the occurrence of any threatened, pending or
completed action, suit, arbitration, alternative dispute resolution
mechanism, investigation, inquiry, administrative hearing or any
other actual, threatened or completed proceeding, in which the
director is a party or is threatened to be made a party, by reason
of the fact that the individual is a director of our company,
against any and all expenses, including all costs, charges and
expenses incurred in connection with any proceeding (including
reasonable expert, consultant and attorneys’ fees and all
reasonable disbursements), judgments, fines and amounts paid in
settlement including, without limitation, expenses of
investigation, judicial or administrative proceedings and appeals.
We expect to enter into similar agreements with our director
nominees in the near future.
Insofar
as the limitation of, or indemnification for, liabilities arising
under the Securities Act of 1933 may be permitted to directors
pursuant to the agreements, or otherwise, we have been advised
that, in the opinion of the Securities and Exchange Commission,
such limitation or indemnification is against public policy as
expressed in the Securities Act of 1933 and is, therefore,
unenforceable.
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Our
audit committee will review any transaction in which we or any of
our directors, nominees for director, executive officers or holders
of more than 5% of our common stock or any of their immediate
family members, is, was or is proposed to be a participant and the
amount involved exceeds the lesser of $120,000 or 1% of our average
total assets at year-end for our last two completed fiscal
years. Our management is responsible for determining
whether a transaction contains the characteristics described above
requiring review by our board of directors.
Since
our inception in March 2015 we have engaged in the following
transactions with our directors, executive officers, and owners of
10% or more of our common stock. A number of these transactions
related to loans providing working capital to us or transactions
involving the provision of management advisory services while in
our early stage of development. We do not expect to enter into
similar related party transactions in the future following the
closing of this offering. The foregoing transactions are in
addition to compensatory issuances to our directors and executive
officers which are described earlier in this Offering Circular. Set
forth below are all related party transactions with our directors,
executive officers and 10% or greater shareholders since
inception:
Transactions with affiliates of Mr. Sumichrast
●
|
in March 2015 we borrowed $150,000 from Stone Street Partners, LLC,
an affiliate of Mr. Sumichrast, under the terms of a promissory
note. We used these proceeds for general working capital. In April
2015 we entered into a conversion agreement with Stone Street
Partners, LLC under which this note, plus an additional $850,000
paid to us, was converted into 1,000,000 shares of our common
stock;
|
●
|
in April 2015, we entered into an advisory services agreement with
Stone Street Partners, LLC pursuant to which it agreed to provide
us certain management services for a monthly fee of $10,000,
payable at the earlier of such time as we had sufficient capital to
satisfy this obligation or upon the closing of an offering
resulting in gross proceeds to us of at least $5 million. In
October 2016 we entered into a termination agreement of this
advisory services agreement under which we paid Stone Street
Partners, LLC $50,000 and issued it 36,000 shares of our common
stock, valued at $270,000, in full satisfaction of all obligations.
In addition, we issued 40,000 shares of our common stock for
additional consulting services which were outside the original
scope of service, which were valued at $300,000.
|
●
|
in August 2015, we entered into revolving line of credit for up to
$1 million with LBGLOC LLC. Stone Street Partners Opportunity Fund
II, LLC, an affiliate of Mr. Sumichrast, was a member of LBGLOC LLC
at the time we entered into the revolving credit facility. Amounts
drawn by us under the credit line bore interest at 10% per annum
and we granted LBGLOC LLC a security interest in our assets to
secure our obligations under this credit line. Stone Street
partners Opportunity Fund II, LLC provided $300,000 under this
credit line which were used for inventory related expense. In
November 2015 the fund exited the line of credit and we repaid the
principal with interest of $8,750. In June 2017 the lender
converted $879,380 due under the line of credit, representing
outstanding principal and accrued but unpaid interest, into 222,627
shares of our common stock at a conversion price of $3.95 per share
in full satisfaction of these obligations. Upon this conversion,
the security interest we had previously granted in our assets was
released.
|
●
|
from time to time Stone Street Partners, LLC advanced funds to us
for working capital under the terms of a promissory note dated July
20, 2016. Between July 2016 and August 2016 we borrowed $303,966
under this note. Between September 2016 and December 2016 we repaid
the advances together with interest in the amount of
$3,352;
|
|
|
●
|
in March 2017 I'M1 entered into a consulting agreement and a
license agreement with Kure Corp. Mr. Sumichrast served as Chairman
of the Board of Kure Corp. from its formation in 2014 until March
1, 2017 and he continues to beneficially own approximately 9% of
Kure Corp. We sub-lease our principal executive offices from a
subsidiary of Kure Corp.; and
|
|
|
●
|
in July 2017 we sold Stone Street Partners, LLC the 65 shares of
NuGene's Series B Convertible Preferred Stock which was issued to
us as partial compensation under the terms of the consulting
agreement between NuGene and I'M1 for $475,000. At closing, Stone
Street Partners, LLC tendered $200,000 in cash to us together with
a $275,000 principal amount 3% promissory note due July 31, 2018.
To secure the payment of this note, 38 of these shares were
deposited into escrow with our counsel. Upon the payment of the
note, the shares will be released to Stone Street Partners, LLC. If
the note is not timely paid, the shares will be returned to us by
the escrow agent.
|
Transactions with affiliates of Mr. Sterling
●
|
in April 2015, we sold kathy ireland® Worldwide, an affiliate
of Mr. Sterling, a five-year warrant to purchase 500,000 shares of
our common stock at an exercise price of $1.25 per share for
$25,000. Subsequent to this transaction, kathy ireland®
Worldwide transferred a portion of the warrant to a third-party.
These warrants were exercised on a cashless basis in March
2016;
|
●
|
in April 2015, we also entered into a management services agreement
with kathy ireland® Worldwide pursuant to which it agreed to
provide management certain creative and marketing services. As
compensation, we paid kathy ireland® Worldwide $100,000 upon
the execution of the agreement and agreed to pay it a deferred
monthly fee of $10,000, to the extent kathy ireland® Worldwide
was providing services to us, an annual fee of 10% of the gross
margins of our company after the first $10 million in revenues; and
a $750,000 royalty fee. In October 2016 we entered into a
termination of management services agreement with kathy
ireland® Worldwide under which the management services
agreement was terminated upon the payment to it of
$50,000;
|
|
|
●
|
in February 2017, we entered into a master advisory and consulting
agreement with kathy ireland® Worldwide, as amended, pursuant
to which we have engaged the company to provide non-exclusive
strategic advisory services to us under a term expiring in February
2015. As compensation under the agreement we agreed to pay kathy
ireland® Worldwide a nominal monthly fee. We are also
responsible for the payment of expenses incurred by Ms. Ireland or
kathy ireland® Worldwide in providing these services to us. In
September 2017, we entered into an amendment to the agreement,
under which the parties also granted each other certain rights for
opportunities introduced by one party to the other, including
rights of first refusal and the payment of referral
fees;
|
|
|
●
|
in
September 2017, we entered into a license agreement with kathy
ireland® Worldwide under which it granted us a
non-transferrable license to use the kathy ireland® trademark,
as well as Ms. Ireland's likeness, videos, photographs and other
visual representations in connection with this offering, including
the associated road shows, subject to its prior approval. Under the
terms of the agreement, which expires on October 31, 2017, we
agreed to pay kathy ireland® Worldwide $100,000, of which
$50,000 has been paid, and the balance will be paid from the
proceeds of this offering; and
|
|
|
●
|
in
September 2017, we also entered into a wholesale license agreement
with kathy ireland® Worldwide under which we were granted an
exclusive, royalty free right to license, assign and use the kathy
ireland® Health & Wellness™ trademark, and all trade
names, trademarks and service marks related to the intellectual
property including any derivatives or modifications, goodwill
associated with this intellectual property when used in conjunction
with health and wellness as well as Ms. Ireland's likeness, videos,
photographs and other visual representations connected with kathy
ireland® Health & Wellness™. As compensation under
this agreement, we agreed to pay kathy ireland® Worldwide a
marketing fee of $840,000, of which $360,000 is payable from the
proceeds of this offering and the balance is payable in equal
annual installments beginning January 1, 2018, subject to
acceleration. Under the terms of this agreement, we also agreed to
pay kathy ireland® Worldwide a royalty of 33 1/3% of our net
proceeds under any sublicense agreements we may enter into for this
intellectual property.
|
Transactions with affiliates of Mr. Shriver
●
|
in January 2016 Beauty & Pin-Up's entered into a charitable
agreement, as amended, with Best Buddies International pursuant we
issued 30,000 shares of our common stock valued at $225,000 as a
charitable contribution. Under the terms of this agreement which
expires in December 2021 we agreed to recognize Best Buddies
International as Beauty & Pin-Up's official charity partner and
include its logo on our products. The agreement also provides
that we make a mandatory annual charitable cash contribution to
Best Buddies International of ½ of 1% of Beauty & Pin-Up's
annual net sales (after discounts and returns) for all sales of
Beauty & Pin-Up's branded products up to $10 million, which
increases to 1% of annual net sales in excess of $10 million. These
cash contributions totaled $10,157 in fiscal 2016 and $1,114 during
the first quarter of fiscal 2017;
|
●
|
in October 2016 we issued Best Buddies International an additional
20,000 shares of our common stock valued at $17,000 as a charitable
contribution; and
|
|
|
●
|
in August 2017 EE1 entered into a representation agreement with
Romero Britto and Britto Central, Inc. Alina Shriver, Mr. Shriver's
wife, is President of Britto Licensing, an affiliate of the
licensor. She also serves as Vice President of Art and Merchandise
of Best Buddies International.
|
Transactions with affiliates of G. Tyler Runnels, a former member
of our board of directors.
●
|
in April 2015, we sold Mr. G. Tyler Runnels, a former member of our
board of directors, 500,000 shares of our common stock in a private
transaction at a purchase price of $1.00 per share;
|
●
|
In June 2015, we engaged T.R. Winston & Co., LLC, a
broker-dealer and member of FINRA that is an affiliate of Mr.
Runnels, to serve as our exclusive placement agent in a private
placement of our securities which resulted in gross proceeds to us
of $1,000,000. In this offering, we paid T.R. Winston & Co.,
LLC cash commissions of $60,000 and issued its affiliates five year
placement agent warrants to purchase 50,000 shares of our common
stock at an exercise price of $2.75 per share, which are
exercisable on a cashless basis; and
|
●
|
in December 2015, we engaged T.R Winston & Co., LLC to serve as
our exclusive placement agent in a private placement of our
securities which resulted in gross proceeds to us of $2,150,000 in
February 2016. In this offering, we paid T.R. Winston & Co.,
LLC cash commissions of $150,500 and issued its affiliates four
year placement agent warrants to purchase 20,067 shares of our
common stock at an exercise price of $8.75 per share, which are
exercisable on a cashless basis. In February 2016 we reduced the
exercise price of these warrants to $5.00 per share. These warrants
and the warrants associated with the June 2015 placement were
exercised on a cashless basis in October 2016.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
At
September 14, 2017, we had 5,764,668 shares of our common stock
issued and outstanding. The following table sets forth information
regarding the beneficial ownership of our common stock
by:
|
●
|
each person known by us to be the beneficial owner of more than 5%
of our common stock;
|
|
|
|
|
●
|
each of our directors;
|
|
|
|
|
●
|
each of our named executive officers;
|
|
|
|
|
●
|
our named executive officers and directors as a group;
and
|
|
|
|
|
●
|
on a pro forma basis giving effect to the sale of _________ shares
of common stock offered hereby, but giving no effect to the sale of
the Additional Shares, if any, or the exercise of any outstanding
options or warrants.
|
Unless
specified below, the business address of each shareholder is c/o
4521 Sharon Road, Suite 407, Charlotte, NC 28211. The percentages
in the table have been calculated on the basis of treating as
outstanding for a particular person, all shares of our common stock
outstanding on that date and all shares of our common stock
issuable to that holder in the event of exercise of outstanding
options, warrants, rights or conversion privileges owned by that
person at that date which are exercisable within 60 days of that
date. Except as otherwise indicated, the persons listed below have
sole voting and investment power with respect to all shares of our
common stock owned by them, except to the extent that power may be
shared with a spouse.
|
|
|
Name of
Beneficial Owner
|
Amount
and Nature of Beneficial Ownership
|
Prior to
Offering
|
|
Directors and Named Executive Officers
|
|
|
|
Martin A. Sumichrast (1)
|
891,060
|
15.6%
|
%
|
Mark S. Elliott (2)
|
81,600
|
1.4%
|
%
|
Erik Sterling (3)(6)
|
166,667
|
2.9%
|
%
|
Anthony K. Shriver (4)
|
87,500
|
1.5%
|
%
|
Seymour G.
Siegel
|
0
|
*
|
*
|
Bakari
Sellers
|
0
|
*
|
*
|
Gregory G.
Morris
|
0
|
*
|
*
|
All officers and directors as a group (seven
persons) (1)(2)(3)(4)(6)
|
1,176,867
|
20.7%
|
%
|
5% or Greater Holders
|
|
|
|
G. Tyler Runnels (5)
|
600,000
|
10.5%
|
%
|
IM1 Holdings LLC (6)
|
583,000
|
10.2%
|
%
|
EE1 Holdings LLC (6)
|
283,000
|
5.0%
|
%
|
*
Less than 1%.
(1)
|
The number of shares of our common stock owned by Mr. Sumichrast
includes:
|
|
●
|
325,834 shares owned of record by Stone Street Partners,
LLC;
|
|
|
|
|
|
|
●
|
294,586 shares owned of record by Stone Street Partners Opportunity
Fund II, LLC; and
|
|
|
|
|
|
|
●
|
270,600 shares owned of record by Washington Capital,
LLC.
|
|
|
|
|
Mr.
Sumichrast in his position at Stone Street Partners, LLC has the
right to direct the vote and disposition of securities owned by
Stone Street Partners, LLC. SCAP Management Group, LLC is the
managing member of Stone Street Partners Opportunity Fund II, LLC.
Mr. Sumichrast in his position at SCAP Management Group, LLC has
the right to direct the vote and disposition of securities owned
Stone Street Partners Opportunity Fund II, LLC. Mr. Sumichrast has voting and dispositive control
over securities owned by Washington Capital LLC. Mr. Sumichrast
disclaims beneficial ownership of the securities held of record by
each of these entities except to the extent of his pecuniary
interest therein. The number of shares of our common stock owned by
Mr. Sumichrast excludes a grant of 150,000 shares which have not
yet vested.
|
(2)
|
The number of shares of our common stock beneficially owned by Mr.
Elliott includes:
|
|
|
●
|
1,680 shares held of record by his spouse's retirement account;
and
|
|
|
●
|
50,000 shares underlying vested stock options.
|
|
|
The number of shares owned by Mr. Elliott excludes 100,000 shares
underlying options which have not yet vested.
|
(3)
|
The number of shares of our common stock owned of record by Mr.
Sterling include 166,667 shares owned of record by The
Sterling/Winters Living Trust. Mr. Sterling has voting and
dispositive control over securities held of record by The
Sterling/Winters Living Trust. Mr. Sterling disclaims beneficial
ownership of the securities held of record by this entity except to
the extent of his pecuniary interest therein. See footnote 6. The
number of shares of our common stock owned by Mr. Sterling excludes
a grant of 40,000 shares which have not yet
vested.
|
(4)
|
The number of shares of our common stock owned by Mr. Shriver
includes 50,000 shares of our common stock held of record by Best
Buddies International over which Mr. Shriver has voting and
dispositive control, but excludes a grant of 40,000 shares which
has not yet vested.
|
(5)
|
The number of shares of our common stock owned by Mr. Runnels
includes 600,000 shares held of record by his family trust. Mr.
Runnels has voting and dispositive control over securities held of
record by his family trust. Mr. Runnel’s address is 2049
Century Park East, Suite 320, Los Angeles, CA 90067. Mr. Runnels
was a member of our board of directors from April 2015 until August
2016.
|
(6)
|
Ms. Ireland, Mr. Sterling and Messrs. Jason Winters, Steven
Roseberry and Jon Carrasco have shared voting and dispositive
control over securities held of record by IM1 Holdings, LLC and EE1
Holdings, LLC. Each of these individuals disclaims beneficial
ownership of the securities held of record by these entities except
to the extent of her or his pecuniary interest therein. The address
for each of these entities is 39 Princeton Drive, Rancho Mirage, CA
92270.
|
Securities authorized for issuance under equity compensation
plans
The
following table sets forth securities authorized for issuance under
any equity compensation plans approved by our shareholders as well
as any equity compensation plans not approved by our shareholders
as of September 30, 2016.
Plan category
|
Number of
securities to
be issued upon
exercise
of outstanding
options,
warrants
and rights
(a)
|
Weighted
average
exercise
price of outstanding
options,
warrants
and rights
|
Number of
securities
remaining
available
for future issuance
under
equity compensation
plans
(excluding securities
reflected
in column
(a))
|
Plans
approved by our shareholders:
|
|
|
|
2015
Equity Compensation Plan
|
40,000
|
$2.00
|
1,135,000
|
Plans
not approved by shareholders:
|
0
|
n/a
|
n/a
|
2015
Equity Compensation Plan
On
June 2, 2015, our board of directors and shareholders adopted our
2015 Equity Compensation Plan, which we refer to as the “2015
Plan,” initially covering 1,175,000 shares of common stock.
The 2015 Plan also contains an “evergreen formula”
pursuant to which the number of shares of common stock available
for issuance under the 2015 Plan will automatically increase on the
first trading day of January each calendar year during the term of
the 2015 Plan, beginning with calendar year 2016, by an amount
equal to 1% of the total number of shares of common stock
outstanding on the last trading day in December of the immediately
preceding calendar year, up to a maximum annual increase of 100,000
shares of common stock. The purpose of the 2015 Plan is to enable
us to offer to our employees,officers, directors and consultants,
whose past, present and/or potential contributions to our company
have been, are or will be important to our success, an opportunity
to acquire a proprietary interest in our company. The 2015 Plan is
administered by our board of directors. Plan options may either
be:
●
incentive
stock options (ISOs);
●
non-qualified
options (NSOs);
●
awards
of our common stock; or
●
rights
to make direct purchases of our common stock which may be subject
to certain restrictions
Any
option granted under the 2015 Plan must provide for an exercise
price of not less than 100% of the fair market value of the
underlying shares on the date of grant, but the exercise price of
any ISO granted to an eligible employee owning more than 10% of our
outstanding common stock must not be less than 110% of fair market
value on the date of the grant. The plan further provides that with
respect to ISOs the aggregate fair market value of the common stock
underlying the options which are exercisableby any option holder
during any calendar year cannot exceed $100,000. The term of each
plan option and the manner in which it may be exercised is
determined by the board of directors or the compensation committee,
provided that no option may be exercisable more than 10 years after
the date of its grant and, in the case of an incentive option
granted to an eligible employee owning more than 10% of the common
stock, no more than five years after the date of the grant. In the
event of any stock split of our outstanding common stock, the board
of directors in its discretion may elect to maintain the stated
amount of shares reserved under the plan without giving effect to
such stock split. Subject to the limitation on the aggregate number
of shares issuable under the plan, there is no maximum or minimum
number of shares as to which a stock grant or plan option may be
granted to any person.
DESCRIPTION OF SECURITIES
Our
authorized capital is 150,000,000 shares of common stock, par value
$0.001 per share, and 50,000,000 shares of blank check preferred
stock, par value $0.001 per share. At September 14, 2017, there
were 5,764,668 shares of common stock and no shares of preferred
stock issued and outstanding.
Common Stock
Holders
of common stock are entitled to one vote for each share on all
matters submitted to a shareholder vote. Holders of common stock do
not have cumulative voting rights. Holders of common stock are
entitled to share in all dividends that the board of directors, in
its discretion, declares from legally available funds. In the event
of our liquidation, dissolution or winding up, subject to the
preferences of any shares of our preferred stock which may then be
outstanding, each outstanding share entitles its holder to
participate in all assets that remain after payment of liabilities
and after providing for each class of stock, if any, having
preference over the common stock.
Holders
of common stock have no conversion, preemptive or other
subscription rights, and there are no redemption provisions for the
common stock. The rights of the holders of common stock are subject
to any rights that may be fixed for holders of preferred stock,
when and if any preferred stock is authorized and issued. All
outstanding shares of common stock are duly authorized, validly
issued, fully paid and non-assessable.
Preferred Stock
Our
board of directors, without further shareholder approval, may issue
preferred stock in one or more series from time to time and fix or
alter the designations, relative rights, priorities, preferences,
qualifications, limitations and restrictions of the shares of each
series. The rights, preferences, limitations and restrictions of
different series of preferred stock may differ with respect to
dividend rates, amounts payable on liquidation, voting rights,
conversion rights, redemption provisions, sinking fund provisions
and other matters. Our board of directors may authorize the
issuanceof preferred stock, which ranks senior to our common stock
for the payment of dividends and the distribution of assets on
liquidation. In addition, our board of directors can fix
limitations and restrictions, if any, upon the payment of dividends
on both classes of our common stock to be effective while any
shares of preferred stock are outstanding.
Stock Options
As
of September 14, 2017, there are issued and outstanding stock
options to purchase 333,300 shares of common stock, of which 71,632
are exercisable, with a weighted average exercise price of $5.83
per share.
Warrants
As of
September 14, 2017, there are outstanding warrants to purchase
212,176 shares of common stock at an exercise price of $6.54 per
share.
Registration Rights
In
October 2016 we sold an aggregate amount of $2,125,000 of our 8%
convertible promissory notes to accredited investors, and in
connection with the issuance of the notes issued warrants to
purchase 141,676 shares of our common stock at an exercise price of
$7.80 per share. In June 2017, the note holders converted the
principal amount of the notes and all accrued interest into 570,254
shares of our common stock. At the time of the original
transaction, we granted the note holders piggy-back registration
rights, which are exercisable following this offering, covering the
shares of our common stock issued upon the conversion of the note
and upon the future exercise of the warrants.
Transfer Agent
The
transfer agent and registrar for our common stock is VStock
Transfer, LLC, 18 Lafayette Place, Woodmere, NY 11598.
NYSE American Listing
We
intend to apply to the NYSE American to list shares of our common
stock under the symbol “LEVB.” In order to meet one of
the requirements for listing our common stock on the NYSE American,
the selling agents intend to sell lots of 100 or more shares to a
minimum of 400 beneficial holders. Our common stock will not
commence trading on the NYSE American until each of the following
conditions are met: (i) the offering is terminated;and (ii) we have
filed a post-qualification amendment to the Offering Statement and
a registration statement on Form 8-A; and such post-qualification
amendment is qualified by the SEC and the Form 8-A has become
effective. Pursuant to applicable rules under Regulation A, the
Form 8-A will not become effective until the SEC qualifies the
post-qualification amendment. We intend to file the
post-qualification amendment and request its qualification
immediately prior to the termination of the offering in orderthat
the Form 8-A may become effective as soon as practicable. Even if
we meet the minimum requirements for listing on the NYSE American,
we may wait before terminating the offering and commencing the
trading of our common stock on the NYSE American in order to raise
additional proceeds. As a result, you may experience a delay
between the closing of your purchase of shares of our common stock
and the commencement of exchange trading of our common stock on the
NYSE American.
SHARES ELIGIBLE FOR FUTURE SALE
Future
sales of our common stock in the public market, or the availability
of such shares for sale in the public market, could adversely
affect market prices prevailing from time to time. Based on the
number of shares outstanding as of the date of this Offering
Circular, upon the completion of this offering, _________ shares of
our common stock will be outstanding, assuming no Additional Shares
are sold and no exercise of outstanding options or
warrants.
Rule 144
Pursuant
to Rule 144 of the Securities Act, a person who has beneficially
owned restricted shares of our common stock for at least six months
would be entitled to sell their securities provided
that:
●
|
such person is not deemed to have been one of our affiliates at the
time of, or at any time during, the three months preceding, a sale;
and
|
●
|
we are subject to the Exchange Act periodic reporting requirements
for at least three months before the sale and have filed all
required reports under Section 13 or 15(d) of the Exchange Act
during the 12 months (or such shorter period as we were required to
file reports) preceding the sale.
|
Persons
who have beneficially owned restricted shares of our common stock
or warrants for at least six months but who are our affiliates at
the time of, or at any time during the three months preceding, a
sale, would be subject to additional restrictions, by which such
person would be entitled to sell within any three-month period only
a number of securities that does not exceed the greater
of:
●
|
1% of the total number of shares of common stock then outstanding;
or
|
●
|
the average weekly reported trading volume of the common stock
during the four calendar weeks preceding the filing of a notice on
Form 144 with respect to the sale.
|
Sales
by our affiliates under Rule 144 are also limited by manner of sale
provisions and notice requirements and to the availability of
current public information about us.
For
purposes of the six-month holding period requirement of Rule 144, a
person who beneficially owns restricted shares of our common stock
issued pursuant to a cashless exercise of a warrant shall be deemed
to have acquired such shares, and the holding period for such
shares shall be deemed to have commenced on the date the warrant
was originally issued.
Rule
701
In
general, Rule 701 allows a shareholder who purchased shares of our
capital stock pursuant to a written compensatory plan or contract
and who is not deemed to have been an affiliate of ours during the
immediately preceding 90 days to sell those shares in reliance upon
Rule 144, but without being required to comply with the public
information, holding period, volume limitation or notice provisions
of Rule 144. All holders of Rule 701 shares, however, are required
to wait until 90 days after the date of this Offering Circular
before selling shares pursuant to Rule 701.
Lock-Up Agreements
In
connection with this offering, we and our officers and directors
and holders of our outstanding securities have agreed to enter into
lock-up agreements with the representative of the selling agents.
See “Plan of Distribution” for more
information.
PLAN OF DISTRIBUTION
Engagement Agreement
with Joseph Gunnar
We are
currently party to an engagement agreement, as amended, with
Joseph
Gunnar & Co., LLC (“Joseph Gunnar”), who has
agreed to act as sole book-runner and lead selling agent for us for
the sale of our common stock in this offering. Joseph Gunnar has
made no commitment to purchase all or any part of the shares of
common stock but has agreed to use its best efforts to sell the
shares of common stock being offered by us in the offering. The
term of the engagement agreement began on __________ and will
continue until _________, 2017, unless one of the following events
occurs prior to ___________, in which case the engagement agreement
would be terminated early:
●
we or Joseph
Gunnar terminate the engagement agreement for any
reason;
●
we execute a
definitive selling agency agreement, which we intend to enter into
with Joseph Gunnar, as lead selling agent; or
●
we
decide not to proceed with the offering or withdraw any offering
statement submitted to or filed with the SEC.
The
selling agents (as defined below) are not purchasing any of the
shares in this offering and are not required to sell any specific
number or dollar amount of securities, but will instead arrange for
the sale of securities to investors on a “best efforts”
basis, meaning that they need only use their best efforts to sell
the securities. The selling agents may sell some of the shares in
this offering through selected dealers.
Reimbursable
expenses in the event of termination. In the event the offering does not
close or the engagement agreement is terminated for any reason, we
have agreed to reimburse Joseph Gunnar for all unreimbursed,
reasonable, documented, out-of-pocket fees, expenses, and
disbursements, including Joseph Gunnar’s legal fees, up to
$150,000, less the $30,000 paid to date.
Commission and
Expenses. We will pay
Joseph Gunnar a commission equal to 7% of the gross proceeds of the
sale of shares of common stock sold by us in this offering,
including any shares sold subject to the additional share option.
If any shares are sold through selected dealers, such selected
dealers will receive a commission of $ per share sold.
We have
agreed to pay Joseph Gunnar, as lead selling agent, a
non-accountable expense allowance of 1% of the gross proceeds
received by us in the offering. We have paid an expense
deposit of $30,000 to the lead selling agent, which will be applied
against the out-of-pocket accountable expenses that will be paid by
us to the lead selling agent in connection with this offering, and
will be reimbursed to us to the extent not
incurred.
In
addition, we have also agreed to pay the following expenses of the
lead selling agent relating to the offering: (a) all fees, expenses
and disbursements relating to background checks of our officers and
directors in an amount not to exceed $15,000 in the aggregate; (b)
all filing fees and communication expenses associated with the
review of this offering by FINRA; (c) all fees, expenses and
disbursements relating to the registration, qualification or
exemption of securities offered under the securities laws of
foreign jurisdictions designated by the underwriter, including the
reasonable fees and expenses of the underwriter’s blue sky
counsel up to $20,000; (d) $29,500 for the underwriters’ use
of Ipreo’s book-building, prospectus tracking and compliance
software for this offering; (e) the selling agents’ legal
fees incurred in connection with this offering in an amount up to
$75,000; (f) $20,000 of the representatives’ actual
accountable road show expenses for the offering; and (g) the costs
associated with bound volumes of the public offering materials as
well as commemorative mementos and Lucite tombstones in an amount
not to exceed $2,500 in the aggregate.
We
estimate the expenses of this offering payable by us, not including
commissions, will be approximately $ .
Officer and
Directors. Our officers and directors shall be entitled to
purchase shares in the offering. Any such purchases shall be
conducted in compliance with the applicable provisions of
Regulation M.
Additional Share Option
We
have granted the selling agents an option, exercisable no later
than 45 calendar days after the closing of this offering, to sell
up to an additional $5,000,000 of shares of common stock from us at
the same price as the other shares sold for us in this offering.
There is no minimum number of shares of common stock that must be
sold in order to close this offering; however, the offering is
contingent upon notification from the NYSE American that our common
stock has been approved for listing hereby.
Selling Agents’ Warrants
Upon each closing of this offering, we have agreed to issue to
Joseph Gunnar as additional compensation warrants to purchase a
number of shares of the common stock equal to 5% of the total
shares of the common stock sold in the offering (the Selling
Agents’ Warrants). The Selling Agents’ Warrants will be
exercisable at a per share exercise price equal to 125% of the
public offering price per share of the shares of common stock sold
in this offering. The Selling Agents’ Warrants are
exercisable at any time and from time to time, in whole or in part,
during the four year period commencing one year from the date on
which the offering statement is qualified.
The
Selling Agents' Warrants and the shares of our common stock
underlying the Selling Agents’ Warrants have been deemed
compensation by FINRA and are therefore subject to a 180-day
lock-up pursuant to Rule 5110(g)(1) of FINRA. Joseph Gunnar, or
permitted assignees under such rule, may not exercise, sell,
transfer, assign, pledge, or hypothecate the Selling Agents’
Warrants or the shares of our common stock underlying the Selling
Agents' Warrants, nor will they engage in any hedging, short sale,
derivative, put, or call transaction that would result in the
effective economic disposition of the Selling Agents’
Warrants or the underlying shares for a period of 180 days from the
applicable closing. In addition, the
warrants provide for registration rights upon request, in certain
cases. The demand registration right provided will not be greater
than five years from the the date on which the offering statement
is qualified in compliance with FINRA Rule 5110(f)(2)(G)(iv). The
piggyback registration right provided will not be greater than
seven years from the the date on which the offering statement is
qualified in compliance with FINRA Rule 5110(f)(2)(G)(v). We will
bear all fees and expenses attendant to registering the securities
issuable on exercise of the warrants other than underwriting
commissions incurred and payable by the holders. The exercise price
and number of shares issuable upon exercise of the warrants may be
adjusted in certain circumstances including in the event of a stock
dividend or our recapitalization, reorganization, merger or
consolidation. However, the warrant exercise price or underlying
shares will not be adjusted for issuances of shares of common stock
at a price below the warrant exercise price.
Right of First Refusal
Until 12 months from the closing, Joseph Gunnar
shall have an irrevocable right of first refusal to act as sole
investment banker, sole book-runner and/or sole placement agent, at
Joseph Gunnar’s discretion, for each and every future public
and private equity and debt offerings for our company, or any
successor to or any subsidiary of our company, including all equity
linked financings, on terms customary for Joseph
Gunnar. Joseph Gunnar
shall have the sole right to determine
whether or not any other broker-dealer shall have the right to
participate in any such offering and the economic terms of any such
participation.
Lock-Up Agreements
We,
each of our directors and officers and all of our shareholders,
have agreed for a period of (i) 12 months after the date of this
Offering Circular in the case of our directors and officers and
(ii) 180 days after the date of this Offering Circular in the
case of Level Brands and any other holder of our outstanding
securities, without the prior written consent of the
representative, not to directly or indirectly:
●
issue
(in the case of us), offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, lend or
otherwise transfer or dispose of any shares of our common stock or
other capital stock or any securities convertible into or
exercisable or exchangeable for our common stock or other capital
stock; or
●
in
the case of us, file or cause the filing of any registration
statement under the Securities Act with respect to any shares of
our common stock or other capital stock or any securities
convertible into or exercisable or exchangeable for our common
stock or other capital stock; or
●
complete
any offering of our debt securities, other than entering into a
line of credit with a traditional bank; or
●
enter
into any swap or other agreement, arrangement, hedge or transaction
that transfers to another, in whole or in part, directly or
indirectly, any of the economic consequences of ownership of our
common stock or other capital stock or any securities convertible
into or exercisable or exchangeable for our common stock or other
capital stock, whether any transaction described in any of the
foregoing bullet points is to be settled by delivery of our common
stock or other capital stock, other securities, in cash or
otherwise, or publicly announce an intention to do any of the
foregoing.
Pricing of the Offering
Prior
to the offering, there has been no public market for our common
stock. The initial public offering price was determined by
negotiation between us and Joseph Gunnar. The principal factors
considered in determining the initial public offering price
include:
●
the information set
forth in this Offering Circular and otherwise available to Joseph
Gunnar;
●
our history and
prospects and the history of and prospects for the industry in
which we compete;
●
our past and
present financial performance;
●
our prospects for
future earnings and the present state of our
development;
●
the general
condition of the securities markets at the time of this
offering;
●
the recent market
prices of, and demand for, publicly traded common stock of
generally comparable companies; and
●
other factors
deemed relevant by Joseph Gunnar and us.
Indemnification and Control
We
have agreed to indemnify the selling agents against liabilities
relating to the offering arising under the Securities Act and the
Exchange Act, liabilities arising from breaches of some or all of
the representations and warranties contained in the underwriting
agreement, and to contribute to payments that the underwriters may
be required to make for these liabilities.
The
selling agents and their respective affiliates are engaged in
various activities, which may include securities trading,
commercial and investment banking, financial advisory, investment
management, investment research, principal investment, hedging,
financing and brokerage activities. The selling agents and their
respective affiliates may in the future perform various financial
advisory and investment banking services for us, for which they
received or will receive customary fees and expenses.
Our Relationship with the Selling Agents
In the
ordinary course of their various business activities, the selling
agents and their respective affiliates may make or hold a broad
array of investments and actively trade debt and equity securities
(or related derivative securities) and financial instruments
(including bank loans) for their own account and for the accounts
of their customers, and such investment and securities activities
may involve securities and/or instruments of the issuer. The
selling agents and their respective affiliates may also make
investment recommendations and/or publish or express independent
research views in respect of such securities or instruments, or
recommend to clients that they acquire, long and/or short positions
in such securities and instruments.
Offering Period and Expiration Date
This
offering will start on or after the date that the offering
statement is qualified by the SEC and will terminate on the
Termination Date (the "Offering Period").
Procedures for Subscribing
We plan to market this offering to
potential investors through the selling agents. This offering will
terminate on __________, 2017, subject to extension for up to
ninety (90) days with the mutual consent of us and Joseph Gunnar.
We will hold an initial closing on any number of shares of common
stock at any time during the Offering Period after we have received
notification of approval when we and Joseph Gunnar determine and
thereafter may hold one or more additional closings until we
determine to cease having any additional closings during the
Offering Period. We will close on proceeds based upon the order in
which they are received. No closing will be conducted unless we
have received Notification of Approval to list our common stock on
the NYSE American, LLC subject to meeting all of the requirements
of the NYSE American listing standards and official notice of
issuance, although we will elect to delay trading thereon until
after the earlier of final closing of the offering and the end of
the Offering Period. We and Joseph Gunnar will consider various
factors in determining the timing of any additional closings
following the initial closing, including the amount of proceeds
received at the initial closing and any prior additional closings,
and coordination with the commencement of trading on NYSE American,
LLC.
Unless
deposited in a clearing firm account, all funds received by Joseph
Gunnar and TriPoint in connection with the sale of the common stock
in this offering will be promptly transmitted to Wilmington Trust,
N.A. pursuant to the terms of an escrow agreement between us, the
escrow agent and the selling agents. In addition, subscribers may
pay for the aggregate shares to be purchased by the subscriber by a
check made payable to ___________,
by ACH electronic transfer or wire transfer to an account
designated by us, or by any combination of such methods. The
purchase price for the shares shall be paid simultaneously with the
execution and delivery to us of the subscription agreement.
Investors who participate in this offering (other than
through BANQ® an online
brokerage division of TriPoint or selected dealers who participate
after the Notification of
Approval has been received), will either deposit funds in
their brokerage account that will be promptly deposited in the
escrow account or be required to deposit their funds in an escrow
account held at ___________;
any such funds that ___________ receives will be held in escrow
until the applicable closing of the offering or such other time as
mutually agreed between us and Joseph Gunnar, and then used to
complete securities purchases, or returned if this offering fails
to close. Selected dealers shall only participate in this offering
after the contingency has been met and shall settle transactions
through DTC.
After
the Contingency has been met, we will notify clearing firms and
other brokers holding funds when it will conduct such closing. All
such funds received by Joseph Gunnar and TriPoint will then be
transferred, if not previously transferred, to the escrow account
until the earlier of the date of a closing with respect to such
proceeds (at which time such proceeds shall be used to complete
share purchases in the offering) and the end of the Offering Period
(at which time, such proceeds shall be returned to the applicable
investors without interest or deduction). Pursuant to Rule 15c2-4,
unless there is a closing with respect to escrowed proceeds in the
offering, we will not have any access to such proceeds. We may
begin accepting investment proceeds into escrow at any time
beginning two days after this offering circular has been qualified
by the SEC. After a closing, the selling agent and other brokers
will thereafter send trade confirmations to the
investors.
We may
decide to close the offering early or cancel it, in our sole
discretion. If we extend the offering, we will provide that
information in an amendment to this offering circular. If we close
the offering early or cancel it, we may do so without notice to
you, although if we cancel the offering all funds that may have
been provided by any investors will be promptly returned without
interest or deduction.
U.S.
investors may participate in this offering by opening an account
with BANQ®. The
BANQ®
website may be found at Banq.co. BANQ® is open to
qualified U.S. investors and accepts individual, joint, corporate
or IRA accounts. The application process takes approximately five
minutes and there are no account minimums. Deposits to
BANQ®
can be made via wire transfer or ACH deposit or by mailing in a
check. Deposits usually post to an account in three to five days.
BANQ®
is a division of the TriPoint, a member of FINRA and the Securities
Investor Protection Corporation, or “SIPC”, which
protects the securities of its members’ customers up to
$500,000 (including $250,000 for claims for cash). TriPoint and
BANQ®
do not charge a fee for opening an account or for depositing shares
purchased in the offering into such account.
Investors investing
through BANQ® will be
required to open their accounts and deposit funds into their
respective BANQ® accounts after
the qualification of this offering statement relating to this
offering but prior to the applicable closing of this offering in
which such investor is participating; in all events, no funds may
be used to purchase securities issued in this offering until the
offering statement relating to this offering and filed by us with
the SEC has been qualified by the SEC. After an account is opened
but before 48 hours prior to the applicable closing of the
offering, the investor will be required to deposit funds into the
account sufficient to purchase the amount of securities that the
investor intends to purchase in this offering. Such funds will not
be held in an escrow account or otherwise segregated as part of the
offering process. During the marketing period for the offering and
after the offering statement has been qualified, the investor will
provide an indication of interest as to the amount of securities
the investor intends to purchase. Approximately 24- 48 hours prior
to the completion of a closing in this offering, each investor that
has money deposited with BANQ® for this
offering will be asked by BANQ® via e-mail and
notification to the secure messages section of the website for the
BANQ®
online brokerage account will be notified of the final allocation
of the amount of securities such investor shall receive.
Indications will not be finalized without sufficient funds in the
investor’s BANQ® online
brokerage account. Upon the applicable closing, the funds required
to purchase that amount of securities will be removed from such
investor’s account and transferred to the account of Level
Brands, and the amount of securities purchased will be deposited
into such investor’s account.. In addition, if this offering
fails to close, no funds will be withdrawn, no securities will be
provided, the investor’s indication will not be confirmed and
the funds in the investor’s BANQ® account will
remain available for withdrawal, in accordance with the
investor’s account agreement with BANQ®.
Right to reject
subscriptions. After we receive your complete, executed
subscription agreement (forms of which are attached to the offering
statement as Exhibits 4.1 and 4.2) and the funds required under the
subscription agreement have been transferred to the escrow account,
we have the right to review and accept or reject your subscription
in whole or in part, for any reason or for no reason. We will
return all monies from rejected subscriptions immediately to you,
without interest or deduction.
Acceptance of
subscriptions. Upon our acceptance of a subscription
agreement, we will countersign the subscription agreement and issue
the shares subscribed at closing. Once you submit the subscription
agreement and it is accepted, you may not revoke or change your
subscription or request your subscription funds. All accepted
subscription agreements are irrevocable.
LEGAL MATTERS
The
validity of the securities offered by this Offering Circular has
been passed upon for us by Pearlman Law Group LLP, Fort Lauderdale,
Florida. Certain matters under North Carolina law have been passed
upon for us by ______________. The underwriter is represented by
Gracin & Marlow, LLP, New York, New York.
EXPERTS
Our
consolidated balance sheets as of September 30, 2016 and 2015 and
the related consolidated statements of operations,
shareholders’ deficit and cash flows for the period of
inception (March 17, 2015) through September 30, 2015 and the
fiscal year ended September 30, 2016 included in this Offering
Circular have been audited by Cherry Bekaert LLP, independent
registered public accounting firm, as indicated in their report
with respect thereto, and have been so included in reliance upon
the report of such firm given on their authority as experts in
accounting and auditing.
WHERE YOU CAN FIND ADDITIONAL INFORMATION
We have filed with the SEC a Regulation A Offering
Statement on Form 1-A under the Securities Act with respect to the
shares of our common stock to be sold in this offering. This
Offering Circular, which constitutes a part of the Offering
Statement, does not contain all of the information set forth in the
Offering Statement and exhibits and schedules to the Offering
Statement. For further information with respect to our company and
the shares of common stock to be sold in this offering, reference
is made to the Offering Statement, including the exhibits and
schedules to the Offering Statement. Statements contained in this
Offering Circular as to the contents of any contract is an exhibit
to the Offering Statement, each statement is qualified in all
respects by the exhibit to which the reference relates. In
addition, upon completion of this offering, we will become subject
to the information and periodic reporting requirements of the
Exchange Act, and will file annual, quarterly and current reports
and other information with the SEC. You may read and copy
this information at the SEC’s Public Reference Room, 100 F
Street, N.E., Room 1580, Washington, D.C. 20549. You may obtain
information on the operation of the Public Reference Room by
calling the SEC at 1-800-SEC-0330. The SEC also maintains an
Internet website that contains reports, proxy statements and other
information about issuers, including us, that file electronically
with the SEC. The address of this site is www.sec.gov.
LEVEL BRANDS, INC.
INDEX TO FINANCIAL STATEMENTS
Unaudited Interim Financial Statements
|
|
|
|
|
Condensed Consolidated Balance Sheets as of June 30, 2017 and
September 30, 2016
|
|
|
F-2
|
|
Condensed Consolidated Statements of Operations For the Three and
Nine Months Ended June 30, 2017 and 2016
|
|
|
F-3
|
|
Condensed
Consolidated Statements of Cash Flows For the Nine Months Ended
June 30, 2017 and 2016
|
|
|
F-4
|
|
Notes
to Condensed Consolidated Financial Statements
|
|
|
F-5
|
|
Report of Independent Registered Public Accounting
Firm
|
|
|
F-27
|
|
Consolidated
Balance Sheets as of September 30, 2016 and 2015
|
|
|
F-28
|
|
Consolidated Statements of Operations For the Years Ended September
30, 2016 and the initial period March 17, 2015 (inception) to
September 30, 2015
|
|
|
F-29
|
|
Consolidated
Statements of Cash Flows For the Years Ended September 30, 2016 and
the initial period March 17, 2015 (inception) to September 30,
2015
|
|
|
F-30
|
|
Consolidated
Statements of Shareholders’ Equity (Deficit) For the Years
Ended September 30, 2016 and the initial period March 17, 2015
(inception) to September 30, 2015
|
|
|
F-32
|
|
Notes
to Consolidated Financial Statements
|
|
|
F-33
|
|
See
Notes to Condensed Consolidated Financial Statements
F-1
LEVEL BRANDS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
JUNE
30, 2017 AND SEPTEMBER 30, 2016
|
|
|
|
|
|
Assets
|
|
|
|
|
|
Current
assets:
|
|
|
Cash
and cash equivalents
|
$398,350
|
$34,258
|
Accounts
receivable
|
318,719
|
163,974
|
Accounts
receivable other
|
114,000
|
-
|
Marketable
Securities
|
475,000
|
-
|
Investment
Other Securities
|
912,000
|
-
|
Inventory
|
797,126
|
687,465
|
Prepaid
expenses and other current assets
|
3,185
|
70,620
|
Total
current assets
|
3,018,380
|
956,317
|
Property and
equipment, net
|
149,148
|
180,281
|
Intangible
assets
|
1,930,094
|
486,760
|
|
|
|
Total
assets
|
$5,097,622
|
$1,623,358
|
|
|
|
Liabilities
and shareholders' equity (deficit)
|
|
|
|
|
|
Current
liabilities:
|
|
|
Accounts
payable
|
$496,058
|
$206,156
|
Deferred
Revenue
|
47,333
|
-
|
Accrued
Expenses
|
60,214
|
787,139
|
Interest
Payable
|
-
|
113,241
|
Line of
credit payable, to related party, net of unamortized costs of $0
and $96,250, respectively
|
-
|
797,547
|
Total
current liabilities
|
603,605
|
1,904,083
|
|
|
|
Deferred tax
liability
|
54,250
|
12,000
|
|
|
|
Total
liabilities
|
657,855
|
1,916,083
|
|
|
|
Level Brands, Inc.
shareholders' equity:
|
|
|
Preferred stock,
authorized 50,000,000 shares, $0.001 par value, no shares issued
and outstanding
|
-
|
-
|
Common stock,
authorized 150,000,000 shares, $0.001 par value,
|
|
|
5,529,568
and 3,400,834 shares issued and outstanding,
respectively
|
5,530
|
3,401
|
Additional paid in
capital
|
9,302,974
|
4,847,362
|
Accumulated
deficit
|
(5,949,627)
|
(4,487,336)
|
Total
Level Brands, Inc. shareholders' equity
|
3,358,877
|
363,427
|
Noncontrolling
interest
|
1,080,890
|
(656,152)
|
Total
shareholders' equity (deficit)
|
4,439,767
|
(292,725)
|
|
|
|
Total
liabilities and shareholders' equity (deficit)
|
$5,097,622
|
$1,623,358
|
LEVEL BRANDS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED JUNE 30, 2017 AND
2016
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
$1,867,590
|
$492,319
|
$4,199,412
|
$2,043,491
|
Allowances
|
(80,581)
|
(106,833)
|
(804,025)
|
(242,137)
|
Net Sales
|
1,787,009
|
385,486
|
3,395,387
|
1,801,354
|
|
|
|
|
|
Cost
of goods sold
|
261,420
|
321,341
|
822,556
|
1,248,984
|
|
|
|
|
|
Gross
Profit
|
1,525,589
|
64,145
|
2,572,831
|
552,370
|
|
|
|
|
|
Operating
expenses
|
853,670
|
1,485,887
|
2,536,586
|
3,255,901
|
Income
(Loss) from
operations
|
671,919
|
(1,421,742)
|
36,245
|
(2,703,531)
|
Debt
conversion expense
|
(446,250)
|
-
|
(446,250)
|
-
|
Other
than temporary impairment on marketable
securities
|
(175,000)
|
-
|
(175,000)
|
-
|
Interest
expense
|
(229,220)
|
(15,433)
|
(500,353)
|
(67,026)
|
Loss before provision for
income taxes
|
(178,551)
|
(1,437,175)
|
(1,085,358)
|
(2,770,557)
|
|
|
|
|
|
Provision for income taxes
|
36,642
|
(2,000)
|
(42,250)
|
(6,000)
|
Net Income (Loss)
|
(141,909)
|
(1,439,175)
|
(1,127,608)
|
(2,776,557)
|
Net Income (Loss) attributable to
noncontrolling
interest
|
68,781
|
(232,704)
|
272,798
|
(451,958)
|
|
|
|
|
|
Net Loss attributable to Level Brands, Inc.
common shareholders
|
$(210,690)
|
$(1,206,471)
|
$(1,400,406)
|
$(2,324,599)
|
|
|
|
|
|
Net loss per share:
|
|
|
|
|
Basic
|
$(0.04)
|
$(0.40)
|
$(0.34)
|
$(0.82)
|
Diluted
|
$(0.04)
|
$(0.40)
|
$(0.34)
|
$(0.82)
|
|
|
|
|
|
Weighted
average number of shares:
|
4,686,947
|
3,037,631
|
4,128,541
|
2,840,567
|
See
Notes to Condensed Consolidated Financial Statements
F-3
LEVEL BRANDS, INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE NINE MONTHS ENDED JUNE 30, 2017 AND 2016
(unaudited)
|
Nine Months
Ended June 30,
|
Nine Months
Ended June 30,
|
|
|
|
|
|
|
Cash
flows from operating activities:
|
|
|
Net
loss
|
$(1,127,608)
|
$(2,776,557)
|
Adjustments
to reconcile net loss to net
|
|
|
cash
used by operating activities:
|
|
|
Stock
based compensation
|
40,453
|
8,570
|
Restricted
stock
|
117,300
|
-
|
Amortization
of debt discounts
|
5,159
|
-
|
Amortization
of debt issue costs
|
305,800
|
31,500
|
Depreciation
|
42,151
|
31,149
|
Stock
issued for services
|
22,667
|
-
|
Loss on
sale of property and equipment
|
4,000
|
-
|
Common stock
issued as charitable contribution
|
17,000
|
-
|
Other-than-temporary
impairment on marketable securities
|
175,000
|
-
|
Debt
Conversion Expense
|
446,250
|
-
|
Marketable
and Investment Other Securities received for
services
|
(1,562,000)
|
|
Changes
in operating assets and liabilities:
|
|
|
Accounts
receivable and accounts receivable other
|
(268,745)
|
13,078
|
Inventory
|
(109,661)
|
(796,013)
|
Prepaid
expenses and other current assets
|
67,434
|
461,905
|
Accounts
payable and accrued expenses
|
132,976
|
324,644
|
Interest
Payable
|
184,889
|
34,321
|
Deferred
Revenue
|
47,333
|
-
|
Deferred
tax liability
|
42,250
|
6,000
|
Cash used by
operating activities
|
(1,417,352)
|
(2,661,403)
|
|
|
|
Cash
flows from investing activities:
|
|
|
Purchase
of property and equipment
|
(15,018)
|
(115,259)
|
Cash used by
investing activities
|
(15,018)
|
(115,259)
|
|
|
|
Cash
flows from financing activities:
|
|
|
Proceeds
from sale of common stock
|
201,450
|
2,375,000
|
Proceeds
from convertible notes
|
2,125,000
|
-
|
Distributions
paid to members’ of EE1
|
(59,551)
|
-
|
Distribution
income
|
30,363
|
-
|
Debt
issuance cost
|
(200,800)
|
(160,381)
|
Proceeds
from line of credit
|
-
|
1,325,807
|
Repayments
of line of credit
|
(300,000)
|
(1,165,183)
|
Repayment
of note payable shareholder
|
-
|
(90,078)
|
Cash provided by
financing activities
|
1,796,462
|
2,285,165
|
Net (decrease)
increase in cash
|
364,092
|
(491,497)
|
Cash and cash
equivalents, beginning of period
|
34,258
|
546,461
|
Cash
and cash equivalents, end
of period
|
$398,350
|
$54,964
|
LEVEL BRANDS, INC.
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE NINE MONTHS ENDED JUNE 30, 2017 AND 2016
(unaudited)
(continued)
Supplemental Disclosures of Cash Flow Information:
|
Nine Months
ended June 30,
|
Nine Months
Ended June 30,
|
|
|
|
|
|
|
Cash Payments
for:
|
|
|
Interest
expense
|
$5,210
|
$1,206
|
|
|
|
Non-cash financial
activities:
|
|
|
Common stock
subscription
|
$-
|
$325,000
|
Common stock issued
to purchase membership interest – I’M1
|
971,667
|
-
|
Common stock issued
to purchase membership interest – EE1
|
471,667
|
-
|
Common stock issued
for services
|
569,999
|
-
|
Warrants issued
with convertible notes
|
5,159
|
-
|
Noncontrolling
interest transfer
|
856,547
|
|
Strike price
adjustment on placement agent warrants
|
31,505
|
-
|
Common stock issued
for warrant exercise
|
85,950
|
-
|
Equity issued to
purchase membership interest in subsidiary
|
242,000
|
-
|
Fixed asset write
off
|
7,000
|
-
|
Stock subscription
receivable
|
-
|
325,000
|
Common Stock issued
for conversion of Line of Credit
|
773,177
|
|
Common Stock issued
for conversion of Promissory Notes
|
2,252,500
|
|
|
|
|
See
Notes to Condensed Consolidated Financial Statements
F-5
LEVEL BRANDS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND NINE MONTHS ENDED JUNE 30, 2017 AND
2016
NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Organization
and Nature of Business – Level Brands, Inc. ("Level Brands",
"we", "us", “our”, "Parent Company” or the
“Company”) is a North Carolina corporation formed on
March 17, 2015 as Level Beauty Group, Inc. In November 2016 we
changed the name of the company to Level Brands Inc. We operate
from our offices located in Charlotte, North Carolina. Our fiscal
year end is established as September 30, therefore our first fiscal
reporting period is a partial period defined as the period from
inception (March 17, 2015) to September 30, 2015, whereas our
fiscal year end 2016 is a full period from October 1, 2015 to
September 30, 2016 (the “periods”).
The
accompanying unaudited interim condensed consolidated financial
statements of Level Brands have been prepared in accordance with
accounting principles generally accepted in the United States of
America (“GAAP”) and the rules of the Securities and
Exchange Commission (“SEC”) and should be read in
conjunction with the audited consolidated financial statements and
notes for the year ended September 30, 2016. In the opinion of
management, all adjustments, consisting of normal recurring
adjustments, necessary for a fair presentation of consolidated
financial position and the consolidated results of operations for
the interim periods presented have been reflected herein. Notes to
the financial statements which would substantially duplicate the
disclosure contained in the audited consolidated financial
statements for fiscal year 2016 have been omitted.
In
March 2015, the Company formed Beauty and Pin-Ups, LLC ("BPU"), a
North Carolina limited liability company, and contributed $250,000
in exchange for our member interest. As of September 30, 2016 we
owned a 78% member interest in BPU. In addition, pursuant to the
Amended and Restated Operating Agreement of Beauty & Pin-Ups,
we were granted the right to redeem the 10% membership interest of
Sigan Industries Group for $110,000 at any time before April 13,
2017. In October 2016, as amended in March 2017, we acquired Sigan
Industries’ membership interest in exchange for 129,412
shares of our common stock valued at $110,000. As of March 31, 2017
we owned an 88% member interest in BPU. In April 2017 we acquired
the remaining 12% membership interest in exchange for 155,294
shares of our common stock valued at $132,000. As of June 30, 2017
we owned a 100% member interest in BPU. BPU manufactures, markets
and sells an array of beauty and personal care products, including
hair care and hair treatments, as well as beauty tools. The
Company's products are sold to the professional segment,
principally through distributors to professional salons in the
North America.
I’M1
was formed in California in September 2016. IM1 Holdings, LLC, a
California limited liability company, or “IM1 Holdings“
was the initial member of IM'1. In January 2017, we acquired all of
the Class A voting membership interests in I’M1 from IM1
Holdings in exchange for 583,000 shares of our common stock, which
represents 51% of the interest in I’M1. IM1 Holdings
continues to own the Class B non-voting membership interest of
I’M1. I’M1 – Ireland Men One is a brand inspired
by Kathy Ireland that plans to provide millennial-inspired
lifestyle products under the I’M1 brand. I’M1 has
entered into an exclusive wholesale license agreement with kathy
ireland® Worldwide in connection with the use of the
intellectual property related to this brand.
EE1 was
formed in California in March 2016. EE1 Holdings, LLC, a California
limited liability company, or “EE1 Holdings" was the initial
member of EE1 Holdings. In January 2017, we acquired all of the
Class A voting membership interests in EE1 from EE1 Holdings in
exchange for 283,000 shares of our common stock, which represents
51% of the interest in EE1. EE1 Holdings continues to own the Class
B non-voting membership interests of EE1. EE1 is a company and
brand, which is designed to serve as a producer and marketer of
multiple entertainment distribution platforms under the EE1
brand.
Principles of Consolidation
The
condensed consolidated financial statements include the accounts of
the Company and its majority owned subsidiaries I’M1 and
EE1 and wholly owned subsidiary BPU. All material intercompany
transactions and balances have been eliminated in consolidation.
The third party ownership of the Company’s subsidiaries is
accounted for as noncontrolling interest in the consolidated
financial statements. Changes in the noncontrolling interest are
reported in the statement of stockholders’
deficit.
Use of Estimates
The
preparation of the Company's condensed consolidated financial
statements have been prepared in accordance with accounting
principles generally accepted in the United States (GAAP), and
requires management to make estimates and assumptions that affect
amounts of assets and liabilities and disclosures of contingent
assets and liabilities as of the date of the financial statements
and reported amounts of revenues and expenses during the periods
presented. Estimates and assumptions are reviewed periodically and
the effects of revisions are reflected in the consolidated
financial statements in the period they are determined to be
necessary. Significant estimates made in the accompanying
consolidated financial statements include, but are not limited to,
allowances for doubtful accounts, inventory valuation reserves,
expected sales returns and allowances, trade support costs, certain
assumptions related to the valuation of common stock, acquired
intangible and long-lived assets and the recoverability of
intangible and long-lived assets and income taxes, including
deferred tax valuation allowances and reserves for estimated tax
liabilities. Actual results could differ from these
estimates.
Cash and Cash Equivalents
For
financial statements purposes, the Company considers all highly
liquid investments with a maturity of less than three months when
purchased to be cash equivalents.
Accounts receivable
Accounts
receivable are stated at cost less an allowance for doubtful
accounts, if applicable. Credit is extended to customers after an
evaluation of customer’s financial condition, and generally
collateral is not required as a condition of credit extension.
Management’s determination of the allowance for doubtful
accounts is based on an evaluation of the receivables, past
experience, current economic conditions, and other risks inherent
in the receivables portfolio. As of June 30, 2017 and 2016, all
receivables were considered by management to be fully
collectible.
In
addition, the Company may, from time to time, enter into
contracts where a portion of the consideration provided by the
customer in exchange for the Company's services is common stock,
options or warrants (an equity position). In these
situations, upon invoicing the customer for the stock or other
instruments, the Company will record the receivable as accounts
receivable other, and use the value of the stock or other
instrument upon invoicing to determine the value. Where an accounts
receivable is settled with the receipt of the common stock or other
instrument, the common stock or other instrument will be classified
as an asset on the balance sheet as either an investment marketable
security (when the customer is a public entity) or as an investment
other security (when the customer is a private entity). As of
June 30, 2017, the Company has recorded $475,000 as marketable
securities, $912,000 as investment other securities, and $114,000
as accounts receivable other in relation to contracts where stock
was issued or will be issued in consideration for services
provided.
Marketable Securities
At the
time of acquisition, the marketable security is designated as
available-for-sale as the intent is to hold for a period of time
before selling. Available-for-sale securities are carried at fair
value on the consolidated statements of financial condition with
changes in fair value recorded in the accumulated other
comprehensive income component of shareholders’ equity in the
period of the change in accordance with ASC 320-10. Upon the
disposition of an available-for-sale security, the Company
reclassifies the gain or loss on the security from accumulated
other comprehensive income to non-operating income on the
Company’s consolidated statements of
operations.
Investment Other Securities
For
equity investments where the Company neither controls nor has
significant influence over the investee and which are
non-marketable, the investments are accounted for using the cost
method of accounting in accordance with ASC 325-10. Under the cost
method, dividends received from the investment are recorded as
dividend income within non-operating income.
Other-than-Temporary Impairment
The
Company’s management periodically assesses its marketable
securities and investment other securities, for any unrealized
losses that may be other-than-temporary and require recognition of
an impairment loss in the consolidated statement of operations. If
the cost of an investment exceeds its fair value, the Company
evaluates, among other factors, general market conditions, the
length of time the security has been in a loss position, the extent
to which the security’s market value is less than its cost,
the financial condition and prospects of the security’s
issuer and the Company’s ability and intent to hold the
security for a length of time sufficient to allow for recovery. If
the impairment is considered other-than-temporary, an impairment
charge is recorded in non-operating income in the consolidated
statements of operations.
Inventory
Inventory
is stated at the lower of cost or net realizable value with cost
being determined on a weighted average basis. The cost of inventory
includes product cost, and production fill and labor (which we
outsource to third party manufacturers). Write-offs of potentially
slow moving or damaged inventory are recorded based on
management’s analysis of inventory levels, forecasted future
sales volume and pricing and through specific identification of
obsolete or damaged products. Prepaid Inventory represents deposits
made with third party manufacturers in order to begin production of
an order for product. We assess inventory quarterly for slow moving
products and potential impairments and perform a physical inventory
count annually near fiscal year end.
Fair value accounting
The
Company utilizes accounting standards for fair value, which include
the definition of fair value, the framework for measuring fair
value, and disclosures about fair value measurements. Fair value is
a market-based measurement, not an entity-specific measurement.
Therefore, a fair value measurement should be determined based on
the assumptions that market participants would use in pricing the
asset or liability. As a basis for considering market participant
assumptions in fair value measurements, fair value accounting
standards establish a fair value hierarchy that distinguishes
between market participant assumptions based on market data
obtained from sources independent of the reporting entity
(observable inputs that are classified within Levels 1 and 2
of the hierarchy) and the reporting entity’s own assumptions
about market participant assumptions (unobservable inputs
classified within Level 3 of the hierarchy).
Level 1
inputs utilize quoted prices in active markets for identical assets
or liabilities that the Company has the ability to access.
Level 2 inputs are inputs other than quoted prices included in
Level 1 that are directly or indirectly observable for the
asset or liability. Level 2 inputs may include quoted prices
for similar assets and liabilities in active markets, as well as
inputs that are observable for the asset or liability. Level 3
inputs are unobservable inputs for the asset or liability, which
are based on an entity’s own assumptions, as there is little,
if any, observable market activity. In instances where the fair
value measurement is based on inputs from different levels of the
fair value hierarchy, the level in the fair value hierarchy within
which the entire fair value measurement falls is based on the
lowest level input that is significant to the fair value
measurement in its entirety. The Company’s assessment of the
significance of a particular input to the fair value measurement in
its entirety requires judgment and considers factors specific to
the asset or liability.
When
the Company records an investment in marketable securities the
asset is valued at fair value. For investment other securities, it
will value the asset using the cost method of accounting. Any
changes in fair value for marketable securities, during a given
period will be recorded as a gain or loss in other comprehensive
income, unless a decline is determined to be other-than-temporary.
For investment other securities we use the cost method and compare
the fair value to cost in order to determine if there is an
other-than-temporary impairment. In the three months ended June 30,
2017, the Company determined that an other-than-temporary
impairment on securities of $175,000 occurred and recorded the loss
in earnings.
Intangible Assets
The
Company's intangible assets consist of trademarks and other
intellectual property. The Company employs the non-amortization
approach to account for purchased intangible assets having
indefinite lives. Under the non-amortization approach, intangible
assets having indefinite lives are not amortized into the results
of operations, but instead are reviewed annually or more frequently
if events or changes in circumstances indicate that the assets
might be impaired, to assess whether their fair value exceeds their
carrying value. We perform an impairment analysis at August 1
annually on the indefinite-lived intangible assets following the
steps laid out in ASC 350-30-35-18. Our annual impairment analysis
includes a qualitative assessment to determine if it is necessary
to perform the quantitative impairment test. In performing a
qualitative assessment, we review events and circumstances that
could affect the significant inputs used to determine if the fair
value is less than the carrying value of the intangible assets. If
a quantitative analysis is necessary, we would analyze various
aspects including number of contracts acquired and retained as well
as revenues from those contracts, associated with the intangible
assets. In addition, intangible assets will be tested on an interim
basis if an event or circumstance indicates that it is more likely
than not that an impairment loss has been incurred. Events that are
assessed include contracts acquired and lost that are associated
with the intangible assets, as well as the revenues associated with
those contracts.
In
Conjunction with any acquisitions, the Company refers to ASC-805 as
amended by ASU 2017-01in determining if the Company is acquiring
any inputs, processes or outputs and the impact that such factors
would have on the classification of the acquisition as a business
combination or asset purchase. Additionally, the Company refers to
the aforementioned guidance in reviewing all potential assets and
liabilities for valuation including the determination of intangible
asset values.
There
were no impairments on intangible assets during the three and nine
months ended June 30, 2017 and 2016.
Common stock
Level
Brands is a private company and as such there is no market for the
shares of its common stock. We value a share of common stock based
on recent financing transactions that include the issuance of
common stock to an unrelated party at a specified price. In the
event, however, there is not a recent and significant equity
financing transaction or the nature of the business has
significantly changed subsequent to an equity financing, we will
use valuation techniques, which could include discounted cash flow
analysis, comparable company review, and consultation with third
party valuation experts to assist in estimating the value of our
common stock.
Revenue Recognition
The
Company receives revenue from three different types of
arrangements: sale of products, license and royalty agreements, and
sales for services provided (advisory or consulting
agreements).
In
regards to the sale of products, the Company's policy is to
recognize revenue when persuasive evidence of an arrangement
exists, shipping has occurred, the sales price is fixed or
determinable and collection is probable. The Company records
revenue from the sale of its products when risk of loss and title
to the product are transferred to the customer, which is upon
shipping. Net sales are comprised of gross revenues less expected
product returns, trade discounts and customer allowances, which
include costs associated with off-invoice mark-downs and other
price reductions, as well as trade promotions and coupons. These
incentive costs are recognized at the later of the date on which
the Company recognizes the related revenue or the date on which the
Company offers the incentive. Although, the Company does not have a
formal return policy, from time to time the Company will allow
customers to return certain products. A business decision
related to customer returns is made by the Company and is performed
on a case-by-case basis. We record returns as a reduction in sales
and based on whether we dispose of the returned product adjust
inventory and record expense as appropriate. There were no
allowances for sales returns during the three and nine months ended
June 30, 2017 and 2016.
The
Company also enters into various license agreements that provide
revenues based on royalties as a percentage of sales and
advertising/marketing fees. The contracts can also have a minimum
royalty, with which this and the advertising/marketing revenue is
recognized on a straight-line basis over the term of each contract
year, as defined, in each license agreement. Royalties exceeding
the defined minimum amounts are recognized as income during the
period corresponding to the licensee’s sales, as are all
royalties that do not have a minimum royalty. Payments received as
consideration of the grant of a license are recognized ratably as
revenue over the term of the license agreement and are reflected on
the Company’s consolidated balance sheets as deferred license
revenue at the time payment is received and recognized ratably as
revenue over the term of the license
agreement. Similarly, advanced royalty payments are
recognized ratably over the period indicated by the terms of the
license and are reflected in the Company’s consolidated
balance sheet in deferred license revenue at the time the payment
is received. Revenue is not recognized unless
collectability is reasonably assured. If licensing arrangements are
terminated prior to the original licensing period, we will
recognize revenue for any contractual termination fees, unless such
amounts are deemed non-recoverable.
In
regard to sales for services provided, the Company records revenue
when persuasive evidence of any agreement exists, services have
been rendered, and collectability is reasonably assured; therefore,
revenue is recognized when the Company invoices customers for
completed services at agreed upon rates and terms. Therefore,
revenue recognition may differ from the timing of cash
receipts.
Advertising Costs
The
Company expenses all costs of advertising and related marketing and
promotional costs as incurred. The Company incurred $148,098 and
$194,299 in advertising and related marketing and promotional costs
included in operating expenses during the three months ended June
30, 2017 and 2016, respectively. For the nine months ended June 30,
2017 and 2016, the Company incurred expenses of $278,978 and
$517,888 respectively.
Concentrations of Credit Risk
Financial
instruments that potentially expose the Company to concentrations
of credit risk consist primarily of cash and cash equivalents,
accounts receivable, and securities.
The
Company places its cash and cash equivalents on deposit with
financial institutions in the United States. The Federal Deposit
Insurance Corporation (“FDIC”) covers $250,000 for
substantially all depository accounts. The Company from time to
time may have amounts on deposit in excess of the insured limits.
The Company had an uninsured balance of $91,503 at June 30, 2017
and had no uninsured balance as of September 30, 2016.
Concentration
of credit risk with respect to receivables is principally limited
to trade receivables with corporate customers that meet specific
credit policies. Management considers these customer receivables to
represent normal business risk. The Company had two customers whose
revenue collectively represented 79.7% of the Company’s net
sales for the three months ended June 30, 2017 and whose accounts
receivable balance individually represented 22.6% of the
Company’s total accounts receivable as of June 30, 2017. The
Company had four customers whose revenue collectively represented
81.5% of the Company’s net sales for the nine months ended
June 30, 2017. The Company had one customer whose revenue
collectively represented 83.4% of the Company’s net sales for
the three months ended June 30, 2016 and whose balance represented
98.6% of the Company’s total accounts receivable as of
September 30, 2016. The Company had two customers whose revenue
collectively represented 90.7% of the Company’s net sales for
the nine months ended June 30, 2016.
Debt Issuance Costs
Debt
issuance costs related to a recognized debt liability are presented
in the balance sheet as a direct deduction from the carrying value
of that debt liability, consistent with debt discounts.
Amortization of debt issuance costs are included as a component of
interest expense.
Net Loss Per Share
The
Company uses ASC 260-10, “Earnings Per Share” for
calculating the basic and diluted loss per share. The Company
computes basic loss per share by dividing net loss and net loss
attributable to common shareholders by the weighted average number
of common shares outstanding. Common equivalent shares are excluded
from the computation of net loss per share if their effect is
anti-dilutive.
At June
30, 2017 and 2016, 697,476 and 110,067 potential shares,
respectively, were excluded from the shares used to calculate
diluted loss per share as their inclusion would reduce net loss per
share.
New Accounting Standards
In May
2014, August 2015 and May 2016, the Financial Accounting Standards
Board (FASB) issued ASU 2014-09, Revenue from Contracts with Customers,
and ASU 2015-14 Revenue from
Contracts with Customers, Deferral of the Effective Date,
respectively, which implement ASC Topic 606. ASC Topic 606 outlines
a single comprehensive model for entities to use in accounting for
revenue arising from contracts with customers and supersedes most
current revenue recognition guidance under US GAAP, including
industry-specific guidance. It also requires entities to disclose
both quantitative and qualitative information that enable financial
statements users to understand the nature, amount, timing, and
uncertainty of revenue and cash flows arising from contracts with
customers. The amendments in these ASUs are effective for annual
periods beginning after December 15, 2017, and interim periods
therein. Early adoption is permitted for annual periods beginning
after December 15, 2016. These ASUs may be applied retrospectively
to all prior periods presented, or retrospectively with a
cumulative adjustment to retained earnings in the year of adoption.
The Company is assessing the impact, if any, of implementing this
guidance on its consolidated financial position, results of
operations and liquidity.
In
August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties about an Entity's
Ability to Continue as a Going Concern. This standard sets
forth management's responsibility to evaluate, each reporting
period, whether there is substantial doubt about the Company's
ability to continue as a going concern, and if so, to provide
related disclosures. ASU 2014-15 is effective for annual reporting
periods ending after December 15, 2016 and interim periods within
annual periods beginning after December 15, 2016. The Company is
assessing the impact, if any, of implementing this guidance on its
evaluation of going concern.
In July
2015, the FASB issued ASU 2015-11, Inventory: Simplifying the Measurement of
Inventory. The purpose of ASU 2015-11 is to more closely
align the measurement of inventory in U.S. GAAP with the
measurement of inventory in International Financial Reporting
Standards. ASU 2015-11 requires entities to measure most inventory
at the "lower of cost or net realizable value." Additionally, some
of the amendments are designed to more clearly articulate the
requirements for the measurement and disclosure of inventory. ASU
2015-11 is effective for fiscal years and interim periods beginning
after December 15, 2016. The Company is assessing the impact, if
any, of implementing this guidance on its consolidated financial
position, results of operations and liquidity.
In
February 2016, the FASB issued ASU 2016-02, Leases. The purpose of ASU
2016-02 is to establish the principles to report transparent and
economically neutral information about the assets and liabilities
that arise from leases. This guidance results in a more faithful
representation of the rights and obligations arising from operating
and capital leases by requiring lessees to recognize the lease
assets and lease liabilities that arise from leases in the
statement of financial position and to disclose qualitative and
quantitative information about lease transactions, such as
information about variable lease payments and options to renew and
terminate leases. ASU 2016-02 is effective for fiscal years and
interim periods beginning after December 15, 2018. The Company is
assessing the impact, if any, of implementing this guidance on its
consolidated financial position, results of operations and
liquidity.
In
March 2016, the FASB issued ASU 2016-09, Stock Compensation: Improvements to Employee
Share-Based Payment Accounting. The purpose of ASU
2016-09 is to simplify several aspects of the accounting for
share-based payment transactions, including the income tax
consequences, classification of awards as either equities or
liabilities, and classification of amounts in the statement of cash
flows. ASU 2016-09 is effective for fiscal years and interim
periods beginning after December 15, 2016. The Company is
assessing the impact, if any, of implementing this guidance on its
consolidated financial position, results of operations and
liquidity.
In
August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230),
Classification of Certain Cash Receipts and Cash Payments.
The amendments in this update provided guidance on eight specific
cash flow issues. This update is to provide specific guidance on
each of the eight issues, thereby reducing the diversity in
practice in how certain transactions are classified in the
statement of cash flows. ASU 2016-15 is effective for fiscal years
and interim periods beginning after December 15, 2017. Early
adoption is permitted. The Company is assessing the impact, if any,
of implementing this guidance on its consolidated financial
position, results of operations and liquidity.
NOTE 2 –
ACQUISITIONS
In
March 2015 Level Brands formed Beauty and Pinups, LLC
(“BPU”), a North Carolina limited liability company,
and contributed $250,000 in exchange for its member interest. In
April 2015 BPU entered into a Contribution Agreement with Beauty
& Pinups, Inc., a New York corporation ("BPUNY"), and two
members. Under the terms of the Contribution Agreement, BPUNY and
its founder contributed the business and certain assets, including
the trademark “Beauty & Pin Ups” and its variants,
certain other intellectual property and certain inventory to Beauty
and Pinups in exchange for a (i) 22% membership interest for two
members, and (ii) $150,000 in cash. At closing we assumed $277,500
of BPUNY's accounts payable to its product vendor, which bears
interest at 6% annually. The payable was paid off in April 2016.
The fair value of the noncontrolling membership interest issued was
based on the value of the initial contribution of $250,000 made by
Level Brands. The total consideration paid was allocated to the net
assets acquired based on relative fair values of those net assets
as of the transaction date, in accordance with the Fair Value
Measurement topic of the FASB ASC 820. The fair value is comprised
of the cash, accounts payable acquired, non-controlling interest
and a minimal amount of inventory, all in aggregate valued at
$486,760.
I’M1
was formed in California in September 2016. IM1 Holdings, LLC, a
California limited liability company, or “IM1 Holdings”
was the initial member of IM'1. In January 2017, we acquired all of
the Class A voting membership interests in I’M1 from IM1
Holdings in exchange for 583,000 shares of our common stock, which
represents 51% of the interest in I’M1. The shares were
valued by the Company based upon assumptions and other information
provided by management, and used three approaches available when
valuing a closely held business interest: the cost approach, the
income approach and the market approach. Consequently, the market
approach was deemed most appropriate, as it considers values
established by non-controlling buyers and sellers of interests in
the Company as evidenced by implied pricing in rounds of financing.
In addition, given the limited data and outlook, the backsolve
method was applied to assign values to the common equity, options
and warrants after giving consideration to the preference of the
convertible debt holders. The valuation determined the price per
share of $0.85 which put the value of the 583,000 shares at
$495,550. IM1 Holdings continues to own the Class B non-voting
membership interest of I’M1. We accounted for the membership
acquired by allocating the purchase price to the tradename and
intellectual property valued at $971,667.
EE1 was
formed in California in March 2016. EE1 Holdings, LLC, a California
limited liability company, or “EE1 Holdings" was the initial
member of EE1 Holdings. In January 2017, we acquired all of the
Class A voting membership interests in EE1 from EE1 Holdings in
exchange for 283,000 shares of our common stock, which represents
51% of the interest in EE1. We used the same valuation from the
Company of $0.85 per share which put the value of the 283,000
shares at $240,550. EE1 Holdings continues to own the Class B
non-voting membership interests of EE1. We accounted for the
membership acquired by allocating the purchase price to the
tradename and intellectual property valued at
$471,667.
NOTE 3 – MARKETABLE SECURITIES AND INVESTMENT OTHER
SECURITIES
The
Company may, from time to time, enter into contracts where a
portion of the consideration provided by the customer in exchange
for the Company's services is common stock, options or
warrants (an equity position). In these situations, upon
invoicing the customer for the stock or other instruments, the
Company will record the receivable as accounts receivable other,
and use the value of the stock or other instrument upon invoicing
to determine the value. Where an accounts receivable is settled
with the receipt of the common stock or other instrument, the
common stock or other instrument will be classified as an asset on
the balance sheet as either an investment marketable security (when
the customer is a public entity) or as an investment other security
(when the customer is a private entity).
As of
April 2017, the Company received 2,500,000 shares of common stock
as terms of its agreement for services, which was valued at
$650,000 based on the trading price on the OTC Markets, Inc. the
day of issuance, which was $0.26 per share. The shares are
restricted as indicated under Securities Act of 1933 and may not be
resold without registration under the Securities Act of 1933 or an
exemption therefrom. The Company determined that this common stock
was classified as Level 1 for fair value measurement purposes as
the stock was actively traded on an exchange. As of June 30, 2017
the trading price on the OTC Markets, Inc. was $0.03 and the
Company had exchangedthe 2,500,000 shares of common stock with the
issuer for 65 shares of preferred stock. The 65 shares of preferred
stock issued are each convertible using the lesser of either $0.26
per share or the 30 day trading average, that would provide a
number of shares equal to the value of $10,000 per share. The
Company has classified the preferred stock as Level 3 for fair
value measurement purposes as there are not observable inputs. The
preferred shares also contain a put option for the holder for the
stated value per share. The Company determined that the value of
the preferred shares was $475,000. On July 31, 2017 the Company
sold the preferred shares to a related party for $475,000; $200,000
in cash and a short term note for $275,000. As a result, the
Company has recorded an other-than-temporary impairment on
securities as of June 30, 2017 of $175,000 in the consolidated
statement of operations.
On
June 23, 2017, the Company exercised a warrant for 1,600,000 shares
of common stock for services delivered to a customer and accounted
for this in Investment Other Securities. The customer is a private
entity and the stock was valued at $912,000, which was based on its
recent financing in June 2017 at $0.57 per share, the shares are
not restricted. The Company has classified this common stock as
Level 3 for fair value measurement purposes as there are not
observable inputs. In valuing the stock the Company used factors
including comparable industry valuations, financial projections
provided by the issuer, and conversations with the issuer
management regarding the Company’s recent results and future
plans and the Company’s recent financing transaction from
June 2017. The Company assessed the common stock and determined
there was not an impairment as of June 30, 2017
The table below summarizes the assets valued at fair value as of
June 30, 2017:
|
In Active
Markets for Identical Assets and Liabilities
(Level
1)
|
Significant
Other Observable Inputs (Level 2)
|
Significant
Unobservable Inputs (Level 3)
|
Total Fair Value
at June 30, 2017
|
|
|
|
|
|
Marketable
securities
|
-
|
-
|
$475,000
|
$475,000
|
Investment other
securities
|
-
|
-
|
$912,000
|
$912,000
|
|
|
|
|
|
Balance at
September 30, 2016 and March 31, 2017
|
$0
|
$0
|
$0
|
$0
|
Receipt of equity
investment upon completion of contracts
|
$650,000
|
$0
|
$912,000
|
$1,562,000
|
Exchange of common
stock for preferred stock
|
$(650,000)
|
$0
|
$650,000
|
$0
|
Other-than-temporary
impairment on
marketable securities
|
$0
|
$0
|
$(175,000)
|
$(175,000)
|
Balance at June 30,
2017
|
$0
|
$0
|
$1,387,000
|
$1,387,000
|
NOTE 4 –
INVENTORY
Inventory at June 30, 2017 and September 30, 2016 consists of the
following:
|
|
|
|
|
|
Finished
goods
|
$565,562
|
$656,607
|
Inventory
components
|
231,564
|
30,858
|
Inventory
reserve
|
-
|
-
|
Total
|
$797,126
|
$687,465
|
NOTE 5 – INTANGIBLE
ASSETS
On
April 13, 2015, BPU acquired from Beauty & Pinups, Inc., a New
York corporation ("BPUNY") certain assets, including the trademark
"Beauty & Pin Ups" and its variants and certain other
intellectual property and assumed $277,500 of BPUNY's accounts
payable to its product vendor, which was paid off in April
2016.
On
January 6, 2017, the Company acquired 51% ownership in I’M1
from I’M1 Holdings LLC. I’M1’s assets include the
trademark "I’M1” and its variants and certain other
intellectual property. Specifically, a licensing agreement with
kathy ireland WorldWide and an advisory agreement for services with
kathy ireland WorldWide. The licensing agreement provides the
rights to use of the tradename for business and licensing purposes,
this is the baseline of the business and will be required as long
as the business is operating. Our capability for renewals of these
agreements are extremely likely as the agreements are with a
related party. We also believe the existence of this agreement does
not have limits on the time it will contribute to the generation of
cash flows for I’M1 and therefore we have identified these as
indefinite-lived intangible assets.
On
January 6, 2017, the Company acquired 51% ownership in EE1 from EE1
Holdings LLC. EE1’s assets include the trademark "EE1”
and its variants and certain other intellectual property.
Specifically, a production deal agreement with BMG Rights
Management US and an advisory agreement for services with kathy
ireland WorldWide. We believe the production deal agreement and the
advisory agreement do not have limits on the time they will
contribute to the generation of cash flows for EE1 and therefore we
have identified these as indefinite-lived intangible
assets.
The
fair value of the intangible assets was determined upon acquisition
and allocated based on our assessment of the importance of the
intellectual property as it relates to the ability to generate
revenue / profits.
Intangible
assets as of June 30, 2017 and September 30, 2016 consisted of the
following:
|
|
|
Trademark and other
intellectual property related to
BPU
|
$486,760
|
$486,760
|
Trademark and other
intellectual property related to
I’M1
|
971,667
|
-
|
Trademark and other
intellectual property related to
EE1
|
471,667
|
-
|
Total
|
$1,930,094
|
$486,760
|
The
Company performs an impairment analysis at August 1 annually on the
indefinite-lived intangible assets following the steps laid out in
ASC 350-30-35-18. Our annual impairment analysis includes a
qualitative assessment to determine if it is necessary to perform
the quantitative impairment test. In performing a qualitative
assessment we review events and circumstances that could affect the
significant inputs used to determine if the fair value is less than
the carrying value of the intangible assets. In addition,
intangible assets will be tested on an interim basis if an event or
circumstance indicates that it is more likely than not that an
impairment loss has been incurred. For the three and nine months
ended June 30, 2017 and June 30, 2016 there has been no
impairment.
NOTE 6 – PROPERTY AND EQUIPMENT
Major classes of property and equipment at June 30, 2017 and
September 30, 2016 consist of the following:
|
|
|
|
|
|
Computers,
furniture and equipment
|
$36,329
|
$14,311
|
Show
booth and equipment
|
171,986
|
171,986
|
Manufacturers’
molds and plates
|
34,200
|
34,200
|
Software
|
-
|
12,000
|
|
242,515
|
232,497
|
Less
accumulated depreciation
|
(93,367)
|
(52,216)
|
Net
property and equipment
|
$149,148
|
$180,281
|
Depreciation expense related to property and equipment was $14,520
and $12,786 for the three months ended June 30, 2017 and 2016,
respectively. Depreciation expense was $42,151 and $31,149 for the
nine months ended June 30, 2017 and 2016,
respectively.
NOTE 7 – CONVERTIBLE PROMISSORY NOTES
On October 4, 2016 and October 24, 2016, the Company issued in
aggregate $2,125,000 of 8% Convertible Promissory Notes to
accredited investors. The securities consist of 8% Convertible
Notes with warrants to purchase 141,676 shares of the
Company’s stock (the “Notes”). The Notes may
convert upon an initial public offering (“IPO”)
resulting in gross proceeds to the Company of at least $10,000,000,
prior to July 1, 2017, at the option of the investor. The
conversion price for the Notes is $5.00. All Notes converted will
be subject to a 12-month lockup post IPO. The warrants have an
exercise price of $7.80. The warrants expire in September 2021 and
are exercisable beginning the earlier of: (i) immediately after the
IPO closing; or (ii) July 1, 2017.
Effective June 30, 2017, the Company converted the $2,125,000
principal amount of convertible promissory notes and all accrued
interest of $127,500 into common shares of the Company at a price
of $3.95 per share. In this transaction, the Company issued 570,254
shares of common stock.
The Company accounted for the initial issuance of these Notes in
accordance with FASB ASC Topic 470-20 “Debt with Conversion
and Other Options”. The Black-Scholes value of the
warrants, $5,159, associated with the issuance was recorded as a
discount to debt and was amortized into interest expense. In
addition, the issuance of the Notes and warrants were assessed and
did not contain an embedded beneficial conversion feature as the
effective conversion price was not less than the relative fair
value of the instrument. We also had fees of $200,800 associated
with the financing, which was recorded as a debt discount and is
being amortized over the term of the Notes. With the June 30, 2017
conversion of the Notes, we accelerated the debt discount and have
recorded interest expense related to these amounts in aggregate of
$107,457 and $205,959 for the three and nine months ended June 30,
2017, respectively. In addition, we accounted for a conversion
inducement in accordance with ASC 470-20 on the conversion price
reduction from $5.00 to $3.95 per share and recorded a non-cash
debt conversion expense of $446,250 in the consolidated statement
of operations.
NOTE 8 – LINE OF CREDIT
In
August 2015, we entered into a one year $1,000,000 revolving line
of credit agreement with LBGLOC, LLC, a related party. Under the
terms of the agreement, we pay interest on any amounts available
for advance at the rate of 10% per annum. We granted LBGLOC, LLC a
blanket security agreement on our assets as collateral for amounts
advanced under the credit line. As additional consideration for
granting the credit line, we issued the lender 16,000 shares of
common stock, valued at $32,000 and was recorded as a debt discount
and amortized over the term of the note.
The
agreement was renewed for an additional one year period on
September 1, 2016. As additional consideration for renewing the
credit line, we issued the lender 14,000 shares of common stock,
which was valued at $105,000 based on the most recent equity
financing in February 2016, and was recorded as a debt discount and
was being amortized over the term of the note.
On June 6, 2017, pursuant to an agreement dated May 15, 2017, the
Company converted the outstanding principal balance of the line of
credit in the amount of $593,797, together with the accrued
interest of $179,380 for a total payoff amount of $773,177 into
common shares of the Company at a price of $3.95 per share. The
Company recorded a loss on extinguishment of $8,750 which was
recorded as interest expense in the consolidated statement of
operations. In this transaction, the Company issued 195,740 shares
of common stock.
The
outstanding balances due under the agreements were $0 and $893,797
at June 30, 2017 and September 30, 2016, respectively.
NOTE 9 – RELATED PARTY TRANSACTIONS
In
April 2015, we entered into a two year Advisory Services Agreement
(“ASA”) with a shareholder for management, creative and
marketing services. The agreement provides for a monthly fee of
$10,000, which the shareholder has agreed to defer payment of until
the Company has sufficient available cash or upon closing of a
capital raise in excess of $5,000,000. On October 1, 2016 the
Company and the shareholder agreed as follows: (1) to terminate the
ASA and all fees owed by providing 36,000 shares of the
Company’s common stock and (2) a lump sum payment of $50,000,
which was paid on November 4, 2016. In addition we issued 40,000
shares of the Company’s common stock for additional
consulting services which were outside the original scope of
service. All shares were issued on November 15, 2016. We have
recorded expense of $0 and $30,000 for the three months ended June
30, 2017 and 2016, respectively, and $0 and $90,000 for the nine
months ended June 30, 2017 and 2016, respectively, which has been
accrued during the periods.
In
April 2015, we entered into a two year consulting agreement with a
member of BPU for creative influence, leadership and direction
services. The agreement provides for a monthly fee of $12,000. As
of June 30, 2017 and September 30, 2016, we have recorded prepaid
expense of $0 and $15,625 respectively, and have recorded expense
of $6,038 and $36,269, for the three months ended June 30, 2017 and
2016, respectively. We recorded expense of $127,894 and $107,852
for the nine months ended June 30, 2017 and 2016,
respectively.
In
April 2015, we entered into a Management Services Agreement (the
“MSA”) with Kathy Ireland World Wide
(“kiWW”) pursuant to which it agreed to provide
management certain
creative and marketing services. One of our board members is the
CFO for kiWW. As compensation, we generally agreed to pay, a
deferred monthly fee of $10,000 which we accrued as an expense and
liability each period, and to the extent kiWW is providing services
with respect to BPU, an annual fee of 10% of the gross margins of
BPU after the first $10 million in revenues; and a $750,000 royalty
fee, of which this criteria has not been met. We paid kiWW $100,000
upon the execution of this agreement. On October 1, 2016, the
Company and kiWW agreed to terminate the MSA agreement and all fees
owed by providing a lump sum payment
of $50,000, which was paid on November 3, 2016. We have
recorded expense of $0 and $30,000 for the three months ended June
30, 2017 and 2016, respectively, and $0 and $90,000 for the nine
months ended June 30, 2017 and 2016, respectively, which has been
accrued during the periods.
In
April 2015, we sold to kiWW, an affiliate of one of our board
members, a five-year warrant to purchase 500,000 shares of our
common stock at an exercise price of $1.25 per share for $25,000.
Subsequent to this transaction, kiWW transferred a portion of the
warrant to a third-party. The warrants were exercised in March
2016.
In
December 2015, we engaged T.R Winston & Co., LLC to serve as
our exclusive placement agent in a private placement of our
securities which resulted in gross proceeds to us of $2,150,000 in
February 2016. In this offering, we paid T.R. Winston & Co.,
LLC cash commissions of $150,500 and issued its affiliates four
year placement agent warrants topurchase 20,067 shares of our
common stock at an exercise price of $8.75 per share, which are
exercisable on a cashless basis. In February 2016 we reduced the
exercise price of these warrants to $5.00 per share. These warrants
and the warrants associated with the June 2015 placement were
exercised on a cashless basis in October 2016.
In
January 2016 we entered into a charitable agreement, as amended,
with Best Buddies International, an affiliate of a member of our
board of directors. Pursuant to the agreement in June 2016, we
issued 30,000 shares of our common stock valued at $225,000 as a
charitable contribution.
In
March 2017, our subsidiary I’M1 entered into a consulting
agreement with Kure Corporation (“Kure”). In this
agreement I’M1 will provide services delivered in two phases.
The first phase was delivered by March 31, 2017 which included a
social media blitz and marketing and branding support and
strategies for $200,000. The second phase was delivered by June 22,
2017 which included modeling impressions for the brand and
extension of publicity to other media outlets for $400,000. In
addition, in March 2017, I’M1 entered into a separate
licensing agreement for 10 years with Kure under which we will
receive royalties based on gross sales of Kure products with the
I’M1 brand. A shareholder of Kure is Stone Street Capital,
LLC, an affiliate of our CEO and Chairman and our CEO and Chairman
was the past Chairman of Kure.
On June 6, 2017, pursuant to an agreement dated May 15, 2017, the
Company converted the line of credit with LBGLOC LLC, which
included the outstanding principal balance of $593,797 and the
accrued interest of $179,380 for a total payoff amount of $773,177
into common shares of the Company at a price of $3.95 per share.
One member of LBGLOC LLC, Stone Street Partners Opportunity Fund II
LLC is an affiliate of our CEO and Chairman and received 94,475
shares of common stock in this transaction.
Effective June 30, 2017, the Company converted the $2,125,000
principal amount of convertible promissory notes and all accrued
interest of $127,500 into common shares of the Company at a price
of $3.95 per share. One note holder, Stone Street Partners
Opportunity Fund II LLC is an affiliate of our CEO and Chairman and
received a total of 26,836 shares.
In June
2017, the Company earned a referral fee from kiWW after
establishing a business meeting resulting in a new license
agreement for kiWW. The referral fee was paid out of 200,000
options issued to kiWW from the new client, which were exercised
and transferred to the Company. The shares are valued at $114,000
based on the client’s recent financing event which was
calculated as $0.57 per share based on an enterprise valuation of
$45 million with 79 million shares outstanding. The warrant was
exercised in June 2017 and the shares issued in August
2017.
In June
2017, Kure purchased products from our subsidiary BPU for resale in
their stores. The total purchase was $97,850. Our CEO and Chairman
is the past Chairman of Kure.
NOTE 10 – SHAREHOLDERS’ EQUITY
Preferred Stock – We are authorized to issue 50,000,000
shares of preferred stock, par value $0.001 per share. Our
preferred stock does not have any preference, liquidation, or
dividend provisions. No shares of preferred stock have been
issued.
Common Stock – We are authorized to issue 150,000,000 shares
of common stock, par value $0.001 per share. There were 5,529,568
and 3,400,834 shares of common stock issued and outstanding at June
30, 2017 and September 30, 2016, respectively.
On November 11, 2016, majority shareholders of the Corporation,
upon recommendation of the Board of Directors, approved a reverse
stock split of the Corporation's common stock to be effected at a
specific ratio to be determined by the Board of Directors in the
future within a range up to one for nine (1:9). On December 2,
2016, the Board of Directors fixed the ratio of the reverse stock
split at one to five (1:5) and set the effective date as December
5, 2016. All share and per share amounts within these condensed
consolidated financial statements have been retroactively adjusted
to give effect to the reverse split.
Common stock transactions:
In the three and nine months ended June 30, 2017:
Per terms in the Operating Agreement of BPU, the Company can redeem
the 10% membership interest of Sigan Industries Group
(“Sigan”) for $110,000 at any time before April 13,
2017. On October 14, 2016, as amended in March 2017, Sigan entered
into an agreement with the Company and transferred their 10% member
interest for 129,412 shares of the Company’s common
stock.
In October 2016 we issued 38,358 shares of our stock to six
individuals and entities upon the cashless exercise of 70,067
placement agents warrants previously granted to T.R. Winston &
Co LLC and its affiliates.
In November 2016 we issued Stone Street Partners, LLC an aggregate
of 76,000 shares of our common stock valued at approximately
$570,000 as compensation for services, which had been accrued and
expensed at September 30, 2016. The stock was valued at the time
based on the most recent equity financing from February 2016 which
was priced at what is a post reverse split price of
$7.50.
In November 2016 we issued 20,000 shares of our common stock valued
at $17,000 to Best Buddies International as a charitable
contribution.
In January 2017 we issued 26,667 shares of our stock to two
individuals as part of consulting agreements. The shares were
valued at $22,667, based on the valuation from the Company and
expensed as salary compensation.
In January 2017, the Company acquired 51% ownership in IM1 in
exchange for 583,000 shares of Level Brands Inc. common stock,
which was valued at $495,550.
In January 2017, the Company acquired 51% ownership in EE1 in
exchange for 283,000 shares of Level Brands Inc. common stock,
which was valued at $240,550.
Effective April 28, 2017, Priel Maman entered into an agreement
with the Company to transfer his 12% member interest in BPU for
155,294 shares of the Company’s common stock, valued at
$132,000. The Company now owns 100% membership interest of
BPU.
On June 6, 2017, pursuant to an agreement dated May 15, 2017, the
Company converted the outstanding line of credit principal balance
of $593,797, together with the accrued interest of $179,380 for a
total conversion amount of $773,177 into common shares of the
Company at a price of $3.95 per share. In this transaction, the
Company issued 195,740 shares of common stock.
Effective June 30, 2017, the Company converted the $2,125,000
principal amount of convertible promissory notes and all accrued
interest of $127,500 into common shares of the Company at a price
of $3.95 per share. In this transaction, the Company issued 570,254
shares of common stock.
On June 30, 2017, the Company entered into subscription agreements
for 77,000 shares of common stock with two accredited investors in
a private placement, which resulted in gross proceeds of $304,150
to the Company. In this transaction, $201,450 was received on June
30, 2017 and $102,700 was received subsequent to June 30,
2017.
On June 30, 2017, the Company entered into an agreement with an
investor relations firm and as part of the compensation issued
5,000 shares of the Company’s common stock for services to be
delivered through an IPO and no later than September 30, 2017. The
shares were issued July 5, 2017 and valued at $19,750.
Stock option transactions:
In the three and nine months ended June 30, 2017:
On October 1, 2016 we granted an aggregate of 14,300 common stock
options to two employees. The options vest 16% immediately, 42%
January 1, 2017 and 42% January 1, 2018. The options have an
exercise price of $7.50 per share and a term of five years. We have
recorded an expense for the options of $53 and $524 respectively
for the three and nine months ended June 30, 2017.
On October 1, 2016 we granted an aggregate of 171,500 common stock
options to two employees. The options vest ratably on January 1,
2018. The options have an exercise price of $7.50 per share and a
term of six years. We have recorded an expense for the options of
$4,802 and $14,406 respectively for the three and nine months ended
June 30, 2017.
On May 1, 2017 we granted an aggregate of 100,000 common stock
options to one employee. The options vest 50% immediately and 50%
on January 1, 2018. The options have an exercise price of $4.00 per
share and a term of seven years. We have recorded an expense for
the options of $13,438 and $13,438 respectively for the three and
nine months ended June 30, 2017.
In the three and nine months ended June 30, 2016:
On December 15, 2015 we granted an aggregate of 40,000 common stock
options to two employees. The options vest ratably over three years
on the anniversary of the grant date. The options have an exercise
price of $2.00 per share and a term of six years. We have recorded
an expense for the options of $3,817 and $8,269 respectively for
the three and nine months ended June 30, 2016.
The following table summarizes the inputs used for the
Black-Scholes pricing model on the options issued in the nine
months ended June 30, 2017 and 2016:
|
|
|
Exercise
price
|
$4.00 - $7.50
|
$2.00
|
Risk
free interest rate
|
1.14 – 2.13%
|
1.84%
|
Volatility
|
54.69 – 60.39%
|
61.3%
|
Expected
term
|
|
|
Dividend
yield
|
|
|
Warrant transactions:
In the three and nine months ended June 30, 2017:
On October 1, 2016, the board approved the strike price adjustment
for certain placement agent warrants totaling 20,067 from a strike
price of $8.75 to $5.00. On October 26, 2016, 38,358 shares were
issued, upon a cashless exercise of the 20,067 warrants above and
another 50,000 warrants, at a strike price of $2.75, which had been
issued to a placement agent for prior services related to previous
private placements of our securities.
On October 4, 2016 and October 24, 2016, we issued in aggregate,
warrants exercisable into 141,676 shares of common stock with an
exercise price of $7.80. The warrants expire on September 30, 2021.
The warrants were issued in conjunction with the Company’s 8%
convertible notes, described in Note 6.
In the three and nine months ended June 30, 2016:
During February 2016, we issued placement agent warrants
exercisable into 20,067 shares of common stock with an exercise
price of $8.75. The warrants expire on February 16, 2020, however
the warrants were exercised in October 2016.
The following table summarizes the inputs used for the
Black-Scholes pricing model on the warrants issued in the nine
months ended June 30, 2017 and 2016:
|
|
|
Exercise
price
|
$7.80
|
$8.75
|
Risk
free interest rate
|
1.22-1.27%
|
1.07%
|
Volatility
|
52.77-54.49%
|
43.34%
|
Expected
term
|
|
|
Dividend
yield
|
|
|
NOTE 11 – STOCK-BASED COMPENSATION
Equity Compensation Plan – On June 2, 2015, the
Company’s Board of Directors approved the 2015 Equity
Compensation Plan (“Plan”). The Plan made 1,175,000
common stock shares, either unissued or reacquired by the Company,
available for awards of options, restricted stocks, other stock
grants, or any combination thereof. The number of shares of common
stock available for issuance under the Plan shall automatically
increase on the first trading day of January each calendar year
during the term of the Plan, beginning with calendar year 2016, by
an amount equal to one percent (1%) of the total number of shares
of common stock outstanding on the last trading day in December of
the immediately preceding calendar year, but in no event shall any
such annual increase exceed 100,000 shares of common
stock.
We account for stock-based compensation using the provisions of
FASB ASC 718. FASB ASC 718 codification requires
companies to recognize the fair value of stock-based compensation
expense in the financial statements based on the grant date fair
value of the options. We have only awarded stock options since
December 2015. All options are approved by the Board of Directors
until the board establishes a Compensation Committee. Restricted
stock awards that vest in accordance with service conditions are
amortized over their applicable vesting period using the
straight-line method. The fair value of our stock option awards or
modifications is estimated at the date of grant using the
Black-Scholes option pricing model.
Eligible recipients include employees, officers, directors and
consultants who are deemed to have rendered or to be able to render
significant services to the Company or its subsidiaries and who are
deemed to have contributed or to have the potential to contribute
to the success of the Company. Options granted generally have a
ten-year term and vest over three years from the date of grant.
Certain of the stock options granted under the plan have been
granted pursuant to various stock option agreements. Each stock
option agreement contains specific terms.
Stock Options – The Company currently has awards outstanding
with service conditions and graded-vesting features. We recognize
compensation cost on a straight-line basis over the requisite
service period.
The fair value of each time-based award is estimated on the date of
grant using the Black-Scholes option valuation model. Our
weighted-average assumptions used in the Black-Scholes valuation
model for equity awards with time-based vesting provisions granted
during the three and nine months ended June 30, 2017:
The
following table summarizes stock option activity under the
Plan:
|
|
Weighted-average
exercise price
|
Weighted-average
remaining contractual term(in years)
|
Aggregate
intrinsic value (in thousands)
|
Outstanding at
September 30, 2016
|
40,000
|
2.00
|
|
|
Granted
|
285,800
|
6.28
|
|
|
Exercised
|
—
|
—
|
|
|
Forfeited
|
—
|
—
|
|
|
Outstanding at June
30 2017
|
325,800
|
$5.75
|
5.98
|
$—
|
|
|
|
|
|
Exercisable at June
30, 2017
|
71,634
|
$4.03
|
—
|
$—
|
As of
June 30, 2017, there was approximately $40,036 of total
unrecognized compensation cost related to non-vested stock options
which vest over a period of approximately 1.5 years.
Restricted Stock Award transactions:
On October 1, 2016, the Company issued 230,000 restricted stock
awards in aggregate to board members and the Chairman who is also
our Chief Executive Officer. The restricted stock awards vest
January 1, 2018. The stock awards are valued at fair market upon
issuance at $195,500 and amortized over the vesting period. We
recognized $39,100 and $117,300 of stock based compensation expense
for the three and nine months ended June 30, 2017,
respectively.
NOTE 12 – WARRANTS
Transactions
involving our equity-classified warrants are summarized as
follows:
|
|
Weighted-average
exercise price
|
Weighted-
average
remaining contractual term (in years)
|
Aggregate
intrinsic value (in thousands)
|
Outstanding at
September 30, 2016
|
70,067
|
3.39
|
|
|
Issued
|
141,676
|
7.80
|
|
|
Exercised
|
(70,067)
|
—
|
|
|
Forfeited
|
—
|
—
|
|
|
Outstanding at June
30, 2017
|
141,676
|
$7.80
|
4.2
|
$—
|
|
|
|
|
|
Exercisable at June
30, 2017
|
141,676
|
$7.80
|
4.2
|
$—
|
The
following table summarizes outstanding common stock purchase
warrants as of June 30, 2017:
|
|
Weighted-average
exercise price
|
Expiration
|
|
|
|
|
Exercisable at
$7.80 per share
|
141,676
|
$7.80
|
September
2021
|
|
141,676
|
7.80
|
|
NOTE 13 – SEGMENT INFORMATION
The
Company operates through its three subsidiaries in three business
segments: the Professional Products, the Licensing, and the
Entertainment divisions. The Professional Products division is
designed to be an innovative and cutting-edge producer and marketer
of quality hair care and other beauty products. The Licensing
division is designed to establish a lifestyle brand via licensing
of select products / categories (grooming, personal care, cologne,
accessories, jewelry and apparel) with a focus on addressing the
needs of the men. The Entertainment division’s focus is to
become a producer and marketer of multiple entertainment
distribution platforms. The corporate parent also will generate
revenue from time to time, thru advisory consulting agreements.
This revenue is similar to the Entertainment divisions revenue
process and we have allocated revenue from corporate to the
Entertainment division for segment presentation.
The
Professional Products division operated for the full year in fiscal
2016 and only partially in fiscal 2015 as it was acquired in March
2015. The Licensing and Entertainment divisions were both acquired
in January 2017.
The
performance of the business is evaluated at the segment level.
Cash, debt and financing matters are managed centrally. These
segments operate as one from an accounting and overall executive
management perspective, though each segment has senior management
in place; however they are differentiated from a marketing and
customer presentation perspective, though cross-selling
opportunities exist and continue to be pursued.
Condensed
summary segment information follows for the three and nine months
ended June 30, 2017 and 2016.
Three
months ended June 30, 2017
|
Three Months Ended September 30, 2016
|
|
Professional
Product Division
|
|
|
|
Net
Sales
|
$291,342
|
$870,667
|
$625,000
|
$1,787,009
|
Income
(loss) from Operations before Overhead
|
$(399,304)
|
$41,573
|
$248,497
|
$(109,234)
|
Allocated
Corporate Overhead (a)
|
6,507
|
15,233
|
10,935
|
32,675
|
Net
Loss
|
$(405,811)
|
$26,340
|
$237,562
|
$(141,909)
|
|
|
|
|
|
Three
months ended June 30, 2016
|
Professional
Product Division
|
|
|
|
Net
Sales
|
$385,486
|
$-
|
$-
|
$385,486
|
Income
(loss) from Operations before Overhead
|
$(1,059,745)
|
$-
|
$-
|
$(1,059,745)
|
Allocated
Corporate Overhead (a)
|
379,430
|
|
|
379,430
|
Net
Loss
|
$(1,439,175)
|
$-
|
$-
|
$(1,439,175)
|
|
|
|
|
|
|
|
|
|
|
Nine
months ended June 30, 2017
|
Three Months Ended September 30, 2016
|
|
Professional
Product Division
|
|
|
|
Net
Sales
|
$865,890
|
$1,635,667
|
$893,830
|
$3,395,387
|
Income
(loss) from Operations before Overhead
|
$(1,272,383)
|
$654,962
|
$281,153
|
$(336,268)
|
Allocated
Corporate Overhead (a)
|
201,807
|
381,214
|
208,319
|
791,340
|
Net
Loss
|
$(1,474,190)
|
$273,748
|
$72,834
|
$(1,127,608)
|
|
|
|
|
|
Assets
|
$2,612,192
|
$1,728,290
|
$757,140
|
$5,097,622
|
|
|
|
|
|
Nine
months ended June 30, 2016
|
Three Months Ended September 30, 2016
|
|
Professional
Product Division
|
|
|
|
Net
Sales
|
$1,801,354
|
$-
|
$-
|
$1,801,354
|
Income
(loss) from Operations before Overhead
|
$(2,060,354)
|
$-
|
$-
|
$(2,060,354)
|
Allocated
Corporate Overhead (a)
|
716,203
|
|
|
716,203
|
Net
Loss
|
$(2,776,557)
|
$-
|
$-
|
$(2,776,557)
|
|
|
|
|
|
Assets
|
$1,736,402
|
-
|
-
|
$1,736,402
|
(a)
The Company began
allocating corporate overhead to the business segments in April
2017. We have allocated overhead on a proforma basis for the three
and nine months ended June 30, 2017 and 2016 above for comparison
purposes.
NOTE 14 – INCOME TAXES
With
the addition of IM1 and EE1 through the membership interest
exchange agreements dated in January 2017, we have added additional
indefinite-lived intangibles which are amortized for tax
purposes. This creates a deferred tax liability that cannot
be offset against our deferred tax assets. The effective tax
rate for the nine months ended June 30, 2017 has decreased in
comparison to the fiscal year ended September 30, 2016 effective
rate. This decrease is primarily a result of the deferred tax
liability that must be recorded from the aforementioned
intangibles.
NOTE 15 – SUBSEQUENT EVENTS
The
Company has evaluated subsequent events through September 18, 2017,
in connection with the preparation of these financial statements
which is the date the financial statements were available to be
issued.
On June 30, 2017, the Company entered into subscription agreements
for 77,000 shares of common stock with two accredited investors in
a private placement, which resulted in gross proceeds of $304,150
to the Company. In this transaction, $201,450 was received on June
30, 2017 and $102,700 was received subsequent to June 30,
2017.
Effective July 1, 2017, the Company entered into an agreement with
an investor relations firm and agreed to pay $20,000 and issue
5,000 shares of the Company’s common stock for services to be
delivered through an IPO and no later than September 30, 2017. The
shares were valued at $19,750.
In July 2017, the Company entered into subscription agreements for
133,000 shares of common stock with two accredited investors in a
private placement, which resulted in gross proceeds of $525,350 to
the Company. The accredited investors Stone Street Partners LLC and
Stone Street Partners Opportunity Fund II LLC are affiliates of our
CEO and Chairman.
On July 31 2017, the Company sold preferred shares it had received
as payment for services to a customer. The preferred shares were
sold to a related party. The preferred shares were valued as
marketable securities at $650,000 and were sold for $475,000, which
was paid $200,000 in cash and a short term note of $275,000 at 3%
interest. The Company recorded an impairment of $175,000 as of July
31, 2017 (see Note 3).
On August 24, 2017, the Company issued 19,100 shares of common
stock to a vendor for services. The shares were valued at
$75,445.
On August 31, 2017, the Company issued options to purchase 20,000
shares of common stock at a strike price of $4.00 to 1 employee of
the company and the options vest on August 31, 2018. The options
were valued at $45,040.
On September 1, 2017, the Company entered into a license agreement
with kathy ireland Worldwide for certain use of kathy ireland
trademark, likeness, videos, photos and other visual presentations
for the Company initial public offering and associated roadshow.
The Company agreed to pay $100,000, of which $50,000 has been paid
and $50,000 will be paid out of proceeds from the initial public
offering.
On September 8, 2017, the Company issued options to purchase in
aggregate 7,500 shares of common stock at a strike price of $4.00
to 3 consultants of the company. The options vest on October 1,
2018. The shares were valued at $10,770.
On September 8, 2017, the Company entered into a wholesale license
agreement with Andre Carthen and issued 45,500 shares of common
stock, valued at $179,725. In addition, the Company agreed to pay
$65,000 within 30 days completion of its initial public offering
and also issued warrants to purchase 45,500 shares of common stock
at a strike price of $4.00. The warrants were valued at
$65,338.
On September 8, 2017, the Company entered into a wholesale license
agreement with Nicholas Walker and issued 25,000 shares of common
stock, valued at $98,750. In addition, the Company agreed to pay
$40,000 within 30 days completion of its initial public offering
and also issued warrants to purchase 25,000 shares of common stock
at a strike price of $4.00. The warrants were valued at
$35,900.
On September 8, 2017, the Company extended its Master Advisory and
Consulting Agreement with kathy ireland Worldwide to February
2025.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
To the Shareholders of
Level Brands Inc. and subsidiary
Charlotte, North Carolina
We have audited the accompanying consolidated balance sheets of
Level Brands Inc. and subsidiary (the “Company”) as of
September 30, 2016 and 2015, and the related consolidated
statements of operations, shareholders’ equity, and cash
flows for the year ended September 30, 2016 and the period from
March 17, 2015 (inception) to September 30, 2015. The
Company’s management is responsible for these consolidated
financial statements. Our responsibility is to express an opinion
on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. The Company is not required to have,
nor were we engaged to perform, an audit of its internal control
over financial reporting. Our audit included consideration of
internal control over financial reporting as a basis for designing
audit procedures that are appropriate in the circumstances, but not
for the purpose of expressing an opinion on the effectiveness of
the Company’s internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and
disclosures in the consolidated financial statements, assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis
for our opinion.
In our opinion, the consolidated financial statements referred to
above present fairly, in all material respects, the financial
position of the Company as of September 30, 2016 and 2015, and the
results of its operations and its cash flows for year ended
September 30, 2016 and the period from March 17, 2015 (inception)
to September 30, 2015, in conformity with accounting principles
generally accepted in the United States of America.
|
/s/ Cherry Bekaert LLP
|
|
Charlotte, North Carolina
|
May 1,
2017
|
|
|
|
LEVEL BRANDS, INC.
CONSOLIDATED BALANCE SHEETS
SEPTEMBER 30, 2016 AND 2015
|
|
2016
|
|
|
2015
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
34,258
|
|
|
$
|
546,461
|
|
Accounts receivable
|
|
|
163,974
|
|
|
|
151
|
|
Inventory
|
|
|
687,465
|
|
|
|
167,725
|
|
Prepaid inventory
|
|
|
-
|
|
|
|
374,820
|
|
Prepaid expenses and other current assets
|
|
|
70,620
|
|
|
|
148,886
|
|
Total current assets
|
|
|
956,317
|
|
|
|
1,238,043
|
|
Property and equipment, net
|
|
|
180,281
|
|
|
|
97,957
|
|
Intangible assets
|
|
|
486,760
|
|
|
|
486,760
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
1,623,358
|
|
|
$
|
1,822,760
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders’ (deficit) equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
206,156
|
|
|
$
|
80,892
|
|
Accrued Expenses
|
|
|
787,139
|
|
|
|
125,979
|
|
Note payable - related party
|
|
|
-
|
|
|
|
90,078
|
|
Interest Payable - related party
|
|
|
113,241
|
|
|
|
3,307
|
|
Line of credit payable - related party, net of
unamortized costs of $96,250 and $35,000, respectively
|
|
|
797,547
|
|
|
|
241,156
|
|
Total current liabilities
|
|
|
1,904,083
|
|
|
|
541,412
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liability
|
|
|
12,000
|
|
|
|
4,000
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
1,916,083
|
|
|
|
545,412
|
|
|
|
|
|
|
|
|
|
|
Level Brands, Inc. shareholders’ equity:
|
|
|
|
|
|
|
|
|
Preferred stock, authorized 50,000,000 shares, $0.001 par value, no
shares issued and outstanding
|
|
|
-
|
|
|
|
-
|
|
Common stock, authorized 150,000,000 shares, $0.001 par
value,
|
|
|
|
|
|
|
|
|
3,400,834 and 2,653,500 shares issued and outstanding,
respectively
|
|
|
3,401
|
|
|
|
2,654
|
|
Additional paid in capital
|
|
|
4,847,362
|
|
|
|
2,521,912
|
|
Accumulated deficit
|
|
|
(4,487,336
|
)
|
|
|
(1,130,847
|
)
|
Total Level Brands, Inc. shareholders’ equity
|
|
|
363,427
|
|
|
|
1,393,719
|
|
Noncontrolling interest
|
|
|
(656,152
|
)
|
|
|
(116,371
|
)
|
Total shareholders’ (deficit) equity
|
|
|
(292,725
|
)
|
|
|
1,277,348
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders’ equity
(deficit)
|
|
$
|
1,623,358
|
|
|
$
|
1,822,760
|
|
See
Notes to Consolidated Financial Statements
LEVEL BRANDS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED SEPTEMBER 30, 2016 AND FOR THE INITIAL
PERIOD
MARCH 17, 2015 (INCEPTION) TO SEPTEMBER 30, 2015
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
Sales
|
|
$
|
2,631,125
|
|
|
$
|
12,542
|
|
Allowances
|
|
|
(599,563
|
)
|
|
|
-
|
|
Net Sales
|
|
|
2,031,562
|
|
|
|
12,542
|
|
Costs of goods sold
|
|
|
1,618,432
|
|
|
|
7,618
|
|
Gross profit
|
|
|
413,130
|
|
|
|
4,924
|
|
Operating expenses
|
|
|
4,146,423
|
|
|
|
1,304,109
|
|
Loss from
operations
|
|
|
(3,733,293
|
)
|
|
|
(1,299,185
|
)
|
Interest expense
|
|
|
154,977
|
|
|
|
14,546
|
|
Loss before provision for
income taxes
|
|
|
(3,888,270
|
)
|
|
|
(1,313,731
|
)
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
8,000
|
|
|
|
4,000
|
|
Net loss
|
|
|
(3,896,270
|
)
|
|
|
(1,317,731
|
)
|
Net loss attributable to noncontrolling interest
|
|
|
539,781
|
|
|
|
186,884
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to Level Brands, Inc. common
shareholders
|
|
$
|
(3,356,489
|
)
|
|
$
|
(1,130,847
|
)
|
|
|
|
|
|
|
|
|
|
Loss per share, basic and diluted
|
|
$
|
(1.13
|
)
|
|
$
|
(0.59
|
)
|
Weighted average shares outstanding
|
|
|
2,980,223
|
|
|
|
1,911,768
|
|
See
Notes to Consolidated Financial Statements
LEVEL BRANDS, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED SEPTEMBER 30, 2016 AND FOR THE INITIAL PERIOD
MARCH 17, 2015 (INCEPTION) TO SEPTEMBER 30, 2015
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
Net loss
|
|
$
|
(3,896,270
|
)
|
|
$
|
(1,317,731
|
)
|
Adjustments to reconcile net loss to net
|
|
|
|
|
|
|
|
|
cash used by operating activities:
|
|
|
|
|
|
|
|
|
Stock based compensation
|
|
|
11,450
|
|
|
|
37,500
|
|
Amortization of debt issue costs
|
|
|
43,750
|
|
|
|
7,000
|
|
Depreciation
|
|
|
44,935
|
|
|
|
7,281
|
|
Expenses paid through sale price of
warrants
|
|
|
-
|
|
|
|
25,000
|
|
Common stock issued as charitable
contribution
|
|
|
225,000
|
|
|
|
-
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(163,823
|
)
|
|
|
4,901
|
|
Inventory
|
|
|
(519,740
|
)
|
|
|
(161,525
|
)
|
Prepaid inventory
|
|
|
374,820
|
|
|
|
(374,820
|
)
|
Prepaid expenses and other current assets
|
|
|
78,266
|
|
|
|
(148,885
|
)
|
Accounts payable and accrued expenses
|
|
|
785,916
|
|
|
|
206,871
|
|
Interest Payable
|
|
|
110,442
|
|
|
|
3,307
|
|
Deferred tax liability
|
|
|
8,000
|
|
|
|
4,000
|
|
Cash used by operating activities
|
|
|
(2,897,254
|
)
|
|
|
(1,707,101
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
Purchase of Intangible Assets
|
|
|
-
|
|
|
|
(150,000
|
)
|
Purchase of property and equipment
|
|
|
(127,259
|
)
|
|
|
(105,238
|
)
|
Cash used by investing activities
|
|
|
(127,259
|
)
|
|
|
(255,238
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from sale of common stock
|
|
|
1,984,747
|
|
|
|
2,280,066
|
|
Proceeds from notes payable
|
|
|
-
|
|
|
|
150,000
|
|
Debt issuance cost
|
|
|
-
|
|
|
|
(10,000
|
)
|
Proceeds from line of credit
|
|
|
1,782,814
|
|
|
|
276,156
|
|
Repayments of line of credit
|
|
|
(1,165,173
|
)
|
|
|
-
|
|
Repayment of note payable
shareholder
|
|
|
(90,078
|
)
|
|
|
(187,422
|
)
|
Cash provided by financing activities
|
|
|
2,512,310
|
|
|
|
2,508,800
|
|
Net (decrease) increase in cash
|
|
|
(512,203
|
)
|
|
|
546,461
|
|
Cash and cash equivalents, beginning of period
|
|
|
546,461
|
|
|
|
-
|
|
Cash and cash equivalents, end of
period
|
|
$
|
34,258
|
|
|
$
|
546,461
|
|
See
Notes to Consolidated Financial Statements
LEVEL BRANDS, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED SEPTEMBER 30, 2016 AND FOR THE INITIAL PERIOD
MARCH 17, 2015 (INCEPTION) TO SEPTEMBER 30, 2015
(continued)
Supplemental Disclosures of Cash Flow Information:
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
Cash Payments for:
|
|
|
|
|
|
|
Interest expense
|
|
$
|
1,293
|
|
|
$
|
4,239
|
|
|
|
|
|
|
|
|
|
|
Non-cash financial activities:
|
|
|
|
|
|
|
|
|
Common stock issued for financing fees
|
|
$
|
105,000
|
|
|
$
|
32,000
|
|
Note converted to common stock
|
|
|
-
|
|
|
|
150,000
|
|
Trade accounts payable assumed to purchase intangible asset
|
|
|
-
|
|
|
|
277,500
|
|
Equity issued to purchase intangible asset
|
|
|
-
|
|
|
|
70,513
|
|
|
|
|
|
|
|
|
|
|
See
Notes to Consolidated Financial Statements
LEVEL BRANDS, INC.
CONSOLIDATED STATEMENT OF SHAREHOLDERS’ (DEFICIT)
EQUITY
FOR THE YEAR ENDED SEPTEMBER 30, 2016 AND FOR THE INITIAL
PERIOD
MARCH 17, 2015 (INCEPTION) TO SEPTEMBER 30, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, March 17, 2015
|
-
|
$-
|
-
|
$-
|
$-
|
$-
|
$-
|
$-
|
Sale
of common stock net fees
|
-
|
-
|
2,450,000
|
2,450
|
2,277,616
|
-
|
-
|
2,280,066
|
Issuance
of common stock for finance fee
|
-
|
-
|
16,000
|
16
|
31,984
|
-
|
-
|
32,000
|
Common
stock issued for services
|
-
|
-
|
37,500
|
38
|
37,462
|
-
|
-
|
37,500
|
Common stock issued as payment for note payable
|
-
|
-
|
150,000
|
150
|
149,850
|
-
|
-
|
150,000
|
Sale
of common stock warrants
|
|
|
-
|
-
|
25,000
|
-
|
-
|
25,000
|
Subsidiary
interest issued for asset acquisition
|
-
|
-
|
-
|
-
|
-
|
-
|
70,513
|
70,513
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
(1,130,847)
|
(186,884)
|
(1,317,731)
|
Balance,
September 30, 2015
|
-
|
-
|
2,653,500
|
2,654
|
2,521,912
|
(1,130,847)
|
(116,371)
|
1,277,348
|
Sale
of common stock
|
-
|
-
|
286,667
|
286
|
1,984,461
|
-
|
-
|
1,984,747
|
Common stock issued upon cashless exercise
of warrants
|
-
|
-
|
416,667
|
417
|
(417)
|
-
|
-
|
-
|
Issuance
of common stock for finance fee
|
-
|
-
|
14,000
|
14
|
104,986
|
-
|
-
|
105,000
|
Common
stock issued for charitable contribution
|
-
|
-
|
30,000
|
30
|
224,970
|
-
|
-
|
225,000
|
Stock
based compensation
|
-
|
-
|
-
|
-
|
11,450
|
-
|
-
|
11,450
|
Net
loss
|
-
|
-
|
-
|
-
|
-
|
(3,356,489)
|
(539,781)
|
(3,896,270)
|
Balance, September 30, 2016
|
-
|
$-
|
3,400,834
|
$3,401
|
$4,847,362
|
$(4,487,336)
|
$(656,152)
|
$(292,725)
|
See
Notes to Consolidated Financial Statements
LEVEL BRANDS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED SEPTEMBER 30, 2016 AND FOR THE INITIAL
PERIOD
MARCH 17, 2015 (INCEPTION) TO SEPTEMBER 30, 2015
NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Organization and Nature of Business – Level Brands, Inc.
(“Level Brands”, “we”, “us”,
“our”, “Parent Company” or the
“Company”) is a North Carolina corporation formed on
March 17, 2015 as Level Beauty Group, Inc. In November 2016 we
changed the name of the company to Level Brands Inc. We intend to
invest in, acquire, develop and take the lead equity management
position in early stage growth brands. We operate from our offices
located in Charlotte, North Carolina. Our fiscal year end is
established as September 30, therefore our first fiscal reporting
period is a partial period defined as the period from inception
(March 17, 2015) to September 30, 2015, whereas our fiscal year end
2016 is a full period from October 1, 2015 to September 30, 2016
(the “periods”).
In March 2015, we formed Beauty and Pin-Ups, LLC
(“BPU”), a North Carolina limited liability company,
and contributed $250,000 in exchange for our member interest. As of
September 30, 2016 we own a 78% member interest in BPU. BPU
manufactures, markets and sells an array of beauty and personal
care products, including hair care and hair treatments, as well as
beauty tools. The Company’s products are sold to the
professional segment, principally through distributors to
professional salons in the North America.
Principles of Consolidation
The consolidated financial statements include the accounts of the
Company and its majority owned subsidiary BPU. All material
intercompany transactions and balances have been eliminated in
consolidation. The third party ownership of the Company’s
subsidiary is accounted for as noncontrolling interest in the
consolidated financial statements. Changes in the noncontrolling
interest are reported in the statement of shareholders’
deficit.
Use of Estimates
The preparation of the Company’s consolidated financial
statements have been prepared in accordance with accounting
principles generally accepted in the United States (GAAP), and
requires management to make estimates and assumptions that affect
amounts of assets and liabilities and disclosures of contingent
assets and liabilities as of the date of the financial statements
and reported amounts of revenues and expenses during the periods
presented. Estimates and assumptions are reviewed periodically and
the effects of revisions are reflected in the consolidated
financial statements in the period they are determined to be
necessary. Significant estimates made in the accompanying
consolidated financial statements include, but are not limited to,
allowances for doubtful accounts, inventory valuation reserves,
expected sales returns and allowances, trade support costs, certain
assumptions related to the valuation of acquired intangible and
long-lived assets and the recoverability of intangible and
long-lived assets and income taxes, including deferred tax
valuation allowances and reserves for estimated tax liabilities.
Actual results could differ from these estimates.
Cash and Cash Equivalents
For financial statements purposes, the Company considers all highly
liquid investments with a maturity of less than three months when
purchased to be cash equivalents.
Accounts receivable
Accounts receivable are stated at cost less an allowance for
doubtful accounts, if applicable. Credit is extended to customers
after an evaluation of customer’s financial condition, and
generally collateral is not required as a condition of credit
extension. Management’s determination of the allowance for
doubtful accounts is based on an evaluation of the receivables,
past experience, current economic conditions, and other risks
inherent in the receivables portfolio. As of September 30, 2016 and
2015, all receivables were considered by management to be fully
collectible.
Inventory
Inventory is stated at the lower of cost or market value with cost
being determined on a weighted average basis. The cost of inventory
includes product cost, and production fill and labor (which we
outsource to third party manufacturers). Write-offs of potentially
slow moving or damaged inventory are recorded based on
management’s analysis of inventory levels, future sales
forecasts and through specific identification of obsolete or
damaged products. Prepaid Inventory represents deposits made with
third party manufacturers in order to begin production of an order
for product.
Property and Equipment
Property and equipment items are stated at cost less accumulated
depreciation. Expenditures for maintenance and repairs are charged
to operations as incurred. Depreciation is charged to expense over
the estimated useful lives of the assets using the straight-line
method. Generally, the useful lives are 5 years for trade show
booths, 3 years for manufacturer’s molds and plates and 3
years for computer equipment. The cost and accumulated depreciation
of property are eliminated from the accounts upon disposal, and any
resulting gain or loss is included in the consolidated statement of
operations for the applicable period. Long-lived assets held and
used by the Company are reviewed for impairment whenever changes in
circumstance indicate the carrying value of an asset may not be
recoverable. There were no impairments during the year ended
September 30, 2016 and for the initial period from March 17, 2015
to September 30, 2015.
Intangible Assets
The Company’s intangible assets consist of trademarks and
other intellectual property. The Company employs the
non-amortization approach to account for purchased intangible
assets having indefinite lives. Under the non-amortization
approach, intangible assets having indefinite lives are not
amortized into the results of operations, but instead are reviewed
annually or more frequently if events or changes in circumstances
indicate that the assets might be impaired, to assess whether their
fair value exceeds their carrying value. There were no impairments
during the year ended September 30 2016 and for the initial period
from March 17, 2015 to September 30, 2015.
Revenue Recognition
The Company’s policy is to recognize revenue when persuasive
evidence of an arrangement exists, shipping has occurred, the sales
price is fixed or determinable and collection is probable. The
Company records revenue from the sale of its products when risk of
loss and title to the product are transferred to the customer,
which is upon shipping. Net sales are comprised of gross revenues
less expected product returns, trade discounts and customer
allowances, which include costs associated with off-invoice
mark-downs and other price reductions, as well as trade promotions
and coupons. These incentive costs are recognized at the later of
the date on which the Company recognizes the related revenue or the
date on which the Company offers the incentive. Although, the
Company does not have a formal return policy, from time to time the
Company will allow customers to return certain products. A
business decision related to customer returns is made by the
Company and is performed on a case-by-case basis. We record returns
as a reduction in sales and based on whether we dispose of the
returned product adjust inventory and record expense as
appropriate. There were no allowances for sales returns during the
year ended September 30, 2016 and for the initial period from March
17, 2015 to September 30, 2015.
Cost of Goods Sold
Cost of goods sold includes the cost of product sold, inventory
shortages, damages and certain freight charges. Cost of goods sold
also includes the cost of refurbishing products returned by
customers that will be offered for resale and the cost of inventory
write-downs associated with adjustments of held inventories to
their net realizable value. These costs are reflected in the
Company’s consolidated statement of operations when the
product is sold and net sales revenues are recognized or, in the
case of inventory write-downs, when circumstances indicate that the
carrying value of inventories is in excess of their recoverable
value.
Advertising Costs
The Company expenses all costs of advertising and related marketing
and promotional costs as incurred. The Company incurred
approximately $670,000 and $107,000 in advertising and related
marketing and promotional costs included in operating expenses
during the periods ended September 30, 2016 and 2015,
respectively.
Shipping and Handling Fees and Costs
All fees billed to customers for shipping and handling are
classified as a component of sales. All costs associated with
shipping and handling are classified as a component of cost of
goods sold.
Income Taxes
The Parent Company is a North Carolina corporation that is treated
as a corporation for federal and state income tax purposes. BPU is
a multi-member limited liability company that is treated as a
partnership for federal and state income tax purposes. As such, the
Parent’s partnership share in the taxable income or loss of
BPU is included in the tax return of the Parent.
The Parent Company accounts for income taxes pursuant to the
provisions of the Accounting for Income Taxes topic of the
Financial Accounting Standards Board (“FASB”)
Accounting Standards Codification (“ASC”), which
requires, among other things, an asset and liability approach to
calculating deferred income taxes. The asset and liability approach
requires the recognition of deferred tax assets and liabilities for
the expected future tax consequences of temporary differences
between the carrying amounts and the tax bases of assets and
liabilities. The Parent Companyuses the inside basis approach to
determine deferred tax assets and liabilities associated with its
investment in a consolidated pass-through entity. A valuation
allowance is provided to offset any net deferred tax assets for
which management believes it is more likely than not that the net
deferred asset will not be realized.
GAAP requires management to evaluate tax positions taken by the
Company and recognize a tax liability (or asset) if the Company has
taken an uncertain tax position that more likely than not would not
be sustained upon examination by the Internal Revenue Service.
Management has analyzed the tax positions taken by the Company, and
has concluded that as of September 30, 2016 and September 30, 2015,
there were no uncertain tax positions taken or expected to be taken
that would require recognition of a liability (or asset) or
disclosure in the consolidated financial statements.
The Company early adopted ASU 2015-17, Income Taxes (Topic 740):
Balance Sheet Classification of Deferred Taxes as of September 30, 2016 and 2015, and as a result
deferred tax assets and liabilities are classified as noncurrent on
the balance sheet.
Concentrations of Credit Risk
Financial instruments that potentially expose the Company to
concentrations of credit risk consist primarily of cash and cash
equivalents and accounts receivable.
The Company places its cash and cash equivalents on deposit with
financial institutions in the United States. The Federal Deposit
Insurance Corporation (“FDIC”) covers $250,000 for
substantially all depository accounts. The Company from time to
time may have amounts on deposit in excess of the insured limits.
The Company had no uninsured balances at September 30, 2016 and had
an uninsured balance of $242,419 as of September 30,
2015.
Concentration of credit risk with respect to receivables is
principally limited to trade receivables with corporate customers
that meet specific credit policies. Management considers these
customer receivables to represent normal business risk. The Company
had one customers whose revenue individually represented 89% of the
Company’s net sales for the reporting period ended September
30, 2016 and whose accounts receivable balance individually
represented 99% of the Company’s total accounts receivable as
of September 30, 2016. The Company had four customers whose revenue
collectively represented 79.8% of the Company’s net sales for
the reporting period ended September 30, 2015 and one customer
whose balance represented 100% of the Company’s total
accounts receivable as of September 30, 2015.
Fair Value of Financial Instruments
The Fair Value Measurements and Disclosures topic of the FASB ASC
requires disclosure of the fair value of financial assets and
liabilities for which it is practicable to estimate. Fair value is
defined as the amount at which the instrument could be exchanged in
a current transaction between willing parties, other than in a
forced or liquidation sale. The carrying amounts of cash and cash
equivalents, accounts receivable and accounts payable approximate
fair value because of the short maturity of these instruments. The
Company determined the estimated fair value of its debt by
discounting future cash payments at their effective rates of
interest, which approximate current market rates of interest for
similar loans. Accordingly, there is no material difference between
their carrying amount and fair value.
Debt Issuance Costs
Debt issuance costs related to a recognized debt liability are
presented in the balance sheet as a direct deduction from the
carrying value of that debt liability, consistent with debt
discounts. Amortization of debt issuance costs are included as a
component of interest expense.
Stock-Based Compensation
We account for our stock compensation under the Compensation -
Stock Compensation topic of the FASB ASC using the fair value based
method. Under this method, compensation cost is measured at the
grant date based on the value of the award and is recognized over
the service period, which is usually thevesting period. This
guidance establishes standards for the accounting for transactions
in which an entity exchanges its equity instruments for goods or
services. It also addresses transactions in which an entity incurs
liabilities in exchange for goods or services that are based on the
fair value of the entity’s equity instruments or that may be
settled by the issuance of those equity instruments.
We use the Black-Scholes model for measuring the fair value of
options and warrants. The stock based fair value compensation is
determined as of the date of the grant or the date at which the
performance of the services is completed (measurement date) and is
recognized over the vesting periods.
Net Loss Per Share
The Company uses ASC 260-10, “Earnings Per Share” for
calculating the basic and diluted loss per share. The Company
computes basic loss per share by dividing net loss and net loss
attributable to common shareholders by the weighted average number
of common shares outstanding. Common equivalent shares are excluded
from the computation of net loss per share if their effect is
anti-dilutive.
At September 30, 2016 and 2015, 110,067 and 550,000 potential
shares, respectively, were excluded from the shares used to
calculate diluted loss per share as their inclusion would reduce
net loss per share.
New Accounting Standards
In May 2014, August 2015 and May 2016, the Financial Accounting
Standards Board (FASB) issued ASU 2014-09, Revenue from Contracts with
Customers, and ASU
2015-14 Revenue from Contracts with
Customers, Deferral of the Effective Date, respectively, which implement ASC Topic 606. ASC
Topic 606 outlines a single comprehensive model for entities to use
in accounting for revenue arising from contracts with customers and
supersedes most current revenue recognition guidance under US GAAP,
including industry-specific guidance. It also requires entities to
disclose both quantitative and qualitative information that enable
financial statements users to understand the nature, amount,
timing, anduncertainty of revenue and cash flows arising from
contracts with customers. The amendments in these ASUs are
effective for annual periods beginning after December 15, 2017, and
interim periods therein. Early adoption is permitted for annual
periods beginning after December 15, 2016. These ASUs may be
applied retrospectively to all prior periods presented, or
retrospectively with a cumulative adjustment to retained earnings
in the year of adoption. The Company is assessing the impact, if
any, of implementing this guidance on its consolidated financial
position, results of operations and liquidity.
In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties
about an Entity’s Ability to Continue as a Going
Concern. This standard sets
forth management’s responsibility to evaluate, each reporting
period, whether there is substantial doubt about the
Company’s ability to continue as a going concern, and if so,
to provide related disclosures. ASU 2014-15 is effective for annual
reporting periods ending after December 15, 2016 and interim
periods within annual periods beginning after December 15, 2016.
The Company is assessing the impact, if any, of implementing this
guidance on its evaluation of going concern.
In July 2015, the FASB issued ASU 2015-11, Inventory: Simplifying the
Measurement of Inventory. The
purpose of ASU 2015-11 is to more closely align the measurement of
inventory in U.S. GAAP with the measurement of inventory in
International Financial Reporting Standards. ASU 2015-11 requires
entities to measure most inventory at the “lower of cost or
net realizable value.” Additionally, some of the amendments
are designed to more clearly articulate the requirements for the
measurement and disclosure of inventory. ASU 2015-11 is effective
for fiscal years and interim periods beginning after December 15,
2016. The Company is assessing the impact, if any, of implementing
this guidance on its consolidated financial position, results of
operations and liquidity.
In February 2016, the FASB issued ASU 2016-02, Leases. The purpose of ASU 2016-02 is to establish
the principles to report transparent and economically neutral
information about the assets and liabilities that arise from
leases. This guidance results in a more faithful representation of
the rights and obligations arising from operating and capital
leases by requiring lessees to recognize the lease assets and lease
liabilities that arise from leases in the statement of financial
position and to disclose qualitative and quantitative
informationabout lease transactions, such as information about
variable lease payments and options to renew and terminate leases.
ASU 2016-02 is effective for fiscal years and interim periods
beginning after December 15, 2018. The Company is assessing the
impact, if any, of implementing this guidance on its consolidated
financial position, results of operations and
liquidity.
In March 2016, the FASB issued ASU 2016-09, Stock Compensation:
Improvements to Employee Share-Based Payment
Accounting. The purpose
of ASU 2016-09 is to simplify several aspects of the accounting for
share-based payment transactions, including the income tax
consequences, classification of awards as either equities or
liabilities, and classification of amounts in the statement of cash
flows. ASU 2016-09 is effective for fiscal years and interim
periods beginning after December 15, 2016. The Company is
assessing the impact, if any, of implementing this guidance on its
consolidated financial position, results of operations and
liquidity.
In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic
230), Classification of Certain Cash Receipts and Cash
Payments. The amendments in
this update provided guidance on eight specific cash flow issues.
This update is to provide specific guidance on each of the eight
issues, thereby reducing the diversity in practice in how certain
transactions are classified in the statement of cash flows. ASU
2016-15 is effective for fiscal years and interim periods beginning
after December 15, 2017. Early adoption is permitted. The Company
is assessing the impact, if any, of implementing this guidance on
its consolidated financial position, results of operations and
liquidity.
NOTE
2 – INTANGIBLE ASSETS
On April 13, 2015, BPU acquired from Beauty & Pinups, Inc., a
New York corporation (“BPUNY”) certain assets,
including the trademark “Beauty & Pin Ups” and its
variants and certain other intellectual property and assumed
$277,500 of BPUNY’s accounts payable to its product vendor,
which bears interest at 6% annually, on which we are making
periodic payments.
Intangible assets as of September 30, 2016 and 2015 consisted of
the following:
|
|
|
Trademark and other intellectual
property
|
$486,760
|
$486,760
|
The Company performs an impairment analysis at August 1 annually on
the indefinite-lived intangible assets following the steps laid out
in ASC 350-30-35-18. As of September 30, 2016 and September 30,
2015 there has been no impairment.
NOTE 3 – INVENTORY
Inventory at September 30, 2016 and 2015 consists of the
followings:
|
|
|
Finished
goods
|
$656,607
|
$100,348
|
Inventory
components
|
|
|
Inventory
reserve
|
-
|
-
|
|
-
|
|
Total
|
$687,465
|
$167,725
|
NOTE 4 – PROPERTY AND EQUIPMENT
Major classes of property and equipment at September 30, 2016 and
2015 consist of the followings:
|
|
|
Computers
and equipment
|
$14,311
|
$8,935
|
Show
booth and equipment
|
171,986
|
62,103
|
Manufacturers’
molds and plates
|
34,200
|
34,200
|
Software
|
12,000
|
-
|
|
232,497
|
105,238
|
Less
accumulated depreciation
|
(52,216)
|
(7,281)
|
Net
property and equipment
|
$180,281
|
$97,957
|
Depreciation expense related to property and equipment was $44,935
and $7,281 for the periods ended September 30, 2016 and 2015,
respectively.
NOTE 5 – LINE OF CREDIT
In August 2015, we entered into a one year $1,000,000 revolving
line of credit agreement with LBGLOC, LLC, a related party. Under
the terms of the agreement, we pay interest on any amounts advanced
at the rate of 10% per annum. We granted LBGLOC, LLC a blanket
security agreement on our assets as collateral for amounts advanced
under the credit line. As additional consideration for granting the
credit line, we issued the lender 16,000 shares of common
stock.
The agreement was renewed for an additional one year period on
September 1, 2016. As additional consideration for renewing the
credit line, we issued the lender 14,000 shares of common
stock.
The outstanding balances due under the agreements were $893,797 and
$276,156 at September 30, 2016 and 2015, respectively.
NOTE 6 – RELATED PARTY TRANSACTIONS
Pursuant to the acquisition of assets from BPUNY described in Note
2, we assumed a trade payable of $277,500 due to a vendor, which is
now a member of BPU. The trade payable was converted to a note that
matured in April 2016 and interest on the outstanding balance
accrued at 6% per annum. We made payments on the liability
aggregating $90,078 and $187,422 during the reporting periods ended
September 30, 2016 and 2015, respectively. The note was fully paid
as of September 30, 2016. The balance due at September 30, 2015 was
$90,078. Interest expense was $1,207 and $4,239 for the reporting
periods ended September 30, 2016 and 2015,
respectively.
In March 2015 we borrowed $150,000 from Stone Street Partners, LLC,
an affiliate of Mr. Sumichrast, under the terms of a promissory
note. We used these proceeds for general working capital. In April
2015 we entered into a conversion agreement with Stone Street
Partners, LLC under which this note, plus an additional $850,000
paid to us, was converted into 1,000,000 shares of our common
stock.
In April 2015, we sold Mr. G. Tyler Runnels, a former member of our
board of directors, 500,000 shares of our common stock in a private
transaction at a purchase price of $1.00 per share.
In April 2015, we entered into a two year Advisory Services
Agreement (“ASA”) with a shareholder for management,
creative and marketing services. The agreement provides for a
monthly fee of $10,000, which the shareholder has agreed to defer
payment of until the Company has sufficient available cash or upon
closing of a capital raise in excessof $5,000,000. We have recorded
expense of $120,000 and $50,000 for the reporting periods ended
September 30, 2016 and 2015, respectively, which has been accrued
during the periods. No payments have been made for the monthly fees
during the periods ended September 30, 2016 and 2015. On October 1,
2016 the Company and the shareholder agreed as follows: (1) to
terminate the ASA and all fees owed by providing 36,000 shares of
the Company’s common stock and (2) a lump sum payment of
$50,000, which was paid on November 4, 2016. In addition we issued
40,000 shares of the Company’s common stock for additional
consulting services which were outside the original scope of
service. All shares were issued on November 15, 2016.
In April 2015, we entered into a two year consulting agreement with
a member of BPU for creative influence, leadership and direction
services. The agreement provides for a monthly fee of $12,000.
During the reporting periods ended September 30, 2016 and 2015, we
have recorded prepaid expense of $10,393 and $15,500 respectively,
and have recorded expense of $144,000 and $65,750, respectively,
related to this agreement.
In April 2015, we entered into a Management Services Agreement (the
“MSA”) with kathy ireland® Worldwide
(“kiWW”) pursuant to which it agreed to provide
management certain creative and marketing services. One of
our board members is the CFO for kiWW. As compensation, we
generally agreed to pay, a deferred monthly fee of $10,000, to the
extent kiWW is providing services with respect to BPU, an annual
fee of 10% of the gross margins of BPU after the first $10 million
in revenues; and a $750,000 royalty fee, of which this criteria has
not been met as of the year ended September 30, 2016. We paid kiWW
$100,000 upon the execution of this agreement. On October 1, 2016,
the Company and kiWW agreed to terminate the MSA agreement and all
fees owed by providing a lump sum payment of $50,000, which was
paid on November 3, 2016.
In April 2015, we sold to kiWW, an affiliate of one of our board
members, a five-year warrant to purchase 500,000 shares of our
common stock at an exercise price of $1.25 per share for $25,000.
Subsequent to this transaction, kiWW transferred a portion of the
warrant to a third-party. The warrants were exercised in March
2016.
In June 2015, we engaged T.R. Winston & Co., LLC
(“TRW”), a broker-dealer and member of FINRA that is an
affiliate of a shareholder, to serve as our exclusive placement
agent in a private placement of our securities which resulted in
gross proceeds to us of $1,000,000. In this offering, we paid TRW
cash commissions of $60,000 and issued its affiliates five year
placement agent warrants to purchase 50,000 shares of our common
stock at an exercise price of $2.75 per share, which are
exercisable on acashless basis. Pursuant to the terms of the
agreement with TRW, until February 2017 we agreed to pay the firm a
tail fee on proceeds we may receive which will be identical to the
compensation it is to receive in the earlier offering in the event
of any subsequent public or private offerings or other capital
raising transactions resulting from investment made by purchasers
in the earlier offering that were introduced to us, directly or
indirectly, by TRW.
In August 2015, we entered into an agreement for a one million
dollar line of credit with a 10% annual interest rate with LBGLOC
LLC. One of the members of this LBGLOC LLC was Stone Street
Partners Opportunity Fund II LLC (the “Fund”) of which
at the time our Chairman of the board was the manager and a member
of this LLC. The Fund invested $300,000 toward the line of credit
provide by LBGLOC LLC to the Company. The Fund exited the line of
credit on November 23, 2015, when a new unrelated member joined
LBGLOC LLC, and the Fund was paid principal and interest totaling
$308,750. The Company issued 16,000 shares of common stock to
LBGLOC LLC as a fee for setting up the line of credit.
In December 2015, we engaged T.R Winston & Co., LLC to serve as
our exclusive placement agent in a private placement of our
securities which resulted in gross proceeds to us of $2,150,000 in
February 2016. In this offering, we paid T.R. Winston & Co.,
LLC cash commissions of $150,500 and issued its affiliates four
year placement agent warrants to purchase 20,067 shares of our
common stock at an exercise price of $8.75 per share, which are
exercisable on a cashless basis. In February 2016 we reduced the
exercise price of these warrants to $5.00 per share. These warrants
and the warrants associated with the June 2015 placement were
exercised on a cashless basis in October 2016.
In January 2016 we entered into a charitable agreement, as amended,
with Best Buddies International, an affiliate of a member of our
board of directors. Pursuant to the agreement we issued 30,000
shares of our common stock valued at $225,000 as a charitable
contribution.
In July 2016, we entered into a one year promissory note with a
shareholder for amounts to be advanced as needed at an annual
interest rate of 7%. Our Chairman of the board at the time was a
member of the shareholder. From July through August 18, 2016 the
Company was advanced $303,966 and paid this principal back in full
on September 9, 2016. Interest of $3,352 had been accrued by the
Company and was paid on November 23, 2016.
In August 2016, we renewed an agreement for a one million dollar
line of credit with a 10% annual interest rate with LBGLOC LLC. One
of the members of this LLC was Stone Street Partners Opportunity
Fund II LLC (the “Fund”) of which at the time our
Chairman of the board was the manager and a member of this LLC. The
Fund invested $300,000 toward the line of credit provide by LBGLOC
LLC to the company. The Company also issued 14,000 shares of common
stock as a fee to LBGLOC LLC for the renewal of the line of credit.
The Fund exited the line of credit on October 6, 2016 and was paid
principal and interest totaling $302,500, thus reducing the
available borrowing limit on the line of credit to
$700,000.
NOTE 7 – SHAREHOLDERS’ EQUITY
Preferred Stock – We are authorized to issue 50,000,000
shares of preferred stock, par value $0.001 per share. Our
preferred stock does not have any preference, liquidation, or
dividend provisions. No shares of preferred stock have been
issued.
Common Stock – We are authorized to issue 150,000,000 shares
of common stock, par value $0.001 per share. There were 3,400,834
and 2,653,500 shares of common stock issued and outstanding at
September 30, 2016 and 2015, respectively.
On November 11, 2016, majority shareholders of the Corporation,
upon recommendation of the Board of Directors, approved a reverse
stock split of the Corporation’s common stock to be effected
at a specific ratio to be determined by the Board of Directors in
the future within a range up to one for nine (1:9). On December 2,
2016, the Board of Directors fixed the ratio of the reverse stock
split at one to five (1:5) and set the effective date as December
5, 2016. All share and per share amounts within these consolidated
financial statements have been retroactively adjusted to give
effect to the reverse split.
Common stock transactions:
Fiscal year 2016:
We issued 416,667 shares of common stock upon the cashless exercise
of 500,000 warrants.
We sold 286,667 shares of common stock in a private placement for
gross proceeds of $2,150,000. Costs of $165,253 were deducted from
the proceeds.
We issued 14,000 shares of common stock, valued at $105,000, as an
incentive to LBGLOC, LLC to renew a revolving credit agreement. The
shares were valued using the price established from the most recent
equity financing in January and February 2016.
We issued 30,000 shares of common stock, valued at $225,000, as a
charitable contribution. The shares were valued using the price
established from the most recent equity financing in January and
February 2016.
Fiscal year 2015:
We sold 600,000 shares of common stock to our founders for
aggregate proceeds of $3,000.
We sold 1,350,000 shares of common stock in a private placement for
aggregate proceeds of $1,350,000.
We issued 150,000 shares of common stock upon settlement of a note
with Stone Street Partners LLC in the amount of
$150,000.
We issued 37,500 shares of common stock, valued at $37,500, to a
board member upon joining the board of directors.
We sold an aggregate of 500,000 shares of common stock in a private
placement and received $1,000,000 in gross proceeds. We incurred
placement fees and other costs aggregating $64,000 which were
deducted from the proceeds. We also paid $8,934 of legal
fees.
We issued 16,000 shares of common stock, valued at $32,000, as an
incentive to LBGLOC LLC to enter into a revolving credit agreement.
The shares were valued using the price established from the most
recent equity financing in June 2015.
Stock option transactions:
On December 15, 2015 we granted an aggregate of 40,000 common stock
options to two employees. The options vest ratably over three years
on the anniversary of the grant date. The options have an exercise
price of $2.00 per share and a term of six years. The options have
a grant date fair value of $1.15 per option, determined using the
Black-Scholes method based on the following assumptions: (1) risk
free interest rate of 1.84%; (2) dividend yield of 0%; (3)
volatility factor of the expected market price of our common stock
of 61%; and (4) an expected life of the options of 6 years. The
risk free interest rate is based on the U.S. Treasury rates on the
grant date with maturity dates approximating the expected life of
the option on the grant date. As the Company’s common stock
has no public trading volume, volatility is calculated based on the
average volatility of a group of peer companies. We have recorded
an expense for the options of $11,450 for the year ended September
30, 2016.
Warrant transactions:
Fiscal year 2016
During February 2016, we issued placement agent warrants
exercisable into 20,067 shares of common stock with an exercise
price of $8.75. The warrants expire on February 16,
2020.
Fiscal year 2015
In April 2015, the Company sold 500,000 common stock warrants for
proceeds of $25,000. The warrants have an exercise price of $1.25
and expire July 27, 2020.
During August 2015 we issued placement agent warrants exercisable
into 50,000 shares of common stock with an exercise price of $2.75.
The warrants expire on August 20, 2020.
All of these warrants were exercised during the year ended
September 30, 2016.
The following table summarizes the inputs used for the
Black-Scholes pricing model on the warrants issued in the periods
ended September 30, 2016 and 2015:
Period
ended September 30,
|
2016
|
|
2015
|
Exercise price
|
$8.75
|
|
$1.25 - $2.75
|
Risk free interest rate
|
1.07%
|
|
1.36% - 1.52%
|
Volatility
|
43.34%
|
|
56.61% - 58.08%
|
Expected term
|
4
years
|
|
5 years
|
Dividend yield
|
None
|
|
None
|
NOTE 8 – STOCK-BASED COMPENSATION
Equity Compensation Plan – On June 2, 2015, the Board of
Directors of Level Brands, Inc. approved the 2015 Equity
Compensation Plan (“Plan”). The Plan made 1,175,000
common stock shares, either unissued or reacquired by the Company,
available for awards of options, restricted stocks, other stock
grants, or any combination thereof. The number of shares of common
stock available for issuance under the Plan shall automatically
increase on the first trading day of January each calendar year
during the term of the Plan, beginning with calendar year 2016, by
an amount equal to one percent (1%) of the total number of shares
of common stock outstanding on the last trading day in December of
the immediately preceding calendar year, but in no event shall any
such annual increase exceed 100,000 shares of common
stock.
Eligible recipients include employees, officers, directors and
consultants who are deemed to have rendered or to be able to render
significant services to the Company or its subsidiaries and who are
deemed to have contributed or to have the potential to contribute
to the success of the Company. Options granted generally have a
ten-year term and vest over three years from the date of grant.
Certain of the stock options granted under the plan have been
granted pursuant to various stock option agreements. Each stock
option agreement contains specific terms.
Stock Options – The Company currently has awards outstanding
with service conditions and graded-vesting features. We recognize
compensation cost on a straight-line basis over the requisite
service period.
The fair value of each time-based award is estimated on the date of
grant using the Black-Scholes option valuation model, which uses
the assumptions described below. Our weighted-average assumptions
used in the Black-Scholes valuation model for equity awards with
time-based vesting provisions granted during the reporting periods
ended September 30, 2016 and 2015:
The following table summarizes stock option activity under the
Plan:
|
|
Weighted-average exercise price
|
Weighted-average remaining contractual term (in
years)
|
Aggregate intrinsic value (in thousands)
|
Outstanding
at March 17, 2015
|
—
|
$—
|
|
|
Granted
|
—
|
—
|
|
|
Exercised
|
—
|
—
|
|
|
Forfeited
|
—
|
—
|
|
|
Outstanding
at September 30, 2015
|
—
|
|
|
|
Granted
|
40,000
|
2.00
|
|
|
Exercised
|
—
|
—
|
|
|
Forfeited
|
—
|
—
|
|
|
Outstanding
at September 30, 2016
|
40,000
|
$2.00
|
5.2
|
$—
|
|
|
|
|
|
Exercisable
at September 30, 2016
|
—
|
$—
|
—
|
$—
|
As of September 30, 2016, there was approximately $34,000 of total
unrecognized compensation cost related to non-vested stock options
which vest over a period of approximately 2.25 years.
The following table summarizes the inputs used for the
Black-Scholes pricing model on the options issued during the year
ended September 30, 2016. No options were issued in
2015.
Period
ended September 30,
|
2016
|
|
2015
|
Exercise price
|
$2.00
|
|
|
Risk free interest rate
|
1.84%
|
|
|
Volatility
|
61.3%
|
|
|
Expected Term
|
6
Years
|
|
|
Dividend yield
|
None
|
|
|
The expected volatility rate was estimated based on comparison to
the volatility of a peer group of companies in the similar
industry. The expected term used was the full term of the contract
for the issuances. The risk-free interest rate for periods within
the contractual life of the option is based on U.S. Treasury
securities. The pre-vesting forfeiture rate of zero is based upon
the experience of the Company. As required under ASC 718, we will
adjust the estimated forfeiture rate to our actual experience.
Management will continue to assess the assumptions and
methodologies used to calculate estimated fair value of share-based
compensation. Circumstances may change and additional data may
become available over time, which could result in changes to these
assumptions and methodologies, and thereby materially impact our
fair value determination.
NOTE 9 – WARRANTS
Transactions involving our equity-classified warrants are
summarized as follows:
|
|
Weighted-average exercise price
|
Weighted-
average remaining contractual term (in years)
|
Aggregate intrinsic value (in thousands)
|
Outstanding
at March 17, 2015
|
—
|
$—
|
|
|
Issued
|
550,000
|
1.39
|
|
|
Exercised
|
—
|
—
|
|
|
Forfeited
|
—
|
—
|
|
|
Outstanding
at September 30, 2015
|
550,000
|
1.39
|
|
|
Issued
|
20,067
|
8.75
|
|
|
Exercised
|
(500,000)
|
1.25
|
|
|
Forfeited
|
—
|
—
|
|
|
Outstanding
at September 30, 2016
|
70,067
|
$4.47
|
3.7
|
$—
|
|
|
|
|
|
Exercisable
at September 30, 2016
|
70,067
|
$4.47
|
3.7
|
$—
|
The following table summarizes outstanding common stock purchase
warrants as of September 30, 2016:
|
|
Number of shares
|
|
|
Weighted-average exercise price
|
|
Expiration
|
|
|
|
|
|
|
|
|
Exercisable at $2.75 per share
|
|
|
50,000
|
|
|
$
|
2.75
|
|
August 2020
|
Exercisable at $8.75 per share
|
|
|
20,067
|
|
|
$
|
8.75
|
|
February 2020
|
|
|
|
70,067
|
|
|
|
4.47
|
|
|
NOTE 10 – INCOME TAXES
The Company generated operating losses for the years ended
September 30, 2016 and 2015 on which it has recognized a full
valuation allowance. The Company accounts for its state franchise
and minimum taxes as a component of its general and administrative
expenses.
The following table presents the components of the provision for
income taxes for the periods presented:
|
Periods Ended September 30,
|
|
|
|
Current
|
|
|
Federal
|
$—
|
$—
|
State
|
—
|
—
|
Total
current
|
—
|
—
|
Deferred
|
|
|
Federal
|
7,000
|
4,000
|
State
|
1,000
|
—
|
Total
deferred
|
8,000
|
4,000
|
Total
provision
|
$8,000
|
$4,000
|
A reconciliation of the federal statutory income tax rate to the
Company’s effective income tax rate is as
follows:
|
Periods Ended September 30,
|
|
|
|
Federal
statutory income tax rate
|
34.0%
|
34.0%
|
State
income taxes, net of federal benefit
|
2.6
|
2.6
|
Permanent
differences
|
(7.7)
|
(6.79)
|
Change
in valuation allowance
|
(29.1)
|
(30.2)
|
|
|
|
Provision
for income taxes
|
(0.2)%
|
(0.3)%
|
Significant components of the Company’s deferred income taxes
are shown below:
|
Periods Ended September 30,
|
|
|
|
Deferred
tax assets:
|
|
|
Net
operating loss carryforwards
|
$1,333,000
|
$334,000
|
Stock
compensation
|
4,000
|
—
|
Management
fees
|
189,000
|
65,000
|
Charitable
contributions
|
5,000
|
—
|
|
|
|
Total
deferred tax assets
|
1,531,000
|
399,000
|
|
|
|
Deferred
tax liabilities
|
|
|
Depreciation
and amortization
|
(14,000)
|
(6,000)
|
Total
deferred tax liabilities
|
(14,000)
|
(6,000)
|
Net
deferred tax assets
|
1,517,000
|
393,000
|
Valuation
allowance
|
(1,505,000)
|
(389,000)
|
|
|
|
Net deferred tax liability
|
$12,000
|
$4,000
|
The Company has established a valuation allowance against net
deferred tax assets due to the uncertainty that such assets will be
realized. The Company periodically evaluates the recoverability of
the deferred tax assets. At such time as it is determined that it
is more likely than not that deferred tax assets will be
realizable, the valuation allowance will be reduced. The valuation
allowance increased by $1,116,000 and $389,000 for the periods
ended September 30, 2016 and 2015, respectively.
At September 30, 2016, the Company has federal net operating
losses, or NOL, carryforwards of approximately $3.6 million. The
NOL carryforwards begin to expire in 2035.
The above NOL carryforward may be subject to an annual limitation
under Section 382 and 383 of the Internal Revenue Code of
1986, and similar state provisions if the Company experienced one
or more ownership changes.
The Company files income tax returns in the United States, and
various state jurisdictions. The Company’s policy is to
recognize interest expense and penalties related to income tax
matters as tax expense. At September 30, 2016 and 2015, there
are no unrecognized tax benefits, and there are no significant
accruals for interest related to unrecognized tax benefits or tax
penalties.
NOTE 11 – LEASES
The Company leases its office space on a month-to-month basis. Rent
expense was $108,166 and $20,000 for the reporting periods ended
September 30, 2016 and 2015, respectively.
NOTE 12 – COMMITMENTS AND CONTINGENCIES
Management Services Agreement
In April 2015, the Company entered into a Management Services
Agreement (“MSA”) with kiWW in which management,
creative, and marketing services are provided over a two year
period. The Company has agreed to pay a monthly fee equal to
$10,000 which can be deferred if the Company does not have
sufficient available cash to pay the fee. In addition, the Company
paid a $100,000 fee upon the signing of the MSA, which has been
charged to expense during the period ended September 30, 2015. We
have recorded expense of $120,000 and $50,000 for the reporting
periods ended September 30, 2016 and 2015, respectively, which has
been accrued during the periods. No payments have been made for the
monthly fees (see Note 13).
In April 2015, we entered into a two year Advisory Services
Agreement (“ASA”) with a shareholder for management,
creative and marketing services. The agreement provides for a
monthly fee of $10,000, which the shareholder has agreed to defer
payment of until the Company has sufficient available cash or upon
closing of a capital raise in excess of $5,000,000. We have
recorded expense of $120,000 and $50,000 for the reporting periods
ended September 30, 2016 and 2015, respectively, which has been
accrued during the periods. No payments have been made for the
monthly fees during the periods ended September 30, 2016 and 2015
(see Note 13).
NOTE 13 – SUBSEQUENT EVENTS
The
Company has evaluated subsequent events through May 1, 2017, in
connection with the preparation of these financial statements which
is the date the financial statements were available to be
issued.
On October 4, 2016 and October 24, 2016, the Company issued in
aggregate a total of $2,125,000 of 8% Convertible Promissory Notes
to accredited investors. The securities consist of 8% Convertible
Notes with warrants to purchase 141,676 shares of the
Company’s stock (the “Notes”). The Notes may
convert upon an initial public offering (“IPO) resulting in
gross proceeds to the Company of at least $10,000,000, prior to
July 1, 2017. The conversion price for the notes is $5.00. All
notes converted will be subject to a 12-month lockup post IPO. The
warrants expire five years from the date of issuance and have an
exercise price of $7.80. The Warrant is exercisable beginning the
earlier of: (i) immediately after the IPO Closing; or (ii) July 1,
2017.
On October 1, 2016, the Company and kiWW agreed to terminate their
MSA agreement and all fees owed by providing a lump sum payment of
$50,000, which was paid on November 3, 2016.
On October 1, 2016, the company and Stone Street Capital LLC agreed
to terminate their ASA and all fees owed by providing 36,000 shares
of the Company’s common stock and a lump sum payment of
$50,000, which was paid on November 4, 2016. In addition, the
Company issued 40,000 shares of the Company’s common stock
for additional consulting services provided from August to
September 2016 which were outside the original scope of service.
All shares were issued on November 15, 2016.
On October 1, 2016, the Company issued 230,000 restricted stock
awards in aggregate to board members. The restricted stock awards
vest January 1, 2018.
On October 1, 2016, the board approved the issuance of options to
purchase 14,300 shares of common stock at a strike price of $7.50
to 2 employees of the company. The options vest as follows: 2,300
vest immediately, 6,000 vest on January 1, 2017 and 6,000 vest on
January 1, 2018.
On October 1, 2016, the board approved the issuance of options to
purchase 171,500 shares of common stock at a strike price of $7.50
to 2 employees of the company. The shares vest on January 1,
2018.
On October 1, 2016, the board approved the strike price adjustment
for certain placement agent warrants totaling 20,067 from a strike
price of $8.75 to $5.00.
On October 1, 2016, the board approved the issuance of 20,000
shares of stock to its designated charitable foundation, valued at
$0.85 per share for an aggregate value of $17,000.
On October 26, 2016, 38,358 shares were issued, upon a cashless
exercise of 70,067 warrants, which had been issued to a placement
agent for prior services related to previous private placements of
our securities.
On November 11, 2016, majority shareholders of the Company, upon
recommendation of the Board of Directors, approved a reverse stock
split of the Company's common stock to be effected at a specific
ratio to be determined by the Board of Directors in the future
within a range up to one for nine (1:9). On December 2, 2016 the
Board of Directors fixed the ratio of the reverse stock split at
one to five (1:5) and set the effective date as December 5,
2016.
Per terms in the Operating Agreement of BPU, the Company can redeem
the 10% membership interest of Sigan Industries Group for $110,000
at any time before April 13, 2017. On October 14, 2016, Sigan
Industries entered into an agreement with the Company to transfer
their 10% member interest for 129,412 shares of the Company's
common stock.
On January 1, 2017, the Company issued in aggregate 26,667 shares
of common stock to 2 employees as additional compensation. The
shares were valued at $22,667.
Effective January 6, 2017, the Company acquired 51% ownership in
IM1, LLC (“I’M1”) in exchange for 583,000 shares
of Level Brands Inc. common stock valued at $495,550. I’M1
has entered into a License Agreement with kathy ireland®
Worldwide for rights for 10 years regarding the mark, intellectual
property and other rights in connection with
“I’M1” and all trade names, trademarks and
service marks related to such intellectual property,
Effective January 6, 2017, the Company acquired 51% ownership in
Encore Endeavor 1 LLC (“EE1”) in exchange for 283,000
shares of Level Brands Inc. common stock valued at
$240,550.
On February 8, 2017 the Company entered into a one year master
advisory and consulting agreement with kathy ireland®
Worldwide (“kiWW”) pursuant to which we have engaged
the company to provide non-exclusive strategic advisory services to
us. Under the terms of this agreement, Ms. Ireland serves in the
non-executive positions as our Chairman Emeritus and Chief Brand
Strategist. We will pay kiWW $1.00 per month for these
services.
On February 8, 2017 the Company entered into one year advisory
agreements with Mr. Tommy Meharey pursuant to which he provides
advisory and consulting services to us, including serving as
co-Managing Director of I’M1. We have agreed to pay Mr.
Meharey a fee of $15,000 per month for his services.
On February 8, 2017 the Company entered into one year advisory
agreements with Mr. Nic Mendoza pursuant to which he provides
advisory and consulting services to us, including serving as
co-Managing Director of EE1. We have agreed to pay Mr. Mendoza a
fee of $10,000 per month for his services.
On February 8, 2017 the Company entered into one year advisory
agreements with Mr. Stephen Roseberry pursuant to which he provides
advisory and consulting services to us, including serving as
co-Managing Director of EE1 and I’M1. We have agreed to pay
Mr. Roseberry a fee of $1.00 per month for his
services.
On April 13, 2017, the board approved the issuance of options to
purchase 100,000 shares of common stock at a strike price of $4.00
to one employee of the Company. The shares vest 50,000 upon
issuance and 50,000 on January 1, 2018.
[________] Shares of Common Stock
——————
OFFERING CIRCULAR
——————
Sole Book Running Manager
Joseph Gunnar & Co.
Co-Manager
TriPoint Global Equities, LLC
[_____________], 2017
PART III
EXHIBITS
Exhibit No.
|
|
Description
|
1.1
|
|
Form of Selling Agency Agreement**
|
2.1
|
|
Articles of Incorporation*
|
2.2
|
|
Articles of Amendment to the Articles of Incorporation filed April
22, 2015*
|
2.3
|
|
Articles of Amendment to the Articles of Incorporation filed June
22, 2015*
|
2.4
|
|
Articles of Amendment to the Articles of Incorporation filed
November 17, 2016*
|
2.5
|
|
Articles of Amendment to the Articles of Incorporation filed
December 5, 2016*
|
2.6
|
|
Bylaws, as amended*
|
3.1
|
|
Form of 8% convertible promissory note*
|
3.2
|
|
Form of amendment to Subscription Agreement, 8% convertible
promissory note and common stock purchase warrant*
|
3.3
|
|
Form of placement agent warrant issued in June 2015 private
placement*
|
3.4
|
|
Form of placement agent warrant issued in December 2015 private
placement*
|
3.5
|
|
Form of warrant issued in 8% convertible promissory note
offering*
|
3.6
|
|
Form of Selling Agent's Warrant Agreement**
|
3.7
|
|
Form of common stock certificate of the registrant*
|
3.8
|
|
2015 Equity Compensation Plan *+
|
3.9
|
|
Form of stock option award under the 2015 Equity Compensation Plan
*
|
3.10
|
|
Form of warrant issued to Andre Carthen *
|
3.11
|
|
Form of warrant issued to Nicholas Walker*
|
4.1
|
|
Form of Subscription Agreement **
|
4.2
|
|
Form of Subscription Agreement for BANQ subscribers **
|
6.1
|
|
Operating Agreement of Beauty and Pin Ups LLC, as
amended*
|
6.2
|
|
Consulting Agreement dated April 13, 2015 by and between Beauty and
Pin Ups LLC and Priel Mamam*
|
6.3
|
|
Management Services Agreement dated April 27, 2015 by and between
kathy ireland® Worldwide and Level Beauty Group, Inc.
*
|
6.4
|
|
Advisory Services Agreement dated April 27, 2015 by and between
Stone Street Partners, LLC and Level Beauty Group, Inc.
*
|
6.5
|
|
Termination Agreement dated October 31, 2016 by and between kathy
ireland® Worldwide and Level Beauty Group, Inc. *
|
6.6
|
|
Termination Agreement dated September 30, 2016 by and between
Siskey Capital, LLC and Level Beauty Group, Inc. *
|
6.7
|
|
Revolving Line of Credit Loan Agreement dated August 7, 2015 from
Level Beauty Group, Inc. to LBGLOC, LLC *
|
6.8
|
|
Promissory Note dated August 7, 2015 from Level Beauty Group, Inc.
to LBGLOC LLC *
|
6.9
|
|
Security Agreement dated August 7, 2015 from Level Beauty Group,
Inc. to LBGLOC LLC *
|
6.10
|
|
Executive Employment Agreement dated January 1, 2017 by and between
Level Brands, Inc. and Martin A. Sumichrast*+
|
6.11
|
|
Executive Employment Agreement dated January 2, 2017 by and between
Level Brands, Inc. and Mark S. Elliott*+
|
6.12
|
|
Master Advisory and Consulting Agreement dated February 8, 2017 by
and between Level Brands, Inc. and kathy ireland®
Worldwide*+
|
6.13
|
|
Advisory Agreement dated February 8, 2017 by and between Level
Brands, Inc. and Stephen Roseberry*+
|
6.14
|
|
Advisory Agreement dated February 8, 2017 by and between Level
Brands, Inc. and Tommy Meharey*+
|
6.15
|
|
Advisory Agreement dated February 8, 2017 by and between Level
Brands, Inc. and Nicolas Mendoza*+
|
6.16
|
|
Sublease dated January 1, 2017 by and between Kure Franchise, LLC
and Level Brands, Inc. *
|
6.17
|
|
Form of Filler Supply Agreement for Beauty and Pin Ups
LLC*
|
6.18
|
|
Wholesale License Agreement dated January 12, 2017 by and between
kathy ireland® Worldwide and I'M1, LLC*
|
6.19
|
|
Amended and Restated Limited Liability Company Agreement of I'M1,
LLC effective January 1, 2017*
|
6.20
|
|
Amended and Restated Limited Liability Company Agreement of Encore
Endeavor 1 LLC effective January 1, 2017 *
|
6.21
|
|
Form of Indemnification Agreement *
|
6.22
|
|
Charitable Agreement between Beauty & Pin Ups and Best Buddies
International, as amended *
|
6.23
|
|
Amendment No. 1 to Transaction Fee Agreement dated March 27, 2017
by and between Level Brands, Inc. and T.R. Winston & Company
LLC *
|
6.24
|
|
Form of I'M1 License Agreement *
|
6.25
|
|
Consulting Agreement dated March 20, 2017 by and between I'M1, LLC
and Kure Corp. *
|
6.26
|
|
Amended and Restated Consulting Agreement dated June 8, 2017 by and
between I'M1, LLC and NuGene International, Inc.*
|
6.27
|
|
Amendment to Executive Employment Agreement dated April 1, 2017 by
and between Level Brands, Inc. and Martin A. Sumichrast
*
|
6.28
|
|
License Agreement dated March 29, 2017 by and among I'M1, LLC, Kure
Corp. and Kure Franchise, LLC *
|
6.29
|
|
License Agreement dated March 31, 2017 by and between I'M1, LLC and
NuGene International, Inc. *
|
6.30
|
|
Television Series Consulting Agreement dated March 1, 2017 by and
between Multi-Media Productions Inc. and Encore Endeavor 1, LLC
*
|
6.31
|
|
Advisory Agreement dated May 9, 2017 by and between Formula Four
Beverages Inc., I'M1, LLC and Encore Endeavor 1, LLC *
|
6.32
|
|
Termination of License Agreement Ab Initio dated June 8, 2017 by
and between I'M1, LLC and NuGene International, Inc. *
|
6.33
|
|
Membership Interest Sale and Purchase Agreement by and among Priel
Maman, Level Brands, Inc. and Beauty and Pin-Ups, LLC dated April
26, 2017 *
|
6.34
|
|
Debt Conversion Agreement dated May 15, 2017 by and between Level
Brands, Inc. and LBGLOC, LLC, as amended *
|
6.35
|
|
License Agreement dated March 29, 2017 by and between I'M1, LLC and
Andre Phillipe, Inc. *
|
6.36
|
|
Recording Master License Agreement dated May 23, 2017 by and
between McCoo & Davis, Inc. and Encore Endeavor 1 LLC
*
|
6.37
|
|
Form of note conversion agreement *
|
6.38
|
|
Management Consulting Agreement dated July 1, 2017 by and between
Level Brands, Inc. and Market Development Consulting Group, Inc.
*
|
6.39
|
|
Amendment No. 1 to Amended and Restated Consulting Agreement dated
July 27, 2017 by and between I'M1, LLC and NuGene International,
Inc. and Irrevocable Proxy *
|
6.40
|
|
Stock Purchase and Escrow Agreement dated July 31, 2017 and among
I'M1, LLC, Stone Street Partners, LLC and Pearlman Law Group LLP
*
|
6.41
|
|
Promissory Note dated July 31, 2017 in the principal amount of
$275,000 from Stone Street Partners, LLC *
|
6.42
|
|
License Agreement dated June 27, 2017 by and between I'M1, LLC and
Loose Leaf Eyewear and Accessories LLC. *
|
6.43
|
|
Advisory Agreement dated August 9, 2017 by and among Damiva Inc.,
I'M1, LLC and Encore Endeavor 1, LLC *
|
6.44
|
|
Representation Agreement dated August 1, 2017 by and among Encore
Endeavor 1 LLC, Romero Britto and Britto Central, Inc.
*
|
6.45
|
|
Amended and Restated Representation Agreement dated September 12,
2017 by and among Encore Endeavor 1 LLC, Dada Media, Inc. and David
Tutera *
|
6.46
|
|
Master Services Agreement dated August 24, 2017 by and between
WhoYouKnow LLC d/b/a CrowdfundX and Level Brands, Inc., including
initial Statement of Work of even date therewith *
|
6.47
|
|
Amendment dated September 8, 2017 to Master Advisory and Consulting
Agreement by and between Level Brands, Inc. and kathy Ireland®
Worldwide*
|
6.48
|
|
Wholesale License Agreement dated September 8, 2017 by and between
Level Brands, Inc. and kathy ireland® Worldwide*
|
6.49
|
|
Wholesale License Agreement dated September 8, 2017 by and between
Level Brands, Inc. and Andre Carthen *
|
6.50
|
|
Wholesale License Agreement dated September 8, 2017 by and between
Level Brands, Inc. and Nicholas Walker*
|
6.51
|
|
Distribution Agreement dated August 29, 2017 by and between Beauty
and Pinups, LLC and East Coast Enterprises, Inc.*
|
6.52
|
|
Advisory Agreement dated September 1, 2017 by and between Level
Brands, Inc. and Jon Carrasco*
|
6.53
|
|
[intentionally omitted]
|
6.54
|
|
License Agreement dated September 8, 2017 by and between Level
Brands, Inc. and kathy ireland® Worldwide *
|
7.1
|
|
Contribution Agreement by and between Beauty & Pin-Ups, Inc.
and Beauty and Pin Ups LLC dated April 13, 2015*
|
7.2
|
|
Amended and Restated Membership Interest Exchange Agreement dated
March 24, 2017, effective January 6, 2017, by and among IM1
Holdings, LLC, I'M1, LLC and Level Brands, Inc.*
|
7.3
|
|
Amended and Restated Membership Interest Exchange Agreement dated
March 24, 2017, effective January 6, 2017, by and among EE1
Holdings, LLC, Encore Endeavor I LLC and Level Brands,
Inc.*
|
7.4
|
|
Amendment to Swap Agreement dated March 28, 2017 by and among
Beauty and Pin Ups, LLC, Level Brands, Inc. and Dean Gangbar
*
|
8.1
|
|
Escrow Agreement**
|
11.1
|
|
Consent of Cherry Bekaert LLP*
|
11.2
|
|
Consent of Pearlman Law Group LLP (included in exhibit
12.1)*
|
11.3
|
|
Consent of [special North Carolina counsel]**
|
12.1
|
|
Opinion of Pearlman Law Group LLP **
|
12.2
|
|
Opinion of [special North Carolina counsel]**
|
13
|
|
"Testing the waters" materials*
|
15.1
|
|
Code of Business Conduct and Ethics*
|
* filed herewith
** to be filed by amendment
+ indicates management contract
or compensatory plan
SIGNATURES
Pursuant
to the requirements of Regulation A, the issuer certifies that it
has reasonable grounds to believe that it meets all of the
requirements for filing on Form 1-A and has duly caused this
offering statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Charlotte, State of North
Carolina on September 18, 2017.
|
Level Brands, Inc.
|
|
|
|
|
|
By:
|
/s/ Martin A.
Sumichrast
|
|
|
|
Martin A. Sumichrast,
|
|
|
|
Chief Executive Officer
|
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that
each person whose signature appears below constitutes and appoints
Mark S. Elliott his true and lawful attorney-in-fact and agent,
with full power of substitution, for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments to
this Form 1-A offering statement, and to file the same with all
exhibits thereto, and other documents in connection therewith, with
the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent full power and authority to do and
perform each and every act and thing requisite and ratifying and
confirming all that said attorney-in-fact and agent or his
substitute or substitutes may lawfully do or cause to be done by
virtue hereof.
This offering statement has been signed by the following persons in
the capacities and on the dates indicated.
Name
|
|
Positions
|
|
Date
|
|
|
|
|
|
/s/ Martin A.
Sumichrast
Martin
A. Sumichrast
|
|
Chairman of the Board of Directors, Chief Executive Officer and
President (principal executive officer)
|
|
September 18, 2017
|
|
|
|
|
|
/s/ Mark S.
Elliott
Mark S.
Elliott
|
|
Chief Financial Officer and Chief Operating Officer (principal
financial and accounting officer); Director
|
|
September 18, 2017
|
|
|
|
|
|
/s/ Erik
Sterling
Erik
Sterling
|
|
Director
|
|
September 18, 2017
|
|
|
|
|
|
/s/ Anthony K.
Shriver
Anthony
K. Shriver
|
|
Director
|
|
September 18, 2017
|
|
|
|
|
|
/s/ Seymour G.
Siegel
Seymour
G. Siegel
|
|
Director
|
|
September 18, 2017
|
|
|
|
|
|
/s/ Bakari
Sellers
Bakari
Sellers
|
|
Director
|
|
September 18, 2017
|
|
|
|
|
|
/s/ Gregory C.
Morris
Gregory
C. Morris
|
|
Director
|
|
September 18, 2017
|
Exhibit 2.2
Exhibit 2.3
Exhibit 2.4
Exhibit 2.5
Level
Beauty Group, Inc.
BYLAWS
Effective
as of
March
18, 2015
TABLE
OF CONTENTS
Page
1
|
Offices
|
i
|
1.1.
|
Registered
Office
|
i
|
1.2.
|
Other
Offices
|
i
|
2
|
Meetings
of Stockholders
|
i
|
2.1.
|
Place
of Meetings
|
i
|
2.2.
|
Annual
Meetings
|
i
|
2.3.
|
Special
Meetings
|
i
|
2.4.
|
Notice
of Meetings
|
ii
|
2.5.
|
Waivers
of Notice
|
ii
|
2.6.
|
List
of Stockholders
|
ii
|
2.7.
|
Quorum
at Meetings
|
iii
|
2.8.
|
Voting
and Proxies
|
iii
|
2.9.
|
Required
Vote
|
iii
|
2.10.
|
Action
Without a Meeting
|
iii
|
3
|
Directors
|
iv
|
3.1.
|
Powers
|
iv
|
3.2.
|
Number
of Directors
|
iv
|
3.3.
|
Nomination
and Election of Directors
|
iv
|
3.4.
|
Vacancies
|
v
|
3.5.
|
Meetings
|
v
|
3.6.
|
Quorum
and Vote at Meetings
|
vi
|
3.7.
|
Committees
of Directors
|
vi
|
3.8.
|
Compensation
of Directors
|
vii
|
3.9.
|
Chairman
of the Board
|
vii
|
4
|
Officers
|
vii
|
4.1.
|
Positions
|
vii
|
4.2.
|
President
|
vii
|
4.3.
|
Vice
President
|
vii
|
4.4.
|
Secretary
|
viii
|
4.5.
|
Assistant
Secretary
|
viii
|
4.6.
|
Treasurer
|
viii
|
4.7.
|
Assistant
Treasurer
|
viii
|
4.8.
|
Term
of Office
|
viii
|
4.9.
|
Compensation
|
ix
|
4.10.
|
Fidelity
Bonds
|
ix
|
5
|
Capital
Stock
|
ix
|
5.1.
|
Certificates
of Stock; Uncertificated Shares
|
ix
|
5.2.
|
Lost
Certificates
|
ix
|
5.3.
|
Record
Date
|
x
|
5.4.
|
Stockholders
of Record
|
xi
|
6
|
Indemnification;
Insurance
|
xi
|
6.1.
|
Authorization
of Indemnification
|
xi
|
6.2.
|
Non-exclusivity
|
xii
|
6.3.
|
Survival
of Indemnification
|
xii
|
6.4.
|
Insurance
|
xii
|
7
|
General
Provisions
|
xii
|
7.1.
|
Inspection
of Books and Records
|
xii
|
7.2.
|
Dividends
|
xii
|
7.3.
|
Reserves
|
xiii
|
7.4.
|
Execution
of Instruments
|
xiii
|
7.5.
|
Fiscal
Year
|
xiii
|
7.6.
|
Seal
|
xiii
|
Bylaws
of
Level
Beauty Group, Inc.,
a
North Carolina corporation
The initial
registered office of Level Beauty Group, Inc., a North Carolina
corporation (the “Corporation”),
shall be located at 4521 Sharon Road, Suite 450, Charlotte, North
Carolina, Mecklenburg County, 28211. The registered agent of the
Corporation at such address shall be Marty A.
Sumichrast.
The Corporation may
also have offices at such other places, both within and without the
State of North Carolina, as the Board of Directors may from time to
time determine or as may be necessary or useful in connection with
the business of the Corporation.
All meetings of the
stockholders shall be held at such place as may be fixed from time
to time by the Board of Directors, the Chairman or the President.
The Board of Directors may, in its sole discretion, determine that
the meeting shall not be held at any place, but may instead be held
solely by means of remote communication as authorized by the
General Corporation Law of the State of North Carolina (the
“North Carolina
General Corporation Law”).
The Corporation
shall hold annual meetings of stockholders, commencing with the
fiscal year 2016, on such date and at such time as shall be
designated from time to time by the Board of Directors, the
Chairman or the President, at which stockholders shall elect a
Board of Directors and transact such other business as may properly
be brought before the meeting.
Special meetings of
the shareholders may be called for any purpose or purposes, unless
otherwise prescribed by statute or these Bylaws, (a) by the
President, the Board of Directors or the Chairman of the Board of
Directors or (b) upon the written request (the “Notice”)
of the holder or holders of not less than ten percent (10%) of the
outstanding shares of common stock, determined on an as-converted
basis. Special meetings called in accordance with subsection (b)
above shall be called by the Secretary within thirty (30) days
after the delivery to the Secretary of the Notice. Such Notice must
be signed, dated and delivered to the Secretary and must describe
the purpose or purposes for which the meeting is to be held.
Business transacted at any special meeting of the shareholders
shall be limited to the purposes stated in the Notice (except to
the extent that such Notice is waived or is not required as
provided in the North Carolina General Corporation Law or these
Bylaws).
Notice of any
meeting of stockholders, stating the place, date and hour of the
meeting, and (if it is a special meeting) the purpose or purposes
for which the meeting is called, shall be given to each stockholder
entitled to vote at such meeting not less than ten nor more than
sixty days before the date of the meeting (except to the extent
that such notice is waived or is not required as provided in the
North Carolina General Corporation Law or these Bylaws). Such
notice shall be given in accordance with, and shall be deemed
effective as set forth in the North Carolina General Corporation
Law.
Whenever the giving
of any notice is required by statute, the Articles of Incorporation
or these Bylaws, a waiver thereof, in writing and delivered to the
Corporation, signed by the person or persons entitled to said
notice, whether before or after the event as to which such notice
is required, shall be deemed equivalent to notice. Attendance of a
stockholder at a meeting shall constitute a waiver of notice
(1) of such meeting, except when the stockholder at the
beginning of the meeting objects to holding the meeting or
transacting business at the meeting, and (2) (if it is a special
meeting) of consideration of a particular matter at the meeting
that is not within the purpose or purposes described in the meeting
notice, unless the stockholder objects to considering the matter at
the beginning of the meeting.
After the record
date for a meeting of stockholders has been fixed, at least ten
days before such meeting, the officer who has charge of the stock
ledger of the Corporation shall make a list of all stockholders
entitled to vote at the meeting, arranged in alphabetical order and
showing the address of each stockholder and the number of shares
registered in the name of each stockholder. Nothing contained in
this Section 2.6 shall require the Corporation to include
electronic mail addresses or other electronic contact information
on such list. Such list shall be open to the examination of any
stockholder, for any purpose germane to the meeting, for a period
of at least ten (10) days prior to the meeting: (i) on a reasonably
accessible electronic network, provided that the information
required to gain access to such list is provided with the notice of
the meeting, or (ii) during ordinary business hours, at the
principal place of business of the Corporation. In the event that
the Corporation determines to make the list available on an
electronic network, the Corporation may take reasonable steps to
ensure that such information is available only to stockholders of
the Corporation. If the meeting is to be held at a place, then the
list shall be produced and kept at the time and place of the
meeting during the whole time thereof, and may be inspected by any
stockholder who is present. If the meeting is to be held solely by
means of remote communication, then the list shall also be open to
the examination of any stockholder during the whole time of the
meeting on a reasonably accessible electronic network, and the
information required to access such list shall be provided with the
notice of the meeting.
Stockholders may
take action on a matter at a meeting only if a quorum exists with
respect to that matter.
Except as otherwise provided by statute or by the Articles of
Incorporation, the holders of a majority of the shares entitled to
vote at the meeting, and who are present in person or represented
by proxy, shall constitute a quorum at all meetings of the
stockholders for the transaction of business. Once a share is
represented for any purpose at a meeting (other than solely to
object (1) to holding the meeting or transacting business at the
meeting, or (2) (if it is a special meeting) to consideration of a
particular matter at the meeting that is not within the purpose or
purposes described in the meeting notice), it is deemed present for
quorum purposes for the remainder of the meeting and for any
adjournment of that meeting unless a new record date is or must be
set for the adjourned meeting. The holders of a majority of the
voting shares represented at a meeting, whether or not a quorum is
present, may adjourn such meeting from time to time.
Unless otherwise
provided in the North Carolina General Corporation Law or in the
Corporation’s Articles of Incorporation, and subject to the
other provisions of these Bylaws, each stockholder shall be
entitled to one vote on each matter, in person or by proxy, for
each share of the Corporation’s capital stock that has voting
power and that is held by such stockholder. No proxy shall be voted
or acted upon after three years from its date, unless the proxy
provides for a longer period. A duly executed appointment of proxy
shall be irrevocable if the appointment form states that it is
irrevocable and if, and only as long as, it is coupled with an
interest sufficient in law to support an irrevocable
power.
When a quorum is
present at any meeting of stockholders, all matters shall be
determined, adopted and approved by the affirmative vote (which
need not be by ballot) of the holders of a majority of the shares
present in person or represented by proxy at the meeting and
entitled to vote with respect to the matter, unless the proposed
action is one upon which, by express provision of statutes or of
the Articles of Incorporation, a different vote is specified and
required, in which case such express provision shall govern and
control with respect to that vote on that matter. Notwithstanding
the foregoing, directors shall be elected by a plurality of the
votes of the shares present in person or represented by proxy at
the meeting and entitled to vote on the election of
directors.
Any action required
or permitted to be taken at a stockholders’ meeting may be
taken without a meeting, without prior notice and without a vote,
if the action is taken by persons who would be entitled to vote at
a meeting and who hold shares having voting power equal to not less
than the minimum number of votes that would be necessary to
authorize or take the action at a meeting at which all shares
entitled to vote were present and voted. The action must be
evidenced by one or more written consents describing the action
taken, signed by the stockholders entitled to take action without a
meeting, and delivered to the Corporation in the manner prescribed
by the North Carolina General Corporation Law for inclusion in the
minute book. Electronic transmission consenting to an action to be
taken and transmitted by a stockholder or proxyholder, or by a
person or persons authorized to act for a stockholder or
proxyholder, shall be deemed to be written, signed and dated for
the purposes of this Section 2.10, provided that the procedures
and requirements set forth in the North Carolina General
Corporation Law are met. No
consent shall be effective to take the corporate action specified
unless the number of consents required to take such action are
delivered to the Corporation within sixty days of the delivery of
the earliest-dated consent. Written notice of the action taken
shall be given in accordance with the North Carolina General
Corporation Law to all stockholders who do not participate in
taking the action who would have been entitled to notice if such
action had been taken at a meeting having a record date on the date
that written consents signed by a sufficient number of holders to
take the action were delivered to the Corporation.
The business and
affairs of the Corporation shall be managed by or under the
direction of the Board of Directors, which may exercise all such
powers of the Corporation and do all such lawful acts and things,
subject to any limitation set forth in the Articles of
Incorporation or as otherwise may be provided in the North Carolina
General Corporation Law.
The number of
directors which shall constitute the whole board shall not be fewer
than one (1) nor more than ten (10). The first board shall consist
of two (2) directors.
Thereafter, within the limits above specified, the number of
directors shall be determined by resolution adopted by a majority
of the Board of Directors.
3.3.
Nomination and Election of
Directors
Except as otherwise
provided by the Articles of Incorporation or any agreement between
the Company and all stockholders, the Board of Directors shall
nominate candidates to stand for election as directors, and the
directors shall then be elected at the annual meeting of the
stockholders, except as provided in Section 3.4 hereof. Each director elected shall
hold office until such director’s successor is elected and
qualified or until the director’s earlier death, resignation,
retirement, removal or disqualification. Those persons who receive
the highest number of votes at a meeting at which a quorum is
present shall be deemed to have been elected. Directors need not be
stockholders. If authorized by the Board of Directors, a ballot
submitted by electronic transmission shall be effective to elect
directors, provided
that any such electronic transmission must either set forth or be
submitted with information from which it can be determined that the
electronic transmission was authorized by the stockholder or
proxyholder.
Vacancies and newly
created directorships resulting from any increase in the authorized
number of directors may be filled by the affirmative vote of a
majority of the directors then in office, although fewer than a
quorum, or by a sole remaining director. Each director so chosen
shall hold office until the next election of directors of the class
to which such director was appointed, and until such
director’s successor is elected and qualified, or until the
director’s earlier death, resignation or removal. In the
event that one or more directors resign from the Board, effective
at a future date, a majority of the directors then in office,
including those who have so resigned, shall have power to fill such
vacancy or vacancies, the vote thereon to take effect when such
resignation or resignations shall become effective, and each
director so chosen shall hold office until the next election of
directors, and until such director’s successor is elected and
qualified, or until the director’s earlier death, resignation
or removal.
Regular meetings of
the Board of Directors may be held without notice at such time and
at such place as shall from time to time be determined by the Board
of Directors.
Special meetings of
the Board of Directors may be called by the President, the Chairman
of the Board of Directors or any two (2) directors on 24
hours-notice to each director, either personally or by telephone,
express delivery service (so that the scheduled delivery date of
the notice is at least 24 hours in advance of the meeting),
telegram or facsimile transmission, and on five (5) days’
notice by mail (effective upon deposit of such notice in the mail).
The notice need not describe the purpose of a special
meeting.
3.5.3.
Telephone Meetings
Members of the
Board of Directors may participate in a meeting of the board by any
communication by means of which all participating directors can
simultaneously hear each other during the meeting. A director
participating in a meeting by this means is deemed to be present in
person at the meeting.
3.5.4.
Action Without Meeting
Unless otherwise
restricted by the Articles of Incorporation or these Bylaws, any
action required or permitted to be taken at any meeting of the
Board of Directors or of any committee thereof may be taken without
a meeting if the action is taken by all members of the Board or
committee, as the case may be. The action must be evidenced by (i)
one or more written consents describing the action taken, signed by
each director, and delivered to the Corporation for filing in the
minute book or (ii) one or more electronic transmissions describing
the action taken and delivered to the Corporation for filing in the
minute book. Such filing shall be in paper form if the minutes are
maintained in paper form and shall be in electronic form if the
minutes are maintained in electronic form.
3.5.5.
Waiver of Notice of Meeting
A director may
waive any notice required by statute, the Articles of Incorporation
or these Bylaws before or after the date and time stated in the
notice. Except as set forth below, the waiver must be in writing,
signed by the director entitled to the notice, and delivered to the
Corporation for inclusion in the minute book. Notwithstanding the
foregoing, a director’s attendance at or participation in a
meeting waives any required notice to the director of the meeting
unless the director at the beginning of the meeting objects to
holding the meeting or transacting business at the meeting and does
not thereafter vote for or assent to action taken at the
meeting.
3.6.
Quorum and Vote at
Meetings
At all meetings of
the board, a quorum of the Board of Directors consists of a
majority of the total number of directors prescribed pursuant to
Section 3.2 of these
Bylaws. The vote of a majority of the directors present at any
meeting at which there is a quorum shall be the act of the Board of
Directors, except as may be otherwise specifically provided by
statute or by the Articles of Incorporation or by these
Bylaws.
The Board of
Directors may designate one or more committees, each committee to
consist of one or more directors. The Board may designate one or
more directors as alternate members of any committee, who may
replace any absent or disqualified member at any meeting of the
committee. If a member of a committee shall be absent from any
meeting, or disqualified from voting thereat, the remaining member
or members present and not disqualified from voting, whether or not
such member or members constitute a quorum, may, by unanimous vote,
appoint another member of the Board of Directors to act at the
meeting in the place of such absent or disqualified member. Any
such committee, to the extent provided in the resolution of the
Board of Directors, shall have and may exercise all the powers and
authority of the Board of Directors in the management of the
business and affairs of the Corporation, and may authorize the seal
of the Corporation to be affixed to all papers which may require
it; but no such committee shall have the power or authority in
reference to approving or adopting, or recommending to the
stockholders, any action or matter expressly required by the North
Carolina General Corporation Law to be submitted to stockholders
for approval or adopting, amending or repealing any bylaw of the
Corporation; and unless the resolution designating the committee,
these bylaws or the Articles of Incorporation expressly so provide,
no such committee shall have the power or authority to declare a
dividend, to authorize the issuance of stock, or to adopt a
certificate of ownership and merger pursuant to the North Carolina
General Corporation Law. Such committee or committees shall have
such name or names as may be determined from time to time by
resolution adopted by the Board of Directors. Each committee shall
keep regular minutes of its meetings and report the same to the
Board of Directors, when required. Unless otherwise specified in
the Board resolution appointing the Committee, all provisions of
the North Carolina General Corporation Law and these Bylaws
relating to meetings, action without meetings, notice (and waiver
thereof), and quorum and voting requirements of the Board of
Directors apply, as well, to such committees and their
members.
3.8.
Compensation of
Directors
The Board of
Directors shall have the authority to fix the compensation of
directors. No such payment shall preclude any director from serving
the Corporation in any other capacity and receiving compensation
therefor.
There may be a
Chairman and a Vice Chairman of the Board of Directors, both of
which shall be appointed by the directors. The Chairman shall (when
present) preside at all meetings of the Board of Directors and
perform such other duties as may be directed by the Board. The
Chairman may call meetings of the Board and of any committee
thereof, whenever he deems necessary, and he shall call to order
and preside at all meetings of the shareholders of the Corporation.
In addition he shall have such other powers and duties as the Board
of Directors shall designate from time to time.
The officers of the
Corporation shall be a President, Vice President, Treasurer, and
Secretary, and such other officers as the Board of Directors (or an
officer authorized by the Board of Directors) from time to time may
appoint, including one or more Executive Vice Presidents, Vice
Presidents, Assistant Secretaries and Assistant Treasurers. Each
such officer shall exercise such powers and perform such duties as
shall be set forth below and such other powers and duties as from
time to time may be specified by the Board of Directors or by any
officer(s) authorized by the Board of Directors to prescribe the
duties of such other officers. Any number of offices may be held by
the same person, except that in no event shall the President and
the Secretary be the same person.
The President shall
be the chief executive officer of the Corporation and shall have
overall responsibility and authority for management of the
day-to-day operations of the Corporation in accordance with these
Bylaws (subject to the authority of the Board of Directors), and
shall ensure that all orders and resolutions of the Board of
Directors and stockholders are carried into effect. The President
shall, in general, perform all duties incident to the office of
President and such other duties as may be prescribed by the Board
of Directors from time to time. The President may execute any
deeds, bonds, mortgages and other contracts, under the seal of the
Corporation, if required, except where required or permitted by law
to be otherwise signed and executed and except where the signing
and execution thereof shall be expressly delegated by the Board of
Directors to some other officer or agent of the
Corporation.
In the absence of
the President or in the event of the President’s inability or
refusal to act, the Vice President (or in the event there be more
than one Vice President, the Vice Presidents in the order
designated, or in the absence of any designation, then in the order
of their election) shall perform the duties of the President, and
when so acting shall have all the powers of, and be subject to all
the restrictions upon, the President. The Vice President may
execute any deeds, bonds, mortgages and other contracts, under the
seal of the Corporation, if required, except where required or
permitted by law to be otherwise signed and executed and except
where the signing and execution thereof shall be expressly
delegated by the Board of Directors to some other officer or agent
of the Corporation.
The Secretary shall
have responsibility for preparation of minutes of meetings of the
Board of Directors and of the stockholders and for authenticating
records of the Corporation. The Secretary shall give, or cause to
be given, notice of all meetings of the stockholders and special
meetings of the Board of Directors. The Secretary or an Assistant
Secretary may also attest all instruments signed by any other
officer of the Corporation.
The Assistant
Secretary, or if there be more than one, the Assistant Secretaries
in the order determined by the Board of Directors (or if there
shall have been no such determination, then in the order of their
election), shall, in the absence of the Secretary or in the event
of the Secretary’s inability or refusal to act, perform the
duties and exercise the powers of the Secretary.
The Treasurer shall
have responsibility for the custody of the corporate funds and
securities and shall see to it that full and accurate accounts of
receipts and disbursements are kept in books belonging to the
Corporation. The Treasurer shall render to the Chairman, the
President, and the Board of Directors, upon request, an account of
all financial transactions and of the financial condition of the
Corporation.
The Assistant
Treasurer, or if there shall be more than one, the Assistant
Treasurers in the order determined by the Board of Directors (or if
there shall have been no such determination, then in the order of
their election), shall, in the absence of the Treasurer or in the
event of the Treasurer’s inability or refusal to act, perform
the duties and exercise the powers of the Treasurer.
The officers of the
Corporation shall hold office until their successors are chosen and
qualify or until their earlier resignation or removal. Any officer
may resign at any time upon written notice to the Corporation. Any
officer elected or appointed by the Board of Directors may be
removed at any time, with or without cause, by the affirmative vote
of a majority of the Board of Directors.
The compensation of
officers of the Corporation shall be fixed by the Board of
Directors or by any officer(s) authorized by the Board of Directors
to prescribe the compensation of such other officers.
The Corporation may
secure the fidelity of any or all of its officers or agents by bond
or otherwise.
5.1.
Certificates of Stock; Uncertificated
Shares
The shares of the
Corporation shall be represented by certificates, provided that the
Board of Directors may provide by resolution that some or all of
any or all classes or series of the Corporation’s stock shall
be uncertificated shares. Any such resolution shall not apply to
shares represented by a certificate until such certificate is
surrendered to the Corporation. Notwithstanding the adoption of
such a resolution by the Board of Directors, every holder of stock
represented by certificates, and upon request every holder of
uncertificated shares, shall be entitled to have a certificate
(representing the number of shares registered in certificate form)
signed in the name of the Corporation by the Chairman, President or
any Vice President, and by the Treasurer, Secretary or any
Assistant Treasurer or Assistant Secretary of the Corporation. Any
or all the signatures on the certificate may be
facsimile. In case any
officer, transfer agent or registrar whose signature or facsimile
signature appears on a certificate shall have ceased to be such
officer, transfer agent or registrar before such certificate is
issued, it may be issued by the Corporation with the same effect as
if such person were such officer, transfer agent or registrar at
the date of issue.
The Board of
Directors, Chairman, President or Secretary may direct a new
certificate of stock to be issued in place of any certificate
theretofore issued by the Corporation and alleged to have been
lost, stolen or destroyed, upon the making of an affidavit of that
fact by the person claiming that the certificate of stock has been
lost, stolen or destroyed. When authorizing such issuance of a new
certificate, the board or any such officer may, as a condition
precedent to the issuance thereof, require the owner of such lost,
stolen or destroyed certificate or certificates, or such
owner’s legal representative, to advertise the same in such
manner as the board or such officer shall require and/or to give
the Corporation a bond or indemnity, in such sum or on such terms
and conditions as the board or such officer may direct, as
indemnity against any claim that may be made against the
Corporation on account of the certificate alleged to have been
lost, stolen or destroyed or on account of the issuance of such new
certificate or uncertificated shares.
5.3.1.
Actions by Stockholders
In order that the
Corporation may determine the stockholders entitled to notice of or
to vote at any meeting of stockholders, the Board of Directors may
fix a record date, which record date shall not precede the date
upon which the resolution fixing the record date is adopted by the
Board of Directors, and which record date shall not be more than
sixty (60) days nor less than ten (10) days before the date of such
meeting. If no record date is fixed by the Board of Directors, the
record date for determining stockholders entitled to notice of or
to vote at a meeting of stockholders shall be the close of business
on the day next preceding the day on which notice is given, or, if
notice is waived, at the close of business on the day next
preceding the day on which the meeting is held. A determination of
stockholders of record entitled to notice of or to vote at a
meeting of stockholders shall apply to any adjournment of the
meeting, unless the Board of Directors fixes a new record date for
the adjourned meeting.
In order that the
Corporation may determine the stockholders entitled to consent to
corporate action in writing without a meeting, the Board of
Directors may fix a record date, which record date shall not
precede the date upon which the resolution fixing the record date
is adopted by the Board of Directors, and which record date shall
not be more than ten (10) days after the date upon which the
resolution fixing the record date is adopted by the Board of
Directors. If no record date has been fixed by the Board of
Directors, the record date for determining stockholders entitled to
consent to corporate action in writing without a meeting, when no
prior action by the Board of Directors is required by the North
Carolina General Corporation Law, shall be the first date on which
a signed written consent setting forth the action taken or proposed
to be taken is delivered to the Corporation in the manner
prescribed by the North Carolina General Corporation Law. If no
record date has been fixed by the Board of Directors and prior
action by the Board of Directors is required by the North Carolina
General Corporation Law, the record date for determining
stockholders entitled to consent to corporate action in writing
without a meeting shall be at the close of business on the day on
which the Board of Directors adopts the resolution taking such
prior action.
In order that the
Corporation may determine the stockholders entitled to receive
payment of any dividend or other distribution or allotment of any
rights or the stockholders entitled to exercise any rights in
respect of any change, conversion or exchange of stock, or for the
purpose of any other lawful action, the Board of Directors may fix
a record date, which record date shall not precede the date upon
which the resolution fixing the record date is adopted, and which
record date shall be not more than sixty (60) days prior to such
action. If no record date is fixed, the record date for determining
stockholders for any such purpose shall be at the close of business
on the day on which the Board of Directors adopts the resolution
relating thereto.
The Corporation
shall be entitled to recognize the exclusive right of a person
registered on its books as the owner of shares to receive
dividends, to receive notifications, to vote as such owner, and to
exercise all the rights and powers of an owner. The Corporation
shall not be bound to recognize any equitable or other claim to or
interest in such share or shares on the part of any other person,
whether or not it shall have express or other notice thereof,
except as otherwise may be provided by the North Carolina General
Corporation Law.
6.
Indemnification;
Insurance
6.1.
Authorization of
Indemnification
Each person who was
or is a party or is threatened to be made a party to or is involved
in any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative and
whether by or in the right of the Corporation or otherwise (a
“Proceeding”),
by reason of the fact that he or she, or a person of whom he or she
is the legal representative, is or was a director or officer of the
Corporation or is or was serving at the request of the Corporation
as a director, officer, employee, partner (limited or general) or
agent of another corporation or of a partnership, joint venture,
limited liability company, trust or other enterprise, including
service with respect to an employee benefit plan, shall be (and
shall be deemed to have a contractual right to be) indemnified and
held harmless by the Corporation (and any successor to the
Corporation by merger or otherwise) to the fullest extent
authorized by, and subject to the conditions and (except as
provided herein) procedures set forth in the North Carolina General
Corporation Law, as the same exists or may hereafter be amended
(but any such amendment shall not be deemed to limit or prohibit
the rights of indemnification hereunder for past acts or omissions
of any such person insofar as such amendment limits or prohibits
the indemnification rights that said law permitted the Corporation
to provide prior to such amendment), against all expenses,
liabilities and losses (including attorneys’ fees, judgments,
fines, ERISA taxes or penalties and amounts paid or to be paid in
settlement) reasonably incurred or suffered by such person in
connection therewith; provided,
however, that the Corporation shall indemnify any such
person seeking indemnification in connection with a Proceeding (or
part thereof) initiated by such person only if such Proceeding (or
part thereof) was authorized by the Board of Directors of the
Corporation. Persons who are not directors or officers of the
Corporation and are not so serving at the request of the
Corporation may but need not be similarly indemnified in respect of
such service to the extent authorized at any time by the Board of
Directors of the Corporation. The indemnification conferred in this
Section 6.1 also shall include
the right to be paid by the Corporation (and such successor) the
expenses (including attorneys’ fees) incurred in the defense
of or other involvement in any such Proceeding in advance of its
final disposition; provided,
however, that, if and to the extent the North Carolina
General Corporation Law requires, the payment of such expenses
(including attorneys’ fees) incurred by a director or officer
in advance of the final disposition of a Proceeding shall be made
only upon delivery to the Corporation of an undertaking by or on
behalf of such director or officer to repay all amounts so paid in
advance if it shall ultimately be determined that such director or
officer is not entitled to be indemnified under this Section
6.1 or otherwise; and
provided further, that,
such expenses incurred by other employees and agents may be so paid
in advance upon such terms and conditions, if any, as the Board of
Directors deems appropriate.
The rights to
indemnification and advance payment of expenses provided by Section
6.1 hereof shall not be deemed
exclusive of any other rights to which those seeking
indemnification and advance payment of expenses may be entitled
under any by-law, agreement, vote of stockholders or disinterested
directors or otherwise, both as to action in his or her official
capacity and as to action in another capacity while holding such
office.
6.3.
Survival of
Indemnification
The indemnification
and advance payment of expenses and rights thereto provided by, or
granted pursuant to, Section 6.1 hereof shall, unless otherwise
provided when authorized or ratified, continue as to a person who
has ceased to be a director, officer, employee, partner or agent
and shall inure to the benefit of the personal representatives,
heirs, executors and administrators of such person.
The Corporation
shall have power to purchase and maintain insurance on behalf of
any person who is or was a director, officer, employee or agent of
the Corporation, or is or was serving at the request of the
Corporation as a director, officer, employee, partner (limited or
general) or agent of another corporation or of a partnership, joint
venture, limited liability company, trust or other enterprise,
against any liability asserted against such person or incurred by
such person in any such capacity, or arising out of such
person’s status as such, and related expenses, whether or not
the Corporation would have the power to indemnify such person
against such liability under the provisions of the North Carolina
General Corporation Law.
7.1.
Inspection of Books and
Records
Any stockholder, in
person or by attorney or other agent, shall, upon written demand
under oath stating the purpose thereof, have the right during the
usual hours for business to inspect for any proper purpose the
Corporation’s stock ledger, a list of its stockholders, and
its other books and records, and to make copies or extracts
therefrom. A proper purpose shall mean a purpose reasonably related
to such person’s interest as a stockholder. In every instance
where an attorney or other agent shall be the person who seeks the
right to inspection, the demand under oath shall be accompanied by
a power of attorney or such other writing which authorizes the
attorney or other agent to so act on behalf of the stockholder. The
demand under oath shall be directed to the Corporation at its
registered office or at its principal place of
business.
The Board of
Directors may, but shall not be obligated to, declare dividends
upon the capital stock of the Corporation, subject to the
provisions of the Articles of Incorporation and the laws of the
State of North Carolina.
The directors of
the Corporation may set apart, out of the funds of the Corporation
available for dividends, a reserve or reserves for any proper
purpose and may abolish any such reserve.
All checks, drafts
or other orders for the payment of money, and promissory notes of
the Corporation shall be signed by such officer or officers or such
other person or persons as the Board of Directors may from time to
time designate.
The fiscal year of
the Corporation shall end on the 31st day of December of
each year.
The corporate seal
shall be in such form as the Board of Directors shall approve. The
seal may be used by causing it or a facsimile thereof to be
impressed or affixed or otherwise reproduced.
*
* * * *
The foregoing
Bylaws are hereby certified as the Bylaws of the Corporation as
adopted and in effect on March 18, 2015.
________________________
Secretary
Exhibit
3.1
FORM OF 8% CONVERTIBLE PROMISSORY NOTE
THE SECURITIES REPRESENTED BY THIS NOTE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES
ACT”), OR THE SECURITIES LAWS OF ANY STATE, AND MAY
NOT BE OFFERED, SOLD TRANSFERRED, PLEDGED, HYPOTHECATED OR
OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE
STATE LAWS, (ii) OR RULE 144 UNDER THE SECURITIES ACT (OR ANY
SIMILAR RULES UNDER THE SECURITIES ACT RELATING TO THE DISPOSITION
OF SECURITIES), OR (iii) AN OPINION OF COUNSEL, IF SUCH OPINION
SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO LEVEL BEAUTY GROUP,
INC., THAT AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
AND APPLICABLE STATE LAW IS AVAILABLE.
8% CONVERTIBLE PROMISSORY NOTE
Original Principal
Amount: U.S. $[•]
|
Issuance Date:
[•], 2016
|
No.
[____]
|
Charlotte, North Carolina
|
FOR VALUE RECEIVED, the undersigned,
LEVEL BEAUTY GROUP, INC., a
North Carolina corporation (the “Borrower”),
hereby promises to pay to the order of [•] (the
“Lender”),
in lawful money of the United States of America, and in immediately
payable funds, the principal amount of [•] Dollars
($[•]) on September 30, 2017 (the “Maturity
Date”), together with interest on the unpaid principal
balance hereof from the date of this Note at a rate of eight
percent (8%) per annum, unless the principal amount shall have
theretofore converted as set forth herein. This Note is one of a
series of like Notes included in the Units being issued and sold by
the Borrower in accordance with the terms and conditions of the
Confidential Offering Documents for Accredited Investors dated
September 12, 2016 including the Subscription Agreement (the
"Subscription
Agreement") dated [•], 2016 by and between the
Borrower and the Lender (collectively, the "Offering
Documents").
1. Interest.
The Borrower shall pay interest to the Lender on the unpaid
outstanding principal balance owed to Lender hereunder at the rate
of eight percent (8%) per annum, payable in arrears, on the
Maturity Date. Interest shall be computed on the basis of a year of
360 days, for the actual number of days elapsed.
2.
Application of
Payments. All payments received on account of this Note
shall first be applied to the reduction of the unpaid principal
balance of this Note. Payment of all amounts due hereunder shall be
made at the address of the Lender as set forth herein.
3. Payment
of Note; Prepayment; No Security Interest. Upon the payment
of all amounts due hereunder by the Borrower, whether at the
Maturity Date or upon a Conversion (as hereinafter defined), the
Lender shall promptly deliver the original of this Note to the
Borrower, marked “cancelled.” From and after the date
hereof, the Borrower shall have the option to prepay all or any
portion of the principal balance and accrued but unpaid interest
due under this Note, without premium or penalty, upon five (5)
business days' notice to the Lender. The obligations represented by
this Note are the unsecured general obligations of the
Borrower.
4. Conversion.
(a) In
the event of a firm commitment initial public offering of the
Company's securities resulting in gross proceeds to the Company of
at least $10,000,000 (the "Initial Public
Offering") prior to July 1, 2017, on the closing date of the
Initial Public Offering (the "IPO Closing
Date"), the outstanding principal amount of this Note and
all accrued interest due hereunder may be converted by Lender, in
whole or in part (the "Conversion")
into the shares (the “Conversion
Shares”) of the Borrower’s common stock (the
"Common
Stock") at a conversion price (the “IPO Conversion
Price”) equal to the lesser of: (i) 75% of the per
share Initial Public Offering price of the Company’s Common
Stock to be issued and sold in the Initial Public Offering; or (ii)
the price equal to the quotient of $20,000,000 divided by the
aggregate number of outstanding shares of the Company’s
Common Stock as of immediately prior to the IPO Closing Date
(assuming full conversion or exercise of all convertible and
exercisable securities then outstanding other than the Notes),
subject to adjustment as hereinafter set forth. If no Initial
Public Offering occurs prior to July 1, 2017, the conversion price
("Fixed
Conversion Price") will be $1.50 per share. The IPO
Conversion Price and the Fixed Conversion Price are collectively
referred to as the "Conversion
Price".
(b) The
Borrower will provide the Lender with five (5) days prior notice of
the IPO Closing Date together with a good faith estimate of the IPO
Conversion Price. Any election to convert the principal and
interest on the Note at the IPO Conversion Price will be made in
writing and delivered to the Borrower at least three (3) days prior
to the IPO Closing Date, and the Conversion shall take place
concurrently with the IPO Closing at the IPO Conversion
Price. If no Initial
Public Offering shall have occurred prior to July 1, 2017 the
Borrower shall promptly provide written notice to the Lender and
the amounts due under this Note shall automatically become
convertible at the Fixed Conversion Price.
(c) Upon
a Conversion, the Borrower shall issue and cause to be delivered
with all reasonable dispatch to its transfer agent written
instructions authorizing the issuance of the Conversion Shares in
such name and in such amounts as the Lender may instruct in
writing. Upon any Conversion of this Note in accordance with the
terms hereof, any amounts due hereunder which are so converted
shall be deemed paid in full and the Borrower shall have no further
obligations to the Lender for such converted amounts. All
Conversion Shares which may be issued upon conversion of the Note,
will, upon issuance, be duly issued, fully paid and non-assessable
and free from all taxes, liens, and charges with respect to the
issuance thereof. Unless such shares shall have been registered
under the Securities Act, the certificates representing the
Conversion Shares shall bear the appropriate legend in accordance
with the provisions of Rule 144 of the Securities Act and shall be
subject to the "lock-up" agreement contemplated by the Subscription
Agreement.
5. Adjustment
Provisions.
(a) If
the Borrower at any time subdivides (by any stock split, stock
dividend, recapitalization or otherwise) its outstanding shares of
Common Stock into a greater number of shares, the Conversion Price
pursuant to Section 4 hereof in effect immediately prior to such
subdivision will be proportionately reduced. If the Borrower at any
time combines (by combination, reverse stock split or otherwise)
its outstanding shares of Common Stock into a smaller number of
shares, the Conversion Price pursuant to Section 4 hereof in effect
immediately prior to such combination will be proportionately
increased.
(b) Whenever
the Conversion Price is adjusted as herein provided, the Borrower
shall promptly, but no later than ten (10) days after any request
by the Holder, cause a notice setting forth the adjusted Conversion
Price, and, if requested, information describing the transactions
giving rise to such adjustment(s), to be mailed to the Holder at
its last address appearing in the records of the
Borrower.
6.
Default. The
occurrence of any one of the following events shall constitute an
Event of Default upon notice thereof as hereinafter
provided:
(a) The
non-payment, when due, of any principal or interest pursuant to
this Note, and such failure continues unremedied for a period of
ten (10) days after written or facsimile notice from Lender to the
Borrower of such failure; or
(b) The
commencement against the Borrower of any proceeding relating to the
Borrower under any bankruptcy, insolvency, adjustment of debt,
receivership or liquidation law or statute or any jurisdiction,
whether now or hereafter in effect, provided,
however, that the commencement of such a proceeding shall
not constitute an Event of Default unless the Borrower consents to
the same or admits in writing the material allegations of same, or
said proceeding shall remain undismissed for thirty (30) days; or
the issuance of any order, judgment or decree for the appointment
of a receiver or trustee for the Borrower or for all or a
substantial part of the property of the Borrower, which order,
judgment or decree remains undismissed for thirty (30) days; or a
warrant of attachment, execution, or similar process shall be
issued against any substantial part of the property of the
Borrower.
Upon
the occurrence of any Event of Default, the Lender may, by written
notice to the Borrower, declare all or any portion of the unpaid
principal amount due to Lender, together with all accrued interest
thereon, immediately due and payable.
7. Notices.
Any notice, request, instruction, or other document required by the
terms of this Note, or deemed by any of the parties hereto to be
desirable, to be given to any other party hereto shall be in
writing and shall be given by personal delivery, overnight
delivery, mailed by registered or certified mail, postage prepaid,
with return receipt requested to the addresses of the parties set
forth below
If to
the
Borrower:
4521 Sharon Road, Suite 450
Charlotte, NC
28211
Attention:
President and Chief Financial Officer
If to
the
Lender:
to the address set forth in the Subscription Agreement
These
addresses may be changed from time to time by a notice sent as
aforesaid. If notice is given by personal delivery or overnight
delivery in accordance with the provisions of this Section, such
notice shall be conclusively deemed given at the time of such
delivery provided a receipt is obtained from the recipient. If
notice is given by mail in accordance with the provisions of this
Section, such notice shall be conclusively deemed given upon
receipt and delivery or refusal. If notice is given by facsimile
transmission in accordance with the provisions of this Section,
such notice shall be conclusively deemed given at the time of
delivery if during business hours and if not during business hours,
at the next business day after delivery, provided a confirmation is
obtained by the sender.
8. Governing
Law. This Note shall be governed by and construed and
interpreted in accordance with the laws of the State of North
Carolina applicable to contracts made and to be performed entirely
therein, without giving effect to the rules and conflicts of law.
Any suit, action or proceeding arising out of or relating to this
Note shall be brought in State Circuit Court or Federal District
Court located in Mecklenburg County, North Carolina.
9. Conformity
with Law. It is the intention of the Borrower and of the
Lender to conform strictly to applicable usury and similar laws.
Accordingly, notwithstanding anything to the contrary in this Note,
it is agreed that the aggregate of all charges which constitute
interest under applicable usury and similar laws that are contract
for, chargeable or receivable under or in respect of this Note,
shall under no circumstances exceed the maximum amount of interest
permitted by such laws, and any excess, whether occasioned by
acceleration or maturity of this Note or otherwise, shall be
canceled automatically, and if theretofore paid, shall be either
refunded to the Borrower or credited on the principal amount of
this Note.
10. Entire
Agreement; Amendment. This Note and the Offering Documents
constitute the entire agreement between the parties with respect to
the subject matter hereof and supersede all prior and
contemporaneous agreements, whether oral or written, between the
parties hereto with respect to the subject matter hereof. The
holders of fifty-one percent (51%) of the then aggregate
outstanding principal amount of all Notes issued and sold pursuant
to the Offering Documents may amend any terms of this Note and such
amendment shall be binding upon the Lender, its successors and
assigns.
IN WITNESS WHEREOF, the Borrower has
signed and sealed this Note and delivered as of the day and date
first above written.
Level
Beauty Group, Inc.
By:
_______________________
______________
Its:
_____________________
Exhibit 3.2
Amendment to
Subscription Agreement,
8% Convertible Promissory Note and Common Stock Purchase
Warrant
This
Amendment to Subscription Agreement (the "Subscription
Agreement"), 8% Convertible Promissory Note (the
"Convertible
Note") and Common Stock Purchase Warrant (the "Warrant")
and, with the Subscription Agreement and the Convertible Note,
collectively, “Agreement”)
is made as of this 15th day of November, 2016, by and between Level
Brands, Inc., a North Carolina corporation formerly known as Level
Beauty Group, Inc. (the “Company”),
and the Purchaser identified on the signature page hereto (the
“Purchaser”).
This Agreement amends certain sections of the Convertible Note and
the Warrant issued by the Company to Purchaser on the issuance date
set forth on the signature page hereto (“Issuance
Date”) as it relates to a purchase of the Convertible
Note and Warrant by the undersigned pursuant to the Company’s
Confidential Offering Documents for Accredited Investors dated
September 12, 2016 (the “Offering
Documents”). All terms not otherwise defined herein
shall have the same meaning as in the Offering
Documents.
Recitals
A. Pursuant
to the Offering Documents, the undersigned Purchaser (i) purchased
the Convertible Note in principal amount set forth on the signature
page hereto, which is convertible into a number of shares of the
Company’s Common Stock (the “Shares”),
and (ii) was issued a Warrant for the number of Shares as set forth
on the signature page hereto.
B. The
parties desire to amend the Conversion Price of the Convertible
Note and Exercise Price of the Warrant to set a fixed price for
both including lowering the Fixed Conversion Price of the
Convertible Note from $1.50 to $1.00 per Share. A copy of the
blacklined changes to such sections are attached hereto as
Exhibit
A.
Agreement
NOW THEREFORE, in consideration of the
premises and mutual covenants herein contained, the parties agree
as follows:
1.
Convertible Note. Section 4(a)
of the Convertible Note is hereby deleted in its entirety and the
following Section 4(a) shall be inserted in lieu
thereof:
(a) In
the event of a firm commitment initial public offering of the
Company's securities resulting in gross proceeds to the Company of
at least $10,000,000 (the "Initial Public
Offering") prior to July 1, 2017, on the closing date of the
Initial Public Offering (the "IPO Closing
Date"), the outstanding principal amount of this Note and
all accrued interest due hereunder may be converted by Lender, in
whole or in part (the "Conversion")
into the shares (the “Conversion
Shares”) of the Borrower’s common stock (the
"Common
Stock") at a conversion price (the “IPO Conversion
Price”) equal to $1.00 per share. If no Initial Public
Offering occurs prior to July 1, 2017, the conversion price
("Fixed
Conversion Price") will be $1.00 per share. The IPO
Conversion Price and the Fixed Conversion Price are collectively
referred to as the "Conversion
Price". In all instances the Conversion Price is subject to
adjustment as hereinafter set forth.
2.
Warrant. Section 1.2 of the
Warrant is hereby deleted in its entirety and the following Section
1.2 shall be inserted in lieu thereof:
1.2 Exercise
Price. The exercise price ("Exercise
Price") shall be $1.56 per share. In all instances the
Exercise Price is subject to adjustment as hereinafter set
forth.
3.
General. All other provisions
in the Convertible Note and Warrant shall remain unchanged and be
in full force and effect. All provisions in the Offering Documents
(including the summary descriptions under the subheadings
“Conversion” and “Description of Warrants”
under “OFFERING”) which are not reflective of the
amendments set forth in this Agreement shall be deemed amended
hereby and be interpreted consistent with this Agreement. This
Agreement shall be deemed to be effective as of the Issuance Date.
This Agreement may be executed in any number of counterparts, each
of which when so executed shall be deemed to be an original and,
all of which taken together shall constitute one and the same
Agreement. In the event that any signature is delivered
electronically, such signature shall create a valid binding
obligation of the party executing (or on whose behalf such
signature is executed) the same with the same force and effect as
if such facsimile signature were the original thereof.
IN WITNESS WHEREOF, the parties hereto
have executed this Agreement as of the day and date first above
written.
Level
Beauty Group, Inc.
By:
____________________________
Martin
A. Sumichrast,
Chief
Executive Officer
Name of
Purchaser: [ ]
Signature of Purchaser:
_____________________________
Principal Amount of
Convertible Note: $__________
Note
No: _______________________
No. of
Warrants: ___________
Warrant
No: _____________________
Issuance Date:
______________, 2016
Exhibit
A
Changes
to Convertible Note, Section 4(a):
In the
event of a firm commitment initial public offering of the Company's
securities resulting in gross proceeds to the Company of at least
$10,000,000 (the "Initial Public
Offering") prior to July 1, 2017, on the closing date of the
Initial Public Offering (the "IPO Closing
Date"), the outstanding principal amount of this Note and
all accrued interest due hereunder may be converted by Lender, in
whole or in part (the "Conversion")
into the shares (the “Conversion
Shares”) of the Borrower’s common stock (the
"Common
Stock") at a conversion price (the “IPO Conversion
Price”) equal to $1.00 per share. If no Initial Public
Offering occurs prior to July 1, 2017, the conversion price
("Fixed
Conversion Price") will be $1.00 per share. The IPO
Conversion Price and the Fixed Conversion Price are collectively
referred to as the "Conversion
Price". In all instances the Conversion Price is subject to
adjustment as hereinafter set forth.
Changes
to Warrant, Section 1.2:
Exercise Price. The exercise price ("Exercise
Price") shall be $1.56 per share. In all instances the
Exercise Price is subject to adjustment as hereinafter set
forth.
Exhibit
3.3
FORM OF PLACEMENT AGENT WARRANT
COMMON STOCK PURCHASE WARRANT
THE SECURITIES EVIDENCED BY THIS WARRANT HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED
OR OTHERWISE DISPOSED OF WITHOUT (i) EFFECTIVE REGISTRATION
STATEMENT RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER
EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH
REGISTRATION IS NOT REQUIRED, OR (iii) RECEIPT OF NO-ACTION LETTERS
FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES.
________________, 2015 No. W-_______
LEVEL BEAUTY GROUP, INC.
This
certifies that, for good and valuable consideration, receipt of
which is hereby acknowledged, T.R.
WINSTON & COMPANY, LLC (“Holder”)
is entitled to purchase, subject to the terms and conditions of
this Warrant, from Level Beauty Group, Inc., a North Carolina
corporation (the “Company”),
______________ (____________) fully paid and non-assessable shares
of the Company’s common stock, par value $0.001 per share
(“Common
Stock”). Holder shall be entitled to purchase the
shares of Common Stock in accordance with Section 2 at any time
subsequent to the date of this Warrant set forth above and prior to
the Expiration Date (as defined below). The shares of Common Stock
of the Company for which this Warrant is exercisable, as adjusted
from time to time pursuant to the terms hereof, are hereinafter
referred to as the “Shares.”
This Warrant is issued as compensation under the terms of the
Transaction Fee Agreement dated June __, 2015 by and between the
Company and the Holder (the “Agreement”).
1. Exercise Period;
Price.
1.1 Exercise
Period. This Warrant shall be immediately exercisable and
the exercise period (“Exercise
Period”) shall terminate at 5:00 p.m. Pacific time on
_________, 2020 (the “Expiration
Date”).
1.2 Exercise
Price. The initial purchase price for each of the Shares
shall be $0.55 per share. Such price shall be subject to adjustment
pursuant to the terms hereof (such price, as adjusted from time to
time, is hereinafter referred to as the “Exercise
Price”).
2. Exercise and
Payment.
2.1 At
any time after the date of this Warrant, this Warrant may be
exercised, in whole or in part, from time to time by the Holder,
during the term hereof, by surrender of this Warrant and the Notice
of Exercise attached hereto as Annex I, duly completed and
executed by the Holder, to the Company at the principal executive
offices of the Company, together with payment in the amount
obtained by multiplying the Exercise Price then in effect by the
number of Shares thereby purchased, as designated in the Notice of
Exercise. Payment may be in cash, wire transfer or by check payable
to the order of the Company in immediately available funds. If not
exercised in full, this Warrant must be exercised for a whole
number of Shares.
2.2 If
at any time thereafter during the Exercise Period there is not an
effective registration statement registering the Shares, or the
prospectus contained therein is not available for the issuance of
the Shares to the Holder, then this Warrant may also be exercised,
in whole or in part, at such time by means of a “cashless
exercise” in which the Holder shall be entitled to receive a
certificate for the number of Shares equal to the quotient obtained
by dividing [(A-B) (X)] by (A), where:
(A) =
the average of the closing sale prices of the Company's Common
Stock on the principal exchange on which such shares may be issued,
or in the over-the-counter market if the shares of Common Stock are
so quoted, for the five (5) trading days immediately prior to (but
not including) the exercise date;
(B) =
the Exercise Price of this Warrant, as adjusted hereunder;
and
(X) =
the number of Shares that would be issuable upon exercise of this
Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless
exercise.
For
purposes of Rule 144 promulgated under the Securities Act of 1933,
as amended (the “Act”),
it is intended, understood and acknowledged that the Shares issued
in a cashless exercise transaction shall be deemed to have been
acquired by the Holder, and the holding period for the Shares shall
be deemed to have commenced, on the date this Warrant was
originally issued pursuant to the Agreement (provided the
Securities and Exchange Commission (“SEC”)
continues to take the position that such treatment is proper at the
time of such exercise).
2.3 The
Company shall not effect any exercise of this Warrant, and a Holder
shall not have the right to exercise any portion of this Warrant,
pursuant to Section
2 or otherwise, to the extent that after giving effect to
such issuance after exercise as set forth on the applicable Notice
of Exercise, the Holder (together with the Holder’s
Affiliates, and any other Persons acting as a group together with
the Holder or any of the Holder’s Affiliates), would
beneficially own in excess of the Beneficial Ownership Limitation
(as defined below). When used in this paragraph,
“Affiliates”
of the Holder means any entity which directly or indirectly
controls or is controlled by the Holder and “Persons”
means any individual, partnership, limited liability company,
limited liability partnership, corporation, trust, joint venture,
joint stock company, or other entity. For purposes of the foregoing
sentence, the number of shares of Common Stock beneficially owned
by the Holder and its Affiliates shall include the number of shares
of Common Stock issuable upon exercise of this Warrant with respect
to which such determination is being made, but shall exclude the
number of shares of Common Stock which would be issuable upon (i)
exercise of the remaining, non-exercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates and (ii)
exercise or conversion of the unexercised or non-converted portion
of any other securities of the Company (including, without
limitation, any other Common Stock Equivalents, as hereinafter
defined, subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by
the Holder or any of its Affiliates. Except as set forth in the
preceding sentence, for purposes of this Section 2.3, beneficial
ownership shall be calculated in accordance with Section 13(d) of
the Securities Exchange Act of 1934, as amended (the
“Exchange
Act”) and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is
not representing to the Holder that such calculation is in
compliance with Section 13(d) of the Exchange Act and the Holder is
solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained
in this Section 2.3 applies, the determination of whether this
Warrant is exercisable (in relation to other securities owned by
the Holder together with any Affiliates) and of which portion of
this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed
to be the Holder’s determination of whether this Warrant is
exercisable (in relation to other securities owned by the Holder
together with any Affiliates) and of which portion of this Warrant
is exercisable, in each case subject to the Beneficial Ownership
Limitation, and the Company shall have no obligation to verify or
confirm the accuracy of such determination. In addition, a
determination as to any group status as contemplated above shall be
determined in accordance with Section 13(d) of the Exchange Act and
the rules and regulations promulgated thereunder. For purposes of
this Section 2.3, in determining the number of outstanding shares
of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (a) the Company’s most
recent periodic or annual report filed with the SEC, as the case
may be, (b) a more recent public announcement by the Company or (c)
a more recent written notice by the Company setting forth the
number of shares of Common Stock outstanding. Upon the written
request of a Holder, the Company shall within two (2) trading days
confirm orally and in writing to the Holder the number of shares of
Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates since the
date as of which such number of outstanding shares of Common Stock
was reported. The “Beneficial
Ownership Limitation” shall be 4.99% of the number of
shares of the Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon not less than sixty-one
(61) days prior notice to the Company, may increase or decrease the
Beneficial Ownership Limitation provisions of this Section 2.3,
provided that the Beneficial Ownership Limitation in no event
exceeds 9.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of
shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2.3 shall continue to
apply. Any such increase or decrease will not be effective until
the sixty-first (61st) day after such
notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2.3 to
correct this paragraph (or any portion hereof) which may be
defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a
successor holder of this Warrant.
3. Reservation of
Shares. The Company hereby agrees that at all times there
shall be reserved for issuance and delivery upon exercise of this
Warrant such number of Shares or other shares of capital stock of
the Company from time to time issuable upon exercise of this
Warrant . All such shares shall be duly authorized, and when issued
upon such exercise, shall be validly issued, fully paid and
non-assessable, free and clear of all liens, security interests,
charges and other encumbrances or restrictions on sale and free and
clear of all preemptive rights.
4. Delivery of Stock
Certificates. Within three (3) trading days after exercise,
in whole or in part, of this Warrant, the Company shall issue in
the name of and deliver to the Holder a certificate or certificates
for the number of fully paid and nonassessable Shares which the
Holder shall have requested in the Notice of Exercise. If this
Warrant is exercised in part, the Company shall deliver to the
Holder a new Warrant (dated the date hereof and of like tenor) for
the unexercised portion of this Warrant at the time of delivery of
such stock certificate or certificates. In lieu of delivering
physical certificates representing the Shares issuable upon
exercise of this Warrant, provided the Company is participating in
the Depository Trust Company (“DTC”)
Fast Automated Securities Transfer (FAST) program, upon request of
the Holder in the Notice of Exercise, the Company shall use its
best efforts to cause its transfer agent to electronically transmit
the Shares issuable upon exercise to the Holder by crediting the
account of Holder’s Prime Broker with DTC through its Deposit
Withdrawal Agent Commission
(DWAC) system.
5. No Fractional
Shares. This Warrant must be exercised for a whole number of
Shares. No fractional shares or scrip representing fractional
Shares will be issued upon exercise of this Warrant. Any fractional
Share which otherwise might be issuable on the exercise of this
Warrant as a result of the provisions Section 9 hereof will be
rounded up to the nearest whole Share.
6. Charges, Taxes and
Expenses. The Company shall pay all transfer taxes or other
incidental charges, if any, in connection with the transfer of the
Shares purchased pursuant to the exercise hereof from the Company
to the Holder.
7. Loss, Theft,
Destruction or Mutilation of Warrant. Upon receipt by the
Company of evidence reasonably satisfactory to it of the loss,
theft, destruction or mutilation of this Warrant, and in case of
loss, theft or destruction, of indemnity or security reasonably
satisfactory to the Company, and upon reimbursement to the Company
of all reasonable expenses incidental thereto, and upon surrender
and cancellation of this Warrant, if mutilated, the Company will
make and deliver a new Warrant of like tenor and dated as of such
cancellation, in lieu of this Warrant.
8. Saturdays, Sundays,
Holidays, Etc. If the last or appointed day for the taking
of any action or the expiration of any right required or granted
herein shall be a Saturday or a Sunday or shall be a legal holiday,
then such action may be taken or such right may be exercised on the
next succeeding weekday which is not a legal holiday.
9. Adjustment of
Exercise Price and Number of Shares. The Exercise Price and
the number of and kind of securities purchasable upon exercise of
this Warrant shall be subject to adjustment from time to time as
follows:
9.1 Subdivisions,
Combinations and Other Issuances. If the Company shall at
any time after the date hereof but prior to the expiration of this
Warrant subdivide its outstanding securities as to which purchase
rights under this Warrant exist, by split-up or otherwise, or
combine its outstanding securities as to which purchase rights
under this Warrant exist, the number of Shares as to which this
Warrant is exercisable as of the date of such subdivision, split-up
or combination shall forthwith be proportionately increased in the
case of a subdivision, or proportionately decreased in the case of
a combination. Appropriate adjustments shall also be made to the
Exercise Price, but the aggregate purchase price payable for the
total number of Shares purchasable under this Warrant as of such
date shall remain the same.
9.2 Stock
Dividend. If at any time after the date hereof the Company
declares a dividend or other distribution on Common Stock payable
in Common Stock or other securities or rights convertible into
Common Stock (“Common Stock
Equivalents”) without payment of any consideration by
such holder for the additional shares of Common Stock or the Common
Stock Equivalents (including the additional shares of Common Stock
issuable upon exercise or conversion thereof), then the number of
shares of Common Stock for which this Warrant may be exercised
shall be increased as of the record date (or the date of such
dividend distribution if no record date is set) for determining
which holders of Common Stock shall be entitled to receive such
dividend, in proportion to the increase in the number of
outstanding shares (and shares of Common Stock issuable upon
conversion of all such securities convertible into Common Stock) of
Common Stock as a result of such dividend, and the Exercise Price
shall be adjusted so that the aggregate amount payable for the
purchase of all the Shares issuable hereunder immediately after the
record date (or on the date of such distribution, if applicable),
for such dividend shall equal the aggregate amount so payable
immediately before such record date (or on the date of such
distribution, if applicable).
9.3 Other
Distributions. If at any time after the date hereof the
Company distributes to holders of its Common Stock, other than as
part of its dissolution or liquidation or the winding up of its
affairs, any shares of its capital stock, any evidence of
indebtedness or any of its assets (other than cash, Common Stock or
Common Stock Equivalents), then the Company may, at its option,
either (i) decrease the Exercise Price of this Warrant by an
appropriate amount based upon the value distributed on each share
of Common Stock as determined in good faith by the Company’s
Board of Directors, or (ii) provide by resolution of the
Company’s Board of Directors that on exercise of this
Warrant, the Holder hereof shall thereafter be entitled to receive,
in addition to the shares of Common Stock otherwise receivable on
exercise hereof, the number of shares or other securities or
property which would have been received had this Warrant at the
time been exercised.
9.4 Effect of
Consolidation, Merger or Sale. In case of any
reclassification, capital reorganization, or change of securities
of the class issuable upon exercise of this Warrant (other than a
change in par value, or from par value to no par value, or from no
par value to par value, or as a result of any subdivision,
combination, stock dividend or other distribution provided for in
Sections 9.1,
9.2 and
9.3 above), or in
case of any consolidation or merger of the Company with or into any
corporation (other than a consolidation or merger with another
corporation in which the Company is the acquiring and the surviving
corporation and which does not result in any reclassification or
change of outstanding securities issuable upon exercise of this
Warrant), or in case of any sale of all or substantially all of the
assets of the Company, the Company, or such successor or purchasing
corporation, as the case may be, shall duly execute and deliver to
the holder of this Warrant a new Warrant (in form and substance
satisfactory to the holder of this Warrant), or the Company shall
make appropriate provision without the issuance of a new Warrant,
so that the holder of this Warrant shall have the right to receive,
at a total purchase price not to exceed that payable upon the
exercise of the unexercised portion of this Warrant, and in lieu of
the Shares theretofore issuable upon exercise of this Warrant, the
kind and amount of shares of stock, other securities, money and
property receivable upon such reclassification, capital
reorganization, change, merger or sale by a holder of the number of
Shares then purchasable under this Warrant. In any such case,
appropriate provisions shall be made with respect to the rights and
interest of Holder so that the provisions hereof shall thereafter
be applicable to any shares of stock or other securities and
property deliverable upon exercise hereof, or to any new Warrant
delivered pursuant to this Section 9.4, and appropriate
adjustments shall be made to the Exercise Price per share payable
hereunder, provided, that the aggregate Exercise Price shall remain
the same. The provisions of this Section 9.4 shall similarly
apply to successive reclassifications, capital reorganizations,
changes, mergers and transfers.
10. Notice of
Adjustments; Notices. Whenever the Exercise Price or number
of Shares purchasable hereunder shall be adjusted pursuant to
Section 9 hereof,
the Company shall execute and deliver to the Holder a certificate
setting forth, in reasonable detail, the event requiring the
adjustment, the amount of the adjustment, the method by which such
adjustment was calculated and the Exercise Price and number of and
kind of securities purchasable hereunder after giving effect to
such adjustment, and shall cause a copy of such certificate to be
mailed (by first class mail, postage prepaid) to the
Holder.
11. Rights As
Shareholder; Notice to Holders. Nothing contained in this
Warrant shall be construed as conferring upon the Holder or his or
its transferees the right to vote or to receive dividends or to
consent or to receive notice as a shareholder in respect of any
meeting of shareholders for the election of directors of the
Company or of any other matter, or any rights whatsoever as
shareholders of the Company.
12. Restricted
Securities. The Holder understands that this Warrant and the
Shares purchasable hereunder constitute “restricted
securities” under the federal securities laws inasmuch as
they are, or will be, acquired from the Company in transactions not
involving a public offering and accordingly may not, under such
laws and applicable regulations, be resold or transferred without
registration under the Act, or an applicable exemption from such
registration. The Holder further acknowledges that a securities
legend to the foregoing effect shall be placed on any Shares issued
to the Holder upon exercise of this Warrant.
13. Disposition of
Shares; Transferability.
13.1 Transfer.
This Warrant shall be transferable only on the books of the
Company, upon delivery thereof duly endorsed by the Holder or by
its duly authorized attorney or representative, accompanied by
proper evidence of succession, assignment or authority to transfer.
Upon any registration of transfer, the Company shall execute and
deliver new Warrants to the person entitled thereto.
13.2 Rights,
Preferences and Privileges of Common Stock. The powers,
preferences, rights, restrictions and other matters relating to the
shares of Common Stock will be as determined in the Company’s
Articles of Incorporation, as then in effect.
14. Miscellaneous.
14.1 Binding
Effect. This Warrant and the various rights and obligations
arising hereunder shall be binding upon and inure to the benefit of
the parties hereto and their respective successors and
assigns.
14.2 Entire
Agreement. This Warrant constitutes the entire agreement
between the parties with respect to the subject matter hereof and
supersede all prior and contemporaneous agreements, whether oral or
written, between the parties hereto with respect to the subject
matter hereof.
14.3 Amendment
and Waiver. Any term of this Warrant may be amended and the
observance of any term hereof may be waived (either generally or in
a particular instance and either retroactively or prospectively),
with the written consent of the Company and the Holders
representing a majority-in-interest of the shares of Common Stock
underlying the Warrants pursuant to the Purchase Agreement. Any
waiver or amendment effected in accordance with this Section 14.3 shall be binding
upon the Holder and the Company.
14.4 Governing
Law. This Agreement shall be governed by and construed under
the laws of the State of North Carolina without reference to the
conflicts of law principles thereof. The exclusive jurisdiction for
any legal suit, action or proceeding arising out of or related to
this Warrant shall be either the North Carolina State Supreme
Court, County of Mecklenburg, or in the United States District
Court for the Western District of North Carolina.
14.5 Headings.
The headings in this Agreement are for convenience only and shall
not alter or otherwise affect the meaning hereof.
14.6 Severability.
If one or more provisions of this Warrant are held to be
unenforceable under applicable law, such provision shall be
excluded from this Warrant and the balance of the Warrant shall be
interpreted as if such provision were so excluded and the balance
shall be enforceable in accordance with its terms.
14.7 Notices.
Unless otherwise provided, any notice required or permitted under
this Warrant shall be given in the same manner as provided in the
Agreement.
IN WITNESS WHEREOF, the parties hereto
have executed and delivered this Warrant as of the date appearing
on the first page of this Warrant.
THE
COMPANY:
LEVEL
BEAUTY GROUP, INC.
By:_______________________________________
Kenneth
F. Kahn, Chief Executive Officer
ANNEX I
NOTICE OF EXERCISE
To:
Level Beauty Group,
Inc.
1.
The undersigned
Holder hereby elects to purchase _____________ shares of common
stock, $0.001 par value per share (the “Shares”)
of Level Beauty Group, Inc., a North Carolina corporation (the
“Company”),
pursuant to the terms of the attached Warrant. The Holder shall
make payment of the Exercise Price as follows (check
one):
☐
“Cash Exercise” under Section 2.1
☐
“Cashless Exercise” under
Section
2.2
If the
Holder is making a Cash Exercise, the Holder is hereby delivering
the sum of $____________, in lawful money of the United States, to
the Company in accordance with the terms of the
Warrant.
If the
Holder is making a Cashless Exercise, the Company shall deliver to
the Holder ______________ Warrant Shares in accordance with the
terms of the Warrant.
2.
Please issue and
deliver certificates representing the Warrant Shares purchased
hereunder to Holder: Address: in the following
denominations: ____________________________.
Taxpayer
ID No.: __________________________________
If
delivery of the Warrant Shares is requested via DWAC, please check
this box and provide the requested information:
☐
The Company is
requested to electronically transmit the Warrant Shares issuable
pursuant to this Notice of Exercise to the account of the Holder
with DTC through its Deposit Withdrawal Agent Commission system
(“DWAC Transfer”).
Name of DTC Prime
Broker:
_______________________________
Account
Number:
_______________________________
3.
Please issue a new
Warrant for the unexercised portion of the attached Warrant, if
any, in the name of the undersigned.
4.
Investor Status. The
undersigned is an “accredited investor” as defined in
Regulation D promulgated under the Securities Act of 1933, as
amended.
[SIGNATURE OF HOLDER]
Name of Investing
Entity:
Signature of Authorized Signatory of Investing
Entity:
Name of Authorized
Signatory:
Title of Authorized
Signatory:
Exhibit
3.4
PLACEMENT AGENT WARRANT
COMMON STOCK PURCHASE WARRANT
THE SECURITIES EVIDENCED BY THIS WARRANT HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED
OR OTHERWISE DISPOSED OF WITHOUT (i) EFFECTIVE REGISTRATION
STATEMENT RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER
EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH
REGISTRATION IS NOT REQUIRED, OR (iii) RECEIPT OF NO-ACTION LETTERS
FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES.
[•] No. W-[•]
LEVEL BEAUTY GROUP, INC.
This
certifies that, for good and valuable consideration, receipt of
which is hereby acknowledged, [•] (“Holder”)
is entitled to purchase, subject to the terms and conditions of
this Warrant, from Level Beauty Group, Inc., a North Carolina
corporation (the “Company”),
[•] ([•]) fully paid and
non-assessable shares of the Company’s common stock, par
value $0.001 per share (“Common
Stock”). Holder shall be entitled to purchase the
shares of Common Stock in accordance with Section 2 at any time
subsequent to the date of this Warrant set forth above and prior to
the applicable Expiration Date (as defined below). The shares of
Common Stock of the Company for which this Warrant is exercisable,
as adjusted from time to time pursuant to the terms hereof, are
hereinafter referred to as the “Shares.”
Pursuant to the terms and conditions of that certain Transaction
Fee Agreement dated November 23, 2015 (the “Agreement”)
by and between the Company and T.R. Winston & Company, LLC
("T.R.
Winston"), T.R. Winston was entitled to receive certain
warrants to purchase Shares as partial compensation for its
services to the Company. This Warrant, which is one of a series,
was issued to the Holder at the direction of T.R. Winston in
satisfaction of that obligation.
1. Exercise Period;
Price.
1.1 Exercise
Period. This Warrant shall be immediately exercisable and
the exercise periods (the "Exercise
Period") on [•] (the
“Expiration
Date”).
1.2 Exercise
Price. The initial purchase price for each of the Shares
shall be $1.75 per share. Such price shall be subject to adjustment
pursuant to the terms hereof (such price, as adjusted from time to
time, is hereinafter referred to as the “Exercise
Price”).
2. Exercise and
Payment.
2.1 At
any time after the date of this Warrant, this Warrant may be
exercised, in whole or in part, from time to time by the Holder,
during the term hereof, by surrender of this Warrant and the Notice
of Exercise attached hereto as Annex I, duly completed and
executed by the Holder, to the Company at the principal executive
offices of the Company, together with payment in the amount
obtained by multiplying the Exercise Price then in effect by the
number of Shares thereby purchased, as designated in the Notice of
Exercise. Payment may be in cash, wire transfer or by check payable
to the order of the Company in immediately available funds. If not
exercised in full, this Warrant must be exercised for a whole
number of Shares.
2.2 If
at any time thereafter during the Exercise Period there is not an
effective registration statement registering the Shares, or the
prospectus contained therein is not available for the issuance of
the Shares to the Holder, then this Warrant may also be exercised,
in whole or in part, at such time by means of a “cashless
exercise” in which the Holder shall be entitled to receive a
certificate for the number of Shares equal to the quotient obtained
by dividing [(A-B) (X)] by (A), where:
(A) =
the average of the closing sale prices of the Company's Common
Stock on the principal exchange on which such shares may be issued,
or in the over-the-counter market if the shares of Common Stock are
so quoted, for the five (5) trading days immediately prior to (but
not including) the exercise date;
(B) =
the Exercise Price of this Warrant, as adjusted hereunder;
and
(X) =
the number of Shares that would be issuable upon exercise of this
Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless
exercise.
For
purposes of Rule 144 promulgated under the Securities Act of 1933,
as amended (the “Act”),
it is intended, understood and acknowledged that the Shares issued
in a cashless exercise transaction shall be deemed to have been
acquired by the Holder, and the holding period for the Shares shall
be deemed to have commenced, on the date this Warrant was
originally issued pursuant to the Agreement (provided the
Securities and Exchange Commission (“SEC”)
continues to take the position that such treatment is proper at the
time of such exercise).
2.3 The
Company shall not effect any exercise of this Warrant, and a Holder
shall not have the right to exercise any portion of this Warrant,
pursuant to Section
2 or otherwise, to the extent that after giving effect to
such issuance after exercise as set forth on the applicable Notice
of Exercise, the Holder (together with the Holder’s
Affiliates, and any other Persons acting as a group together with
the Holder or any of the Holder’s Affiliates), would
beneficially own in excess of the Beneficial Ownership Limitation
(as defined below). When used in this paragraph,
“Affiliates”
of the Holder means any entity which directly or indirectly
controls or is controlled by the Holder and “Persons”
means any individual, partnership, limited liability company,
limited liability partnership, corporation, trust, joint venture,
joint stock company, or other entity. For purposes of the foregoing
sentence, the number of shares of Common Stock beneficially owned
by the Holder and its Affiliates shall include the number of shares
of Common Stock issuable upon exercise of this Warrant with respect
to which such determination is being made, but shall exclude the
number of shares of Common Stock which would be issuable upon (i)
exercise of the remaining, non-exercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates and (ii)
exercise or conversion of the unexercised or non-converted portion
of any other securities of the Company (including, without
limitation, any other Common Stock Equivalents, as hereinafter
defined, subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by
the Holder or any of its Affiliates. Except as set forth in the
preceding sentence, for purposes of this Section 2.3, beneficial
ownership shall be calculated in accordance with Section 13(d) of
the Securities Exchange Act of 1934, as amended (the
“Exchange
Act”) and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is
not representing to the Holder that such calculation is in
compliance with Section 13(d) of the Exchange Act and the Holder is
solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained
in this Section 2.3 applies, the determination of whether this
Warrant is exercisable (in relation to other securities owned by
the Holder together with any Affiliates) and of which portion of
this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed
to be the Holder’s determination of whether this Warrant is
exercisable (in relation to other securities owned by the Holder
together with any Affiliates) and of which portion of this Warrant
is exercisable, in each case subject to the Beneficial Ownership
Limitation, and the Company shall have no obligation to verify or
confirm the accuracy of such determination. In addition, a
determination as to any group status as contemplated above shall be
determined in accordance with Section 13(d) of the Exchange Act and
the rules and regulations promulgated thereunder. For purposes of
this Section 2.3, in determining the number of outstanding shares
of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (a) the Company’s most
recent periodic or annual report filed with the SEC, as the case
may be, (b) a more recent public announcement by the Company or (c)
a more recent written notice by the Company setting forth the
number of shares of Common Stock outstanding. Upon the written
request of a Holder, the Company shall within two (2) trading days
confirm orally and in writing to the Holder the number of shares of
Common Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates since the
date as of which such number of outstanding shares of Common Stock
was reported. The “Beneficial
Ownership Limitation” shall be 4.99% of the number of
shares of the Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon not less than sixty-one
(61) days prior notice to the Company, may increase or decrease the
Beneficial Ownership Limitation provisions of this Section 2.3,
provided that the Beneficial Ownership Limitation in no event
exceeds 9.99% of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of
shares of Common Stock upon exercise of this Warrant held by the
Holder and the provisions of this Section 2.3 shall continue to
apply. Any such increase or decrease will not be effective until
the sixty-first (61st) day after such
notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2.3 to
correct this paragraph (or any portion hereof) which may be
defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a
successor holder of this Warrant.
3. Reservation of
Shares. The Company hereby agrees that at all times there
shall be reserved for issuance and delivery upon exercise of this
Warrant such number of Shares or other shares of capital stock of
the Company from time to time issuable upon exercise of this
Warrant . All such shares shall be duly authorized, and when issued
upon such exercise, shall be validly issued, fully paid and
non-assessable, free and clear of all liens, security interests,
charges and other encumbrances or restrictions on sale and free and
clear of all preemptive rights.
4. Delivery of Stock
Certificates. Within three (3) trading days after exercise,
in whole or in part, of this Warrant, the Company shall issue in
the name of and deliver to the Holder a certificate or certificates
for the number of fully paid and nonassessable Shares which the
Holder shall have requested in the Notice of Exercise. If this
Warrant is exercised in part, the Company shall deliver to the
Holder a new Warrant (dated the date hereof and of like tenor) for
the unexercised portion of this Warrant at the time of delivery of
such stock certificate or certificates. In lieu of delivering
physical certificates representing the Shares issuable upon
exercise of this Warrant, provided the Company is participating in
the Depository Trust Company (“DTC”)
Fast Automated Securities Transfer (FAST) program, upon request of
the Holder in the Notice of Exercise, the Company shall use its
best efforts to cause its transfer agent to electronically transmit
the Shares issuable upon exercise to the Holder by crediting the
account of Holder’s Prime Broker with DTC through its Deposit
Withdrawal Agent Commission
(DWAC) system.
5. No Fractional
Shares. This Warrant must be exercised for a whole number of
Shares. No fractional shares or scrip representing fractional
Shares will be issued upon exercise of this Warrant. Any fractional
Share which otherwise might be issuable on the exercise of this
Warrant as a result of the provisions Section 9 hereof will be
rounded up to the nearest whole Share.
6. Charges, Taxes and
Expenses. The Company shall pay all transfer taxes or other
incidental charges, if any, in connection with the transfer of the
Shares purchased pursuant to the exercise hereof from the Company
to the Holder.
7. Loss, Theft,
Destruction or Mutilation of Warrant. Upon receipt by the
Company of evidence reasonably satisfactory to it of the loss,
theft, destruction or mutilation of this Warrant, and in case of
loss, theft or destruction, of indemnity or security reasonably
satisfactory to the Company, and upon reimbursement to the Company
of all reasonable expenses incidental thereto, and upon surrender
and cancellation of this Warrant, if mutilated, the Company will
make and deliver a new Warrant of like tenor and dated as of such
cancellation, in lieu of this Warrant.
8. Saturdays, Sundays,
Holidays, Etc. If the last or appointed day for the taking
of any action or the expiration of any right required or granted
herein shall be a Saturday or a Sunday or shall be a legal holiday,
then such action may be taken or such right may be exercised on the
next succeeding weekday which is not a legal holiday.
9. Adjustment of
Exercise Price and Number of Shares. The Exercise Price and
the number of and kind of securities purchasable upon exercise of
this Warrant shall be subject to adjustment from time to time as
follows:
9.1 Subdivisions,
Combinations and Other Issuances. If the Company shall at
any time after the date hereof but prior to the expiration of this
Warrant subdivide its outstanding securities as to which purchase
rights under this Warrant exist, by split-up or otherwise, or
combine its outstanding securities as to which purchase rights
under this Warrant exist, the number of Shares as to which this
Warrant is exercisable as of the date of such subdivision, split-up
or combination shall forthwith be proportionately increased in the
case of a subdivision, or proportionately decreased in the case of
a combination. Appropriate adjustments shall also be made to the
Exercise Price, but the aggregate purchase price payable for the
total number of Shares purchasable under this Warrant as of such
date shall remain the same.
9.2 Stock
Dividend. If at any time after the date hereof the Company
declares a dividend or other distribution on Common Stock payable
in Common Stock or other securities or rights convertible into
Common Stock (“Common Stock
Equivalents”) without payment of any consideration by
such holder for the additional shares of Common Stock or the Common
Stock Equivalents (including the additional shares of Common Stock
issuable upon exercise or conversion thereof), then the number of
shares of Common Stock for which this Warrant may be exercised
shall be increased as of the record date (or the date of such
dividend distribution if no record date is set) for determining
which holders of Common Stock shall be entitled to receive such
dividend, in proportion to the increase in the number of
outstanding shares (and shares of Common Stock issuable upon
conversion of all such securities convertible into Common Stock) of
Common Stock as a result of such dividend, and the Exercise Price
shall be adjusted so that the aggregate amount payable for the
purchase of all the Shares issuable hereunder immediately after the
record date (or on the date of such distribution, if applicable),
for such dividend shall equal the aggregate amount so payable
immediately before such record date (or on the date of such
distribution, if applicable).
9.3 Other
Distributions. If at any time after the date hereof the
Company distributes to holders of its Common Stock, other than as
part of its dissolution or liquidation or the winding up of its
affairs, any shares of its capital stock, any evidence of
indebtedness or any of its assets (other than cash, Common Stock or
Common Stock Equivalents), then the Company may, at its option,
either (i) decrease the Exercise Price of this Warrant by an
appropriate amount based upon the value distributed on each share
of Common Stock as determined in good faith by the Company’s
Board of Directors, or (ii) provide by resolution of the
Company’s Board of Directors that on exercise of this
Warrant, the Holder hereof shall thereafter be entitled to receive,
in addition to the shares of Common Stock otherwise receivable on
exercise hereof, the number of shares or other securities or
property which would have been received had this Warrant at the
time been exercised.
9.4 Effect of
Consolidation, Merger or Sale. In case of any
reclassification, capital reorganization, or change of securities
of the class issuable upon exercise of this Warrant (other than a
change in par value, or from par value to no par value, or from no
par value to par value, or as a result of any subdivision,
combination, stock dividend or other distribution provided for in
Sections 9.1,
9.2 and
9.3 above), or in
case of any consolidation or merger of the Company with or into any
corporation (other than a consolidation or merger with another
corporation in which the Company is the acquiring and the surviving
corporation and which does not result in any reclassification or
change of outstanding securities issuable upon exercise of this
Warrant), or in case of any sale of all or substantially all of the
assets of the Company, the Company, or such successor or purchasing
corporation, as the case may be, shall duly execute and deliver to
the holder of this Warrant a new Warrant (in form and substance
satisfactory to the holder of this Warrant), or the Company shall
make appropriate provision without the issuance of a new Warrant,
so that the holder of this Warrant shall have the right to receive,
at a total purchase price not to exceed that payable upon the
exercise of the unexercised portion of this Warrant, and in lieu of
the Shares theretofore issuable upon exercise of this Warrant, the
kind and amount of shares of stock, other securities, money and
property receivable upon such reclassification, capital
reorganization, change, merger or sale by a holder of the number of
Shares then purchasable under this Warrant. In any such case,
appropriate provisions shall be made with respect to the rights and
interest of Holder so that the provisions hereof shall thereafter
be applicable to any shares of stock or other securities and
property deliverable upon exercise hereof, or to any new Warrant
delivered pursuant to this Section 9.4, and appropriate
adjustments shall be made to the Exercise Price per share payable
hereunder, provided, that the aggregate Exercise Price shall remain
the same. The provisions of this Section 9.4 shall similarly
apply to successive reclassifications, capital reorganizations,
changes, mergers and transfers.
10. Notice of
Adjustments; Notices. Whenever the Exercise Price or number
of Shares purchasable hereunder shall be adjusted pursuant to
Section 9 hereof,
the Company shall execute and deliver to the Holder a certificate
setting forth, in reasonable detail, the event requiring the
adjustment, the amount of the adjustment, the method by which such
adjustment was calculated and the Exercise Price and number of and
kind of securities purchasable hereunder after giving effect to
such adjustment, and shall cause a copy of such certificate to be
mailed (by first class mail, postage prepaid) to the
Holder.
11. Rights As
Shareholder; Notice to Holders. Nothing contained in this
Warrant shall be construed as conferring upon the Holder or his or
its transferees the right to vote or to receive dividends or to
consent or to receive notice as a shareholder in respect of any
meeting of shareholders for the election of directors of the
Company or of any other matter, or any rights whatsoever as
shareholders of the Company.
12. Restricted
Securities. The Holder understands that this Warrant and the
Shares purchasable hereunder constitute “restricted
securities” under the federal securities laws inasmuch as
they are, or will be, acquired from the Company in transactions not
involving a public offering and accordingly may not, under such
laws and applicable regulations, be resold or transferred without
registration under the Act, or an applicable exemption from such
registration. The Holder further acknowledges that a securities
legend to the foregoing effect shall be placed on any Shares issued
to the Holder upon exercise of this Warrant.
13. Disposition of
Shares; Transferability.
13.1 Transfer.
This Warrant shall be transferable only on the books of the
Company, upon delivery thereof duly endorsed by the Holder or by
its duly authorized attorney or representative, accompanied by
proper evidence of succession, assignment or authority to transfer.
Upon any registration of transfer, the Company shall execute and
deliver new Warrants to the person entitled thereto.
13.2 Rights,
Preferences and Privileges of Common Stock. The powers,
preferences, rights, restrictions and other matters relating to the
shares of Common Stock will be as determined in the Company’s
Articles of Incorporation, as then in effect.
14. Miscellaneous.
14.1 Binding
Effect. This Warrant and the various rights and obligations
arising hereunder shall be binding upon and inure to the benefit of
the parties hereto and their respective successors and
assigns.
14.2 Entire
Agreement. This Warrant constitutes the entire agreement
between the parties with respect to the subject matter hereof and
supersede all prior and contemporaneous agreements, whether oral or
written, between the parties hereto with respect to the subject
matter hereof.
14.3 Amendment
and Waiver. Any term of this Warrant may be amended and the
observance of any term hereof may be waived (either generally or in
a particular instance and either retroactively or prospectively),
with the written consent of the Company and the Holders
representing a majority-in-interest of the shares of Common Stock
underlying the Warrants pursuant to the Purchase Agreement. Any
waiver or amendment effected in accordance with this Section 14.3 shall be binding
upon the Holder and the Company.
14.4 Governing
Law. This Agreement shall be governed by and construed under
the laws of the State of North Carolina without reference to the
conflicts of law principles thereof. The exclusive jurisdiction for
any legal suit, action or proceeding arising out of or related to
this Warrant shall be either the North Carolina State Supreme
Court, County of Mecklenburg, or in the United States District
Court for the Western District of North Carolina.
14.5 Headings.
The headings in this Agreement are for convenience only and shall
not alter or otherwise affect the meaning hereof.
14.6 Severability.
If one or more provisions of this Warrant are held to be
unenforceable under applicable law, such provision shall be
excluded from this Warrant and the balance of the Warrant shall be
interpreted as if such provision were so excluded and the balance
shall be enforceable in accordance with its terms.
14.7 Notices.
Unless otherwise provided, any notice required or permitted under
this Warrant shall be given in the same manner as provided in the
Agreement.
IN WITNESS WHEREOF, the parties hereto
have executed and delivered this Warrant as of the date appearing
on the first page of this Warrant.
THE
COMPANY:
LEVEL
BEAUTY GROUP, INC.
By:
________________________________________
Kenneth
F. Kahn, Chief Executive Officer
ANNEX I
NOTICE OF EXERCISE
To:
Level Beauty Group,
Inc.
1.
The undersigned
Holder hereby elects to purchase _____________ shares of common
stock, $0.001 par value per share (the “Shares”)
of Level Beauty Group, Inc., a North Carolina corporation (the
“Company”),
pursuant to the terms of the attached Warrant. The Holder shall
make payment of the Exercise Price as follows (check
one):
☐
“Cash Exercise” under Section 2.1
☐
“Cashless Exercise” under
Section
2.2
If the
Holder is making a Cash Exercise, the Holder is hereby delivering
the sum of $____________, in lawful money of the United States, to
the Company in accordance with the terms of the
Warrant.
If the
Holder is making a Cashless Exercise, the Company shall deliver to
the Holder ______________ Warrant Shares in accordance with the
terms of the Warrant.
2.
Please issue and
deliver certificates representing the Warrant Shares purchased
hereunder to Holder: Address: in the following
denominations: ____________________________.
Taxpayer
ID No.: __________________________________
If
delivery of the Warrant Shares is requested via DWAC, please check
this box and provide the requested information:
☐
The Company is
requested to electronically transmit the Warrant Shares issuable
pursuant to this Notice of Exercise to the account of the Holder
with DTC through its Deposit Withdrawal Agent Commission system
(“DWAC Transfer”).
Name of DTC Prime
Broker:
_______________________________
Account
Number:
_______________________________
3.
Please issue a new
Warrant for the unexercised portion of the attached Warrant, if
any, in the name of the undersigned.
4.
Investor Status. The
undersigned is an “accredited investor” as defined in
Regulation D promulgated under the Securities Act of 1933, as
amended.
[SIGNATURE OF HOLDER]
Name of Investing
Entity:
Signature of Authorized Signatory of Investing
Entity:
Name of Authorized
Signatory:
Title of Authorized
Signatory:
Exhibit
3.5
FORM OF COMMON STOCK PURCHASE WARRANT
THE SECURITIES EVIDENCED BY THIS WARRANT HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED
OR OTHERWISE DISPOSED OF WITHOUT (i) EFFECTIVE REGISTRATION
STATEMENT RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER
EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH
REGISTRATION IS NOT REQUIRED, OR (iii) RECEIPT OF NO-ACTION LETTERS
FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES.
[●], 2016 No. W-__
LEVEL BEAUTY GROUP, INC.
COMMON
STOCK PURCHASE WARRANT
This
certifies that, for good and valuable consideration, receipt of
which is hereby acknowledged, [●] (“Holder”)
is entitled to purchase, subject to the terms and conditions of
this Warrant, from Level Beauty Group, Inc., a North Carolina
corporation (the “Company”),
[●]fully paid and nonassessable shares of the Company’s
Common Stock, par value $0.01 per share (“Common
Stock”). Holder shall be entitled to purchase the
shares of Common Stock in accordance with Section 2 at any time during
the Exercise Period (as defined below). The shares of Common Stock
of the Company for which this Warrant is exercisable, as adjusted
from time to time pursuant to the terms hereof, are hereinafter
referred to as the “Shares.”
This Warrant is one of a series of Warrants included in the Units
issued and sold by the Company pursuant to the terms and conditions
of the Company’s Confidential Offering Documents for
Accredited Investors dated September 12, 2016 and the Subscription Agreement
(the "Subscription
Agreement") dated [•], 2016 by and between the Company
and the Holder (collectively, the "Offering
Documents").
1. Exercise
Period; Price.
1.1 Exercise
Period. This Warrant shall become exercisable (the
"Exercise
Period") on the
earlier of (i) the IPO Closing Date; or (ii) the Maturity Date and
shall terminate at 5:00 p.m. Eastern time on September 30, 2021
(the “Expiration
Date”). When used herein, "IPO Closing
Date" shall mean the date the Company closes a firm
commitment initial public offering (the "Initial Public
Offering") of its securities resulting in gross proceeds to
the Company of at least $10,000,000 prior to the Maturity Date, and
the "Maturity
Date" shall mean September 30, 2017.
1.2 Exercise
Price. In the event of an Initial Public Offering prior to
the Maturity Date, the exercise price ("Exercise
Price") will be equal to the lesser of: (i) 120% of the per
share price paid by the purchasers of the Common Stock in the
Initial Public Offering; or (ii) the price equal to the quotient of
$20,000,000 divided by the aggregate number of shares outstanding
of the Company’s Common Stock immediately prior to the IPO
Closing Date (assuming full conversion or exercise of all
convertible or exercisable securities then outstanding other than
the Notes). In the event there is no Initial Public Offering by the
Maturity Date, the Exercise Price will be equal to the quotient of
$20,000,000 divided by the aggregate number of shares outstanding
of the Company’s Common Stock immediately prior to the
exercise of such Warrant (assuming full conversion or exercise of
all convertible or exercisable securities then outstanding other
than the Notes). In all instances the Exercise Price is subject to
adjustment as hereinafter set forth.
2. Exercise
and Payment. At any time during the Exercise Period, this
Warrant may be exercised, in whole or in part, from time to time by
the Holder, during the term hereof, by surrender of this Warrant
and the Notice of Exercise attached hereto as Annex I, duly completed and
executed by the Holder, to the Company at the principal executive
offices of the Company, together with payment in the amount
obtained by multiplying the Exercise Price then in effect by the
number of Shares thereby purchased, as designated in the Notice of
Exercise. Payment may be in cash, wire transfer or by check payable
to the order of the Company in immediately available funds. If not
exercised in full, this Warrant must be exercised for a whole
number of Shares.
3. Reservation
of Shares. The
Company hereby agrees that at all times there shall be reserved for
issuance and delivery upon exercise of this Warrant such number of
Shares or other shares of capital stock of the Company from time to
time issuable upon exercise of this Warrant. All such shares shall
be duly authorized, and when issued upon such exercise, shall be
validly issued, fully paid and non-assessable, free and clear of
all liens, security interests, charges and other encumbrances or
restrictions on sale and free and clear of all preemptive
rights.
4. Delivery
of Stock Certificates. Within three (3) trading days after
exercise, in whole or in part, of this Warrant, the Company shall
issue in the name of and deliver to the Holder a certificate or
certificates for the number of fully paid and nonassessable Shares
which the Holder shall have requested in the Notice of Exercise. If
this Warrant is exercised in part, the Company shall deliver to the
Holder a new Warrant (dated the date hereof and of like tenor) for
the unexercised portion of this Warrant at the time of delivery of
such stock certificate or certificates.
5. Charges,
Taxes and Expenses.
The Company shall pay all transfer taxes or other incidental
charges, if any, in connection with the transfer of the Shares
purchased pursuant to the exercise hereof from the Company to the
Holder.
6. Loss,
Theft, Destruction or Mutilation of Warrant. Upon receipt by the Company of
evidence reasonably satisfactory to it of the loss, theft,
destruction or mutilation of this Warrant, and in case of loss,
theft or destruction, of indemnity or security reasonably
satisfactory to the Company, and upon reimbursement to the Company
of all reasonable expenses incidental thereto, and upon surrender
and cancellation of this Warrant, if mutilated, the Company will
make and deliver a new Warrant of like tenor and dated as of such
cancellation, in lieu of this Warrant.
7. Saturdays,
Sundays, Holidays, Etc. If the last or appointed day for the
taking of any action or the expiration of any right required or
granted herein shall be a Saturday or a Sunday or shall be a legal
holiday, then such action may be taken or such right may be
exercised on the next succeeding weekday which is not a legal
holiday.
8. Adjustment
of Exercise Price and Number of Shares. The Exercise Price and the number of
and kind of securities purchasable upon exercise of this Warrant
shall be subject to adjustment from time to time as
follows:
8.1 Subdivisions,
Combinations and Other Issuances. If the Company shall at
any time after the date hereof but prior to the expiration of this
Warrant subdivide its outstanding securities as to which purchase
rights under this Warrant exist, by split-up or otherwise, or
combine its outstanding securities as to which purchase rights
under this Warrant exist, the number of Shares as to which this
Warrant is exercisable as of the date of such subdivision, split-up
or combination shall forthwith be proportionately increased in the
case of a subdivision, or proportionately decreased in the case of
a combination. Appropriate adjustments shall also be made to the
Exercise Price, but the aggregate purchase price payable for the
total number of Shares purchasable under this Warrant as of such
date shall remain the same.
8.2 Stock
Dividend. If at any time after the date hereof the Company
declares a dividend or other distribution on its Common Stock
payable in shares of Common Stock or other securities or rights
convertible into shares of Common Stock (“Common Stock
Equivalents”) without payment of any consideration by
such holder for the additional shares of Common Stock or the Common
Stock Equivalents (including the additional shares of Common Stock
issuable upon exercise or conversion thereof), then the number of
Shares for which this Warrant may be exercised shall be increased
as of the record date (or the date of such dividend distribution if
no record date is set) for determining which holders of Common
Stock shall be entitled to receive such dividend, in proportion to
the increase in the number of outstanding shares (and shares of
Common Stock issuable upon conversion of all such securities
convertible into Common Stock) of Common Stock as a result of such
dividend, and the Exercise Price shall be adjusted so that the
aggregate amount payable for the purchase of all the Shares
issuable hereunder immediately after the record date (or on the
date of such distribution, if applicable), for such dividend shall
equal the aggregate amount so payable immediately before such
record date (or on the date of such distribution, if
applicable).
8.3 Other
Distributions. If at any time after the date hereof the
Company distributes to holders of its Common Stock, other than as
part of its dissolution or liquidation or the winding up of its
affairs, any shares of its capital stock, any evidence of
indebtedness or any of its assets (other than cash, shares of
Common Stock or Common Stock Equivalents), then the Company may, at
its option, either (i) decrease the Exercise Price of this Warrant
by an appropriate amount based upon the value distributed on each
share of Common Stock as determined in good faith by the
Company’s Board of Directors, or (ii) provide by resolution
of the Company’s Board of Directors that on exercise of this
Warrant, the Holder hereof shall thereafter be entitled to receive,
in addition to the shares of Common Stock otherwise receivable on
exercise hereof, the number of shares or other securities or
property which would have been received had this Warrant at the
time been exercised.
8.4 Effect
of Consolidation, Merger or Sale. In case of any
reclassification, capital reorganization, or change of securities
of the class issuable upon exercise of this Warrant (other than a
change in par value, or from par value to no par value, or from no
par value to par value, or as a result of any subdivision,
combination, stock dividend or other distribution provided for in
Sections 8.1,
8.2 and
8.3 above), or in
case of any consolidation or merger of the Company with or into any
corporation (other than a consolidation or merger with another
corporation in which the Company is the acquiring and/or the
surviving corporation and which does not result in any
reclassification or change of outstanding securities issuable upon
exercise of this Warrant), or in case of any sale of all or
substantially all of the assets of the Company, the Company, or
such successor or purchasing corporation, as the case may be, shall
duly execute and deliver to the holder of this Warrant a new
Warrant (in form and substance satisfactory to the holder of this
Warrant), or the Company shall make appropriate provision without
the issuance of a new Warrant, so that the holder of this Warrant
shall have the right to receive, at a total purchase price not to
exceed that payable upon the exercise of the unexercised portion of
this Warrant, and in lieu of the Shares theretofore issuable upon
exercise of this Warrant, the kind and amount of shares of stock,
other securities, money and property receivable upon such
reclassification, capital reorganization, change, merger or sale by
a holder of the number of Shares then purchasable under this
Warrant. In any such case, appropriate provisions shall be made
with respect to the rights and interest of Holder so that the
provisions hereof shall thereafter be applicable to any shares of
stock or other securities and property deliverable upon exercise
hereof, or to any new Warrant delivered pursuant to this
Section 8.4, and
appropriate adjustments shall be made to the Exercise Price per
share payable hereunder, provided, that the aggregate Exercise
Price shall remain the same. The provisions of this Section 8.4 shall similarly
apply to successive reclassifications, capital reorganizations,
changes, mergers and transfers.
9. Notice
of Adjustments; Notices. Whenever the Exercise Price or number
of Shares purchasable hereunder shall be adjusted pursuant to
Section 8 hereof,
the Company shall execute and deliver to the Holder a certificate
setting forth, in reasonable detail, the event requiring the
adjustment, the amount of the adjustment, the method by which such
adjustment was calculated and the Exercise Price and number of and
kind of securities purchasable hereunder after giving effect to
such adjustment, and shall cause a copy of such certificate to be
mailed (by first class mail, postage prepaid) to the
Holder.
10. Rights
As Shareholder; Notice to Holders. Nothing contained in this Warrant
shall be construed as conferring upon the Holder or his or its
transferees the right to vote or to receive dividends or to consent
or to receive notice as a shareholder in respect of any meeting of
shareholders for the election of directors of the Company or of any
other matter, or any rights whatsoever as shareholders of the
Company. The Company shall give notice to the Holder by registered
mail if at any time prior to the expiration or exercise in full of
the Warrants, any of the following events shall occur:
(i) a
dissolution, liquidation or winding up of the Company shall be
proposed;
(ii) a
capital reorganization or reclassification of the Common Stock
(other than a change in par value, or from par value to no par
value, or from no par value to par value, or as a result of any
subdivision, combination, stock dividend or other distribution) or
any consolidation or merger of the Company with or into another
corporation (other than a consolidation or merger with another
corporation in which the Company is the acquiring and/or the
surviving corporation and which does not result in any
reclassification or change of outstanding securities issuable upon
exercise of this Warrant), or in case of any sale of all or
substantially all of the assets of the Company; or
(iii) a
taking by the Company of a record of the holders of any class of
securities for the purpose of determining the holders thereof who
are entitled to receive any dividend (other than a cash dividend)
for other distribution, any right to subscribe for, purchase or
otherwise acquire any shares of stock of any class or any other
securities or property, or to receive any other
rights.
Such
giving of notice shall be simultaneous with (or in any event, no
later than) the giving of notice to holders of Common Stock. Such
notice shall specify the record date or the date of closing the
stock transfer books, as the case may be. Failure to provide such
notice shall not affect the validity of any action contemplated in
this Section
10.
11. Restricted
Securities; Lockup.
This Warrant and the Shares purchasable hereunder constitute
“restricted securities” under the federal securities
laws inasmuch as they are, or will be, acquired from the Company in
transactions not involving a public offering and accordingly may
not, under such laws and applicable regulations, be resold or
transferred without registration under the Securities Act of 1933,
as amended, or an applicable exemption from such registration. This
Warrant and the Shares are subject to the terms of the "lock-up"
agreement as set forth in the Subscription Agreement. The Company
will place a securities legend to the foregoing effect on any
Shares issued to the Holder upon exercise of this
Warrant.
12. Disposition
of Shares; Transferability.
12.1 Transfer.
This Warrant shall be transferable only on the books of the
Company, upon delivery thereof duly endorsed by the Holder or by
its duly authorized attorney or representative, accompanied by
proper evidence of succession, assignment or authority to transfer.
Upon any registration of transfer, the Company shall execute and
deliver new Warrants to the person entitled thereto.
12.2 Rights,
Preferences and Privileges of Common Stock. The powers,
preferences, rights, restrictions and other matters relating to the
shares of Common Stock will be as determined in the Company’s
Articles of Incorporation, as amended, as then in
effect.
13. Miscellaneous.
13.1 Binding
Effect. This Warrant and the various rights and obligations
arising hereunder shall be binding upon and inure to the benefit of
the parties hereto and their respective successors and
assigns.
13.2 Entire
Agreement. This Warrant and the Offering Documents
constitute the entire agreement between the parties with respect to
the subject matter hereof and supersede all prior and
contemporaneous agreements, whether oral or written, between the
parties hereto with respect to the subject matter
hereof.
13.3 Amendment
and Waiver. Any term of this Warrant may be amended and the
observance of any term hereof may be waived (either generally or in
a particular instance and either retroactively or prospectively),
with the written consent of the Company and the Holders
representing a majority-in-interest of the Shares underlying the
Warrants pursuant to the Offering Documents. Any waiver or
amendment effected in accordance with this Section 13.3 shall be binding
upon the Holder and the Company.
13.4 Governing
Law. This Warrant shall be governed by and construed and
interpreted in accordance with the laws of the State of North
Carolina applicable to contracts made and to be performed entirely
therein, without giving effect to the rules and conflicts of law.
Any suit, action or proceeding arising out of or relating to this
Warrant shall be brought in State Circuit Court or Federal District
Court located in Mecklenburg County, North Carolina.
13.5 Headings.
The headings in this Agreement are for convenience only and shall
not alter or otherwise affect the meaning hereof.
13.6 Severability.
If one or more provisions of this Warrant are held to be
unenforceable under applicable law, such provision shall be
excluded from this Warrant and the balance of the Warrant shall be
interpreted as if such provision were so excluded and the balance
shall be enforceable in accordance with its terms.
13.7 Notices.
Unless otherwise provided, any notice required or permitted under
this Warrant shall be given in the same manner as provided in the
Agreement.
IN WITNESS WHEREOF, the parties hereto
have executed and delivered this Warrant as of the date appearing
on the first page of this Warrant.
THE
COMPANY:
LEVEL
BEAUTY GROUP, INC.
By:
_______________________________
___________________
Its:
__________________
ANNEX I
NOTICE OF EXERCISE
To:
Level
Beauty Group, Inc.
1.
The undersigned
Holder hereby elects to purchase _____________ shares of common
stock, $0.01 par value per share (the “Shares”)
of Level Beauty Group, a North Carolina corporation (the
“Company”),
pursuant to the terms of the attached Warrant. The Holder shall
make payment of the Exercise Price by delivering the sum of
$____________, in lawful money of the United States, to the Company
in accordance with the terms of the Warrant.
2.
Please issue and
deliver certificates representing the Warrant Shares purchased
hereunder to Holder: ,Address: in the following
denominations: ____________________________.
Taxpayer
ID No.: __________________________________
If
delivery of the Warrant Shares is requested via DWAC, please check
this box and provide the requested information:
☐
The Company is
requested to electronically transmit the Warrant Shares issuable
pursuant to this Notice of Exercise to the account of the Holder
with DTC through its Deposit Withdrawal Agent Commission system
(“DWAC
Transfer”).
Name of DTC Prime
Broker:
_______________________________
Account
Number:
_______________________________
3.
Please issue a new
Warrant for the unexercised portion of the attached Warrant, if
any, in the name of the undersigned.
4.
The undersigned is
an “accredited investor” as defined in Regulation D
promulgated under the Securities Act of 1933, as
amended.
[SIGNATURE OF HOLDER]
Name of Investing
Entity:
Signature of Authorized Signatory of Investing
Entity:
Name of Authorized
Signatory:
Title of Authorized
Signatory:
Exhibit
3.8
LEVEL BEAUTY GROUP, INC.
2015 EQUITY COMPENSATION PLAN
1.1
Purpose.
The purpose of this 2015 Equity Compensation Plan is to enable the
Company to offer to its employees, officers, directors and
consultants whose past, present and/or potential contributions to
the Company and its Subsidiaries have been, are or will be
important to the success of the Company, an opportunity to acquire
a proprietary interest in the Company. The types of long-term
incentive Awards that may be provided under the Plan will enable
the Company to respond to changes in compensation practices, tax
laws, accounting regulations and the size and diversity of its
businesses.
2.1
Definitions.
For purposes of the Plan, the following terms shall be defined as
set forth below:
(a)
“Agreement”
means the agreement between the Company and the Holder setting
forth the terms and conditions of an Award under the Plan.
Agreements shall be in the form(s) attached
hereto.
(b)
“Award”
means Stock Options, Restricted Stock and/or other Stock Based
Awards awarded under the Plan.
(c)
“Board”
means the Board of Directors of the Company.
(d)
“Code”
means the Internal Revenue Code of 1986, as amended from time to
time.
(e)
“Committee”
means the Compensation Committee of the Board or any other
committee of the Board that the Board may designate to administer
the Plan or any portion thereof. If no Committee is so designated,
then all references in this Plan to “Committee” shall
mean the Board.
(f)
“Common
Stock” means the common
stock of the Company, $0.001 par value per
share.
(g)
“Company”
means Level Beauty Group, Inc., a corporation organized under the
laws of the State of North Carolina.
(h)
“Disability”
means physical or mental impairment as determined under procedures
established by the Committee for purposes of the
Plan.
(i)
“Effective
Date” means the date set
forth in Section 11.1, below.
(j)
“Fair
Market Value”, unless
otherwise required by any applicable provision of the Code or any
regulations issued thereunder, means, as of any given date: (i) if
the Common Stock is listed on a national securities exchange, the
closing price of the Common Stock in the principal trading market
for the Common Stock on such date, as reported by the exchange (or
on the last preceding trading date if such security was not traded
on such date); (ii) if the Common Stock is not listed on a national
securities exchange, but is traded in the over-the-counter market,
the closing bid price for the Common Stock on such date, as
reported by the OTC Markets Inc. or similar publisher of such
quotations; and (iii) if the fair market value of the Common Stock
cannot be determined pursuant to clause (i) or (ii) above, such
price as the Committee shall determine, in good
faith.
(k)
“Holder”
means a person who has received an Award under the
Plan.
(l)
“Incentive
Stock Option” means any
Stock Option intended to be and designated as an “incentive
stock option” within the meaning of Section 422 of the
Code.
(m)
“Nonqualified
Stock Option” means any
Stock Option that is not an Incentive Stock
Option.
(n)
“Normal
Retirement” means
retirement from active employment with the Company or any
Subsidiary, other than for Cause or due to death or disability, of
a Holder who; (i) has reached the age of 65; (ii) has reached the
age of 62 and has completed five years of service with the Company;
or (iii) has reached the age of 60 and has completed 10 years of
service with the Company.
(o)
“Other
Stock-Based Award” means
an Award under Section 8, below, that is valued in whole or in part
by reference to, or is otherwise based upon, Common
Stock.
(p)
“Parent”
means any present or future “parent corporation” of the
Company, as such term is defined in Section 424(e) of the
Code.
(q)
“Plan”
means the Level Beauty Group, Inc. 205 Equity Compensation Plan, as
hereinafter amended from time to time.
(r)
“Repurchase
Value” shall mean the
Fair Market Value in the event the Award to be repurchased under
Section 9.2 is comprised of shares of Common Stock and the
difference between Fair Market Value and the Exercise Price (if
lower than Fair Market Value) in the event the Award is a Stock
Option; in each case, multiplied by the number of shares subject to
the Award.
(s)
“Restricted
Stock” means Common
Stock, received under an Award made pursuant to Section 7, below
that is subject to restrictions under said Section
7.
(t)
“Stock
Option” or
“Option”
means any option to purchase shares of Common Stock that is granted
pursuant to the Plan.
(u)
“Subsidiary”
means any present or future “subsidiary corporation” of
the Company, as such term is defined in Section 424(f) of the
Code.
3.1
Committee
Membership. The Plan shall be
administered by the Committee, the Board or a committee designated
by the Board. Committee members shall serve for such term as the
Board may in each case determine, and shall be subject to removal
at any time by the Board. The Committee members, to the extent
deemed to be appropriate by the Board, shall be “non-employee
directors” as defined in Rule 16b-3 promulgated under the
Securities Exchange Act of 1934, as amended
(“Exchange
Act”), and “outside
directors” within the meaning of Section 162(m) of the Code.
The Committee shall conduct itself in conformance with the
provisions of the Compensation Committee
Charter.
3.2
Powers of
Committee. The Committee shall
have the authority and responsibility to recommend to the Board for
approval, Awards for Board members, executive officers,
non-executive employees and consultants of the Company, pursuant to
the terms of the Plan: (i) Stock Options, (ii) Restricted Stock,
and/or (iii) Other Stock-Based Awards. For purposes of illustration
and not of limitation, the Committee shall have the authority
(subject to the express provisions of this
Plan):
(a)
to
select the officers, employees, directors and consultants of the
Company or any Subsidiary to whom Stock Options, Restricted Stock,
and/or Other Stock-Based Awards may from time to time be awarded
hereunder.
(b)
to
determine the terms and conditions, not inconsistent with the terms
of the Plan or requisite Board approval, of any Award granted
hereunder including, but not limited to, number of shares, share
exercise price or types of consideration paid upon exercise of
Stock Options and the purchase price of Common Stock awarded under
the Plan (including without limitation by a Holder’s
conversion of deferred salary or other indebtedness of the Company
to the Holder), such as other securities of the Company or other
property, any restrictions or limitations, and any vesting,
exchange, surrender, cancellation, acceleration, termination,
exercise or forfeiture provisions, as the Committee shall
determine;
(c)
to
determine any specified performance goals or such other factors or
criteria which need to be attained for the vesting of an Award
granted hereunder;
(d)
to
determine the terms and conditions under which Awards granted
hereunder are to operate on a tandem basis and/or in conjunction
with or apart from other equity awarded under this Plan and cash
Awards made by the Company or any Subsidiary outside of this Plan;
and
(e)
to
determine the extent and circumstances under which Common Stock and
other amounts payable with respect to an Award hereunder shall be
deferred that may be either automatic or at the election of the
Holder; and
3.3
Interpretation of Plan.
3.1
Committee
Authority. Subject to Section
10, below, the Committee shall have the authority to adopt, alter
and repeal such administrative rules, guidelines and practices
governing the Plan as it shall, from time to time, deem advisable,
to interpret the terms and provisions of the Plan and any Award
issued under the Plan (and to determine the form and substance of
all Agreements relating thereto), and to otherwise supervise the
administration of the Plan. Subject to Section 10, below, all
decisions made by the Committee pursuant to the provisions of the
Plan shall be made in the Committee’s sole discretion,
subject to Board authorization if indicated, and shall be final and
binding upon all persons, including the Company, its Subsidiaries
and Holders.
3.2
Incentive Stock
Options. Anything in the Plan
to the contrary notwithstanding, no term or provision of the Plan
relating to Incentive Stock Options or any Agreement providing for
Incentive Stock Options shall be interpreted, amended or altered,
nor shall any discretion or authority granted under the Plan be so
exercised, so as to disqualify the Plan under Section 422 of the
Code, or, without the consent of the Holder(s) affected, to
disqualify any Incentive Stock Option under such Section
422.
4.
Stock Subject to Plan.
4.1
Number of
Shares. The total number of
shares of Common Stock reserved and available for issuance under
the Plan shall be One Million One Hundred Seventy-Five Thousand
(1,175,000) shares. Shares of Common Stock under the Plan may
consist, in whole or in part, of authorized and unissued shares or
treasury shares. The number of shares of Common Stock available for
issuance under the Plan shall automatically increase on the first
trading day of January each calendar year during the term of the
Plan, beginning with calendar year 2016, by an amount equal to one
percent (1%) of the total number of shares of Common Stock
outstanding on the last trading day in December of the immediately
preceding calendar year, but in no event shall any such annual
increase exceed One Hundred Thousand (100,000) shares of Common
Stock. If any share of Common Stock that have been granted pursuant
to a Stock Option ceases to be subject to a Stock Option, or if any
shares of Common Stock that are subject to any Restricted Stock,
Deferred Stock Award, or Other Stock-Based Award granted hereunder
are forfeited or any such Award otherwise terminates without a
payment being made to the Holder in the form of Common Stock, such
shares shall again be available for distribution in connection with
future grants and Awards under the Plan.
4.2
Adjustment Upon
Changes in Capitalization, Etc.
In the event of any dividend (other than a cash dividend) payable
on shares of Common Stock, stock split, reverse stock split,
combination or exchange of shares, or other similar event (not
addressed in Section 4.3, below) occurring after the grant of an
Award, which results in a change in the shares of Common Stock of
the Company as a whole, (i) the number of shares issuable in
connection with any such Award and the purchase price thereof, if
any, shall be proportionately adjusted to reflect the occurrence of
any such event and (ii) the Committee shall determine
whether such change requires an adjustment in the aggregate number
of shares reserved for issuance under the Plan or to retain the
number of shares reserved and available under the Plan in their
sole discretion. Any adjustment
required by this Section 4.2 shall be made by the Committee, in
good faith, subject to Board authorization if indicated, whose
determination will be final, binding and
conclusive.
4.3
Certain Mergers and
Similar Transactions. In the
event of (a) a dissolution or liquidation of the Company, (b) a
merger or consolidation in which the Company is not the surviving
corporation (other than a merger or consolidation with a
wholly-owned subsidiary, a reincorporation of the Company in a
different jurisdiction, or other transaction in which there is no
substantial change in the shareholders of the Company or their
relative stock holdings and the Awards granted under this Plan are
assumed, converted or replaced by the successor corporation, which
assumption will be binding on all Awardees, (c) a merger in which
the Company is the surviving corporation but after which the
shareholders of the Company immediately prior to such merger (other
than any shareholder that merges, or which owns or controls another
corporation that merges, with the Company in such merger) cease to
own their shares or other equity interest in the Company, (d) the
sale of substantially all of the assets of the Company, or (e) the
acquisition, sale, or transfer of more than 50% of the outstanding
shares of the Company by tender offer or similar transaction, any
or all outstanding Awards may be assumed, converted or replaced by
the successor corporation (if any), which assumption, conversion or
replacement will be binding on all Awardees. In the alternative,
the successor corporation may substitute equivalent Awards or
provide substantially similar consideration to Awardees as was
provided to shareholders (after taking into account the existing
provisions of the Awards). The successor corporation may also
issue, in place of outstanding Shares of the Company held by the
Holder, substantially similar shares or other property subject to
repurchase restrictions no less favorable to the Holder. In the
event such successor corporation (if any) refuses or otherwise
declines to assume or substitute Awards, as provided above, (i) the
vesting of any or all Awards granted pursuant to this Plan will
accelerate immediately prior to the effective date of a transaction
described in this Section 4.3 and (ii) any or all Options granted
pursuant to this Plan will become exercisable in full prior to the
consummation of such event at such time and on such conditions as
the Committee determines. If such Options are not exercised prior
to the consummation of the corporate transaction, they shall
terminate at such time as determined by the Committee. Subject to
any greater rights granted to Awardees under the foregoing
provisions of this Section 4.3, in the event of the occurrence of
any transaction described in this Section 4.3, any outstanding
Awards will be treated as provided in the applicable agreement or
plan of merger, consolidation, dissolution, liquidation, or sale of
assets.
Awards
may be made or granted to employees, officers, directors and
consultants who are deemed to have rendered or to be able to render
significant services to the Company or its Subsidiaries and who are
deemed to have contributed or to have the potential to contribute
to the success of the Company. No Incentive Stock Option shall be
granted to any person who is not an employee of the Company or a
Subsidiary at the time of grant. Notwithstanding anything to the
contrary contained in the Plan, Awards covered or to be covered
under a registration statement on Form S-8 which may be filed with
the United States Securities and Exchange Commission may be made
under the Plan only if (a) they are made to natural persons, (b)
who provide bona fide services to the Company or its Subsidiaries,
and (c) the services are not in connection with the offer and sale
of securities in a capital raising transaction, and do not directly
or indirectly promote or maintain a market for the Company’s
securities.
6.1
Grant and
Exercise. Stock Options granted
under the Plan may be of two types: (i) Incentive Stock Options and
(ii) Nonqualified Stock Options. Any Stock Option granted under the
Plan shall contain such terms, not inconsistent with this Plan, or
with respect to Incentive Stock Options, not inconsistent with the
Plan and the Code, as the Committee may from time to time approve.
The Committee shall have the authority to grant Incentive Stock
Options or Non-qualified Stock Options, or both types of Stock
Options, which may be granted alone or in addition to other Awards
granted under the Plan. To the extent that any Stock Option
intended to qualify as an Incentive Stock Option does not so
qualify, it shall constitute a separate Nonqualified Stock
Option.
6.2
Terms and
Conditions. Stock Options
granted under the Plan shall be subject to the following terms and
conditions:
(a)
Option
Term. The term of each Stock
Option shall be fixed by the Committee; provided, however, that an
Incentive Stock Option may be granted only within the ten-year
period commencing from the Effective Date and may only be exercised
within ten years of the date of grant (or five years in the case of
an Incentive Stock Option granted to an optionee who, at the time
of grant, owns Common Stock possessing more than 10% of the total
combined voting power of all classes of stock of the Company
(“10%
Shareholder”).
(b)
Exercise
Price. The exercise price per
share of Common Stock purchasable under a Stock Option shall be
determined by the Committee at the time of grant and may not be
less than 100% of the Fair Market Value on the day of grant;
provided, however, that the exercise price of an Incentive Stock
Option granted to a 10% Shareholder shall not be less than 110% of
the Fair Market Value on the date of grant.
(c)
Exercisability.
Stock Options shall be exercisable at such time or times and
subject to such terms and conditions as shall be determined by the
Committee and as set forth in Section 9, below. If the Committee
provides, in its discretion, that any Stock Option is exercisable
only in installments, i.e., that it vests over time, the Committee
may waive such installment exercise provisions at any time at or
after the time of grant in whole or in part, based upon such
factors as the Committee shall determine.
(d)
Method of
Exercise. Subject to whatever
installment, exercise and waiting period provisions are applicable
in a particular case; Stock Options may be exercised in whole or in
part at any time during the term of the Option, by giving written
notice of exercise to the Company specifying the number of shares
of Common Stock to be purchased. Such notice shall be accompanied
by payment in full of the purchase price, which shall be in cash
or, if provided in the Agreement, either in shares of Common Stock
(including Restricted Stock and other contingent Awards under this
Plan) or partly in cash and partly in such Common Stock, or such
other means which the Committee determines are consistent with the
Plan’s purpose and applicable law. Cash payments shall be
made by wire transfer, certified or bank check or personal check,
in each case payable to the order of the Company; provided,
however, that the Company shall not be required to deliver
certificates for shares of Common Stock with respect to which an
Option is exercised until the Company has confirmed the receipt of
good and available funds in payment of the purchase price thereof.
Payments in the form of Common Stock shall be valued at the Fair
Market Value on the date prior to the date of exercise. Such
payments shall be made by delivery of stock certificates in
negotiable form that are effective to transfer good and valid title
thereto to the Company, free of any liens or encumbrances. A Holder
shall have none of the rights of a shareholder with respect to the
shares subject to the Option until such shares shall be transferred
to the Holder upon the exercise of the Option.
(e)
Transferability.
Except as may be set forth in the Agreement, no Stock Option shall
be transferable by the Holder other than by will or by the laws of
descent and distribution, and all Stock Options shall be
exercisable, during the Holder’s lifetime, only by the Holder
(or, to the extent of legal incapacity or incompetency, the
Holder’s guardian or legal
representative).
(f)
Termination by Reason
of Death. If a Holder’s
employment by the Company or a Subsidiary terminates by reason of
death, any Stock Option held by such Holder, unless otherwise
determined by the Committee at the time of grant and set forth in
the Agreement, shall thereupon automatically terminate, except that
the portion of such Stock Option that has vested on the date of
death may thereafter be exercised by the legal representative of
the estate or by the legatee of the Holder under the will of the
Holder, for a period of one year (or such other greater or lesser
period as the Committee may specify at grant) from the date of such
death or until the expiration of the stated term of such Stock
Option, whichever period is the shorter.
(g)
Termination by Reason
of Disability. If a
Holder’s employment by the Company or any Subsidiary
terminates by reason of Disability, any Stock Option held by such
Holder, unless otherwise determined by the Committee at the time of
grant and set forth in the Agreement, shall there upon
automatically terminate, except that the portion of such Stock
Option that has vested on the date of termination may thereafter be
exercised by the Holder for a period of one year (or such other
greater or lesser period as the Committee may specify at the time
of grant) from the date of such termination of employment or until
the expiration of the stated term of such Stock Option, whichever
period is the shorter.
(h)
Other
Termination. Subject to the
provisions of Section 12, below, and unless otherwise determined by
the Committee at the time of grant and set forth in the Agreement,
if a Holder is an employee of the Company or a Subsidiary at the
time of grant and if such Holder’s employment by the Company
or any Subsidiary terminates for any reason other than death or
Disability, the Stock Option shall thereupon automatically
terminate, except that if the Holder’s employment is
terminated by the Company or a Subsidiary without cause or due to
Normal Retirement, then the portion of such Stock Option that has
vested on the date of termination of employment may be exercised
for the lesser of three months after termination of employment or
the balance of such Stock Option’s term.
(i)
Additional Incentive
Stock Option Limitation. In the
case of an Incentive Stock Option, the aggregate Fair Market Value
(on the date of grant of the Option) with respect to which
Incentive Stock Options become exercisable for the first time by a
Holder during any calendar year (under all such plans of the
Company and its Parent and Subsidiary) shall not exceed
$100,000.
(j)
Buyout and Settlement
Provisions. The Committee may
at any time, subject to Board authorization, if indicated, offer to
repurchase a Stock Option previously granted, based upon such terms
and conditions as the Committee shall establish and communicate to
the Holder at the time that such offer is made.
7.1
Grant.
Shares of Restricted Stock may be awarded either alone or in
addition to other Awards granted under the Plan. The Committee,
subject to Board authorization, if indicated, shall determine the
eligible persons to whom, and the time or times at which, grants of
Restricted Stock will be awarded, the number of shares to be
awarded, the price (if any) to be paid by the Holder, the time or
times within which such Awards may be subject to forfeiture
(“Restriction
Period”), the vesting
schedule and rights to acceleration thereof, and all other terms
and conditions of the Awards.
7.2
Terms and
Conditions. Each Restricted
Stock Award shall be subject to the following terms and
conditions:
(a)
Certificates.
Restricted Stock, when issued, will be represented by a stock
certificate or certificates registered in the name of the Holder to
whom such Restricted Stock shall have been awarded. During the
Restriction Period, certificates representing the Restricted Stock
and any securities constituting Retained Distributions (as defined
below) shall bear a legend to the effect that ownership of the
Restricted Stock (and such Retained Distributions), and the
enjoyment of all rights appurtenant thereto, are subject to the
restrictions, terms and conditions provided in the Plan and the
Agreement. Such certificates shall be deposited by the Holder with
the Company, together with stock powers or other instruments of
assignment, each endorsed in blank, which will permit transfer to
the Company of all or any portion of the Restricted Stock and any
securities constituting Retained Distributions that shall be
forfeited or that shall not become vested in accordance with the
Plan and the Agreement.
(b)
Rights of
Holder. Restricted Stock shall
constitute issued and outstanding shares of Common Stock for all
corporate purposes. The Holder will have the right to vote such
Restricted Stock, to receive and retain all regular cash dividends
and other cash equivalent distributions as the Board may in its
sole discretion designate, pay or distribute on such Restricted
Stock and to exercise all other rights, powers and privileges of a
holder of Common Stock with respect to such Restricted Stock, with
the exceptions that (i) the Holder will not be entitled to delivery
of the stock certificate or certificates representing such
Restricted Stock until the Restriction Period shall have expired
and unless all other vesting requirements with respect thereto
shall have been fulfilled; (ii) the Company will retain custody of
the stock certificate or certificates representing the Restricted
Stock during the Restriction Period; (iii) other than regular cash
dividends and other cash equivalent distributions as the Board may
in its sole discretion designate, pay or distribute, the Company
will retain custody of all distributions
(“Retained
Distributions”) made or
declared with respect to the Restricted Stock (and such Retained
Distributions will be subject to the same restrictions, terms and
conditions as are applicable to the Restricted Stock) until such
time, if ever, as the Restricted Stock with respect to which such
Retained Distributions shall have been made, paid or declared shall
have become vested and with respect to which the Restriction Period
shall have expired; (iv) a breach of any of the restrictions, terms
or conditions contained in this Plan or the Agreement or otherwise
established by the Committee with respect to any Restricted Stock
or Retained Distributions will cause a forfeiture of such
Restricted Stock and any Retained Distributions with respect
thereto.
(c)
Vesting;
Forfeiture. Upon the expiration
of the Restriction Period with respect to each Award of Restricted
Stock and the satisfaction of any other applicable restrictions,
terms and conditions (i) all or part of such Restricted Stock shall
become vested in accordance with the terms of the Agreement,
subject to Section 9, below, and (ii) any Retained Distributions
with respect to such Restricted Stock shall become vested to the
extent that the Restricted Stock related thereto shall have become
vested, subject to Section 9, below. Any such Restricted Stock and
Retained Distributions that do not vest shall be forfeited to the
Company and the Holder shall not thereafter have any rights with
respect to such Restricted Stock and Retained Distributions that
shall have been so forfeited.
8.
Other Stock-Based Awards.
Other
Stock-Based Awards may be awarded, subject to limitations under
applicable law, that are denominated or payable in, valued in whole
or in part by reference to, or otherwise based on, or related to,
shares of Common Stock, as deemed by the Committee to be consistent
with the purposes of the Plan, including, without limitation,
purchase rights, shares of Common Stock awarded which are not
subject to any restrictions or conditions, or other rights
convertible into shares of Common Stock and Awards valued by
reference to the value of securities of or the performance of
specified Subsidiaries. Other Stock-Based Awards may be awarded
either alone or in addition to or in tandem with any other Awards
under this Plan or any other plan of the Company. Each other
Stock-Based Award shall be subject to such terms and conditions as
may be determined by the Committee.
9.
Accelerated Vesting and Exercisability.
9.1
Non-Approved
Transactions. If any
“person” (as such term is used in Sections 13(d) and
14(d) of the Exchange Act) is or becomes the “beneficial
owner” (as referred in Rule 13d-3 under the Exchange Act),
directly or indirectly, of securities of the Company representing
30% or more of the combined voting power of the Company’s
then outstanding securities in one or more transactions, and the
Board does not authorize or otherwise approve such acquisition,
then the vesting periods of any and all Stock Options and other
Awards granted and outstanding under the Plan shall be accelerated
and all such Stock Options and Awards will immediately and entirely
vest, and the respective holders thereof will have the immediate
right to purchase and/or receive any and all Common Stock subject
to such Stock Options and Awards on the terms set forth in this
Plan and the respective agreements respecting such Stock Options
and Awards.
9.2
Approved
Transactions. The Committee
may, subject to Board authorization, if indicated, in the event of
an acquisition of substantially all of the Company’s assets
or at least 50% of the combined voting power of the Company’s
then outstanding securities in one or more transactions (including
by way of merger or reorganization) which has been approved by the
Company’s Board of Directors, (i) accelerate the vesting of
any and all Stock Options and other Awards granted and outstanding
under the Plan, and (ii) require a Holder of any Award granted
under this Plan to relinquish such Award to the Company upon the
tender by the Company to Holder of cash in an amount equal to the
Repurchase Value of such Award.
10.
Amendment and Termination.
The
Board may at any time, and from time to time, amend alter, suspend
or discontinue any of the provisions of the Plan, but no amendment,
alteration, suspension or discontinuance shall be made that would
impair the rights of a Holder under any Agreement theretofore
entered into hereunder, without the Holder’s
consent.
11.1
Effective
Date. The Plan shall become
effective at such time as the Plan is approved and adopted by the
Company’s Board of Directors (the “Effective
Date”), subject to the
following provisions:
(a)
to
the extent that the Plan authorizes the Award of Incentive Stock
Options, shareholder approval for the Plan shall be obtained within
12 months of the Effective Date; and
(b)
the
failure to obtain shareholder for the Plan as contemplated by
subparagraph (a) of this Section 11 shall not invalidate the Plan;
provided, however, that (i) in the absence of such shareholder
approval, Incentive Stock Options may not be awarded under the Plan
and (ii) any Incentive Stock Options theretofore awarded under the
Plan shall be converted into Non-Qualified Options upon terms and
conditions determined by the Committee to reflect, as nearly as is
reasonably practicable in its sole determination, the terms and
conditions of the Incentive Stock Options being so
converted.
1.2
Termination
Date. Unless otherwise
terminated by the Board, this Plan shall continue to remain
effective until the earlier of ten (10) years from the Effective
Date or such time as no further Awards may be granted and all
Awards granted under the Plan are no longer outstanding.
Notwithstanding the foregoing, grants of Incentive Stock Options
may be made only during the ten-year period following the Effective
Date.
12.1
Written
Agreements. Each Award granted
under the Plan shall be confirmed by, and shall be subject to the
terms, of the Agreement executed by the Company and the Holder. The
Committee may terminate any Award made under the Plan if the
Agreement relating thereto is not executed and returned to the
Company within 10 days after the Agreement has been delivered to
the Holder for his or her execution.
12.2
Unfunded Status of
Plan. The Plan is intended to
constitute an “unfunded” plan for incentive and
deferred compensation. With respect to any payments not yet made to
a Holder by the Company, nothing contained herein shall give any
such Holder any rights that are greater than those of a general
creditor of the Company.
(a)
Engaging in
Competition with the Company; Disclosure of Confidential
Information. If a
Holder’s employment with the Company or a Subsidiary is
terminated for any reason whatsoever, and within three months after
the date thereof such Holder either (i) accepts employment with any
competitor of, or otherwise engages in competition with, the
Company or (ii) discloses to anyone outside the Company or uses any
confidential information or material of the Company in violation of
the Company’s policies or any agreement between the Holder
and the Company, the Committee, in its sole discretion, may require
such Holder to return to the Company the economic value of any
Award that was realized or obtained by such Holder at any time
during the period beginning on that date that is six months prior
to the date such Holder’s employment with the Company is
terminated.
(b)
Termination for
Cause. The Committee may, if a
Holder’s employment with the Company or a Subsidiary is
terminated for cause, annul any Award granted under this Plan to
such employee and, in such event, the Committee, in its sole
discretion, may require such Holder to return to the Company the
economic value of any Award that was realized or obtained by such
Holder at any time during the period beginning on that date that is
six months prior to the date such Holder’s employment with
the Company is terminated.
(c)
No Right of
Employment. Nothing contained
in the Plan or in any Award hereunder shall be deemed to confer
upon any Holder who is an employee of the Company or any Subsidiary
any right to continued employment with the Company or any
Subsidiary, nor shall it interfere in any way with the right of the
Company or any Subsidiary to terminate the employment of any Holder
who is an employee at any time.
12.4.
Investment
Representations; Company Policy. The Committee may require each person acquiring
shares of Common Stock pursuant to a Stock Option or other Award
under the Plan to represent to and agree with the Company in
writing that the Holder is acquiring the shares for investment
without a view to distribution thereof. Each person acquiring
shares of Common Stock pursuant to a Stock Option or other Award
under the Plan shall be required to abide by all policies of the
Company in effect at the time of such acquisition and thereafter
with respect to the ownership and trading of the Company’s
securities.
12.5
Additional Incentive
Arrangements. Nothing contained
in the Plan shall prevent the Board from adopting such other or
additional incentive arrangements as it may deem desirable,
including, but not limited to, the granting of Stock Options and
the Awarding of Common Stock and cash otherwise than under the
Plan; and such arrangements may be either generally applicable or
applicable only in specific cases.
12.6
Withholding
Taxes. Not later than the date
as of which an amount must first be included in the gross income of
the Holder for Federal income tax purposes with respect to any
option or other Award under the Plan, the Holder shall pay to the
Company, or make arrangements satisfactory to the Committee
regarding the payment of, any Federal, state and local taxes of any
kind required by law to be withheld or paid with respect to such
amount. If permitted by the Committee, tax withholding or payment
obligations may be settled with Common Stock, including Common
Stock that is part of the Award that gives rise to the withholding
requirement. The obligations of the Company under the Plan shall be
conditioned upon such payment or arrangements and the Company or
the Holder’s employer (if not the Company) shall, to the
extent permitted by law, have the right to deduct any such taxes
from any payment of any kind otherwise due to the Holder from the
Company or any Subsidiary.
12.7
Governing
Law. The Plan and all Awards
made and actions taken thereunder shall be governed by and
construed in accordance with the laws of the State of North
Carolina.
12.8
Other Benefit
Plans. Any Award granted under
the Plan shall not be deemed compensation for purposes of computing
benefits under any retirement plan of the Company or any Subsidiary
and shall not affect any benefits under any other benefit plan now
or subsequently in effect under which the availability or amount of
benefits is related to the level of compensation (unless required
by specific reference in any such other plan to Awards under this
Plan).
12.9
Non-Transferability.
Except as otherwise expressly provided in the Plan or the
Agreement, no right or benefit under the Plan may be alienated,
sold, assigned, hypothecated, pledged, exchanged, transferred,
encumbered or charged, and any attempt to alienate, sell, assign,
hypothecate, pledge, exchange, transfer, encumber or charge the
same shall be void.
12.10
Applicable
Laws. The obligations of the
Company with respect to all Stock Options and Awards under the Plan
shall be subject to (i) all applicable laws, rules and regulations
and such approvals by any governmental agencies as may be required,
including, without limitation, the Securities Act of 1933, as
amended (the “Securities
Act”), and (ii) the rules
and regulations of any securities exchange on which the Common
Stock may be listed or quoted.
12.11
Conflicts.
If any of the terms or provisions of
the Plan or an Agreement conflict with the requirements of Section
422 of the Code, then such terms or provisions shall be deemed
inoperative to the extent they so conflict with such requirements.
Additionally, if this Plan or any Agreement does not contain any
provision required to be included herein under Section 422 of the
Code, such provision shall be deemed to be incorporated herein and
therein with the same force and effect as if such provision had
been set out at length herein and therein. If any of the terms or
provisions of any Agreement conflict with any terms or provisions
of the Plan, then such terms or provisions shall be deemed
inoperative to the extent they so conflict with the requirements of
the Plan. Additionally, if any Agreement does not contain any
provision required to be included therein under the Plan, such
provision shall be deemed to be incorporated therein with the same
force and effect as if such provision had been set out at length
therein.
12.12
Non-Registered
Stock. The shares of Common
Stock to be distributed under this Plan have not been, as of the
Effective Date, registered under the Securities Act or any
applicable state or foreign securities laws and the Company has no
obligation to any Holder to register the Common Stock or to assist
the Holder in obtaining an exemption from the various registration
requirements, or to list the Common Stock on a national securities
exchange or any other trading or quotation
system.
Plan
Amendments
Date Approved by Board
|
Date Approved by Shareholders, if necessary
|
Sections Amended
|
Description of Amendment(s)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FORM OF OPTION AWARD AGREEMENT
LEVEL BEAUTY GROUP, INC.
4521 Sharon Road
Charlotte, NC 28211
[DATE]
_________________
_________________
_________________
Dear __________:
We are pleased to advise you that, on [_______],
the Board of Directors of Level Beauty Group, Inc., a North
Carolina corporation (the “Company”)
authorized the Award to you of an option to purchase [_______]
shares of our common stock, par value $0.001 per share (the
“Option”),
upon the following terms and conditions:
1.
The Option is granted in accordance with and
subject to the terms and conditions of the Company’s 2015
Equity Compensation Plan (the “Plan”).
2.
The
Option is [an incentive] [non-qualified] stock option.
3.
The
Option is exercisable commencing on [__________] and terminating at
5:00 pm New York time on [__________].
4.
The
price at which the Option may be exercised is $[_____] per
share.
5.
The
Option is non-transferable and may be exercised, in whole or in
part, during the exercise period, only by you, except that upon
your death, the Option may be exercised strictly in accordance with
the terms and conditions of the Plan.
6.
The exercise price and number of shares issuable
upon exercise of the Option (the “Option
Shares”) are subject to
adjustment in accordance with the Plan in the event of stock
splits, dividends, reorganizations and similar corporate
events.
7.
If, neither the Option nor the Option Shares have
been registered under the Securities Act of 1933, as amended (the
“Act”),
and the Option Shares may not be sold, assigned, pledged,
transferred or otherwise disposed of absent registration under the
Act or the availability of an applicable exemption from
registration. All certificates evidencing the Option Shares will
contain a legend describing this restriction on resale of the
Option Shares. There is [currently no public market for the
Company’s securities and there is] no assurance that there
will be a public market into which you may sell the Option Shares
or that you will be able to sell your Option Shares at a profit or
at all.
8.
In
order to exercise the Option, you must provide us with written
notice that you are exercising all or a portion of your Option. The
written notice must specify the number of Option Shares that you
are exercising your Option for, and must be accompanied by the
exercise price described in paragraph 4, above. Your Option Shares
will be issued to you within approximately one week following our
receipt of your exercise notice and cleared funds evidencing the
exercise price.
9.
No
rights or privileges of a shareholder of the Company are conferred
by reason of the grant of the Option to you. You will have no
rights of a shareholder until you have delivered your exercise
notice to us and we have received the exercise price of the Option
in cleared funds.
You
understand that the Plan contains important information about your
Option and your rights with respect to the Option. The Plan
includes terms relating to your right to exercise the Option;
important restrictions on your ability to transfer the Option or
Option Shares; provisions relating to adjustments in the number of
Option Shares and the exercise price; and early termination of the
Option following the occurrence of certain events; including the
termination of your relationship with us. By signing below, you
acknowledge your receipt of a copy of the Plan. By acceptance of
your Option, you agree to abide by the terms and conditions of the
Plan.
10.
Our
business is subject to many risks and uncertainties. We may never
operate profitably. The exercise of your Option is a speculative
investment and there is no assurance that you will realize a profit
on the sale of Option Shares received upon exercise of your
Option.
11.
The
Option will become effective upon your acknowledgment of the terms
and conditions of this Agreement and your delivery to us of a
signed counterpart of this Agreement.
12.
This
Agreement and Plan contain all of the terms and conditions of your
Option and supersedes all prior agreements or understandings
relating to your Option. This Agreement shall be governed by the
laws of the State of Florida without regard to the conflicts of law
provisions thereof.
13.
This
Agreement may not be amended orally.
Very
truly yours,
__________________________
Kenneth
Kahn,
Chief
Executive Officer
AGREED TO AND ACCEPTED THIS
_____ DAY OF ________ 20__
________________________________
(Signature)
_________________________________
(Print Name)
Exhibit 3.9
FORM OF OPTION AWARD AGREEMENT
LEVEL BRANDS, INC.
4521 Sharon Road
Suite 407
Charlotte, NC 28211
[DATE]
_________________
_________________
_________________
Dear __________:
We are pleased to advise you that, on [_______],
the Board of Directors of Level Brands, Inc., a North Carolina
corporation (the “Company”)
authorized the Award to you of an option to purchase [_______]
shares of our common stock, par value $0.001 per share (the
“Option”),
upon the following terms and conditions:
1.
The Option is granted in accordance with and
subject to the terms and conditions of the Company’s 2015
Equity Compensation Plan (the “Plan”).
2.
The
Option is [an incentive] [non-qualified] stock option.
3.
The
Option is exercisable commencing on [__________] and terminating at
5:00 pm New York time on [__________].
4.
The
price at which the Option may be exercised is $[_____] per
share.
5.
The
Option is non-transferable and may be exercised, in whole or in
part, during the exercise period, only by you, except that upon
your death, the Option may be exercised strictly in accordance with
the terms and conditions of the Plan.
6.
The exercise price and number of shares issuable
upon exercise of the Option (the “Option
Shares”) are subject to
adjustment in accordance with the Plan in the event of stock
splits, dividends, reorganizations and similar corporate
events.
7.
If, neither the Option nor the Option Shares have
been registered under the Securities Act of 1933, as amended (the
“Act”),
and the Option Shares may not be sold, assigned, pledged,
transferred or otherwise disposed of absent registration under the
Act or the availability of an applicable exemption from
registration. All certificates evidencing the Option Shares will
contain a legend describing this restriction on resale of the
Option Shares. There is [currently no public market for the
Company’s securities and there is] no assurance that there
will be a public market into which you may sell the Option Shares
or that you will be able to sell your Option Shares at a profit or
at all.
8.
In
order to exercise the Option, you must provide us with written
notice that you are exercising all or a portion of your Option. The
written notice must specify the number of Option Shares that you
are exercising your Option for, and must be accompanied by the
exercise price described in paragraph 4, above. Your Option Shares
will be issued to you within approximately one week following our
receipt of your exercise notice and cleared funds evidencing the
exercise price.
9.
No
rights or privileges of a shareholder of the Company are conferred
by reason of the grant of the Option to you. You will have no
rights of a shareholder until you have delivered your exercise
notice to us and we have received the exercise price of the Option
in cleared funds.
You
understand that the Plan contains important information about your
Option and your rights with respect to the Option. The Plan
includes terms relating to your right to exercise the Option;
important restrictions on your ability to transfer the Option or
Option Shares; provisions relating to adjustments in the number of
Option Shares and the exercise price; and early termination of the
Option following the occurrence of certain events; including the
termination of your relationship with us. By signing below, you
acknowledge your receipt of a copy of the Plan. By acceptance of
your Option, you agree to abide by the terms and conditions of the
Plan.
10.
Our
business is subject to many risks and uncertainties. We may never
operate profitably. The exercise of your Option is a speculative
investment and there is no assurance that you will realize a profit
on the sale of Option Shares received upon exercise of your
Option.
11.
The
Option will become effective upon your acknowledgment of the terms
and conditions of this Agreement and your delivery to us of a
signed counterpart of this Agreement.
12.
This
Agreement and Plan contain all of the terms and conditions of your
Option and supersedes all prior agreements or understandings
relating to your Option. This Agreement shall be governed by the
laws of the State of Florida without regard to the conflicts of law
provisions thereof.
13.
This
Agreement may not be amended orally.
Very
truly yours,
__________________________
Martin
A. Sumichrast,
Chief
Executive Officer
AGREED TO AND ACCEPTED THIS
_____ DAY OF ________ 20__
________________________________
(Signature)
_________________________________
(Print Name)
2
Exhibit
6.1
THE
LIMITED LIABILITY COMPANY OWNERSHIP (AND THE PERCENTAGE INTEREST SO
REPRESENTED) ISSUED IN ACCORDANCE WITH AND REPRESENTED BY THE
OPERATING AGREEMENT HAVE NOT BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), UNDER THE NORTH
CAROLINA SECURITIES ACT OR UNDER SIMILAR LAWS OR ACTS OF OTHER
STATES IN RELIANCE UPON EXEMPTIONS UNDER THOSE ACTS. THESE
INTERESTS ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE
AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER (A)
THIS AGREEMENT AND (B) THE SECURITIES ACT AND APPLICABLE STATE
SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.
INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE
FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF
TIME.
OPERATING
AGREEMENT
OF
Beauty
and pin ups, LLC
A NORTH
CAROLINA LIMITED LIABILITY COMPANY
OPERATING
AGREEMENT
OF
Beauty
and Pin Ups, LLC
a North
Carolina limited liability company
This
OPERATING AGREEMENT (the “Agreement”) dated as of
April 13, 2015, is made among Beauty and Pin Ups, LLC, a North
Carolina limited liability company (the “Company”), and the
undersigned, each of whom, by executing this Agreement, has agreed
to become a Member of the Company.
INTRODUCTION
The
Company was formed on March 17, 2015.
Now,
therefore, in consideration of the foregoing, and the agreements
contained herein, the parties agree as follows.
ARTICLE
I
DEFINITIONS
1.1 Definitions.
The following terms, as used herein, have the following meanings,
provided that certain additional tax related definitions are set
forth on Schedule B
hereto:
“Acquisition
Consideration” has the meaning set forth in Section
5.9.
“Act” means the North
Carolina Limited Liability Company Act, of The North Carolina
General Statutes, as it may be amended from time to
time.
“Affiliates” of a
specified Person means any other Persons who directly or indirectly
control, are controlled by, or are under common control with such
specified Person. For this purpose, “control” of a
Person means possession, directly or indirectly (through one or
more intermediaries), of the power to direct or cause the direction
of management and policies of such Person through ownership of
voting securities (or other ownership interests), contract, voting
trust or otherwise.
“Annual Tax Liability”
means, for any Fiscal Year, an amount equal to:
(i) the product of (A)
the Applicable Tax Rate and (B) the estimated taxable income (if
any) of the Company (determined as if the Company were itself a
corporate taxpayer for such Fiscal Year taking into account any net
operating loss carryforwards); minus
(ii) the
sum of any applicable federal income tax credits (determined as if
the Company were itself a corporate taxpayer, but only to the
extent that all the Members are eligible to claim any such credit
or would be so eligible if they had sufficient tax liability
against which to utilize such credit) for such Fiscal
Year.
“Applicable Tax Rate”
means the sum of (i) the highest marginal federal income tax rate
applicable to individuals for the relevant Fiscal Year under
Section 1 of the Code (expressed as a percentage) and (ii) the
product of (A) the highest marginal North Carolina income tax rate
applicable to individuals for such Fiscal Year (also expressed as a
percentage) and (B) 100% minus the rate determined under clause
(i).
“Approved Sale” has the
meaning set forth in Section 5.8.
“Assignee” means a Person
to whom all or part of a Member’s Membership Interest has
been Transferred, but who has not been admitted as a Substitute
Member.
“Authorized Person” has
the meaning set forth in Section 5.4.
“Available Cash” means all
cash funds of the Company from operations, refinancings or other
sources at any particular time legally available for Distribution
after the Manager has made reasonable provision for (i) payment of
all operating expenses of the Company as of such time, (ii) payment
of all outstanding and unpaid current obligations of the Company as
of such time, (iii) any capital expenditures made by the Company
and (iv) appropriate reserves.
“Bona Fide Offer” means an
offer made in good faith and in writing which includes a
description of the Transferred Interest, including, without
limitation, the amount of interest to be Transferred, the name and
address of the proposed transferee, the proposed consideration for
the interest and the other terms of the proposed sale or
disposition.
“Buy-Sell Notice” has the
meaning set forth in Section 5.4.
“Capital Account” has the
meaning set forth in Schedule B.
“Capital Contribution”
means, with respect to a Member, the amount of money and the
initial Gross Asset Value of the property (other than money)
contributed to the capital of the Company by a Member or its
predecessor in interest.
“Closing” has the meaning
set forth in Section 5.4.
“Code” means the Internal
Revenue Code of 1986, as amended from time to time, or any
successor thereto.
"Disclosing Party" has the
meaning set forth in Section 11.2.
“Distribution” or
“Distributions” means with
respect to a Member, the amount of money and the Gross Asset Value
of property other than money distributed to a Member by the Company
as provided in Article VI or Article IX or in redemption of all or
any portion of such Member’s interest in the Company.
“Distribute” means to make
one or more Distributions.
“Fiscal Year” means the
annual accounting period of the Company, which shall be the taxable
year of the Company determined in the manner provided by section
706 of the Code and the regulations thereunder, or relevant portion
thereof. The initial Fiscal Year shall be the calendar year ending
December 31.
"Information Receiving Party"
has the meaning set forth in Section 11.2.
“Joinder Agreement” means
the Joinder Agreement in substantially the form attached hereto as
Schedule C,
pursuant to which such Person will thereupon become a party to, and
be bound by and obligated to comply with the terms and provisions
of this Agreement as a Member.
“Majority in Interest”
means Members holding at least a majority in Percentage Interest in
the Company.
“Manager” or
“Managers” has the meaning
set forth in Section 4.1.
“Member List” has the
meaning set forth in Section 3.2.
“Members” has the meaning
set forth in Section 3.1.
“Membership Interest”
means all of a Member’s rights in the Company, including,
without limitation, the Member’s share of the profits and
losses of the Company, the right to receive distributions of the
Company’s assets, any right to vote, and any right to
participate in the management of the Company as provided in the Act
and this Agreement.
“Net Income” has the
meaning set forth in Section 1.9 of Schedule B hereto.
“Net Losses” has the
meaning set forth in Section 1.9 of Schedule B hereto.
“Organization” means any
corporation, partnership, joint venture or enterprise, limited
liability company, unincorporated association, trust, estate,
governmental entity or other entity or organization, and shall
include the successor (by merger or otherwise) of any such entity
or organization.
“Percentage Interest” of a
Member means, at any particular time, with respect to each Member,
the percentage interest for each Member set forth opposite the name
of the Member on Schedule
A until adjusted by the agreement of the Members or as
otherwise provided herein.
“Permitted Transfer” has
the meaning set forth in Section 5.2.
“Permitted Transferee” has
the meaning set forth in Section 5.2.
“Person” means an
individual or an entity.
“Principal Office” means
the principal executive office of the Company. It may be located in
North Carolina or another state.
“Proceeding” has the
meaning set forth in Article VIII.
“Pro Rata” means in
proportion to the applicable Members’ respective Percentage
Interests.
“Proxy” has the meaning
set forth in Section 5.8.
“Regulations” means the
final and temporary regulations of the U.S. Department of the
Treasury promulgated under the Code.
“Repurchase Interest” has
the meaning set forth in Section 5.3.
“Repurchase Notice” has
the meaning set forth in Section 5.3.
“Repurchase Purchase
Price” has the meaning set forth in Section
5.3.
“Subject Transaction”
means, in a single transaction or series of related transactions,
any (a) merger or consolidation involving the Company with or into
another Organization or any share or membership interest exchange
(or equivalent thereof) between the Members and another Person(s)
(including any combination with, or other conversion to, a
corporation), or (b) Transfer of greater than fifty percent (50%)
of the equity of the Company or the assets of the
Company.
“Substitute Member” means
any Person who is admitted as a Substitute Member pursuant to
Article V.
“Transfer” means, as a
noun, any voluntary or involuntary conveyance or other alienation,
lease, mortgage, pledge, encumber, or hypothecate; and, as a verb,
the act of making any of the foregoing.
“Unauthorized Transfer”
has the meaning set forth in Section 5.1.
“Withdrawing Member” has
the meaning set forth in Section 5.4.
ARTICLE
II
BASIC
STRUCTURE
2.1 Formation; Ratification. The Company was
formed as a North Carolina limited liability company pursuant to
the provisions of the Act. The Members shall execute and cause to
be recorded such additional documents as may be required for a
limited liability company pursuant to the laws of the State of
North Carolina. The Members and Manager hereby ratify and approve
all actions taken by the Company, the other Members, the Manager
and the organizer(s) prior to the date hereof, including, but not
limited to, the actions set forth above in the
Introduction.
2.2 Purpose.
The Company has been formed for the purpose of engaging in any
lawful business.
2.3 Tax
Classification. The Members intend that the Company be
classified as a partnership for federal income tax purposes, and
this Agreement shall be interpreted accordingly.
2.4 Limited
Liability. No Member, Manager or other agent of the Company
shall have any personal obligation for any liabilities of the
Company solely by reason of being a Member, Manager or agent,
except as provided by law.
2.5 Date
of Dissolution. The Company shall have perpetual
existence.
ARTICLE
III
MEMBERS
3.1 General.
The term “Members” means only the
undersigned and any Persons subsequently admitted as Members
according to Section 3.4. A Member ceases to be a Member upon the
Transfer of such Person’s entire interest in the
Company.
3.2 Member
List. The Company shall maintain at its Principal Office a
current list (the “Member List”) showing the
names, address, Capital Contributions, and Percentage Interests of
the Members, a copy of the initial list is attached as Schedule A, which schedule will
be updated in accordance herewith. The Member List as updated shall
also include such information for Assignees.
3.3 Meetings.
(a) Regular meetings of
the Members may be held on an annual basis, or more often
(including a special meeting) as determined by the Manager. Special
Meetings of the Members may be called by a Majority in Interest or
the Manager. The Manager shall provide reasonable notice of such
meeting to the Members, but in no event less than ten (10) days,
unless such notice requirement is waived in writing by each Member.
Notice of any meeting of the Members shall be deemed to have been
waived by attendance at the meeting unless the Member attends the
meeting solely for the purpose of objecting to notice and so
objects at the beginning of the meeting. Meetings of the Members
may be held at the Principal Office of the Company, or at such
other place as shall be designated from time to time by the
Manager. Members may participate in a meeting of the Members by
means of conference telephone or other similar communication
equipment whereby all Members participating in the meeting can hear
each other.
(b) Unless otherwise
specifically provided herein, action of the Members shall require
the affirmative vote of a Majority in Interest.
3.4 Admission
of Members. Except as set forth in Article V, Persons, other
than the undersigned Members, acquiring interests in the Company by
Transfer or otherwise will not become Members until their admission
as Members is approved by the Manager and a Majority in Interest,
they execute a Joinder Agreement, they pay any appropriate expenses
relating to their admission as a Member and comply with any other
provisions contained herein.
3.5 Withdrawal
of Members. Except to the extent that all the Members agree
or except in connection with a Transfer of a Member’s entire
interest in the Company in a manner permitted by this Agreement,
the Members are prohibited from resigning or withdrawing from the
Company.
ARTICLE
IV
MANAGEMENT
4.1 Management.
The Company shall be managed by one or more Managers. The term
“Manager”
shall include multiple Managers, if applicable. Managers may be
given such titles as are approved by Members. If multiple Managers,
any action taken by the Managers must be agreed to by all of the
Managers; provided, however, that any one Manager shall have the
power to carry out the direction of the Members (as contemplated
under this Agreement).
4.2 Duties
of Manager. Except as is otherwise set forth in this
Agreement, the Manager shall have the right, duty and power to
manage the business of the Company and to make all decisions and
take all actions concerning such business.
4.3 Restrictions
on Manager. The Manager may not take any of the following
actions without first obtaining the consent of a Majority in
Interest of the Company:
(a) sell, or otherwise
dispose of, or contract to sell or otherwise dispose of, all or
substantially all the assets of the Company, or assets of the
Company valued in an amount in excess of $100,000;
(b) enter into any
agreement outside of the ordinary course of business;
(c) enter into any
agreement where dollar amount involved exceeds
$100,000;
(d) issue any
additional ownership interest of the Company;
(e) borrow more than
$100,000, in the aggregate, for the conduct of the business of the
Company or pledge, or grant a security interest in all, or
substantially all, of the assets of the Company; or
(f) make
any assignment for the benefit of creditors of the Company, or
otherwise cause the Company to seek protection under any bankruptcy
or insolvency law.
4.4 Designation
of Manager. Level Beauty Group, Inc. is designated as the
initial Manager. The Members must approve the appointment of
successor or additional Managers.
4.5 Removal
of or Additional Manager; Tenure. The Members may remove a
Manager or add a new a Manager at any time upon the approval of all
the Members. The term of a
Manager shall expire upon such individual’s death,
resignation, permanent incapacity or removal.
4.6 Compensation.
The Managers shall be entitled to receive compensation, in the form
of a management fee, for services to the Company as may be set by a
Majority in Interest. Such compensation shall be considered
expenses in determining profits and losses.
4.7 Officers,
Appointment, Term, Removal and Compensation. The Manager may
appoint from time to time one or more officers of the Company with
such titles, powers, duties, compensation and other terms as the
Manager may determine to be necessary or appropriate, but in no
event shall an officer’s authority exceed that of a Manager.
Any such officers shall serve, subject to the provisions of this
Agreement, until their respective successors are duly appointed and
qualified. Any officer may be removed by the Manager at any time
with or without cause; but such removal shall not itself affect the
contractual rights, if any, of the officer so removed. The
compensation, if any, of all officers (other than with respect to
an officer who is also the Manager) shall be fixed by the Manager.
Initially, Priel Maman shall also serve as the Company’s
Founder, Kenneth Kahn shall also serve as the Company’s Chief
Executive Officer, and Brian Anderson shall serve as the
Company’s Chief Operating Officer.
4.8 Actions
Without Meeting, Members and Managers. Any action required
or permitted to be taken at a meeting of the Members or Managers
may be taken without a meeting if one or more proposed written
consents, setting forth the action so taken or to be taken, (a) is
sent to all the Members and Manager, (b) is signed by those Members
or Managers having the voting interest required to approve, consent
to or adopt such action, and (c) such signed written consent is
included in the Company’s permanent records. Action taken
under this Section 4.8 shall be effective when the Members or
Managers needed to approve such action or matter have signed the
proposed written consent or counterpart thereof, unless the written
consent specifies that it is effective as of an earlier or later
date. The written consent on any matter pursuant to this Section
4.8 has the same force and effect as if such matter was voted upon
at a duly called meeting of the Members or Managers and may be
described as such in any document or instrument.
ARTICLE
V
TRANSFERS
5.1 Restrictions
on Transfer and Addition of New Members. Except as set forth
in Sections 5.2, 5.3, 5.4 and 5.8, (a) no Member shall Transfer or
otherwise dispose of all or any portion of such Member’s
Membership Interest in the Company without the prior approval of
the Manager and a Majority in Interest in the Company; and (b) the
Manager may specify the rights and obligations the transferee shall
have, including whether the transferee is to be admitted as a
Substitute Member or an Assignee with such rights as provided in
Section 5.6; if, however, the Manager does not specify otherwise,
the transferee shall be admitted as an Assignee. Any purported
Transfer (an “Unauthorized Transfer”)
of any Member’s Membership Interest without the prior
approval of the Manager shall be null and void and of no force or
effect whatsoever, except, if the Company is
required by a court of competent jurisdiction to recognize an
Unauthorized Transfer, in which case the Person to whom such
Membership Interest is Transferred shall have only the rights of an
Assignee with respect to the Transferred Interest. Any
Distributions with respect to such Transferred Interest may be
applied (without limiting any other legal or equitable rights of
the Company) towards the satisfaction of any debts, obligations, or
liabilities for damages that the transferor or transferee of such
Membership Interest may have to the Company.
5.2 Permitted
Transfers. Upon written notice to Manager, a Member may
Transfer all or a portion of its Membership Interest (a) in the
case of a Member that is an individual, during such
individual’s life and upon death, only to a spouse, lineal
ancestor or lineal descendant, or to a trust, limited partnership
or limited liability company solely for the personal benefit of the
Member or any such persons; (b) in the case of a Member that is a
corporation, partnership, limited liability company or other
business entity, to or among its Affiliates; (c) to the Company; or
(d) to another Member (such Transfer, a “Permitted Transfer” and
each such transferee, a “Permitted Transferee”).
The Manager may specify the rights and obligations the Permitted
Transferee shall have, including whether the Permitted Transferee
is to be admitted as a Substitute Member or an Assignee with such
rights as provided in Section 5.6; if, however, (x) the Manager
does not specify otherwise, the Permitted Transferee shall be
admitted as an Assignee, and
(z) the Transfer is accomplished pursuant to clauses (d) of Section
5.2, such transferees shall be admitted as full substitute
Members.
5.3 Call
Right.
(a) Repurchase. At any time until
the first anniversary of the date hereof (or, if sooner, promptly
following the second round of capital raise for the Company), the
Manager may elect to repurchase the all Membership Interest held by
Sigan Industries Group by providing notice to such Group (the
“Repurchase
Notice”). The Repurchase Notice will set forth the
aggregate consideration to be paid for such Investor Member’s
Membership Interest (“Repurchase Interest”) and
the time and place for the closing of the transaction, in each
case, as provided for in this Section 5.3. At the election of the
Manager, the Company may assign its rights to purchase the
Repurchase Interests to the Manager or any other
designee(s).
(b) Purchase Price and
Closing.
(i) The purchase price
for the Repurchase Interest in connection with the repurchase right
provided in this Section 5.3 shall be One Hundred and Ten Thousand
Dollars ($110,000) (“Repurchase Purchase
Price”).
(ii) The
acquirer of the Repurchase Interest will pay the purchase price by
delivery of cash or immediately available funds and the seller will
be required to make representations and warranties regarding the
valid and authorized sale of the Repurchase Interest and that Sigan
Industries Group has good and marketable title to the Repurchase
Interest, free and clear of all liens, claims and other
encumbrances. The closing of the acquisition of any Repurchase
Interest shall occur no later than thirty (30) days following the
date of the Repurchase Notice. The closing of such call of such
Repurchased Interest shall be deemed to occur on such designated
closing date with no further action necessary by any party other
than the tender of the Repurchase Purchase Price to Sigan
Industries Group. The Company has authority to change the
membership ownership records upon such tender of the Repurchase
Purchase Price to Sigan Industries Group.
5.4 Buy-Sell.
(a) Buy-Sell Events. The following
events shall constitute a “Buy-Sell Event” for purposes
of this Agreement with respect to any Member (the
“Withdrawing
Member”):
(i) in the case of an
individual that is a Member, upon the death of such Member, but
only in the event that such Member has not provided for the
Transfer of his or her Membership Interest to a Permitted
Transferee; and
(ii) who
is subject to a bankruptcy, declares insolvency or is otherwise
dissolved.
(b) Buy-Sell Notice. The
Withdrawing Member, the trustee, administrator, or other legal
representative of the Withdrawing Member (such legal representative
or Withdrawing Member, as the case may be, the “Authorized Person”),
shall give notice of the Buy-Sell Event (the “Buy-Sell Notice”) to the
Company. If the Authorized Person fails to give the Buy-Sell
Notice, any remaining Member or Manager may give the notice at any
time thereafter and by so doing commence the buy-sell procedure
provided for in this Section 5.4.
(c) Purchase Option. Upon delivery
of the Buy-Sell Notice (or, in the event the Authorized Person
fails to give the Buy-Sell Notice, at the time the requirement to
give the Buy-Sell Notice arises), the Company may purchase all of
the Withdrawing Member’s Membership Interest on the terms and
conditions described herein (such purchase, the “Purchase
Option”).
(d) Purchase Price. The purchase
price for the Withdrawing Member’s Percentage Interest shall
be mutually agreed upon by the Authorized Person and the Members
bound by the Purchase Option. In the event the parties are unable
to agree on the value within a reasonable period of time following
the delivery of the Buy-Sell Notice, then the purchase price shall
be equal to the fair market value of the Withdrawing Member’s
Percentage Interest in the Company on the date of such Buy-Sell
Event as reasonably determined by the Company's
Manager.
(e) Closing. The closing (the
“Closing”) of the purchase
of the Membership Interest shall take place on the date agreed upon
by the purchaser(s) and seller(s), but not later than nine months
from the date of the Buy-Sell Event. The Members, other than the
Withdrawing Member, who purchase Membership Interest pursuant to a
Buy-Sell Event shall pay the Authorized Person at Closing a down
payment of twenty percent (20%) of the purchase price (determined
in accordance with Section 5.4(d)). The remainder of the purchase
price (determined in accordance with Section 5.4(d)) shall bear
interest from the date of Closing at the prime rate of interest as
published by Bank of America, NA from time to time, and (prior to
increase for interest due) be payable in equal monthly installments
over the succeeding 12 month period.
(f) Purchaser’s Obligations.
In connection with the sale of the Membership Interest under this
Section 5.4, unless otherwise agreed by the purchaser(s) and
seller, the purchaser(s) will assume the Withdrawing Member’s
allocable portion of such Withdrawing Member’s obligations to
the Company to the extent related to the Transferred Interest,
other than income tax liabilities of or debt owed to other Persons
by the seller.
(g) Effect on Withdrawing Member’s
Interest. From the date of the occurrence of the Buy-Sell
Event to the earlier of (i) 90 days after the delivery of the
Buy-Sell Notice, or (ii) the date of the Transfer of the
Withdrawing Member’s Membership Interest at Closing under
Section 5.4(e), the Percentage Interest represented by the
Withdrawing Member’s Membership Interest will be excluded
from any calculation of aggregate Percentage Interests for purposes
of any approval required of Members under this
Agreement.
5.5 Rights
and Obligations of a Substitute Member. Upon fulfilling the
requirements of Section 3.4, a Substitute Member shall have all the
rights and powers, and shall be subject to all the restrictions and
liabilities, of the Member from whom the Transferred Interest were
acquired relative to such Transferred Interest. The admission of a
Substitute Member, without more, shall not release the transferor
Member from any liability with respect to the Transferred Interest
(or otherwise) that may have existed prior to the substitution of
membership. Notwithstanding the foregoing, no party hereto shall
avoid the provisions of this Agreement by making one or more
Transfers to Permitted Transferees and then disposing of all or any
portion of such party’s interest in any such Permitted
Transferee.
5.6 Rights
of Assignees. An Assignee shall be entitled only to
allocations pursuant to Article VI and Schedule B, and Distributions
in accordance with this Agreement with respect to the Membership
Interest (and the Percentage Interest that such Membership Interest
represents) Transferred to such Assignee. An Assignee shall (a)
have no right to vote or otherwise participate in Company matters,
(b) take no part in the management of the Company’s business
and affairs or transact any business on behalf of the Company, (c)
have no right to any notices provided hereunder, (d) have no power
to sign on behalf of, or to bind, the Company, (e) have no right to
any information or accounting of the affairs of the Company, (f)
not be entitled to inspect the books or records of the Company and
(g) not have any other rights of a Member under the Act or this
Agreement other than those described in the first sentence of this
Section 5.6. The term
"Member" when used with respect to allocations pursuant to Article
VI and Schedule B
and Distributions in accordance with this Agreement shall include
Assignees.
5.7 Additional
Restrictions on Transfer. In addition to any other
restrictions on Transfer of a Member’s Membership Interest,
as contained in this Agreement or otherwise, no Membership Interest
may be Transferred unless prior to such Transfer the following
occurs, or such requirement is waived by the Manager:
(a) the Company
determines within a reasonable period of time after notice of such
proposed Transfer that such Transfer would not (i) cause a
termination of the Company for federal tax purposes within the
meaning of Section 708 of the Code; (ii) cause the Company to cease
to be classified as a partnership for federal or state income tax
purposes; (iii) cause the Company to become a “publicly
traded partnership,” as such term is defined in Sections
469(k)(2) or 7704(b) of the Code; (iv) subject the Company to
regulation under the Investment Company Act of 1940 or would
subject the Company of any of its Affiliates to the Investment
Advisers Act of 1940 or the Employee Retirement Income Security Act
of 1974, each as amended; (v) violate any applicable laws; or (vi)
be made to any Person who lacks the legal right, power, or capacity
to own such Membership Interest;
(b) the Company is
furnished with an opinion of counsel, which is satisfactory to the
Company both as to the counsel so used and as to the content of the
opinion, (at the transferee’s expense) that the registration
of the Transfer of such Membership Interest under the applicable
federal and state securities laws and regulations is not
required;
(c) the transferor and
the transferee shall have executed a written agreement, in form and
substance reasonably satisfactory to the Manager, to indemnify and
hold the Company, the Manager and the Members harmless from and
against all liabilities, losses, costs and expenses arising out of
the Transfer, including, without limitation, any liability arising
by reason of the violation of any securities laws of the United
States, any State of the United States, or any foreign
country;
(d) the transferee
makes representations and warranties to the Company that it is
purchasing such Membership Interest for its own account, for
investment purposes only, and without a view towards resale, and
any other such representations and warranties as the Company shall
reasonably see fit to require concerning such purchaser’s
investment in the Company; and
(e) the transferee
shall have paid the reasonable expenses incurred by the Company and
the other Members in connection with the Transfer of Membership
Interest and, if applicable, the admission of the transferee as a
Member.
5.8 Approved
Sales.
(a) If the Manager
approves any bona fide Subject Transaction with respect to the
Company (an “Approved Sale”), each
Member shall vote for, consent to and raise no objections against
such Approved Sale and shall waive any dissenters’ rights,
appraisal rights or similar rights in connection therewith. If the
Approved Sale is structured as a sale of equity, each Member shall
agree to sell all his, her or its Membership Interest and rights to
acquire Membership Interest on the terms and conditions approved by
the Manager. Each Member shall take all necessary and desirable
actions in his, her or its capacity as a Member in connection with
the consummation of the Approved Sale as requested by the Manager
(including attendance at meetings in person or by proxy for
purposes of obtaining a quorum and execution of written consents in
lieu of meetings if necessary).
(b) The obligations of
the Members with respect to an Approved Sale are subject to the
condition that all the Members shall receive the same form and
amount of consideration on a Pro Rata basis, or if any Members are
given an option as to the form and amount of consideration to be
received, all Members shall be given the same option.
(c) Each Member shall
bear his, her or its Pro Rata share of the costs of any Approved
Sale to the extent such costs are incurred for the benefit of all
Members and are not otherwise paid by the Company or the acquiring
party and shall be obligated to join on a Pro Rata basis in any
indemnification or other obligations that the Manager agrees to
provide in connection with such Approved Sale (other than any such
obligations that relate specifically to a Member such as
indemnification with respect to representations and warranties
given by a Member regarding such Member’s title to and
ownership of Membership Interest).
(d) In order to secure
each Member’s obligation to vote his, her or its Membership
Interest and other voting securities of the Company in accordance
with the provisions of this Section 5.8, each Member hereby
appoints the Chief Executive Officer of the Company (the
“Proxy”) as his, her or
its true and lawful proxy and attorney-in-fact, with full power of
substitution, to vote all his, her or its Membership Interest for
the approval and consummation of an Approved Sale and all such
other matters as expressly provided for in this Section 5.8. The
Proxy may exercise the irrevocable proxy granted to him hereunder
at any time any Member fails to comply with the provisions of this
Section 5.8. The proxies and powers granted by each Member pursuant
to this Section 5.8(d) are coupled with an interest and are given
to secure the performance of each Member’s obligations and
duties under this Section 5.8. Such proxies and powers shall be
irrevocable for so long as such Member holds any Membership
Interest and shall survive the death, incompetency, disability,
bankruptcy or dissolution of such Member and the subsequent holders
of his, her or its Membership Interest.
5.9 Sale of Membership Interest. In the
event of any acquisition of the Company by means of a purchase of
all its outstanding Membership Interest, merger, or other form of
reorganization in which Membership Interest of the Company are
exchanged for cash, securities, and/or other consideration issued,
or caused to be issued, by the acquiring entity, then the Members
hereby agree that all consideration payable to the Members in
connection with such transaction (the “Acquisition
Consideration”) shall be distributed amongst the
Members such that each Member receives the amount that he, she or
it would have received if (a) all the Company’s assets
had been sold (and all its liabilities had been assumed) for an
amount equal to the sum of the Acquisition Consideration
plus the amount of
the Company’s total liabilities, (b) the hypothetical
profit or loss resulting therefrom had been allocated to the
Members in accordance herewith, and (c) the Company had
distributed the Acquisition Consideration to the Members in
accordance with Article IX.
ARTICLE
VI
CAPITAL
ACCOUNTS AND CONTRIBUTIONS; PROFITS AND LOSSES;
DISTRIBUTIONS
6.1 Capital
Accounts. The Company shall maintain a separate and single
Capital Account for each Member. Each Capital Account shall be
maintained and adjusted in accordance with the Code (including but
not limited to Code Section 704) and the Regulations (including but
not limited to Regulation Section 1.704-1(b)(2)(iv)), and in
compliance with the provisions of Schedule B hereof. No Member
shall have any obligation to restore any deficit balance in such
Member’s Capital Account. The Members shall have no right to
receive interest with respect to their Capital Accounts, to
withdraw or borrow money from their Capital Accounts, or to pledge,
or otherwise encumber, any part of their Capital Accounts, except
as may be expressly provided in this Agreement.
6.2 Capital
Contributions. The Members have previously made their agreed
to Capital Contributions. Notwithstanding any other provision of
this Agreement, no Member shall have the right to demand and
receive cash or other property of the Company in return of its
Capital Contributions prior to the termination of its ownership
interest in the Company.
6.3 Additional
Capital Contributions. No Member may or shall be required to
contribute any additional capital to the Company, unless agreed to
by all the Members, and no Member shall have any personal liability
for any obligation of the Company. Neither the Company nor the
Members shall be liable for the return of the Capital Contributions
of any Member, and upon dissolution, the Members shall look solely
to the assets of the Company.
6.4 Net
Income and Net Losses. After giving effect to the special
allocations required under Sections 2.2 and 2.3 of Schedule B hereto, and subject
to Section 2.5 of Schedule
B hereto, Net Income and Net Losses for each Fiscal Year
shall be allocated to the Members on a Pro Rata basis.
6.5 Tax
Distributions. Annually, or more often as determined by the
Manager, the Company shall Distribute to the Members, out of
Available Cash to the extent permitted by law an amount equal to
the estimated Annual Tax Liability for the Fiscal Year to date,
less any Distributions already made with respect to such Fiscal
Year under this Section 6.5. Such Distribution shall be made to the
Members in proportion to the amounts estimated by the Manager to be
the Members’ allocable shares (determined pursuant to Section
6.4 above, adjusted to reflect the special allocations required
under Schedule B to
this Agreement) of the Net Income of the Company for such Fiscal
Year.
6.6 Non-Tax
Distributions. The Manager may from time to time determine
the amount of Available Cash that shall be distributed among the
Members, any such Distribution to be made in proportion to the
Members’ respective holdings of Percentage Interests.
Notwithstanding any other provision of this Agreement, no Member
shall have the right to demand and receive cash or other property
of the Company in return of its Capital Contributions prior to the
termination of its ownership interest in the Company.
ARTICLE
VII
TAX
MATTERS
The
Company shall file its tax returns, make tax elections (if any),
and make any other decisions on tax matters in compliance with the
Code, as well as applicable state tax laws. The Manager shall serve
as the “Tax Matters Partner” required by the Code. The
Person so designated shall take such action as is required by the
Code. With its initial federal tax return the Company shall elect
pursuant to Section 6231(a)(1)(B)(ii) of the Code to have
subchapter C of Chapter 63 of Subtitle F of the Code
apply.
ARTICLE
VIII
INDEMNIFICATION
(a) Except as provided
by the Act, the Company shall indemnify each officer, director,
employee, Member or Manager who was, is or is threatened to be made
a party to any action, suit or proceeding (including a proceeding
by or in the name of the Company or by or on behalf of its
Members), whether civil, criminal, administrative, arbitrative or
investigative, and whether formal or informal (a
“Proceeding”),
solely by reason of his or her position with the Company or as a
result of having served any other business entity (including an
employee benefit plan) in any capacity at the request of the
Company against any liability and reasonable expenses (including
reasonable attorney’s fees), incurred as a result of such
Proceeding, except such liabilities and expenses which are incurred
as a result of a breach of this Agreement or willful misconduct.
The extent of such obligation to indemnify shall be limited to the
aggregate amount, if any, of any deductible, retention or
co-insurance amounts relating to the liability insurance maintained
by the Company, and there shall be no obligation to indemnify as a
result of conduct which is covered by liability insurance,
regardless of how the premiums were paid.
(b) Except as provided
by the Act, the Company shall promptly make advances or
reimbursements for reasonable expenses (including attorney’s
fees) incurred by each officer, director, employee, Member or
Manager claiming indemnification under this Article unless it has
been determined that such Person is not entitled to
indemnification. Advances or reimbursements made in advance of any
such determination shall be conditioned upon receipt from the
Person claiming indemnification of a written undertaking to repay
the amount of such advances or reimbursements if it is ultimately
determined that such Person is not entitled to
indemnification.
(c) The determination
that indemnification is permissible under the foregoing provisions
of this Article shall be made by a Majority in
Interest.
(d) Nothing contained
in this Article shall be deemed to preclude such other
indemnification of the officer, director, employee, Member or
Manager of the Company, as the Members not seeking indemnification
deem proper.
ARTICLE
IX
DISSOLUTION,
WINDING UP AND TERMINATION
9.1 Events
of Dissolution. The Company shall be dissolved upon the
first to occur of:
(a) the consent of all
the Members;
(b) at any time there
are no Members; however, the Company shall not be dissolved and is
not required to be wound up if, within a period of six months after
the occurrence of the event that caused the dissolution of the last
remaining Member, the personal representative of the last remaining
Member agrees in writing to continue the Company until the
admission of the personal representative of such Member, or its
nominee or designee to the Company as a Member, effective as of the
occurrence of the event that caused the dissociation of the last
remaining Member;
(c) the entry of a
decree of judicial dissolution;
(d) as otherwise
required by law; or
(e) pursuant to event
requiring dissolution of the Company under the terms
hereof.
9.2 Winding
Up and Termination. The business of the Company shall be
wound up following its dissolution. Upon completion of the winding
up, the Company shall terminate.
9.3 Distributions
Following Dissolution. Following the dissolution of the
Company and the winding up of its affairs, the assets shall be
distributed in the following order of priority:
(a) to the creditors of
the Company, including Members who are creditors, in the order of
priority provided by law;
(b) to set up any
reserves deemed appropriate by the Manager; and
(c) to the Members and
Assignees in proportion to their positive Capital Account
balances.
9.4 In-Kind
Distributions. Whenever distributions following dissolution
are to be made in kind, rather than in cash, the fair market value
of property distributed shall first be approved by a Majority in
Interest, and no Member (or Assignee) shall be required to accept
more than such Person’s proportionate share of distributions
made in kind, rather than in cash, without such Person’s
consent.
ARTICLE
X
ADMINISTRATIVE
PROVISIONS
10.1 Offices.
The initial Principal Office, registered office, and registered
agent shall be as set forth in the Articles of Organization. The
Members may change the Principal Office, the registered office, or
the registered agent.
10.2 Books
and Records. The Manager shall keep full and accurate books
of account and records at the Principal Office, as required by the
Act. Upon reasonable notice, each Member, or the Member’s
designated representative, shall have access to such books and
records during regular business hours and may inspect and make
copies of them at the Member’s expense.
ARTICLE
XI
MISCELLANEOUS
11.1 General
Amendments. This Agreement may be amended by the Members in
any manner only upon the approval of a Majority in Interest;
provided, that (a) subject to compliance with the terms of this
Agreement, the Manager shall be entitled to include additional
Members as parties to this Agreement, or adjust the Percentage
Interest owned by the existing Members, in accordance with the
provisions of this Agreement without the consent of the other
parties hereto, and to treat such Persons as Members hereunder, by
updating Schedule A
attached hereto and keeping such Schedule A, as updated,
available at the Company’s offices and subject to the
inspection rights of the applicable parties, and (b) except as
specifically permitted herein, this Agreement shall not be amended
without the consent of each Member adversely affected by such
amendment if such amendment would (i) modify the limited liability
of a Member or (ii) alter the Membership Interest of a Member with
respect to profits, losses, allocations, Percentage Interest or
Distributions.
11.2 Confidentiality. Each Member or Assignee
(such Member or Assignee, the “Information Receiving
Party”) shall use, and shall cause its officers,
directors, managers, agents, employees, subsidiaries, partners,
members, shareholders, attorneys, accountants and controlling
persons to use, all reasonable best efforts to maintain the secrecy
and confidentiality of all information furnished by each other
Member, Assignee or the Company (such other Member, Assignee or the
Company, as the case may be, the “Disclosing Party”),
including technologies, intellectual property, financial terms and
financial and organizational information contained in any
documents, statements, certificates, materials or information
furnished, or to be furnished, by the Disclosing Party in
connection with their affiliation with the Company; provided, however, that the foregoing
shall not be construed, now or in the future, to apply to any
information that is shown to be independently developed by the
Information Receiving Party, obtained from sources other than the
Information Receiving Party or in the public domain, nor shall it
be construed to prevent the Information Receiving Party from (a)
making any disclosure of any information (i) if such disclosure is
necessary to comply with any requirement of law, (ii) to any
governmental authority having or claiming authority to regulate or
oversee any aspect of the Information Receiving Party’s
business in connection with the exercise of such authority or
claimed authority, or (iii) pursuant to subpoena; or (b) making, on
a confidential basis, such disclosures as the Information Receiving
Party deems necessary or appropriate to such Information Receiving
Party’s legal counsel or accountants (including outside
auditors). The efforts the Information Receiving Party uses to
maintain the secrecy and confidentiality of the information
described in this 11.2 shall be at least equivalent to that degree
of care that the Information Receiving Party usually exercises with
respect to its own confidential information.
11.3 Dealings
with the Company. The Manager may engage the services of, or
cause the Company to transact business with (a) any Member or
Manager, (b) any Person who is related to or affiliated with a
Member or such Manager, (c) any Person having a financial interest
in a Member, or (d) any Person in which a Member or Manager has a
financial interest. The provisions of any contracts with any of
such Persons shall not be less favorable to the Company than would
generally be obtainable from unaffiliated Persons. The Manager is
in the business of providing various beauty and related products
through various distribution channels and it shall not be deemed a
breach of the Manager’s duties to the Company or otherwise to
invest in, manage or conduct business with various beauty and
competitive companies.
11.4 Notices.
Any notice, payment, demand or communication (collectively a
“notice”) required or
permitted to be given by this Agreement or applicable law shall be
in writing and shall be delivered (a) personally; (b) by registered
or certified first class mail, proper postage prepaid, return
receipt requested; (c) by nationally recognized overnight courier
service; or (d) by facsimile or electronic mail where such notice
is electronically confirmed as received and is followed by delivery
of a copy of such notice in a manner described above in (a), (b) or
(c) within three business days. Such notices shall be addressed as
follows (or to such other address as such Person may from time to
time specify by notice to the Company in accordance herewith): if
to the Company, to the Company at the then current address of its
principal place of business, to the attention of the President; and
if to a Member, to their last known address. Unless otherwise
indicated herein, any such notice shall be deemed to be delivered,
given and received for all purposes (x) as of the date it is
personally delivered; (y) three days after it is sent, if sent by
nationally recognized overnight courier service; or (z) one day
after the date of receipt, as evidenced by the return receipt or
electronic confirmation, as applicable, described
above.
11.5 Interpretation.
Unless the context otherwise requires, terms used and not defined
in this Agreement shall have the same definitions set forth in the
Act.
11.6 No
Third Party Beneficiaries. No provision in this Agreement
shall affect the Members’ and transferors’ insulation
from personal liability for Company debts that is provided for in
the Act, nor shall any such provision inure to the benefit of, or
be enforceable by, any third party, including, without limitation,
any creditor of the Company or of any of its Members.
11.7 Counterparts.
This Agreement may be executed in several counterparts, all of
which together shall constitute one agreement binding on all
parties hereto, notwithstanding that all the parties have not
signed the same counterpart.
11.8 Entire
Agreement. This Agreement contains the entire agreement
between the parties (and supersedes all prior writings or
agreements) with respect to the specific subject matter hereof;
provided, however, it is understood that the parties may enter into
separate agreements relating to the purchase and sale of their
interests in the Company.
11.9 Partition.
The Members agree that the property of the Company is not and will
not be suitable for partition. Accordingly, each of the Members
hereby irrevocably waives any and all right it may have to maintain
any action for partition of any of the property.
11.10 Governing
Law. This Agreement shall be governed by the laws of the
State of North Carolina, without giving effect to its choice of law
rules.
[Signature Page To
Follow]
IN
WITNESS WHEREOF, the Company and Members have executed this
Agreement.
Company:
|
|
Beauty and Pin Ups, LLC
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Kenneth Kahn
|
|
|
|
Name:Kenneth
Kahn
|
|
|
|
Title:CEO
|
|
|
|
|
|
|
|
|
|
Members:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level
Beauty Group, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Kenneth Kahn
|
|
|
|
Print
Name: Kenneth Kahn
|
|
|
|
Title:
CEO
|
|
|
|
/s/
Priel Maman
Priel
Maman
Sigan
Industries Group
/s/
Dean Gangbar
Dean
Gangbar
|
|
SCHEDULE A
MEMBER
LIST
OF
Beauty
and Pin Ups, LLC
Member
|
|
Level Beauty Group,
Inc.
|
78%
|
|
|
Priel
Maman
|
12%
|
Sigan Industries
Group
|
10%
|
|
|
Total
|
100.00%
|
SCHEDULE B
PARTNERSHIP
TAXATION PROVISIONS
ARTICLE
I
DEFINITIONS
Capitalized words
and phrases used in this Schedule B not otherwise
defined in this Agreement shall have the meanings set forth in this
Article I:
12.1 “Adjusted
Capital Account Deficit” means the deficit balance, if
any, in a Member’s Capital Account as of the end of a Fiscal
Year (or other applicable period), after giving effect to the
following adjustments:
(a) Credit to such
Capital Account any amounts (i) described in section
1.704-1(b)(2)(ii)(c) of the Regulations which such Member is
unconditionally obligated to contribute to the Company pursuant to
this Agreement or applicable law or (ii) which such Member is
deemed obligated to restore pursuant to the penultimate sentences
of Regulations sections 1.704-2(g)(1) and 1.704-2(i)(5);
and
(b) Debit to such
Capital Account the items described in sections
1.704-l(b)(2)(ii)(d)(4), 1.704-1(b)(2)(ii)(d)(5) and
1.704-1(b)(2)(ii)(d)(6) of the Regulations.
The
foregoing definition of Adjusted Capital Account Deficit in
conjunction with Sections 2.2(f) and 2.2(g) of this Schedule B is intended to
comply with the allocation rules of the alternate test for economic
effect contained in section 1.704-1(b)(2)(ii)(d) of the Regulations
and shall be interpreted consistently therewith.
12.2 “Book
Depreciation” means, with respect to a particular
asset of the Company, for each Fiscal Year (or other applicable
period), an amount equal to the depreciation, amortization or other
cost recovery deduction allowable with respect to such asset for
such Fiscal Year (or other applicable period), except that if the
Gross Asset Value of such asset differs from its adjusted basis for
federal income tax purposes, Book Depreciation for such asset shall
be an amount which bears the same ratio to such beginning Gross
Asset Value as the federal income tax depreciation, amortization or
other cost recovery deduction with respect thereto for such Fiscal
Year (or other applicable period) bears to such beginning adjusted
tax basis; provided, however, that if the adjusted
basis for federal income tax purposes of an asset is zero, Book
Depreciation for such asset shall be determined with reference to
its Gross Asset Value using any reasonable method selected by the
Members.
12.3 “Capital
Account” has the meaning set forth in Section 2.1 of
this Schedule
B.
12.4 “Company
Minimum Gain” has the meaning set forth in sections
1.704-2(b)(2) and 1.704-2(d) of the Regulations.
12.5 “Gross
Asset Value” means, with respect to any asset, the
asset’s adjusted basis for federal income tax purposes,
except as follows:
(a) Fair Market Value of Contributed
Property. The initial Gross Asset Value of any asset
contributed by a Member to the Company shall be the gross fair
market value of such asset as of the date of such contribution, as
determined by the Members or as otherwise provided in this
Agreement;
(b) Book Ups and Book Downs. The
Gross Asset Values of the Company’s assets shall be adjusted
to equal their respective gross fair market values (taking into
account Code section 7701(g)), as reasonably determined by the
Members as of the following times: (i) the acquisition of an
additional equity interest in the Company by any new or existing
Member in exchange for more than a de minimis Capital Contribution;
(ii) the Distribution by the Company to a Member of more than a
de minimis amount of property
(including cash) as consideration for all or part of such
Member’s interest in the Company; and (iii) the liquidation
of the Company within the meaning of Regulations section
1.704-1(b)(2)(ii)(g); provided, however, that adjustments
pursuant to Clauses (i) and (ii) above shall be made only if the
Members reasonably determines that such adjustments are necessary
or appropriate to reflect the Members’ respective economic
interests in the Company;
(c) Distributions of Property. The
Gross Asset Value of any of the Company’s assets (other than
cash) Distributed to any Member shall be adjusted to equal the
gross fair market value (taking into account Code section 7701(g))
of such asset on the date of Distribution as determined by the
Members or as otherwise provided in this Agreement;
and
(d) Adjustments Related to Section 754
Election. The Gross Asset Values of the Company’s
assets shall be increased (or decreased) to reflect any adjustments
to the federal adjusted tax basis of each asset pursuant to Code
section 734(b) or Code section 743(b), but only to the extent that
such adjustments are taken into account in determining Capital
Accounts pursuant to Regulations section 1.704-1(b)(2)(iv)(m) and
Sections 1.9(f) and 2.2(e) of this Schedule B; provided, however, that Gross Asset
Values shall not be adjusted pursuant to this Section 1.5(d) to the
extent the Members determines that an adjustment pursuant to
Section 1.5(b) of this Schedule B is necessary or
appropriate in connection with a transaction that would otherwise
result in an adjustment pursuant to this Section
1.5(d).
If the
Gross Asset Value of an asset has been determined or adjusted
pursuant to Section 1.5(a), Section 1.5(b) or Section 1.5(d)
of this Schedule B,
such Gross Asset Value shall thereafter be adjusted by the Book
Depreciation taken into account with respect to such asset for
purposes of computing Net Income and Net Losses.
12.6 “Member
Nonrecourse Debt” has the meaning set forth in section
1.704-2(b)(4) of the Regulations.
12.7 “Member
Nonrecourse Debt Minimum Gain” means an amount, with
respect to each Member Nonrecourse Debt, equal to the Company
Minimum Gain that would result if such Member Nonrecourse Debt were
treated as a Nonrecourse Liability, determined in accordance with
section 1.704-2(i)(3) of the Regulations.
12.8 “Member
Nonrecourse Deductions” has the meaning set forth in
sections 1.704-2(i)(1) and 1.704-2(i)(2) of the
Regulations.
12.9 “Net
Income” and “Net Losses” means,
for each Fiscal Year or other applicable period, an amount equal to
the Company’s taxable income or loss for such Fiscal Year or
other applicable period, as the case may be, determined in
accordance with Code section 703(a) (for this purpose, all items of
income, gain, loss, or deduction required to be stated separately
pursuant to Code section 703(a)(1) shall be included in taxable
income or loss), with the following adjustments:
(a) Tax Exempt Income. Any income
of the Company that is exempt from federal income tax and not
otherwise taken into account in computing Net Income or Net Losses
pursuant to this Section 1.9 shall be added to such taxable income
or loss;
(b) Section 705(a)(2)(B)
Expenditures. Any expenditures of the Company described in
Code section 705(a)(2)(B), or treated as Code section 705(a)(2)(B)
expenditures pursuant to Regulations section 1.704-1(b)(2)(iv)(i),
and not otherwise taken into account in computing Net Income or Net
Losses pursuant to this Section 1.9 shall be subtracted from such
taxable income or loss;
(c) Book Ups and Book Downs. In the
event the Gross Asset Value of any of the Company’s assets is
adjusted pursuant to Section 1.5(b) or Section 1.5(c) of this
Schedule B, the
amount of such adjustment shall be taken into account as gain or
loss from the disposition of such asset for purposes of computing
Net Income or Net Losses;
(d) Use of Book Value for Determining Gain
or Loss. Gain or loss resulting from any disposition of the
Company’s assets with respect to which gain or loss is
recognized for federal income tax purposes shall be computed by
reference to the Gross Asset Value of the asset disposed of,
notwithstanding that the adjusted tax basis of such asset differs
from its Gross Asset Value;
(e) Use of Book Depreciation. In
lieu of the depreciation, amortization and other cost recovery
deductions taken into account in computing such taxable income or
loss, there shall be taken into account Book Depreciation for such
Fiscal Year or other period in accordance with Regulations section
1.704-1(b)(2)(iv)(g);
(f) Adjustments Related to Section 754
Election. To the extent an adjustment to the adjusted tax
basis of any of the Company’s assets pursuant to Code section
734(b) or Code section 743(b) is required pursuant to Regulations
section 1.704-1(b)(2)(iv)(m)(4) to be taken into account in
determining Capital Accounts as a result of a Distribution other
than in liquidation of a Member’s Membership Interest in the
Company, the amount of such adjustment shall be treated as an item
of gain (if the adjustment increases the basis of the asset) or
loss (if the adjustment decreases the basis of the asset) from the
disposition of the asset and shall be taken into account for
purposes of computing Net Income or Net Losses; and
(g) Specially Allocated Items of Income,
Gain, Loss and Deduction. Notwithstanding any other
provision of this Section 1.9, any items of income, gain, loss or
deduction which are specially allocated pursuant to this
Schedule B (other
than Section 2.5) shall not be taken into account in computing Net
Income or Net Losses.
The
amounts of the items of Company income, gain, loss or deduction
available to be specially allocated pursuant to this Schedule B (other than Sections
2.4 and 2.5) shall be determined by applying rules comparable to
those set forth in Subparagraphs (a) through (f) of this Section
1.9.
12.10 “Nonrecourse
Deductions” has the meaning set forth in section
1.704-2(b)(1) of the Regulations.
12.11 “Nonrecourse
Liability” has the meaning set forth in section
1.704-2(b)(3) of the Regulations.
12.12 “Regulatory
Allocations” has the meaning set forth in Section 2.3
of this Schedule B.
ARTICLE
II
REGULATORY, TAX AND
SPECIAL ALLOCATIONS
13.1 Capital
Accounts. The Capital Account of each Member shall be
maintained in accordance with the following
provisions:
(a) Credits. To each Member’s
Capital Account there shall be credited such Member’s (i)
Capital Contributions, including the Gross Asset Value of any
property contributed to the Company by the Member, (ii)
distributive share of Net Income and any items in the nature of
income or gain which are specially allocated pursuant to Sections
2.2 and 2.3 of this Schedule B, and (iii) the
amount of any Company liabilities assumed by such Member or which
are secured by any assets of the Company Distributed to such
Member;
(b) Debits. To each Member’s
Capital Account there shall be debited the amount of cash and the
Gross Asset Value of any assets of the Company Distributed to such
Member, such Member’s distributive share of Net Losses and
any items in the nature of expenses, deductions or losses which are
specially allocated pursuant to Sections 2.2 and 2.3 of this
Schedule B, and the
amount of any liabilities of such Member assumed by the Company or
which are secured by any property contributed by such Member to the
Company;
(c) Transfer of Capital Accounts.
In the event all or any portion of a Member’s Membership
Interest in the Company is conveyed in accordance with the terms of
this Agreement, the transferee shall succeed to the Capital Account
of the transferor to the extent it relates to the conveyed
interest; and
(d) Section 752(c). In determining
the amount of any liability for purposes of this Section 2.1, there
shall be taken into account Code section 752(c) and any other
applicable provisions of the Code and Regulations.
The
foregoing provisions and the other provisions of this Agreement
relating to the maintenance of Capital Accounts are intended to
comply with the relevant provisions of subchapter K of Chapter 1 of
Subtitle A of the Code and the Regulations promulgated thereunder
and shall be interpreted and applied in a manner consistently
therewith; and appropriate modifications to this Agreement shall be
made by the Members, if necessary, and to the extent necessary, for
it to comply with the capital account maintenance requirements of
Regulations section 1.704-1(b)(2)(iv).
13.2 Special
Allocations. The following special allocations shall be made
in the following order:
(a) Nonrecourse Deductions.
Nonrecourse Deductions for any Fiscal Year (or other applicable
period) shall be specially allocated among the Members Pro Rata for
such Fiscal Year. The allocations of Nonrecourse Deductions shall
be offset or revised by Minimum Gain Chargebacks pursuant to
Section 2.2(c) of this Schedule B and not by
allocations of Net Income pursuant to Article VI of this Agreement.
The objective of the preceding sentence is to avoid the result
illustrated in Example 1 of Regulations section 1.704-2(f)(7) and
shall be interpreted and applied consistent with such
intent.
(b) Member Nonrecourse Deductions.
Any Member Nonrecourse Deductions for any Fiscal Year (or other
applicable period) shall be specially allocated to the Member who
bears the economic risk of loss with respect to the Member
Nonrecourse Debt to which such Member Nonrecourse Deductions are
attributable in accordance with Regulations section 1.704-2(i)(1).
The allocations of Member Nonrecourse Deductions shall be offset or
revised by Member Minimum Gain Chargebacks pursuant to Section
2.2(d) of this Schedule
B and not by allocations of Net Income pursuant to Article
VI. The objective of the preceding sentence is to avoid the result
illustrated in Example 1 of Regulations section 1.704-2(f)(7) and
shall be interpreted and applied consistent with such
intent.
(c) Minimum Gain Chargeback. Except
as otherwise provided in section 1.704-2(f) of the Regulations,
notwithstanding any other provision of this Article II, if there is
a net decrease in Company Minimum Gain during any Fiscal Year (or
other applicable period), each Member shall be specially allocated
items of Company income and gain for such Fiscal Year (or other
applicable period) (and, if necessary, subsequent Fiscal Years or
other applicable periods) in an amount equal to such Member’s
share of the net decrease in Company Minimum Gain, determined in
accordance with Regulations section 1.704-2(g). Allocations
pursuant to the previous sentence shall be made in proportion to
the respective amounts required to be allocated to each Member
pursuant thereto. The items to be so allocated shall be determined
in accordance with sections 1.704-2(f)(6) and 1.704-2(j)(2) of the
Regulations. This Section 2.2(c) is intended to comply with the
minimum gain chargeback requirement in section 1.704-2(f) of the
Regulations and shall be interpreted consistently
therewith.
(d) Member Minimum Gain Chargeback.
Except as otherwise provided in section 1.704-2(i)(4) of the
Regulations, notwithstanding any other provision of this Article
II), if there is a net decrease in Member Nonrecourse Debt Minimum
Gain attributable to a Member Nonrecourse Debt during any Fiscal
Year (or other applicable period), each Member who has a share of
the Member Nonrecourse Debt Minimum Gain attributable to such
Member Nonrecourse Debt, determined in accordance with section
1.704-2(i)(5) of the Regulations, shall be specially allocated
items of Company income and gain for such Fiscal Year (or other
applicable period) (and, if necessary, subsequent Fiscal Years or
other applicable periods) in an amount equal to such Member’s
share of the net decrease in Member Nonrecourse Debt Minimum Gain
attributable to such Member Nonrecourse Debt, determined in
accordance with Regulations section 1.704-2(i)(4). Allocations
pursuant to the previous sentence shall be made in proportion to
the respective amounts required to be allocated to each Member
pursuant thereto. The items to be so allocated shall be determined
in accordance with sections 1.704-2(i)(4) and 1.704-2(j)(2) of the
Regulations. This Section 2.2(d) is intended to comply with the
partner minimum gain chargeback requirement in section
1.704-2(i)(4) of the Regulations and shall be interpreted
consistently therewith.
(e) Code Section 754 Adjustment. To
the extent an adjustment to the adjusted tax basis of any of the
Company’s assets pursuant to Code section 734(b) or Code
section 743(b) is required, pursuant to Regulations section
1.704-1(b)(2)(iv)(m)(2) or Regulations section
1.704-1(b)(2)(iv)(m)(4), to be taken into account in determining
Capital Accounts as the result of a Distribution to a Member in
complete liquidation of its Membership Interest, the amount of such
adjustment to the Capital Accounts shall be treated as an item of
gain (if the adjustment increases the basis of the asset) or loss
(if the adjustment decreases such basis) and such gain or loss
shall be specially allocated to the Members in proportion to their
respective interests in the Company (as reasonably determined by
the Members) in the event Regulations section
1.704-1(b)(2)(iv)(m)(2) applies, or to the Member to whom such
Distribution was made in the event Regulations section
1.704-1(b)(2)(iv)(m)(4) applies.
(f) Gross Income Allocation. In the
event a Member has a deficit Capital Account balance at the end of
any Fiscal Year (or other applicable period) that is in excess of
(i) the amount, if any, such Member, in the manner and to the
extent provided in Regulations section 1.704-1(b)(2)(ii)(c), is
unconditionally obligated to contribute to the Company pursuant to
any provision of this Agreement or applicable law; and (ii) the
amount such Member is deemed to be obligated to restore pursuant to
the penultimate sentences of sections 1.704-2(g)(1) and
1.704-2(i)(5) of the Regulations, such Member shall be specially
allocated items of Company income and gain in the amount of such
excess as quickly as possible, provided that an allocation pursuant
to this Section 2.2(f) shall be made only if and to the extent that
such Member would have such an excess deficit Capital Account after
all other allocations provided for in this Article II tentatively
have been made as if this Section 2.2(f) and Section 2.2(g) were
not in this Agreement. This Section 2.2(f) is intended to minimize
the potential distortion to the economic arrangement of the Members
that might otherwise be caused by Section 2.2(g), while ensuring
that this Agreement complies with the requirements of the alternate
test for economic effect contained in section 1.704-1(b)(2)(ii)(d)
of the Regulations and shall be interpreted in a manner consistent
with such intent.
(g) Qualified Income Offset. In the
event any Member unexpectedly receives an adjustment, allocation,
or Distribution described in sections 1.704-1(b)(2)(ii)(d)(4),
1.704-1(b)(2)(ii)(d)(5), or 1.704-1(b)(2)(ii)(d)(6) of the
Regulations, items of Company income and gain shall be specially
allocated to such Member in an amount and manner sufficient to
eliminate, to the extent required by the Regulations, the Adjusted
Capital Account Deficit of the Member as quickly as possible,
provided that an allocation pursuant to this Section 2.2(g) shall
be made only if and to the extent that the Member would have an
Adjusted Capital Account Deficit after all other allocations
provided for in this Article II have been tentatively made as if
this Section 2.2(g) were not in this Agreement. This Section 2.2(g)
is intended to comply with the qualified income offset requirement
of the alternative test for economic effect in section
1.704-1(b)(2)(ii)(d) of the Regulations and shall be interpreted
consistently therewith.
(h) Reallocation of Loss. The Net
Losses allocated pursuant to Article VI of this Agreement
(excluding any such allocations made pursuant to this Schedule B other than Section
2.5) shall not exceed the maximum amount of Net Losses that can be
so allocated without causing a Member to have an Adjusted Capital
Account Deficit at the end of any Fiscal Year (or other applicable
period). In the event a Member would have an Adjusted Capital
Account Deficit as a consequence of an allocation of Net Losses
pursuant to Article VI of this Agreement (excluding any such
allocations made pursuant to this Schedule B other than Section
2.5), Net Losses shall be allocated to the other Members until such
allocations would cause all such other Members to each have an
Adjusted Capital Account Deficit; thereafter, allocations of Net
Losses shall be allocated among the Members in the same ratios that
Net Losses would be allocated among the Members for such Fiscal
Year.
13.3 Curative
Allocations. The allocations set forth in Section 2.2 (the
“Regulatory
Allocations”) are intended, but only to the extent
necessary, to comply with certain requirements of the Regulations.
It is intended that, to the extent possible, the application and
effect of all Regulatory Allocations shall be minimized and offset
either with other Regulatory Allocations or with special
allocations of other items of Company income, gain, loss, or
deduction pursuant to this Section 2.3. Therefore, notwithstanding
any other provision of Article VI of this Agreement (including this
Article II of this Schedule B (other than the
Regulatory Allocations)), the Members shall make such offsetting
special allocations of Company income, gain, loss, or deduction or
items thereof in whatever manner it determines appropriate so that,
after such offsetting allocations are made, each Member’s
Capital Account balance is, to the extent possible, equal to the
Capital Account balance such Member would have had if the
Regulatory Allocations were not part of this Agreement and all
Company items were allocated pursuant to Article VI of this
Agreement (excluding any such allocations made pursuant to this
Schedule B other
than Section 2.5). In exercising its discretion under this Section
2.3, the Members shall take into account future Regulatory
Allocations under Sections 2.2(c) and 2.2(d) of this Schedule B that, although not
yet made, are likely to offset other Regulatory Allocations
previously made under Sections 2.2(a) and 2.2(b) of this
Schedule
B.
13.4 Section
704(c) Allocations.
(a) Section 704(c) Allocations. In
accordance with Code section 704(c) and the Regulations thereunder,
any income, gain, loss or deduction with respect to any Capital
Contribution of property by a Member shall, solely for income
purposes, be allocated among the Members so as to account for any
variation at the time of contribution between the adjusted federal
income tax basis of such property to the Company and its initial
Gross Asset Value (computed in accordance with Section 1.5(a) of
this Schedule B)
(such allocations shall be referred to herein as “704(c)
allocations”).
(b) Reverse 704(c) Allocations. In
the event the Gross Asset Value of any of the Company’s
assets is adjusted on the books of the Company pursuant to Section
1.5(b) of this Schedule
B, subsequent allocations of income, gain, loss, and
deduction with respect to such property shall account for any
variation at the time of such adjustment between the adjusted
federal income tax basis of such asset and its Gross Asset Value in
the same manner as provided under Code section 704(c) and the
Regulations thereunder (such allocations shall be referred to
herein as “reverse 704(c) allocations”).
(c) Elections. All decisions and
elections relating to such 704(c) allocations or reverse 704(c)
allocations -- including the selection of the method, or of
different methods (to the extent permitted by the Regulations), of
allocation, whether the “traditional method” described
in Regulations section 1.704-3(b), the “traditional method
with curative allocations” described in Regulations section
1.704-3(c), the “remedial allocation method” described
in Regulations section 1.704-3(d), or any other reasonable method
contemplated by Regulations section 1.704-3(a)(1) and the preamble
to the Code section 704(c) Regulations in Treasury Decision 8500
(Dec. 22, 1993) (published in 58 Fed. Reg. 67676, 67676-78 and
reprinted in 1994-1 C.B. 183, 183-85) for making such allocations
which need not be specifically identified in the Regulations
– shall be made by the Members in any reasonable manner.
Allocations pursuant to this Section 2.4 are solely for purposes of
federal, state, and local taxes and shall not affect, or in any way
be taken into account, in computing, any Member’s Capital
Account or share of Net Income, Net Losses (or items thereof) or
Distributions pursuant to any provision of this Agreement. This
Section 2.4 is intended to comply with, and grant the Members the
maximum flexibility afforded under, Code section 704(c) and the
Regulations promulgated thereunder and shall be interpreted
consistent with such intent.
13.5 Varying
Interests. In the event of any changes in Member Percentage
Interest during a Fiscal Year (or other applicable period), then
for purposes of this Section 2.5, the Members shall take into
account the requirements of Code section 706(d) and other relevant
provisions of the Code and Regulations and shall have the right to
select any reasonable method of determining the varying interests
of the Members during the year which satisfies Code section 706(d)
or such other relevant provisions of the Code and
Regulations.
SCHEDULE C
JOINDER
AGREEMENT
The
undersigned is executing and delivering this Joinder Agreement
pursuant to the Operating Agreement dated as of [_________], ____ (as the same may
hereafter be amended, the “Operating Agreement”), by
and among [____________________], a North Carolina limited
liability company (the “Company”), and the
Members named therein.
By
executing and delivering this Joinder Agreement to the Company, the
undersigned hereby agrees to become a party to, to be bound by, and
to comply with the terms and provisions of the Operating Agreement,
in each case in the same manner as if the undersigned were an
original signatory to the Operating Agreement.
Accordingly, the
undersigned has executed and delivered this Joinder Agreement as of
the ___ day of _____, _____.
Name:
|
|
|
Address
forNotices:
|
with
copies to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature:
|
|
|
|
|
Date:
|
|
Beauty and Pinups, LLC
AMENDMENT NO. 1
TO
OPERATING AGREEMENT
THIS
AMENDMENT NO. 1 TO OPERATING AGREEMENT (the
“Amendment”) of Beauty and Pinups, LLC, a North
Carolina limited liability company (the “Company”), is
entered into this 18th day of March 2016,
by and among the Company and its undersigned members having such
Membership Interest as set forth in Exhibit A
(“Members”).
WHEREAS, the
Company and its Members entered into an Operating Agreement of the
Company dated as of April 13, 2015 (the “Operating
Agreement”); and
WHEREAS, Section
5.3 of the Operating Agreement provides that the Manager may elect
a Repurchase Right on April 13, 2016 or promptly following the
second round of capital raise for the company for all the
Membership Interest held by Sigan Industries Group;
and
WHEREAS, the
Company and the Members desire to amend Section 5.3 of the
Operating Agreement as set forth herein;
NOW,
THEREFORE, in consideration of the mutual promises, covenants and
conditions set forth in this Amendment, and other good and valuable
consideration, the receipt of which is hereby acknowledged, the
parties to this Amendment mutually agree as follows.
1.
Capitalized Terms. All
capitalized terms used herein that are not otherwise defined herein
shall have the meanings assigned to them in the Operating Agreement
unless the context hereof requires otherwise.
2. Amendment.
The first sentence of Section 5.3(a) of the Operating Agreement is
hereby amended and restated in its entirety as
follows:
At any
time until April 30, 2017, the Manager may elect to repurchase all
the Membership Interest held by Sigan Industries Group by providing
notice to Sigan Industries Group (the “Repurchase
Notice”).
The
remainder of Section 5.3 shall remain unchanged.
5.
No Other Amendment. Except as
specifically amended pursuant to this Amendment, the Rights
Agreement remains in full force and effect in accordance with its
terms.
6.
Governing Law. All questions
concerning the construction, validity and interpretation of this
Amendment will be governed by and construed in accordance with the
internal law (and not the law of conflicts) of North
Carolina.
7.
Counterparts. This Amendment
may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one
and the same instrument.
8.
Binding Effect. This Amendment
shall be binding upon and shall inure to the benefit of the parties
hereto and their heirs, successors and assigns.
IN WITNESS WHEREOF, the parties have
executed and delivered this Amendment on the 18th day of March,
2016.
Members:
Level
Beauty Group, Inc.
/s/ Kenny Kahn
Kenny
Kahn, President
Sigan
Industries Group
/s/ Dean Gangbar
Dean
Gangbar, President
/s/ Priel Maman
Priel
Maman
Manager:
Level
Beauty Group, Inc.
/s/ Kenny Kahn
Kenny
Kahn, President
Exhibit A
MEMBER
LIST
OF
BEAUTY
AND PIN UPS, LLC
Member
|
|
Level Beauty Group,
Inc.
|
78%
|
|
|
Priel
Maman
|
12%
|
Sigan Industries
Group
|
10%
|
|
|
Total
|
100.00%
|
Exhibit 6.2
CONSULTING AGREEMENT
This
Consulting Agreement (the “Agreement”) is made and
entered into as of the 13th day of April, 2015,
by and between Beauty and Pin Ups, LLC, a North Carolina
corporation (hereinafter the “Company”) and Priel
Maman, an independent contractor consultant (hereinafter
“Consultant”).
W
I T N E S S E T H:
WHEREAS, the
Company is in the business of providing technical hardware and
software services (the “Business”);
WHEREAS, the
Company desires to retain the services of Consultant for the
purposes of Creative influence, leadership and direction and is
willing to provide such services to the Company;
WHEREAS, the
parties desire to enter into this Agreement to set forth the terms
and conditions of the consulting relationship between the Company
and Consultant;
NOW,
THEREFORE, for and in consideration of the mutual promises,
covenants and conditions hereinafter set forth, and other good and
valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the Company and Consultant hereby agree as
follows:
Section
1. Consulting Services. Consultant shall
provide the following services:
Creative influence,
leadership and direction of the company’s products, services
and brand. As the Company’s Founder he will participate in
multiple distribution and salon oriented trade and educational
events, promotional exercises, videos and other marketing
vehicles.
Term.
Consultant’s term of engagement (the “Engagement
Term”) under this Agreement shall be for two years,
commencing on the day of closing and shall expire on two year from
the date of such closing, unless extended in writing by both the
Company and Consultant or earlier terminated pursuant to the terms
and conditions set forth in this Agreement. The Company may
terminate the Consultant for cause. Cause is defined as used
herein, the term “Cause”
shall mean only (i) the commission of a felony by the Executive
(other than motor vehicle offenses the effect of which do not
materially impair the Executive’s performance of his/her
duties hereunder), (ii) the commission by the Executive of an act
of fraud or embezzlement against the Company or any of its
affiliates, (iii) conduct which is negligent or willful and
deliberate on the Executive’s part and which is (or would
reasonably be expected to be) materially detrimental to the Company
or any of its affiliates, (iv) the Executive’s material
breach of this Agreement, the Restricted Stock Purchase Agreement,
the Nondisclosure and Confidentiality Agreement or the Assignment
of Intellectual Property Agreement, each between the Executive and
the Company, which breach the Executive has failed to cure (if
curable) within ten (10) business days after receiving written
notice thereof, (v) the Executive’s material violation of any
policies or procedures of the Company if the Company has given
Executive written notice of such violation and Executive persists
in such violation, (vi) insubordination consisting of the
Executive’s continued failure to take specific action
requested by the Board of Directors that is within his individual
control and consistent with his status as a senior executive of the
Company and his duties and responsibilities under any agreement
with the Company or any law, or (vii) the continued use of alcohol
or drugs by the Executive following written notice by the Company
that, in the good faith determination of the Board of Directors,
such use materially interferes with the performance of the
Executive’s duties and responsibilities.
Section
2. Exclusive Services
and Best Efforts. Consultant agrees to devote his/her best
efforts, energies and skills to the discharge of the duties and
responsibilities attributable to his/her position. Consultant also
agrees that he shall not take personal advantage of any business
opportunities that arise during his/her employment and that may
benefit the Company. All material facts regarding such
opportunities must be promptly reported to the Company’s
CEO-Kenneth Kahn for consideration by the Company, and only Kenneth
Kahn may waive this provision, and thereby permit Consultant to
take personal advantage of any such business
opportunities.
Section
3. Compensation.
The Company agrees to pay Consultant the sum of $12,000 per
month.
Section
4. Taxes and
Insurance. Consultant understands that he is solely
responsible for paying all federal, state and local income taxes
and FICA taxes on any earnings pursuant to this Agreement.
Consultant further understands that he is responsible for all
insurance, including health, life, and worker’s compensation.
Consultant will be issued a 1099 tax form and hereby agrees to
indemnify and hold harmless the Company from and for the payment of
any taxes, interest, penalties, levies or assessments applicable
thereto.
Section
5. Non-Competition and
Confidential Information. Consultant acknowledges that
his/her position with the Company is special, unique, and
intellectual in character and his/her position with the Company
will place him/her in a position of confidence and trust with
employees and clients of the Company.
Section
(a) Non-Competition.
Consultant agrees that during the term and for a period of one (1)
year thereafter within the restricted territory (as defined below)
Consultant will not directly or indirectly: (i) employ or attempt
to employ or assist anyone in employing any person who is an
employee of the Company or was an employee of the Company during
the previous one year period; or (ii) attempt in any manner to or
persuade any client of the Company to cease doing business or
reduce the amount of business that such client has customarily done
with the Company. The term “restricted territory”
includes the United States of America.
Section
(b) Confidentiality.
Consultant acknowledges that he will have access to certain
proprietary and confidential information of the Company and its
clients including, but not limited to, contemplated new mergers and
acquisitions, investment services, sales, projections, and
financial information. Consultant agrees not to use or disclose any
confidential information during the term of this Agreement or
thereafter other than in connection with performing
Consultant’s services for the Company in accordance with this
Agreement.
Section
(c) Enforcement.
(i)
Consultant agrees
that the restrictions set forth in this paragraph, and each
subparagraph therein, are reasonable and necessary to protect the
goodwill of the Company. If any of the covenants set forth herein
are deemed to be invalid or unenforceable based upon the duration
or otherwise, the parties contemplate that such provisions shall be
modified to make them enforceable to the fullest extent permitted
by law.
(ii)
In the event of a
breach or threatened breach by Consultant of the provisions set
forth in this paragraph, Consultant acknowledges that the Company
will be irreparably harmed and that monetary damages shall be an
insufficient remedy to the Company. Therefore, Consultant consents
to enforcement of this paragraph by means of temporary or permanent
injunction and other appropriate equitable relief in any competent
court, in addition to any other remedies the Company may have under
this Agreement or otherwise.
Section
6. Intellectual
Property.
(a)
The Company has
hired Consultant to perform consulting services full time so
anything Consultant produces during the agreement term is the
property of the Company. Any writing, invention, design, system,
process, development or discovery conceived, developed, created, or
made by Consultant, alone or with others, during the period of this
Agreement and applicable to the business of the Company, whether or
not patentable, registrable, or copyrightable shall become the sole
and exclusive property of the Company, excluding any writing,
invention, design, system, development or discovery (i) that
Consultant developed on his/her own time without using the
Company’s equipment, supplies, business or trade secrete
information and (ii) that do not relate to the Company’s
business or actual or demonstrably anticipated research or
development, or that do not result from any services performed by
Consultant for the Company.
(b)
Consultant shall
report all writings, inventions, designs, systems, developments, or
discoveries, together with related records, developed by
Consultant, solely or jointly, to the Company of the
Company.
(c)
Consultant shall,
during the period of this Agreement and at any time from time to
time hereafter, (i) execute all documents requested by the Company
for vesting in the Company the entire right, title and interest in
and to the same, (ii) execute all documents requested by the
Company for filing such applications for and procuring patents,
trademarks, service marks or copyrights as the Company, in its sole
discretion, may desire to prosecute, and (iii) give the Company all
assistance it may reasonably require, including the giving of
testimony in any suit, action, investigation or other proceeding,
in order to obtain, maintain and protect the Company’s right
therein and thereto.
Section
7. Representations and
Warranties of Consultant. Consultant hereby represents and
warrants to the Company as follows: (i) Consultant has the legal
capacity and unrestricted right to execute and deliver this
Agreement and to perform all of his/her obligations hereunder; (ii)
the execution and delivery of this Agreement by Consultant and the
performance of his/her obligations hereunder will not violate or be
in conflict with any fiduciary or other duty, instrument,
agreement, document, arrangement, or other understanding to which
Consultant is a party or by which he is or may be bound or subject;
and (iii) Consultant is not a party to any instrument, agreement,
document, arrangement, or other understanding with any person
(other than the Company) requiring or restricting the use or
disclosure of any confidential information.
Section
8. Post-Engagement
Obligations. All records, files, lists, including computer
generated lists, drawings, documents, equipment and similar items
relating to the Company’s business that Consultant prepared
or received from the Company shall remain the Company’s sole
and exclusive property. Upon termination of this Agreement,
Consultant promptly returns to the Company all property of the
Company in his/her possession. Consultant further represents that
he will not copy or cause to be copied, print out, or cause to be
printed out any software, documents or other materials originating
with or belonging to the Company. Consultant additionally
represents that, upon termination of his/her engagement with the
Company, he will not retain in his/her possession any such
software, documents, or other materials.
Section
9. Breach of
Agreement. Consultant recognizes that irreparable damage
would result to the Company and its business if Consultant was to
disclose to anyone any of the information provided to him/her by
and/or through his/her work with the Company. the Company shall be
entitled to pursue any available remedies, whether legal or
equitable, including injunctive relief, in the case of violation of
the provisions of this Agreement and, if the Company prevails in
any such legal action, Consultant will be obligated to pay the
Company’s reasonable attorney’s fees. Any breach of
this Agreement will be governed by the laws of the State of North
Carolina.
Section
10. Governing
Law. This Agreement shall be governed by, construed and
enforced in accordance with the laws of the State of North
Carolina, without regard to the conflicts of law rules of North
Carolina.
Section
11. Jurisdiction.
Each of the parties hereto hereby irrevocably consents and submits
to the jurisdiction of the Supreme Court of the State of North
Carolina, Superior and/or District Court in Mecklenburg County, and
of the United States District Court for the Western District of
North Carolina in connection with any suit, action, or other
proceeding concerning the interpretation and/or enforcement of this
Agreement. Consultant waives and agrees not to assert any defense
that the court lacks jurisdiction, venue is improper, inconvenient
forum or otherwise. Consultant waives the right to a jury trial and
agrees to accept service of process by certified mail at
Consultant’s last known address.
Section
12. Successors and
Assigns. Neither this Agreement, nor any of
Consultant’s rights, powers, duties or obligations hereunder,
may be assigned by Consultant. This Agreement shall be binding upon
and inure to the benefit of Consultant and his/her heirs and legal
representatives and the Company and its successors. Successors of
the Company shall include, without limitation, any company or
companies acquiring, directly or indirectly, all or substantially
all of the assets of the Company, whether by merger, consolidation,
purchase, lease or otherwise, and such successor shall thereafter
be deemed “the company” for the purpose
hereof.
Section
13. Waiver. Any
waiver or consent from the Company with respect to any term or
provision of this Agreement or any other aspect of
Consultant’s conduct or engagement shall be effective only in
the specific instance and for the specific purpose for which given
and shall not be deemed, regardless of frequency given, to be a
further or continuing waiver or consent. The failure or delay of
the Company at any time or times to require performance of, or to
exercise any of its powers, rights or remedies with respect to any
term or provision of this Agreement or any other aspect of
Consultant’s conduct or engagement shall in no manner (except
as otherwise expressly provided herein) affect the Company’s
right at a later time to enforce any such term or
provision.
Section
14. Notice. All
notices, requests, demands and other communications hereunder shall
be in writing and shall be deemed to have been duly given if
delivered by hand or mailed within the continental United States by
first class, registered mail, return receipt requested, postage and
registry fees prepaid, to the applicable party and addressed as
follows:
|
(a)
|
the Company:
|
Kenneth
Kahn
|
|
|
|
Level Beauty Group,
Inc.
|
|
|
|
4521 Sharon Road,
Suite 400
|
|
|
|
Charlotte, NC
28211
|
|
|
|
|
|
(b)
|
The
Consultant:
|
Priel
Maman
|
|
|
|
2253 Esplanda
Circle
|
|
|
|
West Boca Raton, FL
33433
|
Section
15. Amendment.
No amendment or modification of this Agreement shall be valid or
effective, unless in writing and signed by the parties to this
Agreement.
Section
16. Entire
Agreement.
(a)
This Agreement
embodies the entire agreement of the parties hereto with respect to
its subject matter and merges with and supersedes all prior
discussions, agreements, commitments, or understandings of every
kind and nature relating thereto, whether oral or written, between
Consultant and the Company. Neither party shall be bound by any
term or condition other than as is expressly set forth
herein.
(b)
Consultant
represents and agrees that he fully understands his right to
discuss all aspects of this Agreement with his private attorney,
that to the extent he desired, he availed himself of this right,
that he has carefully read and fully understands all of the
provisions of this Agreement, that he is competent to execute this
Agreement, that his decision to execute this Agreement has not been
obtained by any duress and that he freely and voluntarily enters
into this Agreement, and that he has read this document in its
entirety and fully understands the meaning, intent and consequences
of this Agreement.
CONSULTANT:
/s/ Priel
Mamam
DATE:4/7/15
COMPANY:
Beauty
and Pin Ups, LLC
/s/ Kenneth
Kahn
DATE:4/7/15
Name:
Kenneth Kahn
Title:
Chief Executive Officer
Exhibit
6.3
MANAGEMENT SERVICES AGREEMENT
This Management Agreement (the
“Agreement”) is made as of the 27th day of April, 2015,
by and between kathy ireland Worldwide LLC (“Manager”),
and Level Beauty Group, Inc., a North Carolina corporation
(“Managee”).
RECITALS
WHEREAS, Manager has agreed to provide
certain management, creative and marketing services to Managee;
and
WHEREAS, the parties desire to set forth
in writing the terms and conditions on which Manager shall provide
such services to Managee.
AGREEMENT
NOW THEREFORE in consideration of the
foregoing and the mutual agreements set forth herein, the parties
agree as follows:
1. Management
Services. The Company
hereby retains Manager to provide the “Services” (as
defined below) to Managee for a period of two years initially
(“Initial Term”), then on a at will basis upon the
terms and conditions of this Agreement, commencing on the date
hereof. The parties understand and agree that Kathy Ireland shall
be named as Chief Creative Advisor to the Managee; provided, that
public disclosure of Kathy Ireland’s association or
affiliation with the Company, as well as her title, shall require
her prior written consent.
2. Compensation.
(a) For services
rendered by Manager to Managee, Managee shall pay (the
“Management Fee”) a monthly fee equal to $10,000. To
the extent the Board of Directors of the Managee reasonably
determines that the Managee and/or any of its portfolio companies
do not have sufficient available cash to pay such Management Fee in
a particular month, the parties agree that the portion of the
Management Fee not paid shall accrue and the accrued amount shall
be paid to Manager upon the earliest to occur of the following: (a
“Liquidation Event”): (i) when the Board of Directors
reasonably believes that the Managee or such Managee portfolio
company has such cash available for payment, (ii) upon the closing
of a future capital raise (after the $2,000,000 capital raise
currently in process is completed) in excess of $5,000,000 (on an
aggregate basis, through a single or series of subsequent capital
raises), (iii) the sale of all or substantially all of the assets
or a majority of the common stock of the Managee, or (iv) an
initial public offering of the Managee’s securities listed
through NASDAQ or other national securities exchange.
(b) To the extent that
Manager is offering its services with respect to a particular
Managee portfolio company, an annual fee in an amount equal to ten
percent (10%) of the gross margin (gross consolidated revenue less
cost of goods sold, as determined by the Managee’s
accountants under Generally Accepted Accounting Principles) of such
Managee portfolio company shall be paid to Manager annually;
provided, that, it is understood and agreed that the Management Fee
owed under this Section 2(b) shall not be paid on the gross margin
attributable to the first Ten Million Dollars ($10,000,000) in
annual revenue of such Managee portfolio company (the
“Royalty Fee”). By way of illustration, in any given
calendar year, if Managee has $30,000,000 in revenue and COGS is
$15,000,000 (a 50% gross margin), then the fee under this Section
2(b) shall equal $1,000,000 ($30,000,000 less the $10,000,000
threshold, the result of which is multiplied by the 50% gross
margin, times the 10% royalty).
(c) In addition,
Managee shall pay to Manager a $750,000 fee as follows: (i) a cash
payment of $100,000 will be paid to Manager on the date of
execution hereof, and (ii) the remaining $650,000 (“Remaining
Amount”) will be an obligation of the Company. The Remaining
Amount will be paid through the Royalty Fee set forth in Section
2(b) (and will not be in addition to the Royalty Fee set forth in
Section 2(b)); subject to the following: (y) promptly upon a
Liquidation Event, the portion of the Remaining Amount not
theretofore recouped through payment of the Royalty Fee will be
paid in full (such portion of the Remaining Amount so paid is
referred to as the “Liquidation Event Royalty
Advance”); and (z) the Liquidation Event Royalty Advance will
be a non recoupable advance, will not be recoverable or recoupable
from Managee or its affiliates, and shall solely be credited
against and used to offset any Royalty Fee due after closing of a
Liquidation Event on a dollar for dollar basis.
3. Services.
Manager shall, from time to time and when, as and if determined in
her sole discretion, provide management, creative and marketing
services reasonably requested by the Managee from time to time (the
“Services”) at no additional expense to Manager except
as set forth herein. The Managee understands, acknowledges and
agrees that Manager has a variety of different obligations, duties
and commitments to third parties, some or all of which may
conflict, limit or prohibit the performance of the Services. As a
result, the manner, type and scope of the Services shall be
determined by Manager in her sole discretion, and her failure or
refusal to provide Services at any time and/or for any reason shall
in no way be deemed to be a breach of this Agreement or result in
any liability to Manager or her affiliates.
4. Limitation
of Liability. Manager
shall not be liable to Managee, its members, managers, officers,
employees, creditors, representatives or agents for any loss,
damage, liability, cost or expense suffered by it on account of any
action or omission by Manager or its agents unless arising from
Manager’s bad faith or willful misconduct.
5. Indemnification.
Managee shall indemnify, defend and hold harmless Manager and each
of its directors, officers, employees, partners, agents,
Affiliates, successors and assigns thereof from and against any and
all losses, judgments, fines, penalties, costs and expenses
(including, without limitation, reasonable attorney’s fees),
damages, and any other liabilities asserted against, imposed upon
or incurred or suffered by such person or entity which arises out
of, results from or relates to any act or failure to act on the
part of Managee or her affiliates that in any way relates to the
negotiation, execution, performance and/or existence of this
Agreement.
6. Nonexclusivity.
Manager's Services hereunder are not exclusive. Manager shall at
all times be free to perform the same or similar services for
others, including providing services for a competitor of Managee,
as well as to engage in any and all other business
activities.
7. Termination.
This Agreement may be terminated by either party by giving thirty
(30) days written notice to the other, and shall terminate
automatically, without further obligation of either party other
than the payment of fees previously earned but unpaid, in the event
that either party ceases operations.
8. No
Waiver. No delay on
Managee’s part in exercising any right, power or privilege
under this Agreement shall operate as a waiver of any such
privilege, power or right.
9. Notices.
All notices and other communications hereunder shall be in writing
and shall be deemed validly given if delivered personally or sent
by certified mail, postage prepaid, return receipt requested, to
either party at its principal place of business, and shall be
deemed to have been given as of the date so personally delivered or
received.
10. Integration/Severability.
This Agreement expresses the entire agreement of the parties
relative to the subject matter. In the event that any provision of
this Agreement should be held to be void, voidable or
unenforceable, the remaining portions hereof shall remain in full
force and effect and shall be enforced to the fullest extent
permitted by law.
11. Assignment/Binding
Agreement. This
Agreement may not be assigned by either Manager or Managee without
the prior written consent of the other party. This Agreement shall
be binding upon and inure to the benefit of the parties, their
respective successors and permitted assigns.
12. Confidentiality.
Managee, and its respective affiliates, employees, attorneys,
accountants and agents shall hold in confidence and shall not use
or disclose, except as permitted by Manager in writing (which may
be withheld or granted in Manager’s sole and absolute
discretion), (i) the terms of this Agreement, including without
limitation the financial arrangement between the Managee and
Manager, and (ii) Manager’s name, likeness, marks and/or
brand; provided, that Managee may disclose the terms of this
Agreement if required by law so long as prior written notice of
such disclosure has been sent to Manger and Managee has taken all
actions reasonably within its control in order to avoid disclosure
(and any such disclosure shall be limited to the minimum
information required by law).
13. Governing
Law. This Agreement
and the rights and obligations of the parties hereunder shall in
all respects be governed by, and construed and enforced in
accordance with, the laws of the State of North Carolina (exclusive
of its choice of laws rules) applicable to agreements performed
entirely within such State.
IN WITNESS WHEREOF, the parties have
executed this Agreement to be effective as of the date first above
written.
Level
Beauty Group, Inc.
By:/s/
Kenneth Kahn
Kenneth
Kahn, President
kathy
ireland Worldwide LLC
By:/s/
Kathy Ireland
Kathy
Ireland, CEO
Exhibit
6.4
ADVISORY SERVICES AGREEMENT
This Advisory Services Agreement (the
“Agreement”) is made as of the 27th day of April, 2015,
by and between Siskey Capital, LLC, a North Carolina limited
liability agreement (“Manager”), and Level Beauty
Group, Inc., a North Carolina corporation
(“Managee”).
R E C I T A L S
WHEREAS, Manager has agreed to provide
certain management, creative and marketing services to Managee;
and
WHEREAS, the parties desire to set forth
in writing the terms and conditions on which Manager shall provide
such services to Managee.
A G R E E M E N T
NOW THEREFORE in consideration of the
foregoing and the mutual agreements set forth herein, the parties
agree as follows:
1. Management
Services. Manager
agrees to provide management, creative and marketing services to
Managee for a period of two years initially (“Initial
Term”), then on a year-to-year basis upon the terms and
conditions of this Agreement, commencing on the date hereof. This
Agreement shall be automatically renewed for successive one-year
periods after the Initial Term commencing on the first day of
January of each calendar year unless terminated as provided
herein.
Compensation.
For services rendered by Manager to Managee, Managee shall pay (the
“Management Fee”) a monthly fee equal to $10,000. To
the extent the Board of Directors of the Managee reasonably
determines that the Managee and such Managee portfolio company does
not have sufficient available cash to pay such Management Fee, the
parties agree that the Management Fee shall accrue and be paid to
Manager upon the earliest to occur of the following: (i) when the
Board of Directors reasonably believes that the Managee or such
Managee portfolio company has such cash available for payment, or
(ii) upon the closing of a capital raise (after the date hereof) in
excess of $5,000,000.
2. Services.
Manager shall provide management, creative and marketing services
reasonably requested by the Managee from time to time and agreed to
by the Manager (at no additional expense to Manager).
3. Limitation
of Liability. Manager
shall not be liable to Managee, its members, managers, officers,
employees, creditors, representatives or agents for any loss,
damage, liability, cost or expense suffered by it on account of any
action or omission by Manager or its agents unless arising from
Manager’s bad faith or willful misconduct.
4. Termination.
Following the Initial Term, this Agreement may be terminated by
either party by giving thirty (30) days written notice prior to the
end of the relevant calendar year, and shall terminate
automatically, without further obligation of either party other
than the payment of fees previously earned but unpaid, in the event
that either party ceases operations.
5. No
Waiver. No delay on
Managee’s part in exercising any right, power or privilege
under this Agreement shall operate as a waiver of any such
privilege, power or right.
6. Nonexclusivity.
Manager's Services hereunder are not exclusive. Manager shall at
all times be free to perform the same or similar services for
others, including providing services for a competitor of Managee,
as well as to engage in any and all other business
activities.
7. Notices.
All notices and other communications hereunder shall be in writing
and shall be deemed validly given if delivered personally or sent
by certified mail, postage prepaid, return receipt requested, to
either party at its principal place of business, and shall be
deemed to have been given as of the date so personally delivered or
received.
8. Integration/Severability.
This Agreement expresses the entire agreement of the parties
relative to the subject matter. In the event that any provision of
this Agreement should be held to be void, voidable or
unenforceable, the remaining portions hereof shall remain in full
force and effect and shall be enforced to the fullest extent
permitted by law.
9. Assignment/Binding
Agreement. This
Agreement may not be assigned by either Manager or Managee without
the prior written consent of the other party. This Agreement shall
be binding upon and inure to the benefit of the parties, their
respective successors and permitted assigns.
10. Governing
Law. This Agreement
and the rights and obligations of the parties hereunder shall in
all respects be governed by, and construed and enforced in
accordance with, the laws of the State of North Carolina (exclusive
of its choice of laws rules) applicable to agreements performed
entirely within such State.
[signature
page follows]
IN WITNESS WHEREOF, the parties have
executed this Agreement to be effective as of the date first above
written.
Level
Beauty Group, Inc.
By:/s/ Kenneth Kahn
Kenneth
Kahn, President
Siskey
Capital, LLC
By:Martin A.
Sumichrast
Martin
A. Sumichrast, Manager
EXECUTIVE EMPLOYMENT AGREEMENT
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement")
is made and entered this 1st day of January, 2017 (the
“Effective
Date”) between Level Brands, Inc., a North Carolina
corporation whose principal place of business is 4521 Sharon Road,
Charlotte, NC 28211 (the "Corporation")
and Marty Sumichrast, an individual whose address is 11125 Colonial
Country Lane, Charlotte, NC (the "Executive").
RECITALS
WHEREAS, the Corporation is a branding and
marketing company focusing on lifestyle based segments including
women’s, men’s and entertainment segments (the
"Business").
WHEREAS, the Corporation desires to
employ the Executive and the Executive desires to be employed by
the Corporation.
WHEREAS, the Executive, by virtue of the
Executive's employment with the Corporation, will become familiar
with and possessed with the manner, methods, trade secrets and
other confidential information pertaining to the Corporation's
business, including the Corporation's client base.
NOW, THEREFORE, in consideration of the
mutual agreements herein made, the Corporation and the Executive do
hereby agree as follows:
1. Recitals.
The above recitals are true, correct, and are herein incorporated
by reference.
2. Employment.
The Corporation hereby employs the Executive, and the Executive
hereby accepts employment, upon the terms and conditions
hereinafter set forth.
3. Authority
and Power During Employment Period.
a. Duties
and Responsibilities. During the term of this Agreement, the
Executive will serve as Chief Executive Officer and shall have
general executive operating supervision over the property, business
and affairs of the Corporation, its subsidiaries and divisions,
subject to the guidelines and direction of the Board of Directors
of the Corporation.
b. Time
Devoted. Throughout the term of the Agreement, the Executive
shall devote substantially of the Executive's business time and
attention to the business and affairs of the Corporation consistent
with the Executive's senior executive position with the
Corporation, except for reasonable vacations and except for illness
or incapacity, but nothing in the Agreement shall preclude the
Executive from engaging in personal business, including as a member
of the Board of Directors of affiliated companies, charitable and
community affairs, provided that such activities do not interfere
with the regular performance of the Executive's duties and
responsibilities under this Agreement.
c. Corporate
Policies. The Executive shall abide by all corporate
governance and employment policies of the Corporation which may be
adopted or modified from time to time including, but not limited
to, any insider trading and code of ethics polities.
4. Term.
The Term of employment hereunder will commence on the Effective
Date and end on the first (1st) anniversary of the Effective Date
and may be extended for additional one (1) year periods (each a
"Renewal
Term") by written notice given by the Corporation to the
Executive at least 60 days before the expiration of the Term or the
Renewal Term, as the case may be, unless this Agreement shall have
been terminated pursuant to Section 6 of this
Agreement.
5. Compensation
and Benefits.
a. Salary.
The Executive shall be paid a base salary (“Base
Salary”), payable in accordance with the Corporation's
policies from time to time for senior executives, at an annual rate
One Hundred Twenty Thousand dollars ($120,000), such Base Salary
shall accrue until such time as the Corporation completes its
initial public offering, after which time all accrued but unpaid
salary shall be paid to the Executive].
b. Discretionary
Bonus. The Executive may be awarded a bonus from time to
time and in such amounts as may be determined by the Board of
Directors of the Corporation in their sole discretion.
c. Executive
Benefits. The Executive shall be entitled to participate in
all benefit programs of the Corporation currently existing or
hereafter made available to executive and/or salaried employees
including, but not limited to, stock option plans, pension and
other retirement plans, group life insurance, hospitalization,
surgical and major medical coverage, sick leave, salary
continuation, vacation and holidays, long-term disability, and
other fringe benefits.
d. Vacation.
During each fiscal year of the Corporation, the Executive shall be
entitled to such amount of vacation consistent with the Executive's
position and length of service to the Corporation.
e. Business
Expense Reimbursement. During the Term of employment, the
Executive shall be entitled to receive proper reimbursement for all
reasonable, out of-pocket expenses incurred by the Executive (in
accordance with the policies and procedures established by the
Corporation) in performing services hereunder, provided the
Executive properly accounts therefor.
6. Termination.
a. Death.
This Agreement will terminate upon the death of the
Executive.
b. Disability.
(1) The
Executive's employment will terminate in the event of his
disability, upon the first day of the month following the
determination of disability as provided below. Following such a
termination, the Executive shall be entitled to compensation in
accordance with the Corporation's disability compensation practice
for senior executives, including any separate arrangement or policy
covering the Executive, but in all events the Executive shall
continue to receive his Base Salary, at the annual rate in effect
immediately prior to the commencement of disability, for three (3)
months after the termination. Any amounts provided for in this
Section 6b shall not be offset by other long-term disability
benefits provided to the Executive by the Corporation or Social
Security.
(2) "Disability,"
for the purposes of this Agreement, shall be deemed to have
occurred if (A) the Executive is unable, by reason of a physical or
mental condition, to perform his duties under this Agreement for an
aggregate of ninety (90) days in any 12-month period or (B) the
Executive has a guardian of the person or estate appointed by a
court of competent jurisdiction.
Anything
herein to the contrary notwithstanding, if, following a termination
of employment due to disability, the Executive becomes re-employed,
whether as an executive or a consultant, any compensation, annual
incentive payments or other benefits earned by the Executive from
such employment shall be offset against any compensation
continuation due to the Executive hereunder.
c. Termination
by the Corporation For Cause.
(1) Nothing
herein shall prevent the Corporation from terminating Executive for
Cause, as hereinafter defined. The Executive shall continue to
receive compensation only for the period ending with the date of
such termination as provided in this Section 6c. Any rights and
benefits the Executive may have in respect of any other
compensation shall be determined in accordance with the terms of
such other compensation arrangements or such plans or
programs.
(2) "Cause"
shall mean (A) committing or participating in an injurious act of
fraud, gross neglect, misrepresentation, embezzlement or dishonesty
against the Corporation; (B) committing or participating in any
other injurious act or omission wantonly, willfully, recklessly or
in a manner which was grossly negligent against the Corporation;
(C) engaging in a criminal enterprise involving moral turpitude;
(D) conviction for a felony under the laws of the United States or
any state thereof; (E) violation of any Federal or state securities
laws, rules or regulations, or any rules or regulations of any
stock exchange or other market on which the Corporation's
securities may be listed or quoted for trading; (F) violation of
the Corporation's corporate governance policies; or (G) any
assignment of this Agreement in violation of Section 14 of this
Agreement.
(3) Notwithstanding
anything else contained in this Agreement, this Agreement will not
be deemed to have been terminated for Cause unless and until there
shall have been delivered to the Executive a notice of termination
stating that the Executive committed one of the types of conduct
set forth in Section 6c(2) of this Agreement and specifying the
particulars thereof and the Executive shall be given a thirty (30)
day period to cure such conduct set forth in Section
6c(2).
d. Termination
by the Corporation Other Than For Cause.
(1) The
foregoing notwithstanding, the Corporation may terminate the
Executive's employment for whatever reason it deems appropriate;
provided, however, that in the event such termination is not based
on Cause, as provided in Section 6c above, the Corporation may
terminate this Agreement upon giving the Executive thirty (30)
days' prior written notice. During such thirty (30) day period, the
Executive shall continue to perform the Executive's duties pursuant
to this Agreement. Notwithstanding any such termination, the
Corporation shall continue to pay to the Executive the Base Salary
and Executive Benefits he would be entitled to receive under this
Agreement for the balance of the Term of this Agreement in
accordance with the Corporation's regular payroll
policies.
(2) In
the event that the Executive's employment with the Corporation is
terminated pursuant to this Section 6d, Section 6f, then Section 7a
of this Agreement and all references thereto shall be voidable as
to the Executive and the Corporation.
e. Voluntary
Termination. If the Executive terminates the Executive's
employment on the Executive's own volition (except as provided in
Section 6f) prior to the expiration of the Term of this Agreement,
including any renewals thereof, such termination shall constitute a
voluntary termination and in such event the Executive shall be
limited to the same rights and benefits as provided in connection
with a termination for Cause as provided in Section
6c.
f. Constructive
Termination of Employment. A termination by the Corporation
without Cause under Section 6d shall be deemed to have occurred
upon the occurrence of one or more of the following events without
the express written consent of the Executive:
(1) a
material breach of the Agreement by the Corporation;
or
(2) failure
by a successor company to assume the obligations under the
Agreement.
Anything
herein to the contrary notwithstanding, the Executive shall give
written notice to the Board of Directors of the Corporation that
the Executive believes an event has occurred which would result in
a Constructive Termination of the Executive's employment under this
Section 6f, which written notice shall specify the particular act
or acts, on the basis of which the Executive intends to so
terminate the Executive's employment, and the Corporation shall
then be given the opportunity, within thirty (30) days of its
receipt of such notice, to cure said event; provided, however,
there shall be no period permitted to cure a second occurrence of
the same event and in no event will there be any period to cure
following the occurrence of two events described in this Section
6f.
7. Covenant
Not To Compete and Non-Disclosure of
Information.
a. Covenant
Not To Compete. The Executive acknowledges and recognizes
the highly competitive nature of the Corporation's Business and the
goodwill, continued patronage, and the names and addresses of the
Corporation's Clients (as hereinafter defined) constitute a
substantial asset of the Corporation having been acquired through
considerable time, money and effort. Accordingly, in consideration
of the execution of this Agreement, and as except as may
specifically otherwise approved by the Corporation’s Board of
Directors, the Executive agrees to the following:
(1) That
during the Restricted Period (as hereinafter defined) and within
the Restricted Area (as hereinafter defined), the Executive will
not, individually or in conjunction with others, directly or
indirectly, engage in any Business Activities (as hereinafter
defined), whether as an officer, director, proprietor, employer,
partner, independent contractor, investor (other than as a holder
solely as an investment of less than one percent (1%) of the
outstanding capital stock of a publicly traded corporation),
consultant, advisor, agent or otherwise.
(2) That
during the Restricted Period and within the Restricted Area, the
Executive will not, directly or indirectly, compete with the
Corporation by soliciting, inducing or influencing any of the
Corporation's Clients which have a business relationship with the
Corporation at the time during the Restricted Period to discontinue
or reduce the extent of such relationship with the
Corporation.
(3) That
during the Restricted Period and within the Restricted Area, the
Executive will not (A) directly or indirectly recruit, solicit or
otherwise influence any employee or agent of the Corporation to
discontinue such employment or agency relationship with the
Corporation, or (B) employ or seek to employ, or cause or permit
any business which competes directly or indirectly with the
Business Activities of the Corporation (the "Competitive
Business") to employ or seek to employ for any Competitive
Business any person who is then (or was at any time within two (2)
years prior to the date Executive or the Competitive Business
employs or seeks to employ such person) employed by the
Corporation.
b. Non-Disclosure
of Information. The Executive acknowledges that the
Corporation's trade secrets, private or secret processes, methods
and ideas, as they exist from time to time, customer lists and
information concerning the Corporation's sources, products,
services, pricing, training methods, development, technical
information, marketing activities and procedures, credit and
financial data concerning the Corporation and/or the Corporation's
Clients, and (the "Proprietary
Information") are valuable, special and unique assets of the
Corporation, access to and knowledge of which are essential to the
performance of the Executive hereunder. In light of the highly
competitive nature of the industry in which the Corporation's
business is conducted, the Executive agrees that all Proprietary
Information, heretofore or in the future obtained by the Executive
as a result of the Executive's association with the Corporation
shall be considered confidential.
In
recognition of this fact, the Executive agrees that the Executive,
during the Restricted Period, will not use or disclose any of such
Proprietary Information for the Executive's own purposes or for the
benefit of any person or other entity or organization (except the
Corporation) under any circumstances unless such Proprietary
Information has been publicly disclosed generally or, unless upon
written advice of legal counsel reasonably satisfactory to the
Corporation, the Executive is legally required to disclose such
Proprietary Information. Documents (as hereinafter defined)
prepared by the Executive or that come into the Executive's
possession during the Executive's association with the Corporation
are and remain the property of the Corporation, and when this
Agreement terminates, such Documents shall be returned to the
Corporation at the Corporation's principal place of business, as
provided in the Notice provision (Section 10) of this
Agreement.
c. Documents.
"Documents"
shall mean all original written, recorded, or graphic matters
whatsoever, and any and all copies thereof, including, but not
limited to: papers; books; records; tangible things;
correspondence; communications; telex messages; memoranda;
work-papers; reports; affidavits; statements; summaries; analyses;
evaluations; client records and information; agreements; agendas;
advertisements; instructions; charges; manuals; brochures;
publications; directories; industry lists; schedules; price lists;
client lists; statistical records; training manuals; computer
printouts; books of account, records and invoices reflecting
business operations; all things similar to any of the foregoing
however denominated. In all cases where originals are not
available, the term "Documents" shall also mean identical copies of
original documents or non-identical copies thereof.
d. Corporation's
Clients. The "Corporation's
Clients" shall be deemed to be any persons, partnerships,
corporations, professional associations or other organizations for
or with whom the Corporation
has performed Business Activities,
including, but not limited to, suppliers or vendors with whom the
Corporation has done or is endeavoring to do
business.
e. Restrictive
Period. The "Restrictive
Period" shall be deemed to be one (1) year following
termination of this Agreement.
f. Restricted
Area. The "Restricted
Area" shall be deemed to mean the United
States.
g. Business
Activities. "Business
Activities" shall be deemed to any business activities
concerning owning, operating, managing, promoting or
soliciting clients for the
Corporation’s Business, and any additional activities
which the Corporation or any of its affiliates may engage in during
any portion of the twelve (12)
months prior to the termination of Executive's
employment.
h. Covenants
as Essential Elements of this Agreement. It is understood by
and between the parties hereto that the foregoing covenants
contained in Sections 7a and b are essential elements of this
Agreement, and that but for the agreement by the Executive to
comply with such covenants, the Corporation would not have agreed
to enter into this Agreement. Such covenants by the Executive shall
be construed to be agreements independent of any other provisions
of this Agreement. The existence of any other claim or cause of
action, whether predicated on any other provision in this
Agreement, or otherwise, as a result of the relationship between
the parties shall not constitute a defense to the enforcement of
such covenants against the Executive. To
the extent that the covenants contained in this Section 7 may later
be deemed by a court to be too broad to be enforced with respect to
their duration or with respect to any particular activity or
geographic area, the court making such determination shall have the
power to reduce the duration or scope of the provision, and to add
or delete specific words or phrases to or from the provision. The
provision as modified shall then be enforced.
i. Survival
After Termination of Agreement. Notwithstanding anything to
the contrary contained in this Agreement, the covenants in Sections
7a and b shall survive the termination of this Agreement and the
Executive's employment with the Corporation.
j. Remedies.
(1) The
Executive acknowledges and agrees that the Corporation's remedy at
law for a breach or threatened breach of any of the provisions of
Section 7a or b herein would be inadequate and the breach shall be
per se deemed as causing irreparable harm to the Corporation. In
recognition of this fact, in the event of a breach by the Executive
of any of the provisions of Section 7a or b, the Executive agrees
that, in addition to any remedy at law available to the
Corporation, including, but not limited to monetary damages, all
rights of the Executive to payment or otherwise under this
Agreement and all amounts then or thereafter due to the Executive
from the Corporation under this Agreement may be terminated and the
Corporation, without posting any bond, shall be entitled to obtain,
and the Executive agrees not to oppose the Corporation's request
for equitable relief in the form of specific performance, temporary
restraining order, temporary or permanent injunction or any other
equitable remedy which may then be available to the
Corporation.
(2) The
Executive acknowledges that the granting of a temporary injunction,
temporary restraining order or permanent injunction merely
prohibiting the use of Proprietary Information would not be an
adequate remedy upon breach or threatened breach of Section 7a or b
and consequently agrees, upon proof of any such breach, to the
granting of injunctive relief prohibiting any form of competition
with the Corporation. Nothing herein contained shall be construed
as prohibiting the Corporation from pursuing any other remedies
available to it for such breach or threatened breach.
8. Indemnification.
The Executive shall be continue to be covered by the Articles of
Incorporation and By-Laws of the Corporation with respect to
matters occurring on or prior to the date of termination of the
Executive's employment with the Corporation, subject to all the
provisions of North Carolina and Federal law, the Articles of
Incorporation of the Corporation and the By-Laws of the Corporation
then in effect. Such reasonable expenses, including attorneys'
fees, that may be covered by the these indemnification provisions
shall be paid by the Corporation on a current basis in accordance
with such provision, the Corporation's Articles of Incorporation,
By-Laws and North Carolina law. To the extent that any such
payments by the Corporation pursuant to these provisions may be
subject to repayment by the Executive pursuant to the provisions of
the Articles of Incorporation and/or By-Laws, or pursuant to North
Carolina or Federal law, such repayment shall be due and payable by
the Executive to the Corporation within twelve (12) months after
the termination of all proceedings, if any, which relate to such
repayment and to the Corporation's affairs for the period prior to
the date of termination of the Executive's employment with the
Corporation and as to which Executive has been covered by such
applicable provisions.
9. Withholding.
Anything to the contrary notwithstanding, all payments required to
be made by the Corporation hereunder to the Executive or the
Executive's estate or beneficiaries shall be subject to the
withholding of such amounts, if any, relating to tax and other
payroll deductions as the Corporation may reasonably determine it
should withhold pursuant to any applicable law or regulation. In
lieu of withholding such amounts, the Corporation may accept other
arrangements pursuant to which it is satisfied that such tax and
other payroll obligations will be satisfied in a manner complying
with applicable law or regulation.
10. Notices.
Any notice required or permitted to be given under the terms of
this Agreement shall be sufficient if in writing and if sent
postage prepaid by registered or certified mail, return receipt
requested; by overnight delivery; by courier; or by confirmed
telecopy, in the case of the Executive to the Executive's last
place of business or residence as shown on the records of the
Corporation, or in the case of the Corporation to its principal
office as set forth in the first paragraph of this Agreement, or at
such other place as it may designate.
11. Waiver.
Unless agreed in writing, the failure of either party, at any time,
to require performance by the other of any provisions hereunder
shall not affect its right thereafter to enforce the same, nor
shall a waiver by either party of any breach of any provision
hereof be taken or held to be a waiver of any other preceding or
succeeding breach of any term or provision of this Agreement. No
extension of time for the performance of any obligation or act
shall be deemed to be an extension of time for the performance of
any other obligation or act hereunder.
12. Completeness
and Modification. This Agreement constitutes the entire
understanding between the parties hereto superseding all prior and
contemporaneous agreements or understandings among the parties
hereto concerning the Agreement. This Agreement may be amended,
modified, superseded or canceled, and any of the terms, covenants,
representations, warranties or conditions hereof may be waived,
only by a written instrument executed by the parties or, in the
case of a waiver, by the party to be charged.
13. Counterparts.
This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original but all of which shall constitute
but one agreement.
14. Binding
Effect/Assignment. This Agreement shall be binding upon the
parties hereto, their heirs, legal representatives, successors and
assigns. This Agreement shall not be assignable by the Executive
but shall be assignable by the Corporation in connection with the
sale, transfer or other disposition of its business or to any of
the Corporation's affiliates controlled by or under common control
with the Corporation.
15. Governing
Law. This Agreement shall become valid when executed and
accepted by Corporation. The parties agree that it shall be deemed
made and entered into in the State of North Carolina and shall be
governed and construed under and in accordance with the laws of the
State of North Carolina. Anything in this Agreement to the contrary
notwithstanding, the Executive shall conduct the Executive's
business in a lawful manner and faithfully comply with applicable
laws or regulations of the state, city or other political
subdivision in which the Executive is located.
16. Further
Assurances. All parties hereto shall execute and deliver
such other instruments and do such other acts as may be necessary
to carry out the intent and purposes of this
Agreement.
17. Headings.
The headings of the sections are for convenience only and shall not
control or affect the meaning or construction or limit the scope or
intent of any of the provisions of this Agreement.
18. Survival.
Any termination of this Agreement shall not, however, affect the
ongoing provisions of this Agreement which shall survive such
termination in accordance with their terms.
19. Severability.
The invalidity or unenforceability, in whole or in part, of any
covenant, promise or undertaking, or any section, subsection,
paragraph, sentence, clause, phrase or word or of any provision of
this Agreement shall not affect the validity or enforceability of
the remaining portions thereof.
20. Enforcement.
Should it become necessary for any party to institute legal action
to enforce the terms and conditions of this Agreement, the
successful party will be awarded reasonable attorneys' fees at all
trial and appellate levels, expenses and costs.
21. Venue.
Corporation and Executive acknowledge and agree that the U.S.
District for the State of North Carolina, or if such court lacks
jurisdiction, the State of North Carolina(or its successor) in and
for Mecklenburg County, North Carolina, shall be the venue and
exclusive proper forum in which to adjudicate any case or
controversy arising either, directly or indirectly, under or in
connection with this Agreement and the parties further agree that,
in the event of litigation arising out of or in connection with
this Agreement in these courts, they will not contest or challenge
the jurisdiction or venue of these courts.
22. Construction.
This Agreement shall be construed within the fair meaning of each
of its terms and not against the party drafting the
document.
23. Role
of Counsel. The Executive acknowledges his understanding
that this Agreement was prepared at the request of the Corporation
by Pearlman Law Group LLP, its counsel, and that such firm did not
represent the Executive in conjunction with this Agreement or any
of the related transactions. The Executive, as further evidenced by
his signature below, acknowledges that he has had the opportunity
to obtain the advice of independent counsel of his choosing prior
to his execution of this Agreement and that he has availed himself
of this opportunity to the extent he deemed necessary and
advisable.
THE EXECUTIVE ACKNOWLEDGES THAT THE EXECUTIVE HAS READ ALL OF THE
TERMS OF THIS AGREEMENT, UNDERSTANDS THE AGREEMENT, AND AGREES TO
ABIDE BY ITS TERMS AND CONDITIONS.
IN WITNESS WHEREOF, the parties have
executed this Agreement as of date set forth in the first paragraph
of this Agreement.
Witness:
|
THE COMPANY:
|
|
|
_____________________________
|
LEVEL BRANDS,
INC.
|
|
|
_____________________________
|
By: /s/ Mark
Elliott
|
|
Mark Elliott, Chief
Financial Officer
|
|
|
|
|
Witness:
|
THE
EXECUTIVE
|
|
|
_____________________________
|
/s/ Martin A.
Sumichrast
|
|
|
_____________________________
|
Martin A.
Sumichrast
|
|
|
|
|
EXECUTIVE EMPLOYMENT AGREEMENT
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement")
is made and entered this 2nd day of January, 2017 (the
“Effective
Date”) between Level Brands, Inc., a North Carolina
corporation whose principal place of business is 4521 Sharon Road,
Charlotte, NC 28211 (the "Corporation")
and Mark Elliott, an individual whose address is 7154 Chameroy Ct,
Charlotte, NC 28270 (the "Executive").
RECITALS
WHEREAS, the Corporation is a branding and
marketing company focusing on lifestyle based segments including
women’s, men’s and entertainment segments (the
"Business").
WHEREAS, the Corporation desires to
employ the Executive and the Executive desires to be employed by
the Corporation.
WHEREAS, the Executive, by virtue of the
Executive's employment with the Corporation, will become familiar
with and possessed with the manner, methods, trade secrets and
other confidential information pertaining to the Corporation's
business, including the Corporation's client base.
NOW, THEREFORE, in consideration of the
mutual agreements herein made, the Corporation and the Executive do
hereby agree as follows:
1. Recitals.
The above recitals are true, correct, and are herein incorporated
by reference.
2. Employment.
The Corporation hereby employs the Executive, and the Executive
hereby accepts employment, upon the terms and conditions
hereinafter set forth.
3. Authority
and Power During Employment Period.
a. Duties
and Responsibilities. During the term of this Agreement, the
Executive will serve as Chief Financial Officer and Chief Operating
Officer and in this
capacity, shall serve as the Corporation’s principal
financial and accounting officer and perform such other or
additional duties and responsibilities consistent with
Executive’s title(s), status, and position as the Chief
Executive Officer or Board of Directors of the Corporation may,
from time to time, prescribe.
b. Time
Devoted. Throughout the term of the Agreement, the Executive
shall devote substantially of the Executive's business time and
attention to the business and affairs of the Corporation consistent
with the Executive's senior executive position with the
Corporation, except for reasonable vacations and except for illness
or incapacity, but nothing in the Agreement shall preclude the
Executive from engaging in personal business, including as a member
of the Board of Directors of affiliated companies, charitable and
community affairs, provided that such activities do not interfere
with the regular performance of the Executive's duties and
responsibilities under this Agreement.
c. Corporate
Policies. The Executive shall abide by all corporate
governance and employment policies of the Corporation which may be
adopted or modified from time to time including, but not limited
to, any insider trading and code of ethics polities.
4. Term.
The Term of employment hereunder will commence on the Effective
Date and end on the first (1st) anniversary of the Effective Date
and may be extended for additional one (1) year periods (each a
"Renewal
Term") by written notice given by the Corporation to the
Executive at least 60 days before the expiration of the Term or the
Renewal Term, as the case may be, unless this Agreement shall have
been terminated pursuant to Section 6 of this
Agreement.
5. Compensation
and Benefits.
a. Salary.
The Executive shall be paid a base salary (“Base
Salary”), payable in accordance with the Corporation's
policies from time to time for senior executives, at an annual rate
One Hundred Twenty Thousand dollars ($120,000).
b. Discretionary
Bonus. The Executive may be awarded a bonus from time to
time and in such amounts as may be determined by the Board of
Directors of the Corporation in their sole discretion.
c. Executive
Benefits. The Executive shall be entitled to participate in
all benefit programs of the Corporation currently existing or
hereafter made available to executive and/or salaried employees
including, but not limited to, stock option plans, pension and
other retirement plans, group life insurance, hospitalization,
surgical and major medical coverage, sick leave, salary
continuation, vacation and holidays, long-term disability, and
other fringe benefits.
d. Vacation.
During each fiscal year of the Corporation, the Executive shall be
entitled to such amount of vacation consistent with the Executive's
position and length of service to the Corporation.
e. Business
Expense Reimbursement. During the Term of employment, the
Executive shall be entitled to receive proper reimbursement for all
reasonable, out of-pocket expenses incurred by the Executive (in
accordance with the policies and procedures established by the
Corporation) in performing services hereunder, provided the
Executive properly accounts therefor.
6. Termination.
a. Death.
This Agreement will terminate upon the death of the
Executive.
b. Disability.
(1) The
Executive's employment will terminate in the event of his
disability, upon the first day of the month following the
determination of disability as provided below. Following such a
termination, the Executive shall be entitled to compensation in
accordance with the Corporation's disability compensation practice
for senior executives, including any separate arrangement or policy
covering the Executive, but in all events the Executive shall
continue to receive his Base Salary, at the annual rate in effect
immediately prior to the commencement of disability, for three (3)
months after the termination. Any amounts provided for in this
Section 6b shall not be offset by other long-term disability
benefits provided to the Executive by the Corporation or Social
Security.
(2) "Disability,"
for the purposes of this Agreement, shall be deemed to have
occurred if (A) the Executive is unable, by reason of a physical or
mental condition, to perform his duties under this Agreement for an
aggregate of ninety (90) days in any 12-month period or (B) the
Executive has a guardian of the person or estate appointed by a
court of competent jurisdiction.
Anything
herein to the contrary notwithstanding, if, following a termination
of employment due to disability, the Executive becomes re-employed,
whether as an executive or a consultant, any compensation, annual
incentive payments or other benefits earned by the Executive from
such employment shall be offset against any compensation
continuation due to the Executive hereunder.
c. Termination
by the Corporation For Cause.
(1) Nothing
herein shall prevent the Corporation from terminating Executive for
Cause, as hereinafter defined. The Executive shall continue to
receive compensation only for the period ending with the date of
such termination as provided in this Section 6c. Any rights and
benefits the Executive may have in respect of any other
compensation shall be determined in accordance with the terms of
such other compensation arrangements or such plans or
programs.
(2) "Cause"
shall mean (A) committing or participating in an injurious act of
fraud, gross neglect, misrepresentation, embezzlement or dishonesty
against the Corporation; (B) committing or participating in any
other injurious act or omission wantonly, willfully, recklessly or
in a manner which was grossly negligent against the Corporation;
(C) engaging in a criminal enterprise involving moral turpitude;
(D) conviction for a felony under the laws of the United States or
any state thereof; (E) violation of any Federal or state securities
laws, rules or regulations, or any rules or regulations of any
stock exchange or other market on which the Corporation's
securities may be listed or quoted for trading; (F) violation of
the Corporation's corporate governance policies; or (G) any
assignment of this Agreement in violation of Section 14 of this
Agreement.
(3) Notwithstanding
anything else contained in this Agreement, this Agreement will not
be deemed to have been terminated for Cause unless and until there
shall have been delivered to the Executive a notice of termination
stating that the Executive committed one of the types of conduct
set forth in Section 6c(2) of this Agreement and specifying the
particulars thereof and the Executive shall be given a thirty (30)
day period to cure such conduct set forth in Section
6c(2).
d. Termination
by the Corporation Other Than For Cause.
(1) The
foregoing notwithstanding, the Corporation may terminate the
Executive's employment for whatever reason it deems appropriate;
provided, however, that in the event such termination is not based
on Cause, as provided in Section 6c above, the Corporation may
terminate this Agreement upon giving the Executive thirty (30)
days' prior written notice. During such thirty (30) day period, the
Executive shall continue to perform the Executive's duties pursuant
to this Agreement. Notwithstanding any such termination, the
Corporation shall continue to pay to the Executive the Base Salary
and Executive Benefits he would be entitled to receive under this
Agreement for the balance of the Term of this Agreement in
accordance with the Corporation's regular payroll
policies.
(2) In
the event that the Executive's employment with the Corporation is
terminated pursuant to this Section 6d, Section 6f, then Section 7a
of this Agreement and all references thereto shall be voidable as
to the Executive and the Corporation.
e. Voluntary
Termination. If the Executive terminates the Executive's
employment on the Executive's own volition (except as provided in
Section 6f) prior to the expiration of the Term of this Agreement,
including any renewals thereof, such termination shall constitute a
voluntary termination and in such event the Executive shall be
limited to the same rights and benefits as provided in connection
with a termination for Cause as provided in Section
6c.
f. Constructive
Termination of Employment. A termination by the Corporation
without Cause under Section 6d shall be deemed to have occurred
upon the occurrence of one or more of the following events without
the express written consent of the Executive:
(1) a
material breach of the Agreement by the Corporation;
or
(2) failure
by a successor company to assume the obligations under the
Agreement.
Anything
herein to the contrary notwithstanding, the Executive shall give
written notice to the Board of Directors of the Corporation that
the Executive believes an event has occurred which would result in
a Constructive Termination of the Executive's employment under this
Section 6f, which written notice shall specify the particular act
or acts, on the basis of which the Executive intends to so
terminate the Executive's employment, and the Corporation shall
then be given the opportunity, within thirty (30) days of its
receipt of such notice, to cure said event; provided, however,
there shall be no period permitted to cure a second occurrence of
the same event and in no event will there be any period to cure
following the occurrence of two events described in this Section
6f.
7. Covenant
Not To Compete and Non-Disclosure of
Information.
a. Covenant
Not To Compete. The Executive acknowledges and recognizes
the highly competitive nature of the Corporation's Business and the
goodwill, continued patronage, and the names and addresses of the
Corporation's Clients (as hereinafter defined) constitute a
substantial asset of the Corporation having been acquired through
considerable time, money and effort. Accordingly, in consideration
of the execution of this Agreement, and as except as may
specifically otherwise approved by the Corporation’s Board of
Directors, the Executive agrees to the following:
(1) That
during the Restricted Period (as hereinafter defined) and within
the Restricted Area (as hereinafter defined), the Executive will
not, individually or in conjunction with others, directly or
indirectly, engage in any Business Activities (as hereinafter
defined), whether as an officer, director, proprietor, employer,
partner, independent contractor, investor (other than as a holder
solely as an investment of less than one percent (1%) of the
outstanding capital stock of a publicly traded corporation),
consultant, advisor, agent or otherwise.
(2) That
during the Restricted Period and within the Restricted Area, the
Executive will not, directly or indirectly, compete with the
Corporation by soliciting, inducing or influencing any of the
Corporation's Clients which have a business relationship with the
Corporation at the time during the Restricted Period to discontinue
or reduce the extent of such relationship with the
Corporation.
(3) That
during the Restricted Period and within the Restricted Area, the
Executive will not (A) directly or indirectly recruit, solicit or
otherwise influence any employee or agent of the Corporation to
discontinue such employment or agency relationship with the
Corporation, or (B) employ or seek to employ, or cause or permit
any business which competes directly or indirectly with the
Business Activities of the Corporation (the "Competitive
Business") to employ or seek to employ for any Competitive
Business any person who is then (or was at any time within two (2)
years prior to the date Executive or the Competitive Business
employs or seeks to employ such person) employed by the
Corporation.
b. Non-Disclosure
of Information. The Executive acknowledges that the
Corporation's trade secrets, private or secret processes, methods
and ideas, as they exist from time to time, customer lists and
information concerning the Corporation's sources, products,
services, pricing, training methods, development, technical
information, marketing activities and procedures, credit and
financial data concerning the Corporation and/or the Corporation's
Clients, and (the "Proprietary
Information") are valuable, special and unique assets of the
Corporation, access to and knowledge of which are essential to the
performance of the Executive hereunder. In light of the highly
competitive nature of the industry in which the Corporation's
business is conducted, the Executive agrees that all Proprietary
Information, heretofore or in the future obtained by the Executive
as a result of the Executive's association with the Corporation
shall be considered confidential.
In
recognition of this fact, the Executive agrees that the Executive,
during the Restricted Period, will not use or disclose any of such
Proprietary Information for the Executive's own purposes or for the
benefit of any person or other entity or organization (except the
Corporation) under any circumstances unless such Proprietary
Information has been publicly disclosed generally or, unless upon
written advice of legal counsel reasonably satisfactory to the
Corporation, the Executive is legally required to disclose such
Proprietary Information. Documents (as hereinafter defined)
prepared by the Executive or that come into the Executive's
possession during the Executive's association with the Corporation
are and remain the property of the Corporation, and when this
Agreement terminates, such Documents shall be returned to the
Corporation at the Corporation's principal place of business, as
provided in the Notice provision (Section 10) of this
Agreement.
c. Documents.
"Documents"
shall mean all original written, recorded, or graphic matters
whatsoever, and any and all copies thereof, including, but not
limited to: papers; books; records; tangible things;
correspondence; communications; telex messages; memoranda;
work-papers; reports; affidavits; statements; summaries; analyses;
evaluations; client records and information; agreements; agendas;
advertisements; instructions; charges; manuals; brochures;
publications; directories; industry lists; schedules; price lists;
client lists; statistical records; training manuals; computer
printouts; books of account, records and invoices reflecting
business operations; all things similar to any of the foregoing
however denominated. In all cases where originals are not
available, the term "Documents" shall also mean identical copies of
original documents or non-identical copies thereof.
d. Corporation's
Clients. The "Corporation's
Clients" shall be deemed to be any persons, partnerships,
corporations, professional associations or other organizations for
or with whom the Corporation
has performed Business Activities,
including, but not limited to, suppliers or vendors with whom the
Corporation has done or is endeavoring to do
business.
e. Restrictive
Period. The "Restrictive
Period" shall be deemed to be one (1) year following
termination of this Agreement.
f. Restricted
Area. The "Restricted
Area" shall be deemed to mean the United
States.
g. Business
Activities. "Business
Activities" shall be deemed to any business activities
concerning owning, operating, managing, promoting or
soliciting clients for the
Corporation’s Business, and any additional activities
which the Corporation or any of its affiliates may engage in during
any portion of the twelve (12)
months prior to the termination of Executive's
employment.
h. Covenants
as Essential Elements of this Agreement. It is understood by
and between the parties hereto that the foregoing covenants
contained in Sections 7a and b are essential elements of this
Agreement, and that but for the agreement by the Executive to
comply with such covenants, the Corporation would not have agreed
to enter into this Agreement. Such covenants by the Executive shall
be construed to be agreements independent of any other provisions
of this Agreement. The existence of any other claim or cause of
action, whether predicated on any other provision in this
Agreement, or otherwise, as a result of the relationship between
the parties shall not constitute a defense to the enforcement of
such covenants against the Executive. To
the extent that the covenants contained in this Section 7 may later
be deemed by a court to be too broad to be enforced with respect to
their duration or with respect to any particular activity or
geographic area, the court making such determination shall have the
power to reduce the duration or scope of the provision, and to add
or delete specific words or phrases to or from the provision. The
provision as modified shall then be enforced.
i. Survival
After Termination of Agreement. Notwithstanding anything to
the contrary contained in this Agreement, the covenants in Sections
7a and b shall survive the termination of this Agreement and the
Executive's employment with the Corporation.
j. Remedies.
(1) The
Executive acknowledges and agrees that the Corporation's remedy at
law for a breach or threatened breach of any of the provisions of
Section 7a or b herein would be inadequate and the breach shall be
per se deemed as causing irreparable harm to the Corporation. In
recognition of this fact, in the event of a breach by the Executive
of any of the provisions of Section 7a or b, the Executive agrees
that, in addition to any remedy at law available to the
Corporation, including, but not limited to monetary damages, all
rights of the Executive to payment or otherwise under this
Agreement and all amounts then or thereafter due to the Executive
from the Corporation under this Agreement may be terminated and the
Corporation, without posting any bond, shall be entitled to obtain,
and the Executive agrees not to oppose the Corporation's request
for equitable relief in the form of specific performance, temporary
restraining order, temporary or permanent injunction or any other
equitable remedy which may then be available to the
Corporation.
(2) The
Executive acknowledges that the granting of a temporary injunction,
temporary restraining order or permanent injunction merely
prohibiting the use of Proprietary Information would not be an
adequate remedy upon breach or threatened breach of Section 7a or b
and consequently agrees, upon proof of any such breach, to the
granting of injunctive relief prohibiting any form of competition
with the Corporation. Nothing herein contained shall be construed
as prohibiting the Corporation from pursuing any other remedies
available to it for such breach or threatened breach.
8. Indemnification.
The Executive shall be continue to be covered by the Articles of
Incorporation and By-Laws of the Corporation with respect to
matters occurring on or prior to the date of termination of the
Executive's employment with the Corporation, subject to all the
provisions of North Carolina and Federal law, the Articles of
Incorporation of the Corporation and the By-Laws of the Corporation
then in effect. Such reasonable expenses, including attorneys'
fees, that may be covered by the these indemnification provisions
shall be paid by the Corporation on a current basis in accordance
with such provision, the Corporation's Articles of Incorporation,
By-Laws and North Carolina law. To the extent that any such
payments by the Corporation pursuant to these provisions may be
subject to repayment by the Executive pursuant to the provisions of
the Articles of Incorporation and/or By-Laws, or pursuant to North
Carolina or Federal law, such repayment shall be due and payable by
the Executive to the Corporation within twelve (12) months after
the termination of all proceedings, if any, which relate to such
repayment and to the Corporation's affairs for the period prior to
the date of termination of the Executive's employment with the
Corporation and as to which Executive has been covered by such
applicable provisions.
9. Withholding.
Anything to the contrary notwithstanding, all payments required to
be made by the Corporation hereunder to the Executive or the
Executive's estate or beneficiaries shall be subject to the
withholding of such amounts, if any, relating to tax and other
payroll deductions as the Corporation may reasonably determine it
should withhold pursuant to any applicable law or regulation. In
lieu of withholding such amounts, the Corporation may accept other
arrangements pursuant to which it is satisfied that such tax and
other payroll obligations will be satisfied in a manner complying
with applicable law or regulation.
10. Notices.
Any notice required or permitted to be given under the terms of
this Agreement shall be sufficient if in writing and if sent
postage prepaid by registered or certified mail, return receipt
requested; by overnight delivery; by courier; or by confirmed
telecopy, in the case of the Executive to the Executive's last
place of business or residence as shown on the records of the
Corporation, or in the case of the Corporation to its principal
office as set forth in the first paragraph of this Agreement, or at
such other place as it may designate.
11. Waiver.
Unless agreed in writing, the failure of either party, at any time,
to require performance by the other of any provisions hereunder
shall not affect its right thereafter to enforce the same, nor
shall a waiver by either party of any breach of any provision
hereof be taken or held to be a waiver of any other preceding or
succeeding breach of any term or provision of this Agreement. No
extension of time for the performance of any obligation or act
shall be deemed to be an extension of time for the performance of
any other obligation or act hereunder.
12. Completeness
and Modification. This Agreement constitutes the entire
understanding between the parties hereto superseding all prior and
contemporaneous agreements or understandings among the parties
hereto concerning the Agreement. This Agreement may be amended,
modified, superseded or canceled, and any of the terms, covenants,
representations, warranties or conditions hereof may be waived,
only by a written instrument executed by the parties or, in the
case of a waiver, by the party to be charged.
13. Counterparts.
This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original but all of which shall constitute
but one agreement.
14. Binding
Effect/Assignment. This Agreement shall be binding upon the
parties hereto, their heirs, legal representatives, successors and
assigns. This Agreement shall not be assignable by the Executive
but shall be assignable by the Corporation in connection with the
sale, transfer or other disposition of its business or to any of
the Corporation's affiliates controlled by or under common control
with the Corporation.
15. Governing
Law. This Agreement shall become valid when executed and
accepted by Corporation. The parties agree that it shall be deemed
made and entered into in the State of North Carolina and shall be
governed and construed under and in accordance with the laws of the
State of North Carolina. Anything in this Agreement to the contrary
notwithstanding, the Executive shall conduct the Executive's
business in a lawful manner and faithfully comply with applicable
laws or regulations of the state, city or other political
subdivision in which the Executive is located.
16. Further
Assurances. All parties hereto shall execute and deliver
such other instruments and do such other acts as may be necessary
to carry out the intent and purposes of this
Agreement.
17. Headings.
The headings of the sections are for convenience only and shall not
control or affect the meaning or construction or limit the scope or
intent of any of the provisions of this Agreement.
18. Survival.
Any termination of this Agreement shall not, however, affect the
ongoing provisions of this Agreement which shall survive such
termination in accordance with their terms.
19. Severability.
The invalidity or unenforceability, in whole or in part, of any
covenant, promise or undertaking, or any section, subsection,
paragraph, sentence, clause, phrase or word or of any provision of
this Agreement shall not affect the validity or enforceability of
the remaining portions thereof.
20. Enforcement.
Should it become necessary for any party to institute legal action
to enforce the terms and conditions of this Agreement, the
successful party will be awarded reasonable attorneys' fees at all
trial and appellate levels, expenses and costs.
21. Venue.
Corporation and Executive acknowledge and agree that the U.S.
District for the State of North Carolina, or if such court lacks
jurisdiction, the State of North Carolina(or its successor) in and
for Mecklenburg County, North Carolina, shall be the venue and
exclusive proper forum in which to adjudicate any case or
controversy arising either, directly or indirectly, under or in
connection with this Agreement and the parties further agree that,
in the event of litigation arising out of or in connection with
this Agreement in these courts, they will not contest or challenge
the jurisdiction or venue of these courts.
22. Construction.
This Agreement shall be construed within the fair meaning of each
of its terms and not against the party drafting the
document.
23. Role
of Counsel. The Executive acknowledges his understanding
that this Agreement was prepared at the request of the Corporation
by Pearlman Law Group LLP, its counsel, and that such firm did not
represent the Executive in conjunction with this Agreement or any
of the related transactions. The Executive, as further evidenced by
his signature below, acknowledges that he has had the opportunity
to obtain the advice of independent counsel of his choosing prior
to his execution of this Agreement and that he has availed himself
of this opportunity to the extent he deemed necessary and
advisable.
THE EXECUTIVE ACKNOWLEDGES THAT THE EXECUTIVE HAS READ ALL OF THE
TERMS OF THIS AGREEMENT, UNDERSTANDS THE AGREEMENT, AND AGREES TO
ABIDE BY ITS TERMS AND CONDITIONS.
IN WITNESS WHEREOF, the parties have
executed this Agreement as of date set forth in the first paragraph
of this Agreement.
Witness:
THE COMPANY:
_____________________________
LEVEL BRANDS, INC.
_____________________________
By: /s/ Martin A.
Sumichrast
Martin A. Sumichrast, CEO
Witness:
THE EXECUTIVE
_____________________________
/s/ Mark
Elliot
_____________________________
Mark
Elliot
Exhibit
6.16
Exhibit
6.17
FILLER
SUPPLY AGREEMENT
THIS
FILLER SUPPLY AGREEMENT (including all Exhibits hereto, the
"Agreement") is made and entered into as of __________ (the
"Effective Date"), between Beauty and Pinups, LLC, a North Carolina
limited liability company ("BPU"), and ___________ ("Filler").
Certain capitalized words used in this Agreement are defined in
Section 11.
In
consideration of the mutual promises contained in this Agreement
and other good and valuable consideration, the receipt and
sufficiency of which is acknowledged, the parties agree as
follows:
1.
Appointment. During the Term
of this Agreement, BPU appoints Filler, and Filler agrees to serve,
as BPU's warehouser, filler and related supply servicer on a
non-exclusive basis for its health and beauty care and other
products (“Products”). Filler may use Affiliates to
provide the Services described herein. Filler must ensure that any
Affiliate that provides Services complies with the terms and
conditions of this Agreement.
2.
Product Receipt and
Warehousing.
2.1
Product Receipt.
(a)
BPU shall enter purchase orders for Products to be supplied by
BPU's vendors into the Purchase Order System. Filler will receive
such delivered Products from BPU or BPU's vendors.
(b)
Upon receipt, Filler will unload the Products, perform a quantity
count and verification, conduct a damage check and assessment,
process the receipt of inventory and warehouse the Products in
accordance with Section 2.2.
2.2
Warehousing.
(a)
During the Term of this Agreement, Filler shall use commercially
reasonable means to receive, handle, store and protect the Products
from damage, theft and other adverse events.
(b)
Filler shall store the Products in a secured facility. Only
Filler's employees and agents and BPU's authorized employees and
agents will have access to the Products. Furthermore, BPU
acknowledges that Filler provides warehousing services to third
parties and that not all of the Products will be maintained in
areas of the Filler’s Facilities which are separate from such
third parties' inventory. Notwithstanding the foregoing, Filler
shall take all reasonable measures to ensure that BPU's inventory
is secure and clearly designated as BPU's inventory.
(c)
BPU shall have the right to inspect the Products, in whole or in
part, upon receipt by Filler and shall have the right to reject
such Products; provided, however, that Filler shall bear no
liability for such rejected Products. Filler shall provide a
holding area for Products received whose acceptability is
questionable. BPU will advise Filler on the disposition within five
(5) Business Days of notification by Filler of such questionable
Products.
(d)
Filler shall conduct cycle counts in order to assure the accuracy
of the inventory on an as requested basis by BPU. If stock
differences are found in any inventory, Filler will list gains as
receipts, and losses as deductions, thus correcting the book record
to agree with the actual Products on hand. These changes will be
made on an ongoing basis; provided, however, that Filler shall
promptly notify BPU in writing when such changes are made. Filler
will take such additional physical inventories as reasonably
requested by BPU upon advanced written notice of not less than two
(2) Business Days, the actual costs of which shall be at BPU's
expense. Representatives of BPU may be present during any
inventory.
3.
Order Processing and
Filling.
3.1
Service. Filler shall provide first-level Services to
BPU.
3.2
Order Processing. Filler shall process all BPU’s orders in
accordance herewith.
(a)
After receipt of an order, Filler will fill the order as set forth
on the terms of the purchase order received from BPU from the
inventory of Products at the Filler’s Facilities, (ii) insert
all packing slips in accordance with Section 3.2(c) below, and
(iii) pursuant to BPU's instructions, and based upon availability
of Products in stock, ship the order to BPU’s designated
party and location either as a multiple shipment or as one
shipment. Filler shall use a common carrier agreed to by BPU. In
the event that Filler does not have a Product in stock in order to
fill an order (a "Backordered Product"), Filler agrees to act in
accordance with Section 3.2(e) below. Furthermore, Filler shall
obtain written approval from BPU before changing agreed-upon common
carriers.
(b)
Filler will acknowledge receipt of orders to BPU in accordance with
BPU’s specifications, which may change from time to time.
Acknowledgment will be made promptly after an order is received by
Filler and will identify the availability of the
Products.
(c)
Filler will print all packing slips, including printing the text of
any special message requested by BPU on the standard packing slip.
Filler will insert the standard packing slip and all additional
packing slips requested by BPU. Furthermore, Filler will print and
apply recipient’s addresses or affix shipping labels on
orders being shipped to recipient as part of its
Services.
(d)
Filler will make available on its Order Management System all
orders filled by Filler on the preceding Business Day and which
includes the following information for each such order: the order
number, the recipient’s name and address, an itemization of
Products shipped, the price charged by Filler to BPU for each
Product and shipping charges.
(e)
Filler shall promptly enter into the Order Management System any
Backordered Products so that BPU may promptly identify which
Products need to be supplied. Upon receipt of any Backordered
Products, Filler shall follow the procedures set forth in Section
3.2(a). For purposes of Section 3.2(a), orders for Backordered
Products shall be deemed to have been placed upon the date the
Backordered Products are received into inventory by
Filler.
3.4
Other Services. In the event that BPU requires services that exceed
the scope or extent of the Services provided for herein, including
other premium services ("New Services"), and if Filler agrees to
provide such New Services, BPU and Filler shall negotiate in good
faith the terms and conditions, including price, under which Filler
shall provide New Services. In the event that the parties agree to
New Services, the scope and duration of the New Services shall be
described in an addendum to Exhibit B hereto and thereafter
such New Services shall be considered Services hereunder. BPU may
elect to reduce or terminate any of the New Services upon not less
than thirty (30) days' prior written notice to Filler. Except as
otherwise provided herein, to the extent BPU elects to reduce or
terminate any of the Services or to the extent the parties mutually
agree to cancel or terminate any of the New Services, such services
shall be deemed modified or deleted, as applicable, from the
appropriate Exhibit hereto, with the remaining services thereafter
constituting the Services.
3.5
Insurance. Filler shall maintain at all times during the Term of
this Agreement insurance as provided below and shall name BPU and
Level Beauty Group, Inc. as additional insureds to the extent of
indemnity provided herein under its liability policies as
follows:
(a)
Commercial general liability insurance including
premises/operations, broad form property damage, independent
contractors, and contractual liability covering Filler's
obligations hereunder for bodily injury and property damage, with a
combined single limit of not less than $1,000,000 each occurrence
and $5,000,000 umbrella coverage.
(b)
Workers' compensation insurance in statutory amounts covering
Filler and its employees, and employer's liability insurance in an
amount not less than $500,000 per accident/disease.
(e)
All insurance required above shall be carried with insurance
companies licensed to do business in the state(s) where operations
are maintained with a rating of no less than A-. Filler shall
deliver to BPU, upon execution of the contract, certificates of
insurance as evidence of the required coverages. Filler agrees that
these policies shall not be canceled or materially changed without
not less than thirty (30) days' prior written notice to BPU. Such
notice shall include written confirmation and details of
replacement insurance coverages and other material revisions to the
policies, which shall be effective immediately upon any
cancellation or material change in Filler's policies in order that
no gap in coverage results.
4.
Terms and Conditions. The
Terms and Conditions for each order and transaction under this
Agreement are attached hereto as Exhibit A, and shall be
incorporated by reference into this Agreement. In the event of any
inconsistency between the body of this Agreement and the Terms and
Conditions, the body of this Agreement shall control. Subject to
the priority set forth in the previous sentence, any other purchase
order, sales order, acknowledgement or invoice presented from one
party to another party with respect to the Products, Services or
New Services shall be subject to the terms of this Agreement, and
this Agreement shall control over any such other purchase order,
sales order, acknowledgement or invoice in the event of any
inconsistency.
5.
Pricing and Payment
Terms.
5.1
Services will be charged as specified on Exhibit B.
5.2
BPU shall be responsible for collection of all payments for sales
of Products and for the determination and payment of all applicable
taxes, including sales taxes.
5.3
Payment Terms. Filler shall invoice BPU as soon as possible but in
no event more than five (5) Business Days after the end of each
month for such Services rendered in the preceding month. For annual
Services, Filler shall invoice BPU within five (5) Business Days
after the end of each month an amount equal to one-twelfth (1/12th)
of the annual amount specified on Exhibit B for such annual
Services, which will be deemed to be Filler's compensation for
annual Services rendered in the preceding month. All invoices for
Services shall be paid by BPU no later than the thirtieth (30) day
following receipt of the month in which such invoice is received by
BPU.
6.
Term and
Termination.
6.1
Term. The term of this Agreement shall begin on the Effective Date
and shall continue until the first anniversary of the date hereof
(the "Initial Term") or until it is terminated in accordance with
this Section 6 or as otherwise provided herein. The parties agree
that either party may terminate this agreement on sixty (60)
days’ prior written notice to the other party.
6.6
Effect of Termination.
(a)
Filler shall complete all orders placed prior to the effective date
of termination but shall have no responsibility to provide any
further Services to BPU as of the effective date of termination.
Notwithstanding the foregoing, Filler shall cooperate in and take
all reasonable steps as reasonably requested by BPU for the
transition of such Services to such party as may be designated by
BPU. Any pre-approved costs or expenses incurred by Filler in
connection with such transition of Services shall be promptly
reimbursed by BPU.
(b)
Except as necessary to perform its obligations hereunder, Filler
shall return all of BPU's property within ten (10) Business Days
following the effective date of termination.
(c)
Except as necessary to perform its obligations hereunder, all
licenses granted hereunder shall immediately terminate, and Filler
shall immediately discontinue its use of the BPU Marks. In
addition, Filler shall promptly, upon the direction of BPU and at
Filler's sole expense, return or destroy any and all Marks or
Confidential Information of BPU in its possession in any
medium.
7.
Confidentiality.
7.1
Confidential Information. Each party shall cause each of its
Affiliates and each of their officers, directors and employees to
hold all information (the "Confidential Information") relating to
the business of the other party disclosed to it by reason of this
Agreement confidential and will not disclose any of such
Confidential Information to any third party, except as provided in
this Agreement. Each party shall limit disclosure of such
Confidential Information to those of its employees who have a need
to know such Confidential Information and shall inform those
employees to whom such disclosure is made of their obligations of
confidentiality and limited use. The obligations of this Section 7
shall not extend to any Confidential Information:
(a)
that, on or after the date of this Agreement, comes into the public
domain through no fault of a party with a confidentiality
obligation under this Agreement;
(b)
that is disclosed to a party with a confidentiality obligation
under this Agreement, without restriction on disclosure, by a third
party who has the lawful right to make such
disclosure;
(c)
that is required to be disclosed by a party by law, or to a court
or by a Governmental Body (as defined below); or
(d)
that is disclosed to their respective directors, officers.
attorneys, accountants and other advisors, who are under an
obligation of confidentiality, on a "need-to-know"
basis.
8.
Ownership;
Liens.
8.1
Property. Except as agreed between the parties in writing, or as
expressly set forth in this Agreement, BPU (or its licensors, as
applicable) shall own all right, title and interest in and to any
and all property provided to Filler hereunder, and nothing
contained in this Agreement shall be deemed to transfer or convey
to Filler any right, title or interest in or to any such or
property by virtue of its use by Filler in relation to any Service
provided hereunder.
8.2
Trademarks. Subject to the terms and conditions set forth herein,
BPU hereby grants to Filler, and Filler hereby accepts, a
non-exclusive, royalty-free, non-transferable (without any right to
sublicense), limited license to use, publish and display such
trademarks, service marks, trade names, service names or other
marks, registered or otherwise, as may be provided by BPU
(collectively, the "BPU Marks"), solely as required to perform
Filler's obligations hereunder. All use by Filler of the BPU Marks
shall conform to the usage guidelines provided by BPU, which
guidelines may be updated from time to time. In the event that BPU
notifies Filler of any incorrect usage of the BPU Marks, Filler
shall promptly correct such usage. BPU (or its Affiliates) shall
own all right, title and interest in and to the BPU Marks. Nothing
contained in this Agreement shall be deemed to transfer or convey
to Filler any ownership rights whatsoever in and to the BPU Marks,
nor will Filler obtain any right, title or interest in the BPU
Marks by virtue of its use under this Agreement. Filler may not
make any modifications or changes to any BPU Mark without the prior
written consent of BPU. Any additional goodwill associated with the
BPU Marks that is created through Filler's use of the BPU Marks
shall inure solely to the benefit of BPU and its Affiliates, and
BPU and its Affiliates shall be the sole entities entitled to
register the BPU Marks. All rights not specifically granted with
respect to the BPU Marks herein are reserved by BPU and its
Affiliates.
8.3
During the Term of this Agreement, Filler shall not allow liens or
encumbrances of any kind to be placed on any of the Products or any
additional property of BPU in the possession of Filler or located
at the Filler’s Facilities other than by BPU.
9.
Relationship of Parties.
Each party hereto is an independent contractor and when its
employees act under the terms of this Agreement, they shall be
deemed at all times to be under the supervision and responsibility
of such party; and no person employed by either party and acting
under the terms of this Agreement shall be deemed to be acting as
agent or employee of such party or any customer of such party for
any purpose whatsoever. Neither of the parties shall act or
represent or hold itself out as having authority to act as an agent
or partner of the other party, or in any way bind or commit the
other party to any obligations. Nothing contained in this Agreement
shall be construed as creating a partnership, joint venture,
agency, trust or other association of any kind, each party being
individually responsible only for its obligations as set forth in
this Agreement.
10.
Force Majeure. Filler shall
be temporarily excused from providing the Services, and BPU shall
be excused from any payment for such Services, during the period of
an applicable Force Majeure event. In the event of any Force
Majeure event lasting more than ten (10) Business Days, BPU may, at
its sole discretion, immediately terminate this Agreement upon
written notice, without penalty.
11.
Miscellaneous.
11.1
Definitions. As used in this Agreement, the following terms have
the following meanings.
"Affiliate"
means any Person who is an "affiliate" as defined in Rule 12b-2 of
the General Rules and Regulations under the Securities Exchange Act
of 1934, and the rules and regulations promulgated
thereunder.
"Business
Day" means any day other than a Saturday, Sunday or other day on
which commercial banks in the State of Illinois are authorized or
required by law or executive order to close. For purposes of this
Agreement, BPU's Business Day ends at 6:00 PM (Central
Time).
"Filler
Facilities" means one (1) or more of Filler's warehouse and filling
facilities as Filler may from time to time designate.
"Force
Majeure" means any cause or condition beyond Filler's reasonable
control, including, without limitation, to acts of God or of the
public enemy; acts of any federal, state or local government or
agency; fires; floods; epidemics; quarantine restrictions; strikes
and labor disputes; war; acts of terrorism; failure of
communications capabilities; earthquakes or general unavailability
of energy or materials.
"Governmental
Body" means any foreign or domestic, federal, territorial, state or
local government authority, quasi-governmental authority,
instrumentality, court, government or self-regulatory organization,
commission, tribunal or organization or any regulatory,
administrative or other agency, or any political or other
subdivision, department, board, bureau or branch or official of any
of the foregoing.
"Order
Management System" means Filler's current inventory and customer
order system or any successor system.
"Person"
means any individual, corporation, partnership, firm, joint
venture, limited liability company, association, joint-stock
company, trust, unincorporated organization, Governmental Body or
other entity.
"Purchase
Order System" means Filler's current purchase order dispatch and
receiving system or any successor system.
"Services"
means all services provided by Filler hereunder.
11.2
Notices. Any notice or other communication required or permitted
hereunder shall be in writing and shall be delivered personally,
sent by facsimile transmission or sent by certified, registered or
overnight courier, postage prepaid. Any such notice shall be deemed
given when so delivered personally, or sent by facsimile
transmission, if delivered by commercial overnight courier service,
one (1) day after delivery or, if mailed, five (5) days after the
date of deposit in the United States mails, to the other party at
their last known address. Either party may, by notice given in
accordance with this Section 11.2 to the other party, designate
another address or Person for receipt of notices
hereunder.
11.3
Entire Agreement. This Agreement (including the Exhibits) contains
the entire agreement among the parties with respect to the
transactions contemplated hereby and supersedes all prior
agreements, written or oral, with respect thereto.
11.4
Waivers and Amendments; Non-Contractual Remedies. This Agreement
may be amended, superseded, canceled, renewed or extended, and the
terms hereof may be waived, only by a written instrument signed by
the parties hereto or, in the case of a waiver, by the party
waiving compliance. No delay on the part of either party in
exercising any right, power or privilege hereunder shall operate as
a waiver thereof, nor shall any waiver on the part of either party
of any such right, power or privilege, nor any single or partial
exercise of any such right, power or privilege, preclude any
further exercise thereof or the exercise of any other such right,
power or privilege.
11.5
Binding Effect; Assignment. This Agreement shall be binding upon
and inure to the benefit of the parties and their respective
successors and legal representatives. This Agreement is not
assignable except by operation of law, except that BPU or Filler
may assign this Agreement to any of its Affiliates or to any
successor to all or substantially all of its business or
assets.
11.6
Counterparts. This Agreement may be executed by the parties hereto
in separate counterparts, each of which when so executed and
delivered shall be an original, but all such counterparts shall
together constitute one and the same instrument. Each counterpart
may consist of a number of copies hereof each signed by less than
all, but together signed by all of the parties hereto. The parties
hereto confirm that any facsimile copy of another party's executed
counterpart of this Agreement (or the signature page thereof) shall
be deemed to be an executed original thereof.
11.7
Exhibits. The Exhibits are a part of this Agreement as if fully set
forth herein. All references herein to Sections and Exhibits shall
be deemed references to such parts of this Agreement, unless the
context shall otherwise require.
11.8
Headings. The headings in this Agreement are for reference only,
and shall not affect the interpretation of this
Agreement.
11.9
Interpretation. Wherever from the context it appears appropriate,
each term stated in either the singular or the plural shall include
the singular and the plural, and pronouns stated in the masculine,
the feminine or neuter gender shall include the masculine, the
feminine and the neuter.
11.10
Certain Acknowledgments. Each of the parties hereto acknowledge
that it has been represented by legal counsel of its own choice
throughout all negotiations and preparation and review of this
Agreement, and that it has executed this Agreement voluntarily.
Each of the parties hereto acknowledge that it is sophisticated in
transactions of the type contemplated by this Agreement and each
party wishes to create a relationship based on the terms set forth
in this Agreement.
11.11
Severability. If any term, provision, covenant or restriction of
this Agreement is held by a court of competent jurisdiction to be
invalid, void or unenforceable, the parties hereto directs that
such court interpret and apply the remainder of this Agreement in
the manner that it determines most closely effectuates their intent
in entering into this Agreement, and in doing so particularly take
into account the relative importance of the term, provision,
covenant or restriction being held invalid, void or
unenforceable.
11.12
Survival. The provisions of Agreement which are contemplated to
survive the termination shall survive.
11.13
Governing Law. This Agreement shall be governed and construed in
accordance with the laws of the State of North Carolina applicable
to agreements made and to be performed entirely within such
State.
[Signature page
follows]
IN
WITNESS WHEREOF, the parties have executed this Filler Supply
Agreement on the date first above written.
Beauty
and Pinups, LLC
______________________________
Name:
________________________
Title:
_________________________
[
]
______________________________
Name:
________________________
Title:
_________________________
Exhibit A
Beauty and Pinups, LLC
Terms and Conditions
1.
ACCEPTANCE, ENTIRE
AGREEMENT AND MODIFICATION. (a) By acceptance of the order,
the party providing the product or goods under this order
(“Seller”) agrees to the terms and conditions contained
herein and incorporated herein by reference, which terms and
conditions shall constitute the entire agreement between the Seller
and Beauty and Pinups, LLC (“Buyer”). Buyer rejects any
additional and inconsistent terms and conditions offered by Seller
at any time and irrespective of Buyer’s acceptance of or
payment for Seller’s items or services. This order shall be
deemed accepted upon the return of the acknowledgment copy of this
order, other verbal or written acceptance or the commencement of
performance by Seller. These terms and conditions constitute the
entire agreement between the parties and no change to or
modification of this order shall be binding upon Buyer unless
signed by an authorized representative of Buyer’s procurement
or purchasing office at Buyer’s place of business issuing
this order.
(b)
Notwithstanding the above, the Parties acknowledge and agree that
in the interest of time certain matters of a practicable business
nature, such as material and product releases, minor changes in
delivery dates, shipment instructions, variances in orders and the
like may be sent by Buyer to Seller via electronic data
interchange, facsimile or telephonic communication. The Parties
agree that such communications, and any deliveries thereunder,
shall constitute part of this order and be subject to these terms
and conditions.
2.
PRICES, TAXES, CASH
DISCOUNTS AND NEW MATERIAL. Seller warrants that each price
for items sold to Buyer under this order is no less favorable than
that extended during the term of this order to any other customer
for the same or like items in equal or less quantities. Unless
otherwise provided on the face of this order, the prices appearing
herein include all packaging, crating and federal, state and local
taxes.
3.
DRAWINGS AND
DATA. All drawings,
data, designs, engineering instructions, models, specifications or
other technical information, written, oral or otherwise, supplied
by or on behalf of Buyer or prepared by Seller specifically in
connection with performance of this order (hereinafter
“Information”) shall be and remain the property of
Buyer. Seller shall not use or disclose such Information except in
the performance of orders for Buyer and upon Buyer’s request
such Information and all copies thereof shall immediately be
returned to Buyer. Where such Information is furnished to
Seller’s suppliers for procurement of supplies by Seller for
use in the performance of Buyer’s orders, Seller shall insert
the substance of this provision in any purchase order or
subcontract hereunder.
4.
CHANGES.
Buyer may at any time by a written order, make changes in any one
or more of the following: (a) drawings, designs or specifications
where the items to be furnished are to be specifically manufactured
for the Buyer in accordance herewith, (b) method of shipment or
packing, or (c) place or time of inspection, delivery or
acceptance. If any such change causes an increase or decrease in
the cost of or time required for the performance of this order, an
equitable adjustment shall be made in the price or delivery
schedule or both.
5.
STOP WORK
ORDERS. Buyer may at
any time by written order, stop all or any part of the work under
this order for a period of 90 days. At any time, during such
period, Buyer may with respect to all or any part of the work
covered by the stop work order, either cancel the stop work order
or terminate the work in accordance with subparagraph (a) or (b) of
the “Termination” clause of this order. To the extent
the stop work order is canceled or expires, Seller shall resume
work. If a stop work order has a material effect on cost of
delivery, an equitable adjustment shall be made in the price
(excluding profit) or the delivery schedule or both.
6.
DELIVERIES AND
SHIPMENTS. Time is of
the essence in making deliveries under this order. Unless otherwise
specified in this order, risk of loss for each item delivered
pursuant to this order shall pass to Buyer upon delivery to
Buyer’s factory or designated delivery location and delivery
shall be F.O.B. destination. If delivery is to be in accordance
with Buyer’s written releases, Seller shall not procure,
fabricate, assemble or ship any item except to the extent
authorized by the Buyer in such written releases. Unless otherwise
specified on the face of this order, no variation in the quantity
is authorized for shipment. All items are to be suitably prepared
for shipment and must be packed and shipped in accordance with the
governing classification and tariffs applicable
thereto.
7.
INSPECTION AND
QUALITY CONTROL.
Notwithstanding (a) payment, (b) passage of title or (c) prior
inspection or test, all items are subject to final inspection and
acceptance or rejection at destination stated herein. Seller shall
provide and maintain quality control and inspection systems
acceptable to Buyer.
8.
WARRANTY.
Unless otherwise stated on the face of this order, Seller warrants
to Buyer its successors, assigns and customers that all items
furnished (including all replacement items and all replacement or
corrected components which Seller furnishes pursuant to this
warranty) (a) will be free from defects in materials and
workmanship for a period of two years, (b) will conform to
applicable drawings, specifications, samples and other descriptions
furnished or specified by Buyer and to the extent such items are
not of a detailed design furnished by Buyer, (c) will be
merchantable, suitable for the intended purposes and free from all
other defects, including defects in design, and (d) will be free
from any and all security interests, claims, demands, liens or
other encumbrances. In the event Seller is required to replace or
correct any component of any item pursuant to a breach of the
foregoing warranty, the running of the warranty period for the item
of which the defective component is a part, shall be suspended from
the date Seller receives notice of the breach of warranty until the
date the component is replaced or corrected. Buyer’s approval
of Seller’s samples or first articles shall not be construed
as a waiver by the Buyer of any requirement of the drawings,
specifications and/or other referenced descriptions applicable
hereto or of any express or implied warranty.
9.
DEFECTIVE OR
NONCONFORMING ITEMS/BREACH OF WARRANTY. In the event of Seller’s
delivery of defective or nonconforming items or Seller’s
breach of warranty, Buyer may at its election and in addition to
any other rights or remedies it may have at law or equity or under
this order, recover from Seller any costs of removing such items
from property or products in which such items have been
incorporated, and any additional costs of reinstallation,
reinspection and retesting and (a) return the items at
Seller’s risk and expense and recover from Seller the price
paid therefore and, if elected by Buyer, purchase or manufacture
similar items and recover from Seller the costs and expenses
thereof, (b) accept or retain the items and equitably reduce their
price, or (c) require Seller, at Seller’s expense to promptly
replace or correct the items and pending redelivery, to repay Buyer
any amount Seller’s customer paid for such items. If Seller
fails to promptly replace or correct such items as directed by
Buyer, Buyer may repair them or have them repaired at
Seller’s expense or purchase or manufacture similar items and
recover from Seller the costs and expenses thereof.
10.
TERMINATION.
Buyer may terminate this order in whole or in part at any time by
written notice stating the extent and effective date of such
termination. Upon receipt thereof, Seller shall to the extent
directed by Buyer (i) stop work under this order and place no
further orders relating hereto (ii) terminate work under
outstanding orders, which relate to work terminated by such notice
and (iii) protect property in Seller’s possession in which
Buyer has or may acquire an interest. Buyer reserves the right to
terminate this order in whole or in part for default (i) if Seller
fails to perform in accordance with any of the requirements of this
order or to make progress so as to endanger performance hereunder,
or (ii) if Seller becomes insolvent or suspends any of its
operations or if any petition is filed or proceeding commenced by
or against Seller under any state or federal law relating to
bankruptcy, arrangement, reorganization, receivership or assignment
for the benefit of creditors. Any such termination will be without
liability to Buyer for any or all property produced or procured by
Seller for performance of the work terminated and Seller shall be
credited with the reasonable value thereof not to exceed
Seller’s cost.
11.
EXCUSABLE
DELAYS. Neither party
shall be in default for any delay or failure to perform hereunder
due to causes beyond its control and without its fault or
negligence, provided that any delay or failure to perform caused by
default of a supplier of the Seller, must be beyond the control of
both Seller and such supplier and without the fault of or
negligence of either and the items to be furnished must not be
obtainable from other sources in sufficient time to permit Seller
to meet the delivery schedule and provided further, that Seller
furnishes prompt written notice to Buyer of the occurrence of any
such cause which will or may delay Seller’s
performance.
13.
INDEMNIFICATION.
Seller shall indemnify and hold Buyer harmless, its employees,
agents and invitees from and against all liability, demands,
claims, loss, cost, damage and expenses by reason of or on account
of property damage, death and personal injury of whatsoever nature
or kind arising out of, as a result of, or in connection with the
performance of the order and the Filler Supply Agreement entered
into between the parties which is occasioned by the acts or
omissions of Seller or its suppliers.
16.
ASSIGNMENT AND
SUBCONTRACTING. Any
assignment of this order or the work to be performed, in whole or
in part, or of any other interest hereunder, without Buyer’s
written consent shall be void. Seller agrees not to subcontract for
any complete or substantially complete materials, supplies and/or
services called for by this order without the prior written
approval of Buyer.
17.
RIGHTS AND REMEDIES
OF BUYER. The rights
and remedies of Buyer set forth herein shall be in addition to any
other rights and remedies provided in law or equity and the failure
or delay by Buyer to exercise any rights or remedies hereunder
shall not operate as a waiver thereof, or preclude the exercise of
any other rights or remedies.
18.
GOVERNING LAW;
DISPUTES. This order
is to be interpreted in accordance with, and its administration and
performance governed by, the laws of the State of North Carolina.
The parties hereto agree that Charlotte, North Carolina shall be the exclusive
forum for any cause of action filed in any court of law or equity
arising out of the execution of or performance under this order.
Notwithstanding the foregoing, in the event Buyer is located
outside the United States of America and purchases items pursuant
to the terms hereof for use outside the United States of America,
any dispute between such Buyer and Seller respecting the items so
purchased shall be finally resolved by arbitration in the English
language in Charlotte, North Carolina, U.S.A. in accordance with
the rules then obtaining of the American Arbitration Association,
and judgment upon the award rendered may be entered in any court
having jurisdiction thereof.
Exhibit
B
Pricing Structure
For
Beauty & Pin Ups
The prices below include warehousing and filling and other related
Services. Prices are based upon Scope of Work outlined
below.
[to follow]
Exhibit 6.18
WHOLESALE LICENSE AGREEMENT
THIS WHOLESALE LICENSE AGREEMENT (this
“Agreement”) is made and entered into as of the
12th day
of January, 2017, by and between kathy ireland WorldWide, a
California corporation (“Licensor”), and I|M 1, LLC, a
California limited liability company
(“Licensee”).
WITNESSETH
WHEREAS, Licensor is, and for many years
has been, engaged in the creation, design, development, improvement
and branding of various products and, by virtue of its many years
in the business and the excellence of its branded products,
Licensor has acquired a valuable reputation and good will for
itself and its branded products; and
WHEREAS, Licensor desires to license to
Licensee the mark, intellectual property and other rights in
connection with “I|M1”and all trade
names, trademarks and service marks related to such intellectual
property, including any derivatives, modifications and goodwill
associated with the same; and
WHEREAS, Licensee desires to sublicense
the Marks pursuant to license agreements with third parties for the
manufacture, marketing and sale of products utilizing the Marks
(“Sublicense Agreements” or “Sublicense
Agreement”);
AGREEMENT
NOW, THEREFORE, in consideration of the
premises and the mutual agreements herein contained, as well as
other good and valuable consideration to Licensor in connection
herewith and other agreements being entered into concurrently
herewith, the parties hereto agree as follows:
(a)
Exclusive, Royalty Free Grant of Rights
Pursuant to a Sublicense Agreement. Subject to any
restrictions set forth herein, Licensor hereby grants to Licensee
an exclusive, royalty free right and license to use, assign and
sublicense the Marks anywhere in the world pursuant to a Sublicense
Agreement, and to cause the manufacture, marketing and sale of any
products sold under or otherwise using the Marks to be
manufactured, marketed or sold pursuant to a Sublicense Agreement.
For purposes hereof, “Marks” shall mean all trade
names, trademarks and service marks now used or registered by
Licensor or which Licensor may use or register during the term of
this Agreement in any countries of the world with respect to the
Marks set forth on Exhibit
A, attached hereto and made a part hereof, including any
derivatives, modifications and goodwill associated
therewith.
(b)
No Rights in Licensor’s Other
Intellectual Property. Licensee agrees not to use, assign or
sublicense, during the term of this Agreement or at any time
thereafter, any other trademark, service mark, trade or business
name or other intellectual property of Licensor (other than those
included in the Marks).
(c)
Licensor Approval of Sublicense
Agreements. Prior to entering any Sublicense Agreement
between Licensee and any other party for the sublicense, assignment
or transfer of any rights to the Marks, Licensee must obtain the
written consent of Licensor to such Sublicense Agreement, which may
be withheld at Licensor’s sole discretion.
(d)
Jurisdiction Registrations. Each party
shall have the right anywhere in the world to file and prosecute to
issuance at its own expense applications for letters patent or
registrations of trade names, trademarks or service marks relating
to the Marks, but in any such event the application or registration
shall be in the name of Licensor and Licensor shall be the sole
owner of any such letters patent, trade names, trademarks or
service marks, subject only to the terms of this Agreement;
provided, however, that before taking any action under this
subparagraph, Licensee shall notify Licensor of its intention to do
so, and Licensor shall have the right within sixty days after such
notice at its own expense to take such action or any other action
it deems necessary or which may be lawfully available, in which
event Licensee shall not proceed to take the proposed action set
forth in its notice. Each party will keep the other fully informed
of its activities with respect to the filing of patent applications
or registering trade names, trademarks or service marks in
connection with the Products. In the event that Licensor determines
not to take necessary measures to maintain any such letters patent,
trademarks, service marks or trade names, Licensor shall notify
Licensee of such determination in writing and, thereafter, Licensee
shall have the right, at its own expense, to take any such measures
as may by it be deemed advisable to maintain such coverage;
provided, however, that Licensee shall not thereafter be obligated
to maintain such coverage.
2.
Sales
Promotion; Brand Development.
Licensee agrees at
all times to use efforts reasonably consistent with its resources
to promote and develop the sale of the products under any
Sublicense Agreements. Licensee will work diligently to conduct
market research and design support and to develop a merchandise
strategy and business plan for the Brand development representing
the Marks.
3.
Duration and Termination.
(a)
10 year-term. This Agreement shall be
effective as of the date first written above and remain in force
and effect until the tenth anniversary of the date first written
above, unless earlier terminated as hereinafter
provided.
(b)
Termination Events. Licensor shall have
the right to immediately terminate this Agreement by notice of
termination to the Licensee upon any of the following, unless
Licensor consents to such action or event: (i) Licensee terminates
or removes any officers or appoints additional officers, (ii) if
Level Brands, Inc. (“Level”) ceases to be the Manager
of Licensee and any new Manager is appointed without
Licensor’s approval, or (iii) if Level competes with, or
invests in businesses that competes with Licensee.
(c)
Mutual Consent. This Agreement may be
terminated at any time by mutual consent of both
parties.
(d)
Bankruptcy. In the event of
governmental expropriation of a substantial portion of the business
of either party or in the event of an appointment of a receiver,
trustee, liquidator, assignee, custodian, sequestrator or the like
of either party hereto or of a substantial part of such
party’s property or in the event that either party hereto
shall (i) be dissolved or liquidated (except as an incident to
a permitted merger or consolidation), (ii) apply or consent to
the appointment of or the taking of possession by a receiver,
trustee, liquidator, assignee, custodian, sequestrator or the like
of itself or of a substantial part of its property,
(iii) become bankrupt or insolvent, (iv) make a general
assignment for the benefit of creditors, (v) file a petition
in bankruptcy or a petition or answer seeking reorganization with
creditors or to take advantage of any insolvency law or an answer
admitting the material allegations of a petition filed against it
in any bankruptcy, reorganization under any insolvency or similar
law; then and upon the occurrence of any of such events, this
Agreement may be cancelled and terminated immediately by the other
party by giving notice of termination to the first
party.
(e)
Effect of Termination. No termination
of this Agreement pursuant to any cause whatsoever shall release
either party from liability to the other party with respect to any
payments of monies already accrued, any liabilities arising under
the provisions hereof. Termination of this Agreement shall not
terminate any Sublicense Agreements, which shall terminate in
accordance with their terms.
This
Agreement may not in whole or in part be assigned, voluntarily or
by operation of law, or otherwise transferred to others by either
party without the written consent of the other party.
This
Agreement shall be governed by and construed and interpreted in all
respects in accordance with the laws of the State of California to
agreements made and to be performed entirely within such State,
including all matters of construction, validity and performance.
Licensee hereby submits to the jurisdiction of the courts of the
State of California and of the United States of
America.
(a)
This Agreement
shall be binding upon the parties hereto, and their respective
successors and assigns.
(b)
This Agreement may
be modified at any time or from time to time only by the written
agreement of both parties.
(c)
The failure of
either party to require performance by the other party of any
provision hereof, or to enforce any remedies it may have against
the other party, shall in no way affect the right thereafter to
enforce this Agreement and require full performance by the other
party. The waiver by either party of any breach of any provision of
this Agreement shall not constitute a waiver of any succeeding
breach of that provision or of any other provision.
(d)
Neither party
hereto shall, through any affiliated person, corporation,
organization or entity or otherwise, do anything indirectly which
it is prohibited hereunder from doing so directly.
(e)
The parties agree
that Licensee is an independent contractor. Under no circumstances
shall Licensee be considered to be an agent, employee, partner or
representative of Licensor or otherwise attempt to bind
Licensor.
(f)
Except as otherwise
expressly provided herein, if any provisions of this Agreement
shall be adjudicated to be invalid or unenforceable in any action
or proceeding whether in its entirety or in any portion, then such
part shall be deemed amended, if possible, or deleted, as the case
may be, from the Agreement in order to render the remainder of the
Agreement and any provision thereof both valid and enforceable. Any
such deletion or amendment shall apply only where the court
rendering the same has jurisdiction.
(g)
This Agreement
cancels and supersedes all previous agreements, written or oral,
between the parties hereto relating to the subject matter hereof
and constitutes the entire agreement between the parties hereto,
and there are no understandings, representations or warranties
expressed or implied not specifically set forth
herein.
(h)
This Agreement may
be executed in any number of counterparts each of which shall be an
original and taken together shall constitute one and the same
instrument.
[signature
page follows]
IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be executed by their duly authorized
officers and their corporate seals to be hereunto
affixed.
[CORPORATE
SEAL]
kathy ireland
WorldWide
By:/s/
Stephen Roseberry
Title:President
[CORPORATE
SEAL]
I|M 1, LLC, by its
Manager, Level Brands, Inc.
By:/s/
Martin A. Sumichrast
Martin
A. Sumichrast, CEO
Exhibit A
o
Serial No.
87-035,341, application by kathy ireland WorldWide.
o
Publication Date
November 16, 2016; Filing Date May 12, 2016.
●
“Intelligent
Millennials”
Exhibit
6.19
AMENDED
AND RESTATED
LIMITED
LIABILITY COMPANY AGREEMENT
OF
I | M
1, LLC
A
CALIFORNIA LIMITED LIABILITY COMPANY
Effective
Date: January 6, 2017
THE
LIMITED LIABILITY COMPANY MEMBERSHIP UNITS REPRESENTED BY THIS
LIMITED LIABILITY COMPANY AGREEMENT HAVE NOT BEEN REGISTERED WITH
THE SECURITIES AND EXCHANGE COMMISSION UNDER THE SECURITIES ACT OF
1933, AS AMENDED, OR UNDER THE SECURITIES ACTS OR LAWS OF ANY STATE
IN RELIANCE UPON EXEMPTIONS UNDER THOSE ACTS. THE SALE OR OTHER
DISPOSITION OF SUCH MEMBERSHIP UNITS IS RESTRICTED AS STATED IN
THIS LIMITED LIABILITY COMPANY AGREEMENT, AND IN ANY EVENT IS
PROHIBITED UNLESS THE LLC RECEIVES AN OPINION OF COUNSEL
SATISFACTORY TO IT AND ITS COUNSEL THAT SUCH SALE OR OTHER
DISPOSITION CAN BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES ACTS
AND LAWS. BY ACQUIRING MEMBERSHIP UNITS REPRESENTED BY THIS LIMITED
LIABILITY COMPANY AGREEMENT, EACH MEMBER REPRESENTS THAT IT WILL
NOT SELL OR OTHERWISE DISPOSE OF ITS MEMBERSHIP UNITS WITHOUT
COMPLYING WITH THE PROVISIONS OF THIS LIMITED LIABILITY COMPANY
AGREEMENT AND REGISTRATION OR OTHER COMPLIANCE WITH THE AFORESAID
ACTS AND THE RULES AND REGULATIONS ISSUED
THEREUNDER.
AMENDED
AND RESTATED
LIMITED
LIABILITY COMPANY AGREEMENT
OF
I | M
1, LLC
A
CALIFORNIA LIMITED LIABILITY COMPANY
THIS AMENDED AND RESTATED LIMITED LIABILITY
COMPANY AGREEMENT (this “Agreement”) is made and entered
into effective as of January 6, 2017 (the “Effective Date”) by and among the
Persons whose names and addresses are listed on the Information
Exhibit attached hereto as Exhibit A. Unless otherwise
indicated, capitalized words and phrases in this Agreement shall
have the meanings set forth in the Glossary of Terms attached
hereto as Exhibit
B.
RECITALS
A. I
| M 1, LLC, a California limited liability company (the
“LLC”), was
formed pursuant to the Act on September 23, 2016 upon the filing of
the Articles of Organization with the Secretary of State of the
State of California.
B. On
December 29, 2016, the LLC and IM1 Holdings entered into that
certain Limited Liability Company Agreement of the LLC (the
“Original Operating
Agreement”) as the sole member of the
Company.
C. On
the date hereof, (i) Level Brands, Inc., a North Carolina
corporation (“Level”) acquired 583,000 Class A
Units of the LLC from IM1 Holdings pursuant to the Member Interests
Exchange Agreement dated as of January 6, 2017, by and between
Level and IM1 Holdings (the “Exchange Agreement”) and, upon the
execution of this Agreement, Level became a Member.
D. The
undersigned parties hereto wish to amend and restate the Original
Operating Agreement in its entirety as of the date hereof to read
as follows and wish to provide herein for the management and the
conduct of the business and affairs of the LLC and their relative
rights and obligations with respect thereto.
AGREEMENT
In
consideration of the mutual promises of the parties hereto, and
other good and valuable consideration, the receipt and legal
sufficiency of which is hereby acknowledged, the parties hereto,
intending to be legally bound, do hereby agree that the Amended and
Restated Limited Liability Company Agreement of the LLC shall be as
follows:
ARTICLE
I
FORMATION;
GOVERNING LAW
Section
1.1 Formation;
Governing Law; Ratification. The LLC was formed on September
23, 2016 upon the filing of the Articles of Organization with the
Secretary of State of the State of California. The rights and
obligations of the Members and the terms and conditions of the LLC
shall be governed by the Act and this Agreement, including all the
Exhibits to this Agreement. To the extent the Act and this
Agreement are inconsistent with respect to any subject matter
covered in this Agreement, this Agreement shall, to the extent
permitted by the Act, govern. The Manager shall cause to be
executed and filed on behalf of the LLC all other instruments or
documents, and shall do or cause to be done all such filing,
recording or other acts, including the filing of the LLC’s
annual report with the Secretary of State of the State of
California, as may be necessary or appropriate from time to time to
comply with the requirements of law for the continuation and
operation of a limited liability company in California and in the
other states and jurisdictions in which the LLC shall transact
business. The Members and the LLC hereby ratify and approve all
actions taken by the LLC, its Manager and the other Members prior
to the date hereof, including, but not limited to, the appointment
of the new Manager set forth herein, any and all actions taken by
the organizer, the transfer and sale of the membership interests in
the LLC, the actions set forth above in the Recitals, and the class
designations of the Members set forth on Exhibit A attached
hereto.
Section
1.2 Name. The
name of the LLC shall be “I | M 1, LLC”. The name of
the LLC shall be the exclusive property of the LLC and no Member
shall have any commercial rights in the LLC’s name or any
derivation thereof, even if the name contains such Member’s
own name or a derivation thereof. The LLC’s name may be
changed only by an amendment to the Articles of Organization
adopted by the Manager.
Section
1.3 Purposes.
The LLC has been formed for the purpose of engaging in any lawful
business.
Section
1.4 Registered Agent;
Registered Office. The LLC’s registered agent and
registered office are set forth in the Articles of Organization and
may be changed from time to time by the Manager pursuant to the
provisions of the Act.
Section
1.5 Commencement and
Term. The LLC commenced at the time and on the date
appearing in the Articles of Organization and shall continue until
it is dissolved, its affairs are wound up and final liquidating
distributions are made pursuant to this Agreement.
Section
1.6 No State Law
Partnership. The Members intend that the LLC not be a
partnership (including, without limitation, a limited partnership)
or joint venture, and that no Member be a partner or joint venturer
of any other Member by virtue of this Agreement, for any purposes
other than as set forth in the last sentence of this Section 1.6, and neither
this Agreement nor any other document entered into by the LLC or
any Member relating to the subject matter hereof shall be construed
to suggest otherwise. The Members intend that the LLC shall be
treated as a partnership for federal and, if applicable, state or
local income tax purposes, and that each Member and the LLC shall
file all tax returns and shall otherwise take all tax and financial
reporting positions in a manner consistent with such
treatment.
ARTICLE
II
CAPITAL
ACCOUNTS
Section
2.1 Class A Units and
Class B Units. The names, addresses, Capital Contributions
and Units, as of the date hereof are set forth on Information Exhibit. The
Manager shall update the Information Exhibit from time
to time to reflect changes thereto in accordance herewith. In the
event the Information
Exhibit is not so amended, such matters shall be reflected
in the books and records of the LLC, and the books and records of
the LLC shall be controlling. Each Member acknowledges and agrees
that the number and class of Units held by each Member as of the
date of this Agreement is reflected opposite such Member’s
name on the Information Exhibit.
Section
2.2 Additional Capital
Contributions; Participation Rights.
(a) Subject to the
provisions in Article V, the Manager may from time to time
authorize and cause the LLC to issue additional Interests, secured
or unsecured debt obligations of the LLC, debt obligations of the
LLC convertible into Interests, options or warrants to purchase
Interests, or any combination of the foregoing (collectively,
“New
Securities”) with such terms and conditions and in
exchange for such cash or other property as it may determine;
provided, however, no Member shall have any obligation to
contribute additional capital to the LLC except to the extent such
Member exercises its participation rights pursuant to this Section
2.2 or elsewhere as provided in this Agreement. The LLC shall offer
to each Member holding Units the right to purchase all or any
portion of that number of New Securities being issued equal to (i)
the number of New Securities being issued times (ii) a fraction,
the numerator of which is the number of Units held by such Member,
and the denominator of which is the number of Units held by all
Members, on the same terms and subject to the same conditions as
the proposed issuance to others. Any New Securities not initially
subscribed for by the holders of Units (the “Unsubscribed Securities”) shall be
reoffered to those Persons electing initially to purchase their
full proportionate share of New Securities hereunder in proportion
to the number of Units held by them or in such other amounts as
they may agree. Any Unsubscribed Securities not subscribed for by
the Members in accordance with the previous sentence may be offered
to those Persons selected by the Manager. The failure of any Member
to exercise participation rights hereunder shall not alter the
obligation of the Manager to ensure that the issuance of New
Securities is fair to all impacted classes of Units.
(b) Subject to the
provisions in Article V, the LLC shall not (i) issue or sell any
additional Interests, secured or unsecured debt obligations of any
of the Subsidiaries, debt obligations of any of the Subsidiaries
convertible into equity securities, options or warrants to purchase
equity securities, or any combination of the foregoing, or any
securities convertible into, or exchangeable or exercisable for,
any equity securities or debt obligations of any of its
Subsidiaries, or any combination of the foregoing (collectively,
the “Other
Securities”), or (ii) permit any of its Subsidiaries
to issue or sell any Other Securities to any Person that is a
Member or an Affiliate of a Member without offering the Members
holding Units the right to purchase such Other Securities to the
same extent that such Members would be entitled under the
provisions of this Section 2.2 if such issuance or sale of Other
Securities were an issuance of New Securities, and no Member shall,
or shall permit any of its Affiliates to, acquire any Other
Securities other than pursuant to an issuance or sale in accordance
with this sentence. The Manager shall determine the timing and such
other procedures as may be necessary and appropriate to enable the
holders of Units to exercise their rights under this Section 2.2,
provided that in no event shall such Persons be given less than ten
(10) days nor more than thirty (30) days prior notice before being
required to commit to purchase any New Securities or Other
Securities which they may initially become entitled to purchase
pursuant to this Section 2.2. The participation rights set forth in
this Section 2.2 may be waived on behalf of all Members upon the
receipt of both (i) the Approval of the Members and (ii) the
written approval and consent of the holders of at least a majority
of the Class B Units.
Section
2.3 Liability of
Members. No Member shall be liable for any debts or losses
of capital or profits of the LLC or be required to guarantee the
liabilities of the LLC. Except as set forth in Sections 2.1, 2.2
(to the extent such Member exercises its participation rights) and
3.4 of this Agreement, no Member shall be required to contribute or
lend funds to the LLC. In no event shall any Member be liable with
respect to, or be required to contribute capital to restore, a
negative or deficit balance in such Member’s Capital Account
upon the dissolution or liquidation or at any other time of either
the LLC or such Member’s Interest. No Member shall be
entitled to withdraw or demand any part of such Member’s
Capital’s Account. No Member shall be liable for the return
of any other Member’s Capital Contributions; any such return
shall be made solely from the assets of the LLC available
therefore. No interest shall accrue for the benefit of, or be paid
to, any Member on such Member’s Capital Contributions. A
Member has no right to, interest in, or claim against any specific
property of the LLC by reason of the Member's
Interests.
Section
2.4 Maintenance of
Capital Accounts; Withdrawals; Interest. Separate Capital
Accounts amounts shall be maintained for each of the Members. No
Members shall be entitled to withdraw or receive any part of its
Capital Account or receive any distribution with respect to its
Interest except as provided in this Agreement. No Member shall be
entitled to receive any interest on its Capital Account. Each
Member shall look solely to the assets of the LLC for distributions
with respect to its Interest and, except as otherwise provided in
this Agreement, shall have no right or power with respect to its
Interest to demand or receive any property or cash from the LLC. No
Member shall have priority over any other Member as to LLC
distributions or allocations relating to its Units except as
provided in this Agreement.
Section
2.5 Classes of
Units. Each Member shall hold an Interest. Each
Member’s Interest shall be denominated in Units, and the
relative rights, privileges, preferences and obligations with
respect to each Member’s Interest shall be determined under
this Agreement and the Act to the extent herein provided based upon
the number and the class of Units held by such Member with respect
to its Interest. The total number of Units which the LLC initially
shall have authority to issue is One Million One Hundred
Forty-Three Thousand One Hundred and Thirty-Seven (1,143,137),
divided into two (2) classes: Five Hundred Eighty-Three Thousand
(583,000) Class A Units and Five Hundred Sixty Thousand One Hundred
and Thirty-Seven (560,137) Class B Units. The Class A Units and
Class B Units shall be identical and of equal rank, except with
respect to voting rights as provided below. The number and class of
Units held by each Member on the Effective Date is set forth
opposite each Member’s name on the Information Exhibit. On
the date hereof, the total number of Units set forth on the
Information Exhibit (comprising all the Class A Units and Class B
Units) are issued and outstanding. A description of the classes of
Units are as follows:
(a) Class A Units
(Voting). “Class A
Units” shall consist of those Units designated as
Class A Units held by the Members listed on the Information Exhibit
as holding Class A Units. Class A Units shall have all the rights,
privileges, preferences and obligations as are specifically
provided for in this Agreement for Class A Units, and as may
otherwise be generally applicable to all classes of Units, unless
such application is specifically limited to one or more other
classes of Units. On the Effective Date, Class A Units are issued
and are outstanding as set forth on Exhibit A.
(b) Class B Units
(Non-Voting). “Class B
Units” shall consist of those Units designated as
Class B Units held by the Members listed on the Information Exhibit
as holding Class B Units. Class B Units shall, to the extent
permitted by the Act, be “non-voting” Units, but have
all the rights, privileges, preferences and obligations as are
specifically provided for in this Agreement for Class B Units, and
as may otherwise be generally applicable to all classes of Units,
unless such application is specifically limited to one or more
other classes of Units. The only difference in the rights,
privileges, preferences and obligations as between the Class A
Units and the Class B Units shall be that the Class B Units are
“non-voting” Units. On the Effective Date, the Class B
Units issued and are outstanding shall be as set forth on
Exhibit
A.
ARTICLE
III
DISTRIBUTIONS
Section
3.1 Tax
Distributions. To the extent permitted under the Act, within
fifteen (15) days following the end of each Tax Estimation Period,
the Manager shall use commercially reasonable efforts to cause the
LLC to distribute to the Members cash in an amount equal to the
LLC’s Adjusted Taxable Income allocated to such Member for
the Tax Estimation Period in question (provided that the
LLC’s Adjusted Taxable Income is a positive number),
multiplied by the Combined Effective Marginal Tax. Additionally, in
the event that based on the LLC’s tax returns the Manager
determines that the LLC’s actual Adjusted Taxable Income
computed through the end of the preceding Fiscal Year is more than
the amount used for purposes of computing the amount distributable
pursuant to the previous sentence, the Manager shall use
commercially reasonable efforts to cause the LLC to distribute,
within ninety (90) days after the end of that Fiscal Year, any
additional amounts the Manager determines are necessary to account
for the taxes attributable to such increased Adjusted Taxable
Income. If the Manager determines that the tax distributions
pursuant to this Section 3.1 with respect to a Tax Estimation
Period cannot be made in full or that that it is not in the
interest of the Members to make such tax distributions in full,
then the tax distributions shall be made in the highest aggregate
amount the Manager determines to be appropriate and shall be
apportioned among the Members based on their relative entitlement
to distributions pursuant to this Section 3.1.
To the
extent distributions are made pursuant to this Section 3.1, all
such distributions shall be treated as advances against, and thus
shall reduce the amount of, distributions otherwise to be made to
such Member pursuant to this Agreement, including Sections 3.2, 3.3
and 8.3 hereof, currently or in future periods, and such
distributions shall be deemed to have been received pursuant to the
particular Sections or subsections (other than this Section 3.1)
against which the tax distributions are treated as
advances.
Section
3.2 Discretionary
Distributions. At any time prior to a Capital Transaction or
the dissolution of the LLC, the LLC may make discretionary
distributions of cash or property to the extent permitted under the
Act, subject to Section 3.4, in such amounts, at such times and as
of such record dates as the Manager shall determine to the holders
of Class A Units and Class B Units in proportion to the number of
such Units held by them. Distributions under Section 3.2 shall be
made to the Members in the proportion that the number of Units held
by such Person bears to the total number of Units.
Section
3.3 Capital Transaction
Distributions. Proceeds from a Capital Transaction, after
payment of, or adequate provision for, the debts and obligations of
the LLC, shall be distributed and applied in accordance with
Section 3.2.
Section
3.4 Withholding.
In the event any federal, foreign, state or local jurisdiction
requires the LLC to withhold taxes or other amounts with respect to
any Member’s allocable share of Profits, taxable income or
any portion thereof, or with respect to distributions, the LLC
shall withhold from distributions or other amounts then due to such
Member an amount necessary to satisfy the withholding
responsibility and shall pay any amounts withheld to the
appropriate taxing authorities. In such a case, for purposes of
this Agreement the Member for whom the LLC has paid the withholding
tax shall be deemed to have received the withheld distribution or
other amount due and to have paid the withholding tax directly and
such Member’s share of cash distributions or other amounts
due shall be reduced by a corresponding amount.
If it
is anticipated that at the due date of the LLC’s withholding
obligation the Member’s share of cash distributions or other
amounts due is less than the amount of the withholding obligation,
the Member with respect to which the withholding obligation applies
shall pay to the LLC the amount of such shortfall within thirty
(30) days after notice of such shortfall is given to such Member by
the LLC. In the event a Member fails to make the required payment
when due hereunder, and the LLC nevertheless pays the withholding,
in addition to the LLC’s remedies for breach of this
Agreement, the amount paid shall be deemed a recourse loan from the
LLC at the prime rate of interest plus two percent (2%), and the
LLC shall apply all distributions or payments that would otherwise
be made to such Member toward payment of the loan and interest,
which payments or distributions shall be applied first to interest
and then to principal until the loan is repaid in
full.
Section
3.5 Noncash
Distributions. The Manager may cause the LLC to make
distributions to the Members in property (valued for such purpose
at its fair market value determined in good faith by the Manager)
other than in cash in accordance with the provisions of Section
3.2, 3.3 or 8.3, as applicable, so long as such non-cash property
is distributed among all the Members entitled to receive such
distributions in proportion to the total amounts each Member is
entitled to receive in respect of such distributions.
ARTICLE
IV
ALLOCATIONS
Section
4.1 Profits and
Losses. Except as otherwise provided in the Regulatory
Allocations Exhibit, Profits (and items thereof) and Losses (and
items thereof) for each Fiscal Year shall be allocated among the
Members such that the ending Capital Account of each Member,
immediately after giving effect to such allocations, is, as nearly
as possible, equal to (a) the amount of the distributions that
would be made to such Member pursuant to Section 8.3 if (i) the LLC
were dissolved and terminated at the end of the Fiscal Year; (ii)
its affairs were wound up and each asset on hand at the end of the
Fiscal Year were sold for cash equal to its Agreed Value; (iii) all
liabilities of the LLC were satisfied (limited with respect to each
nonrecourse liability to the fair market value of the assets
securing such liability); and (iv) the net assets of the LLC were
distributed to the Members in accordance with Section 8.3; minus
(b) such Member’s share of LLC Minimum Gain and Member
Nonrecourse Debt Minimum Gain, computed immediately prior to the
hypothetical sale of assets.
Section
4.2 Code Section 704(c)
Tax Allocations. Income, gain, loss and deduction with
respect to any Section 704(c) Property shall, solely for tax
purposes, be allocated among the Members so as to take account of
any variation between the adjusted basis of such property to the
LLC for federal income tax purposes and its initial Agreed Value
using any permissible method under Code § 704(c) and the
Treasury Regulations promulgated thereunder, as determined by the
Manager; provided, however, that no method other than the
“traditional method” described in Treasury Regulations
§1.704-3(b) may be selected without the written approval and
consent by holders of at least fifty-one percent (51%) of the Class
B Units. Notwithstanding any other provision of this Agreement,
allocations pursuant to this Section 4.2 are solely for purposes of
federal, state and local taxes and shall not be taken into account
in computing any Member’s Capital Account, share of Profits,
Losses, or distributions (including tax distributions pursuant to
Section 3.1) pursuant to any provision of this
Agreement.
Section
4.3 Miscellaneous.
(a) Allocations
Attributable to Particular Periods. For purposes of determining
Profits, Losses or any other items allocable to any period, such
items shall be determined on a daily, monthly or other basis, as
determined by the Manager using any permissible method under Code
§ 706 and the Treasury Regulations promulgated
thereunder.
(b) Other Items. Except
as otherwise provided in this Agreement, all items of LLC income,
gain, loss, deduction, credit and any other allocations not
otherwise provided for shall be divided among the Members in the
same proportion as they share Profits or Losses, as the case may
be, for the year.
(c) Tax Consequences;
Consistent Reporting. The Members are aware of the income tax
consequences of the allocations made by this Article IV and by the
Regulatory Allocations and hereby agree to be bound by and utilize
those allocations as reflected on the information returns of the
LLC in reporting their shares of LLC income and loss for income tax
purposes. Each Member agrees to report its distributive share of
LLC items of income, gain, loss, deduction and credit on its
separate return in a manner consistent with the reporting of such
items to it by the LLC. Any Member failing to report consistently
shall notify the Internal Revenue Service of the inconsistency as
required by law and shall reimburse the LLC for any legal and
accounting fees incurred by the LLC in connection with any
examination of the LLC by federal or state taxing authorities with
respect to the year for which the Member failed to report
consistently.
ARTICLE
V
ADMINISTRATION AND
MANAGEMENT
Section
5.1 Manager.
Except as otherwise provided in this Agreement, including, but not
limited to, Section 5.2, the overall direction and management of
the business and affairs of the LLC (including, without limitation,
investment and acquisition decisions) shall be the responsibility
of the Manager. The Manager may appoint or remove, from time to
time, one or more officers who shall have and may exercise all the
powers and authority of the Manager in the management of the
business, property and affairs of the LLC as set forth in Section
5.2.
Section
5.2 Officers.
The LLC shall have a President, Chief Financial Officer and
Secretary. The LLC may also have, at the discretion of the Manager,
such other officers as may be appointed by the Manager. The current
officers of the LLC shall continue in such roles until replaced by
the Manager (with to the approval of the Class B
Member).
(a) President. Subject
to such supervisory powers, if any, as may be given by the Manager,
the President shall be the chief executive officer of the LLC and
shall, subject to the control of the Manager, have general
supervision, direction and control of the business and the officers
of the corporation. The President shall preside at all meetings of
the Members. The President shall have the general powers and duties
of management usually vested in the office of president of a
corporation, and shall have such other powers and duties as may be
prescribed by the Manager or this Agreement.
(b) Chief Financial
Officer. The Chief Financial Officer shall keep and maintain, or
cause to be kept and maintained, adequate and correct books and
records of accounts of the properties and business transactions of
the LLC, including accounts of its assets, liabilities, receipts,
disbursements, gains, losses, capital, retained earnings and Units.
The books of account shall at all reasonable times be open to
inspection by the Manager and the Members. The Chief Financial
Officer shall deposit all moneys and other valuables in the name
and to the credit of the LLC with such depositaries as may be
designated by the Manager. The Chief Financial Officer shall
disburse the funds of the LLC as may be ordered by the President or
the Manager, shall render to the President and the Manager,
whenever they request it, an account of all transactions as chief
financial officer and of the financial condition of the
corporation, and shall have such other powers and perform such
other duties as may be prescribed by the Manager or this
Agreement.
(c) Secretary. The
Secretary shall keep or cause to be kept, at the principal
executive office or such other place as the Manager may order, a
book of minutes of all meetings and actions of the Manager and
Members, with the time and place of holding, whether regular or
special, and, if special, how authorized, the notice thereof given,
the names of those present and the number of shares present or
represented at Members’ meetings, and the proceedings
thereof. The Secretary shall keep, or cause to be kept, at the
principal executive office or at the office of the LLC’s
transfer agent or registrar, as determined by the Manager, the
Information Exhibit, or a duplicate of the Information Exhibit,
showing the names of all Members and their addresses, the number
and classes of Units held by each, the number and date of
certificates, if any, issued for the same, and the number and date
of cancellation of any such certificate surrendered for
cancellation. The Information Exhibit shall be kept in written or
electronic form or in any other form capable of being converted
into written or electronic form. The Secretary shall give, or cause
to be given, notice of all meetings of the Members required by this
Agreement or by law to be given, and the Secretary shall keep the
seal of the LLC, if one be adopted, in safe custody, and shall have
such other powers and perform such other duties as may be
prescribed by the Manager or this Agreement.
Section
5.3 Certain
Decisions. Notwithstanding anything to the contrary
contained herein, the following actions shall not be taken by the
LLC or any of its Subsidiaries without the written approval and
consent by holders of at least a majority of the Class B
Units:
(a) the issuance or
creation of any class or series of Units with rights upon
liquidation or otherwise superior or pari passu to the Class B
Units or modification to the preferences and rights of existing
equity securities;
(b) any change to the
authorized number of Units;
(c) any issuances of
New Securities or Other Securities;
(d) any amendment to
this Agreement;
(e) any action
contemplated by Section 8.1;
(f) the
conversion of the LLC into a corporation; and
(g) any transaction,
contract or business arrangement with any Member or Affiliate
thereof, other than the License Agreement (but including any
amendment to the License Agreement).
Section
5.4 Member
Approval. No amendment, variation, or modification of this
Agreement shall be effective or valid if such amendment, variation
or modification alters a Member’s personal liability for any
liability or obligation of the LLC or the Member’s obligation
to make capital contributions or loans to the LLC, unless, in
addition to any other consent or other approval or action required
by this Agreement, such Member (regardless of whether such Member
is otherwise entitled to vote or participate in management under
this Agreement) consents to such amendment, variation or
modification. The Members understand, approve, consent to and
acknowledge that kiWW has entered into the License Agreement with
the LLC for certain intellectual property dated January 6,
2017.
Section
5.5 Effect of
Terminating Event on Manager.
(a) A Person shall
immediately terminate as and cease to be a Manager upon the written
resignation as Manager (a “Terminating Event”).
(b) The termination of
the Manager shall be deemed to occur immediately.
(c) In the event the
Manager, or his successor (if any), ceases to be the Manager
pursuant to the terms above, a new Manager shall be appointed upon
the Approval of the Members.
Section
5.6 Standard of
Care.
(a) In acting on behalf
of the LLC, a Covered Person shall act in good faith and with that
degree of care that an ordinarily prudent Person in a like position
would use under similar circumstances and shall perform diligently
and faithfully the Covered Person's duties for the benefit of the
LLC in accordance with the LLC’s purposes, policies,
procedures and objectives. A Covered Person shall devote such time
and effort to such duties as the Covered Person deems necessary and
appropriate.
(b) In performing any
duty, a Covered Person shall be entitled to rely on information,
opinions, reports or statements, including financial statements and
other financial data, in each case prepared or presented
by:
(i)
one or more agents
or employees of the LLC;
(ii)
counsel, public
accountants, business, investment or financial consultants or
advisors, or other Persons as to matters that such Covered Person
believes to be within such Person's professional or expert
competence; or
(iii)
another Member,
Manager or Officer duly designated in accordance with this
Agreement, as to matters within designated authority of such
Member, Manager or Officer which the Covered Person believes to
merit confidence;
provided that in so
relying, such Covered Person shall be acting in good faith and with
such degree of care, but such Covered Person shall not be
considered to be acting in good faith if such Covered Person has
knowledge concerning the matter in question that would cause such
reliance to be unwarranted.
(c) A Covered Person
performing such Covered Person's duties in accordance with this
Agreement shall have no liability by reason of being or having been
a Covered Person or acting on behalf of the LLC pursuant to the
provisions and authority of this Agreement, unless such liability
shall have been the result of fraud, deceit, gross negligence, bad
faith, willful misconduct or wrongful taking by such Covered
Person.
Section
5.7 Limitation of
Liability. No Covered Person shall be liable to the LLC or
any Member for any damages suffered or incurred by any Person on
account of, or by reason of any claim based on or arising from, any
act taken or omitted to be taken in the course of representing or
performing services for the LLC or otherwise in the capacity as a
Member, Manager or Officer, including, without limitation, the
appointment or retention of, or reliance upon, any employee or
agent of the LLC or any Person except to the extent that a judgment
or other final adjudication (in each case which is not subject to
appeal) adverse to the Covered Person establishes that (a) the acts
of the Covered Person or omissions were in violation of any
provision of this Agreement, or were the result of fraud, deceit,
gross negligence, bad faith, willful misconduct or wrongful taking
by such Covered Person or involved a knowing violation of law, (b)
such Covered Person, in fact, personally gained a financial profit
or other advantage to which such Member, Manager or Officer was not
legally entitled or (c) with respect to a distribution was made in
violation of the Act, the acts of the Covered Person were not
performed in accordance with this Agreement.
Section
5.8 Indemnification.
The LLC shall at all times maintain managers’ and
officers’ insurance coverage, in an amount customary for a
similar business and otherwise in form and substance satisfactory
to the Manager. The LLC shall indemnify each Covered Person and
hold each Covered Person harmless from and against any damages
suffered or incurred by such Covered Person, as such, in the course
of serving in any office of, or otherwise representing or acting
for or on behalf of the LLC (in each case within the scope of the
authority of the Covered Person), except to the extent that a
judgment or other final adjudication (in each case which is not
subject to appeal) adverse to such Covered Person establishes (a)
that acts of the Covered Person were committed in bad faith or were
the result of fraud, deceit, gross negligence, willful misconduct
or wrongful taking or (b) that the Covered Person personally gained
in fact a financial profit or other advantage to which the Covered
Person was not legally entitled; provided that, any other provision
hereof notwithstanding, any such indemnification shall be solely
from the net assets of the LLC, and no Member shall be required to
make any capital contribution or otherwise pay any amount from such
Member's own assets as a result thereof. The LLC may procure
insurance in such amounts and covering such risks as the Manager
determines to be appropriate to fund any indemnification required
or permitted to be made hereunder. Upon making a claim for
indemnification, a Covered Person, as applicable, may request in
writing that the LLC advance to such Covered Person the expenses of
defending the claim, action, suit or proceeding giving rise to such
indemnification claim and the LLC shall advance such expenses;
provided that the Covered Person furnishes the LLC with such
assurances and security as may be reasonably requested by the LLC
to assure repayment of the amounts advanced by the LLC in the event
that a judgment or other final adjudication (in each case which is
not subject to appeal) is rendered holding that such Covered Person
was not entitled to be indemnified by the LLC pursuant to this
Agreement. Any such Covered Person shall agree to return to the LLC
amounts advanced by the LLC in the event that a judgment or other
final adjudication (in each case which is not subject to appeal) is
rendered holding that such Covered Person is or was not entitled to
be indemnified by the LLC in accordance with this Agreement or
applicable law.
Section
5.9 Bank
Accounts. The LLC shall maintain one or more accounts
(including, but not limited to, brokerage, custodial, checking,
cash management and/or money market accounts) in such banks,
brokerage houses or other financial institutions as the Manager may
determine. All amounts deposited by or on behalf of the LLC in
those accounts shall be and remain the property of the LLC and be
used only for the benefit of the LLC. All withdrawals from such
accounts shall be made only by the Manager or any Officer. No funds
of the LLC shall be kept in any account other than an LLC account,
and funds of the LLC shall not be commingled with the funds of any
other Person; and no Member, Manager or Officer shall apply, or
permit any other Person to apply, such funds in any manner, except
for the benefit of the LLC.
Section
5.10 Organizer
Indemnification. The Organizer’s acts and conduct in
connection with the organization of the LLC are hereby ratified and
adopted by the LLC as acts and conduct by and on behalf of the LLC
and are deemed to be in its best interest. The organizational and
other activities for which the Organizer was responsible have been
completed, the LLC is hereby relieved of any further duties and
responsibilities in that regard, and the LLC and the Members hereby
jointly and severally agree to indemnify and hold harmless the
Organizer for any loss, liability, or expense arising from his
actions or conduct in his capacity as organizer of the
LLC.
Section
5.11 Independent
Activities.
(a) The Manager shall
be required to devote only such time to the affairs of the LLC as
the Manager determines in its sole discretion may be necessary to
manage and operate the LLC in accordance with this Agreement, and,
subject to the foregoing, the Manager shall be free to serve any
other Person or enterprise in any capacity that the Manager may
deem appropriate in the Manager’s discretion.
(b) Each Member
acknowledges that the Manager and other Members and their
Affiliates are free to engage or invest in an unlimited number of
activities, businesses or entities, any one or more of which may be
related to the activities or businesses of the LLC (including, but
not limited to, investing in securities or financial instruments
that are the same or similar to those purchased or held by the LLC
or licensing rights that are the same or similar to the rights
licensed to or by the LLC), without having or incurring any
obligation to offer any interest in such activities to the LLC or
any Member, and neither this Agreement nor any activity undertaken
pursuant to this Agreement shall prevent any Member from engaging
in such activities, or require any Member to permit the LLC or any
Member to participate in any such activities, and as a material
part of the consideration for the execution of this Agreement by
each Member, each Member hereby waives, relinquishes, and renounces
any such right or claim of participation. The Members acknowledge
that certain conflicts of interest may thus arise and hereby agree
that the specific rights with respect to the Members' and their
Affiliates' freedom of action provided in this Section 5.11(b) are
sufficient to protect their respective interests in relation to
such possible conflicts and are to be in lieu of all other possible
limitations that might otherwise be implied in fact, in law, or in
equity.
ARTICLE
VI
TRANSFER OF
INTERESTS
Section
6.1 In General.
A Member may not Transfer all or any portion of its Interest or
Units unless such Transfer complies with the provisions of this
Article VI. Any Transfer that does not comply with the provisions
of this Article VI shall be void.
Section
6.2 Limited Exception
for Transfers of Interests. A Member may Transfer all or any
portion of its Units if each of the following conditions are
satisfied:
(a) Prior Notice. The
Member proposing to effect a Transfer of such Units delivers a
Transfer Notice at least twenty (20) days prior to any such
proposed Transfer, which Transfer Notice shall indicate the
transferee of such Units, the number and class of Units to be
transferred and the price and other terms on which the Transfer is
to be effected.
(b) Securities Law
Compliance. Either (i) the Units proposed to be transferred are
registered under the Securities Act and the rules and regulations
thereunder and any applicable state securities laws; or (ii) the
LLC and its counsel determine, in their reasonable discretion, that
the Transfer qualifies for an exemption from the registration
requirements of the Securities Act, any applicable state securities
laws and any securities laws of any applicable jurisdiction and, if
requested by the LLC, counsel to the Member proposing to effect
such Transfer provides a written legal opinion to that
effect.
(c) Member Consent. The
Transfer has received both (i) the Approval of the Members and (ii)
the written approval and consent of the holders of at least a
majority of the Class B Units.
Notwithstanding the
foregoing, the consents required by clause (c) above shall not be
required for a Permitted Transfer. Any attempted Transfer not in
compliance with any of the above conditions shall be null and void,
and the LLC shall not recognize the attempted purchaser, assignee
or transferee for any purpose whatsoever, and the Member attempting
such Transfer shall have breached this Agreement for which the LLC
and the other Members shall have all remedies available for breach
of contract.
Section
6.3 Legends.
Unit certificates, if any are issued, shall have imprinted thereon
a legend substantially to the following effect:
“The
securities represented hereby have not been registered under the
Securities Act of 1933, as amended, or under the securities laws of
any state or other jurisdiction (together, the “Securities Laws”) and may not be
offered for sale, sold or otherwise transferred or encumbered in
the absence of compliance with such Securities
Laws.”
“The sale,
transfer or other disposition or pledge or other encumbrance of
shares represented by this Certificate is subject to an Amended and
Restated Limited Liability Company Agreement dated January 6, 2017
(as may be further amended, restated and otherwise modified from
time to time, the “Agreement”), among I | M 1, LLC, a
California limited liability company (the “Company”), the Member named on
this Certificate and certain other parties named in the Agreement,
which Agreement includes certain restrictions on transfer of the
Units represented by this Certificate. A copy of the Agreement is
on file in the office of the Secretary of the Company and may be
reviewed by application thereto. Each holder hereof shall be bound
by all provisions of the Agreement.”
Section
6.4 Rights of
Assignees. If a Transfer complies with the provisions of the
preceding Section 6.2, but the Person acquiring such Units is not
admitted as a Member as a result of such Person’s failure to
comply with the provisions of Section 6.5, such Person shall become
an assignee with respect to such Units. An assignee with respect to
any Units is entitled only to receive distributions and allocations
with respect to such Units as set forth in this Agreement, and
shall have no other rights, benefits or authority of a Member under
this Agreement or the Act, including no right to receive notices to
which Members are entitled under this Agreement, no right to vote,
no right to inspect the books or records of the LLC, no right to
bring derivative actions on behalf of the LLC, no right to purchase
additional Interests, and no other rights of a Member under the Act
or this Agreement; provided, however, that the Units of an assignee
shall be subject to all of the restrictions, obligations and
limitations under this Agreement and the Act, including the
restrictions on Transfer contained in this Article VI.
Section
6.5 Admission as a
Member. No Person taking or acquiring, by whatever means,
all or any portion of any Units and the Interest represented
thereby shall be admitted as a Member unless such Person (a) elects
to become a Member and, together with its transferor, executes,
acknowledges and delivers to the LLC a written assignment of such
Units and Interest in such form as may be reasonably required by
the Manager as well as a joinder to this Agreement, and (b) such
Person has the Approval of the Members and the written approval and
consent of the holders of at least a majority of the Class B Units
to be a full substitute Member. Any transferee shall automatically
be admitted as a Member of the LLC upon compliance with this
Section 6.5 and shall succeed to all of the rights, restrictions
and obligations of the transferor under this Agreement. The Manager
shall amend the Information Exhibit from time to time to reflect
the admission of Members pursuant to this Section 6.5.
Section
6.6 Distributions and
Allocations With Respect to Transferred Units. If any Units
are transferred in compliance with the provisions of this Article
VI, then (a) Profits, Losses and all other items attributable to
such Units for such period shall be divided and allocated between
the transferor and the transferee by taking into account their
varying interests during such Fiscal Year in accordance with Code
§ 706(d) using any conventions permitted by the Code and
selected by the transferor and transferee in connection with the
transfer and Approved by the Members; (b) all distributions on or
before the date of such Transfer shall be made to the transferor,
and all distributions thereafter shall be made to the transferee;
and (c) the transferee shall succeed to and assume the Capital
Account and other similar items of the transferor to the extent
related to the transferred Units. Solely for purposes of making the
allocations and distributions, the LLC shall recognize such
Transfer not later than the end of the calendar month during which
the LLC receives notice of such Transfer and all of the conditions
in Section 6.2 are satisfied. If the LLC does not receive a notice
stating the date the Units were transferred and such other
information as the LLC may reasonably require within thirty (30)
days after the end of the Fiscal Year during which the Transfer
occurs, then all of such items shall be allocated, and all
distributions shall be made to the Person, who, according to the
books and records of the LLC on the last day of the Fiscal Year
during which the Transfer occurs, was the owner of such Units.
Neither the LLC nor any Member shall incur any liability for making
allocations and distributions in accordance with the provisions of
this Section 6.6, whether or not such Person had knowledge of any
transfer of ownership of any Units.
ARTICLE
VII
MEMBERSHIP
Section
7.1 When Membership
Ceases. A Person who is a Member shall cease to be a Member
upon the Transfer of such Member’s entire Interest as
permitted under this Agreement. A Member is not entitled to
withdraw voluntarily from the LLC.
Section
7.2 Deceased,
Incompetent or Dissolved Members. The personal
representative, executor, administrator, guardian, conservator or
other legal representative of a deceased individual Member or of an
individual Member who has been adjudicated incompetent may exercise
the rights of the Member for the purpose of administration of such
deceased Member’s, estate or such incompetent Member’s
property. The beneficiaries of a deceased Member’s estate
shall become Members of the LLC only upon compliance with the
conditions of this Agreement. If a Member who is a Person other
than an individual is dissolved, the legal representative or
successor of such Person may exercise the rights of the Member
pending liquidation. The distributees of such Person may become
assignees of the dissolved Member only upon compliance with the
conditions of this Agreement.
Section
7.3 Consequences of
Cessation of Membership. In the event a Person ceases to be
a Member as provided in Section 7.1 above, the Person (or the
Person’s successor in interest) shall continue to be liable
for all obligations of the former Member to the LLC and, with
respect to any Interest owned by such Person, shall be an assignee
with only the rights and subject to the restrictions, conditions
and limitations described above.
ARTICLE
VIII
DISSOLUTION,
WINDING UP AND LIQUIDATING DISTRIBUTIONS
Section
8.1 Dissolution
Triggers. The LLC shall dissolve upon the first occurrence
of the following events (“Liquidating Events”):
(a) The determination
by Approval of the Members that the LLC should be
dissolved;
(b) The sale or other
disposition of all or substantially all of the assets of the LLC;
or
(c) The entry of a
decree of judicial dissolution or the administrative dissolution of
the LLC as provided in the Act.
Section
8.2 Winding Up;
Termination. Upon the occurrence of a Liquidating Event, the
LLC shall continue solely for the purpose of winding up its affairs
in an orderly manner, liquidating its assets and satisfying the
claims of its creditors and Members and neither the Manager nor any
Member shall take any action that is inconsistent with, or not
necessary to or appropriate for, the winding up of the LLC’s
business and affairs. The Manager, or, if there is no Manager, a
court appointed liquidating trustee, shall, as promptly as
practicable, take full account of the LLC’s assets and
liabilities and wind up the affairs of the LLC. The Persons charged
with winding up the LLC shall settle and close the LLC’s
business, and dispose of and convey the LLC’s noncash assets
as promptly as reasonably possible following dissolution as is
consistent with obtaining the fair market value for the LLC’s
assets.
Section
8.3 Liquidating
Distributions. Upon a dissolution of the LLC pursuant to
Section 8.1 and subject to the provisions of Section 3.3 relating
to Capital Transactions, the LLC’s cash, the proceeds, if
any, from the disposition of the LLC’s noncash assets and
those noncash assets to be distributed to the Members, shall be
distributed in the following order:
(a) First, to the
LLC’s creditors, including Members who are creditors, to the
extent otherwise permitted by law, in satisfaction of liabilities
of the LLC;
(b) Next, to the
Members who are creditors whose claims are not satisfied by
distributions pursuant to the preceding subsection;
and
(c) Next, to the
holders of Units as set forth in Section 3.2.
ARTICLE
IX
BOOKS
AND RECORDS
Section
9.1 Books and
Records. The LLC shall keep adequate books and records at
its principal place of business, which shall set forth an accurate
account of all transactions of the LLC as well as the other
information required by the Act.
Section
9.2 Taxable Year;
Accounting Methods. The LLC shall use the Fiscal Year as its
taxable year unless otherwise required by applicable law. The LLC
shall report its income for income tax purposes using such method
of accounting selected by the Manager and permitted by
law.
Section
9.3 Information.
(a) Tax Information.
Estimated tax information necessary to enable each Member to
prepare its state, local and foreign income tax returns shall be
delivered to each Member within sixty (60) days of the end of each
tax year. Final tax information necessary to enable each Member to
prepare its state, federal, local and foreign income tax returns
shall be delivered to each Member within seventy-five (75) days of
the end of each tax year.
(b) Other
Information.
(i)
Within forty-five
(45) days of the end of each calendar quarter, the LLC shall
deliver to each Member holding Units an unaudited consolidated
balance sheet and statements of income and cash flows of the LLC
and its Subsidiaries for and as of the end of such quarter, in
reasonable detail, consistently applied (with the exception that no
notes need be attached to such statements and year-end audit
adjustments may not have been made), which statements shall also
set forth year-to-date information.
(ii)
As soon as
available after the close of each calendar year but no later than
one hundred (120) days thereafter, the LLC will deliver to each
Member holding Units an audited consolidated balance sheet and
statements of income and retained earnings and of cash flows of the
LLC and its Subsidiaries audited by a firm of independent certified
public accountants of national standing showing the financial
condition of the LLC and its Subsidiaries as of the close of such
calendar year and the results of the operations of the LLC and its
Subsidiaries during such calendar year, prepared in accordance with
GAAP, consistently applied.
(iii)
The LLC shall
provide to each Member holding Units such other information
relating to the financial condition, business, prospects or
corporate affairs of the LLC and its Subsidiaries as such Member
may from time to time reasonably request.
(c) Confidentiality.
(i)
Each Member agrees
that the provisions of this Agreement, all understandings,
agreements and other arrangements between and among the LLC, the
Members and its and their Affiliates, and all other non-public
information received from or otherwise relating to the LLC, or
disclosed to such Members and/or their Affiliates as a consequence
of or through their relationship with the LLC, shall be
confidential, and shall not be disclosed or otherwise released to
any other Person, other than such Member’s Affiliates and the
attorneys, accountants, agents, representatives, lenders and other
parties having a need to know such confidential information and
with whom such Member or such Member’s Affiliates deal
(collectively, the “Necessary
Parties”). Each Member shall use all reasonable
efforts to cause his, her or its Affiliates and the Necessary
Parties of such Member and its Affiliates to treat such
confidential information as confidential. Each Member shall be
responsible for any breach of this Section 9.3(c) by his, her
or its Affiliates or by any of the Necessary Parties of such Member
or any of his, her or its Affiliates. The obligations hereunder
shall not apply to the extent that the disclosure of information
otherwise confidential is required by applicable law, provided that, prior to disclosing such
confidential information, the applicable Member, Affiliate or
Necessary Party shall notify all other Members thereof, which
notice shall include the basis upon which such Member, Affiliate or
Necessary Party believes the information is required to be
disclosed and, if practicable, shall be delivered at least
seventy-two (72) hours prior to the making of such disclosure, so
that the LLC or such other Members may seek a protective order or
other appropriate remedy and/or waive compliance with the
provisions of this Section 9.3(c)(i).
Notwithstanding anything to the contrary contained herein,
confidential information does not include information received by
any party in connection with the LLC which (a) is or becomes
generally available to the public other than as a result of a
disclosure by such party or its Necessary Parties, or (b) becomes
available to such party on a non-confidential basis from a source
other than the LLC, any other party or any of their respective
Necessary Parties, provided
that such source is not known by such party to be bound by a
confidentiality agreement with or other contractual, legal or
fiduciary obligation of confidentiality to the LLC, any other party
or any other Person with respect to such information.
(ii)
The Company,
Manager and the Members understand that the Company will be deemed
a consolidated reporting entity with the Class A Member, and that
the Class A Member will have accounting and other public reporting
obligations concerning the Company, its financials and its
business. The Company agrees to cooperate with the Class A Member
with respect to any such financial statement consolidation. To the
extent that the Class A Member believes it reasonably necessary to
report on events, financial condition or other confidential
information in its filings with the Securities and Exchange
Commission, any national exchange or other regulatory authority,
the Company and the Members hereby waive any provisions in this
Section 9.3 to the
contrary.
ARTICLE
X
MISCELLANEOUS
Section
10.1 Notices. Any
notice, payment, demand or communication required or permitted to
be given by any provision of this Agreement shall be in writing and
shall be delivered personally to the Person or to an officer of the
Person to whom the same is directed, or sent by registered or
certified United States mail return receipt requested, or by
nationally recognized overnight delivery service, or by electronic
mail to such address provided on the Information Exhibit, addressed
as follows: if to the LLC or the Manager, to the LLC’s
principal office address as set forth in the Articles of
Organization, or to such address provided on the Information
Exhibit, or to such other address as may be specified from time to
time by notice to the Members; if to a Member, to the
Member’s address as set forth on the Information Exhibit, or
to such other address as may be specified from time to time by
notice to the Members; if to the Manager, to the address of the
Manager as set forth in the records of the LLC (with a copy to the
Member entitled to designate the Manager), or to such address
provided on the Information Exhibit, or to such other address as
the Manager may specify from time to time by notice to the Members.
Any such notice shall be deemed to be delivered, given and received
for all purposes as of the date and time of actual
receipt.
Section
10.2 Binding
Effect. Except as otherwise provided in this Agreement,
every covenant, term and provision of this Agreement shall be
binding upon and inure to the benefit of the Members, and their
respective Permitted Transferees, heirs, legatees, legal
representatives and permitted successors, transferees and
assigns.
Section
10.3 Construction.
Every covenant, term and provision of this Agreement shall be
construed simply according to its fair meaning and not strictly for
or against any Member. No provision of this Agreement is to be
interpreted as a penalty upon, or a forfeiture by, any party to
this Agreement. The parties acknowledge that each party to this
Agreement, together with such party’s legal counsel, has
shared equally in the drafting and construction of this Agreement
and, accordingly, no court construing this Agreement shall construe
it more strictly against one party hereto than the other. All
pronouns and any variations thereof shall be deemed to refer to
masculine, feminine or neuter, singular or plural, as the identity
of the Person or Persons may require. Time is of the essence with
respect to each and every term and provision of this
Agreement.
Section
10.4 Entire Agreement;
No Oral Agreements; Amendments to the Agreement. This
Agreement constitutes the entire agreement among the Members with
respect to the affairs of the LLC and the conduct of its business,
and supersedes all prior agreements and understandings, whether
oral or written. The LLC shall have no oral operating agreements.
This Agreement may not be amended without the written Approval of
the Members and written approval and consent by holders of at least
fifty-one percent (51%) of the Class B Units.
Section
10.5 Headings.
Article, Section and other headings contained in this Agreement are
for reference purposes only and are not intended to describe,
interpret, define or limit the scope, extent or intent of this
Agreement or any provision hereof.
Section
10.6 Severability.
Every provision of this Agreement is intended to be severable. If
any term or provision hereof is illegal or invalid for any reason
whatsoever, such illegality or invalidity shall not affect the
validity or legality of the remainder of this
Agreement.
Section
10.7 Additional
Documents. Each Member, upon the request of the Manager,
agrees to perform all further acts and execute, acknowledge and
deliver any documents that may be reasonably necessary, appropriate
or desirable to carry out the provisions of this
Agreement.
Section
10.8 Governing Law;
Consent to Exclusive Jurisdiction; Submission to
Jurisdiction. The laws of the State of California shall
govern the validity of this Agreement, the construction and
interpretation of its terms, the organization and internal affairs
of the LLC and the limited liability of the Members. Each of the
Members (a) agrees not to commence any suit, action or other
proceeding arising out of or based upon this Agreement except in
the federal or state courts of the State of California, and (b)
hereby waives, and agrees not to assert, by way of motion, as a
defense, or otherwise, in any such suit, action or proceeding, any
claim that such Member is not subject personally to the
jurisdiction of the above-named courts, that such Member or such
Member’s property is exempt or immune from attachment or
execution, that the suit, action or proceeding is brought in an
inconvenient forum, that the venue of the suit, action or
proceeding is improper or that this Agreement or the subject matter
hereof may not be enforced in or by such court. Each Member shall
bear its own costs in respect of any disputes arising under this
Agreement. The prevailing party shall be entitled to reasonable
attorneys’ fees, costs, and necessary disbursements in
addition to any other relief to which such party may be entitled.
Each of the Members to this Agreement consents to personal
jurisdiction for any equitable action sought in any federal or
state court of the State of California having subject matter
jurisdiction.
Section
10.9 Waiver of Action
for Partition. Each of the Members irrevocably waives any
right that it may have to maintain any action for partition with
respect to any of the assets of the LLC.
Section
10.10 Counterpart
Execution; Facsimile or Electronic Mail Execution. This
Agreement may be executed in any number of counterparts with the
same effect as if all of the Members had signed the same document.
Such executions may be transmitted to the LLC and/or the other
Members by facsimile or electronic mail and such facsimile or
electronic mail execution shall have the full force and effect of
an original signature. All fully executed counterparts, whether
original, facsimile or electronic mail executions or a combination,
shall be construed together and shall constitute one and the same
agreement.
Section
10.11 Tax Matters
Member. The Manager shall be the “tax matters
partner” of the LLC within the meaning of Code §
6231(a)(7) and the “representative” of the LLC within
the meaning of Code § 6223(a) (as amended by the Bipartisan
Budget Act of 2015) (the “Tax
Matters Member”), and shall serve as the Tax Matters
Member until its successor is duly designated by both the Approval
of the Members and the written approval and consent of the holders
of at least a majority of the Class B Units. The Tax Matters Member
shall have authority to take any action that may be taken by a
“tax matters partner” or a
“representative,” as applicable, under the
Code.
Section
10.12 Creditors.
None of the provisions of this Agreement shall be for the benefit
of or enforced by any creditor of the LLC or of any
Member.
Section
10.13 Remedies
Cumulative. No remedy herein conferred upon any party is
intended to be exclusive of any other remedy, and each and every
such remedy shall be cumulative and shall be in addition to every
other remedy given hereunder or now or hereafter existing at law or
in equity or by statute or otherwise. No single or partial exercise
by any party of any right, power or remedy hereunder shall preclude
any other or further exercise thereof.
Section
10.14 Exhibits.
The Exhibits to this Agreement, each of which is incorporated by
reference, are:
Exhibit
A:
Information
Exhibit
Exhibit
B.
Glossary of
Terms
Exhibit
C:
Regulatory
Allocations Exhibit
[Signature
Page Follows]
IN
WITNESS WHEREOF, the Members and the Manager have executed this
Agreement on the following execution pages, to be effective as of
the Effective Date.
CLASS A
MEMBER
LEVEL
BRANDS, INC.
/s/ Martin A. Sumichrast
Name:
Martin A. Sumichrast
Title:
Chief Executive Officer
CLASS B
MEMBER
IM1
HOLDINGS, LLC
/s/ Stephen Roseberry
Name:
Stephen Roseberry
Title:
President
MANAGER:
Level
Brands, Inc.
/s/ Martin A. Sumichrast
Name:
Martin A. Sumichrast
Title:
Chief Executive Officer
EXHIBIT
A
INFORMATION EXHIBIT
Member
Name and Notice Address
|
Class A
Units
|
Class B
Units
|
|
|
|
Level
Brands, Inc.
4521
Sharon Road, Ste. 450, Charlotte, NC 28211
|
583,000
|
0
|
IM1
Holdings, LLC
39
Princeton Drive, Rancho Mirage, CA
|
0
|
560,137
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals
|
583,000
|
560,137
|
EXHIBIT
B
GLOSSARY OF TERMS
Many of
the capitalized words and phrases used in this Agreement are
defined below. Some defined terms used in this Agreement are
applicable to only a particular Section of this Agreement or an
Exhibit and are not listed below, but are defined in the Section or
Exhibit in which they are used.
“Act” means the California Revised
Uniform Limited Liability Company Act, California Corporations Code
Sections 17701.01 to 17713.06, as amended from time to time (or any
corresponding provisions of succeeding law).
Adjusted Taxable Income” means the
LLC’s items of taxable income or gain less items of loss or
deduction under the Code computed for the applicable Tax Estimation
Period.
“Affiliate” means, with respect to
any Person, (a) any Person directly or indirectly controlling,
controlled by or under common control with such Person, (b) any
Person directly or indirectly owning or controlling fifty percent
(50%) or more of any class of outstanding equity interests of such
Person or of any Person which such Person directly or indirectly
owns or controls fifty percent (50%) or more of any class of equity
interests, (c) any employee, officer, director, general partner or
trustee of such Person, or any Person of which such Person is an
employee, officer, director, general partner or trustee, or (d) any
Person who is an officer, director, general partner, trustee or
holder of fifty percent (50%) or more of the equity interests of
any Person described in clauses (a) through (c) of this sentence;
provided, that in the case of a Person who is an individual, such
terms shall also include members of such specified Person’s
immediate family (as defined in Instruction 2 of Item 404(a) of
Regulation S-K under the Securities Act).
“Agreed Value” means with respect
to any noncash asset of the LLC an amount determined and adjusted
in accordance with the following provisions:
(a) The
initial Agreed Value of any noncash asset contributed to the
capital of the LLC by any Member shall be its gross fair market
value, as agreed to by the contributing Member and the
LLC.
(b) The
initial Agreed Value of any noncash asset acquired by the LLC other
than by contribution by a Member shall be its adjusted basis for
federal income tax purposes.
(c) The
initial Agreed Value of all the LLC’s noncash assets,
regardless of how those assets were acquired, shall be reduced by
depreciation or amortization, as the case may be, determined in
accordance with the rules set forth in Treasury Regulations §
1.704-1(b)(2)(iv)(f) and (g).
(d) The
initial Agreed Value, as reduced by depreciation or amortization,
of all noncash assets of the LLC, regardless of how those assets
were acquired, shall be adjusted from time to time to equal their
gross fair market values, as determined by the Manager, as of the
following times:
(i) the
acquisition of an Interest or an additional Interest in the LLC by
any new or existing Member in exchange for more than a de minimis
Capital Contribution;
(ii) the
distribution by the LLC of more than a de minimis amount of money
or other property as consideration for all or part of an Interest
in the LLC;
(iii) the
termination of the LLC for federal income tax purposes pursuant to
Code § 708(b)(1)(B); and
(iv) each
issuance of Units.
“Agreement” means this Limited
Liability Company Agreement of the LLC (including all exhibits
hereto), as amended from time to time.
“Approval of the Members” shall
mean the approval by vote or written consent of the holders holding
at least a majority of the issued and outstanding Class A
Units.
“Articles of Organization” means
the articles or organization filed by the LLC on September 23, 2016
pursuant to the Act together with any amendments
thereto.
“Capital Account” means with
respect to each Member or assignee an account maintained and
adjusted in accordance with the following provisions:
(a) Each
Person’s Capital Account shall be increased by such
Person’s Capital Contributions, such Person’s
distributive share of Profits, any items in the nature of income or
gain that are allocated pursuant to the Regulatory Allocations and
the amount of any LLC liabilities that are assumed by such Person
or that are secured by LLC property distributed to such
Person.
(b) Each
Person’s Capital Account shall be decreased by the amount of
cash and the Agreed Value of any LLC property distributed to such
Person pursuant to any provision of this Agreement, such
Person’s distributive share of Losses, any items in the
nature of loss or deduction that are allocated pursuant to the
Regulatory Allocations, and the amount of any liabilities of such
Person that are assumed by the LLC or that are secured by any
property contributed by such Person to the LLC.
In the
event all or any portion of an Interest is transferred in
accordance with the terms of this Agreement, the transferee shall
succeed to the Capital Account of the transferor to the extent it
relates to the portion of the Interest so transferred. In the event
the Agreed Value of the LLC assets is adjusted pursuant to the
definition of Agreed Value contained in this Agreement, the Capital
Accounts of all Members shall be adjusted simultaneously to reflect
the aggregate adjustments as if the LLC recognized gain or loss
equal to the amount of such aggregate adjustment.
The
foregoing provisions and the other provisions of this Agreement
relating to the maintenance of Capital Accounts are intended to
comply with Treasury Regulations § 1.704-1(b), and shall be
interpreted and applied in a manner consistent with such
regulations.
“Capital Contribution” means with
respect to any Member, the amount of money and the initial Agreed
Value of any property contributed to the LLC with respect to the
Interest of such Member.
“Capital Transaction” means (a) the
acquisition by any Person or Persons (other than a Subsidiary of
the LLC) of all or substantially all of the assets of the LLC in
one or a series of related transactions, (b) the merger of the LLC
with or into any Person (other than a subsidiary of the LLC), or
(c) the termination or liquidation of the LLC.
“Class A Member” shall mean any
Member holding Class A Units.
“Class A Units” shall have the
meaning set forth in Section 2.5(a).
“Class B Member” shall mean any
Member holding Class B Units.
“Class B Units” shall have the
meaning set forth in Section 2.5(b).
“Code” means the United
States Internal Revenue Code of 1986, as amended from time to time,
or any corresponding provisions of succeeding law.
“Combined Effective Marginal Tax
Rate” means the single highest single combined rate
(expressed as a percentage) of United States federal, state and
local income taxation that would be applicable to any Member who is
a natural person determined as of the last day of each Tax
Estimation Period, without giving effect to the deductibility (or
any limitation on the deductibility) of state and local taxes and
other itemized deductions in computing United States federal
taxable income and assuming that such Member is subject to the
highest United States federal and highest state and local ordinary
income tax rates on all income allocated by the LLC.
“Covered Person” means any Person who or
that is or was a Member, Manager, Officer or any successor of any
of the foregoing.
“Depreciation” means, for each
Fiscal Year, an amount equal to the depreciation, amortization or
other cost recovery deduction allowable for federal income tax
purposes with respect to an asset for such Fiscal Year, provided,
however, that if the Agreed Value of an asset differs from its
adjusted basis for federal income tax purposes at the beginning of
such Fiscal Year, Depreciation shall be an amount that bears the
same ratio to such beginning Agreed Value as the federal income tax
depreciation, amortization or other cost recovery deduction with
respect to such asset for such Fiscal Year bears to such beginning
adjusted tax basis; and, provided further, that if the federal
income tax depreciation, amortization or other cost recovery
deduction for such Fiscal Year is zero, Depreciation shall be
determined with reference to such beginning Agreed Value using any
reasonable method selected by the Manager.
“Effective Date” shall have the
meaning set forth in the introductory paragraph of this
Agreement.
“Exchange Agreement” shall have the
meaning set forth in the Recitals.
“Family Member” means, with respect
to any Person, such Person’s spouse or descendants (whether
natural or adopted).
“Fiscal Year” means, with respect
to the year of the LLC’s formation, the period beginning upon
such formation and ending on September 30 of each year and, with
respect to the last year of the LLC, the period beginning on the
preceding January 1 and ending with the date of the final
liquidating distributions.
“IM1 Holdings” means IM1 Holdings,
LLC, a California limited liability company.
“Information Exhibit” means the
Information Exhibit attached hereto as Exhibit A.
“Interest” means all of the rights
of a Member or assignee with respect to the LLC created under this
Agreement or under the Act.
“kiWW” means kathy ireland
Worldwide, LLC, a California s-corporation.
“License Agreement” means that
certain License Agreement between kiWW and the LLC for certain
intellectual property dated January 6, 2017.
“Liquidating Events” shall have the
meaning set forth in Section 8.1.
“LLC” means the limited liability
company formed pursuant to the Articles of Organization filed with
the Secretary of State of California.
“Manager” shall initially mean
Level Brands, Inc. and then any successors appointed in accordance
with this Agreement.
“Members” shall refer collectively
to the Persons listed on the Information Exhibit as Members and to
any other Persons who are admitted to the LLC as Members or who
become Members under the terms of this Agreement until such Persons
have ceased to be Members under the terms of this Agreement.
“Member” means any one of the Members.
“Necessary Parties” shall have the
meaning set forth in Section 9.3(c).
“New Securities” shall have the
meaning set forth in Section 2.2(a).
“Officers” means the Officers of
the LLC as initially set forth in Section 5.2 and, thereafter, as
designated by the Manager pursuant to the terms hereof.
“Officer” means
any one of the Officers.
“Organizer” means the Person
signing the Articles of Organization as the organizer.
“Original Operating Agreement”
shall have the meaning set forth in the Recitals.
“Other Securities” shall have the
meaning set forth in Section 2.2(b).
“Permitted Transfer” means any of
the following: (a) any Transfer by a Member of all or any part of
his, her or its Units into a trust or other estate planning vehicle
for estate tax or estate planning purposes where (in each case) the
beneficiary is primarily said Member and/or a Family Member and
from which such Units, pursuant to the express terms of the
governing instrument of such trust, cannot be distributed other
than to said Member during said Member’s lifetime and such
Member retains voting control of said Units during said
Member’s lifetime; provided, however that the LLC shall not
be obligated to recognize any such Transfer into trust (including
without limitation a voting trust) until such trustee has agreed in
writing to be bound as a “Member” under this Agreement
and to hold the Units transferred subject to all the terms and
conditions hereof; (b) upon termination of a trust, custodianship,
guardianship or similar arrangement, the beneficiary of which is
either a Member or a Permitted Transferee, a Transfer by the
trustee, custodian, guardian or other fiduciary to the Person or
Persons who, in accordance with the provisions of said trust,
custodianship, guardianship or similar arrangement, are entitled to
receive the Units held therein; (c) with respect to a Member that
is a corporation, partnership or limited liability company, a
Transfer of all or a portion of such Member’s Units on a
pro-rata basis to the shareholders of such corporation, partners of
such partnership or the members of such limited liability company;
and (e) any Transfer of all or a portion of a Member’s Units
to an Affiliate. Each Member shall be solely responsible for any
and all tax consequences to him, her or it resulting from any
Permitted Transfers under this Agreement. Notwithstanding the
foregoing, however, a Transfer shall not be deemed to be a
Permitted Transfer unless the Permitted Transferee of the Units
expressly assumes, in writing, all of the obligations of the
transferring Member under this Agreement and agrees in writing to
be bound by the provisions of this Agreement as a holder of such
Units.
“Permitted Transferee” shall mean a
Transferee of any Unit in a Permitted Transfer.
“Person”
means any natural person, partnership, trust, estate, association,
limited liability company, corporation, custodian, nominee,
governmental instrumentality or agency, body politic or any other
entity in its own or any representative capacity.
“Profits and Losses” means, for
each Fiscal Year or other period, an amount equal to the
LLC’s taxable income or loss for such year or period,
determined in accordance with Code § 703(a) (for this purpose,
all items of income, gain, loss or deduction required to be stated
separately pursuant to Code § 703(a)(1) shall be included in
taxable income or loss), with the following
adjustments:
(a) Any
income of the LLC that is exempt from federal income tax and not
otherwise taken into account in computing Profits or Losses shall
be added to such taxable income or subtracted from such
loss;
(b) Any
expenditures of the LLC described in Code § 705(a)(2)(B) or
treated as Code § 705(a)(2)(B) expenditures pursuant to
Treasury Regulations § 1.704-1(b)(2)(iv)(i), and not otherwise
taken into account in computing Profits or Losses, shall be
subtracted from such taxable income or added to such
loss;
(c) Gain
or loss resulting from dispositions of LLC assets with respect to
which gain or loss is recognized for federal income tax purposes
shall be computed by reference to the Agreed Value of the property
disposed of, notwithstanding that the adjusted tax basis of such
property differs from its Agreed Value.
(d) In
the event the Agreed Value of any LLC asset is adjusted in
accordance with paragraph (d) or paragraph (e) of the definition of
“Agreed Value” above, the amount of such adjustment
shall be taken into account as gain or loss from the disposition of
such asset for purposes of computing Profits or
Losses;
(e) In
lieu of the depreciation, amortization and other cost recovery
deductions taken into account in computing such taxable income or
loss, there shall be taken into account Depreciation for such
Fiscal Year, and
(f) Notwithstanding
any other provision of this definition, any items that are
specially allocated pursuant to this Agreement shall not be taken
into account in computing Profits and Losses.
The
amounts of the items of LLC income, gain, loss or deduction
available to be specially allocated pursuant to this Agreement
shall be determined by applying rules analogous to those set forth
in subparagraphs (a) through (f) above.
“Regulatory Allocations Exhibit”
means the Regulatory Allocations Exhibit attached hereto as
Exhibit
C.
“Section 704 Property” shall have
the meaning ascribed such term in Treasury Regulation §
1.704-3(a)(3) and shall include assets treated as Section 704(c)
property by virtue of revaluations of LLC assets as permitted by
Treasury Regulation § 1.704-1(b)(2)(iv)(f).
“Securities Act” means the
Securities Act of 1933, as amended, and applicable rules and
regulations thereunder, and any successor to such statute, rules or
regulations. Any reference herein to a specific section, rule or
regulation of the Securities Act shall be deemed to include any
corresponding provision of future law.
“Subsidiaries” means any other
Person all or any portion of the equity interest of which is owned,
directly or indirectly, by the LLC.
“Tax Estimation Period” means (a)
January, February and March, (b) April and May, (c) June, July and
August, and (d) September, October, November and December of each
year during the term of the LLC, or other periods for which
estimates of individual federal income tax liability are required
to be made under the Code; provided, that the LLC’s first Tax
Estimation Period shall begin on the Effective Date of this
Agreement.
“Terminating Event” shall have the
meaning set forth in Section 5.5(a).
“Transfer” means, directly or
indirectly, any sale, assignment, transfer, conveyance, pledge,
hypothecation or other disposition, voluntarily or involuntarily,
by operation of law, with or without consideration or otherwise
(including, by way of intestacy, will, gift, bankruptcy,
receivership, levy, execution, charging order or other similar sale
or seizure by legal process or transfer of equity interests) of all
or any portion of any Interest. The terms “Transferee,”
“Transferor,” “Transferred,” and other
forms of the word “Transfer” shall have the correlative
meanings.
“Transfer Notice” means a written
notice given to the LLC of all details of any proposed Transfer of
any Interest including the name of the proposed transferee, the
date of the proposed Transfer of the Interest, the portion of the
Member’s Interest to be transferred, the price or other
consideration, if any, to be received, and a complete description
of all noncash consideration to be received.
“Treasury
Regulations” means the final and temporary Income Tax
Regulations promulgated under the Code, as such regulations may be
amended from time to time (including corresponding provisions of
succeeding regulations).
“Units” represent the basis on
which Interests are denominated and the basis on which the
Members’ relative rights, privileges, preferences and
obligations are determined under this Agreement and the Act, and
the total number and class of Units attributed to each Member shall
be the number recorded on the Information Exhibit as of the
relevant time. Unless specifically denominated as Class A Units or
Class B Units, all references in this Agreement to
“Units” shall mean the Class A Units and the Class B
Units taken collectively.
“Unsubscribed Securities” shall
have the meaning set forth in Section 2.2(a).
[THE
REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK.]
EXHIBIT
C
REGULATORY ALLOCATIONS EXHIBIT
This
Exhibit contains special rules for the allocation of items of LLC
income, gain, loss and deduction that override the basic
allocations of Profits and Losses in Section 4.1 of the Agreement
to the extent necessary to cause the overall allocations of items
of LLC income, gain, loss and deduction to have substantial
economic effect pursuant to Treasury Regulations § 1.704-1(b)
and shall be interpreted in light of that purpose. Subsection (a)
below contains special technical definitions. Subsections (b)
through (h) contain the Regulatory Allocations themselves.
Subsections (i) and (j) are special rules applicable in applying
the Regulatory Allocations.
(a) Definitions
Applicable to Regulatory Allocations. For purposes of the
Agreement, the following terms shall have the meanings
indicated:
(i)
“Adjusted Capital Account” means,
with respect to any Member or assignee, such Person’s Capital
Account as of the end of the relevant Fiscal Year increased by any
amounts which such Person is obligated to restore, or is deemed to
be obligated to restore pursuant to the next to last sentences of
Treasury Regulations §§ 1.704-2(g)(1) (share of minimum
gain) and 1.704-2(i)(5) (share of member nonrecourse debt minimum
gain).
(ii)
“LLC Minimum Gain” has the meaning
of “partnership minimum gain” set forth in Treasury
Regulations § 1.704-2(d), and is generally the aggregate gain
the LLC would realize if it disposed of its property subject to
Nonrecourse Liabilities in full satisfaction of each such liability
and for no other consideration, with such other modifications as
provided in Treasury Regulations § 1.704-2(d). In the case of
Nonrecourse Liabilities for which the creditor’s recourse is
not limited to particular assets of the LLC, until such time as
there is regulatory guidance on the determination of minimum gain
with respect to such liabilities, all such liabilities of the LLC
shall be treated as a single liability and allocated to the
LLC’s assets using any reasonable basis selected by the
Manager.
(iii)
“Member Nonrecourse Deductions”
means losses, deductions or Code § 705(a)(2)(B) expenditures
attributable to Member Nonrecourse Debt under the general
principles applicable to “partner nonrecourse
deductions” set forth in Treasury Regulations §
1.704-2(i)(2).
(iv)
“Member Nonrecourse Debt” means any
LLC liability with respect to which one or more but not all of the
Members or related Persons to one or more but not all of the
Members bears the economic risk of loss within the meaning of
Treasury Regulations § 1.752-2 as a guarantor, lender or
otherwise.
(v)
“Member Nonrecourse Debt Minimum
Gain” means the minimum gain attributable to Member
Nonrecourse Debt as determined pursuant to Treasury Regulations
§ 1.704-2(i)(3). In the case of Member Nonrecourse Debt for
which the creditor’s recourse against the LLC is not limited
to particular assets of the LLC, until such time as there is
regulatory guidance on the determination of minimum gain with
respect to such liabilities, all such liabilities of the LLC shall
be treated as a single liability and allocated to the LLC’s
assets using any reasonable basis selected by the
Manager.
(vi)
“Nonrecourse Deductions” means
losses, deductions, or Code § 705(a)(2)(B) expenditures
attributable to Nonrecourse Liabilities (see Treasury Regulations
§ 1.704-2(b)(1). The amount of Nonrecourse Deductions for a
Fiscal Year shall be determined pursuant to Treasury Regulations
§ 1.704-2(c), and shall generally equal the net increase, if
any, in the amount of LLC Minimum Gain for that taxable year,
determined generally according to the provisions of Treasury
Regulations § 1.704-2(d), reduced (but not below zero) by the
aggregate distributions during the year of proceeds of Nonrecourse
Liabilities that are allocable to an increase in LLC Minimum Gain,
with such other modifications as provided in Treasury Regulations
§ 1.704-2(c).
(vii)
“Nonrecourse Liability” means any
LLC liability (or portion thereof) for which no Member bears the
economic risk of loss under Treasury Regulations §
1.752-2.
(viii)
“Regulatory Allocations” means
allocations of Nonrecourse Deductions provided in Paragraph (b)
below, allocations of Member Nonrecourse Deductions provided in
Paragraph (c) below, the minimum gain chargeback provided in
Paragraph (d) below, the member nonrecourse debt minimum gain
chargeback provided in Paragraph (e) below, the qualified income
offset provided in Paragraph (f) below, the gross income allocation
provided in Paragraph (g) below, and the curative allocations
provided in Paragraph (h) below.
(b) Nonrecourse
Deductions. All Nonrecourse Deductions for any Fiscal Year
shall be allocated to the Members in proportion to the number of
Units held by such Member during such Fiscal Year.
(c) Member
Nonrecourse Deductions. All Member Nonrecourse Deductions
for any Fiscal Year shall be allocated to the Member who bears the
economic risk of loss under Treasury Regulations § 1.752-2
with respect to the Member Nonrecourse Debt to which such Member
Nonrecourse Deductions are attributable.
(d) Minimum
Gain Chargeback. If there is a net decrease in LLC Minimum
Gain for a Fiscal Year, each Member shall be allocated items of LLC
income and gain for such year (and, if necessary, subsequent years)
in an amount equal to such Member’s share of such net
decrease in LLC Minimum Gain, determined in accordance with
Treasury Regulations § 1.704-2(g)(2) and the definition of LLC
Minimum Gain set forth above. This provision is intended to comply
with the minimum gain chargeback requirement in Treasury
Regulations § 1.704-2(f) and shall be interpreted consistently
therewith.
(e) Member
Nonrecourse Debt Minimum Gain Chargeback. If there is a net
decrease in Member Nonrecourse Debt Minimum Gain attributable to a
Member Nonrecourse Debt for any Fiscal Year, each Member who has a
share of the Member Nonrecourse Debt Minimum Gain attributable to
such Member Nonrecourse Debt as of the beginning of the Fiscal
Year, determined in accordance with Treasury Regulations §
1.704-2(i)(5), shall be allocated items of LLC income and gain for
such year (and, if necessary, subsequent years) in an amount equal
to such Member’s share of the net decrease in Member
Nonrecourse Debt Minimum Gain attributable to such Member
Nonrecourse Debt, determined in accordance with Treasury
Regulations §§ 1.704-2(i)(4) and (5) and the definition
of Member Nonrecourse Debt Minimum Gain set forth above. This
Paragraph is intended to comply with the member nonrecourse debt
minimum gain chargeback requirement in Treasury Regulations §
1.704-2(i)(4) and shall be interpreted consistently
therewith.
(f) Qualified
Income Offset. In the event any Member unexpectedly receives
any adjustments, allocations, or distributions described in
Treasury Regulations §§ 1.704-1(b)(2)(ii)(d)(4), (5), or
(6), items of LLC income and gain (consisting of a pro rata portion
of each item of LLC income, including gross income, and gain for
such year) shall be allocated to such Member in an amount and
manner sufficient to eliminate any deficit in such Member’s
Capital Account created by such adjustments, allocations or
distributions as quickly as possible. This provision is intended to
constitute a “qualified income offset” within the
meaning of Treasury Regulation § 1.704-1(b)(2)(ii)(d) and
shall be interpreted consistently therewith.
(g) Gross
Income Allocation. In the event any Member has a deficit in
its Adjusted Capital Account at the end of any Fiscal Year, each
such Member shall be allocated items of LLC gross income and gain,
in the amount of such Adjusted Capital Account deficit, as quickly
as possible.
(h) Curative
Allocations. When allocating Profits and Losses under
Section 4.1, such allocations shall be made so as to offset any
prior allocations of gross income under paragraphs (b) through (g)
above and paragraph (j) below to the greatest extent possible so
that overall allocations of Profits and Losses shall be made as if
no such allocations of gross income occurred.
(i) Ordering.
The allocations in this Exhibit to the extent they apply shall be
made before the allocations of Profits and Losses under Section 4.1
and in the order in which they appear above.
(j) Code
Section 754 Adjustments. To the extent an adjustment to the
adjusted tax basis of any LLC asset pursuant to Code § 734(b)
or Code § 743(b) is required, pursuant to Treasury Regulations
§ 1.704-1(b)(2)(iv)(m), to be taken into account in
determining Capital Accounts, the amount of such adjustment to the
Capital Accounts shall be treated as an item of gain (if the
adjustment increases the basis of the asset) or loss (if the
adjustment decreases such basis), and such gain or loss shall be
specially allocated to the Members in a manner consistent with the
manner in which their Capital Accounts are required to be adjusted
pursuant to such Section of the Regulations.
[THE
REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK.]
INDEMNIFICATION
AGREEMENT
THIS
INDEMNIFICATION AGREEMENT (this “Agreement”)
is made and entered into as of the ___ day of ________________,
20__, by and between Level Brands Inc., a North Carolina
corporation (the “Corporation”),
and ___________________________ (“Indemnified
Party”), an individual having an address at
__________________________________________.
RECITALS:
WHEREAS, the
Indemnified Party is a [director] of the Corporation and performs a
valuable service in such capacity for the Corporation;
WHEREAS, it is
essential to the Corporation to retain and attract, as directors
and officers, the most capable persons available;
WHEREAS, both the
Corporation and the Indemnified Party recognize the increased risk
of litigation and other claims currently being asserted against
directors and officers of corporations; and
WHEREAS, in order
to induce the Indemnified Party to continue to serve as a
[director] of the Corporation, the Corporation has determined and
agreed to enter into this Agreement with the Indemnified
Party;
NOW,
THEREFORE, in consideration of the Indemnified Party’s
continued service as a director after the date hereof, the parties
agree as follows:
1. Definitions.
As used in this Agreement:
(a) The term
“Proceeding”
shall include any threatened, pending or completed action, suit,
arbitration, alternative dispute resolution mechanism,
investigation, inquiry, administrative hearing or any other actual,
threatened or completed proceeding, whether brought by or in the
right of the Corporation or otherwise and whether of a civil,
criminal, administrative or investigative nature, and whether
formal or informal in any case, in which the Indemnified Party is a
party or is threatened to be made a party, by reason of the fact
that the Indemnified Party: (i) is, was or agreed to become a
director or an officer of the Corporation (or of any predecessor or
subsidiary of the Corporation or any successor to the Corporation
by merger), including any actions taken by the Indemnified Party in
such capacity; or (ii) is or was serving or agreed to serve at the
request of the Corporation as a director, partner, trustee,
officer, employee or agent of another corporation, domestic or
foreign, non-profit or for-profit, partnership, joint venture,
trust or other enterprise, in each case described in subsection (i)
and (ii) above whether or not he is acting or serving in any such
capacity at the time any Expense is incurred for which
indemnification or reimbursement can be provided under this
Agreement. “Proceeding” also includes an action by the
Indemnified Party, including without limitation, any mediation or
arbitration to establish or enforce a right of Indemnified Party
under this Agreement.
(b) The term
“Expense”
or “Expenses”
shall mean all costs, charges and expenses incurred in connection
with any proceeding (including reasonable expert, consultant and
attorneys’ fees and all reasonable disbursements), judgments,
fines and amounts paid in settlement including, without limitation,
expenses of investigation, judicial or administrative proceedings
and appeals.
2. Actions,
Suits and Proceedings Other than by or in the Right of the
Corporation. The Corporation shall indemnify the Indemnified
Party in accordance with the provisions of this Agreement if the
Indemnified Party is a party or is threatened to be made a party to
any Proceeding (other than an action against the Indemnified Party
by or in the right of the Corporation) to the greatest extent
permitted by governing law against all Expenses actually and
reasonably incurred by the Indemnified Party or on the Indemnified
Party’s behalf in connection with such Proceeding and any
appeal therefrom, unless it is determined by final, non-appealable
order of a court of competent jurisdiction that governing law bars
and prohibits the Corporation from providing such indemnification;
provided further, that notwithstanding anything herein contained to
the contrary, any settlement of a Proceeding must be approved in
advance in writing by the Corporation (which approval shall not be
unreasonably withheld). The termination of any action, suit or
proceeding by judgment, order, settlement, conviction or upon a
plea of nolo contendere or its equivalent, shall not, of itself,
create a presumption that the Corporation is barred and prohibited
by governing law from providing indemnification to the Indemnified
Party.
3. Actions
or Suits by or in the Right of the Corporation. The
Corporation shall indemnify the Indemnified Party in accordance
with the provisions of this Agreement if the Indemnified Party is a
party, or is threatened to be made a party, to any Proceeding
brought against the Indemnified Party by or in the right of the
Corporation, to the greatest extent permitted by governing law,
against all Expenses actually and reasonably incurred by the
Indemnified Party or on the Indemnified Party’s behalf in
connection which such Proceeding and any appeal therefrom, unless
it is determined by final, non-appealable order of a court of
competent jurisdiction that governing law bars and prohibits the
Corporation from providing such indemnification; except that
indemnification shall be made in respect of any claim, issue or
matter as to which the Indemnified Party shall have been adjudged
to be liable to the Corporation by final, non-appealable order of a
court of competent jurisdiction only to the extent that it is
determined by final, non-appealable order of a court of competent
jurisdiction, upon application, that, despite the adjudication of
such liability but in view of all the circumstances of the case,
the Indemnified Party is fairly and reasonably entitled to
indemnity for Expenses in respect of such claim, issue or matter to
the extent such court shall deem proper.
4. Costs
and Expenses Relating to Service as a Witness. The
Corporation shall indemnify the Indemnified Party in accordance
with the provisions of this Agreement with respect to all Expenses
incurred or suffered by the Indemnified Party as a result of the
service, attendance or appearance by the Indemnified Party as a
witness (or in any other non-party capacity) in any suit or
proceeding, whether brought by or in the right of the Corporation
or otherwise and whether of a civil, criminal, administrative or
investigative nature (including any part thereof such as appearance
at a hearing, deposition or trial or any actions taken in response
to any subpoena, order, discovery request or the like) if such
service, attendance or appearance related to or results from the
fact that he (i) is, was or agreed to become a director or an
officer of the Corporation; or (ii) is or was serving or agreed to
serve at the request of the Corporation as a director, partner,
trustee, officer, employee or agent of another corporation,
domestic or foreign, non-profit or for-profit, partnership, joint
venture, trust or other enterprise, in each case described in
subsection (i) and (ii) above whether or not he is acting or
serving in any such capacity at the time any Expense is incurred
for which indemnification or reimbursement can be provided under
this Agreement (a “Witness
Proceeding”).
5. Notification
and Defense of Claim. As a condition precedent to the
Indemnified Party’s right to be indemnified, the Indemnified
Party must promptly notify the Corporation of receipt of notice of
any Proceeding or Witness Proceeding for which indemnity is sought,
provided, however, that the failure to give such notice will not
relieve the Corporation of any liability that it may have to any
Indemnified Party, except and only to the extent that it is
determined by final, non-appealable order of a court of competent
jurisdiction that the defense of the Indemnified Party in such
Proceeding or Witness Proceeding was materially prejudiced by the
Indemnified Party’s failure to give such notice. With respect
to any Proceeding or Witness Proceeding of which the Corporation is
so notified, the Corporation will be entitled to participate
therein at its own expense and/or to assume the defense thereof at
its own expense, with legal counsel reasonably acceptable to the
Indemnified Party. After notice from the Corporation to the
Indemnified Party of its election so to assume such defense, the
Corporation shall not be liable to the Indemnified Party for any
attorney fees subsequently incurred by the Indemnified Party for so
long as the Corporation maintains such defense in connection with
such claim, other than as provided below in this Paragraph 5. The
Indemnified Party shall have the right to employ his own counsel in
connection with such Proceeding or Witness Proceeding, but the fees
and expenses of such counsel incurred after notice from the
Corporation of its assumption of the defense thereof shall be at
the expense of the Indemnified Party unless (i) the employment of
counsel by the Indemnified Party has been authorized by the
Corporation, (ii) counsel to the Indemnified Party shall have
reasonably concluded that there may be a conflict of interest or
position on any significant issue between the Corporation and the
Indemnified Party in the conduct of such Proceeding or Witness
Proceeding, or (iii) the Corporation shall not in fact have
employed counsel to assume the defense of such action, in each of
which cases the fees and expenses of counsel for the Indemnified
Party shall be at the expense of the Corporation, except as
otherwise expressly provided by this Agreement.
6. Advance
of Costs, Charges and Expenses. Subject to the provisions of
Paragraph 7 below, any Expenses for which the Corporation is
authorized to indemnify the Indemnified Party under the terms of
this Agreement (including costs, charges, and expenses, including
reasonable attorney’s fees) incurred by an Indemnified Party
in connection with any Proceeding or Witness Proceeding shall be
paid by the Corporation in advance of the final disposition of such
matter; provided, however, that the payment of such Expenses in
advance of the final disposition of such Proceeding or Witness
Proceeding shall be made only upon receipt of (i) statements by or
on behalf of the Indemnified Party reasonably evidencing the
Expenses to be incurred, and (ii) an undertaking by or on behalf of
the Indemnified Party to repay all amounts so advanced in the event
that it shall ultimately be determined that the Indemnified Party
is not entitled to be indemnified by the Corporation as authorized
in this Agreement. Such undertaking shall be accepted without
reference to the financial ability of the Indemnified Party to make
such repayment. Any advances and undertakings to repay pursuant to
this Paragraph 6 shall be unsecured and interest free.
7. Procedure
for Indemnification. Any indemnification or advancement of
expenses pursuant to Paragraphs 2, 3, 4, 5 or 6 of this Agreement
shall be made promptly, and in any event within thirty (30) days
after receipt by the Corporation of the written request of the
Indemnified Party. The right to indemnification or advances as
granted by this Agreement shall be enforceable by the Indemnified
Party in any court of competent jurisdiction if the Corporation
denies such request, in whole or in part, or if no disposition
thereof is made within the thirty (30) day period referred to
above. The Indemnified Party’s costs, charges and expenses
(including reasonable attorneys’ fees) incurred in connection
with successfully establishing his right to indemnification, in
whole or in part, in any such proceeding shall also be indemnified
by the Corporation. Unless otherwise provided by governing law, the
burden of proving that the Indemnified Party is not entitled to
indemnification or advancement of expenses under this Agreement
shall be on the Corporation.
8. Other
Rights. The indemnification and advancement of Expenses
provided by this Agreement shall not be deemed exclusive of any
other rights to which the Indemnified Party may be entitled under
the Certificate of Incorporation of the Corporation, the Bylaws of
the Corporation or any law (common or statutory), agreement or vote
of stockholders or disinterested directors or otherwise, both as to
action in his official capacity and as to action in any other
capacity while holding office for the Corporation, and shall
continue as to the Indemnified Party even though he shall have
ceased to be a director or officer, and shall inure to the benefit
of the estate, heirs, executors and administrators of the
Indemnified Party.
9. Partial
Indemnification. If the Indemnified Party is entitled under
any provision of this Agreement to indemnification by the
Corporation for some or a portion of the Expenses incurred by or on
behalf of the Indemnified Party in connection with any Proceeding
or Witness Proceeding but not, however, for the total amount
thereof, the Corporation shall nevertheless indemnify the
Indemnified Party for the portion of such Expenses to which the
Indemnified Party is entitled.
10. Prohibited
Indemnification. No
indemnification pursuant to this Agreement shall be paid by the
Corporation on account of any Proceeding in which judgment is
rendered against Indemnified Party for an accounting of profits
made from the purchase or sale by Indemnified Party of securities
of the Corporation pursuant to the provisions of Section 16(b) of
the Exchange Act, or similar provisions of any federal, state, or
local laws or for which payment is prohibited by
law.
11. Initiation
of Proceeding. Notwithstanding anything in this Agreement to
the contrary, Indemnified Party shall not be entitled to
indemnification pursuant to this Agreement in connection with any
Proceeding initiated by Indemnified Party against the Corporation
or any director or officer of the Corporation unless (i) the
Corporation has joined in or the board of directors has consented
to the initiation of such Proceeding; (ii) the Proceeding is one to
enforce Indemnified Party’s rights under this Agreement, or
any other agreement or insurance policy or the Corporation’s
Certificate of Incorporation or Bylaws to indemnification or
advancement of expenses; or (iii) as otherwise required under
applicable law.
12. Reimbursement
to Corporation by Indemnified Party; Limitation on Amounts Paid by
Corporation. To the extent the Indemnified Party has been
indemnified by the Corporation hereunder for certain Expenses, and
the Corporation has fully and completely fulfilled all its
obligations to the Indemnified Party hereunder, and the Indemnified
Party later receives payments from any insurance carrier covering
the same Expenses paid by the Corporation hereunder, the
Indemnified Party shall reimburse the Corporation hereunder for
such amounts received from the insurer net of costs of collection.
To the extent the Indemnified Party has been indemnified by the
Corporation hereunder and it is later determined by a court of
competent jurisdiction that the Indemnified Party was not entitled
to indemnification under Section 2 or 3, as the case may be, the
Indemnified Party shall immediately reimburse the Corporation
hereunder for all such amounts. Notwithstanding anything contained
herein to the contrary, the Indemnified Party shall not be entitled
to recover amounts under this Agreement which, when added to the
amount of indemnification payments made to, or on behalf of, the
Indemnified Party, under the Certificate of Incorporation or Bylaws
of the Corporation, in the aggregate exceed the Expenses actually
and reasonably incurred by the Indemnified Party
(“Excess
Amounts”). To the extent the Corporation has paid
Excess Amounts to the Indemnified Party, the Indemnified Party
shall be obligated to promptly reimburse the Corporation for such
Excess Amounts.
13. Continuation
of Rights and Obligations. All rights and obligations of the
Corporation and the Indemnified Party hereunder shall continue in
full force and effect despite the subsequent amendment or
modification of the Corporation’s Certificate of
Incorporation or Bylaws, as such are in effect on the date hereof,
and such rights and obligations shall not be affected by any such
amendment or modification, any resolution of directors or
stockholders of the Corporation, or by any other corporate action
which conflicts with or purports to amend, modify, limit or
eliminate any of the rights or obligations of the Corporation
and/or the Indemnified Party hereunder.
14. Severability;
Survival. If this Agreement or any portion thereof shall be
invalidated on any ground by any court of competent jurisdiction,
the Corporation shall nevertheless indemnify the Indemnified Party
as to Expenses to the full extent permitted by any applicable
portion of this Agreement that shall not have been invalidated or
by any other applicable law. This Agreement and all of the
provisions hereof shall be binding upon and inure to the benefit of
the parties hereto and their respective heirs, executors,
successors and assigns, including, without limitation, any
successor to the Corporation by way of merger, consolidation and/or
sale or disposition of all or substantially all of the shares of
the Corporation.
15. Counterparts;
Facsimile Signatures. This Agreement may be executed in one
or more counterparts, including via facsimile or other electronic
means, each of which shall for all purposes be deemed to be an
original but all of which together shall constitute one and the
same Agreement.
16. Modification
and Waiver. No supplement, modification or amendment of this
Agreement shall be binding unless executed in writing by all of the
parties hereto. No waiver of any of the provisions of this
Agreement shall be deemed or shall constitute a waiver of any other
provisions hereof (whether or not similar) nor shall such waiver
constitute a continuing waiver.
17. Notice
by Indemnified Party. Indemnified Party agrees promptly to
notify the Corporation in writing upon being served with any
summons, citation, subpoena, complaint, indictment, information or
other document relating to any Proceeding or matter which may be
subject to indemnification or advancement of Expenses covered
hereunder. Failure of Indemnified Party to provide such notice
shall not constitute a waiver of any of the rights or privileges of
the Indemnified Party hereunder or render the By-laws, any other
source of indemnification or applicable law.
18. Notices.
Any and all notices or elections permitted or required to be made
under this Agreement shall be in writing and shall be deemed
effectively given: (a) upon personal delivery to the party to be
notified, (b) when sent by confirmed electronic mail or facsimile
if sent during normal business hours of the recipient, (c) five (5)
days after having been sent by registered or certified mail, return
receipt requested, postage prepaid, or (d) one (1) day after
deposit with a nationally recognized overnight courier, specifying
next day delivery, with written verification of receipt. All
communications shall be sent to the respective parties at their
address as set forth on the signature page, or to such e-mail
address, facsimile number or address as subsequently modified by
written notice given in accordance with this Paragraph 15. If
notice is given to the Corporation, a copy shall also be sent to
[PAUL OR BRIAN CONTACT] .
19. Liability
Insurance. To the extent the Corporation maintains an
insurance policy or policies providing general and/or
directors’ and officers’ liability insurance,
Indemnified Party shall be covered by such policy or policies, in
accordance with its or their terms, to the maximum extent of the
coverage available for any Corporation director or
officers.
20. Governing
Law. The parties agree that this Agreement shall be governed
by, and construed and enforced in accordance with, the laws of the
State of North Carolina.
IN
WITNESS WHEREOF, the parties hereby have caused this Agreement to
be duly executed and signed effective as of the day and year first
above written.
|
LEVEL
BRANDS INC.
By:
Name: Mark
Elliott
Title:
CFO
INDEMNIFIED
PARTY:
.
|
Exhibit 6.23
AMENDMENT NO. 1
TO
TRANSACTION FEE AGREEMENT
This
Amendment No. 1 to the Transaction Fee Agreement (the
“Agreement”)
is made as of March 17, 2017 by and between T.R. Winston &
Company, LLC (the “Broker”),
and Level Brands, Inc. (the “Company”).
The Company and the Broker are collectively herein referred to as
the “Parties”.
WITNESSETH
WHEREAS, the Company and the Broker are
parties to that certain Transaction Fee Agreement dated November
23, 2015 (the "November 2015
Agreement") pursuant to which the Broker acted as placement
agent for the Company in a private placement of its securities (the
"Offering").
WHEREAS, under the terms of the November
2015 Agreement, following the Closing of the Offering the Broker is
entitled to a Tail Fee with respect to any Subsequent Financing by
the Company (both of which such terms are as defined in the
November 2015 Agreement).
WHEREAS, the final closing of the
Offering occurred on February 16, 2016.
WHEREAS, the Company has advised the
Broker that it intends to undertake a Subsequent Financing and has
requested that the Broker terminate its rights to a Tail Fee and
the Broker has so consented.
NOW, THEREFORE, in consideration of
mutual promises, covenants and agreements hereinafter set forth,
the Parties agree as follows:
1. Section
2 of the November 2015 Agreement is hereby deleted in its
entirety.
2.
Except as otherwise amended by this Agreement, all other terms and
conditions of the November 2015 Agreement remain in full force and
effect.
IN WITNESS WHEREOF, the Parties have
caused their respective signature page to this Agreement to be duly
executed as of the date first written above.
T.R. WINSTON & COMPANY, LLC
|
|
LEVEL BRANDS, INC.
|
|
|
|
By:
|
/s/
Karen Kang
|
|
By:
|
/s/
Mark Elliott
|
|
Karen
Kang
|
|
|
Mark
Elliott
|
|
Vice
President
|
|
|
CFO/COO
|
Exhibit 6.24
FORM OF LICENSE AGREEMENT
THIS LICENSE AGREEMENT
(“Agreement”) is made and
entered into as of this ___ day of [ ], 2017, by and between I|M1,
LLC, a California limited liability company
(“Licensor”), and [ ]., a [ ]
(“Licensee”).
RECITALS
A. Licensor has the right and authority to license
certain trademarks and rights to the name, likeness, and visual
representation of “I’M1” and other marks and has
developed and used intellectual property (collectively, the
“I’M1 IP”) and is engaged in the licensing of the
property identified in the attached Exhibit
A, as well as multiple names,
likeness, and visual representations being known and recognized by
the public and associated in the public mind with Licensor
(hereinafter, with the I’M1 IP, collectively referred to as
the “Licensed Marks”, the “Licensed
Property” or the “Brand”).
B. Licensor is the owner, by assignment, of the name,
nick name, image, likeness, initials, mark, appearance, signature
(including reproduced signature), autograph, endorsement, voice,
and biographical material (including history, video and motion
picture film portrayals, and still photography), Internet domain
names and online social media user/screen names of the Licensed
Marks.
C. Ms.
Kathy Ireland, an internationally famous person and designer with a
highly favorable public image and strong, favorable identity for
branding; and a strong portfolio of multiple brands and
ambassadors, also with a highly favorable public image and strong
brand identities serves as Chief Brand Advisor of
Licensor.
D. Licensee is an importer, manufacturer, distributor
and/or seller of products and desires to use the Licensed Marks in
the Channels of Distribution as contemplated in Exhibit
B.
AGREEMENT
In
consideration of the mutual promises herein contained, it is hereby
agreed:
1. DEFINITIONS
1.1 The term
“Allowance” mean any reductions in the wholesale sales
price of any Licensed Product approved in advance, in writing, by
Licensor off-invoice amounts or accruals.
1.2 The term "Brand" shall mean
only the Licensed Products offered under the Licensed Marks set
forth in Exhibit
A.
1.3 The term “Channels of
Distribution” shall mean only those channels, which are
listed and mutually agreed on Exhibit B attached hereto
and incorporated by reference herein. Exhibit B may only be modified,
supplemented, and/or amended by written agreement of the Parties as
provided herein.
1.4 The term “Code of
Conduct” shall refer to the Licensor’s Human Rights
– Code of Conduct, incorporated by this reference as set
forth in Exhibit C,
with respect to which Licensee agrees to fully comply in such form
attached and as it may be amended or updated by the Licensor from
time to time upon written notice to Licensee of such
changes.
1.5 The term “Effective
Date” shall mean the date this Agreement is executed by
Licensor as set forth above.
1.6 The term “Gross
Sales” shall mean the gross amount billed (exclusive of any
sales, use or value added tax (VAT)). No other costs incurred in
the manufacturing, selling, advertising, and/or distribution of the
Licensed Products shall be deducted.
1.7 The term “Initial
Term” shall have the meaning set forth in Section
4.
1.8 The term “Licensed
Marks” shall mean the Brand and Licensed Products set forth
in Exhibit B,
including, without limitation, their likeness, visual
representation and/or each of the individual components thereof,
and those trademarks, service marks, logos, designs, and/or any
other symbols/devices, which are set forth in Exhibit A attached hereto and
incorporated by reference herein.
1.9 The term “Licensed
Products” shall mean only those items, which are listed in
Exhibit B attached
hereto. Exhibit B
may only be modified, supplemented, and/or amended by written
agreement of the Parties as provided herein.
1.10 The Term “Licensing
Fee” shall have that meaning set out in Section 5.1
below.
1.11 The term “Manufacturing
Territory” shall mean the United States.
1.12 The Term “Millennium
Development Goals” shall refer to the Millennium Development
Goals, incorporated by this reference as set forth in Exhibit F, with respect to
which Licensee agrees to fully adopt, as well as meaningfully
contribute to, one or more of such goals either economically or
through other Licensee resources.
1.13 The term “Minimum
Guaranteed Royalties” shall have the meaning set forth in
Section 5.5.
1.14 The term “Parties”
(or “Party”) shall mean the parties entering into this
Agreement.
1.15 The term “Returns”
shall mean any Licensed Product, which Licensee accepts back from
any customer after purchase and delivery thereof and for which
Licensee refunds the actual purchase price, or issues a credit
memo.
1.16 The term “Royalty”
or “Royalties” shall have that meaning set out in
Section 5.2 below.
1.17 The term “Term”
shall mean the Initial Term plus any extensions, renewals of this
Agreement or modifications thereof.
1.18 The term “Termination
Date” shall mean the date, whichever is earliest, that
(i) this Agreement (subject to any renewals or extensions)
expires by its own terms; (ii) is thirty (30) days after
receipt of notice of termination under Section 21; or
(iii) any other event occurs which terminates this Agreement
where no notice is required.
1.19 The term
“Territory” shall mean United States of
America.
1.20 The term “Trade
Discounts” shall mean any reductions or charge backs in the
wholesale sales price of any Licensed Product, and granted by
Licensee in writing to any customer prior to delivery.
2. GRANT OF LICENSE
2.1 Upon the terms and conditions
set forth herein, Licensor hereby grants to Licensee the
non-transferable right, license, and privilege, of using the
Licensed Marks solely for the sale, marketing and distribution of
the Licensed Products through the Channels of Distribution in the
Territory during the Term (with the exceptions as stated on
Exhibit B), and the
non-exclusive, non-transferable right, license, and privilege
of using the
Licensed Marks solely upon and in connection with the manufacture
of Licensed Products in the Manufacturing Territory.
2.2 All proposed Channels of
Distribution and distribution outlets in Exhibit B shall be deemed
approved and any others shall be submitted in advance to Licensor
and shall be subject to Licensor’s prior written
approval.
2.3 Licensee shall not assign or
sub-license the use of the Licensed Marks to any third party
without prior written approval by Licensor, and such right is
expressly withheld from this Agreement. In the event Licensor
approves a sub-license to a third party, the Parties shall mutually
agree upon the terms and conditions of said sub-license, including
without limitation the royalty rate, in a separate writing signed
by the Parties.
2.4 Licensee will not be permitted
to enter into any other branded relationship that competes with
Licensor’s Brand program under this Agreement without the
express prior written approval of Licensor.
3. BRAND DEVELOPMENT
3.1 Licensee will begin shipping of
Licensed Products no later than ____________, 20__.
3.2 Licensee agrees that all
names of Licensed Products are proprietary to Licensor. More
specifically, Licensor shall own all intellectual property rights
in the Licensed Products and related materials and in all sketches,
artwork and/or designs for the Licensed Products and the related
materials, at no cost to Licensor, and to the extent Licensee has
any rights in such intellectual property, Licensee agrees to assign
and does hereby assign to Licensor (or any person or entity
designated by Licensor) all its right, title and interest in and to
such products and materials.
3.3 Licensee agrees to become a
member and utilize (a) Send Out Cards, a customer contact
communication service, (b) Salesforce.com, (c) Dependable
Solutions, a product approval and royalty reports services, (d)
ireland pay, a merchant agreement service, and (e) any similar web
platform as may be utilized by Licensor from time to time as a
means of conducting Brand business and coordinating with Licensor
and other licensees.
4. TERM
The
initial term (“Initial Term”) of the license hereby
granted shall commence on the Effective Date and shall be effective
through the fifth anniversary of the Effective Date, unless terminated sooner in accordance
with the provisions hereof.
5. LICENSING, ROYALTY AND OTHER FEES
5.1 Licensing Fee. The licensing
fee (“Licensing Fee”) shall be payable as follows, (a)
upon execution hereof, Licensee shall pay Licensor an amount equal
to [ ], and (b) on [ ], Licensee shall pay Licensor [
].
5.2 Royalty. Commencing on the
Effective Date, in consideration of the grant hereunder, Licensee
shall pay Licensor royalties in U.S. dollars at a rate of five
percent (5%) of 100% the Gross Sales for all Licensed Products sold
under the Licensed Marks (the “Royalty”). Within
fifteen (15) days after the end of each month, Licensee shall
furnish to Licensor a complete sales and royalty report certified
to be accurate by the Chief Financial Officer of Licensee or by
some other authorized designee of Licensee showing the number,
description, and Gross Sales Price of the Licensed Products
distributed and/or sold by Licensee during the preceding month, as
well as the number of Licensed Products in inventory at the
beginning and end of the month along with payment of the royalties
due which shall be sent by wire transfer to the following
account:
Licensor:
I|M1, LLC
4521 Sharon Road, Ste 450
Charlotte, NC 28211
Domestic Wire:
ABA Bank Routing #121000248
Account Name: IM1, LLC
Account No.: 5842344409
|
5.3 Royalty Report. For this
purpose, Licensee shall use the approved report form attached
hereto as Exhibit D
and incorporated by reference herein. Such report shall be
furnished to Licensor whether or not any of the Licensed Products
have been sold during the preceding month. Licensee shall tender
both hard copy sales and royalty report and sales in royalty report
in Excel spreadsheet format to Licensor. Sales and Royalty will be
furnished separately for each brand listed in Exhibit A in Excel spreadsheet
format to the Licensor and sent to the addresses set forth in
Section 21. The receipt or acceptance by Licensor of any of the
reports furnished by Licensee pursuant to this Agreement or of any
royalties paid by Licensee hereunder (or the cashing of any royalty
checks paid by Licensee hereunder) shall not preclude Licensor from
questioning the accuracy thereof at any time, and in the event that
any inconsistencies or mistakes are discovered in such reports or
payments, any inconsistency, mistake, or inaccuracy shall
immediately be rectified, and any appropriate payment due and owing
shall immediately be paid by Licensee to Licensor.
5.4 Late Payment. Any amount (i.e.,
Royalties, Minimum Guaranteed Royalties, marketing fees, brand
participation fee, etc.) not paid to Licensor when due under this
Agreement shall bear a late payment charge on the unpaid balance at
the rate of 1.5% per month, compounded, or the maximum amount
permitted by law, whichever is less.
5.5 Minimum Guaranteed Royalties.
Licensee shall pay Licensor the following minimum guaranteed
royalties (“Minimum Guaranteed Royalties”) on the
schedule set out below (for purposes hereof, a Contract Year shall
be based on the annual anniversary of the first day of the month
immediately preceding the Effective Date):
Contract Year Number
|
Monthly Minimum Guaranteed
Royalty Payment
|
Payment Due Date
|
Contract Year
1
|
$______________
|
on the
15th day of each month
|
Contract
Year 2
|
$______________
|
on the
15th day of each month
|
Contract
Year 3
|
$______________
|
on the
15th day of each month
|
Contract
Year 4
|
$______________
|
on the
15th day of each month
|
Contract
Year 5
|
$______________
|
on the
15th day of each month
|
5.6 Minimum Guaranteed Royalties:
Application and Credit Carryover. Minimum Guaranteed Royalty
payments shall be only credited towards Royalties in the Contract
Year for which they apply (i.e., Licensee receives credit towards
Royalties for the Minimum Guaranteed Royalty payment made in that
Contract Year). Credits for Minimum Guaranteed Royalty payments do
not carry over into other Contract Years. The Parties understand
and agree that each payment, whether it is a Royalty or the Minimum
Guaranteed Royalty amounts as set forth above, is a separate and
independent obligation.
5.7 Brand Participation Fee. In
addition to the payments above, Licensee shall pay Licensor the
following brand participation fee:
Year
1: [$ ] due on execution of this Agreement.
Year
2: [$ ] due on first anniversary of contract Effective
Date.
Year
3: [$ ] due on the second anniversary of contract Effective
Date.
Year
4: [$ ] due on the third anniversary of contract Effective
Date.
Year
5: [$ ] due on the fourth anniversary of contract Effective
Date.
6. ACCOUNTING
6.1 Licensee agrees
to keep accurate books of account and records covering all
transactions relating to the license hereby granted, and Licensor
and its duly authorized representatives shall have the right after
giving reasonable notice at all reasonable hours of the day to an
examination of said books of account and records relating to
Licensee’s performance under the Agreement, and of all other
documents and materials in the possession or under the control of
Licensee or any of its affiliated, associated, or subsidiary
companies or agents, with respect to the subject matter and terms
of this Agreement, and shall have free and full access thereto for
said purposes and for the purpose of making extracts therefrom.
Upon request of Licensor, Licensee shall furnish to Licensor a
detailed statement by an independent certified public accountant
showing the number, description, and Gross Sales of the Licensed
Products covered by this Agreement distributed and/or sold by
Licensee to the date of Licensor’s demand. All books of
account and records shall be kept available for no less than
Seven (7) years, or, as long as required by the Internal
Revenue Service, if longer than 7 years.
6.2 Each calendar year in which
this Agreement is in effect, and after expiration or termination of
this Agreement, Licensor shall be entitled to an independent audit
of and be given access to Licensee’s account books, records,
invoices and other pertinent data by a certified public accountant
or qualified auditor designated by Licensor. The audit shall be
conducted to determine Licensee’s sales of Licensed Products,
as well as all Returns and trade discounts, and shall be conducted
during normal business hours at Licensee’s business office or
location of such files and records. The cost of the audit shall be
borne by Licensor unless the audit reveals that Licensee
understated sales and or royalties of Licensed Products by more
than two percent (2%), in which case Licensee shall be required to
pay all Licensor’s costs of the audit.
6.3 Licensor’s exercise in
whole or in part of its inspection rights under Section 6.2 or
otherwise, Licensor’s acceptance of any statement or
statements from, or the receipt of acceptance by Licensor of any
payment tendered by or on behalf of Licensee, shall be without
prejudice to Licensor’s rights or remedies permitted by this
Agreement or as a matter of law or equity, and shall not preclude
or prevent Licensor from thereafter disputing the accuracy of any
such statement or payment.
7. QUALITY ASSURANCE
7.1 The quality of
the Licensed Products shall be consistent with or exceed the
average of similar products manufactured, distributed, and/or sold
by Licensee, shall serve to enhance Brand recognition of the
Licensed Products to the mutual benefit of the Parties, and shall
be suitable for the use for which they are intended.
7.2 All Licensed Products
developed, manufactured and sold hereunder, and all labels, hang
tags, packaging, catalogs, brochures, publications, printed matter,
advertising, signs, promotional displays, websites, webpages, video
and sound recordings, online social media pages (hereinafter the
"Promotional Materials") and other forms of publicity material for
the Licensed Products, shall be subject to Licensor’s written
approval in advance of use, distribution, marketing or
sale.
7.3 All materials submitted for
approval to Licensor in a language other than English will be
accompanied by a complete and accurate English
translation.
7.4 If any retail customer of
Licensee notifies Licensee or claims to Licensee that there is a
significant quality issue with any Licensed Products sold to it by
Licensee, Licensee shall notify Licensor in writing of any such
alleged quality issues within five (5) business days of being
notified by the retailer customer involved.
7.5 Licensor shall notify Licensee
of consumer quality issues received by Licensor on Licensor’s
website. Licensee shall reply to applicable consumers within
forty-eight (48) hours of its receipt of the issues from
Licensor’s website.
7.6 Licensor will have the right to
purchase products from the Licensee at best available pricing, for
personal use, Social Media Contests, giveaways, and other
promotional uses. Products purchased hereunder shall not be for
commercial resale.
8. DISPLAY OF MERCHANDISE
8.1 If Licensee has
a showroom, Licensee agrees to maintain space in its showroom
located in various high traffic locations and dedicated to display
of the Licensed Products under the Brand. Licensee further agrees
that the Licensed Products shall be displayed at Licensee’s
showroom in the most favorable manner possible to enhance the
recognition of the Brand and the Licensed Products to the mutual
benefit of the Parties. The display of the Licensed Products shall
be subject to the written approval of Licensor prior to any display
thereof.
8.2 Licensee may display and offer
the Licensed Products on its own company or business web page/site
in a manner, which makes the Licensed Products distinctive and
enhances the recognition of the Brand and the Licensed Products to
the mutual benefit of the Parties. Products other than Licensed
Products bearing the Licensed Marks may be displayed on the web
page/site only with the written approval of Licensor. Licensee
shall provide a link from its web page/site to Licensor’s web
page/site. Licensor shall approve any display of the Licensed
Products bearing the Licensed Marks on Licensee’s web
page/site in writing prior to any display or use thereof. Licensee
shall establish its web page/site within forty-five (45) days of
the Effective Date of this Agreement and shall update its web
page/site on a monthly basis. Licensee shall also provide
institutional signage in all warehouse locations.
9. LABELING
9.1 Licensee agrees
that it will cause to appear on or within each Licensed Product
manufactured, sold, and/or distributed under this Agreement and on
or within all advertising, marketing, promotional, or display
material bearing the Licensed Marks, the appropriate trademark and
copyright notices, markings, and/or designations, and/or any other
notice requested by Licensor. In the event any Licensed Product is
distributed and/or sold in a carton, container, packing and/or
wrapping material bearing the Licensed Marks, such notices shall
also appear upon the said carton, container, packing, and/or
wrapping material.
9.2 The Parties further agree that
should any of the Licensed Products be manufactured, distributed,
or sold without the appropriate or requested trademark and
copyright notices, markings, and/or designations, in addition to
any other rights it may have, Licensor may demand the removal of
the offending product from distribution and sale, and may remove
that product from the list of Licensed Products and may also
terminate this Agreement.
10. PROMOTIONAL MATERIAL
Licensee
will run full-page advertising in trade publications to ensure
retail recognition for the Brand in the appropriate marketplace.
Licensee will use its best efforts to convey to the market that it
is a licensee of the Brand, including but not limited to placing
signage depicting the Brand prominently at Licensee's corporate
offices and showrooms, and on Licensee's corporate stationery,
point of sale, marketing and other materials. No advertising,
marketing, promotional, and display materials, or other artwork
shall be used without prior written approval by Licensor. The
Parties further agree that all artwork and designs involving the
Licensed Marks shall be produced under appropriate “work for
hire” provisions, or are hereby assigned to and shall remain
the property of Licensor, notwithstanding their creation by
Licensee or others. Licensee shall ensure that, prior to its
utilizing any non-employees to create advertising, marketing,
promotional, and display materials or other artwork, advertising
copy, and/or other copyrightable materials related to the Licensed
Marks, such persons or entities shall have executed the necessary
valid agreements to convey the ownership and copyrights to these
items to Licensor.
11. CONSULTATION
11.1 Licensor and Licensee agree
to have meaningful consultation with each other regularly
throughout the Term of this Agreement and any renewal or extension
thereof.
11.2 Ms. Kathy Ireland is the Chief
Brand Advisor of the Brand and Thomas Meharey is the Co-Founder of
the Brand. In addition to the services provided by the Brand
Advisor and Co-Founder, Licensor hereby designates Stephen
Roseberry, Jason Winters, Jon Carrasco and Rocco Ingemi to serve as
liaisons with Licensee. Licensor may designate additional members
of the Licensor’s team to serve as its liaison with Licensee.
Licensor reserves the right to change, modify, supplement, and/or
alter this designation in any way and at any time in its sole and
unfettered discretion.
12. PROFESSIONAL CALENDAR
Licensee agrees to
provide Licensor with a full and complete, professional calendar of
all trade shows, meets, sales calls, including but not limited to,
acceptances and rejections of the products, in order to allow the
Parties the finest mutual cooperation for sale of merchandise and
public relations, including, but not limited to any social media
strategy.
13. RECORDING AND FILMING – EE1
13.1 Except as provided herein,
under no circumstance shall any recording be made by Licensee or
anyone acting on behalf of Licensee in any manner whatsoever,
whether on video or audio tape, film, celluloid, and/or by any
other means possible, of Mr. Meharey in connection with any
appearance provided under this Agreement, including without
limitation all personal appearances and photo sessions, without the
express prior written approval of Licensor. The creation of any
content to be exploited in any media, now or hereafter existing,
pursuant to this Agreement shall be exclusively provided by Encore
Endeavor 1 LLC, a California limited liability basis, on a
“work for hire” basis with Licensor as the sole owner
of the results and proceeds of such services.
13.2 Ms. Kathy Ireland and Tommy
Meharey are union members of Guild/Union Requirements (SAG-AFTRA)
and Licensee will make payments accordingly for any audio or visual
recordings.
14. LICENSOR’S RIGHTS
14.1 Nothing in this Agreement
shall be construed to prevent Licensor from granting any other
license for the use of the Licensed Marks or from utilizing the
Licensed Marks in any manner whatsoever.
14.2 Licensee agrees that rights
not specifically granted to Licensee are reserved by Licensor and
may be freely exploited by Licensor without
limitation.
15. PROTECTION OF LICENSOR’S RIGHTS
15.1 Licensee agrees that during
the term of this Agreement, or thereafter, it will not register or
attempt to register any of the Licensed Marks, nor will Licensee
form or incorporate any entity under a name that includes the
Licensed Marks. Licensee will not attack the title or any rights of
Licensor in and to the Licensed Marks or the Licensed Products or
attack the validity of this Agreement.
15.2 Licensee further agrees to
cooperate fully and in good faith with Licensor for the purpose of
securing and preserving Licensor’s rights in and to the
Licensed Marks.
15.3 Licensee also agrees to assist
Licensor to the extent necessary in the procurement of any
protection or to protect any of Licensor’s rights to the
Licensed Marks.
15.4 Licensee acknowledges that
Licensor has sole and exclusive ownership of all right, title, and
interest in and to the Licensed Marks and any registrations that
have been issued or may be issued thereon.
15.5 Nothing contained in this
Agreement shall give Licensee any right, title or interest in or to
the Licensed Marks except for the rights expressly licensed by this
Agreement, and subject to its terms and conditions.
15.6 Adaptations and modifications
of Licensed Marks prepared under this Agreement shall be included
as part of the Licensed Marks, including, without limitation,
Licensor’s ownership thereof.
15.7 All registrations for
intellectual property, Internet domain names and social media
user/screen names in the Licensed Marks are to be applied for and
obtained exclusively in Licensor’s name. Licensee shall not
file or register any intellectual property applications or seek any
Internet domain name and/or social media user/screen name
registration in the Licensed Marks, Licensed Products or any
derivations, improvements, variations or modification thereof,
without Licensor’s prior written approval.
15.8 Licensee shall notify
Licensor, or its designated representative, prior to entering into
any agreement with any individual, company or business, for sales
outside the United States of any Licensed Product, to permit the
timely filing of foreign and/or international trademark and
copyright applications, or other intellectual property protection,
covering the Licensed Marks, in Licensor’s sole
discretion.
15.9 Licensee agrees to cooperate
fully and in good faith with Licensor for the purpose of securing
and preserving Licensor’s rights in and to the Licensed
Marks. In the event there has not been a previous registration of
any Licensed Mark and/or any material relating thereto for a
particular Licensed Product, Licensor may register and maintain, at
Licensee’s expense, trademarks and/or service marks in the
appropriate class(es) and/or copyrights in the name of Licensor.
Licensee is not permitted to register any copyright, trademark,
and/or service mark on behalf of Licensor. It is further agreed
that nothing contained in this Agreement, and no act or omission by
Licensor and/or by Licensee shall be construed as an assignment or
grant to Licensee of any right, title, or interest in or to the
Licensed Marks, it being understood that all rights relating
thereto are reserved by Licensor, except for the license hereunder
to Licensee of the right to use and utilize the Licensed Marks only
as specifically and expressly provided in this
Agreement.
16. WARRANTIES AND INDEMNIFICATION
16.1 Licensor hereby indemnifies
Licensee and undertakes to hold it harmless against any claims or
suits, demands, losses, injuries, liabilities costs, judgments,
arbitration awards, license fees, settlement, damages and expenses
(including reasonable attorneys’ fees and costs, whether or
not any legal proceeding is commenced) (“Losses”) for
trademark infringement arising solely out of the validity of the
rights to the Licensed Marks and from Licensee’s use of the
Licensed Marks as granted herein, provided that prompt written
notice is given to Licensor within ten (10) days of any such claim
or suit, and provided, further, that Licensor shall have the option
to undertake and conduct the defense of any suit so brought, and no
settlement of any such claim or suit is made without the prior
written consent of Licensor. Licensor’s indemnification under
this Section 16.1 shall be apportioned and limited to only the
portion of, and extent that, such Losses are, or are claimed to be,
proximately caused by or attributable specifically to
Licensee’s use of Licensed Marks in a manner permitted by
this Agreement. It is further agreed that Licensor reserves the
unfettered right to select counsel to defend any such
claims.
16.2 Licensee shall defend,
indemnify, and hold Licensor harmless against any and all actions,
claims, demands, lawsuits, loss, costs, damages, judgments,
liabilities, license fees, settlement or expenses incurred,
claimed, obtained, or sustained, including without limitation
attorneys’ fees and costs, of any nature whatsoever, whether
in law or in equity, including without limitation claims relating
to or allegedly relating to the design, manufacture, sale,
purchase, use, advertising, marketing, and/or distribution of any
Licensed Product, whether for personal injury, product liability,
intellectual property infringement, dilution, misappropriation or
otherwise. Licensor reserves the right to select counsel to defend
and/or bring any such claims. Notwithstanding Licensor’s
right to the choice of counsel, Licensee shall solely be
responsible for any and all attorneys’ fees, costs, and
expenses relating to any and all such actions.
16.3 Licensor makes no
representations or warranties with respect to the design,
manufacture, sale, purchase, use, marketing, and/or distribution of
any Licensed Product manufactured, sold, and/or distributed by
Licensee and disclaims any liability arising out of the design,
manufacture, sale, purchase, use, marketing, and/or distribution of
any Licensed Product, and any such express or implied warranties
are hereby disclaimed and Section 16.2 shall apply.
16.4 Licensee represents and
warrants to Licensor that: (i) Licensee has the full power and
authority to enter into this Agreement on behalf of Licensee and to
perform all Licensee’s material obligations pursuant to this
Agreement, and that the Licensed Products manufactured, sold,
and/or distributed by Licensee under this Agreement shall be
suitable for the purpose for which they are intended to be used and
shall comply with all applicable Federal, State, and local laws,
and industry standards, (ii)
Licensee will not harm or misuse the Licensed Property or bring the
Licensed Marks into disrepute, (iii) except as specifically
provided in this Agreement, Licensee will not create any expenses
chargeable to Licensor or Ms. Ireland without the express
prior written approval of Licensor, (iv) all Licensed Products (and
the content contained or used in the Licensed Products) designed,
developed, marketed, distributed, published, performed or sold by
Licensee pursuant to this Agreement do not, and will not, infringe
any intellectual property right or any personal right of any third
party, and (v) Licensee will not knowingly permit, do or commit any
act or thing that would degrade, tarnish or deprecate or disparage
the Licensed Property or Licensor’s or Ms. Ireland’s
public image in society or standing in the community, or prejudice
Licensor or Ms. Ireland and that it will terminate such activities
promptly upon written notice, and failure to do so constitutes a
material breach of this Agreement. Licensee acknowledges and agrees
that there are no warranties, guarantees, conditions, covenants, or
representations by Licensor as to marketability, fitness for a
particular purpose, or other attributes of the Licensed Products,
whether express or implied (in law or in fact), oral or
written.
16.5 Licensee shall provide
Licensor with prompt written notice of any lawsuits or threatened
lawsuits, or other significant developments, investigations,
claims, or final refusals in which Licensee is or may be named as a
party or for which Licensee is obligated or has agreed to indemnify
any party, and Licensee shall thereafter provide Licensor with
periodic written updates concerning relevant developments in any
such lawsuits as they arise.
16.6 For purposes of this
Section 16, the term “Licensor” shall mean
Licensor and, without limitation, any of its agents, employees,
servants, representatives, parents, subsidiaries, affiliates,
officials, directors, officers, shareholders, owners, attorneys,
divisions, branches, units, affiliated organizations, successors,
predecessors, contractors, assigns, and all persons acting by,
through, under, or in concert with them, past or
present.
17. INSURANCE
17.1 Licensee represents that it
has obtained, and agrees to maintain, at its own expense, in full
force and effect at all times during which the Licensed Products
are being manufactured, sold, and distributed, insurance for bodily
injury, advertising injury, property damage, and product liability
from a recognized insurance company approved by Licensor, which is
qualified to do business in the State of California, providing
protection at least in the amount of $5,000,000 per occurrence and
$5,000,000 in the aggregate for Licensor and for Licensee against
any actions, claims, demands, lawsuits, loss, costs,
attorneys’ fees, damages, judgments, and liabilities of any
nature whatsoever relating to the Licensed Products. As proof of
such insurance, a fully paid certificate of insurance naming
Licensor (as defined above) as Licensee shall submit an insured
party to Licensor for Licensor’s prior written approval
before any Licensed Product is manufactured, sold, or distributed.
Any proposed change in certificates of insurance shall be submitted
to Licensor for its prior written approval. Licensor shall be
entitled to a copy of the prevailing certificate of insurance,
which shall be furnished to Licensor by Licensee. The
certificate(s) shall conform to the language requirements set out
in Exhibit E
attached hereto.
17.2 For purposes of this
Section 17, the term “Licensor” shall mean
Licensor and, without limitation, any of its agents, employees,
servants, representatives, parents, subsidiaries, affiliates,
officials, directors, officers, shareholders, owners, attorneys,
divisions, branches, units, affiliated organizations, successors,
predecessors, contractors, assigns, and all persons acting by,
through, under, or in concert with them, past or
present.
18. INSOLVENCY; CHANGE OF CONTROL
18.1 If Licensee files a petition
in bankruptcy or is adjudicated a bankrupt or if a petition in
bankruptcy is filed against Licensee, or if it becomes dissolved,
or becomes insolvent or unable to pay or discharge its liabilities
in the ordinary course of business, or if Licensee assigns the
whole or any substantial part of its assets or undertakings for the
benefit of creditors or makes an assignment for the benefit of its
creditors or any similar arrangement pursuant to any federal or
state law, compulsory or voluntarily, or if a receiver or other
similar officer is appointed for the whole or any part of the
assets or undertakings of Licensee or its business, or if Licensee
stops payment to its creditors generally, or ceases or threatens to
cease to carry on its business or any substantial part thereof, or
if Licensee merges or consolidates with or into any other
corporation, or directly or indirectly sells or otherwise
transfers, sells, or disposes of all or a substantial portion of
its business or assets, or if a third party who does not own stock
acquires a majority of the voting stock of Licensee, Licensor may
terminate this Agreement by giving notice to Licensee of its
intention to terminate and such termination shall be effective
immediately. In the event this Agreement is so terminated,
Licensee, its receivers, representatives, trustees, agents,
administrators, successors, and/or assigns shall have no right to
sell, exploit, or in any way deal with or in any Licensed Products
covered by this Agreement or any related advertising, marketing,
promotional, and display materials, including without limitation
cartons, containers, packing, and wrapping materials, except with
and under the special consent and instructions of Licensor in
writing, which they shall be obligated to follow.
18.2 In the event this Agreement is
so terminated under this Section 18, Licensee, its receivers,
representatives, trustees, agents, administrators, successors,
and/or assigns shall have no right to sell, exploit, or in any way
deal with or in any Licensed Products covered by this Agreement or
any related advertising, marketing, promotional, and display
materials, including without limitation cartons, containers,
packing, and wrapping materials, except with and under the special
consent and instructions of Licensor in writing, which they shall
be obligated to follow.
19. TERMINATION
19.1 Except as otherwise provided
herein, in the event either party breaches or fails to perform any
of its material duties and obligations pursuant to the terms of
this Agreement, the non-breaching party shall have the right to
terminate this Agreement upon thirty (30) days’ notice in
writing, and such notice of termination shall become effective
unless the breaching party shall remedy the breach within the
thirty (30) day period to the reasonable satisfaction of the
non-breaching party. The Parties agree to make a reasonable effort
to resolve any disputes or breaches prior to exercising the right
of termination.
19.2 Termination of this Agreement
shall be without prejudice to any rights, which Licensor may
otherwise have against Licensee. Upon the termination of this
Agreement, notwithstanding anything to the contrary herein, all
royalties on sales theretofore made and any other monies owed,
shall become immediately due and payable, and all rights and
licenses granted hereunder shall cease and revert to Licensor.
Further, Licensee will withdraw or cancel any governmental filings
made on its behalf that include the Licensed Marks. Licensee shall
immediately cease and desist from using the Licensed Marks in any
way. Unless otherwise stated in this Agreement, Licensee shall have
no right to sell, exploit, or in any way deal with or in any
Licensed Products covered by this Agreement or any related
advertising, marketing, promotional, and display materials,
including without limitation cartons, containers, packing, and
wrapping materials, except with and under the special consent and
instructions of Licensor in writing, which they shall be obligated
to follow. Licensee shall immediately return any Confidential
Information of Licensor to Licensor, as well as marketing and
advertising materials bearing the Licensed Marks.
19.3 Upon the natural expiration or
termination of this Agreement, neither Party shall make any
publicly disparaging comments regarding the other or its business,
whether written, oral, or electronic. This provision shall survive
the expiration or termination of this Agreement. However, nothing
herein shall limit either Party’s right to arbitration or
other judicial remedies as set out in this Agreement.
19.4 Licensee acknowledges that a
failure (except as otherwise expressly provided herein) to cease
the manufacture, sale, transmission, broadcast or distribution of
the Licensed Products upon the terminations or expiation of this
Agreement will result in immediate and irreparable damage to
Licensor. Licensee further acknowledges that there is no adequate
remedy at law for such failure to cease manufacture, sale or
distribution, and in the event of such failure, Licensor shall be
entitled to equitable relief and such further relief as a court or
agency with jurisdiction may deem just and proper.
19.5 Upon termination or expiration
of this Agreement, all the rights granted hereunder to Licensee,
and all rights, title and interest in and to the Licensed Marks,
including but not limited to, patent, industrial design, copyright,
trademark, service mark, trade dress and all improvements,
additions and changes thereto, trade secret rights, and goodwill
relating to the Licensed Marks, shall revert to Licensor. Licensee
agrees to promptly execute all documents that may be reasonably
necessary to effect the foregoing. This right and obligation shall
survive the terminations or expiration of this
Agreement.
20. FORCE MAJEURE
The
Parties shall be released from their obligations hereunder, and
this Agreement shall terminate in the event governmental
regulations or other causes arising out of a state or national
emergency or war or causes beyond the control of the Parties render
performance impossible, and one Party so informs the other in
writing of such causes and its desire to be so released. In such
event, all royalties on sales and all other monies due, theretofore
made shall become immediately due and payable to
Licensor.
21. NOTICES
Any
notice, communication, statement, payment, or legal service of
process required or permitted under this Agreement shall be in
writing and shall be effective when hand delivered; or on the date
when the notice, communication, statement, payment, or legal
service of process is transmitted by confirmed electronic facsimile
(with a confirmation copy sent by mail); or the day after the
notice, communication, statement, payment, or legal service of
process is sent by reputable overnight air courier service (e.g.,
Federal Express). All such communications shall be sent to the
Parties at the notice addresses listed below or to such other
persons and the Parties to each other may designate notice
addresses as in writing.
If to Licensor:
|
I|M1, LLC
4521 Sharon Road, Suite 450
Charlotte, NC 28211
Attention: Mark Elliott - CFO
Email: mark@levelbrands.com
|
With a copy to:
|
Paul Porter
4521 Sharon Road, Ste. 450
Charlotte, NC 28211
Email: pporter@sstreetllc.com
And
Erik Sterling
PO Box #1410
Rancho Mirage, CA 92270
Facsimile: 310 557-1722
Attention: Erik Sterling
Email: esterling@sterlingwinters.com
|
If to Licensee:
|
____________________
____________________
Facsimile No.:
Attention:
|
22. NEGATION OF AGENCY
Licensee is an
independent contractor with respect to Licensor. Nothing contained
herein shall be deemed to create an agency, joint venture,
franchise, or partnership relation between the Parties, and neither
Party shall so hold itself out. Licensee shall have no right to
obligate or bind Licensor in any manner whatsoever, and nothing
contained in this Agreement shall give, or is intended to give, any
rights of any kind to any third person(s).
23. ASSIGNABILITY
23.1 This Agreement shall inure to
the benefit of Licensor, its successors, and assigns, but will be
personal to Licensee, and shall be assignable by Licensee only with
the prior written consent of Licensor. Licensee shall not mortgage,
assign, sub-license, or otherwise encumber this Agreement without
the prior written consent of Licensor. Licensor shall be entitled
to assign this Agreement to any third party with notice to
Licensee, including any such assignment in connection with the sale
or transfer of Licensor’s business, provided, however, that
Licensor shall have the option to terminate this Agreement in lieu
of assignment to any successor of Licensor’s business in
connection with any such sale or transfer.
23.2 In the event Licensor
terminates this Agreement in connection with a sale of its
business, Licensee shall have a period of six (6) months from the
effective date of termination in which to sell off its inventory of
Licensed Products, subject to the terms and conditions of this
Agreement, including paying Royalties.
24. MODIFICATION AND WAIVER
24.1 Except as otherwise provided
herein, no agreement or understanding purporting to add to or to
modify the terms and conditions of this Agreement shall be binding
unless agreed to by the Parties in writing. Any terms and
conditions set forth in any forms used by the Parties, which are in
conflict with the terms and conditions of this Agreement, shall be
void and have no effect. The Parties further agree that the
Exhibits to this Agreement may be modified, amended, altered,
and/or supplemented from time to time in writing signed by
authorized representatives of the Parties.
24.2 It is agreed that no waiver by
either Party hereto or any breach or default of any of the
provisions set forth herein shall be deemed a waiver as to any
subsequent and/or similar breach or default.
25. GOVERNING LAW
25.1 This Agreement shall be
construed in accordance with and the laws of the State of
California which shall govern all disputes relating hereto without
giving effect to any conflicts of law provisions. The Parties agree
that any disputes, controversies or claims arising out of,
regarding, or in any way relating to the interpretation,
application, or enforcement of this Agreement, or any matter
reasonably related thereto, shall be handled by way or arbitration
and administered by and in accordance with the JAMS streamlined
Arbitration Rules and Regulations (the ''JAMS Rules '') of the
Judicial Arbitration and Mediation Service in effect at the time of
any such proceedings. Such arbitration shall be the sole,
exclusive, and final remedy for resolving any such claims and
disputes. Judgment on the final award rendered by the arbitrator
may be entered into in any court of competent jurisdiction and
shall be final and binding upon the Parties.
25.2 Notwithstanding the foregoing,
the Parties may seek provisional relief, including a preliminary
injunction or temporary restraining order, in any federal or state
court of competent jurisdiction located in Los Angeles, California,
without prejudice to the above described arbitration procedures, if
in that Parties sole judgment such provisional relief is necessary
to avoid an irreparable injury or to preserve the status quo. Never
the less, the arbitration procedure set forth in this Section 25 is
intended to be the sole and exclusive method of resolving any
claims arising out of, relating to, or regarding this
Agreement.
26. CONFIDENTIALITY
26.1 The Parties agree that the
terms, conditions, and subject matter of this Agreement constitute
confidential and proprietary information belonging to Licensor.
Licensee agrees not to divulge any confidential and proprietary
information pertaining to Licensor or this Agreement to any third
party without prior written consent of Licensor. Licensee shall
take all lawful measures to prevent the unauthorized use and/or
disclosure of such confidential information, and to prevent
unauthorized persons or entities from obtaining or using such
information. Licensee further agrees to refrain from directly or
indirectly taking any action, which would constitute or facilitate
the unauthorized use or disclosure of such confidential
information. Licensee may disclose such confidential and
proprietary information to its officers, directors, employees,
agents, and authorized representatives to the extent necessary to
enable Licensee to perform its obligations under this Agreement;
provided said officers, directors, employees, agents, and/or
authorized representatives execute an appropriate confidentiality
agreement approved by Licensor, which by its terms shall be
enforceable by injunctive relief. Licensee shall be liable for any
unauthorized use and disclosure of such confidential information by
its officers, directors, employees, agents, and authorized
representatives, including without limitation its attorneys and
accountants. The Parties further agree that any breach or
threatened breach of this Section 26.1 would cause irreparable harm
to Licensor, that a remedy at law or in damages would be
inadequate, and that the provisions of this Section 26.1 may be
enforced by way of injunctive relief in addition to any other
rights available to Licensor in law or in equity.
26.2 For purposes of this
Agreement, “confidential and proprietary information”
includes, but is not limited to, the terms, conditions, and subject
matter of this Agreement, and Licensor’s business, including
any financial, cost, pricing, and royalty information; product
development, business, marketing, promotion, distribution, sales,
sales plans, and strategies; information concerning
Licensor’s product development and intellectual property;
information concerning manufacturing processes relating to the
Licensed Products, or trade secrets. The foregoing confidentiality
obligations shall not apply to information that: (1) was
previously known to the recipient free of any obligation to keep it
confidential; (2) was independently developed by recipient; or
(3) is or becomes publicly available by means other than the
unauthorized disclosure by recipient.
26.3 In the event any judicial or
regulatory authority requests or requires disclosure of any
Confidential Information of the other party, the receiving party
shall promptly notify the disclosing party of the requested or
required disclosure and shall cooperate with the disclosing party
in any effort to avoid or limit such disclosure.
27. ENTIRE AGREEMENT AND ADMISSIBILITY
This
Agreement constitutes the complete understanding between the
Parties and supersedes any and makes void all prior agreements,
promises, representations, or inducements, no matter their form,
concerning the subject matter of this Agreement. The Parties desire
that this Agreement represent a single and completely integrated
contract expressing the entire agreement of the Parties with
respect to the subject matter of this Agreement. No promises,
agreements, or modifications to this Agreement made subsequent to
the execution of this Agreement by the Parties shall be binding
unless reduced to writing and signed by authorized representatives
of the Parties. The Parties to this Agreement agree that this
Agreement may be used as evidence in any subsequent proceeding in
which any Party alleges a breach of this Agreement or seeks to
enforce its terms, provisions, or obligations.
28. SEVERABILITY
Whenever possible,
each provision of this Agreement shall be interpreted in such a
manner to be effective and valid under applicable law. Should any
of the provisions or terms of this Agreement be determined illegal,
invalid, or unenforceable by any court of competent jurisdiction,
validity of the remaining parts, terms, or provisions shall not be
affected thereby, and said illegal, invalid, or unenforceable part,
term, or provision shall be deemed not to be a part of this
Agreement.
29. RECITALS AND HEADINGS
The
terms of this Agreement are contractual, not a mere recital, and
are the result of joint negotiations between, and joint drafting
by, the Parties, and are therefore not to be construed in favor of
or against either Party. All recitals are incorporated by reference
into this Agreement. Caption and Section headings are used for
convenience and reference only, are no part of this Agreement, and
shall not be used in interpreting, construing, defining, limiting,
extending, or describing the scope of this Agreement, or any
provision hereof, in any way.
30. ATTORNEY FEES AND COSTS
Should
any action be necessary to enforce the terms of this Agreement, the
prevailing Party will be entitled to recover reasonable
attorneys’ fees and costs.
31. EXECUTION OF COUNTERPARTS
This
Agreement may be executed in two or more duplicate bond or
facsimile counterparts, each of which shall be considered an
original, but all of which together shall constitute one and the
same instrument, and in pleading or proving any provision of the
Agreement, it shall not be necessary to produce more than one such
counterpart.
32. EQUITABLE RELIEF
The
Parties acknowledge that the subject matter of this Agreement
relates to services and rights, which are extraordinary and unique
and which cannot be replaced or adequately compensated in money
damages, and any breach by Licensee of this Agreement will cause
irreparable injury to Licensor.
[signature page
follows]
IN
WITNESS WHEREOF, the Parties hereto have caused this instrument to
be duly executed as of the day and year first above
written.
Licensor:
I|M1, LLC
_________________________________
Name:
___________________________
Title:
____________________________
Licensee:
[ ]
_________________________________
Name:
___________________________
Title:
____________________________
EXHIBIT A
LICENSED MARK
1. Only
for the Licensed Products specified in Exhibit B
to this Agreement and only as shown in
the following specimen(s):
2. Examples on Brand Partner Resource link; upon
Licensee’s signature a password will be
provided.
3. Licensed Products to include styles with each of
the following supporting categories will be provided by Licensor
upon further discussion with Licensee.
Licensor may designate other supporting brands or categories, in
writing from time to time.
EXHIBIT B
LICENSED PRODUCTS AND CHANNELS OF DISTRIBUTION
●
The
following list sets forth the Licensed Products:
[
]
●
Licensee may only use those channels of
distribution approved, in advance, by Licensor. Any mass market and
low tier department stores (i.e., Wal-Mart, K-Mart, Target, and
Sears), as well as club stores (i.e. Sam’s), are
specifically excluded from
the approved Channels of Distribution under this
Agreement.
●
Licensor
shall have prior approval rights relating to any internet retailers
not belonging to retailers in the approved Channels of Distribution
set forth above, which will be reviewed on an individual basis by
Licensor.
EXHIBIT C
CODE OF CONDUCT
行为守则
1. PURPOSE: [LICENSEE] is committed to using only
manufacturers to strive to conduct business in a highly
professional and ethical manner. This document outlines those
commitments each facility makes in respect to its compliance with
applicable law and tis personal practices and
policies.
目的:[被许可人]承诺只使用了力争在一个高度专业和道德的方式开展业务的厂家。本文概述了这些各设施使得在尊重其遵守适用的法律和个人的做法和政策的承诺。
2. CHILD
LABOR: The facility agrees not to use child labor in the
manufacturing, or distribution of the Goods. The term
“child” refers to a person younger than the local legal
minimum age for employment or the age for completing compulsory
education; provided, however, in no event shall the Facility use
any person below the age of (15) fifteen. The Facility also agrees
to comply with all other Laws applicable to employees, regardless
of the age of an employee.
童工:该中心同意不使用童工在制造,或货物配送。
“童工”是指一个人年龄低于当地法定最低就业年龄或年龄在完成义务教育;
提供的,但是,在任何情况下,基金使用任何人(15)15岁以下。该基金还同意遵守适用于所有员工的其他法律,不论雇员的年龄。
3. FORCED
LABOR: The Facility agrees to employ only persons whose presence is
voluntary. The Facility agrees not to use any forced or involuntary
labor, whether prison, bonded, indentured or
otherwise.
强迫劳动:该基金同意只雇用人员,其存在是自愿的。该基金同意不使用任何强迫或非自愿劳动,无论是监狱,保税,契约或其他方面。
4. ABUSE
OF LABOR: The Facility agrees to treat each employee with dignity
and respect and not to use corporal punishment, threats of
violence, or other forms of physical, sexual, psychological or
verbal harassment or abuse.
滥用劳动:该基金同意把每个员工的尊严和尊重,不使用体罚,暴力威胁或其他形式的身体,性,心理或言语上的骚扰或虐待。
5. NON-DISCRIMINATION: The Facility agrees not to
discriminate in hiring and employment practices, including salary,
benefits, advancement, discipline, termination, or retirement on
the basis of race, religion, age, nationality, social or ethnic
origin, sexual orientation, gender, political opinion or
disability.
不歧视:该基金同意不会在雇佣和招聘活动,包括工资,福利,晋升,纪律,终止或退休种族,宗教,年龄,国籍,社会或民族,性取向,性别的基础上歧视,政治观点或残疾。
6. ASSOCIATION: The Facility agrees to follow
employees to organize and bargain collectively without penalty or
interference in accordance with local Laws.
关联关系:该基金同意遵守雇员组织和集体谈判不受处罚或干预按照当地的法律。
7. WAGES,
DENEFITS AND WORKING HOURS: The facility recognizes that wages are
essential to meeting employee’s basic needs. The Facility
agrees to comply, at a minimum, with all applicable wages and hour
Laws, including minimum wage, overtime hours, maximum hours, piece
rates and other elements of compensation and shall provide legally
mandated benefits.
工资,福利和工作时间:该厂认识到,工资是必要的,以满足员工的基本需求。该基金同意遵守,至少,所有适用的工资和工时的法律,包括最低工资,加班,最长工时,计件工资和补偿等内容,并应提供法定福利。
8. HEALTH
AND SAFETY: The Facility agrees to provide employees with a safe
and healthy workplace environment in accordance with all applicable
Laws, ensuring at a minimum, reasonable access to potable water and
sanitary facilities, fine safety and adequate lighting and
ventilation. The Facility also agrees to ensure that the same
standards of health and safety are applied to any housing it
provides for employees.
健康和安全:该基金同意为员工提供一个安全和健康的工作环境符合所有适用法律,确保在最低限度,合理获得饮用水和卫生设施,精美的安全性和足够的照明和通风。该基金也同意,以确保健康和安全的相同标准适用于它提供了雇员的住房
9. COMPLIANCE: The Facility agrees to take
appropriate steps to ensure that the provisions of the COC are
communicated to its employees, including by prominent posting a
copy of this COC in the local language on one or more bulletin
boards in places readily accessible to employees at all
times.
合规性:本基金同意采取适当措施,以确保奥委会的规定传达给员工,其中包括由著名张贴在当地语言的一个或多个电子公告板的名额该行为准则的副本容易获得员工的所有次。
10. ENVIRONMENT: Business partners should share our
concern for the environment and adhere to their local and national
laws regarding the protection and preservation of the
environment.
环境:业务合作伙伴应该分享我们对环境的关注,并坚持对环境的保护和维护当地和国家法律。
11. LEGAL
REQUIREMENTS: Business partners should be in compliance with all
legal requirements involved in conducting the
business.
法律要求:业务合作伙伴应符合参与开展业务的所有法律要求。
12. Our
Business Partners are required to provide full access to their
facilities and those of their manufacturers, vendors and
subcontractors, and to release records relating to employment
practices. We may conduct on-site inspections of facilities to
monitor the standards and assure the quality of our
products.
我们的业务合作伙伴必须提供完全访问他们的设备和那些他们的制造商,供应商和分包商,并发布有关用工行为记录。我们可以进行现场视察设施,以监控标准,确保了产品的质量。
Please report Violations Anonymously by emailing to:
mark@levelbrands.com
EXHIBIT D
Approved Royalty Report Form
●
Example
Royalty Reports are set forth on the Brand Partner Resource link,
upon your signature a password will be provided
EXHIBIT E
REQUIRED INSURANCE CERTIFICATE
Under Description of Operations state the
following:
“Certificate Holder I|M1, LLC, I|M1 Holdings, LLC, Level
Brands, Inc., Encore Endeavor 1, LLC, EE1 Holdings, LLC,
Tommy Meharey, Kathy Ireland,
kathy ireland Worldwide, Inc., kathy ireland LLC, The
Sterling/Winters Company, and their partners, owners,
subsidiaries, affiliates, directors, officers, managers and
employees are named additional insured with regards to liability
arising out of operations of the named
insured.”
The Certificate Holder should be listed as:
I|M1, LLC
4521 Sharon Road, Ste. 450
Charlotte, NC 28211
Send copies of Certificate to:
Mitchka Lyonnais
mlyonnais@mmibi.com
Momentous Insurance Brokerage, Inc.
Mark Elliott
mark@levelbrands.com
I|M1, LLC
EXHIBIT F
Millennium Development Goals
1. We
must eradicate extreme poverty and hunger!
2.
Achieve universal primary education.
3.
Promote gender equality and empower women.
4.
Reduce child mortality.
5.
Improve maternal health.
6.
Combat HIV/AIDS, Malaria, and other diseases.
7.
Ensure environmental sustainability.
8. Build global
partnerships for development.
9.
Bring opportunities of financial stability and healthcare to
American Veterans and their families.
10.
Stop Human Trafficking.
- END OF CONTRACT-
-24-
Exhibit
6.25
CONSULTING AGREEMENT
This Consulting Agreement
(“Agreement”)
is made and entered into as of this 20th
day of March, 2017, by and between
I|M1, LLC, a California limited liability company
(“Consultant”),
and Kure Corp., a Florida corporation (“Company”).
RECITALS
A.
Consultant
is engaged in the licensing of intellectual property relating to
“I’M1” and provides online, event driven and
other marketing and branding consulting services to its clients
using facilitators and visual representations being known and
recognized by the public and associated in the public mind with
Consultant.
B.
Ms.
Ireland, an internationally famous person and designer with a
highly favorable public image and strong, favorable identity for
branding; and a strong portfolio of multiple brands and
ambassadors, also with a highly favorable public image and strong
brand identities serves as Chief Brand Advisor of
Consultant.
C.
Company is a manufacturer, distributor and/or
seller of products and desires to use the branding capabilities of
the Consultant for vape related products, and limited to those
products set forth in Exhibit B
to the Licensing Agreement between
Consultant and Company (“Vape
Products”).
D.
The Consultant possesses unique and appropriate
knowledge and skill to promote the Company, through online and
social media, in regards to the Vape Products set forth in
Exhibit
A to advise the Company in
regard to marketing and brand awareness.
E.
The Company desires to retain Consultant on an
exclusive basis with respect to the Vape Products set forth
in Exhibit A
to provide services to the Company on
the terms and conditions set forth herein.
AGREEMENT
NOW, THEREFORE in consideration of
the mutual covenants and promises contained herein, the receipt and
sufficiency of which is hereby acknowledged, the parties hereby
agree as follows:
1. Consultancy.
The Company hereby engages Consultant to provide assistance in
promotion of the Company and promotion and advice in regard to
marketing and branding of the Vape Products.
2. Duties
and Involvement.
a. The services will generally include assistance in
promotion of the Company's name and products to the public for
greater public awareness and promotion of the Company and its
products in the online community and on television. Consultant will
make use of its social media network for these purposes and will
also provide promotion of the Vape Products on various
media. The Services to be performed will include, without
limitation, (i) a social media blitz, including blogging on
Twitter, Instagram, Facebook and other social media platforms by
March 31, 2017, (ii) modeling impressions with the Company’s
products which will be provided on various social media platforms
by May 31, 2017, (iii) marketing and sales merchandising and
branding materials by March 31, 2017, and (iv) television and
public support statements for “I’M1” along with
“Kure” by May 31, 2017; provided, that it is understood
and agreed that any failure to accomplish one or more of the
Services by the dates set forth above shall not be deemed to be a
material breach of this Agreement for purposes of Section 4(b)
(the “Services”).
b.
Consultant acknowledges that neither it nor any of its employees
will make use of Company proprietary data for personal use or gain,
and will not disclose to any third party any confidential
information or materials which it receives as a result of providing
the Services hereunder.
3. Exclusivity
for Select Identified Products.
Company acknowledges that Consultant provides services to other
entities for other products, and the Services provided herein shall
be exclusive only to those Vape Products set forth on
Exhibit
A. For clarification purposes,
the parties understand and agree that Consultant may perform
services for other entities and for other products (including,
without limitation, Vape Products) to the extent such products are
not specifically set forth in Exhibit
A.
4. Term
and Termination.
a.
This Agreement shall begin effective with the execution of this
Agreement and shall terminate on December 31, 2017.
b.
This Agreement may be terminated upon the following events: (i)
mutual agreement of the parties provided written notice is given;
or (ii) a material breach of any of the provisions hereof by either
party.
5. Compensation.
Company agrees to compensate
Consultant as follows: (i) Two Hundred Thousand Dollars ($200,000)
prior to March 31, 2017 (in exchange for the Services in Section
2(a)(i) and (iii) and a portion of the exclusivity in Section 3),
and (ii) Four Hundred Thousand Dollars ($400,000) prior to May 31,
2017 (in exchange for the remaining Services and remaining
exclusivity in Section 3).
6. Services.
Consultant shall devote such time and
effort necessary to discharge duties hereunder. The Company
acknowledges that Consultant may conduct other business activities
and that it may pursue such during the term of this Agreement so
long as such are not inconsistent with the intent and duties
hereunder.
7. Assignment.
This Agreement may not be assigned by
either party hereto without the written consent of the other but
shall be binding upon the successors the
parties.
8. Governing
Law. This Agreement shall be
constructed by and enforced in accordance with laws of the State of
California.
9. Agreement Drafting. The parties
understand and agree that this Agreement is being prepared as an
accommodation to the parties by a business advisor on behalf of a
shareholder in both parties, and such business advisor is neither
(a) acting in any legal capacity, nor (b) representing either party
in any legal or business capacity. This Agreement represents the
agreement between the parties, which has been reduced to writing by
a third party. Each party should seek their own legal counsel for
review and negotiation prior to execution.
10. General.
This Agreement contains the entire
understanding and agreement between the parties. There are no other
agreements, conditions or, oral or written, express or implied,
with regard. This Agreement may be amended only in writing signed
by both parties. This Agreement may be executed in counterparts,
each of which shall be an original but all of which together shall
constitute one and same agreement. The provisions of the Agreement
shall be binding upon the parties and their successors and assigns.
If any provisions of this Agreement, or application thereof to any
circumstances shall be deemed or held to be invalid, illegal or
unenforceable to any extent, the remainder of this Agreement shall
not be affected and the application of such affected provision
shall be enforced to the greatest extend possible under
law.
IN
WITNESS WHEREOF, the parties hereto have caused this instrument to
be duly executed as of the day and year first above
written.
Consultant:
I|M1, LLC
/s/ Stephen Roseberry
Stephen
Roseberry, President
Company:
Kure Corp.
/s/ Craig Brewer
Craig
Brewer, CEO
Exhibit A
The
following Vape Products specifically labeled under the
“I’M1” brand:
a.
E-liquid (or
e-juice).
g.
Other vape related
hardware.
h.
Retail stores
having inventory for sale comprised primarily of vape related
products.
Exhibit 6.26
AMENDED AND RESTATED CONSULTING AGREEMENT
This Amended and Restated Consulting Agreement
(“Agreement”)
dated June 8, 2017 is effective as of the 20th
day of March, 2017 (the
“Effective
Date”), by and between
I|M1, LLC, a California limited liability company
(“Consultant”),
and NuGene International, Inc., a Nevada corporation
(“Company”).
RECITALS
A.
Consultant
provides online, event driven and other marketing and branding
consulting services to its clients using facilitators and visual
representations being known and recognized by the public and
associated in the public mind with Consultant “for use by
men” or the men’s market.
B.
Ms.
Ireland, an internationally famous person and designer with a
highly favorable public image and strong, favorable identity for
branding; and a strong portfolio of multiple brands and
ambassadors, also with a highly favorable public image and strong
brand identities serves as Chief Brand Advisor of
Consultant.
C.
Company is a manufacturer, distributor and/or
seller of products and desires to use the branding capabilities of
the Consultant for skin and hair care products within the
“for use by men” or the men’s market, which
products contain stem cell derived and containing biologically
active or biologically derived ingredients, and limited to those
products set forth in Exhibit A
hereto (“Men’s
Products”).
D.
The Consultant possesses unique and appropriate
knowledge and skill to promote the Company, through online and
social media, in regards to the Men’s Products set forth
in Exhibit A
to advise the Company in regard to
marketing and brand awareness.
E.
The Company desires to retain Consultant with
respect to the Men’s Products set forth in
Exhibit
A to provide services to the
Company on the terms and conditions set forth
herein.
F.
The
parties wish to enter into this amended and restated agreement to
correct certain ministerial errors and disclosures in the initial
agreement between the parties which was unrelated to this Agreement
and which has been terminated ab initio.
AGREEMENT
NOW, THEREFORE in consideration of
the mutual covenants and promises contained herein, the receipt and
sufficiency of which is hereby acknowledged, the parties hereby
agree as follows:
1. Consultancy.
The Company hereby engages Consultant to provide assistance in
promotion of the Company and promotion and advice in regard to
marketing and branding of the Men’s
Products.
2. Duties
and Involvement.
a.
The services will generally include assistance in promotion of the
Company's name and products to the public for greater public
awareness and promotion of the Company and its products in the
online community and on television. Consultant will make use of its
social media network for these purposes and will also provide
promotion of the Men’s Products on various media. The
Services to be performed by March 31, 2017 will include, without
limitation, (i) an immediate social media blitz, including blogging
on Twitter, Instagram, Facebook and other social media platforms,
(ii) modeling impressions with the Company’s products which
will be provided on various social media platforms, (iii) marketing
and sales merchandising and branding materials, and (iv) television
and public support statements for “NuGene;” provided,
that it is understood and agreed that any failure to accomplish one
or more of the Services by March 31, 2017 shall not be deemed to be
a material breach of this Agreement for purposes of Section 4(b)
(the “Services”).
b.
Consultant acknowledges that neither it nor any of its employees
will make use of Company proprietary data for personal use or gain,
and will not disclose to any third party any confidential
information or materials which it receives as a result of providing
the Services hereunder.
3. Exclusivity
for Select Identified Products.
Company acknowledges that Consultant provides services to other
entities for other products, and the Services provided herein shall
be exclusive only to those Men’s Products set forth on
Exhibit
A. For clarification purposes,
the parties understand and agree that Consultant may perform
services for other entities and for other products (including,
without limitation, Men’s Products) to the extent such
products are not specifically set forth in Exhibit
A.
4. Term
and Termination.
a.
This Agreement shall begin as of and on the Effective Date and
shall terminate on December 31, 2017.
b.
This Agreement may be terminated upon the following events: (i)
mutual agreement of the parties provided written notice is given;
or (ii) a material breach of any of the provisions hereof by either
party.
5. Compensation.
Company agrees to compensate
Consultant as follows: (i) upon execution hereof, Company shall pay
Consultant an amount equal to Two Million Five Hundred Thousand
(2,500,000) shares of the Company’s Common Stock having a par
value of $.0001 per share (the “Shares”);
and (ii) Company shall pay to Consultant Fifty Thousand Dollars (US
$50,000) upon the earlier of (A) any Company equity or debt
offering or financing which provides the Company with proceeds in
an amount equal to or in excess of $10,000,000, or (B) June 30,
2017. With regard to the Shares, Consultant hereby represents and
warrants to Company as follows:
a.
Consultant understands that the Shares are
characterized as “restricted securities” under the
Securities Act of 1933 (as amended, and together with the rules and
regulations promulgated thereunder, the “Act”) and that, under the
Act the Shares may not be resold, pledged, or otherwise transferred
without registration under the Act or an exemption
therefrom.
b.
Consultant
understands that the Shares are being offered in a transaction not
involving any public offering in the United States within the
meaning of the Act, and the Shares have not been registered under
the Act or under any state securities laws, and are being offered
and sold in reliance upon federal and state exemptions for
transactions not involving any public offering.
c.
Consultant is an
“accredited investor”, as that term is defined under
Rule 501(a) of the Act, and it has such knowledge and experience in
business and financial matters that it is capable of evaluating the
merits and risks of acquiring the Shares.
d.
Consultant has had
the opportunity to obtain from Company such information as it
desired in order to evaluate the merits and the risks inherent in
holding the Shares.
6. Services. Consultant shall devote such time and effort
necessary to discharge its duties hereunder. The Company
acknowledges that Consultant may conduct other business activities
and that it may pursue such during the term of this Agreement so
long as such are not inconsistent with the intent and duties
hereunder.
7. Assignment. This Agreement may not be assigned by either party
hereto without the written consent of the other but shall be
binding upon the successors the parties.
8. Governing Law.
This Agreement shall be constructed by
and enforced in accordance with laws of the State of
California.
9. General.
This Agreement contains the entire
understanding and agreement between the parties. There are no other
agreements, conditions or, oral or written, express or implied,
with regard. This Agreement may be amended only in writing signed
by both parties. This Agreement may be executed in counterparts,
each of which shall be an original but all of which together shall
constitute one and same agreement. The provisions of the Agreement
shall be binding upon the parties and their successors and assigns.
If any provisions of this Agreement, or application thereof to any
circumstances shall be deemed or held to be invalid, illegal or
unenforceable to any extent, the remainder of this Agreement shall
not be affected and the application of such affected provision
shall be enforced to the greatest extend possible under
law.
IN WITNESS WHEREOF, the parties hereto have caused
this instrument to be duly executed.
Consultant:
I|M1, LLC
By:
/s/ Mark Elliott
Name:
Mark Elliott
Title:
CFO
Company:
NuGene International, Inc.
By:
/s/ M. Ali Kharazmi
Name:
M. Ali Kharazmi
Title:
Chairman
Exhibit A
Each of
the following products which are currently marketed and sold by the
Company, but as the same may be renamed, rebranded or otherwise for
use by men or in the men’s market containing stem cell
derived or containing biologically active or biologically derived
ingredients: NuGene Face Wash, NuGene universal Cream, NuGene
Universal Serum, NuGene Light and Bright, NuGene Eye Serum, NuGene
Face Mask, NuGene Melasma Serum, NuGene Acne Serum, NuGene
Revitalizing night Cream, NuGene Toner, NuGene Body Lotion, NuGene
Specialty Soap, NuGene Neck & Dècolleté Lotion,
Advanced Infusion Serums and other age-defying products that are
stem cell derived or which contain biologically active or
biologically derived ingredients.
Exhibit 6.27
EXECUTIVE EMPLOYMENT AGREEMENT AMENDMENT
THIS EXECUTIVE EMPLOYMENT AGREEMENT AMENDMENT (this "Amendment”)
is made and entered this 14th day of April, 2017 (the
“Effective
Date”) between Level Brands, Inc., a North Carolina
corporation whose principal place of business is 4521 Sharon Road,
Charlotte, NC 28211 (the "Corporation")
and Marty Sumichrast, an individual whose address is 11125 Colonial
Country Lane, Charlotte, NC (the "Executive").
WHEREAS, the Corporation and Executive
entered into an Employment Agreement effective January 1, 2017 (the
"Agreement").
WHEREAS, the Corporation desires to
amend the Agreement as follows:
Section
5 is replaced to read:
5. Compensation
and Benefits.
a. Salary.
The Executive shall be paid a base salary (“Base
Salary”), payable in accordance with the Corporation's
policies from time to time for senior executives, at an annual rate
One Hundred Twenty Thousand dollars ($120,000). Any accrued and
unpaid salary shall be paid on the next payroll.
General. All other provisions in the Agreement shall remain
unchanged and be in full force and effect. This Agreement may be
executed in any number of counterparts, each of which when so
executed shall be deemed to be an original and, all of which taken
together shall constitute one and the same Agreement. In the event
that any signature is delivered electronically, such signature
shall create a valid binding obligation of the party executing (or
on whose behalf such signature is executed) the same with the same
force and effect as if such facsimile signature were the original
thereof.
IN WITNESS WHEREOF, the parties hereto
have executed this Amendment.
THE COMPANY:
LEVEL
BRANDS, INC.
By:
/s/ Mark
Elliott
CFO
THE EXECUTIVE
/s/ Marty Sumicharst
_____________________________
Exhibit 6.28
LICENSE AGREEMENT
THIS LICENSE AGREEMENT
(“Agreement”) is made and
entered into as of this 29the day of March, 2017, by and between
I|M1, LLC, a California limited liability company
(“Licensor”), Kure Corp., a Florida corporation
(“Kure”), and its wholly owned subsidiary, Kure
Franchise, LLC, a North Carolina limited liability
(“Franchise”) (Kure and Franchise, collectively,
“Licensee”).
RECITALS
A. Licensor has the right and authority to license
certain trademarks and rights to the name, likeness, and visual
representation of “I’M1” and other marks and has
developed and used intellectual property (collectively, the
“I’M1 IP”) and is engaged in the licensing of the
property identified in the attached Exhibit
A, as well as multiple names,
likeness, and visual representations being known and recognized by
the public and associated in the public mind with Licensor
(hereinafter, with the I’M1 IP, collectively referred to as
the “Licensed Marks”, the “Licensed
Property” or the “Brand”).
B. Licensor is the owner, by assignment, of the name,
nick name, image, likeness, initials, mark, appearance, signature
(including reproduced signature), autograph, endorsement, voice,
and biographical material (including history, video and motion
picture film portrayals, and still photography), Internet domain
names and online social media user/screen names of the Licensed
Marks.
C. Ms. Ireland, an internationally famous person and
designer with a highly favorable public image and strong, favorable
identity for branding; and a strong portfolio of multiple brands
and ambassadors, also with a highly favorable public image and
strong brand identities serves as Chief Brand Advisor of
Licensor.
D. Licensee is an importer, manufacturer, distributor
and/or seller of products and desires to use the Licensed Marks in
the Channels of Distribution as contemplated in Exhibit
B.
AGREEMENT
In
consideration of the mutual promises herein contained, it is hereby
agreed:
1. DEFINITIONS
1.1 The term
“Allowance” mean any reductions in the wholesale sales
price of any Licensed Product approved in advance, in writing, by
Licensor off-invoice amounts or accruals.
1.2 The term
"Brand" shall mean only the Licensed Products offered under the
Licensed Marks set forth in Exhibit A.
1.3 The term
“Channels of Distribution” shall mean only those
channels, which are listed and mutually agreed on Exhibit B attached hereto
and incorporated by reference herein. Exhibit B may only be modified,
supplemented, and/or amended by written agreement of the Parties as
provided herein.
1.4 The term
“Code of Conduct” shall refer to the Licensor’s
Human Rights – Code of Conduct, incorporated by this
reference as set forth in Exhibit C, with respect to
which Licensee agrees to fully comply in such form attached and as
it may be amended or updated by the Licensor from time to time upon
written notice to Licensee of such changes.
1.5 The term
“Effective Date” shall mean the date this Agreement is
executed by Licensor as set forth above.
1.6 The term
“Gross Sales” shall mean the gross amount billed
(exclusive of any and all sales, use or value added Tax (VAT)). No
other costs incurred in the manufacturing, selling, advertising,
and/or distribution of the Licensed Products shall be
deducted.
1.7 The term
“Initial Term” shall have the meaning set forth in
Section 4.
1.8 The term
“Licensed Marks” shall mean the Brand and Licensed
Products set forth in Exhibit B, including, without
limitation, their likeness, visual representation and/or each of
the individual components thereof, and those trademarks, service
marks, logos, designs, and/or any other symbols/devices, which are
set forth in Exhibit
A attached hereto and incorporated by reference
herein.
1.9 The term
“Licensed Products” shall mean only those items, which
are listed in Exhibit
B attached hereto. Exhibit B may only be modified,
supplemented, and/or amended by written agreement of the Parties as
provided herein.
1.10 The term
“Manufacturing Territory” shall mean the United
States.
1.11 The Term
“Millennium Development Goals” shall refer to the
Millennium Development Goals, incorporated by this reference as set
forth in Exhibit F,
with respect to which Licensee agrees to fully adopt, as well as
meaningfully contribute to, one or more of such goals either
economically or through other Licensee resources. It is understood
and agreed that the Best Buddies charity is deemed to fall within
these Millennium Development Goals.
1.12 The term
“Parties” (or “Party”) shall mean the
parties entering into this Agreement.
1.13 The term
“Returns” shall mean any Licensed Product, which
Licensee accepts back from any customer after purchase and delivery
thereof and for which Licensee refunds the actual purchase price,
or issues a credit memo.
1.14 The term
“Royalty” or “Royalties” shall have that
meaning set out in Section 5.1 below.
1.15 The term
“Term” shall mean the Initial Term plus any extensions,
renewals of this Agreement or modifications thereof.
1.16 The term
“Termination Date” shall mean the date, whichever is
earliest, that (i) this Agreement (subject to any renewals or
extensions) expires by its own terms; (ii) is thirty (30) days
after receipt of notice of termination under Section 21; or
(iii) any other event occurs which terminates this Agreement
where no notice is required.
1.17 The term
“Territory” shall mean United States of
America.
1.18 The term “Trade
Discounts” shall mean any reductions or charge backs in the
wholesale sales price of any Licensed Product, and granted by
Licensee in writing to any customer prior to delivery.
2. GRANT OF LICENSE
2.1 Upon the terms and conditions set
forth herein, Licensor hereby grants to Licensee the
non-transferable right, license, and privilege, of using the
Licensed Marks solely for the sale, marketing and distribution of
the Licensed Products through the Channels of Distribution in the
Territory during the Term (with the exceptions as stated on
Exhibit B), and the
non-exclusive, non-transferable right, license, and privilege
of using the
Licensed Marks solely upon and in connection with the manufacture
of Licensed Products in the Manufacturing Territory.
2.2 All proposed Channels of
Distribution and distribution outlets in Exhibit B shall be deemed
approved and any others shall be submitted in advance to Licensor
and shall be subject to Licensor’s prior written
approval.
2.3 Licensee shall not assign or
sub-license the use of the Licensed Marks to any third party
without prior written approval by Licensor, and such right is
expressly withheld from this Agreement. In the event that Licensor
approves a sub-license to a third party, the Parties shall mutually
agree upon the terms and conditions of said sub-license, including
without limitation the royalty rate, in a separate writing signed
by the Parties.
2.4 Licensee will not be permitted to
enter into any other branded relationship that competes with
Licensor’s Brand program under this Agreement without the
express prior written approval of Licensor.
3. BRAND DEVELOPMENT
3.1 Licensee will begin shipping of
Licensed Products no later than April 30, 2018.
3.2 Licensee agrees that all names
of Licensed Products are proprietary to Licensor. More
specifically, Licensor shall own all intellectual property rights
in the Licensed Products and related materials and in all sketches,
artwork and/or designs for the Licensed Products and the related
materials, at no cost to Licensor, and to the extent Licensee has
any rights in such intellectual property, Licensee agrees to assign
and does hereby assign to Licensor (or any person or entity
designated by Licensor) all of its right, title and interest in and
to such products and materials.
3.3 Licensee agrees to become a member
and utilize (a) Send Out Cards, a customer contact communication
service, (b) Salesforce.com, (c) Dependable Solutions, a product
approval and royalty reports services, (d) ireland pay, a merchant
agreement service, and (e) any similar web platform as may be
utilized by Licensor from time to time as a means of conducting
Brand business and coordinating with Licensor and other
licensees.
4. TERM
The
initial term (“Initial Term”) of the license hereby
granted shall commence on the Effective Date and shall be effective
through the tenth anniversary of the Effective Date, unless terminated sooner in accordance
with the provisions hereof.
5. ROYALTY
5.1 Royalty. In consideration of
the grant hereunder, Licensee shall pay Licensor royalties in U.S.
dollars at a rate of five percent (5%) of 100% the Gross Sales for
all Licensed Products sold under the Licensed Marks (the
“Royalty”). Within fifteen (15) days after the end of
each month, Licensee shall furnish to Licensor a complete sales and
royalty report certified to be accurate by the Chief Financial
Officer of Licensee or by some other authorized designee of
Licensee showing the number, description, and Gross Sales Price of
the Licensed Products distributed and/or sold by Licensee during
the preceding month, as well as the number of Licensed Products in
inventory at the beginning and end of the month along with payment
of the royalties due which shall be sent by wire transfer to the
following account:
Licensor:
I|M1, LLC
4521 Sharon Road, Ste 450
Charlotte, NC 28277
Domestic Wire:
ABA Bank Routing
#121000248
Account Name: IM1, LLC
Account No.: 5842344409
|
5.2 Royalty Report. For this
purpose, Licensee shall use the approved report form attached
hereto as Exhibit D
and incorporated by reference herein. Such report shall be
furnished to Licensor whether or not any of the Licensed Products
have been sold during the preceding month. Licensee shall tender
both hard copy sales and royalty report and sales in royalty report
in Excel spreadsheet format to Licensor. Sales and Royalty will be
furnished separately for each brand listed in Exhibit A in Excel spreadsheet
format to the Licensor and sent to the addresses set forth in
Section 21. The receipt or acceptance by Licensor of any of the
reports furnished by Licensee pursuant to this Agreement or of any
royalties paid by Licensee hereunder (or the cashing of any royalty
checks paid by Licensee hereunder) shall not preclude Licensor from
questioning the accuracy thereof at any time, and in the event that
any inconsistencies or mistakes are discovered in such reports or
payments, any inconsistency, mistake, or inaccuracy shall
immediately be rectified, and any appropriate payment due and owing
shall immediately be paid by Licensee to Licensor.
5.3 Late Payment. Any amount not
paid to Licensor when due under this Agreement shall bear
a late payment charge on the unpaid balance at the rate of
1.5% per month, compounded, or the maximum amount permitted by law,
whichever is less.
6. ACCOUNTING
6.1 Licensee agrees to
keep accurate books of account and records covering all
transactions relating to the license hereby granted, and Licensor
and its duly authorized representatives shall have the right after
giving reasonable notice at all reasonable hours of the day to an
examination of said books of account and records relating to
Licensee’s performance under the Agreement, and of all other
documents and materials in the possession or under the control of
Licensee or any of its affiliated, associated, or subsidiary
companies or agents, with respect to the subject matter and terms
of this Agreement, and shall have free and full access thereto for
said purposes and for the purpose of making extracts therefrom.
Upon request of Licensor, Licensee shall furnish to Licensor a
detailed statement by an independent certified public accountant
showing the number, description, and Gross Sales of the Licensed
Products covered by this Agreement distributed and/or sold by
Licensee to the date of Licensor’s demand. All books of
account and records shall be kept available for no less than
Seven (7) years, or, as long as required by the Internal
Revenue Service, if longer than 7 years.
6.2 Each calendar year in which this
Agreement is in effect, and after expiration or termination of this
Agreement, Licensor shall be entitled to an independent audit of
and be given access to Licensee’s account books, records,
invoices and other pertinent data by a certified public accountant
or qualified auditor designated by Licensor. The audit shall be
conducted to determine Licensee’s sales of Licensed Products,
as well as all returns and trade discounts, and shall be conducted
during normal business hours at Licensee’s business office or
location of such files and records. The cost of the audit shall be
borne by Licensor unless the audit reveals that Licensee
understated sales and or royalties of Licensed Products by more
than two percent (2%), in which case Licensee shall be required to
pay all Licensor’s costs of the audit.
6.3 Licensor’s exercise in whole
or in part of its inspection rights under Section 6.2 or otherwise,
Licensor’s acceptance of any statement or statements from, or
the receipt of acceptance by Licensor of any payment tendered by or
on behalf of Licensee, shall be without prejudice to
Licensor’s rights or remedies permitted by this Agreement or
as a matter of law or equity, and shall not preclude or prevent
Licensor from thereafter disputing the accuracy of any such
statement or payment.
7. QUALITY ASSURANCE
7.1 The quality of the
Licensed Products shall be consistent with or exceed the average of
similar products manufactured, distributed, and/or sold by
Licensee, shall serve to enhance Brand recognition of the Licensed
Products to the mutual benefit of the Parties, and shall be
suitable for the use for which they are intended.
7.2 All Licensed Products developed,
manufactured and sold hereunder, and all labels, hang tags,
packaging, catalogs, brochures, publications, printed matter,
advertising, signs, promotional displays, websites, webpages, video
and sound recordings, online social media pages (hereinafter the
"Promotional Materials") and other forms of publicity material for
the Licensed Products, shall be subject to Licensor’s written
approval in advance of use, distribution, marketing or
sale.
7.3 All materials submitted for approval
to Licensor in a language other than English will be accompanied by
a complete and accurate English translation.
7.4 If any retail customer of Licensee
notifies Licensee or claims to Licensee that there is a significant
quality issue with any Licensed Products sold to it by Licensee,
Licensee shall notify Licensor in writing of any such alleged
quality issues within five (5) business days of being notified by
the retailer customer involved.
7.5 Licensor shall notify Licensee
of consumer quality issues received by Licensor on Licensor’s
website. Licensee shall reply to applicable consumers within
forty-eight (48) hours of its receipt of the issues from
Licensor’s website.
7.6 Licensor will have the right to
purchase products from the Licensee at best available pricing, for
personal use, Social Media Contests, giveaways, and other
promotional uses. Products purchased hereunder shall not be for
commercial resale.
8. DISPLAY OF MERCHANDISE
8.1 If Licensee has
a showroom, Licensee agrees to maintain space in its showroom
located in various high traffic locations and dedicated to display
of the Licensed Products under the Brand. Licensee further agrees
that the Licensed Products shall be displayed at Licensee’s
showroom in the most favorable manner possible to enhance the
recognition of the Brand and the Licensed Products to the mutual
benefit of the Parties. The display of the Licensed Products shall
be subject to the written approval of Licensor prior to any display
thereof.
8.2 Licensee may display and offer
the Licensed Products on its own company or business web page/site
in a manner, which makes the Licensed Products distinctive and
enhances the recognition of the Brand and the Licensed Products to
the mutual benefit of the Parties. Products other than Licensed
Products bearing the Licensed Marks may be displayed on the web
page/site only with the written approval of Licensor. Licensee
shall provide a link from its web page/site to Licensor’s web
page/site. Licensor shall approve any display of the Licensed
Products bearing the Licensed Marks on Licensee’s web
page/site in writing prior to any display or use thereof. Licensee
shall establish its web page/site within forty-five (45) days of
the Effective Date of this Agreement and shall update its web
page/site on a monthly basis. Licensee shall also provide
institutional signage in all warehouse locations.
9. LABELING
9.1 Licensee agrees
that it will cause to appear on or within each Licensed Product
manufactured, sold, and/or distributed under this Agreement and on
or within all advertising, marketing, promotional, or display
material bearing the Licensed Marks, the appropriate trademark and
copyright notices, markings, and/or designations, and/or any other
notice requested by Licensor. In the event that any Licensed
Product is distributed and/or sold in a carton, container, packing
and/or wrapping material bearing the Licensed Marks, such notices
shall also appear upon the said carton, container, packing, and/or
wrapping material.
9.2 The Parties further agree that
should any of the Licensed Products be manufactured, distributed,
or sold without the appropriate or requested trademark and
copyright notices, markings, and/or designations, in addition to
any other rights it may have, Licensor may demand the removal of
the offending product from distribution and sale, and may remove
that product from the list of Licensed Products and may also
terminate this Agreement.
10. PROMOTIONAL MATERIAL
Licensee
will run full-page advertising in trade publications to ensure
retail recognition for the Brand in the appropriate marketplace.
Licensee will use its best efforts to convey to the market that it
is a licensee of the Brand, including but not limited to placing
signage depicting the Brand prominently at Licensee's corporate
offices and showrooms, and on Licensee's corporate stationery,
point of sale, marketing and other materials. No advertising,
marketing, promotional, and display materials, or other artwork
shall be used without prior written approval by Licensor. The
Parties further agree that all artwork and designs involving the
Licensed Marks shall be produced under appropriate “work for
hire” provisions, or are hereby assigned to and shall remain
the property of Licensor, notwithstanding their creation by
Licensee or others. Licensee shall ensure that, prior to its
utilizing any non-employees to create advertising, marketing,
promotional, and display materials or other artwork, advertising
copy, and/or other copyrightable materials related to the Licensed
Marks, such persons or entities shall have executed the necessary
valid agreements to convey the ownership and copyrights to these
items to Licensor.
11. CONSULTATION
11.1 Licensor and Licensee agree
to have meaningful consultation with each other regularly
throughout the Term of this Agreement and any renewal or extension
thereof.
11.2 Ms. Kathy Ireland is the
Chief Brand Advisor of the Brand and Thomas Meharey is the
Co-Founder of the Brand. In addition to the services provided by
the Brand Advisor and Co-Founder, Licensor hereby designates
Stephen Roseberry, Jason Winters, Jon Carrasco and Rocco Ingemi to
serve as liaisons with Licensee. Licensor may designate additional
members of the Licensor’s team to serve as its liaison with
Licensee. Licensor reserves the right to change, modify,
supplement, and/or alter this designation in any way and at any
time in its sole and unfettered discretion.
12. PROFESSIONAL CALENDAR
Licensee agrees to
provide Licensor with a full and complete, professional calendar of
all trade shows, meets, sales calls, including but not limited to,
acceptances and rejections of the products, in order to allow the
Parties the finest mutual cooperation for sale of merchandise and
public relations, including, but not limited to any social media
strategy.
13. RECORDING AND FILMING – EE1
13.1 Except as provided herein,
under no circumstance shall any recording be made by Licensee or
anyone acting on behalf of Licensee in any manner whatsoever,
whether on video or audio tape, film, celluloid, and/or by any
other means possible, of Mr. Meharey in connection with any
appearance provided under this Agreement, including without
limitation all personal appearances and photo sessions, without the
express prior written approval of Licensor. The creation of any
content to be exploited in any media, now or hereafter existing,
pursuant to this Agreement shall be exclusively provided by Encore
Endeavor 1 LLC, a California limited liability basis, on a
“work for hire” basis with Licensor as the sole owner
of the results and proceeds of such services. The Parties
understand and agree that a portion of the compensation paid to
Licensor hereunder may be allocated to Encore Endeavor 1 LLC due to
the nature of its exclusive relationship with Licensor and
Licensee.
13.2 Ms. Kathy Ireland and Tommy
Meharey are union members of Guild/Union Requirements (SAG-AFTRA)
and Licensee will make payments accordingly for any audio or visual
recordings.
14. LICENSOR’S RIGHTS
14.1 Nothing in this Agreement
shall be construed to prevent Licensor from granting any other
license for the use of the Licensed Marks or from utilizing the
Licensed Marks in any manner whatsoever.
14.2 Licensee agrees that rights
not specifically granted to Licensee are reserved by Licensor and
may be freely exploited by Licensor without
limitation.
15. PROTECTION OF LICENSOR’S RIGHTS
15.1 Licensee agrees that during
the term of this Agreement, or thereafter, it will not register or
attempt to register any of the Licensed Marks, nor will Licensee
form or incorporate any entity under a name that includes the
Licensed Marks. Licensee will not attack the title or any rights of
Licensor in and to the Licensed Marks or the Licensed Products or
attack the validity of this Agreement.
15.2 Licensee further agrees to
cooperate fully and in good faith with Licensor for the purpose of
securing and preserving Licensor’s rights in and to the
Licensed Marks.
15.3 Licensee also agrees to assist
Licensor to the extent necessary in the procurement of any
protection or to protect any of Licensor’s rights to the
Licensed Marks.
15.4 Licensee acknowledges that
Licensor has sole and exclusive ownership of all right, title, and
interest in and to the Licensed Marks and any registrations that
have been issued or may be issued thereon.
15.5 Nothing contained in this
License Agreement shall give Licensee any right, title or interest
in or to the Licensed Marks except for the rights expressly
licensed by this License Agreement, and subject to its terms and
conditions.
15.6 Adaptations and modifications
of Licensed Marks prepared under this License Agreement shall be
included as part of the Licensed Marks, including, without
limitation, Licensor’s ownership thereof.
15.7 All registrations for
intellectual property, Internet domain names and social media
user/screen names in the Licensed Marks are to be applied for and
obtained exclusively in Licensor’s name. Licensee shall not
file or register any intellectual property applications or seek any
Internet domain name and/or social media user/screen name
registration in the Licensed Marks, Licensed Products or any
derivations, improvements, variations or modification thereof,
without Licensor’s prior written approval.
15.8 Licensee shall notify
Licensor, or its designated representative, prior to entering into
any agreement with any individual, company or business, for sales
outside the United States of any Licensed Product, to permit the
timely filing of foreign and/or international trademark and
copyright applications, or other intellectual property protection,
covering the Licensed Marks, in Licensor’s sole
discretion.
15.9 Licensee agrees to cooperate
fully and in good faith with Licensor for the purpose of securing
and preserving Licensor’s rights in and to the Licensed
Marks. In the event there has not been a previous registration of
any Licensed Mark and/or any material relating thereto for a
particular Licensed Product, Licensor may register and maintain, at
Licensee's expense, trademarks and/or service marks in the
appropriate class(es) and/or copyrights in the name of Licensor.
Licensee is not permitted to register any copyright, trademark,
and/or service mark on behalf of Licensor. It is further agreed
that nothing contained in this Agreement, and no act or omission by
Licensor and/or by Licensee shall be construed as an assignment or
grant to Licensee of any right, title, or interest in or to the
Licensed Marks, it being understood that all rights relating
thereto are reserved by Licensor, except for the license hereunder
to Licensee of the right to use and utilize the Licensed Marks only
as specifically and expressly provided in this
Agreement.
16. WARRANTIES AND INDEMNIFICATION
16.1 Licensor hereby indemnifies
Licensee and undertakes to hold it harmless against any claims or
suits, demands, losses, injuries, liabilities costs, judgments,
arbitration awards, license fees, settlement, damages and expenses
(including reasonable attorneys’ fees and costs, whether or
not any legal proceeding is commenced) (“Losses”) for
trademark infringement arising solely out of the validity of the
rights to the Licensed Marks and from Licensee’s use of the
Licensed Marks as granted herein, provided that prompt written
notice is given to Licensor within ten (10) days of any such claim
or suit, and provided, further, that Licensor shall have the option
to undertake and conduct the defense of any suit so brought, and no
settlement of any such claim or suit is made without the prior
written consent of Licensor. Licensor’s indemnification under
this Section 16.1 shall be apportioned and limited to only the
portion of, and extent that, such Losses are, or are claimed to be,
proximately caused by or attributable specifically to
Licensee’s use of Licensed Marks in a manner permitted by
this License Agreement. It is further agreed that Licensor reserves
the unfettered right to select counsel to defend any such
claims.
16.2 Licensee shall defend,
indemnify, and hold Licensor harmless against any and all actions,
claims, demands, lawsuits, loss, costs, damages, judgments,
liabilities, license fees, settlement or expenses incurred,
claimed, obtained, or sustained, including without limitation
attorneys’ fees and costs, of any nature whatsoever, whether
in law or in equity, including without limitation claims relating
to or allegedly relating to the design, manufacture, sale,
purchase, use, advertising, marketing, and/or distribution of any
Licensed Product, whether for personal injury, product liability,
intellectual property infringement, dilution, misappropriation or
otherwise. Licensor reserves the right to select counsel to defend
and/or bring any such claims. Notwithstanding Licensor’s
right to the choice of counsel, Licensee shall solely be
responsible for any and all attorneys’ fees, costs, and
expenses relating to any and all such actions.
16.3 Licensor makes no
representations or warranties with respect to the design,
manufacture, sale, purchase, use, marketing, and/or distribution of
any Licensed Product manufactured, sold, and/or distributed by
Licensee and disclaims any liability arising out of the design,
manufacture, sale, purchase, use, marketing, and/or distribution of
any Licensed Product, and any such express or implied warranties
are hereby disclaimed and Section 16.2 shall apply.
16.4 Licensee represents and
warrants to Licensor that: (i) Licensee has the full power and
authority to enter into this License Agreement on behalf of
Licensee and to perform all of Licensee’s material
obligations pursuant to this License Agreement, and that the
Licensed Products manufactured, sold, and/or distributed by
Licensee under this Agreement shall be suitable for the purpose for
which they are intended to be used and shall comply with all
applicable Federal, State, and local laws, and industry
standards, (ii) Licensee
will not harm or misuse the Licensed Property or bring the Licensed
Marks into disrepute, (iii) except as specifically provided in this
License Agreement, Licensee will not create any expenses chargeable
to Licensor or Ms. Ireland without the express prior written
approval of Licensor, (iv) all Licensed Products (and the content
contained or used in the Licensed Products) designed, developed,
marketed, distributed, published, performed or sold by Licensee
pursuant to this License Agreement do not, and will not, infringe
any intellectual property right or any personal right of any third
party, and (v) Licensee will not knowingly permit, do or commit any
act or thing that would degrade, tarnish or deprecate or disparage
the Licensed Property or Licensor’s or Ms. Ireland’s
public image in society or standing in the community, or prejudice
Licensor or Ms. Ireland and that it will terminate such activities
promptly upon written notice, and failure to do so constitutes a
material breach of this License Agreement. Licensee acknowledges
and agrees that there are no warranties, guarantees, conditions,
covenants, or representations by Licensor as to marketability,
fitness for a particular purpose, or other attributes of the
Licensed Products, whether express or implied (in law or in fact),
oral or written.
16.5 Licensee shall provide
Licensor with prompt written notice of any lawsuits or threatened
lawsuits, or other significant developments, investigations,
claims, or final refusals in which Licensee is or may be named as a
party or for which Licensee is obligated or has agreed to indemnify
any party, and Licensee shall thereafter provide Licensor with
periodic written updates concerning relevant developments in any
such lawsuits as they arise.
16.6 For purposes of this
Section 16, the term “Licensor” shall mean
Licensor and, without limitation, any of its agents, employees,
servants, representatives, parents, subsidiaries, affiliates,
officials, directors, officers, shareholders, owners, attorneys,
divisions, branches, units, affiliated organizations, successors,
predecessors, contractors, assigns, and all persons acting by,
through, under, or in concert with them, past or
present.
17. INSURANCE
17.1 Licensee represents that it
has obtained, and agrees to maintain, at its own expense, in full
force and effect at all times during which the Licensed Products
are being manufactured, sold, and distributed, insurance for bodily
injury, advertising injury, property damage, and product liability
from a recognized insurance company approved by Licensor, which is
qualified to do business in the State of California, providing
protection at least in the amount of $5,000,000 per occurrence and
$5,000,000 in the aggregate for Licensor and for Licensee against
any actions, claims, demands, lawsuits, loss, costs,
attorneys’ fees, damages, judgments, and liabilities of any
nature whatsoever relating to the Licensed Products. As proof of
such insurance, a fully paid certificate of insurance naming
Licensor (as defined above) as Licensee shall submit an insured
party to Licensor for Licensor’s prior written approval
before any Licensed Product is manufactured, sold, or distributed.
Any proposed change in certificates of insurance shall be submitted
to Licensor for its prior written approval. Licensor shall be
entitled to a copy of the prevailing certificate of insurance,
which shall be furnished to Licensor by Licensee. The
certificate(s) shall conform to the language requirements set out
in Exhibit E
attached hereto.
17.2 For purposes of this
Section 17, the term “Licensor” shall mean
Licensor and, without limitation, any of its agents, employees,
servants, representatives, parents, subsidiaries, affiliates,
officials, directors, officers, shareholders, owners, attorneys,
divisions, branches, units, affiliated organizations, successors,
predecessors, contractors, assigns, and all persons acting by,
through, under, or in concert with them, past or
present.
18. INSOLVENCY; CHANGE OF CONTROL
18.1 If Licensee files a petition
in bankruptcy or is adjudicated a bankrupt or if a petition in
bankruptcy is filed against Licensee, or if it becomes dissolved,
or becomes insolvent or unable to pay or discharge its liabilities
in the ordinary course of business, or if Licensee assigns the
whole or any substantial part of its assets or undertakings for the
benefit of creditors or makes an assignment for the benefit of its
creditors or any similar arrangement pursuant to any federal or
state law, compulsory or voluntarily, or if a receiver or other
similar officer is appointed for the whole or any part of the
assets or undertakings of Licensee or its business, or if Licensee
stops payment to its creditors generally, or ceases or threatens to
cease to carry on its business or any substantial part thereof, or
if Licensee merges or consolidates with or into any other
corporation, or directly or indirectly sells or otherwise
transfers, sells, or disposes of all or a substantial portion of
its business or assets, or if a third party who does not own stock
acquires a majority of the voting stock of Licensee, Licensor may
terminate this Agreement by giving notice to Licensee of its
intention to terminate and such termination shall be effective
immediately. In the event this Agreement is so terminated,
Licensee, its receivers, representatives, trustees, agents,
administrators, successors, and/or assigns shall have no right to
sell, exploit, or in any way deal with or in any Licensed Products
covered by this Agreement or any related advertising, marketing,
promotional, and display materials, including without limitation
cartons, containers, packing, and wrapping materials, except with
and under the special consent and instructions of Licensor in
writing, which they shall be obligated to follow.
18.2 In the event this Agreement is
so terminated under this Section 18, Licensee, its receivers,
representatives, trustees, agents, administrators, successors,
and/or assigns shall have no right to sell, exploit, or in any way
deal with or in any Licensed Products covered by this Agreement or
any related advertising, marketing, promotional, and display
materials, including without limitation cartons, containers,
packing, and wrapping materials, except with and under the special
consent and instructions of Licensor in writing, which they shall
be obligated to follow.
19. TERMINATION
19.1 Except as otherwise provided
herein, in the event either party breaches or fails to perform any
of its material duties and obligations pursuant to the terms of
this Agreement, the non-breaching party shall have the right to
terminate this Agreement upon thirty (30) days’ notice in
writing, and such notice of termination shall become effective
unless the breaching party shall remedy the breach within the
thirty (30) day period to the reasonable satisfaction of the
non-breaching party. The Parties agree to make a reasonable effort
to resolve any disputes or breaches prior to exercising the right
of termination.
19.2 Termination of this Agreement
shall be without prejudice to any rights, which Licensor may
otherwise have against Licensee. Upon the termination of this
Agreement, notwithstanding anything to the contrary herein, all
royalties on sales theretofore made and any other monies owed,
shall become immediately due and payable, and all rights and
licenses granted hereunder shall cease and revert to Licensor.
Further, Licensee will withdraw or cancel any governmental filings
made on its behalf that include the Licensed Marks. Licensee shall
immediately cease and desist from using the Licensed Marks in any
way. Unless otherwise stated in this Agreement, Licensee shall have
no right to sell, exploit, or in any way deal with or in any
Licensed Products covered by this Agreement or any related
advertising, marketing, promotional, and display materials,
including without limitation cartons, containers, packing, and
wrapping materials, except with and under the special consent and
instructions of Licensor in writing, which they shall be obligated
to follow. Licensee shall immediately return any and all
Confidential Information of Licensor to Licensor, as well as
marketing and advertising materials bearing the Licensed
Marks.
19.3 Upon the natural expiration or
termination of this Agreement, neither Party shall make any
publicly disparaging comments regarding the other or its business,
whether written, oral, or electronic. This provision shall survive
the expiration or termination of this Agreement. However, nothing
herein shall limit either Party’s right to arbitration or
other judicial remedies as set out in this Agreement.
19.4 Licensee acknowledges that a
failure (except as otherwise expressly provided herein) to cease
the manufacture, sale, transmission, broadcast or distribution of
the Licensed Products upon the terminations or expiation of this
License Agreement will result in immediate and irreparable damage
to Licensor. Licensee further acknowledges that there is no
adequate remedy at law for such failure to cease manufacture, sale
or distribution, and in the event of such failure, Licensor shall
be entitled to equitable relief and such further relief as a court
or agency with jurisdiction may deem just and proper.
19.5 Upon termination or expiration
of this Agreement, all of the rights granted hereunder to Licensee,
and all rights, title and interest in and to the Licensed Marks,
including but not limited to, patent, industrial design, copyright,
trademark, service mark, trade dress and all improvements,
additions and changes thereto, trade secret rights, and goodwill
relating to the Licensed Marks, shall revert to Licensor. Licensee
agrees to promptly execute all documents that may be reasonably
necessary to effect the foregoing. This right and obligation shall
survive the terminations or expiration of this License
Agreement.
20. FORCE MAJEURE
The
Parties shall be released from their obligations hereunder, and
this Agreement shall terminate in the event that governmental
regulations or other causes arising out of a state or national
emergency or war or causes beyond the control of the Parties render
performance impossible, and one Party so informs the other in
writing of such causes and its desire to be so released. In such
event, all royalties on sales and all other monies due, theretofore
made shall become immediately due and payable to
Licensor.
21. NOTICES
Any
notice, communication, statement, payment, or legal service of
process required or permitted under this Agreement shall be in
writing and shall be effective when hand delivered; or on the date
when the notice, communication, statement, payment, or legal
service of process is transmitted by confirmed electronic facsimile
(with a confirmation copy sent by mail); or the day after the
notice, communication, statement, payment, or legal service of
process is sent by reputable overnight air courier service (e.g.,
Federal Express). All such communications shall be sent to the
Parties at the notice addresses listed below or to such other
persons and the Parties to each other may designate notice
addresses as in writing.
If to Licensor:
|
I|M1, LLC
4521 Sharon Road, Suite 450
Charlotte, NC 28211
Attention: Mark Elliott - CFO
Email: mark@levelbrands.com
|
With a copy to:
|
Paul Porter
4521 Sharon Road, Ste 450
Charlotte, NC 28211
pporter@sstreetllc.com
And
Erik Sterling
PO Box #1410
Rancho Mirage, CA 92270
Facsimile: 310 557-1722
Attention: Erik Sterling
Email: esterling@sterlingwinters.com
|
|
|
If to Licensee:
|
Kure Corp.
1440 Westinghouse Blvd, Suite L,
Charlotte, NC 28273
Attention: Craig Brewer
Email: craig.brewer@kuresociety.com
|
22. NEGATION OF AGENCY
Licensee is an
independent contractor with respect to Licensor. Nothing contained
herein shall be deemed to create an agency, joint venture,
franchise, or partnership relation between the Parties, and neither
Party shall so hold itself out. Licensee shall have no right to
obligate or bind Licensor in any manner whatsoever, and nothing
contained in this Agreement shall give, or is intended to give, any
rights of any kind to any third person(s).
23. ASSIGNABILITY
23.1 This Agreement shall inure to
the benefit of Licensor, its successors, and assigns, but will be
personal to Licensee, and shall be assignable by Licensee only with
the prior written consent of Licensor. Licensee shall not mortgage,
assign, sub-license, or otherwise encumber this Agreement without
the prior written consent of Licensor. Licensor shall be entitled
to assign this Agreement to any third party with notice to
Licensee, including any such assignment in connection with the sale
or transfer of Licensor’s business, provided, however, that
Licensor shall have the option to terminate this Agreement in lieu
of assignment to any successor of Licensor’s business in
connection with any such sale or transfer.
23.2 In the event Licensor
terminates this Agreement in connection with a sale of its
business, Licensee shall have a period of six (6) months from the
effective date of termination in which to sell off its inventory of
Licensed Products, subject to the terms and conditions of this
Agreement, including paying Royalties.
24. MODIFICATION AND WAIVER
24.1 Except as otherwise provided
herein, no agreement or understanding purporting to add to or to
modify the terms and conditions of this Agreement shall be binding
unless agreed to by the Parties in writing. Any terms and
conditions set forth in any forms used by the Parties, which are in
conflict with the terms and conditions of this Agreement, shall be
void and have no effect. The Parties further agree that the
Exhibits to this Agreement may be modified, amended, altered,
and/or supplemented from time to time in writing signed by
authorized representatives of the Parties.
24.2 It is agreed that no waiver by
either Party hereto or any breach or default of any of the
provisions set forth herein shall be deemed a waiver as to any
subsequent and/or similar breach or default.
25. GOVERNING LAW
25.1 This Agreement shall be
construed in accordance with and the laws of the State of
California which shall govern all disputes relating hereto without
giving effect to any conflicts of law provisions. The Parties agree
that any and all disputes, controversies or claims arising out of,
regarding, or in any way relating to the interpretation,
application, or enforcement of this Agreement, or any matter
reasonably related thereto, shall be handled by way or arbitration
and administered by and in accordance with the JAMS streamlined
Arbitration Rules and Regulations (the ''JAMS Rules '') of the
Judicial Arbitration and Mediation Service in effect at the time of
any such proceedings. Such arbitration shall be the sole,
exclusive, and final remedy for resolving any such claims and
disputes. Judgment on the final award rendered by the arbitrator
may be entered into in any court of competent jurisdiction and
shall be final and binding upon the Parties.
25.2 Notwithstanding the foregoing,
the Parties may seek provisional relief, including a preliminary
injunction or temporary restraining order, in any federal or state
court of competent jurisdiction located in Los Angeles, California,
without prejudice to the above described arbitration procedures, if
in that Parties sole judgment such provisional relief is necessary
to avoid an irreparable injury or to preserve the status quo. Never
the less, the arbitration procedure set forth in this Section 25 is
intended to be the sole and exclusive method of resolving any
claims arising out of, relating to, or regarding this
Agreement.
26. CONFIDENTIALITY
26.1 The Parties agree that the
terms, conditions, and subject matter of this Agreement constitute
confidential and proprietary information belonging to Licensor.
Licensee agrees not to divulge any confidential and proprietary
information pertaining to Licensor or this Agreement to any third
party without prior written consent of Licensor. Licensee shall
take any and all lawful measures to prevent the unauthorized use
and/or disclosure of such confidential information, and to prevent
unauthorized persons or entities from obtaining or using such
information. Licensee further agrees to refrain from directly or
indirectly taking any action, which would constitute or facilitate
the unauthorized use or disclosure of such confidential
information. Licensee may disclose such confidential and
proprietary information to its officers, directors, employees,
agents, and authorized representatives to the extent necessary to
enable Licensee to perform its obligations under this Agreement,
provided that said officers, directors, employees, agents, and/or
authorized representatives execute an appropriate confidentiality
agreement approved by Licensor, which by its terms shall be
enforceable by injunctive relief. Licensee shall be liable for any
unauthorized use and disclosure of such confidential information by
its officers, directors, employees, agents, and authorized
representatives, including without limitation its attorneys and
accountants. The Parties further agree that any breach or
threatened breach of this Section 26.1 would cause irreparable harm
to Licensor, that a remedy at law or in damages would be
inadequate, and that the provisions of this Section 26.1 may be
enforced by way of injunctive relief in addition to any other
rights available to Licensor in law or in equity.
26.2 For purposes of this
Agreement, “confidential and proprietary information”
includes, but is not limited to, the terms, conditions, and subject
matter of this Agreement, and Licensor’s business, including
any financial, cost, pricing, and royalty information; product
development, business, marketing, promotion, distribution, sales,
sales plans, and strategies; information concerning
Licensor’s product development and intellectual property;
information concerning manufacturing processes relating to the
Licensed Products, or trade secrets. The foregoing confidentiality
obligations shall not apply to information that: (1) was
previously known to the recipient free of any obligation to keep it
confidential; (2) was independently developed by recipient; or
(3) is or becomes publicly available by means other than the
unauthorized disclosure by recipient.
26.3 In the event that any judicial
or regulatory authority requests or requires disclosure of any
Confidential Information of the other party, the receiving party
shall promptly notify the disclosing party of the requested or
required disclosure and shall cooperate with the disclosing party
in any effort to avoid or limit such disclosure.
27. ENTIRE AGREEMENT AND ADMISSIBILITY
This
Agreement constitutes the complete understanding between the
Parties and supersedes any and makes void any and all prior
agreements, promises, representations, or inducements, no matter
their form, concerning the subject matter of this Agreement. The
Parties desire that this Agreement represent a single and
completely integrated contract expressing the entire agreement of
the Parties with respect to the subject matter of this Agreement.
No promises, agreements, or modifications to this Agreement made
subsequent to the execution of this Agreement by the Parties shall
be binding unless reduced to writing and signed by authorized
representatives of the Parties. The Parties to this Agreement agree
that this Agreement may be used as evidence in any subsequent
proceeding in which any Party alleges a breach of this Agreement or
seeks to enforce its terms, provisions, or
obligations.
28. SEVERABILITY
Whenever possible,
each provision of this Agreement shall be interpreted in such a
manner to be effective and valid under applicable law. Should any
of the provisions or terms of this Agreement be determined illegal,
invalid, or unenforceable by any court of competent jurisdiction,
validity of the remaining parts, terms, or provisions shall not be
affected thereby, and said illegal, invalid, or unenforceable part,
term, or provision shall be deemed not to be a part of this
Agreement.
29. RECITALS AND HEADINGS
The
terms of this Agreement are contractual, not a mere recital, and
are the result of joint negotiations between, and joint drafting
by, the Parties, and are therefore not to be construed in favor of
or against either Party. All recitals are incorporated by reference
into this Agreement. Caption and Section headings are used for
convenience and reference only, are no part of this Agreement, and
shall not be used in interpreting, construing, defining, limiting,
extending, or describing the scope of this Agreement, or any
provision hereof, in any way.
30. ATTORNEY REPRESENTATION, FEES AND
COSTS
The
parties understand and agree that this Agreement is being prepared
as an accommodation to the parties by a business advisor on behalf
of a shareholder in both parties, and such business advisor is
neither (a) acting in any legal capacity, nor (b) representing
either party in any legal or business capacity. This Agreement
represents the agreement between the parties, which has been
reduced to writing by a third party. Each party should seek their
own legal counsel for review and negotiation prior to execution.
Should any action be necessary to enforce the terms of this
Agreement, the prevailing Party will be entitled to recover
reasonable attorneys’ fees and costs.
31. EXECUTION OF COUNTERPARTS
This
Agreement may be executed in two or more duplicate bond or
facsimile counterparts, each of which shall be considered an
original, but all of which together shall constitute one and the
same instrument, and in pleading or proving any provision of the
Agreement, it shall not be necessary to produce more than one such
counterpart.
32. EQUITABLE RELIEF
The
Parties acknowledge that the subject matter of this Agreement
relates to services and rights, which are extraordinary and unique
and which cannot be replaced or adequately compensated in money
damages, and any breach by Licensee of this Agreement will cause
irreparable injury to Licensor.
[signature page
follows]
IN
WITNESS WHEREOF, the Parties hereto have caused this instrument to
be duly executed as of the day and year first above
written.
Licensor:
I|M1, LLC
/s/ Stephen Roseberry
Stephen
Roseberry, President
Licensee:
Kure Corp.
/s/ Craig Brewer
Craig
Brewer, CEO
Kure Franchise,
LLC, by its manager,
Kure Corp.
/s/ Craig Brewer
Craig
Brewer, CEO
EXHIBIT A
LICENSED MARK
1. Only
for the Licensed Products specified in Exhibit B
to this Agreement and only as shown in
the following specimen(s):
2. Examples on Brand Partner Resource link; upon
Licensees signature a password will be
provided.
Licensor may designate other supporting brands or categories, in
writing from time to time.
EXHIBIT B
LICENSED PRODUCTS ANDCHANNELS OF DISTRIBUTION
1. The
following list sets forth the Licensed
Products:
a.
E-liquid (or e-juice) branded under the Licensed
Marks.
b.
Vaporizers branded under the Licensed
Marks.
c.
Mods branded under the Licensed
Marks.
d.
Atomizers branded under the Licensed
Marks.
e.
Tanks branded under the Licensed
Marks.
f.
Drip Tips branded under the Licensed
Marks.
g.
Other vape related hardware to be approved by
Licensor branded under the Licensed Marks.
h.
Subject to Section 3 of this Exhibit
B, all products sold by any
retail store location (whether corporate owned, franchise or
otherwise) to the extent that the name of such retail store
location bears the brand name of a Licensed Mark (regardless of
whether the individual product is branded under the Licensed
Marks). For Illustration Purposes, products sold by a
“Kure” corporate or franchise branded retail store
which are not branded under the Licensed Marks will not be deemed a
Licensed Product; however, products sold by an
“I’M1” corporate or franchise branded retail
store which are not separately branded under the Licensed Marks
will be deemed a Licensed Product.
2. Retail
vape stores owned, franchised or otherwise licensed by
Licensee, and, retail websites owned and operated by
Licensee in the above channels.
3. The
Licensed Marks shall not be used by Licensee as a brand name for
any retail store which is offered under a franchise agreement or
similar arrangement with Licensee. The terms of any such use of the
Licensed Marks with respect to such a franchise retail store shall
be separately agreed to prior any such use of the Licensed
Marks.
4. Except
any mass market and low tier department stores (i.e., Wal-Mart,
K-Mart, Target, and Sears), as well as club stores (i.e.
Sam’s), are specifically excluded from
the approved Channels of Distribution under this
Agreement.
5. Licensor shall have prior approval rights relating
to any internet retailers not belonging to retailers in the
approved Channels of Distribution set forth above, which will be
reviewed on an individual basis by Licensor.
EXHIBIT C
CODE OF CONDUCT
行为守则
1. PURPOSE: [LICENSEE] is committed to using only
manufacturers to strive to conduct business in a highly
professional and ethical manner. This document outlines those
commitments each facility makes in respect to its compliance with
applicable law and tis personal practices and
policies.
目的:[被许可人]承诺只使用了力争在一个高度专业和道德的方式开展业务的厂家。本文概述了这些各设施使得在尊重其遵守适用的法律和个人的做法和政策的承诺。
2. CHILD
LABOR: The facility agrees not to use child labor in the
manufacturing, or distribution of the Goods. The term
“child” refers to a person younger than the local legal
minimum age for employment or the age for completing compulsory
education; provided, however, in no event shall the Facility use
any person below the age of (15) fifteen. The Facility also agrees
to comply with all other Laws applicable to employees, regardless
of the age of an employee.
童工:该中心同意不使用童工在制造,或货物配送。
“童工”是指一个人年龄低于当地法定最低就业年龄或年龄在完成义务教育;
提供的,但是,在任何情况下,基金使用任何人(15)15岁以下。该基金还同意遵守适用于所有员工的其他法律,不论雇员的年龄。
3. FORCED
LABOR: The Facility agrees to employ only persons whose presence is
voluntary. The Facility agrees not to use any forced or involuntary
labor, whether prison, bonded, indentured or
otherwise.
强迫劳动:该基金同意只雇用人员,其存在是自愿的。该基金同意不使用任何强迫或非自愿劳动,无论是监狱,保税,契约或其他方面。
4. ABUSE
OF LABOR: The Facility agrees to treat each employee with dignity
and respect and not to use corporal punishment, threats of
violence, or other forms of physical, sexual, psychological or
verbal harassment or abuse.
滥用劳动:该基金同意把每个员工的尊严和尊重,不使用体罚,暴力威胁或其他形式的身体,性,心理或言语上的骚扰或虐待。
5. NON-DISCRIMINATION: The Facility agrees not to
discriminate in hiring and employment practices, including salary,
benefits, advancement, discipline, termination, or retirement on
the basis of race, religion, age, nationality, social or ethnic
origin, sexual orientation, gender, political opinion or
disability.
不歧视:该基金同意不会在雇佣和招聘活动,包括工资,福利,晋升,纪律,终止或退休种族,宗教,年龄,国籍,社会或民族,性取向,性别的基础上歧视,政治观点或残疾。
6. ASSOCIATION: The Facility agrees to follow
employees to organize and bargain collectively without penalty or
interference in accordance with local Laws.
关联关系:该基金同意遵守雇员组织和集体谈判不受处罚或干预按照当地的法律。
7. WAGES,
DENEFITS AND WORKING HOURS: The facility recognizes that wages are
essential to meeting employee’s basic needs. The Facility
agrees to comply, at a minimum, with all applicable wages and hour
Laws, including minimum wage, overtime hours, maximum hours, piece
rates and other elements of compensation and shall provide legally
mandated benefits.
工资,福利和工作时间:该厂认识到,工资是必要的,以满足员工的基本需求。该基金同意遵守,至少,所有适用的工资和工时的法律,包括最低工资,加班,最长工时,计件工资和补偿等内容,并应提供法定福利。
8. HEALTH
AND SAFETY: The Facility agrees to provide employees with a safe
and healthy workplace environment in accordance with all applicable
Laws, ensuring at a minimum, reasonable access to potable water and
sanitary facilities, fine safety and adequate lighting and
ventilation. The Facility also agrees to ensure that the same
standards of health and safety are applied to any housing it
provides for employees.
健康和安全:该基金同意为员工提供一个安全和健康的工作环境符合所有适用法律,确保在最低限度,合理获得饮用水和卫生设施,精美的安全性和足够的照明和通风。该基金也同意,以确保健康和安全的相同标准适用于它提供了雇员的住房
9. COMPLIANCE: The Facility agrees to take
appropriate steps to ensure that the provisions of the COC are
communicated to its employees, including by prominent posting a
copy of this COC in the local language on one or more bulletin
boards in places readily accessible to employees at all
times.
合规性:本基金同意采取适当措施,以确保奥委会的规定传达给员工,其中包括由著名张贴在当地语言的一个或多个电子公告板的名额该行为准则的副本容易获得员工的所有次。
10. ENVIRONMENT: Business partners should share our
concern for the environment and adhere to their local and national
laws regarding the protection and preservation of the
environment.
环境:业务合作伙伴应该分享我们对环境的关注,并坚持对环境的保护和维护当地和国家法律。
11. LEGAL
REQUIREMENTS: Business partners should be in compliance with all
legal requirements involved in conducting the
business.
法律要求:业务合作伙伴应符合参与开展业务的所有法律要求。
12. Our
Business Partners are required to provide full access to their
facilities and those of their manufacturers, vendors and
subcontractors, and to release records relating to employment
practices. We may conduct on-site inspections of facilities to
monitor the standards and assure the quality of our
products.
我们的业务合作伙伴必须提供完全访问他们的设备和那些他们的制造商,供应商和分包商,并发布有关用工行为记录。我们可以进行现场视察设施,以监控标准,确保了产品的质量。
Please report Violations Anonymously by emailing to:
mark@levelbrands.com
EXHIBIT D
Approved Royalty Report Form
●
Example
Royalty Reports are set forth on the Brand Partner Resource link,
upon your signature a password will be provided
EXHIBIT E
REQUIRED INSURANCE CERTIFICATE
Under Description of Operations state the
following:
“Certificate Holder I|M1, LLC, I|M1 Holdings, LLC, Level
Brands, Inc., Encore Endeavor 1, LLC, EE1 Holdings, LLC,
Tommy Meharey, Kathy Ireland,
kathy ireland Worldwide, Inc., kathy ireland LLC, The
Sterling/Winters Company, and their partners, owners,
subsidiaries, affiliates, directors, officers, managers and
employees are named additional insured with regards to liability
arising out of operations of the named
insured.”
The Certificate Holder should be listed as:
I|M1, LLC
4521 Sharon Road, Ste. 450
Charlotte, NC 28211
Attn: Mark Elliott
mark@levelbrands.com
Send copies of Certificate to:
Mitchka Lyonnais
mlyonnais@mmibi.com
Momentous Insurance Brokerage, Inc.
Mark Elliott
mark@levelbrands.com
I|M1, LLC
EXHIBIT F
Millennium Development Goals
1. We
must eradicate extreme poverty and hunger!
2.
Achieve universal primary education.
3.
Promote gender equality and empower women.
4.
Reduce child mortality.
5.
Improve maternal health.
6.
Combat HIV/AIDS, Malaria, and other diseases.
7.
Ensure environmental sustainability.
8. Build global
partnerships for development.
9.
Bring opportunities of financial stability and healthcare to
American Veterans and their families.
10.
Stop Human Trafficking.
- END OF CONTRACT-
Exhibit 6.29
LICENSE AGREEMENT
THIS LICENSE AGREEMENT
(“Agreement”) is made and
entered into as of this 31st
day of March, 2017, by and between
I|M1, LLC, a California limited liability company
(“Licensor”), and NuGene International, Inc., a Nevada
corporation (“Licensee”).
RECITALS
A.
Licensor has the
right and authority to license certain trademarks and rights to the
name, likeness, and visual representation of
“I’M1” and other marks and has developed and used
intellectual property (collectively, the “I’M1
IP”) and is engaged in the licensing of the property
identified in the attached Exhibit A, as well as multiple
names, likeness, and visual representations being known and
recognized by the public and associated in the public mind with
Licensor for use by men or in connection with the men’s
market (hereinafter, with the I’M1 IP, collectively referred
to as the “Licensed Marks”, the “Licensed
Property” or the “Brand”).
B.
Licensor is the
owner, by assignment, of the name, nick name, image, likeness,
initials, mark, appearance, signature (including reproduced
signature), autograph, endorsement, voice, and biographical
material (including history, video and motion picture film
portrayals, and still photography), Internet domain names and
online social media user/screen names of the Licensed
Marks.
C.
Ms. Ireland, an
internationally famous person and designer with a highly favorable
public image and strong, favorable identity for branding; and a
strong portfolio of multiple brands and ambassadors, also with a
highly favorable public image and strong brand identities serves as
Chief Brand Advisor of Licensor.
D.
Licensee is a
manufacturer, distributor and/or seller of products and desires to
use the Licensed Marks in the Channels of Distribution as
contemplated in Exhibit
B.
AGREEMENT
In
consideration of the mutual promises herein contained, it is hereby
agreed:
1. DEFINITIONS
1.1
The term
“Act” means the Securities Exchange Act of 1934, as
amended.
1.2
The term
“Allowance” mean any reductions in the wholesale sales
price of any Licensed Product approved in advance, in writing, by
Licensor off-invoice amounts or accruals.
1.3
The term "Brand"
shall mean only the Licensed Products offered under the Licensed
Marks set forth in Exhibit
A.
NuGene
International, Inc.
1.4
The term
“Change of Control” means any of the following events:
(a) the acquisition by a Group of Beneficial Ownership of 50% or
more of the Stock or the Voting Power of Licensee, but excluding
for this purpose: (i) any acquisition by Licensee (or a
subsidiary), or an employee benefit plan of Licensee, or (ii) any
acquisition of Common Stock of Licensee by management employees of
the Licensee; (b) individuals who constitute the board of directors
of Licensee prior to any such event (the “Incumbent
Board”) cease to constitute at least a majority of such board
of directors, provided that any director whose nomination was
approved by a majority of the Incumbent Board shall be considered a
member of the Incumbent Board unless such individual’s
initial assumption of office is in connection with an actual or
threatened election contest (as such terms are used in Rule 14a-11
of Regulation 14A promulgated under the Act); (c) approval by the
shareholders of Licensee of a reorganization, merger or
consolidation, in each case, in which the owners of more than 50%
of the Stock or Voting Power of Licensee do not, following such
reorganization, merger or consolidation, beneficially own, directly
or indirectly, more than 50% of the Stock or Voting Power of the
entity resulting from such reorganization, merger or consolidation;
or (d) a complete liquidation or dissolution of the Licensee or of
its sale or other disposition of all or substantially all of the
assets of Licensee; provided, that a Change of Control shall not be
deemed to have occurred with respect to (i) any Licensee equity or
debt offering or financing occurring within six months of the
Effective Date and which provides Licensee with proceeds in an
amount equal to or in excess of $10,000,000; or, (ii) a change in
the majority of the Incumbent Board in connection with the
Offering. For purposes of this definition, “Group”
means any individual, entity or group within the meaning of Section
13(d)(3) or 14(d)(2) of the Act, “Beneficial Ownership”
has the meaning in Rule 13d-3 promulgated under the Act,
“Stock” means the then outstanding shares of common
stock, and “Voting Power” means the combined voting
power of the outstanding voting securities entitled to vote
generally in the election of directors.
1.5
The term
“Channels of Distribution” shall mean only those
channels, which are listed and mutually agreed on Exhibit B attached hereto
and incorporated by reference herein. Exhibit B may only be modified,
supplemented, and/or amended by written agreement of the Parties as
provided herein.
1.6
The term
“Code of Conduct” shall refer to the Licensor’s
Human Rights – Code of Conduct, incorporated by this
reference as set forth in Exhibit C, with respect to
which Licensee agrees to fully comply in such form attached. To the
extent that the Code of Conduct may be amended or updated by the
Licensor in the future, Licensor shall provide written notice to
Licensee of such changes, which Licensee shall accept in its sole
discretion.
1.7
The term
“Effective Date” shall mean the date this Agreement is
executed by Licensor as set forth above.
1.8
The term
“Gross Sales” shall mean the gross amount billed
(exclusive of any sales, use or value added Tax (VAT), Returns and
uncollectable accounts included in prior Gross Sales calculations).
No other costs incurred in the manufacturing, selling, advertising,
and/or distribution of the Licensed Products shall be
deducted.
1.9 The
term “Initial Term” shall have the meaning set forth in
Section 4.
1.10
The term
“Licensed Marks” shall mean the Brand and Licensed
Products set forth in Exhibit B, including, without
limitation, their likeness, visual representation and/or each of
the individual components thereof, and those trademarks, service
marks, logos, designs, and/or any other symbols/devices, which are
set forth in Exhibit
A attached hereto and incorporated by reference
herein.
NuGene
International, Inc.
1.11
The term
“Licensed Products” shall mean only those items, which
are listed in Exhibit
B attached hereto. Exhibit B may only be modified,
supplemented, and/or amended by written agreement of the Parties as
provided herein.
1.12
The term
“Manufacturing Territory” shall mean the United
States.
1.13
The term
“Parties” (or “Party”) shall mean the
parties entering into this Agreement.
1.14
The term
“Returns” shall mean any Licensed Product, which
Licensee accepts back from any customer after purchase and delivery
thereof and for which Licensee refunds the actual purchase price,
or issues a credit memo.
1.15
The term
“Royalty” or “Royalties” shall have that
meaning set out in Section 5.1 below.
1.16
The term
“Term” shall mean the Initial Term plus any extensions,
renewals of this Agreement or modifications thereof.
1.17
The term
“Termination Date” shall mean the date, whichever is
earliest, that (i) this Agreement (subject to any renewals or
extensions) expires by its own terms; (ii) is thirty (30) days
after receipt of notice of termination under Section 21; or
(iii) any other event occurs which terminates this Agreement
where no notice is required.
1.18 The
term “Territory” shall mean United States of
America.
1.19
The term
“Trade Discounts” shall mean any reductions or charge
backs in the wholesale sales price of any Licensed Product, and
actually granted by Licensee in writing to any customer prior to
delivery.
2. GRANT
OF LICENSE
2.1 Upon
the terms and conditions set forth herein, Licensor hereby grants
to Licensee the non-transferable right, license, and privilege, of
using the Licensed Marks solely for the sale, marketing and
distribution of the Licensed Products through the Channels of
Distribution in the Territory during the Term (with the exceptions
as stated on Exhibit
B), and the non-exclusive, non-transferable right, license,
and privilege of
using the Licensed Marks solely upon and in connection with the
manufacture of Licensed Products in the Manufacturing
Territory.
2.2 All
proposed Channels of Distribution and distribution outlets in
Exhibit B shall be
deemed approved and any others shall be submitted in advance to
Licensor and shall be subject to Licensor’s prior written
approval.
2.3 Licensee
shall not assign or sub-license the use of the Licensed Marks to
any third party without prior written approval by Licensor, and
such right is expressly withheld from this Agreement. In the event
that Licensor approves a sub-license to a third party, the Parties
shall mutually agree upon the terms and conditions of said
sub-license, including without limitation the royalty rate, in a
separate writing signed by the Parties.
NuGene
International, Inc.
3. BRAND
DEVELOPMENT
3.1 Licensee
will begin shipping of Licensed Products on a date to be determined
by Licensee in its sole and absolute discretion.
3.2 Licensee
agrees that all names of Licensed Products
are proprietary to Licensor. More specifically, Licensor shall
own all intellectual property rights in the Licensed Products and
related materials and in all sketches, artwork and/or designs for
the Licensed Products and the related materials, at no cost to
Licensor, and to the extent Licensee has any rights in such
intellectual property, Licensee agrees to assign and does hereby
assign to Licensor (or any person or entity designated by Licensor)
all of its right, title and interest in and to such products and
materials.
3.3 Licensee
agrees to consider and cooperate with Licensor in becoming a member
and utilize (a) Send Out Cards, a customer contact communication
service, (b) Salesforce.com, (c) Dependable Solutions, a product
approval and royalty reports services, (d) ireland pay, a merchant
agreement service, and (e) any similar web platform as may be
utilized by Licensor from time to time as a means of conducting
Brand business and coordinating with Licensor and other licensees,
though only so long as Licensee determines (x) it is advantageous
to do so, (y) it does not preclude utilizing similar services, and
(z) it does not include any obligation to incur substantial expense
or liability.
4. TERM
The initial term (“Initial Term”) of
the license hereby granted shall commence on the Effective Date and
shall be effective through the fifth anniversary of the Effective
Date,
unless terminated sooner in accordance
with the provisions hereof.
5. ROYALTY
5.1 Royalty.
In consideration of the grant hereunder, Licensee shall pay
Licensor royalties in U.S. dollars at a rate of five percent (5%)
of 100% the Gross Sales for all Licensed Products sold under the
Licensed Marks (the “Royalty”). Within fifteen (15)
days after the end of each month, Licensee shall furnish to
Licensor a complete sales and royalty report certified to be
accurate by the Chief Financial Officer of Licensee or by some
other authorized designee of Licensee showing the number,
description, and Gross Sales Price of the Licensed Products
distributed and/or sold by Licensee during the preceding month, as
well as the number of Licensed Products in inventory at the
beginning and end of the month along with payment of the royalties
due which shall be sent by wire transfer to the following
account:
Licensor:
I|M1, LLC
4521 Sharon Road, Ste 450
Charlotte, NC 28277
Domestic Wire:
ABA Bank Routing #
Account Name: IM1, LLC
Account No.:
|
NuGene
International, Inc.
5.2 Royalty
Report. For this purpose, Licensee shall use the approved
report form attached hereto as Exhibit D and incorporated by
reference herein. Such report shall be furnished to Licensor
whether or not any of the Licensed Products have been sold during
the preceding month. Licensee shall tender both hard copy sales and
royalty report and sales in royalty report in Excel spreadsheet
format to Licensor. Sales and Royalty will be furnished separately
for each brand listed in Exhibit A in Excel spreadsheet
format to the Licensor and sent to the addresses set forth in
Section 21. The receipt or acceptance by Licensor of any of the
reports furnished by Licensee pursuant to this Agreement or of any
royalties paid by Licensee hereunder (or the cashing of any royalty
checks paid by Licensee hereunder) shall not preclude Licensor from
questioning the accuracy thereof at any time, and in the event that
any inconsistencies or mistakes are discovered in such reports or
payments, any inconsistency, mistake, or inaccuracy shall
immediately be rectified, and any appropriate payment due and owing
shall immediately be paid by Licensee to Licensor, or, on the other
hand, the Parties shall determine whether to refund Licensee such
amounts or credit against such amounts against future Royalty
payments.
5.3 Late
Payment. Any amount not paid to Licensor when due under this
Agreement shall bear a late payment charge on the unpaid
balance at the rate of 1.5% per month, compounded, or the maximum
amount permitted by law, whichever is less.
6. ACCOUNTING
6.1 Licensee agrees to
keep accurate books of account and records covering all
transactions relating to the license hereby granted, and Licensor
and its duly authorized representatives shall have the right after
giving reasonable notice at all reasonable hours of the day to an
examination of said books of account and records relating to
Licensee’s performance under the Agreement, and of all other
documents and materials in the possession or under the control of
Licensee or any of its affiliated, associated, or subsidiary
companies or agents, with respect to the subject matter and terms
of this Agreement, and shall have free and full access thereto for
said purposes and for the purpose of making extracts therefrom.
Upon request of Licensor, Licensee shall furnish to Licensor a
detailed statement by an independent certified public accountant
showing the number, description, and Gross Sales of the Licensed
Products covered by this Agreement distributed and/or sold by
Licensee to the date of Licensor’s demand. All books of
account and records shall be kept available for no less than
Seven (7) years, or, as long as required by the Internal
Revenue Service, if longer than 7 years.
6.2 Each
calendar year in which this Agreement is in effect, and after
expiration or termination of this Agreement, Licensor shall be
entitled to an independent audit of and be given access to
Licensee’s account books, records, invoices and other
pertinent data by a certified public accountant or qualified
auditor designated by Licensor. The audit shall be conducted to
determine Licensee’s sales of Licensed Products, as well as
all returns and trade discounts, and shall be conducted during
normal business hours at Licensee’s business office or
location of such files and records. The cost of the audit shall be
borne by Licensor unless the audit reveals that Licensee
understated sales and or royalties of Licensed Products by more
than five percent (5%), in which case Licensee shall be required to
pay all of Licensor’s costs of the audit.
6.3 Licensor’s
exercise in whole or in part of its inspection rights under Section
6.2 or otherwise, Licensor’s acceptance of any statement or
statements from, or the receipt of acceptance by Licensor of any
payment tendered by or on behalf of Licensee, shall be without
prejudice to Licensor’s rights or remedies permitted by this
Agreement or as a matter of law or equity, and shall not preclude
or prevent Licensor from thereafter disputing the accuracy of any
such statement or payment.
NuGene
International, Inc.
7. QUALITY
ASSURANCE
7.1 The quality of the
Licensed Products shall be consistent with or exceed the average of
similar products manufactured, distributed, and/or sold by
Licensee, shall serve to enhance Brand recognition of the Licensed
Products to the mutual benefit of the Parties, and shall be
suitable for the use for which they are intended.
7.2 All
Licensed Products developed, manufactured and sold hereunder, and
all labels, hang tags, packaging, catalogs, brochures,
publications, printed matter, advertising, signs, promotional
displays, websites, webpages, video and sound recordings, online
social media pages (hereinafter the "Promotional Materials") and
other forms of publicity material for the Licensed Products, shall
be subject to Licensor’s written approval in advance of use,
distribution, marketing or sale.
7.3 All
materials submitted for approval to Licensor in a language other
than English will be accompanied by a complete and accurate English
translation.
7.4 If
any retail customer of Licensee notifies Licensee or claims to
Licensee that there is a significant quality issue with any
Licensed Products sold to it by Licensee, Licensee shall notify
Licensor in writing of any such alleged quality issues within five
(5) business days of being notified by the retailer customer
involved.
7.5 Licensor
shall notify Licensee of consumer quality issues received by
Licensor on Licensor’s website. Licensee shall exercise its
best efforts to reply to applicable consumers within forty-eight
(48) hours of its receipt of the issues from Licensor’s
website.
7.6 Licensor
will have the right to purchase products from the Licensee at best
available pricing, for personal use, Social Media Contests,
giveaways, and other promotional uses. Products purchased hereunder
shall not be for commercial resale.
8. DISPLAY
OF MERCHANDISE
8.1 If Licensee has a
showroom, Licensee agrees to maintain space in its showroom located
in various high traffic locations and dedicated to display of the
Licensed Products under the Brand. Licensee further agrees that the
Licensed Products shall be displayed at Licensee’s showroom
in the most favorable manner possible to enhance the recognition of
the Brand and the Licensed Products to the mutual benefit of the
Parties. The display of the Licensed Products shall be subject to
the written approval of Licensor prior to any display
thereof.
8.2 Licensee
may display and offer the Licensed Products on its own company or
business web page/site in a manner, which makes the Licensed
Products distinctive and enhances the recognition of the Brand and
the Licensed Products to the mutual benefit of the Parties.
Products other than Licensed Products bearing the Licensed Marks
may be displayed on the web page/site only with the written
approval of Licensor. Licensee shall provide a link from its web
page/site to Licensor’s web page/site. Licensor shall approve
any display of the Licensed Products bearing the Licensed Marks on
Licensee’s web page/site in writing prior to any display or
use thereof.
NuGene
International, Inc.
9. LABELING
9.1 Licensee agrees
that it will cause to appear on or within each Licensed Product
manufactured, sold, and/or distributed under this Agreement and on
or within all advertising, marketing, promotional, or display
material bearing the Licensed Marks, the appropriate trademark and
copyright notices, markings, and/or designations, and/or any other
notice requested by Licensor. In the event that any Licensed
Product is distributed and/or sold in a carton, container, packing
and/or wrapping material bearing the Licensed Marks, such notices
shall also appear upon the said carton, container, packing, and/or
wrapping material.
9.2 The
Parties further agree that should any of the Licensed Products be
manufactured, distributed, or sold without the appropriate or
requested trademark and copyright notices, markings, and/or
designations, in addition to any other rights it may have, Licensor
may demand the removal of the offending product from distribution
and sale, and may remove that product from the list of Licensed
Products and may also terminate this Agreement.
10. PROMOTIONAL
MATERIAL
In the
event Licensee advertises in trade publications for retail
recognition for the Brand in the appropriate marketplace, Licensee
agrees that such advertisement will be run as a full-page
advertisement. Licensee will use its best efforts, commensurate
with its projections for sales of Licensed Products, to convey to
the market that it is a licensee of the Brand, including but not
limited to placing signage depicting the Brand prominently at
Licensee's corporate offices and showrooms, point of sale,
marketing and other materials. No advertising, marketing,
promotional, and display materials, or other artwork shall be used
without prior written approval by Licensor. The Parties further
agree that all artwork and designs involving the Licensed Marks
shall be produced under appropriate “work for hire”
provisions, or are hereby assigned to and shall remain the property
of Licensor, notwithstanding their creation by Licensee or others.
Licensee shall ensure that, prior to its utilizing any
non-employees to create advertising, marketing, promotional, and
display materials or other artwork, advertising copy, and/or other
copyrightable materials related to the Licensed Marks, such persons
or entities shall have executed the necessary valid agreements to
convey the ownership and copyrights to these items to
Licensor.
11. CONSULTATION
11.1 Licensor
and Licensee agree to have meaningful consultation with each other
regularly throughout the Term of this Agreement and any renewal or
extension thereof. Each Party shall cooperate in good faith with
the other Party generally, and, in particular, the Parties shall
use and exercise their best efforts, taking all reasonable,
ordinary and necessary measures to ensure an orderly and smooth
relationship under this Agreement, and further agree to work
together and negotiate in good faith to resolve any differences or
problems which may arise in the future. However, the obligations
under this Section 11.1 shall not include any obligation to incur
substantial expense or liability.
11.2 Ms.
Kathy Ireland is the Chief Brand Advisor of the Brand and Thomas
Meharey is the Co-Founder of the Brand. In addition to the services
provided by the Brand Advisor and Co-Founder, Licensor hereby
designates Stephen Roseberry, Jason Winters, Jon Carrasco and Rocco
Ingemi to serve as liaisons with Licensee. Licensor may designate
additional members of the Licensor’s team to serve as its
liaison with Licensee. Licensor reserves the right to change,
modify, supplement, and/or alter this designation in any way and at
any time in its sole and unfettered discretion.
NuGene
International, Inc.
12. REPRESENTATIONS
AND WARRANTIES
Licensor represents
and warrants as follows:
12.1 Licensor
has the right and power to grant the licenses granted herein and
that there are no other agreements with any other party in conflict
herewith.
12.2 The
Licensed Marks do not infringe any valid right of any third
party.
12.3 Licensor’s
grant of the license and rights to Licensee hereunder does not, and
will not, infringe or misappropriate any third party’s
tangible property rights or intellectual property rights existing
on the Effective Date.
12.4 Licensor
has not received any notice or claim on or before the Effective
Date asserting that any of the licensed rights infringes or
misappropriates, any intellectual property rights of a third party,
and to the knowledge of the Licensor there is no reasonable basis
therefor.
12.5 None
of the licensed rights is subject to any litigation, judgment,
decree, stipulation, or other dispute as of the Effective Date, and
to the knowledge of Licensor no such dispute
threatened.
12.6 Licensor
has the requisite right, power, authority, and capacity to enter
into, execute, deliver, perform, and carry out the terms and
conditions of this Agreement, as well as all transactions
contemplated hereunder. All requisite proceedings have been taken
and Licensor has obtained all approvals, consents, and
authorizations necessary to authorize the execution, delivery, and
performance by Licensor of this Agreement. This Agreement has been
duly and validly executed and delivered by Licensor and constitutes
the valid, binding, and enforceable obligation of Licensor, except
as such enforcement may be limited by bankruptcy, insolvency,
reorganization, or other similar laws affecting the enforcement of
creditor's rights generally and by general principles of equity
(regardless of whether such enforcement is considered in a
proceeding in equity or at law.
12.7 As
of the Effective Date, the consummation by Licensor of the
transactions herein contemplated, including the execution, delivery
and consummation of this Agreement, will not: (a) violate any
judgment, statute, law, code, act, order, writ, rule, ordinance,
regulation, governmental consent or governmental requirement, or
determination or decree of any arbitrator, court, or other
governmental agency or administrative body, which now or at any
time hereafter may be applicable to and enforceable against the
relevant party, work, or activity in question or any part thereof
applicable to or binding upon Licensor; (b) violate (i) the terms
of the Articles of Organization or the Operating Agreement of
Licensor; or (ii) any material agreement, contract, mortgage,
indenture, bond, bill, note, or other material instrument or
writing binding upon Licensor or to which Licensor is subject; or
(c) result in the breach of, constitute a default under, constitute
an event which with notice or lapse of time, or both, would become
a default under, or result in the creation of any lien, security
interest, charge or encumbrance upon any part of the licenses
granted hereunder under any agreement, commitment, contract
(written or oral) or other instrument to which Licensor is a
party.
12.8 No
consents, approvals or other authorizations or notices, other than
those which have been obtained and are in full force and effect,
are required by any state or federal regulatory authority or other
person or entity in connection with the execution and delivery of
this Agreement and the performance of any obligations contemplated
thereby.
NuGene
International, Inc.
13. RECORDING
AND FILMING – EE1
13.1 Except
as provided herein, under no circumstance shall any recording be
made by Licensee or anyone acting on behalf of Licensee in any
manner whatsoever, whether on video or audio tape, film, celluloid,
and/or by any other means possible, of Mr. Meharey in connection
with any appearance provided under this Agreement, including
without limitation all personal appearances and photo sessions,
without the express prior written approval of Licensor. With regard
to the creation of any content to be exploited in any media, now or
hereafter existing, pursuant to this Agreement, Licensee will
provide Licensor’s affiliate, Encore Endeavor 1 LLC, a last
right of refusal on any vendor contract for the creation of such
content; provided, that it is understood and agreed that Licensee
is only obligated to use Encore Endeavor 1 LLC to the extent that
it at least matches the pricing, terms and conditions and business
capabilities in the creation of such content of such other vendor
being selected for such contract. Notwithstanding the vendor
selected by Licensee, all such work shall be on a “work for
hire” basis with Licensor as the sole owner of the results
and proceeds of such services. The Parties understand and agree
that a portion of the compensation paid to Licensor hereunder may
be allocated to Encore Endeavor 1 LLC due to the nature of its
relationship with Licensor and Licensee.
13.2 Ms.
Kathy Ireland and Tommy Meharey are union members of Guild/Union
Requirements (SAG-AFTRA) and Licensee will make payments
accordingly for any audio or visual recordings.
14. LICENSOR’S
RIGHTS
14.1 Nothing
in this Agreement shall be construed to prevent Licensor from
granting any other license for the use of the Licensed Marks or
from utilizing the Licensed Marks in any manner
whatsoever.
14.2 Licensee
agrees that rights not specifically granted to Licensee are
reserved by Licensor and may be freely exploited by Licensor
without limitation.
15. PROTECTION
OF LICENSOR’S RIGHTS
15.1 Licensee
agrees that during the term of this Agreement, or thereafter, it
will not register or attempt to register any of the Licensed Marks,
nor will Licensee form or incorporate any entity under a name that
includes the Licensed Marks. Licensee will not attack the title or
any rights of Licensor in and to the Licensed Marks or the Licensed
Products.
15.2 Licensee
further agrees to cooperate fully and in good faith with Licensor
for the purpose of securing and preserving Licensor’s rights
in and to the Licensed Marks.
15.3 Licensee
also agrees to assist Licensor to the extent necessary in the
procurement of any protection or to protect any of Licensor’s
rights to the Licensed Marks.
15.4 Licensee
acknowledges that Licensor has sole and exclusive ownership of all
right, title, and interest in and to the Licensed Marks and any
registrations that have been issued or may be issued
thereon.
15.5 Nothing
contained in this License Agreement shall give Licensee any right,
title or interest in or to the Licensed Marks except for the rights
expressly licensed by this License Agreement, and subject to its
terms and conditions.
NuGene
International, Inc.
15.6 Adaptations
and modifications of Licensed Marks prepared under this License
Agreement shall be included as part of the Licensed Marks,
including, without limitation, Licensor’s ownership
thereof.
15.7 All
registrations for intellectual property, Internet domain names and
social media user/screen names in the Licensed Marks are to be
applied for and obtained exclusively in Licensor’s name.
Licensee shall not file or register any intellectual property
applications or seek any Internet domain name and/or social media
user/screen name registration in the Licensed Marks, Licensed
Products or any derivations, improvements, variations or
modification thereof, without Licensor’s prior written
approval.
15.8 Licensee
shall notify Licensor, or its designated representative, prior to
entering into any agreement with any individual, company or
business, for sales outside the United States of any Licensed
Product, to permit the timely filing of foreign and/or
international trademark and copyright applications, if applicable,
or other intellectual property protection, covering the Licensed
Marks, in Licensor’s sole discretion.
15.9 Licensee
agrees to cooperate fully and in good faith with Licensor for the
purpose of securing and preserving Licensor’s rights in and
to the Licensed Marks. In the event there has not been a previous
registration of any Licensed Mark and/or any material relating
thereto for a particular Licensed Product, Licensor may register
and maintain, at Licensee's sole expense, trademarks and/or service
marks in the appropriate class(es) and/or copyrights in the name of
Licensor. Licensee is not permitted to register any copyright,
trademark, and/or service mark on behalf of Licensor. It is further
agreed that nothing contained in this Agreement, and no act or
omission by Licensor and/or by Licensee shall be construed as an
assignment or grant to Licensee of any right, title, or interest in
or to the Licensed Marks, it being understood that all rights
relating thereto are reserved by Licensor, except for the license
hereunder to Licensee of the right to use and utilize the Licensed
Marks only as specifically and expressly provided in this
Agreement.
16. WARRANTIES
AND INDEMNIFICATION
16.1 Licensor
hereby indemnifies Licensee and undertakes to hold Licensee
harmless against any claims or suits, demands, losses, injuries,
liabilities costs, judgments, arbitration awards, license fees,
settlement, damages and expenses (including reasonable
attorneys’ fees and costs, whether or not any legal
proceeding is commenced) (“Losses”) for trademark
infringement arising solely out of the validity of the rights to
the Licensed Marks and from Licensee’s use of the Licensed
Marks as granted herein, provided that prompt written notice is
given to Licensor within ten (10) days of receipt by Licensee of
any such claim or suit, and provided, further, that Licensor shall
have the option to undertake and conduct the defense of any suit so
brought, and no settlement of any such claim or suit is made
without the prior written consent of Licensor. Licensor’s
indemnification under this Section 16.1 shall be apportioned and
limited to only the portion of, and extent that, such Losses are,
or are claimed to be, proximately caused by or attributable
specifically to Licensee’s use of Licensed Marks in a manner
permitted by this License Agreement. It is further agreed that
Licensor reserves the unfettered right to select counsel to defend
any such claims, and this indemnification obligates Licensor to pay
for all costs and expenses as incurred rather than to reimburse
upon conclusion. However, Licensor shall not be obligated to
provide any indemnification hereunder in the event of negligence or
criminal conduct of Licensee which bears directly upon the claim
underlying the indemnification obligation hereunder.
NuGene
International, Inc.
16.2 Licensee
shall defend, indemnify, and hold Licensor harmless against any and
all actions, claims, demands, lawsuits, loss, costs, damages,
judgments, liabilities, license fees, settlement or expenses
incurred, claimed, obtained, or sustained, including without
limitation attorneys’ fees and costs, of any nature
whatsoever, whether in law or in equity, including without
limitation claims relating to or allegedly relating to the design,
manufacture, sale, purchase, use, advertising, marketing, and/or
distribution of any Licensed Product, whether for personal injury,
product liability or otherwise. Licensor reserves the right to
select counsel, reasonably acceptable to Licensor, to defend and/or
bring any such claims, and
this indemnification obligates Licensee to pay for all costs and
expenses as incurred rather than to reimburse upon conclusion.
Notwithstanding Licensor’s right to the choice of counsel,
Licensee shall solely be responsible for any and all
attorneys’ fees, costs, and expenses relating to any and all
such actions. However, Licensee shall not be obligated to provide
any indemnification hereunder in (a) intellectual property claims
arising out of the Licensed Marks, or (b) in the event of
negligence or criminal conduct of Licensor which bears directly
upon the claim underlying the indemnification obligation
hereunder.
16.3 Licensor
makes no representations or warranties with respect to the design,
manufacture, sale, purchase, use, marketing, and/or distribution of
any Licensed Product manufactured, sold, and/or distributed by
Licensee and disclaims any liability arising out of the design,
manufacture, sale, purchase, use, marketing, and/or distribution of
any Licensed Product, and any such express or implied warranties
are hereby disclaimed.
16.4 Licensee
represents and warrants to Licensor that: (i) Licensee has the full
power and authority to enter into this License Agreement on behalf
of Licensee and to perform all of Licensee’s material
obligations pursuant to this License Agreement, and that the
Licensed Products manufactured, sold, and/or distributed by
Licensee under this Agreement shall be suitable for the purpose for
which they are intended to be used and shall comply with all
applicable Federal, State, and local laws, and industry
standards, (ii) Licensee
will not harm or misuse the Licensed Property or bring the Licensed
Marks into disrepute, (iii) except as specifically provided in this
License Agreement, Licensee will not create any expenses chargeable
to Licensor or Ms. Ireland without the express prior written
approval of Licensor, (iv) all Licensed Products (and the content
contained or used in the Licensed Products) designed, developed,
marketed, distributed, published, performed or sold by Licensee
pursuant to this License Agreement do not, and will not, infringe
any intellectual property right or any personal right of any third
party, and (v) Licensee will not knowingly permit, do or commit any
act or thing that would degrade, tarnish or deprecate or disparage
the Licensed Property or Licensor’s or Ms. Ireland’s
public image in society or standing in the community, or prejudice
Licensor or Ms. Ireland and that it will terminate such activities
promptly upon written notice, and failure to do so constitutes a
material breach of this License Agreement. Licensee acknowledges
and agrees that there are no warranties, guarantees, conditions,
covenants, or representations by Licensor as to marketability,
fitness for a particular purpose, or other attributes of the
Licensed Products, whether express or implied (in law or in fact),
oral or written.
16.5 The
Party seeking indemnification shall provide the other with prompt
written notice of any lawsuits or threatened lawsuits, or other
significant developments, investigations, claims, or final refusals
in which it is or may be named as a party or for which it is
obligated or has agreed to indemnify any party, and it shall
thereafter provide the other with periodic written updates
concerning relevant developments in any such lawsuits as they
arise.
16.6 For
purposes of this Section 16, the term “Licensor”
and “Licensee” shall mean such Party and, without
limitation, any of its agents, employees, servants,
representatives, parents, subsidiaries, affiliates, officials,
directors, officers, shareholders, owners, attorneys, divisions,
branches, units, affiliated organizations, successors,
predecessors, contractors, assigns, and all persons acting by,
through, under, or in concert with them, past or
present.
NuGene
International, Inc.
17. INSURANCE
17.1 Licensee
represents that it has obtained, and agrees to maintain, at its own
expense, in full force and effect at all times during which the
Licensed Products are being manufactured, sold, and distributed,
insurance for bodily injury, advertising injury, property damage,
and product liability from a recognized insurance company approved
by Licensor, which is qualified to do business in the State of
California, providing protection at least in the amount of
$5,000,000 per occurrence and $5,000,000 in the aggregate for
Licensor and for Licensee against any actions, claims, demands,
lawsuits, loss, costs, attorneys’ fees, damages, judgments,
and liabilities of any nature whatsoever relating to the Licensed
Products. As proof of such insurance, a fully paid certificate of
insurance naming Licensor (as defined above) as Licensee shall
submit an insured party to Licensor for Licensor’s prior
written approval before any Licensed Product is manufactured, sold,
or distributed. Any proposed change in certificates of insurance
shall be submitted to Licensor for its prior written approval.
Licensor shall be entitled to a copy of the prevailing certificate
of insurance, which shall be furnished to Licensor by Licensee. The
certificate(s) shall conform to the language requirements set out
in Exhibit E
attached hereto.
17.2 For
purposes of this Section 17, the term “Licensor”
shall mean Licensor and, without limitation, any of its agents,
employees, servants, representatives, parents, subsidiaries,
affiliates, officials, directors, officers, shareholders, owners,
attorneys, divisions, branches, units, affiliated organizations,
successors, predecessors, contractors, assigns, and all persons
acting by, through, under, or in concert with them, past or
present.
18. INSOLVENCY;
CHANGE OF CONTROL
18.1 If
Licensee (a) files a petition in bankruptcy or is adjudicated a
bankrupt or if a petition in bankruptcy is filed against Licensee,
or if it becomes dissolved, or becomes insolvent or unable to pay
or discharge its liabilities in the ordinary course of business, or
if Licensee assigns the whole or any substantial part of its assets
or undertakings for the benefit of creditors or makes an assignment
for the benefit of its creditors or any similar arrangement
pursuant to any federal or state law, compulsory or voluntarily, or
if a receiver or other similar officer is appointed for the whole
or any part of the assets or undertakings of Licensee or its
business, or if Licensee stops payment to its creditors generally,
or ceases or threatens to cease to carry on its business or any
substantial part thereof, or (b) if Licensee has a Change of
Control, then in either such event Licensor may terminate this
Agreement by giving notice to Licensee of its intention to
terminate and such termination shall be effective immediately. In
the event this Agreement is so terminated, Licensee, its receivers,
representatives, trustees, agents, administrators, successors,
and/or assigns shall have no right to sell, exploit, or in any way
deal with or in any Licensed Products covered by this Agreement or
any related advertising, marketing, promotional, and display
materials, including without limitation cartons, containers,
packing, and wrapping materials, except with and under the special
consent and instructions of Licensor in writing, which they shall
be obligated to follow.
18.2 In
the event this Agreement is so terminated under this Section 18,
Licensee, its receivers, representatives, trustees, agents,
administrators, successors, and/or assigns shall have no right to
sell, exploit, or in any way deal with or in any Licensed Products
covered by this Agreement or any related advertising, marketing,
promotional, and display materials, including without limitation
cartons, containers, packing, and wrapping materials, except with
and under the special consent and instructions of Licensor in
writing, which they shall be obligated to follow.
NuGene
International, Inc.
19. TERMINATION
19.1 Except
as otherwise provided herein, in the event either party breaches or
fails to perform any of its material duties and obligations
pursuant to the terms of this Agreement, the non-breaching party
shall have the right to terminate this Agreement upon thirty (30)
days’ notice in writing, and such notice of termination shall
become effective unless the breaching party shall remedy the breach
within the thirty (30) day period to the reasonable satisfaction of
the non-breaching party. The Parties agree to make a reasonable
effort to resolve any disputes or breaches prior to exercising the
right of termination.
19.2 Termination
of this Agreement shall be without prejudice to any rights, which
Licensor may otherwise have against Licensee. Upon the termination
of this Agreement, notwithstanding anything to the contrary herein,
all royalties on sales theretofore made and any other monies owed,
shall become immediately due and payable, and all rights and
licenses granted hereunder shall cease and revert to Licensor.
Further, Licensee will withdraw or cancel any governmental filings
made on its behalf that include the Licensed Marks. Licensee shall
immediately cease and desist from using the Licensed Marks in any
way. Unless otherwise stated in this Agreement, Licensee shall have
no right to sell, exploit, or in any way deal with or in any
Licensed Products covered by this Agreement or any related
advertising, marketing, promotional, and display materials,
including without limitation cartons, containers, packing, and
wrapping materials, except with and under the special consent and
instructions of Licensor in writing, which they shall be obligated
to follow. Licensee shall immediately return any and all
Confidential Information of Licensor to Licensor, as well as
marketing and advertising materials bearing the Licensed
Marks.
19.3 Upon
the natural expiration or termination of this Agreement, neither
Party shall make any publicly disparaging comments regarding the
other or its business, whether written, oral, or electronic. This
provision shall survive the expiration or termination of this
Agreement. However, nothing herein shall limit either Party’s
right to arbitration or other judicial remedies as set out in this
Agreement.
19.4 Licensee
acknowledges that a failure (except as otherwise expressly provided
herein) to cease the manufacture, sale, transmission, broadcast or
distribution of the Licensed Products upon the terminations or
expiation of this License Agreement will result in immediate and
irreparable damage to Licensor. Licensee further acknowledges that
there is no adequate remedy at law for such failure to cease
manufacture, sale or distribution, and in the event of such
failure, Licensor shall be entitled to equitable relief and such
further relief as a court or agency with jurisdiction may deem just
and proper.
19.5 Upon
termination or expiration of this Agreement, all of the rights
granted hereunder to Licensee, and all rights, title and interest
in and to the Licensed Marks, including but not limited to, patent,
industrial design, copyright, trademark, service mark, trade dress
and all improvements, additions and changes thereto, trade secret
rights, and goodwill relating to the Licensed Marks, shall revert
to Licensor. Licensee agrees to promptly execute all documents that
may be reasonably necessary to effect the foregoing. This right and
obligation shall survive the terminations or expiration of this
License Agreement.
20. FORCE
MAJEURE
The
Parties shall be released from their obligations hereunder, and
this Agreement shall terminate in the event that governmental
regulations or other causes arising out of a state or national
emergency or war or causes beyond the control of the Parties render
performance impossible, and one Party so informs the other in
writing of such causes and its desire to be so released. In such
event, all royalties on sales and all other monies due, theretofore
made shall become immediately due and payable to
Licensor.
NuGene
International, Inc.
21. NOTICES
Any
notice, communication, statement, payment, or legal service of
process required or permitted under this Agreement shall be in
writing and shall be effective when hand delivered; or on the date
when the notice, communication, statement, payment, or legal
service of process is transmitted by confirmed electronic facsimile
(with a confirmation copy sent by mail); or the day after the
notice, communication, statement, payment, or legal service of
process is sent by reputable overnight air courier service (e.g.,
Federal Express). All such communications shall be sent to the
Parties at the notice addresses listed below or to such other
persons and the Parties to each other may designate notice
addresses as in writing.
If to Licensor:
|
I|M1, LLC
4521 Sharon Road, Suite 450
Charlotte, NC 28211
Attention: Mark Elliott - CFO
Email: mark@levelbrands.com
|
With a copy to:
|
Paul Porter
4521 Sharon Road, Ste. 450
Charlotte, NC 28211
Email: pporter@sstreetllc.com
And
Erik Sterling
PO Box #1410
Rancho Mirage, CA 92270
Facsimile: 310 557-1722
Attention: Erik Sterling
Email: esterling@sterlingwinters.com
|
If to Licensee:
|
NuGene International, Inc.
17912 Cowan Street, Suite A
Irvine, CA 92614
Attention: Steve Carlson
Email: steve@nugene.com
And
Keith A. Rosenbaum
Spectrum Law Group, LLC
1900 Main Street, Ste 300
Irvine, CA 92614
Email: keith@spectrumlawgroup.com
|
|
|
22.
NuGene
International, Inc.
23. NEGATION
OF AGENCY
Licensee is an
independent contractor with respect to Licensor. Nothing contained
herein shall be deemed to create an agency, joint venture,
franchise, or partnership relation between the Parties, and neither
Party shall so hold itself out. Licensee shall have no right to
obligate or bind Licensor in any manner whatsoever, and nothing
contained in this Agreement shall give, or is intended to give, any
rights of any kind to any third person(s).
24. ASSIGNABILITY
24.1 This
Agreement shall inure to the benefit of Licensor, its successors,
and assigns, but will be personal to Licensee, and shall be
assignable by Licensee only with the prior written consent of
Licensor. Licensee shall not mortgage, assign, sub-license, or
otherwise encumber this Agreement without the prior written consent
of Licensor. Licensor shall be entitled to assign this Agreement to
any third party with notice to Licensee, including any such
assignment in connection with the sale or transfer of
Licensor’s business, provided, however, that Licensor shall
have the option to terminate this Agreement in lieu of assignment
to any successor of Licensor’s business in connection with
any such sale or transfer.
24.2 In
the event Licensor terminates this Agreement in connection with a
sale of its business, Licensee shall have a period of six (6)
months from the effective date of termination in which to sell off
its inventory of Licensed Products, subject to the terms and
conditions of this Agreement, including paying
Royalties.
25. MODIFICATION
AND WAIVER
25.1 Except
as otherwise provided herein, no agreement or understanding
purporting to add to or to modify the terms and conditions of this
Agreement shall be binding unless agreed to by the Parties in
writing. Any terms and conditions set forth in any forms used by
the Parties, which are in conflict with the terms and conditions of
this Agreement, shall be void and have no effect. The Parties
further agree that the Exhibits to this Agreement may be modified,
amended, altered, and/or supplemented from time to time in writing
signed by authorized representatives of the Parties.
25.2 It
is agreed that no waiver by either Party hereto or any breach or
default of any of the provisions set forth herein shall be deemed a
waiver as to any subsequent and/or similar breach or
default.
26. GOVERNING
LAW
26.1 This
Agreement shall be construed in accordance with and the laws of the
State of California which shall govern all disputes relating hereto
without giving effect to any conflicts of law provisions. The
Parties agree that any and all disputes, controversies or claims
arising out of, regarding, or in any way relating to the
interpretation, application, or enforcement of this Agreement, or
any matter reasonably related thereto, shall be handled by way or
arbitration and administered by and in accordance with the JAMS
streamlined Arbitration Rules and Regulations (the ''JAMS Rules '')
of the Judicial Arbitration and Mediation Service in effect at the
time of any such proceedings. Such arbitration shall be the sole,
exclusive, and final remedy for resolving any such claims and
disputes. Judgment on the final award rendered by the arbitrator
may be entered into in any court of competent jurisdiction and
shall be final and binding upon the Parties.
NuGene
International, Inc.
26.2 Notwithstanding
the foregoing, the Parties may seek provisional relief, including a
preliminary injunction or temporary restraining order, in any
federal or state court of competent jurisdiction located in Los
Angeles, California, without prejudice to the above described
arbitration procedures, if in that Parties sole judgment such
provisional relief is necessary to avoid an irreparable injury or
to preserve the status quo. Never the less, the arbitration
procedure set forth in this Section 25 is intended to be the sole
and exclusive method of resolving any claims arising out of,
relating to, or regarding this Agreement.
27. CONFIDENTIALITY
27.1 The
Parties agree that the terms, conditions, and subject matter of
this Agreement constitute confidential and proprietary information
belonging to Licensor. Licensee agrees not to divulge any
confidential and proprietary information pertaining to Licensor or
this Agreement to any third party without prior written consent of
Licensor. Licensee shall take any and all lawful measures to
prevent the unauthorized use and/or disclosure of such confidential
information, and to prevent unauthorized persons or entities from
obtaining or using such information. Licensee further agrees to
refrain from directly or indirectly taking any action, which would
constitute or facilitate the unauthorized use or disclosure of such
confidential information. Licensee may disclose such confidential
and proprietary information in compliance with applicable law
(including, without limitation, federal securities laws), and to
its officers, directors, employees, agents, and authorized
representatives to the extent necessary to enable Licensee to
perform its obligations under this Agreement, provided that said
officers, directors, employees, agents, and/or authorized
representatives execute an appropriate confidentiality agreement
approved by Licensor, which by its terms shall be enforceable by
injunctive relief. Licensee shall be liable for any unauthorized
use and disclosure of such confidential information by its
officers, directors, employees, agents, and authorized
representatives, including without limitation its attorneys and
accountants. The Parties further agree that any breach or
threatened breach of this Section 26.1 would cause irreparable harm
to Licensor, that a remedy at law or in damages would be
inadequate, and that the provisions of this Section 26.1 may be
enforced by way of injunctive relief in addition to any other
rights available to Licensor in law or in equity.
27.2 For
purposes of this Agreement, “confidential and proprietary
information” includes, but is not limited to, the terms,
conditions, and subject matter of this Agreement, and
Licensor’s business, including any financial, cost, pricing,
and royalty information; product development, business, marketing,
promotion, distribution, sales, sales plans, and strategies;
information concerning Licensor’s product development and
intellectual property; information concerning manufacturing
processes relating to the Licensed Products, or trade secrets. The
foregoing confidentiality obligations shall not apply to
information that: (1) was previously known to the recipient
free of any obligation to keep it confidential; (2) was
independently developed by recipient; or (3) is or becomes
publicly available by means other than the unauthorized disclosure
by recipient.
27.3 In
the event that any judicial or regulatory authority requests or
requires disclosure of any Confidential Information of the other
party, the receiving party shall promptly notify the disclosing
party of the requested or required disclosure and shall reasonably
cooperate with the disclosing party in any effort, if so requested
by the disclosing party, to avoid or limit such disclosure;
provided, however, nothing in this Section 26 shall prevent such
receiving party from compliance with any law (including, without
limitation, any federal securities laws).
NuGene
International, Inc.
28. ENTIRE
AGREEMENT AND ADMISSIBILITY
This
Agreement constitutes the complete understanding between the
Parties and supersedes any and makes void any and all prior
agreements, promises, representations, or inducements, no matter
their form, concerning the subject matter of this Agreement. The
Parties desire that this Agreement represent a single and
completely integrated contract expressing the entire agreement of
the Parties with respect to the subject matter of this Agreement.
No promises, agreements, or modifications to this Agreement made
subsequent to the execution of this Agreement by the Parties shall
be binding unless reduced to writing and signed by authorized
representatives of the Parties. The Parties to this Agreement agree
that this Agreement may be used as evidence in any subsequent
proceeding in which any Party alleges a breach of this Agreement or
seeks to enforce its terms, provisions, or
obligations.
29. SEVERABILITY
Whenever possible,
each provision of this Agreement shall be interpreted in such a
manner to be effective and valid under applicable law. Should any
of the provisions or terms of this Agreement be determined illegal,
invalid, or unenforceable by any court of competent jurisdiction,
validity of the remaining parts, terms, or provisions shall not be
affected thereby, and said illegal, invalid, or unenforceable part,
term, or provision shall be deemed not to be a part of this
Agreement.
30. RECITALS
AND HEADINGS
The
terms of this Agreement are contractual, not a mere recital, and
are the result of joint negotiations between, and joint drafting
by, the Parties, and are therefore not to be construed in favor of
or against either Party. All recitals are incorporated by reference
into this Agreement. Caption and Section headings are used for
convenience and reference only, are no part of this Agreement, and
shall not be used in interpreting, construing, defining, limiting,
extending, or describing the scope of this Agreement, or any
provision hereof, in any way.
31. ATTORNEY
FEES AND COSTS
Should
any action be necessary to enforce the terms of this Agreement, the
prevailing Party will be entitled to recover reasonable
attorneys’ fees and costs.
32. EXECUTION
OF COUNTERPARTS
This
Agreement may be executed in two or more duplicate bond or
facsimile counterparts, each of which shall be considered an
original, but all of which together shall constitute one and the
same instrument, and in pleading or proving any provision of the
Agreement, it shall not be necessary to produce more than one such
counterpart.
33. EQUITABLE
RELIEF
The
Parties acknowledge that the subject matter of this Agreement
relates to services and rights, which are extraordinary and unique
and which cannot be replaced or adequately compensated in money
damages, and any breach by Licensee of this Agreement will cause
irreparable injury to Licensor.
NuGene
International, Inc.
34. CONSENTS,
APPROVALS, AND DISCRETION
Except
as herein expressly provided to the contrary, whenever this
Agreement requires consent or approval to be given by a party, or a
party must or may exercise discretion, the parties agree that such
consent or approval shall not be unreasonably withheld, conditioned
or delayed, and such discretion shall be reasonably
exercised.
[signature page
follows]
NuGene
International, Inc.
IN
WITNESS WHEREOF, the Parties hereto have caused this instrument to
be duly executed as of the day and year first above
written.
Licensor:
I|M1, LLC
/s/
Stephen Roseberry
Name:
Stephen Roseberry
Title:
President
Licensee:
NuGene International, Inc.
/s/
Steve Carlson
Name:
Steve Carlson
Title:
CEO
NuGene
International, Inc.
EXHIBIT A
LICENSED MARK
1.
Only for the
Licensed Products specified in Exhibit B to this
Agreement and only as shown in the following
specimen(s):
2.
Examples on Brand
Partner Resource link; upon your signature a password will be
provided.
3.
Licensed Products
to include styles with each of the following supporting categories
will be provided by Licensor upon further discussion with
Licensee.
Licensor may designate other supporting brands or categories, in
writing from time to time.
NuGene
International, Inc.
EXHIBIT B
LICENSED PRODUCTS ANDCHANNELS OF DISTRIBUTION
●
The following list
sets forth the Licensed Products:
Each of
the following products which are currently marketed and sold by
Licensee, but as the same may be renamed, rebranded or otherwise
for use by men or in the men’s market containing stem cell
derived or containing biologically active or biologically derived
ingredients: NuGene Face Wash, NuGene universal Cream, NuGene
Universal Serum, NuGene Light and Bright, NuGene Eye Serum, NuGene
Face Mask, NuGene Melasma Serum, NuGene Acne Serum, NuGene
Revitalizing night Cream, NuGene Toner, NuGene Body Lotion, NuGene
Specialty Soap, NuGene Neck & Dècolleté Lotion,
Advanced Infusion Serums and other age-defying products that are
stem cell derived or which contain biologically active or
biologically derived ingredients.
●
Licensee may only
use those channels of distribution approved, in advance, by
Licensor. Any mass market and low tier department stores (i.e.,
Wal-Mart, K-Mart, Target, and Sears), as well as club stores (i.e.
Sam’s), are specifically excluded from the approved Channels of
Distribution under this Agreement.
●
Licensor shall have
prior approval rights relating to any internet retailers not
belonging to retailers in the approved Channels of Distribution set
forth above, which will be reviewed on an individual basis by
Licensor.
Click or tap here to enter text.
EXHIBIT C
CODE OF CONDUCT
行为守则
1.
PURPOSE: [LICENSEE]
is committed to using only manufacturers to strive to conduct
business in a highly professional and ethical manner. This document
outlines those commitments each facility makes in respect to its
compliance with applicable law and tis personal practices and
policies.
目的:[被许可人]承诺只使用了力争在一个高度专业和道德的方式开展业务的厂家。本文概述了这些各设施使得在尊重其遵守适用的法律和个人的做法和政策的承诺。
2.
CHILD LABOR: The
facility agrees not to use child labor in the manufacturing, or
distribution of the Goods. The term “child” refers to a
person younger than the local legal minimum age for employment or
the age for completing compulsory education; provided, however, in
no event shall the Facility use any person below the age of (15)
fifteen. The Facility also agrees to comply with all other Laws
applicable to employees, regardless of the age of an
employee.
童工:该中心同意不使用童工在制造,或货物配送。
“童工”是指一个人年龄低于当地法定最低就业年龄或年龄在完成义务教育;
提供的,但是,在任何情况下,基金使用任何人(15)15岁以下。该基金还同意遵守适用于所有员工的其他法律,不论雇员的年龄。
3.
FORCED LABOR: The
Facility agrees to employ only persons whose presence is voluntary.
The Facility agrees not to use any forced or involuntary labor,
whether prison, bonded, indentured or otherwise.
强迫劳动:该基金同意只雇用人员,其存在是自愿的。该基金同意不使用任何强迫或非自愿劳动,无论是监狱,保税,契约或其他方面。
4.
ABUSE OF LABOR: The
Facility agrees to treat each employee with dignity and respect and
not to use corporal punishment, threats of violence, or other forms
of physical, sexual, psychological or verbal harassment or
abuse.
滥用劳动:该基金同意把每个员工的尊严和尊重,不使用体罚,暴力威胁或其他形式的身体,性,心理或言语上的骚扰或虐待。
5.
NON-DISCRIMINATION:
The Facility agrees not to discriminate in hiring and employment
practices, including salary, benefits, advancement, discipline,
termination, or retirement on the basis of race, religion, age,
nationality, social or ethnic origin, sexual orientation, gender,
political opinion or disability.
不歧视:该基金同意不会在雇佣和招聘活动,包括工资,福利,晋升,纪律,终止或退休种族,宗教,年龄,国籍,社会或民族,性取向,性别的基础上歧视,政治观点或残疾。
6.
ASSOCIATION: The
Facility agrees to follow employees to organize and bargain
collectively without penalty or interference in accordance with
local Laws.
关联关系:该基金同意遵守雇员组织和集体谈判不受处罚或干预按照当地的法律。
7.
WAGES, DENEFITS AND
WORKING HOURS: The facility recognizes that wages are essential to
meeting employee’s basic needs. The Facility agrees to
comply, at a minimum, with all applicable wages and hour Laws,
including minimum wage, overtime hours, maximum hours, piece rates
and other elements of compensation and shall provide legally
mandated benefits.
工资,福利和工作时间:该厂认识到,工资是必要的,以满足员工的基本需求。该基金同意遵守,至少,所有适用的工资和工时的法律,包括最低工资,加班,最长工时,计件工资和补偿等内容,并应提供法定福利。
8.
HEALTH AND SAFETY:
The Facility agrees to provide employees with a safe and healthy
workplace environment in accordance with all applicable Laws,
ensuring at a minimum, reasonable access to potable water and
sanitary facilities, fine safety and adequate lighting and
ventilation. The Facility also agrees to ensure that the same
standards of health and safety are applied to any housing it
provides for employees.
NuGene
International, Inc.
健康和安全:该基金同意为员工提供一个安全和健康的工作环境符合所有适用法律,确保在最低限度,合理获得饮用水和卫生设施,精美的安全性和足够的照明和通风。该基金也同意,以确保健康和安全的相同标准适用于它提供了雇员的住房
9.
COMPLIANCE: The
Facility agrees to take appropriate steps to ensure that the
provisions of the COC are communicated to its employees, including
by prominent posting a copy of this COC in the local language on
one or more bulletin boards in places readily accessible to
employees at all times.
合规性:本基金同意采取适当措施,以确保奥委会的规定传达给员工,其中包括由著名张贴在当地语言的一个或多个电子公告板的名额该行为准则的副本容易获得员工的所有次。
10.
ENVIRONMENT:
Business partners should share our concern for the environment and
adhere to their local and national laws regarding the protection
and preservation of the environment.
环境:业务合作伙伴应该分享我们对环境的关注,并坚持对环境的保护和维护当地和国家法律。
11.
LEGAL REQUIREMENTS:
Business partners should be in compliance with all legal
requirements involved in conducting the business.
法律要求:业务合作伙伴应符合参与开展业务的所有法律要求。
12.
Our Business
Partners are required to provide full access to their facilities
and those of their manufacturers, vendors and subcontractors, and
to release records relating to employment practices. We may conduct
on-site inspections of facilities to monitor the standards and
assure the quality of our products.
我们的业务合作伙伴必须提供完全访问他们的设备和那些他们的制造商,供应商和分包商,并发布有关用工行为记录。我们可以进行现场视察设施,以监控标准,确保了产品的质量。
Please report Violations Anonymously by emailing to:
mark@levelbrands.com
NuGene
International, Inc.
EXHIBIT D
Approved Royalty Report Form
●
Example Royalty
Reports are set forth on the Brand Partner Resource link, upon your
signature a password will be provided
NuGene
International, Inc.
EXHIBIT E
REQUIRED INSURANCE CERTIFICATE
Under Description of Operations state the
following:
“Certificate Holder I|M1, LLC, I|M1 Holdings, LLC, Level
Brands, Inc., Encore Endeavor 1, LLC, EE1 Holdings, LLC, Tommy
Meharey, Kathy Ireland, kathy ireland Worldwide, Inc., kathy
ireland LLC, The Sterling/Winters Company, and their partners,
owners, subsidiaries, affiliates, directors, officers, managers and
employees are named additional insured with regards to liability
arising out of operations of the named insured.”
The Certificate Holder should be listed as:
I|M1, LLC
4521 Sharon Road, Ste. 450
Charlotte, NC 28277
Send copies of Certificate to:
Mitchka Lyonnais
mlyonnais@mmibi.com
Momentous Insurance Brokerage, Inc.
Mark Elliott
mark@levelbrands.com
I|M1, LLC
- END OF CONTRACT-
Exhibit
6.30
TELEVISION SERIES CONSULTING AGREEMENT
This
CONSULTING AGREEMENT (this "Agreement") is made as of the
1st day of
March, 2017, by and between Multi-Media Productions Inc. Inc., a
Florida corporation ("MMP"), and Encore Endeavor 1 LLC
(“Consultant”).
RECITALS
A. MMP
produces the award winning television series Worldwide Business
with kathy ireland® and Modern Living with kathy ireland®
(collectively, the "Series"). While the specific subject matter and
focus of each episode of the Series and each Series will include
B2B and B2C, the specific names of the Series may change from time
to time, at MMP’s option. MMP intends that the Series may
include topics such as energy, transportation, manufacturing,
environment, computers, and real estate for the B2B Series; and
family, parenting, travel, leisure, beauty, fashion, career and
finance for the B2C Series.
B.
Shows will include interviews, on-location packages, monologues,
introductions, news desk presentations and narration. Each
thirty-minute episode of the Series will be underwritten by
multiple sponsors whose technology, products, business strategies
and or services will be featured in specific episodes
C. MMP
desires to engage Consultant to provide creative and content input
and feedback on the Series as described above.
AGREEMENT
NOW,
THEREFORE, in consideration of the mutual covenants, agreements,
representations, warranties, terms and conditions set forth in this
Agreement, the parties hereby agree as follows:
1.
Term of Agreement: The term of
this Agreement will commence upon the signing of this Agreement and
continue until the end of the Production Month (as defined below)
which includes March 1, 2018. For purposes hereof, a
“Production Month” shall be designated by MMP, in its
discretion, and shall effectively mirror MMP’s monthly
production schedule of the Series, which may not be based on a
calendar month.
2.
Consultant Compensation:
Consultant will receive Fifty Thousand Dollars ($50,000) per
Production Month, for a minimum of four Production Months. Wiring
instructions for payment of compensation as described above shall
be set forth on Exhibit A, attached hereto. In the event MMP
determines to not use Consultant in a Production Month during the
term, MMP agrees to provide notice to Consultant of its intention
at least 10 days prior to the commencement of such Production
Month.
3.
Confidentiality: Except as
otherwise required by law, (a) neither MMP or Consultant shall
divulge or make know to any person, firm or corporation any of the
financial terms of this Agreement without the prior written consent
of the other party and (b) Consultant shall not divulge or make
known to any person, firm or corporation any matters of a
confidential nature pertaining to MMP’s business without the
prior written consent of MMP.
This
Agreement has been duly executed as of the date first above
written.
MMP (USA) Inc.
/s/ Thomas W. Clynes
Thomas
W. Clynes, CEO
Executive
Producer of Worldwide Business with kathy ireland® and Modern
Living with kathy ireland®
Encore Endeavor 1 LLC
/s/ Nic Mendoza
Nic
Mendoza, Executive Vice President, Managing Director
EXHIBIT A
WIRING INSTRUCTIONS
Comerica
Bank
2000
Avenue of the Stars. Suite 210
Los
Angeles, CA 9006 7
Account
name: EE1
Domestic
Wire - ________________
Account
#: _____________________
Exhibit 6.31
ADVISORY AGREEMENT
(Level)
THIS ADVISORY AGREEMENT (the
“Agreement”)
is made this 9th day of May, 2017 (the “Effective
Date”) by and between Formula Four Beverages Inc., a
British Columbia, Canada corporation (the “Company”),
I|M1, LLC (“IM1”),
Encore Endeavor 1, LLC (“EE1”)
(IM1 and EE1, collectively, the “Advisor”).
BACKGROUND
A. The Company desires to retain the
Advisor to provide certain advisory services as hereinafter set
forth.
B. The
Advisor desires to provide certain advisory and consulting services
to the Company in accordance with the terms and conditions
contained hereinafter.
AGREEMENT
NOW, THEREFORE, in consideration of the
mutual promises set forth herein and other good and valuable
consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows:
1. Advisory
Services.
(a) During the Term of
this Agreement, the Advisor is hereby retained by the Company on a
non-exclusive basis to provide strategic advisory services (the
“Services”)
to the Company to be mutually agreed to which are anticipated to
include: (a) provide reasonable input to the Company on various
aspects of corporate branding, and (b) work with the Company and
coordinate with other service providers of the Company with respect
to the Services set forth on Exhibit A.
(b) The Services
provided by Advisor and availability of its affiliates will, in all
respects, be subject to the Standard Terms and Conditions set forth
on Exhibit B
(“Standard Terms and
Conditions”) attached hereto and incorporated herein
by this reference. In the event of any conflict between the body of
this Agreement and the Standard Terms and Conditions, the Standard
Terms and Conditions shall control. If Company requests the
affiliates of Advisor to travel in connection with the rendering of
any Services, Advisor shall be entitled to approve each such
request (which approval may be withheld in the Advisor’s sole
discretion), and any arrangements for such travel will be pursuant
to the Standard Terms and Conditions.
2. Term;
Termination. The Term of this Agreement shall commence on
the Effective Date as set forth above and end on December 31, 2021
(the “Expiration
Date”). Either the Advisor or the Company may
terminate this Agreement in the event that the other party breaches
or fails to perform any of its material obligations under this
Agreement, and such failure or default continues uncured for a
period of thirty (30) days following written notice from the
non-defaulting party (or if such breach, failure or default is not
reasonably capable of cure without cost or liability to the non
breaching party, then termination shall be effective immediately
upon delivery of notice). Within the six months prior to the
Expiration Date, the parties agree to meet and discuss, in good
faith, a renewal of this Agreement. The parties acknowledge and
agree that each term and provision in the Standard Terms and
Conditions is a material obligation of the Company under this
Agreement.
3. Compensation.
(a) Unless and until
the parties mutually agree otherwise, the Company agrees to pay to
Advisor the following compensation, with such compensation in each
case divided equally between IM1 and EE1, in exchange for the
Services, and the compensation terms included in this Section 3
shall survive any termination of this Agreement:
(i) Warrant.
Concurrently with the execution hereof, the Company shall issue a
Warrant (a “Warrant”)
to the Advisor to purchase 1,600,000 shares of the common stock of
the Company, for an aggregate exercise price of Four hundred and
one dollars ($401.00), in exchange for the Services performed by
the Advisor hereunder. The parties understand and agree that the
Services to be performed by Advisor hereunder with respect to the
Warrant shall be fully performed within 45 days of the execution
hereof; provided, that a
failure to perform such services within such period shall not be
deemed a material breach of this Agreement.
(ii) Royalty.
In further remuneration, commencing on the date hereof, the Company
shall pay the Advisor royalties in U.S. dollars in an amount equal
to the following amounts based on the total number of cases of
OXiGEN related product (including all current and future products)
sold in the United States in each such year (the
“Royalty”)
(for purposes hereof, the 2017 contract year shall commence on the
date hereof and end on the first anniversary of the date hereof,
and each annual anniversary of the date hereof thereafter shall be
the beginning of the next following contract year):
2017: 750,001 - 1,500,000 cases
at a $0.40 per case, everything over 1,500,001+ cases sold at $0.60
per case;
2018: 750,001 - 2,500,000 cases
at $0.40 per case, everything over 2,500,001+ cases at $0.60 per
case;
2019: 750,001 - 5,000,000 cases
at $0.40 per case, everything over 5,000,001+ cases at $0.60 per
case;
2020: 750,001 - 10,000,000
cases at $0.40 per case, everything over 10,000,001+ cases at $0.60
per case; and
2021: 750,001 - 15,000,000
cases at $0.40 per case, everything over 15,000,001+ cases at $0.60
per case.
For
clarification purposes, as of the date hereof (but subject to
change from time to time with new and/or replacement product
offerings by the Company), a “case” delineates a case
of OXiGEN water being 24 x 20 fl. oz. bottles, 24 x 16.9 fl. oz.,
12 x 1 liter, 12 x 1.5 liter and a case of OXiGEN
“shot” being 30 x 0.5 fl. oz. shots. Notwithstanding
the foregoing, any new product “cases” other that the
aforementioned delineation of cases shall: (i) be a commercially
standardized standard configuration; and (ii) not have an adverse
effect on the Royalty payable to the Advisor pursuant to the
Agreement.
(iii) Royalty
Payments. Within forty five (45) days after the end of each
calendar month, the Company shall furnish to the Advisor a complete
sales and royalty report certified to be accurate by the Chief
Financial Officer of the Company or by some other authorized
designee of the Company showing the number and description of the
cases of product sold during such month, as well as the production
records for the Company’s product during the month for which
the royalty payment to such Advisor are being
provided.
(b) Royalty Report. The Company
shall use a report form agreed to by the parties. Such report shall
be furnished to Advisor whether or not any of the cases of such
product have been sold during the preceding month. The receipt or
acceptance by the Advisor of any of the reports furnished by the
Company pursuant to this Agreement or of any royalties paid by the
Advisor hereunder (or the cashing of any royalty checks paid by the
Company hereunder) shall not preclude the Advisor from questioning
the accuracy thereof at any time, and in the event that any
inconsistencies or mistakes are discovered in such reports or
payments, any inconsistency, mistake, or inaccuracy shall
immediately be rectified, and any appropriate payment due and owing
shall immediately be paid by the Company to the Advisor. Any
amounts not paid to the Advisor when due under this Agreement shall
bear a late payment charge on the unpaid balance at the rate of
1.5% per month, compounded, or the maximum amount permitted by law,
whichever is less.
(c) Audit Rights. the Company
agrees to keep accurate books of account and records covering all
transactions relating to the license hereby granted, and the
Advisor and its duly authorized representatives shall have the
right after giving reasonable notice at all reasonable hours of the
day to an examination of said books of account and records relating
to the Company’s performance under the Agreement, and of all
other documents and materials in the possession or under the
control of the Company or any of its affiliated, associated, or
subsidiary companies or agents, with respect to the subject matter
and terms of this Agreement, and shall have free and full access
thereto for said purposes and for the purpose of making extracts
therefrom. Upon request of Advisor, the Company shall furnish to
Advisor a detailed statement by an independent certified public
accountant showing the number and description of the cases of
product covered by this Agreement distributed and/or sold by the
Company to the date of Advisor’s demand. All books of account
and records shall be kept available for no less than Seven (7)
years, or, as long as required by the Internal Revenue Service, if
longer than 7 years. Each calendar year in which this Agreement is
in effect, and after expiration or termination of this Agreement,
Advisor shall be entitled to an independent audit of and be given
access to the Company’s account books, records, invoices and
other pertinent data by a certified public accountant or qualified
auditor designated by Advisor. The audit shall be conducted to
determine the Company’s sales of products, and shall be
conducted during normal business hours at the Company’s
business office or location of such files and records. The cost of
the audit shall be borne by Advisor unless the audit reveals that
the Company understated the Royalties by more than two percent
(2%), in which case the Company shall be required to pay all
Advisor’s costs of the audit.
(d) Change of Control. In the event
the Company or its US subsidiary, Formula Four Beverages (USA)
Inc., incurs or enters into any agreement pursuant to which a
Change of Control (as defined below) would occur, the Company shall
provide the Advisor notice of such Change of Control. Following
such notice, at the option of any party to this Agreement and upon
notice to the other parties, this Agreement, together with the
Royalty paid to Advisor under Section 3(a)(ii) shall immediately
terminate and the Advisor shall be paid, in lieu thereof, a
one-time, lump sum aggregate payment equal to the cumulative
Royalties paid to the Advisor over the previous trailing 12-month
period. The lump sum payment shall be paid to Advisor within 30
days of the occurrence of the Change of Control. For purposes
hereof, “Change of
Control” means (1) any consolidation or merger of such
entity in which the entity is not the continuing or surviving
entity, or pursuant to which the shares are converted to cash,
other securities or other property, other than a consolidation or
merger of the entity in which the holders of the entities shares
immediately prior to the consolidation or merger have substantially
the same percentage ownership of the interests of the continuing or
surviving entity immediately after the consolidation or merger, or
(2) any sale, lease, exchange or other transfer (in one transaction
or in a series of transactions and not in the ordinary course of
business) of all or substantially all of the entities assets, (3) a
sale of fifty percent (50%) or more of the then outstanding voting
securities of the entity to one party, or (4) any other event,
pursuant to which the members of the Board of Directors (or similar
governing body) who were elected prior to the occurrence no longer
constitute a majority of the members of such governing body.
Notwithstanding the above, any conveyance, transfer or grant of
security title to or a security interest in any goods, accounts,
inventory, general intangibles or other assets of such entity to
secure the obligations of the entity or any of its subsidiaries, or
the exercise of any rights or remedies by such entity after a
default of indebtedness, shall not constitute a “Change of
Control” as used herein.
4. System
Requirements. The Company agrees to become a member and
utilize (a) Dependable Solutions, a product approval and royalty
reports services, (b) to the extent the terms are reasonable and
the Company utilizes payment terms by credit or debit card, ireland
pay, a merchant agreement service, and (c) to the extent the terms
are reasonable, any similar web platform as may be utilized by the
Advisor from time to time as a means of facilitating performance
under this Agreement.
5. Expenses.
The Advisor shall be reimbursed for all out of pocket costs and
expenses incurred by it in the performance of the Services
hereunder subject to preapproval by the Company.
6. Return of
Documents. On termination of this Agreement or at any time
upon the request of Company in writing, Advisor shall return to
Company all documents, including all copies thereof, and all other
property relating to the business of Company and/or its
subsidiaries, including without limitation, the Confidential
Information (as hereinafter defined), in its possession or
control.
7. Amendment or
Assignment. No
modification, waiver, amendment, discharge or change of this
Agreement shall be valid unless the same is evidenced by a written
instrument, executed by the party against which such modification,
waiver, amendment, discharge or change is sought. This Agreement is
not assignable by the Advisor without the prior written consent of
the Company, which such consent may not be forthcoming; provided,
that for the avoidance of doubt, assignment by Advisor of one or
more advisory services to its employees or affiliates shall not
constitute a violation of this Agreement.
8. Confidentiality.
(a) The parties agree
that the terms, conditions, and subject matter of this Agreement
constitute confidential and proprietary information belonging to
each party. Each party agrees not to divulge any confidential and
proprietary information pertaining to the other party or this
Agreement to any third party without prior written consent of the
other party. Each party shall take all lawful measures to prevent
the unauthorized use and/or disclosure of such confidential
information, and to prevent unauthorized persons or entities from
obtaining or using such information. Each party further agrees to
refrain from directly or indirectly taking any action, which would
constitute or facilitate the unauthorized use or disclosure of such
confidential information. Each party may disclose such confidential
and proprietary information to its officers, directors, employees,
agents, and authorized representatives to the extent necessary to
enable such party to perform its obligations under this Agreement;
provided said officers, directors, employees, agents, and/or
authorized representatives agree to abide by the confidentiality
provisions herein, which by its terms shall be enforceable by
injunctive relief. Each party shall be liable for any unauthorized
use and disclosure of such confidential information by its
officers, directors, employees, agents, and authorized
representatives, including without limitation its attorneys and
accountants. Each party further agrees that any breach or
threatened breach of this Section 8 would cause irreparable harm to
the other party, that a remedy at law or in damages would be
inadequate, and that the provisions of this Section 8 may be
enforced by way of injunctive relief in addition to any other
rights available to such party in law or in equity.
(b) For purposes of
this Agreement, “confidential and proprietary
information” includes, but is not limited to, the terms,
conditions, and subject matter of this Agreement, and such
party’s business, including any financial, cost, pricing, and
royalty information; product development, business, marketing,
promotion, distribution, sales, sales plans, and strategies;
information concerning such party’s product development and
intellectual property or trade secrets. The foregoing
confidentiality obligations shall not apply to information that:
(1) was previously known to the recipient free of any obligation to
keep it confidential; (2) was independently developed by recipient;
or (3) is or becomes publicly available by means other than the
unauthorized disclosure by recipient.
(c) In the event any
judicial or regulatory authority requests or requires disclosure of
any confidential information of the other party, the receiving
party shall promptly notify the disclosing party of the requested
or required disclosure and shall cooperate with the disclosing
party in any effort to avoid or limit such disclosure.
9. Indemnity;
Insurance.
(a) Indemnity. The Company shall
indemnify, defend and hold Advisor and its affiliates harmless, at
Company’s own expense, from and against any and all losses,
liability, obligations, damages, third-party claims, demands,
causes of action, costs and expenses of whatever form or nature
(each a “Claim”
and collectively, “Claims”), including reasonable
outside attorney’s fees and other costs of legal defense,
arising out of or related to: (i) the Advisor’s rendering of
Services under this Agreement; (ii) an actual or alleged breach of
any of the representations, warranties or covenants of this
Agreement by the Company; (iii) the Company’s negligence,
willful misconduct, or willful misrepresentation; or (iv) any other
act or omission by or attributable to Company in connection with
this Agreement except to extent such indemnity is prohibited by
law. Company shall give prompt written notice to the Advisor of any
proposed settlement of any Claim. Company may not, without the
Advisor’s prior written consent, which the Advisor shall not
unreasonably withhold, condition or delay, settle or compromise any
claim or consent to the entry of any judgment regarding which
indemnification is being sought hereunder unless such settlement,
compromise or consent: (X) includes an unconditional release of the
Advisor from all liability arising out of such claim; (Y) does not
contain any admission or statement suggesting any wrongdoing or
liability on behalf of the Advisor; and (Z) does not contain any
equitable order, judgment or term (other than the fact of payment
or the amount of such payment) that in any manner affects,
restrains or interferes with the business of the Advisor. The
indemnity contained in this Section 9(a) shall not apply to any
such losses, claims, related expenses, damages or liabilities
arising out of gross negligence, willful misconduct or fraud of the
Advisor, or a material breach of the Advisor’s
representations and warranties hereunder.
(b) Exculpation. Notwithstanding
anything to the contrary herein, the Advisor shall, to the greatest
extent permitted by law at the time this clause is construed, be
exculpated from any liability whatsoever for any alleged abuse of
discretion, tort, breach of fiduciary duty and/or breach of trust
caused by any act or omission in connection with this Agreement. As
a consequence, the Advisor shall under no circumstances ever be
held personally liable to any other person, firm or corporation for
any damages directly or indirectly arising out of any act or
omission committed in connection with this Agreement. This
exculpation shall not, however, protect the Advisor from any
liability for a breach of trust committed intentionally or in bad
faith. Even if this Section 9(b) shall not protect the Advisor due
to the foregoing sentence, in no event shall the Advisor ever be
liable for any punitive or exemplary damages for any act or
omission committed in connection with this Agreement hereunder
regardless of whether such act or omission constituted an act
committed intentionally or in bad faith.
(c) Insurance. The Company
represents that it has obtained, and agrees to maintain, at its own
expense, in full force and effect at all times during which the
Company’s products are being manufactured, sold, and
distributed, insurance for bodily injury, advertising injury,
property damage, and product liability from a recognized insurance
company approved by Advisor, which is qualified to do business in
the State of California, providing protection at least in the
amount of $5,000,000 per occurrence and $5,000,000 in the aggregate
for the Company and for the Advisor against any actions, claims,
demands, lawsuits, loss, costs, attorneys’ fees, damages,
judgments, and liabilities of any nature whatsoever relating to
such products. Any proposed change in certificates of insurance
shall be submitted to the Advisor for its prior written approval.
The Advisor shall be entitled to a copy of the prevailing
certificate of insurance, which shall be furnished to the Advisor
by the Company. The certificate(s) shall conform to the language
requirements set out in Exhibit C attached hereto. For
purposes of this Section 9(c), the term “Advisor” shall
mean the Advisor and, without limitation, any of their agents,
employees, servants, representatives, parents, subsidiaries,
affiliates, officials, directors, officers, shareholders, owners,
attorneys, divisions, branches, units, affiliated organizations,
successors, predecessors, contractors, assigns, and all persons
acting by, through, under, or in concert with them, past or
present.
10. Waiver.
Unless agreed in writing, the failure of either party, at any time,
to require performance by the other of any provisions hereunder
shall not affect its right thereafter to enforce the same, nor
shall a waiver by either party of any breach of any provision
hereof be taken or held to be a waiver of any other preceding or
succeeding breach of any term or provision of this Agreement. No
extension of time for the performance of any obligation or act
shall be deemed to be an extension of time for the performance of
any other obligation or act hereunder.
11. Notices.
All notices, demands or other communications given hereunder shall
be in writing and shall be deemed to have been duly given on the
day when delivered in person or transmitted by confirmed facsimile
transmission or on the third (3rd) calendar day after being mailed
by United States registered or certified mail, return receipt
requested, postage prepaid, to the addresses hereinabove first
mentioned or to such other address as any party hereto shall
designate to the other for such purpose in the manner herein set
forth.
12. Entire
Agreement. This
Agreement contains all of the understandings and agreements of the
parties with respect to the subject matter discussed herein. All
prior agreements, whether written or oral, are merged herein and
shall be of no force or effect.
13. Survival.
Any termination of this Agreement shall not, however, affect the
ongoing provisions of this Agreement which shall survive such
termination in accordance with their terms.
14. Severability.
The invalidity, illegality or unenforceability of any provision or
provisions of this Agreement will not affect any other provision of
this Agreement, which will remain in full force and effect, nor
will the invalidity, illegality or unenforceability of a portion of
any provision of this Agreement affect the balance of such
provision. In the event that any one or more of the provisions
contained in this Agreement or any portion thereof shall for any
reason be held to be invalid, illegal or unenforceable in any
respect, this Agreement shall be reformed, construed and enforced
as if such invalid, illegal or unenforceable provision had never
been contained herein.
15. Governing
Law.
(a) This Agreement
shall be construed in accordance with and the laws of the State of
California which shall govern all disputes relating hereto without
giving effect to any conflicts of law provisions. The parties agree
that any disputes, controversies or claims arising out of,
regarding, or in any way relating to the interpretation,
application, or enforcement of this Agreement, or any matter
reasonably related thereto, shall be handled by way or arbitration
and administered by and in accordance with the JAMS streamlined
Arbitration Rules and Regulations (the ''JAMS Rules
'') of the Judicial Arbitration and Mediation Service in effect at
the time of any such proceedings. Such arbitration shall be the
sole, exclusive, and final remedy for resolving any such claims and
disputes. Judgment on the final award rendered by the arbitrator
may be entered into in any court of competent jurisdiction and
shall be final and binding upon the parties.
(b) Notwithstanding the
foregoing, the parties may seek provisional relief, including a
preliminary injunction or temporary restraining order, in any
federal or state court of competent jurisdiction located in Los
Angeles, California, without prejudice to the above described
arbitration procedures, if in that parties sole judgment such
provisional relief is necessary to avoid an irreparable injury or
to preserve the status quo. Never the less, the arbitration
procedure set forth in this Section 15 is intended to be the sole
and exclusive method of resolving any claims arising out of,
relating to, or regarding this Agreement.
16. Enforcement.
Any suit, action or proceeding with respect to this Agreement shall
be brought in the state or federal courts located in Los Angeles
County in the State of California. The parties hereto hereby accept
the exclusive jurisdiction and venue of those courts for the
purpose of any such suit, action or proceeding. The parties hereto
hereby irrevocably waive, to the fullest extent permitted by law,
any objection that any of them may now or hereafter have to the
laying of venue of any suit, action or proceeding arising out of or
relating to this Agreement or any judgment entered by any court in
respect thereof brought in Los Angeles County, California, and
hereby further irrevocably waive any claim that any suit, action or
proceeding brought in Los Angeles County, California has been
brought in an inconvenient form.
17. Binding
Nature. The terms and provisions of this Agreement shall be
binding upon and inure to the benefit of the parties, and their
respective successors and assigns.
18. Counterparts.
This Agreement may be executed in any number of counterparts,
including facsimile signatures which shall be deemed as original
signatures. All executed counterparts shall constitute one
agreement, notwithstanding that all signatories are not signatories
to the original or the same counterpart.
[signature page
follows]
IN WITNESS WHEREOF, the parties hereto
have executed this Agreement as of the date first above
written.
Company:
Formula
Four Beverages Inc.
By: /s/
Blair Bentham May 9, 2017
Name:
Blair Bentham
Title:
CEO
Advisor:
I|M1,
LLC
By:
Stephen Roseberry
Name:
Stephen Roseberry
Title:
President
Encore
Endeavor 1, LLC
By:
Stephen Roseberry
Name:
Stephen Roseberry
Title:
President
EXHIBIT A
Strategic Alignment Deliverables
INFLUENCER MARKETING / ADVERTISING
●
OXiGEN to work with
Advisors on influencer program. OXiGEN’s presence at upcoming
events; and
●
Advisor to assist
with obtaining best paid advertising rates through its current
partners that are deemed relevant to OXiGEN.
OXiGEN REPRESENTATION BY ADVISOR
●
Advisor, to
include, when appropriate, the OXiGEN story in media opportunities;
and
●
Advisor, when
possible, will incorporate social media posts directly related to
OXiGEN in the social channels.
PRODUCTION ASSETS
●
Advisor in
cooperation with other service providers and OXiGEN to lead the
initiative to create a 5-6 minute video telling the story and
vision of OXiGEN;
●
Advisor in
cooperation with other service providers and OXiGEN will assist
with production resources/facilities at agreed upon times/dates;
and
●
Advisor in
cooperation with other service providers and OXiGEN, will assist
with producing broadcast materials and other visuals for the brand
which may be used globally.
DISTRIBUTION
●
Advisor will
mutually endeavor to enhance OXiGEN’s sales/distribution
networks;
●
Advisor will
mutually endeavor to enhance OXiGEN’s retail accounts;
and
●
Advisor will
mutually endeavor to enhance OXiGEN’s key product
alignment/placement with various entities.
EXHIBIT B
Standard Terms & Conditions
1.
Likeness & Promotional Materials
1.1.1.
Company
acknowledges the good reputation of the Advisor and its affiliates,
and further acknowledges that all uses of the Advisor’s or
its affiliate’s name, photographic image, and
non-photographic likeness manufactured, distributed, and/or
exploited by Company (collectively “Likenesses”) will be utilized in
such a manner as to enhance the reputation and recognition of the
Advisor and its affiliates to the mutual benefit of the parties and
shall be subject advanced approval by the Advisor as provided
hereunder. The quality of each Likeness shall be suitable for the
use for which they are intended.
1.1.2.
All Likenesses
developed hereunder, and all brochures, publications, printed
matter, advertising, signs, promotional displays, websites,
webpages, video and sound recordings, online social media pages
(hereinafter the “Promotional
Materials”) and other forms of advertising,
promotional, and/or publicity material in connection with the
Services, shall be subject to the Advisor’s written approval
in advance of use, distribution, marketing or sale. Without cost to
the Advisor, Company shall submit to the Advisor for its inspection
and approval, at least three (3) samples of each Likeness and/or
Promotional Material prior to any use, marketing, advertising, sale
or other distribution to the public (each a “Sample”). In lieu of submitting
three (3) Samples of the Likenesses and/or Promotional Materials
under this Paragraph, Company may submit either a computer diskette
or e-mail attachment containing a depiction of one (1) Sample for
the Advisor’s inspection and approval. The Advisor’s
representative, or any duly authorized representative of the
Advisor designated by it in writing, shall have TEN (10) BUSINESS
DAYS from the Advisor’s confirmed receipt of the supplied
Samples to approve or reject in writing such samples. If any such
time period lapses without Company receiving express written
approval or rejection of the supplied Samples, the Samples will be
deemed approved by the Advisor, provided that copies of all
correspondence accompanying the Samples are submitted or sent to
the Advisor’s counsel in accordance with the notice
provisions of Section 7 of this Exhibit B. Company shall not
distribute, market and/or exploit any Likeness or Promotional
Material until Company has received the Advisor’s written
approval of the Sample.
1.1.3.
All materials
submitted for approval to the Advisor in a language other than
English will be accompanied by a complete and accurate English
translation.
1.1.4.
In addition to the
standards required above, Company acknowledges the great value of
the goodwill associated with Advisor, and Company agrees that it
will not use the Likenesses or Promotional Material in any manner
which, directly or indirectly, would demean, ridicule or otherwise
tarnish the reputation or image of the Advisor. Without limiting
the foregoing, (i) all Likenesses and Promotional Materials shall
in all respects be manufactured, marketed and distributed in a
manner consistent with the high quality standards and image of the
Advisor, and (ii) Company shall not permit the manufacture,
marketing or distribution of any Promotional Material or any other
material in connection with the rendering of Services that
represents, depicts or promotes (a) the glorification of violence,
including but not limited to any representations of gang- or
terrorist-related imagery, firearms or explosive devices, (b)
sexual activities, including but not limited to any representations
of body parts or sex toys, (c) religious beliefs, including but not
limited to any religious iconography or any image commonly
associated with any religious organization or cult, (d) any
political content, (e) tobacco, alcohol or drug use, or (f)
personal hygiene.
2.
Travel &
Expenses. If the Advisor elects to travel in connection with
the rendering of Services as provided in Section 1 of the
Agreement, all travel, lodging, meals, and related incidental
expenses incurred by the Advisor and by all traveling companions
the Advisor reasonably requires for any personal appearances
provided in this Agreement shall be paid by Company. The Advisor
and the traveling companions she reasonably requires shall either
travel via private plane or first class air and with
portal-to-portal SUV ground transportation. If private plane travel
is used, Company shall pay the round trip fuel costs and landing
fees for the relevant flight, and if airline travel is used, then
Company shall pay for first class air travel. The Advisor or its
affiliates and the traveling companions reasonably requires shall
be lodged in first class hotel accommodations (i.e., a 5-star or
comparable with suite amenities and accommodations), and each shall
be provided with all meals in connection with such appearances.
Company and the Advisor acknowledge that it will be appropriate to
establish a budget in advance of any such travel approved by the
Advisor and takes into account the Advisor’s comfort, support
and other reasonable needs and those of her travelling companions.
All travel and expenses shall be subject to preapproval by the
Company.
3.
Recording &
Filming. Except as provided herein, under no circumstance
shall any recording be made by Company in any manner whatsoever,
whether on video or audio tape, film, celluloid, and/or by any
other means possible, of the Advisor in connection with any
appearance provided under this Agreement or otherwise, including
without limitation all personal appearances and photo sessions,
without the prior written approval of the Advisor. Should the
Advisor approve any such recording of any appearance in connection
herewith, said recording shall be contracted for under “work
for hire” provisions and all rights, including the copyright,
related to said recording, shall belong solely to the Advisor and
are hereby assigned to the Advisor. If Company uses the services of
anyone other than its employees to make any such recording, Company
shall obtain written assignments to the Advisor of all copyright
and other rights in any recordings, negatives, or any other
materials bearing the Advisor’s image and/or voice. It is
further agreed that any such recording of the Advisor, which
Company desires to use for any purpose whatsoever, shall be
submitted to the Advisor for its absolute written approval prior to
any use thereof. In addition to approving the recording itself, the
intended use must also be approved in writing by the Advisor prior
to any use thereof. Company further agrees to pay the
Advisor’s Screen Actors Guild union costs (including
applicable scale compensation and pension, health, and welfare
benefits based thereon) that are attributable to the Advisor
directly in connection with her work for or with Company and her
paid broadcasts in any media.
4.
Good Will.
Company recognizes the great value of the good will associated with
the Advisor’s name and likeness and, consistent with its
general operations, will take all commercially reasonable steps to
enhance the reputation of the Advisor and the good
will.
5.
Consultation.
The Advisor and Company agree to have meaningful consultation with
each other regularly throughout the term of this Agreement and any
renewal or extension thereof. The parties agree that the purpose of
the consultation will be to discuss methods and strategies to
develop, promote, and expand the Advisor brand and image for the
mutual benefit of Company and the Services contemplated hereunder.
To attain this mutual goal, the Advisor or its designees agrees to
meet in person from time to time as may be reasonably appropriate
throughout the calendar year in conformity with mutually agreed
upon schedules to discuss the Services and to solicit input and
ideas from the Advisor or its designees. The Advisor acknowledges
that Company or a parent of Company may be required or may deem it
appropriate to issue press releases relating to periodic
developments and the Advisor agrees that it will either approve or
disapprove any such press release containing references to the
Services, provided that (a) the Advisor shall deliver its
suggestions, corrections or other comments to Company regarding the
press release with in one business day of receipt; (b) both Company
and the Advisor Company shall diligently thereafter work together
to assure a final version of the press release within the five (5)
business days following submission to and receipt by the Advisor;
and (c) if Company has made the requested corrections or changes
agreed upon or if not otherwise disapproved in writing shall be
deemed approved at the end of seven (7) business days following the
initial submission to and receipt by the Advisor. Any disapproval
from the Advisor shall he accompanied by constructive requests for
changes to be made in order for approvals to be given.
6.
Preferred
Vendors. The parties further agree that the Advisor may from
time to time recommend sub-contractors, vendors, and/or
manufacturers to Company that Company will consider in good faith.
Company will use commercially reasonable efforts to use the
sub-contractors, vendors, and/or manufacturers suggested by the
Advisor.
7.
Notices.
Any notice, communication, statement, payment, or legal service of
process required or permitted under this Agreement shall be in
writing and shall be effective when hand delivered; or on the date
when the notice, communication, statement, payment, or legal
service of process is transmitted by confirmed electronic facsimile
(with a confirmation copy sent by mail); or the day after the
notice, communication, statement, payment, or legal service of
process is sent by reputable overnight air courier service (e.g.,
Federal Express). All such communications shall be sent to the
parties at the notice addresses listed below or to such other
persons and the parties to each other may designate notice
addresses as in writing.
If to
Advisor:
|
Level
Brands, Inc.
4521
Sharon Road, Ste 450
Charlotte,
NC 28211
Attention:
Mark Elliott, CFO
Email:
mark@levelbrands.com
|
With a
copy to:
|
Stephen
Roseberry
Sterling/Winters
PO Box
#1410
Rancho
Mirage, CA 92270
sroseberry@sterlingwinters.com
|
With a
second copy to:
|
Paul
Porter, Esq.
4521
Sharon Road, Ste 450
Charlotte,
NC 28211
pporter@sstreetllc.com
|
If to
Company:
|
Formula
Four Beverages Inc.
World
Trade Centre, 999 Canada Place, Suite 404, Vancouver, BC, Canada
V6C 3E2
Telephone:
604-283-1005 ext. 109
Telecopier:
604-648-9183
Attention:
Blair Bentham
Email:
blair.bentham@formula-four.com
Attention:
Scott Ogilvie
Email:
scott.ogilvie@formula-four.com
|
With a
copy to:
|
Matthew
Peters
McCarthy
Tetrault, LLP
745
Thurlow Street, Suite 2400
Vancouver,
BC, Canada, V6E 0C5
Telephone:
604-643-7162
Email:
mpeters@mccarthy.ca
|
8.
No
Relationship. The Advisor is an independent contractor.
Nothing contained herein shall be deemed to create an agency, joint
venture, franchise, or partnership relation between the parties,
and neither party shall so hold itself out. Company shall have no
right to obligate or bind the Advisor in any manner whatsoever, and
nothing contained in this Agreement shall give, or is intended to
give, any rights of any kind to any third person(s).
9.
Equitable
Relief. The parties acknowledge that the subject matter of
this Agreement relates to services and rights, which are
extraordinary and unique and which cannot be replaced or adequately
compensated in money damages, and any breach by Company of the
Standard Terms and Conditions of this Exhibit B will cause
irreparable injury to the Advisor.
10.
Protection.
Company agrees that during the term of this Agreement, or
thereafter, it will not register or attempt to register any of
trademarks, copyrights, or patents including or incorporating any
aspect of the Advisor’s name, likeness, or trademarks, nor
will Company form or incorporate any entity under a name that
includes such name, likeness, or trademarks. Company will not
attack the title or any rights of the Advisor in and to any
trademarks registered or controlled by the Advisor or attack the
validity of this Agreement and further acknowledges the goodwill
inherent to the Advisor’s name, likeness, and related
trademarks.
11.
Code of Conduct and
Millennium Development Goals. The Company agrees to (a) the
Human Rights - Code of Conduct, attached to these Standard Terms
and Conditions as Attachment 1 hereto,
incorporated herein by this reference, with respect to which
Company agrees to fully comply; and (b) the Millennium Development
Goals, attached to these Standard Terms and Conditions as
Attachment 2,
incorporated herein by reference, with respect to which the Company
agrees to fully adopt, as well as meaningfully contribute to, one
or more of such goals either economically or through other Company
resources. Advisor reserves the right to amend and update
Attachment 1 and
Attachment 2 from
time to time upon written notice to the Company of such
changes.
ATTACHMENT 1
To
Standard Terms and Conditions
CODE OF CONDUCT
行为守则
1.
PURPOSE:
The Company is committed to using only manufacturers to strive to
conduct business in a highly professional and ethical manner. This
document outlines those commitments each facility makes in respect
to its compliance with applicable law and tis personal practices
and policies.
目的:[被许可人]承诺只使用了力争在一个高度专业和道德的方式开展业务的厂家。本文概述了这些各设施使得在尊重其遵守适用的法律和个人的做法和政策的承诺。
2.
CHILD
LABOR: The facility agrees not to use child labor in the
manufacturing, or distribution of the Goods. The term
“child” refers to a person younger than the local legal
minimum age for employment or the age for completing compulsory
education; provided, however, in no event shall the Facility use
any person below the age of (15) fifteen. The Facility also agrees
to comply with all other Laws applicable to employees, regardless
of the age of an employee.
童工:该中心同意不使用童工在制造,或货物配送。
“童工”是指一个人年龄低于当地法定最低就业年龄或年龄在完成义务教育;
提供的,但是,在任何情况下,基金使用任何人(15)15岁以下。该基金还同意遵守适用于所有员工的其他法律,不论雇员的年龄。
3.
FORCED
LABOR: The Facility agrees to employ only persons whose presence is
voluntary. The Facility agrees not to use any forced or involuntary
labor, whether prison, bonded, indentured or
otherwise.
强迫劳动:该基金同意只雇用人员,其存在是自愿的。该基金同意不使用任何强迫或非自愿劳动,无论是监狱,保税,契约或其他方面。
4.
ABUSE
OF LABOR: The Facility agrees to treat each employee with dignity
and respect and not to use corporal punishment, threats of
violence, or other forms of physical, sexual, psychological or
verbal harassment or abuse.
滥用劳动:该基金同意把每个员工的尊严和尊重,不使用体罚,暴力威胁或其他形式的身体,性,心理或言语上的骚扰或虐待。
5.
NON-DISCRIMINATION:
The Facility agrees not to discriminate in hiring and employment
practices, including salary, benefits, advancement, discipline,
termination, or retirement on the basis of race, religion, age,
nationality, social or ethnic origin, sexual orientation, gender,
political opinion or disability.
不歧视:该基金同意不会在雇佣和招聘活动,包括工资,福利,晋升,纪律,终止或退休种族,宗教,年龄,国籍,社会或民族,性取向,性别的基础上歧视,政治观点或残疾。
6.
ASSOCIATION:
The Facility agrees to follow employees to organize and bargain
collectively without penalty or interference in accordance with
local Laws.
关联关系:该基金同意遵守雇员组织和集体谈判不受处罚或干预按照当地的法律。
7.
WAGES,
BENEFITS AND WORKING HOURS: The facility recognizes that wages are
essential to meeting employee’s basic needs. The Facility
agrees to comply, at a minimum, with all applicable wages and hour
Laws, including minimum wage, overtime hours, maximum hours, piece
rates and other elements of compensation and shall provide legally
mandated benefits.
工资,福利和工作时间:该厂认识到,工资是必要的,以满足员工的基本需求。该基金同意遵守,至少,所有适用的工资和工时的法律,包括最低工资,加班,最长工时,计件工资和补偿等内容,并应提供法定福利。
8.
HEALTH
AND SAFETY: The Facility agrees to provide employees with a safe
and healthy workplace environment in accordance with all applicable
Laws, ensuring at a minimum, reasonable access to potable water and
sanitary facilities, fine safety and adequate lighting and
ventilation. The Facility also agrees to ensure that the same
standards of health and safety are applied to any housing it
provides for employees.
健康和安全:该基金同意为员工提供一个安全和健康的工作环境符合所有适用法律,确保在最低限度,合理获得饮用水和卫生设施,精美的安全性和足够的照明和通风。该基金也同意,以确保健康和安全的相同标准适用于它提供了雇员的住房
9.
COMPLIANCE:
The Facility agrees to take appropriate steps to ensure that the
provisions of the COC are communicated to its employees, including
by prominent posting a copy of this COC in the local language on
one or more bulletin boards in places readily accessible to
employees at all times.
合规性:本基金同意采取适当措施,以确保奥委会的规定传达给员工,其中包括由著名张贴在当地语言的一个或多个电子公告板的名额该行为准则的副本容易获得员工的所有次。
10.
ENVIRONMENT:
Business partners should share our concern for the environment and
adhere to their local and national laws regarding the protection
and preservation of the environment.
环境:业务合作伙伴应该分享我们对环境的关注,并坚持对环境的保护和维护当地和国家法律。
11.
LEGAL
REQUIREMENTS: Business partners should be in compliance with all
legal requirements involved in conducting the
business.
法律要求:业务合作伙伴应符合参与开展业务的所有法律要求。
12.
Our Business
Partners are required to provide full access to their facilities
and those of their manufacturers, vendors and subcontractors, and
to release records relating to employment practices. We may conduct
on-site inspections of facilities to monitor the standards and
assure the quality of our products.
我们的业务合作伙伴必须提供完全访问他们的设备和那些他们的制造商,供应商和分包商,并发布有关用工行为记录。我们可以进行现场视察设施,以监控标准,确保了产品的质量。
Please report Violations Anonymously by emailing to:
mark@levelbrands.com
ATTACHMENT 2
To
Standard Terms and Conditions
Millennium Development Goals
1. We
must eradicate extreme poverty and hunger!
2.
Achieve universal primary education.
3.
Promote gender equality and empower women.
4.
Reduce child mortality.
5.
Improve maternal health.
6.
Combat HIV/AIDS, Malaria, and other diseases.
7.
Ensure environmental sustainability.
8. Build global
partnerships for development.
9.
Bring opportunities of financial stability and healthcare to
American Veterans and their families.
10.
Stop Human Trafficking.
EXHIBIT C
Level Brands
REQUIRED INSURANCE CERTIFICATE
Under Description of Operations state the
following:
“Certificate Holder: Level Brands, Inc., Kathy Ireland, kathy
ireland WorldWide, Inc., I|M1, LLC, Encore Endeavor 1, LLC, The
Sterling/Winters Company, and their partners, owners,
subsidiaries, affiliates, directors, officers, managers and
employees are named additional insured with regards to liability
arising out of operations of the named insured.”
The Certificate Holder should be listed as:
Level Brands, Inc.
4521 Sharon Road, Ste. 450
Charlotte, NC 28211
Send copies of Certificate to:
Ben Moore, CIC
BB&T
BDMoore@BBandT.com
Level Brands, Inc.
Mark Elliott
mark@levelbrands.com
Ex. C
– Insurance Coverage
Exhibit 6.32
TERMINATION OF LICENSE AGREEMENT AB INITIO
This
TERMINATION OF LICENSE AGREEMENT AB
INITIO (this “Agreement”)
is by and between I|M 1, LLC, a
California limited liability company (the "Licensor")
and NuGene International, Inc., a Nevada corporation (the
"Licensee").
WHEREAS, the parties entered into that
certain License Agreement on March 31, 2017 (the "License
Agreement") pursuant to which Licensor agreed to grant
Licensee certain non-transferrable rights in connection with
Licensed Marks solely for the sale, marketing and distribution of
the Licensed Products as therein set forth.
WHEREAS, as of the date hereof the
Licensed Marks have not been used, no Licensed Products have been
created, marketed, sold or distributed and no Royalties or other
compensation are due the Licensor under the terms of the License
Agreement.
In
consideration of the mutual covenants and promises contained
herein, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties agree
as follows:
1. Termination
of License Agreement. The
Licensor and Licensee each hereby acknowledge and agree that the License
Agreement is terminated ab initio. No party shall have any rights,
obligations or liabilities to the other party under the License
Agreement. All terms not otherwise defined herein shall have the
same meaning as in the License Agreement.
2. General
Release. Each party hereto, (in such capacity, each a
“Releasor”)
hereby releases and forever discharges the other party hereto,
their respective corporate parents, subsidiaries and affiliates and
each of their respective present and former directors, managing
directors, officers, control persons, stockholders, general
partners, limited partners, employees, agents, attorneys,
administrators, successors, personal representatives, executors and
assigns (collectively, the “Released
Group”) from any and all actions, causes of action,
injunctions, accounts, agreements, bonds, bills, covenants,
contracts, controversies, claims, damages, demands, debts, dues,
extents, executions, judgments, liabilities, obligations, promises,
predicate acts, reckonings, specialties, suits, sums of money, and
variances whatsoever, whether known or unknown, in law or in
equity, which against any of them the Releasor, its corporate
parents, subsidiaries and affiliates and each of their present and
former directors, managing directors, officers, control persons,
stockholders, general partners, limited partners, employees,
agents, attorneys, administrators, successors, personal
representatives, executors and assigns may now have, have ever had,
or may hereafter have against any member of the Released Group
arising out of, or in connection with, or in any manner related to,
the License Agreement (the “Release”);
provided, however, that the
Releasor does not hereby waive, release or discharge the Released
Group from any of its obligations under this
Agreement.
(a) Entire Agreement. This
Agreement sets forth the entire agreement and understanding of the
parties hereto with respect to the subject matter hereof, and
supersedes all prior written and oral statements, including any
prior representation, statement, condition or
warranty.
(b) Counterparts. This Agreement
may be executed simultaneously in multiple counterparts, each of
which shall be deemed an original and all of which, when taken
together, constitute one and the same document. The signature of
any party to any counterpart shall be deemed a signature, and may
be appended, to any other counterpart.
(c) Governing
Law; Attorneys’ Fees. This Agreement shall be governed
in all respects by the laws of the State of North Carolina as
applied to contracts made and to be performed entirely within that
state between residents of that state. Exercise of the rights set
forth in this Agreement shall be subject to and conditioned upon
compliance with applicable laws. In the event that any suit or
action is instituted to enforce any provision of this Agreement,
the prevailing party in such dispute shall be entitled to recover
from the losing party all fees, costs and expenses of enforcing any
right of such prevailing party hereunder, including without
limitation, such reasonable fees and expenses of attorneys and
accountants, which shall include, without limitation, all fees,
costs and expenses of appeals.
IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be duly executed as of the day and
year first above written
I|M 1, LLC,
By: /s/
Mark Elliott
Name:
Mark Elliott
Title:
CFO/COO
Date:
6/8, 2017
NuGene
International, Inc.
By: /s/
M. Ali Kharazmi
Name:
M. Ali Karazmi
Title:
Chairman
Date:
06-08, 2017
Exhibit 6.33
MEMBMERSHIP INTEREST SALE AND PURCHASE AGREEMENT
(Priel Maman)
This
Membership Interest Sale and Purchase Agreement (this
“Agreement”) is
made by and between Priel Maman (the “Seller”), Level Brands, Inc. (the
“Buyer”), and
Beauty and Pin Ups, LLC, a North Carolina limited liability company
(the “Company”),
as of April 26, 2017. The Seller and the Buyer are also referred to
herein individually as a “Party” and collectively as
the “Parties.”
RECITALS
A. The
Seller owns 12% of the Membership Interest (“Subject Interest”) of the Company
under the Company’s Operating Agreement dated as of April 13,
2015 by and among the Buyer and Seller (the “Operating
Agreement”).
B. The
Seller desires to sell the Subject Interest to the Buyer on the
terms set forth below.
C. The
Buyer has agreed to buy the Subject Interest in exchange for
155,294 shares of the Buyer’s Common Stock, and the Parties
desire to set forth the terms and conditions governing the purchase
and sale of the Subject Interest.
AGREEMENT
For and
in consideration of the premises, the mutual agreements and
covenants herein contained, and other good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, the Parties hereby agree as follows:
1. Agreement to Sell
and Purchase the Subject Interest.
a.
Purchase and Sale. In
consideration of, and in express reliance upon, the representations
and warranties of the Seller and the Buyer in this Agreement, the
Seller hereby agrees to irrevocably transfer and convey the Subject
Interest to the Buyer, and the Buyer hereby agrees to pay an
aggregate purchase price for the Subject Interest equal to One
Hundred Fifty-Five Thousand Two Hundred and Ninety Four (155,294)
shares of the Buyer’s Common Stock.
b.
Closing. The closing (the
“Closing”) of
the purchase and sale of the Subject Interest under this Agreement
shall occur simultaneously with the execution of this Agreement by
the Parties.
2.
Representations and
Warranties of Seller. The Seller represents and warrants to
the Buyer that the Seller is the lawful and beneficial owner of the
Subject Interest and has good, valid and marketable title to the
Subject Interest free and clear of all mortgages, liens, pledges,
security interests, charges, claims and other encumbrances and
defects of title of any nature whatsoever, except for applicable
restrictions under U.S. securities laws. The Seller is authorized
to enter into this Agreement and perform Seller’s obligations
hereunder, and no consent of any person is necessary in order for
the Seller to sell, assign and transfer the Subject Interest to the
Buyer.
3.
Representations and
Warranties of Buyer. The Buyer represents and warrants to
the Seller that no person has any right or other claim against the
Buyer for any commission, fee or other compensation as a finder or
broker in connection with the transaction contemplated by this
Agreement. The Buyer is authorized to enter into this Agreement and
perform Buyer’s obligations hereunder, and no consent of any
person is necessary in order for the Buyer to purchase the Subject
Interest.
4.
Waiver, Release and
Non Disparagement.
a.
Waiver and Release by Seller.
For valuable consideration from the Buyer, on behalf of himself,
his spouse, beneficiaries, heirs, administrators, executors,
successors, assigns, agents and representatives (collectively
referred to as the “Releasors”), the Seller hereby
releases and forever discharges the Company and the Buyer, their
subsidiaries, affiliated and related entities, and their past,
present, or future directors, administrators, officers, employees,
agents, attorneys, representatives and assigns (collectively
referred to as the “Releasees”) of and from any and
all claims, actions, causes of action, charges, demands, costs,
attorneys’ fees, losses and any other damages of every kind,
nature and description whatsoever, whenever they arose, which the
Seller has ever had or now may have against the Company or the
Buyer as of the date of this Agreement, including, but not limited
to, all claims that the Seller has, may have or may have had
arising from interactions the Seller may have had with the Company
or the Buyer , any claims for discrimination, harassment or
retaliation, including any and all claims related to workers’
compensation claims and/or retaliation based thereupon, any claims
for breach of contract, wrongful or constructive discharge,
intentional or negligent infliction of emotional distress, failure
to hire, negligent supervision, negligent hiring/training,
defamation, libel, slander, intrusion or invasion of privacy, any
and all other claims arising out of or relating in any way to the
Seller’s consulting arrangement with, and separation from,
the Company and the Buyer, whether under tort or contract, whether
at law or in equity, or whether under statute or otherwise, and all
remedies of any type, including, but not limited to, damages and
injunctive relief. It is the Parties’ intent to release all
claims which can be legally released, but no more than that. The
Seller understands, acknowledges and voluntarily agrees that this
Agreement is a total and complete release by him/her of any and all
claims which he has against the Company, the Buyer and the
Releasees as of the effective date of this Agreement, both known or
unknown, even though there may be facts or consequences of facts
which are unknown to him/her. The Seller further waives and
consents to all provisions set forth in the Operating Agreement to
the extent necessary to effectuate the provisions
hereof.
b.
No Waiver of Future Claims.
Subject to the terms above, the Parties agree that this Agreement
does not constitute a waiver of any rights or claims that may arise
after the date hereof, including but not limited to any claims
related to or arising out of this Agreement.
c.
Nondisparagement. Each Party
hereby agrees that they will not disparage, denigrate or otherwise
communicate in a manner intended to have an adverse effect or
result on, the other Party, their family, affiliates, directors,
officers, stockholders, employees or agents, and not to interfere
with any known and existing contracts involving the other party
which could negatively impact such business
relationship.
a.
The Company hereby
consents to the transfer of the Subject Interest under the terms of
Article V of the Operating Agreement.
b.
This Agreement
contains all of the promises, agreements, conditions, terms,
understandings, warranties and representations of the Parties with
respect to the transactions and business relationships contemplated
thereby and herein, and there are no other promises, agreements,
conditions, understandings, warranties or representations, oral or
written, express or implied, among them other than as set forth in
this Agreement. This Agreement supersedes all prior agreements and
understandings among the Parties with respect to its subject
matter.
c.
This Agreement and
all amendments, modifications, authorizations or supplements to
this Agreement and the rights, duties, obligations and liabilities
of the Parties under such document will be determined in accordance
with the applicable provisions of the laws of the State of North
Carolina, without reference to its doctrines or principles of
conflicts of laws.
d.
The Parties shall
execute and deliver or cause to be executed and delivered such
further instruments and take such other action as any other Party
may require to more effectively carry out the transfer of the
Subject Interest and the consummation of the matters contemplated
by this Agreement
e.
This Agreement will
be binding upon and inure to the benefit of the Parties, their
personal and legal representatives, guardians, successors and
assigns.
f.
Neither Party may
assign this Agreement or any of the rights, interests, or
obligations hereunder without the prior written approval of the
other Party.
g.
This Agreement may
be executed in any number of counterparts and by the parties hereto
in separate counterparts, each of which when so executed and
delivered shall be deemed an original and all of which counterparts
when taken together shall constitute but one and the same
instrument.
h.
This agreement must
be executed in conjunction with the Consulting Agreement
Amendment.
In
Witness Whereof, the Parties have executed and delivered this
Agreement as of the dates set forth above.
Seller:
/s/
Priel Maman
Priel
Maman
Buyer:
Level
Brands, Inc.
/s/
Mark Elliott
Mark
Elliott, CFO
Company:
Beauty and Pin Ups, LLC, by its
Manager,
Level
Brands, Inc.
/s/
Mark Elliott
Mark
Elliott, CFO
Exhibit 6.34
DEBT CONVERSION AGREEMENT
THIS DEBT CONVERSION AGREEMENT, dated as
of May 15, 2017 (this “Agreement”), by and among
Level Brands, Inc., a North Carolina corporation (the
“Company”)
and LBGLOC, LLC, a North Carolina limited liability company (the
"Lender").
Capitalized terms used herein and not otherwise defined shall have
the meanings ascribed to such terms in the Loan Agreement (as
defined herein).
WHEREAS, on August 7, 2017 the Company
and the Lender entered into that certain Revolving Line of Credit
Loan Agreement (the "Loan
Agreement") pursuant to which the Lender agreed to lend the
Company up to $1,000,000 to be evidenced by a promissory note (the
"Note") and
secured by a security interest (the "Security
Interest") in the Company's inventory, accounts receivable,
rights to payment and such other property as described in the
Security Agreement of even date therewith (the "Collateral");
WHEREAS, the Company owes the Lender
$770,000 in principal and accrued but unpaid interest (the
"Loan
Balance") under the terms of the Loan Agreement and
Note;and
WHEREAS, the Company is desirous of
converting the Loan Balance into shares of the Company's common
stock subject to the terms of this Agreement and the Lender has
agreed to such conversion.
NOW, THEREFORE, in consideration of the
premises and the representations, warranties and agreements
contained herein, the parties hereto agree as follows:
1. Conversion; Lockup
Agreement.
(a) Contemporaneously
with the execution and delivery of this Agreement, the Loan Balance
is hereby converted into 194,936 shares of the Company’s
common stock (the “Shares”) at a conversion
price of $3.95 per Share (the “Conversion”).
Immediately following the execution of this Agreement by the
parties hereto, the Lender shall tender the original Note to the
Company for cancellation and the Company shall issue the
certificate representing the Shares to the Lender. Notwithstanding
the foregoing or anything to the contrary contained herein, upon
the execution of this Agreement by the Lender, the full amount of
the principal amount of the Note and the accrued but unpaid
interest due thereunder shall automatically convert into the
Shares, without any further action required by the Lender, and the
Security Interest in the Collateral is immediately released. The
parties acknowledge the delivery of the original Note for
cancellation is only for a matter of administrative maintenance,
and that the Company shall file an amendment to any financing
statements filed by the Lender acknowledging the release of all
liens on the Collateral.
(b) As
a condition of the Conversion, the Lender shall execute and deliver
to the Company to be held by it pending the effectiveness of its
registration statement for an initial public offering of its
securities an irrevocable lockup agreement for the benefit of
Joseph A. Gunnar & Co. in the form attached hereto as
Exhibit A and
incorporated herein by such reference, to be dated and released by
the Corporation at such time as it deems appropriate without any
further action or consent of the Lender.
(c) The
parties intend that the issuance of the Shares pursuant to the
terms of this Agreement is an exempt issuance under the Securities
Act of 1933, as amended (the "Securities
Act") in reliance on exemptions provided by Section 3(a)(9)
and 4(a)(2) of such act. The certificate representing the Shares
shall bear the following legends:
"THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED ("1933
ACT"), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD OR
OTHERWISE TRANSFERRED OR DISPOSED OF EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT AND ANY
APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL
SATISFACTORY TO COUNSEL TO LEVEL BRANDS, INC. THAT AN EXEMPTION
FROM REGISTRATION UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES
LAWS IS AVAILABLE."
"THE
SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP
AGREEMENT FOR THE BENEFIT OF LEVEL BRANDS, INC. AND JOSEPH A.
GUNNAR & CO., LLC AND CANNOT BE SOLD, ASSIGNED, TRANSFERRED,
PLEDGED OR OTHERWISE HYPOTHECATED EXCEPT PURSUANT TO THE TERMS OF
SUCH LOCK-UP AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL
OFFICES OF LEVEL BRANDS, INC."
2. Representations
and Warranties of the Company.
The Company represents and warrants to the Lender as of the date
hereof as follows:
(a) Due
Organization. The Company is
duly organized, validly existing and in good standing under the
laws of the jurisdiction of its organization.
(b) Due
Authorization; Binding Agreement; No Conflicts. The Company has full right, power and authority
to execute and deliver this Agreement and to consummate the
transactions contemplated hereby. This Agreement has been duly and
validly authorized, executed and delivered by the Company and
(assuming due authorization, execution and delivery by the Lender)
constitutes the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar laws
relating to or affecting creditors’ rights generally, and
general equitable principles (whether considered in a proceeding in
equity or at law). Neither this Agreement nor the consummation of
the Conversion will violate, conflict with or result in a breach of
or default under (i) the articles of incorporation or bylaws
of the Company, (ii) any agreement or instrument to which the
Company is a party or by which the Company or any of its assets are
bound, or (iii) any laws, regulations or governmental or
judicial decrees, injunctions or orders applicable to the
Company.
(c) Validity
of Shares. The Shares issued
pursuant to this Agreement, will be duly and validly issued, fully
paid and non-assessable.
4. Representations
and Warranties of the Lender.
The Lender hereby represents and warrants to the Company as of the
date hereof as follows:
(a) Due
Organization. The Lender is a
legal entity, it is duly organized and validly existing under the
laws of the jurisdiction of its organization.
(b) Due
Authorization; Binding Agreement. The Lender has full right, power and authority
to execute and deliver this Agreement and to consummate the
transactions contemplated hereby. This Agreement has been duly and
validly authorized, executed and delivered by the Lender and
(assuming due authorization, execution and delivery by the Company)
constitutes the valid and binding obligation of the Lender
enforceable against the Lender in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar laws
relating to or affecting creditors’ rights generally, and
general equitable principles (whether considered in a proceeding in
equity or at law).
(c) Investment
Intent. The Shares to be
acquired by the Lender pursuant to this Agreement shall be acquired
for the Lender’s own account and not with a view to, or
intention of, distribution thereof in violation of the Securities
Act or any applicable state securities laws, and such Shares shall
not be disposed of in contravention of the Securities Act or any
applicable state securities laws.
(e) Accredited
Investor. The Lender is an
“accredited investor” as defined in Rule 501 under
Regulation D of the Securities Act. The Lender is able to bear the
economic risk of its investment in the Shares for an indefinite
period of time and acknowledges that no public market exists for
the Shares and that there is no assurance that a public market will
ever develop for the Shares. The Shares have not been registered
under the Securities Act and, therefore, cannot be sold unless
subsequently registered under the Securities Act or an exemption
from such registration is available. The Lender understands that
the tax consequences of the Conversion may be complex, and
accordingly the Lender represents and warrants that it has
consulted with its own independent tax advisor concerning the
Conversion and is not relying on the Company or any of its
respective affiliates or agents, including its counsel and
accountants, for any tax advice regarding the tax consequences of
the Conversion or any other transactions contemplated by this
Agreement.
(f) Information.
The Lender has reviewed, or has had the opportunity to review, with
the assistance of professional and legal advisors of its choosing,
sufficient information and has had sufficient access to the Company
necessary for the Lender to decide to convert the Loan Balance for
Shares in accordance with this Agreement.
4. General
Provisions.
(a) Closing.
The closing of the transactions contemplated by this Agreement
shall occur simultaneously with the execution and delivery of this
Agreement.
(b) Amendments,
Etc. No amendment,
modification, termination, or waiver of any provision of this
Agreement, and no consent to any departure by the Lender or the
Company from any provision of this Agreement, shall be effective
unless it shall be in writing and signed and delivered by the party
sought to be bound, and then it shall be effective only in the
specific instance and for the specific purpose for which it is
given.
(c) Disclosure.
Nothing contained in this Agreement shall be construed to limit the
Company or the Lender from making such disclosures as may be
required by law.
(d) Notice.
All notices and other communications hereunder shall be in writing
and shall be deemed given if delivered personally, telecopied (with
confirmation), mailed by registered or certified mail (return
receipt requested) or delivered by an express courier (with
confirmation) to the Company at 4521 Sharon Road, Suite 407,
Charlotte, NC 28211, Attention: CFO, and to the Lender to Martin
Sumichrast.
(e) Severability.
Any term or provision of this Agreement which is invalid or
unenforceable in any jurisdiction shall, as to that jurisdiction,
be ineffective to the extent of such invalidity or unenforceability
without rendering invalid or unenforceable the remaining terms and
provisions of this Agreement or affecting the validity or
enforceability of any of the terms or provisions of this Agreement
in any other jurisdiction.
(f) Governing
Law. This Agreement shall be
governed by, and construed in accordance with, the laws of the
State of North Carolina.
(g) Entire
Agreement. This Agreement
embodies the entire agreement and understanding of the parties with
respect to the subject matter hereof and thereof, and supersedes
all prior agreements or understandings, with respect to the subject
matter of this Agreement.
(h) Specific
Performance; Enforcement. Each of the parties hereto
recognizes and acknowledges that a breach by it of any covenants or
agreements contained in this Agreement will cause the other party
to sustain damages for which it would not have an adequate remedy
at law for money damages, and therefore, each of the parties hereto
agrees that in the event of any such breach the aggrieved party
shall be entitled to the remedy of specific performance of such
covenants and agreements and injunctive and other equitable relief
in addition to any other remedy to which it may be entitled at law
or in equity. The parties agree that they shall be entitled to
enforce specifically the terms and provisions of this Agreement in
addition to any other remedy to which they may entitled at law or
in equity.
(i) Counterparts;
Facsimile. This Agreement may
be executed in counterparts, all of which shall be considered one
and the same agreement, and shall become effective when
counterparts have been signed by each of the parties and delivered
to the other parties, it being understood that all parties need not
sign the same counterpart. This Agreement may be executed by
facsimile signatures of the parties hereto.
(j) Expenses.
All fees and expenses with respect to the negotiation of this
Agreement and the consummation of the transactions contemplated
hereby shall be borne by the party incurring such fees and
expenses. Neither the Company nor the Lender is a party to any
agreement, whether written or oral, which provides for the payment
of any brokerage or finder’s fees or commissions to any
broker, financial advisor or consultant, finder, placement agent,
investment banker, bank or other person with respect to the
transactions contemplated by this Agreement.
[signature page to follow]
IN WITNESS WHEREOF, the parties have
caused this Agreement to be executed on its behalf as of the date
first written above.
Level
Brands, Inc.
By: /s/
Mark Elliott
Name:
Mark Elliott
Title:
Chief Operating Officer and Chief Financial Officer
LBGLOC,
LLC
By: /s/
Martin Sumichrast
Name:
Martin Sumichrast
Title:
Manager
Exhibit A
LOCK-UP
LETTER AGREEMENT
Joseph
Gunnar & Co., LLC
30
Broad Street, 11th Floor
New
York, NY 10004
As
Representative of the several Underwriters named on Schedule 1 to
the Underwriting Agreement referenced below
Ladies
and Gentlemen:
The
undersigned understands that you (the “Representative”)
and certain other firms (the “Underwriters”)
propose to enter into an Underwriting Agreement (the
“Underwriting
Agreement”) providing for the purchase by the
Underwriters of shares (the “Stock”) of
Common Stock, par value $0.001 per share (the “Common
Stock”), of Level Brands, Inc., a North Carolina
corporation (the “Company”), and
that the Underwriters propose to reoffer the Stock to the public
(the “Offering”).
In
consideration of the execution of the Underwriting Agreement by the
Underwriters, and for other good and valuable consideration, the
undersigned hereby irrevocably agrees that, without the prior
written consent of the Representative, on behalf of the
Underwriters, the undersigned will not, directly or indirectly, (1)
offer for sale, sell, pledge, or otherwise transfer or dispose of
(or enter into any transaction or device that is designed to, or
could be expected to, result in the transfer or disposition by any
person at any time in the future of) any shares of Common Stock
(including, without limitation, shares of Common Stock that may
bedeemed to be beneficially owned by the undersigned in accordance
with the rules and regulations of the Securities and Exchange
Commission and shares of Common Stock that may be issued upon
exercise of any options or warrants) or securities convertible into
or exercisable or exchangeable for Common Stock, (2) enter into any
swap or other derivatives transaction that transfers to another, in
whole or in part, any of the economic benefits or risks of
ownership of shares of Common Stock, whether any such transaction
described in clause (1) or (2) above is to be settled by delivery
of Common Stock or other securities, in cash or
otherwise, (3) except as
provided for below, make any demand for or exercise any right or
cause to be filed a registration statement, including any
amendments thereto, with respect to the registration of any shares
of Common Stock or securities convertible into or exercisable or
exchangeable for Common Stock or any other securities of the
Company, or (4) publicly disclose the intention to do any of the
foregoing for a period commencing on the date hereof and ending on
the 180th day after the date of the Prospectus relating to the
Offering (such 180-day period, the “Lock-Up
Period”).
The
foregoing paragraph shall not apply to (a) transactions relating to
shares of Common Stock or other securities acquired in the open
market after the completion of the Offering, provided that no filing under Section
16(a) of the Securities Exchange Act of 1934, as amended (the
“Exchange
Act”), shall be required or shall be voluntarily made
in connection with such transfers;(b) bona fide gifts of shares of any class of
the Company’s capital stock or any security convertible into
Common Stock, in each case that are made exclusively between and
among the undersigned or members of the undersigned’s family,
or affiliates of the undersigned, including its partners (if a
partnership) or members (if a limited liability company); (c) any
transfer of shares of Common Stock or any security convertible into
Common Stock by will or intestate succession upon the death of the
undersigned; (d) transfer of shares of Common Stock or any
security convertible into Common Stock to an immediate family
member (for purposes of this Lock-Up Letter Agreement,
“immediate family” shall mean any relationship by
blood, marriage or adoption, not more remote than first cousin) or
any trust, limited partnership, limited liability company or other
entity for the direct or indirect benefit of the undersigned or any
immediate family member of the undersigned;provided that, in the case of clauses (b) - (d) above,
it shall be a condition to any such transfer that (i) the
transferee/donee agrees to be bound by the terms of this Lock-Up
Letter Agreement (including, without limitation, the restrictions
set forth in the preceding sentence) to the same extent as if the
transferee/donee were a party hereto, (ii) each party (donor,
donee, transferor or transferee) shall not be required by law
(including without limitation the disclosure requirements of the
Securities Act of 1933, as amended, (the “Securities
Act”) and the Exchange
Act) to make, and shall agree to not voluntarily make, any filing
or public announcement of the transfer or disposition prior to the
expiration of the 180-day period referred to above, and
(iii) the undersigned notifies the Representative at least two
business days prior to the proposed transfer or disposition; (e)
the transfer of shares to the Company to satisfy withholding
obligations for any equity award granted pursuant to the terms of
the Company’s stock option/incentive plans, such as upon
exercise, vesting, lapse of substantial risk of forfeiture, or
other similar taxable event, in each case on a
“cashless” or “net exercise” basis (which,
for the avoidance of doubt shall not include “cashless”
exercise programs involving a broker or other third party),
provided
that as a condition of any transfer
pursuant to this clause (e), that if the undersigned is required to
file a report under Section 16(a) of the Exchange Act, reporting a
reduction in beneficial ownership of shares of Common Stock or any
securities convertible into or exercisable or exchangeable for
Common Stock during the Lock-Up Period, the undersigned shall
include a statement in such report, and if applicable an
appropriate disposition transaction code, to the effect that such
transfer is being made as a share delivery or forfeiture in
connection with a net value exercise, or as a forfeiture or sale of
shares solely to cover required tax withholding, as the case may
be; (f) transfers of shares of Common Stock or any
security convertible into or exercisable or exchangeable for Common
Stock pursuant to a bona fide third party tender offer made to all
holders of the Common Stock, merger, consolidation or other similar
transaction involving a change of control (as defined below) of the
Company, including voting in favor of any such transaction or
taking any other action in connection with such transaction,
provided that in the event
that such merger, tender offer or other transaction is not
completed, the Common Stock and any security convertible into or
exercisable or exchangeable for Common Stock shall remain subject
to the restrictions set forth herein;
(g) the exercise of warrants or the exercise of stock
options granted pursuant to the Company’s stock
option/incentive plans or otherwise outstanding on the date
hereof;provided, that the
restrictions shall apply to shares of Common Stock issued upon such
exercise or conversion; (h) the establishment of any contract,
instruction or plan that satisfies all of the requirements of Rule
10b5-1 (a “Rule 10b5-1
Plan”) under the Exchange Act; provided, however, that no sales of Common Stock
or securities convertible into, or exchangeable or exercisable for,
Common Stock, shall be made pursuant to a Rule 10b5-1 Plan prior to
the expiration of the Lock-Up Period;provided further, that the Company is not
required to report the establishment of such Rule 10b5-1 Plan in
any public report or filing with the Commission under the Exchange
Act during the lock-up period and does not otherwise voluntarily
effect any such public filing or report regarding such Rule 10b5-1
Plan; and (i) any demands or requests for, exercise any right with
respect to, or take any action in preparation of, the registration
by the Company under the Securities Act of the undersigned’s
shares of Common Stock, provided that no transfer of the
undersigned’s shares of Common Stock registered pursuant to
the exercise of any such right and no registration statement shall
be filed under the Securities Act with respect to any of the
undersigned’s shares of Common Stock during the Lock-Up
Period. For purposes of clause (f) above, “change of
control” shall mean the consummation of any bona fide third
party tender offer, merger, purchase, consolidation or other
similar transaction the result of which is that any
“person” (as defined in Section 13(d)(3) of the
Exchange Act), or group of persons, becomes the beneficial owner
(as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of a
majority of total voting power of the voting stock of the
Company.
The
undersigned also agrees and consents to the entry of stop transfer
instructions with the Company’s transfer agent and registrar
against the transfer of the undersigned’s securities subject
to this Lock-Up Letter Agreement except in compliance with this
Lock-Up Letter Agreement.
If (i)
during the last 17 days of the Lock-Up Period, the Company issues
an earnings release or material news or a material event relating
to the Company occurs, or (ii) prior to the expiration of the
Lock-Up Period, the Company announces that it will release earnings
results or becomes aware that material news or a material event
will occur during the 16-day period beginning on the last day of
theLock-Up Period, the restrictions imposed by this Lock-Up Letter
Agreement shall continue to apply until the expiration of the
18-day period beginning on the issuance of the earnings release or
the occurrence of such material news or material event, as
applicable, unless the Representative waives, in writing, such
extension.
The undersigned agrees that, prior to engaging in any transaction
or taking any other action that is subject to the terms of this
Lock-Up Letter Agreement during the period from the date hereof to
and including the 34th day following the
expiration of the initial Lock-Up Period, the undersigned will give
notice thereof to the Company and will not consummate any such
transaction or take any such action unless it has received written
confirmation from the Company that the Lock-Up Period (as may have
been extended pursuant to the previous paragraph) has
expired.
If the
undersigned is an officer or director of the Company, (i) the
undersigned agrees that the foregoing restrictions shall be equally
applicable to any shares of Common Stock that the undersigned may
purchase in the Offering; (ii) the Representative agrees that, at
least three (3) business days before the effective date of any
release or waiver of the foregoing restrictions inconnection with a
transfer of securities subject to this Lock-Up Letter Agreement,
the Representative will notify the Company of the impending release
or waiver; and (iii) the Company has agreed in the Underwriting
Agreement to announce the impending release or waiver by press
release through a major news service at least two (2) business days
before the effective date of the release or waiver. Any release or
waiver granted by the Representative hereunder to any such officer
or director shall only be effective two (2) business days after the
publication date of such press release. The provisions of this
paragraph will not apply if (a) the release or waiver is effected
solely to permit a transfer of securities subject to this Lock-Up
Letter Agreement not for consideration and (b) the transferee has
agreed in writing to be bound by the same terms described in this
securities subject to this Lock-Up Letter Agreement to the extent
and for the duration that such terms remain in effect at the time
of such transfer.
It is
understood that, if the Company notifies the Underwriters that it
does not intend to proceed with the Offering, if the Underwriting
Agreement does not become effective, or if the Underwriting
Agreement (other than the provisions thereof which survive
termination) shall terminate or be terminated prior to payment for
and delivery of the Stock, the undersigned will be released from
its obligations under this Lock-Up Letter Agreement.
The
undersigned understands that the Company and the Underwriters will
proceed with the Offering in reliance on this Lock-Up Letter
Agreement.
Whether
or not the Offering actually occurs depends on a number of factors,
including market conditions. Any Offering will only be made
pursuant to an Underwriting Agreement, the terms of which are
subject to negotiation between the Company and the
Underwriters.
This
Lock-Up Letter Agreement shall automatically terminate upon the
earliest to occur, if any, of (1) the termination of the
Underwriting Agreement before the sale of any Stock to the
Underwriters or (2) December 31, 2017, in the event that the
Underwriting Agreement has not been executed by that
date.
The
undersigned hereby represents and warrants that the undersigned has
full power and authority to enter into this Lock-Up Letter
Agreement and that, upon request, the undersigned will execute any
additional documents necessary in connection with the enforcement
hereof. Any obligations of the undersigned shall be binding upon
the heirs, personal representative, successors and assigns of the
undersigned.
Very
truly yours,
By:______________________________
Name:
Title:
Dated:
_______________, 2017
DEBT CONVERSION AMENDMENT AGREEMENT
THIS DEBT CONVERSION AMENDMENT
AGREEMENT, dated as of July 6, 2017 and effective as of May
15, 2017 (this “Agreement”),
by and among Level Brands, Inc., a North Carolina corporation (the
“Company”),
and LBGLOC, LLC, a North Carolina limited liability company (the
"Lender").
Capitalized terms used herein and not otherwise defined shall have
the meanings ascribed to such terms in the Loan Agreement (as
defined in the Conversion Agreement).
WHEREAS, on May 15, 2017 the Company and
the Lender entered into a Debt Conversion Agreement (the
"Conversion
Agreement") pursuant to which the Lender agreed to convert
$770,000 in principal and accrued interest (the "Loan
Balance") into 194,936 shares of the Company’s common
stock, the terms of which are incorporated herein by such
reference;
WHEREAS, at the date of the Conversion
Agreement, the Company also owed the Lender $109,380 in additional
accrued but unpaid interest from the period August 1, 2015 through
September 30, 2016 (the "Additional Accrued
Interest") under the terms of the Loan Agreement and Note,
which such amount was inadvertently omitted from the Conversion
Agreement;
WHEREAS, the Company has issued the
Lender an aggregate of 222,627 shares of its common stock (the
"Conversion
Shares") in full satisfaction of the Loan Balance, including
the Additional Accrued Interest; and
WHEREAS, the parties are desirous of
entering into this Agreement to accurately memorialize the full
satisfaction of the Loan Balance and Additional Accrued Interest
through the prior issuance of the Conversion Shares.
NOW, THEREFORE, in consideration of the
premises and the representations, warranties and agreements
contained herein, the parties hereto agree as follows:
1.
Full Conversion;
Lockup Agreement. The Lender hereby acknowledges that it
received the Conversion Shares in full satisfaction of the Loan
Balance, the Additional Accrued Interest and any and all other
obligations of the Company to the Lender. The Lender shall execute
and deliver to the Company to be held by it pending the
effectiveness of its registration statement for an initial public
offering of its securities an irrevocable lockup agreement for the
benefit of Joseph A. Gunnar & Co. in the form attached to the
Conversion Agreement covering the full amount of the Conversion
Shares, to be dated and released by the Company at such time as it
deems appropriate without any further action or consent of the
Lender.
2. No
further modifications. Except as amended hereby, all other
terms and conditions of the Conversion Agreement remain in full
force and effect.
IN WITNESS WHEREOF, the parties have
caused this Agreement to be executed on its behalf as of the date
first written above.
Level
Brands, Inc.
By: /s/
Mark Elliott
Name:
Mark Elliott
Title:
Chief Operating Officer and Chief Financial Officer
LBGLOC,
LLC
By: /s/
Martin Sumichrast
Name:
Martin Sumicharst
Title:
Manager
Exhibit 6.35
LICENSE AGREEMENT
THIS LICENSE AGREEMENT
(“Agreement”) is made and
entered into as of this 29th day of April, 2017, by and between
I|M1, LLC, a California limited liability company
(“Licensor”), and André Phillipe, Inc., a Texas
corporation (“Licensee”).
RECITALS
A.
Licensor has the right and authority to license
certain trademarks and rights to the name, likeness, and visual
representation of “I’M1” and other marks and has
developed and used intellectual property (collectively, the
“I’M1 IP”) and is engaged in the licensing of the
property identified in the attached Exhibit
A, as well as multiple names,
likeness, and visual representations being known and recognized by
the public and associated in the public mind with Licensor
(hereinafter, with the I’M1 IP, collectively referred to as
the “Licensed Marks”, the “Licensed
Property” or the “Brand”).
B.
Licensor
is the owner, by assignment, of the name, nick name, image,
likeness, initials, mark, appearance, signature (including
reproduced signature), autograph, endorsement, voice, and
biographical material (including history, video and motion picture
film portrayals, and still photography), Internet domain names and
online social media user/screen names of the Licensed
Marks.
C.
Ms.
Kathy Ireland ("Ms. Ireland"), an internationally famous person and
designer with a highly favorable public image and strong, favorable
identity for branding; and a strong portfolio of multiple brands
and ambassadors, also with a highly favorable public image and
strong brand identities serves as Chief Brand Advisor of
Licensor.
D.
Licensee is an importer, manufacturer, distributor
and/or seller of products and desires to use the Licensed Marks in
the Channels of Distribution as contemplated in Exhibit
B.
AGREEMENT
In
consideration of the mutual promises herein contained, it is hereby
agreed:
1. DEFINITIONS
2.
The term
"Affiliate" of an individual or entity means any other individual
or entity that directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common
control with, such individual or entity.
3.
The term "Brand"
shall mean only the Licensed Products offered under the Licensed
Marks set forth in Exhibit
A.
4.
The term
“Channels of Distribution” shall mean only those
channels, which are listed and mutually agreed on Exhibit B attached hereto
and incorporated by reference herein. Exhibit B may only be modified,
supplemented, and/or amended by written agreement of the Parties as
provided herein.
5.
The term
“Code of Conduct” shall refer to the Licensor’s
Human Rights – Code of Conduct, incorporated by this
reference as set forth in Exhibit C, with respect to
which Licensee agrees to fully comply in such form attached and as
it may be amended or updated by the Licensor from time to time upon
written notice to Licensee of such changes.
6.
The term
“Earned Royalty” or “Earned Royalties”
shall have that meaning set out in Section 5.2 below.
7.
The term
“Effective Date” shall mean the date this Agreement is
executed by Licensor as set forth above.
8.
The term
“Gross Sales” shall mean the gross amount billed (less
any and all sales, use or value added tax (VAT), Promotional
Products, rebates, Returns or discounts). No other costs incurred
in the manufacturing, selling, advertising, and/or distribution of
the Licensed Products shall be deducted.
9.
The term
“Initial Term” shall have the meaning set forth in
Section 4.
10.
The term
“Licensed Marks” shall mean the Brand and Licensed
Products set forth in Exhibit B, including, without
limitation, their likeness, visual representation and/or each of
the individual components thereof, and those trademarks, service
marks, logos, designs, and/or any other symbols/devices, which are
set forth in Exhibit
A attached hereto and incorporated by reference
herein.
11.
The term
“Licensed Products” shall mean only those items, which
are listed in Exhibit
B attached hereto. Exhibit B may only be modified,
supplemented, and/or amended by written agreement of the Parties as
provided herein.
12.
The Term
“Licensing Fee” shall have that meaning set out in
Section 5.1 below.
13.
The term
“Manufacturing Territory” shall mean the United States
(for clarity this excludes the sourcing of supplies and materials
used in the manufacturing process).
14.
The Term
“Millennium Development Goals” shall refer to the
Millennium Development Goals, incorporated by this reference as set
forth in Exhibit F,
with respect to which Licensee agrees to fully adopt, as well as
meaningfully contribute to, one or more of such goals either
economically or through other Licensee resources.
15.
The term
“Minimum Guaranteed Royalties” shall have the meaning
set forth in Section 5.5.
16.
The term
“Parties” (or “Party”) shall mean the
parties entering into this Agreement.
17.
The term
“Promotional Products” shall have the meaning set forth
in Section 7.6.
18.
The term
“Returns” shall mean any Licensed Product, which
Licensee accepts back from any customer after purchase and delivery
thereof and for which Licensee refunds the actual purchase price,
or issues a credit memo.
19.
The term
“Term” shall mean the Initial Term plus any extensions,
renewals of this Agreement or modifications thereof.
20.
The term
“Termination Date” shall mean the date, whichever is
earliest, that (i) this Agreement (subject to any renewals or
extensions) expires by its own terms; (ii) is thirty (30) days
after receipt of notice of termination under Section 21; or
(iii) any other event occurs which terminates this Agreement
where no notice is required.
21.
The term
“Territory” shall mean United States of
America.
22.
The term
“Trade Discounts” shall mean any reductions or charge
backs in the wholesale sales price of any Licensed Product, and
actually granted by Licensee in writing to any customer prior to
delivery.
23. GRANT OF LICENSE
24.
Upon the terms and
conditions set forth herein, Licensor hereby grants to Licensee the
non-transferable right, license, and privilege, of using the
Licensed Marks solely for the sale, marketing and distribution of
the Licensed Products through the Channels of Distribution in the
Territory during the Term (with the exceptions as stated on
Exhibit B), and the
non-exclusive, non-transferable right, license, and privilege
of using the
Licensed Marks solely upon and in connection with the manufacture
of Licensed Products in the Manufacturing Territory.
25.
All proposed
Channels of Distribution and distribution outlets in Exhibit B shall be deemed
approved and any others shall be submitted in advance to Licensor
and shall be subject to Licensor’s prior written
approval.
26.
Licensee shall not
assign or sub-license the use of the Licensed Marks to any third
party without prior written approval by Licensor, and such right is
expressly withheld from this Agreement. In the event that Licensor
approves a sub-license to a third party, the Parties shall mutually
agree upon the terms and conditions of said sub-license, including
without limitation the royalty rate, in a separate writing signed
by the Parties.
27.
Licensee will not
be permitted to enter into any other branded relationship that
competes with Licensor’s Brand program under this Agreement
without the express prior written approval of
Licensor.
28. BRAND DEVELOPMENT
29.
Licensee will begin
shipping of Licensed Products no later than June 30th,
2017.
30.
Licensee agrees
that all names of Licensed Products are proprietary to
Licensor. More specifically, Licensor shall own all intellectual
property rights in the names used in the Licensed Products and
related materials and in all sketches, artwork and/or designs for
the Licensed Products and the related materials, at no cost to
Licensor, and to the extent Licensee has any rights in such
intellectual property, Licensee agrees to assign and does hereby
assign to Licensor (or any person or entity designated by Licensor)
all its right, title and interest as set forth above.
31.
Licensee agrees to
become a member and utilize (a) Send Out Cards, a customer contact
communication service, (b) Salesforce.com, (c) Dependable
Solutions, a product approval and royalty reports services, (d)
ireland pay, a merchant agreement service, and (e) any similar web
platform as may be utilized by Licensor from time to time as a
means of conducting Brand business and coordinating with Licensor
and other licensees.
32. TERM
The
initial term (“Initial Term”) of the license hereby
granted shall commence on the Effective Date and shall be effective
through the fifth anniversary of the Effective Date, unless terminated sooner in accordance
with the provisions hereof.
33. LICENSING, ROYALTY AND OTHER FEES
34.
Licensing Fee. The licensing
fee (“Licensing Fee”) shall be payable as follows, upon
execution hereof, Licensee shall pay Licensor an amount equal to
Twelve Thousand Dollars (US $12,000), which shall be the Contract
Year 1 Minimum Guaranteed Royalty for Contract Year 1, as set forth
in Section 5.5. The Licensing Fee is an advance against any Earned
Royalty in Contract Year 1.
35.
Royalty. In consideration of
the grant hereunder, Licensee shall pay Licensor royalties in U.S.
dollars at a rate of four percent (4%) of 100% the Gross Sales for
all Licensed Products (excluding Promotional Products) sold under
the Licensed Marks (the “Earned Royalty”). Within
fifteen (15) days after the end of each month, Licensee shall
furnish to Licensor a complete sales and royalty report certified
to be accurate by the Chief Financial Officer of Licensee or by
some other authorized designee of Licensee showing the number,
description, and Gross Sales Price of the Licensed Products
distributed and/or sold by Licensee during the preceding month, as
well as the number of Licensed Products in inventory at the
beginning and end of the month along with payment of the royalties
due which shall be sent by wire transfer to the following
account:
Licensor:
I|M1, LLC
4521 Sharon Road, Ste 450
Charlotte, NC 28211
Domestic Wire:
ABA Bank Routing
Account Name: IM1, LLC
Account No.:
|
36.
Earned Royalty Report. For this
purpose, Licensee shall use the approved report form attached
hereto as Exhibit D
and incorporated by reference herein ("Earned Royalty Report").
Such report shall be furnished to Licensor whether or not any of
the Licensed Products have been sold during the preceding month.
Licensee shall tender both hard copy and Excel spreadsheet formats
of the Earned Royalty Report to Licensor. The number of Licensed
Products sold or distributed and Earned Royalty will be furnished
separately for each brand listed in Exhibit A in Excel spreadsheet
format to the Licensor and sent to the addresses set forth in
Section 21. The receipt or acceptance by Licensor of any of the
reports furnished by Licensee pursuant to this Agreement or of any
royalties paid by Licensee hereunder (or the cashing of any royalty
checks paid by Licensee hereunder) shall not preclude Licensor from
questioning the accuracy thereof at any time, and in the event that
any inconsistencies or mistakes are discovered in such reports or
payments, any inconsistency, mistake, or inaccuracy shall
immediately be rectified, and any appropriate payment due and owing
shall immediately be paid by Licensee to Licensor.
37.
Late Payment. Any amount (i.e.,
Royalties, Minimum Guaranteed Royalties, marketing fees, brand
participation fee, etc.) not paid to Licensor when due under this
Agreement shall bear a late payment charge on the unpaid balance at
the rate of 1.5% per month, or the maximum amount permitted by law,
whichever is less.
38.
Minimum Guaranteed Royalties.
If the Earned Royalty for any month during a Contract Year is less
than the following minimum guaranteed royalties (“Minimum
Guaranteed Royalties”) on the schedule set out below (for
purposes hereof, a Contract Year shall be based on the annual
anniversary of the first day of the month immediately preceding the
Effective Date), then Licensee shall also pay Licensor the
difference between the Minimum Guaranteed Royalty and the Earned
Royalty on a monthly basis, as adjusted for the Licensing Fee in
Contract Year 1:
Contract
Year Number
|
Monthly
Minimum Guaranteed Royalty Payment
|
Payment
Due Date
|
Contract Year
1
|
$12,000
Licensing Fee
|
Effective
Date
|
Contract
Year 2
|
$2,000.00
|
on the
15th day of each month
|
Contract
Year 3
|
$4,000.00
|
on the
15th day of each month
|
Contract
Year 4
|
$6,000.00
|
on the
15th day of each month
|
Contract
Year 5
|
$8,000.00
|
on the
15th day of each month
|
39.
Minimum Guaranteed Royalties:
Application and Credit Carryover. Minimum Guaranteed Royalty
payments shall be only credited towards Earned Royalties in each
month of the Contract Year for which they apply (i.e., Licensee
receives credit towards Royalties for the Minimum Guaranteed
Royalty monthly payment made in that Contract Year). Credits for
Minimum Guaranteed Royalty payments do not carry over into future
months or Contract Years. The Parties understand and agree that
each payment, whether it is an Earned Royalty or the Minimum
Guaranteed Royalty amounts as set forth above, is a separate and
independent obligation.
40. ACCOUNTING
41.
Licensee agrees to
keep accurate books of account and records covering all
transactions relating to the license hereby granted, and Licensor
and its duly authorized representatives shall have the right, but
no more than twice a year, after giving reasonable notice at all
reasonable hours of the day to an examination of said books of
account and records relating to Licensee’s performance under
the Agreement, and of all other documents and materials in the
possession or under the control of Licensee or any of its
affiliated, associated, or subsidiary companies or agents, which is
the subject matter of the Earned Royalty Report and this Agreement
and make extracts therefrom. All books of account and records shall
be kept available for no less than Seven (7) years, or, as
long as required by the Internal Revenue Service, if longer than 7
years.
42.
Each calendar year
in which this Agreement is in effect, and after expiration or
termination of this Agreement, Licensor shall be entitled to an
independent audit of and be given access to Licensee’s
account books, records, invoices and other pertinent data by a
certified public accountant or qualified auditor designated by
Licensor. The audit shall be conducted to determine
Licensee’s sales of Licensed Products, as well as all Returns
and trade discounts, and shall be conducted during normal business
hours at Licensee’s business office or location of such files
and records. The information provided in the audit shall be limited
to information concerning the results of the actual amount of the
royalty due and the amount of any royalty underpayment. The cost of
the audit shall be borne by Licensor unless the audit reveals that
Licensee understated sales and or royalties of Licensed Products by
more than five percent (5%), in which case Licensee shall be
required to pay all of Licensor’s costs of the audit. All
information and materials made available to or otherwise obtained
or prepared by or for the auditor in connection with such audit
shall be Licensee's confidential information, and Licensor shall
treat all such information in accordance with the confidentiality
provisions of this Agreement. If any such audit shows that any
payment made by Licensee is deficient, then Licensee shall pay
Licensor the deficient amount within five (5) business days after
Licensee's receipt of the audit report. If any such audit shows
that payments made by Licensee are in excess of the required
payment, the parties shall mutually agree on the form of such over
payment and, if no such agreement is reached, such amount may be
credited against future royalty payments due to
Licensor.
43. QUALITY ASSURANCE
44.
The quality of the
Licensed Products shall be consistent with or exceed the average of
similar products manufactured, distributed, and/or sold by
Licensee, shall serve to enhance Brand recognition of the Licensed
Products to the mutual benefit of the Parties, and shall be
suitable for the use for which they are intended.
45.
All Licensed
Products developed, manufactured and sold hereunder, and all
labels, hang tags, packaging, catalogs, brochures, publications,
printed matter, advertising, signs, promotional displays, websites,
webpages, video and sound recordings, online social media pages
(hereinafter the "Promotional Materials") and other forms of
publicity material for the Licensed Products, shall be subject to
Licensor’s written approval in advance of use, distribution,
marketing or sale
46.
All materials
submitted for approval to Licensor in a language other than English
will be accompanied by a complete and accurate English
translation.
47.
If any retail
customer of Licensee notifies Licensee or claims to Licensee that
there is a significant quality issue with any Licensed Products
sold to it by Licensee, Licensee shall notify Licensor in writing
of any such alleged quality issues within five (5) business days of
being notified by the retailer customer involved.
48.
Licensor shall
notify Licensee of consumer quality issues received by Licensor by
Licensor’s website. Licensee shall reply to applicable
consumers within forty-eight (48) hours of its receipt of the
issues from Licensor’s website.
49.
Licensor will have
the right to purchase products from the Licensee at best available
pricing, for personal use, Social Media Contests, giveaways, and
other promotional uses ("Promotional Products"). Products purchased
hereunder shall not be for commercial resale.
50. DISPLAY OF MERCHANDISE
51.
If Licensee has a
showroom, Licensee agrees to maintain space in its showroom located
in various high traffic locations and dedicated to display of the
Licensed Products under the Brand. Licensee further agrees that the
Licensed Products shall be displayed at Licensee’s showroom
in a commercially reasonable manner that will enhance the
recognition of the Brand and the Licensed Products to the mutual
benefit of the Parties. The display of the Licensed Products shall
be subject to the written approval of Licensor prior to any display
thereof
52.
Licensee may
display and offer the Licensed Products on its own company or
business web page/site in a manner, which makes the Licensed
Products distinctive and enhances the recognition of the Brand and
the Licensed Products to the mutual benefit of the Parties.
Products other than Licensed Products bearing the Licensed Marks
may be displayed on the web page/site only with the written
approval of Licensor. Licensee shall provide a link from its web
page/site to Licensor’s web page/site. Licensor shall approve
any display of the Licensed Products bearing the Licensed Marks on
Licensee’s web page/site in writing prior to any display or
use thereof. Licensee shall establish its web page/site within
forty-five (45) days of the Effective Date of this Agreement and
shall update its web page/site as reasonably necessary to operate
its business. Licensee shall also provide institutional signage in
all warehouse locations.
53. LABELING
54.
Licensee agrees
that it will cause to appear on or within each Licensed Product
manufactured, sold, and/or distributed under this Agreement and on
or within all advertising, marketing, promotional, or display
material bearing the Licensed Marks, the appropriate trademark and
copyright notices, markings, and/or designations, and/or any other
notice requested by Licensor. In the event that any Licensed
Product is distributed and/or sold in a carton, container, packing
and/or wrapping material bearing the Licensed Marks, such notices
shall also appear upon the said carton, container, packing, and/or
wrapping material.
55.
The Parties further
agree that should any of the Licensed Products be distributed, or
sold without the appropriate or requested trademark and copyright
notices, markings, and/or designations, in addition to any other
rights it may have, Licensor may demand the removal of the
offending product from distribution and sale, and may remove that
product from the list of Licensed Products and may also terminate
this Agreement.
56. PROMOTIONAL MATERIAL
57.
To the extent that
Licensee advertises in trade publications to ensure retail
recognition for the Brand in the marketplace, Licensee agrees to
run full-page advertisements. Licensee will use its best efforts to
convey to the market that it is a licensee of the Brand, including
but not limited to placing signage depicting the Brand prominently
at Licensee's corporate offices and showrooms, and on Licensee's
corporate stationery, point of sale, marketing and other materials.
No advertising, marketing, promotional, and display materials, or
other artwork shall be used without prior written approval by
Licensor. The Parties further agree that all artwork and designs
involving the Licensed Marks shall be produced under appropriate
“work for hire” provisions, or are hereby assigned to
and shall remain the property of Licensor, notwithstanding their
creation by Licensee or others. Licensee shall ensure that, prior
to its utilizing any non-employees to create advertising,
marketing, promotional, and display materials or other artwork,
advertising copy, and/or other copyrightable materials related to
the Licensed Marks, such persons or entities shall have executed
the necessary valid agreements to convey the ownership and
copyrights to these items to Licensor.
58. CONSULTATION
59.
Licensor and
Licensee agree to have meaningful consultation with each other
regularly throughout the Term of this Agreement and any renewal or
extension thereof.
60.
Ms. Ireland is the
Chief Brand Advisor of the Brand and Thomas Meharey is the
Co-Founder of the Brand. In addition to the services provided by
the Brand Advisor and Co-Founder, Licensor hereby designates
Stephen Roseberry, Jason Winters, Jon Carrasco and Rocco Ingemi to
serve as liaisons with Licensee. Licensor may designate additional
members of the Licensor’s team to serve as its liaison with
Licensee. Licensor reserves the right to change, modify,
supplement, and/or alter this designation in any way and at any
time in its sole and unfettered discretion.
61. PROFESSIONAL CALENDAR
Licensee agrees to
provide Licensor with a professional calendar of all trade shows
and material sales promotions regarding the Licensed Products,
including but not limited to, acceptances and rejections of the
products, in order to allow the Parties the finest mutual
cooperation for sale of merchandise and public relations,
including, but not limited to any social media
strategy.
62. RECORDING AND FILMING – EE1
63.
Except as provided
herein, under no circumstance shall any recording be made by
Licensee or anyone acting on behalf of Licensee in any manner
whatsoever, whether on video or audio tape, film, celluloid, and/or
by any other means possible, of Ms. Ireland or Mr. Meharey in
connection with any appearance provided under this Agreement,
including without limitation all personal appearances and photo
sessions, without the express prior written approval of Licensor.
The creation of any content to be exploited in any media, now or
hereafter existing, pursuant to this Agreement shall be exclusively
provided by Encore Endeavor 1 LLC, a California limited liability
basis, on a “work for hire” basis with Licensor as the
sole owner of the results and proceeds of such
services.
64.
Ms. Ireland and
Tommy Meharey are union members of Guild/Union Requirements
(SAG-AFTRA) and Licensee will make payments accordingly for any
audio or visual recordings.
65. LICENSOR’S RIGHTS
66.
Nothing in this
Agreement shall be construed to prevent Licensor from granting any
other license for the use of the Licensed Marks or from utilizing
the Licensed Marks in any manner whatsoever.
67.
Licensee agrees
that rights not specifically granted to Licensee are reserved by
Licensor and may be freely exploited by Licensor without
limitation.
68. PROTECTION OF LICENSOR’S RIGHTS
69.
Licensee agrees
that during the term of this Agreement, or thereafter, it will not
register or attempt to register any of the Licensed Marks, nor will
Licensee form or incorporate any entity under a name that includes
the Licensed Marks. Licensee will not attack the title or any
rights of Licensor in and to the Licensed Marks or the Licensed
Products or attack the validity of this Agreement.
70.
Licensee further
agrees to cooperate fully and in good faith with Licensor for the
purpose of securing and preserving Licensor’s rights in and
to the Licensed Marks.
71.
Licensee also
agrees to assist Licensor, at Licensor's sole expense, to the
extent necessary in the procurement of any protection or to protect
any of Licensor’s rights to the Licensed Marks.
72.
Licensee
acknowledges that Licensor has sole and exclusive ownership of all
right, title, and interest in and to the Licensed Marks and any
registrations that have been issued or may be issued
thereon.
73.
Nothing contained
in this Agreement shall give Licensee any right, title or interest
in or to the Licensed Marks except for the rights expressly
licensed by this Agreement, and subject to its terms and
conditions.
74.
Adaptations and
modifications of Licensed Marks prepared under this Agreement shall
be included as part of the Licensed Marks, including, without
limitation, Licensor’s ownership thereof.
75.
All registrations
for intellectual property, Internet domain names and social media
user/screen names in the Licensed Marks are to be applied for and
obtained exclusively in Licensor’s name. Licensee shall not
file or register any intellectual property applications or seek any
Internet domain name and/or social media user/screen name
registration in the Licensed Marks, Licensed Products or any
derivations, improvements, variations or modification thereof,
without Licensor’s prior written approval.
76.
Licensee shall
notify Licensor, or its designated representative, prior to
entering into any agreement with any individual, company or
business, for sales outside the United States of any Licensed
Product, to permit the timely filing of foreign and/or
international trademark and copyright applications, or other
intellectual property protection, covering the Licensed Marks, in
Licensor’s sole discretion.
77.
Licensee agrees to
cooperate fully and in good faith with Licensor for the purpose of
securing and preserving Licensor’s rights in and to the
Licensed Marks. In the event there has not been a previous
registration of any Licensed Mark and/or any material relating
thereto for a particular Licensed Product, Licensor may register
and maintain, at Licensee's expense, trademarks and/or service
marks in the appropriate class(es) and/or copyrights in the name of
Licensor. Licensee is not permitted to register any copyright,
trademark, and/or service mark on behalf of Licensor. It is further
agreed that nothing contained in this Agreement, and no act or
omission by Licensor and/or by Licensee shall be construed as an
assignment or grant to Licensee of any right, title, or interest in
or to the Licensed Marks, it being understood that all rights
relating thereto are reserved by Licensor, except for the license
hereunder to Licensee of the right to use and utilize the Licensed
Marks only as specifically and expressly provided in this
Agreement.
78. WARRANTIES AND INDEMNIFICATION
79.
Licensor hereby
indemnifies Licensee and its officers, directors, employees, agents
successors and assigns ("Licensee Indemnified Party") and
undertakes to defend, hold it harmless against any claims or suits,
demands, losses, injuries, liabilities costs, judgments,
arbitration awards, license fees, settlement, damages and expenses
(including reasonable attorneys’ fees and costs, whether or
not any legal proceeding is commenced) (“Losses”)
arising out of or in connection with any third-party claim suit
action, or proceeding ("Third-Party Claim") relating to any actual
or alleged, trademark infringement, dilution, or other violation of
any intellectual property or other rights of any individual or
entity resulting from the use of the Licensed Marks by Licensee in
accordance with this Agreement.
80.
Licensee shall
defend, indemnify, and hold Licensor and its officers, directors,
employees, agents successors and assigns (each, a "Licensor
Indemnified Party") (Licensee Indemnified Party and Licensor
Indemnified Party, collectively, “Indemnified Party”)
harmless against any and all Losses arising out of any Third-Party
Claim relating to any actual or alleged design, manufacture, sale,
purchase, use, advertising, marketing, and/or distribution of any
Licensed Product, whether for personal injury, product liability,
intellectual property infringement, dilution, misappropriation or
otherwise.
81.
An Indemnified
Party shall promptly notify the party from whom it is seeking
indemnification ("Indemnifying Party") upon becoming aware of a
Third-Party Claim under this Section 16 ("Indemnified Claim"). The
Indemnifying Party shall promptly assume control of the defense and
investigation of the Indemnified Claim, with counsel of its own,
and the Indemnified Party shall reasonably cooperate with the
Indemnifying Party in connection therewith, in each case at the
Indemnifying Party's sole cost and expense. The Indemnified Party
may participate in the defense of such Indemnified Claim, with
counsel of its own choosing and at its own cost and expense. The
Indemnifying Party shall not settle any Indemnified Claim without
such Indemnified Party's prior written consent (which consent shall
not be unreasonably withheld, conditioned, or delayed). If the
Indemnifying Party fails or refuses to assume control of the
defense of such Indemnified Claim, the Indemnified Party shall have
the right, but no obligation, to defend against such Indemnified
Claim, including settling such Indemnified Claim after giving
notice to the Indemnifying Party, in each case in such manner and
on such terms as the Indemnified Party may deem appropriate.
Neither the Indemnified Party's failure to perform any obligation
under this Section 16.3 nor any act or omission of the Indemnified
Party in the defense or settlement of any Indemnified Claim shall
relieve the Indemnifying Party of its obligations under this
Section 16.3, including with respect to any Losses, except to the
extent that the Indemnifying Party can demonstrate that it has been
materially prejudiced as a result thereof.
82.
Licensor makes no
representations or warranties with respect to the design,
manufacture, sale, purchase, use, marketing, and/or distribution of
any Licensed Product manufactured, sold, and/or distributed by
Licensee and disclaims any liability arising out of the design,
manufacture, sale, purchase, use, marketing, and/or distribution of
any Licensed Product, and any such express or implied warranties
are hereby disclaimed and Section 16.2 shall apply.
83.
Licensee represents
and warrants to Licensor that: (i) Licensee has the full power and
authority to enter into this Agreement on behalf of Licensee and to
perform all of Licensee’s material obligations pursuant to
this Agreement, and that the Licensed Products manufactured, sold,
and/or distributed by Licensee under this Agreement shall be
suitable for the purpose for which they are intended to be used and
shall comply with all applicable Federal, State, and local laws,
and industry standards, (ii)
Licensee will not harm or misuse the Licensed Property or bring the
Licensed Marks into disrepute, (iii) except as specifically
provided in this Agreement, Licensee will not create any expenses
chargeable to Licensor or Ms. Ireland without the express
prior written approval of Licensor, (iv) all Licensed Products (and
the content contained or used in the Licensed Products) designed,
developed, marketed, distributed, published, performed or sold by
Licensee pursuant to this Agreement do not, and will not, infringe
any intellectual property right or any personal right of any third
party, and (v) Licensee will not knowingly permit, do or commit any
act or thing that would degrade, tarnish or deprecate or disparage
the Licensed Property or Licensor’s or Ms. Ireland’s
public image in society or standing in the community, or prejudice
Licensor or Ms. Ireland and that it will terminate such activities
promptly upon written notice, and failure to do so constitutes a
material breach of this Agreement. Licensee acknowledges and agrees
that there are no warranties, guarantees, conditions, covenants, or
representations by Licensor as to marketability, fitness for a
particular purpose, or other attributes of the Licensed Products,
whether express or implied (in law or in fact), oral or
written.
84.
Licensee shall
provide Licensor with prompt written notice of any lawsuits or
threatened lawsuits, or other significant developments,
investigations, claims, or final refusals in which Licensee is or
may be named as a party or for which Licensee is obligated or has
agreed to indemnify any party, and Licensee shall thereafter
provide Licensor with periodic written updates concerning relevant
developments in any such lawsuits as they arise.
85.
For purposes of
this Section 16, the term “Licensor” shall mean
Licensor and, without limitation, any of its agents, employees,
servants, representatives, parents, subsidiaries, Affiliates,
officials, directors, officers, shareholders, owners, attorneys,
divisions, branches, units, affiliated organizations, successors,
predecessors, contractors, assigns, and all persons acting by,
through, under, or in concert with them, past or
present.
86. INSURANCE
87.
Licensee represents that it has
obtained, and agrees to maintain, at its own expense, in full force
and effect at all times during which the Licensed Products are
being manufactured, sold, and distributed, insurance for bodily
injury, advertising injury, property damage, and product liability
from a recognized insurance company approved by Licensor, which is
qualified to do business in the State of California, providing
protection at least in the amount of $5,000,000 per
occurrence and $5,000,000 in the aggregate for Licensor and for
Licensee against any actions, claims, demands, lawsuits, loss,
costs, attorneys’ fees, damages, judgments, and liabilities
of any nature whatsoever relating to the Licensed Products. As
proof of such insurance, a fully paid certificate of insurance
naming Licensor (as defined above) as Licensee shall submit an
insured party to Licensor for Licensor’s prior written
approval before any Licensed Product is manufactured, sold, or
distributed. Any proposed change in certificates of insurance shall
be submitted to Licensor for its prior written approval. Licensor
shall be entitled to a copy of the prevailing certificate of
insurance, which shall be furnished to Licensor by Licensee. The
certificate(s) shall conform to the language requirements set out
in Exhibit E
attached hereto.
88.
For purposes of
this Section 17, the term “Licensor” shall mean
Licensor and, without limitation, any of its agents, employees,
servants, representatives, parents, subsidiaries, Affiliates,
officials, directors, officers, shareholders, owners, attorneys,
divisions, branches, units, affiliated organizations, successors,
predecessors, contractors, assigns, and all persons acting by,
through, under, or in concert with them, past or
present.
89. INSOLVENCY; CHANGE OF CONTROL
90.
If Licensee files a
petition in bankruptcy or is adjudicated a bankrupt or if a
petition in bankruptcy is filed against Licensee, or if it becomes
dissolved, or becomes insolvent or unable to pay or discharge its
liabilities in the ordinary course of business, or if Licensee
assigns the whole or any substantial part of its assets or
undertakings for the benefit of creditors or makes an assignment
for the benefit of its creditors or any similar arrangement
pursuant to any federal or state law, compulsory or voluntarily, or
if a receiver or other similar officer is appointed for the whole
or any part of the assets or undertakings of Licensee or its
business, or if Licensee stops payment to its creditors generally,
or ceases or threatens to cease to carry on its business or any
substantial part thereof, or if Licensee merges or consolidates
with or into any other corporation, or directly or indirectly sells
or otherwise transfers, sells, or disposes of all or a substantial
portion of its business or assets, or if a third party who does not
own stock acquires a majority of the voting stock of Licensee,
Licensor may terminate this Agreement by giving notice to Licensee
of its intention to terminate and such termination shall be
effective immediately. In the event this Agreement is so
terminated, Licensee, its receivers, representatives, trustees,
agents, administrators, successors, and/or assigns shall have no
right to sell, exploit, or in any way deal with or in any Licensed
Products covered by this Agreement or any related advertising,
marketing, promotional, and display materials, including without
limitation cartons, containers, packing, and wrapping materials,
except with and under the special consent and instructions of
Licensor in writing, which they shall be obligated to
follow.
91.
In the event this
Agreement is so terminated under this Section 18, Licensee, its
receivers, representatives, trustees, agents, administrators,
successors, and/or assigns shall have no right to sell, exploit, or
in any way deal with or in any Licensed Products covered by this
Agreement or any related advertising, marketing, promotional, and
display materials, including without limitation cartons,
containers, packing, and wrapping materials, except with and under
the special consent and instructions of Licensor in writing, which
they shall be obligated to follow.
92. TERMINATION
93.
Except as otherwise
provided herein, in the event either party breaches or fails to
perform any of its material duties and obligations pursuant to the
terms of this Agreement, the non-breaching party shall have the
right to terminate this Agreement upon thirty (30) days’
notice in writing, and such notice of termination shall become
effective unless the breaching party shall remedy the breach within
the thirty (30) day period to the reasonable satisfaction of the
non-breaching party. The Parties agree to make a reasonable effort
to resolve any disputes or breaches prior to exercising the right
of termination.
94.
Termination of this
Agreement shall be without prejudice to any rights, which Licensor
may otherwise have against Licensee. Upon the termination of this
Agreement, notwithstanding anything to the contrary herein, all
royalties on sales theretofore made and any other monies owed,
shall become immediately due and payable, and all rights and
licenses granted hereunder shall cease and revert to Licensor.
Further, Licensee will withdraw or cancel any governmental filings
made on its behalf that include the Licensed Marks. Licensee shall
immediately cease and desist from using the Licensed Marks in any
way. Unless otherwise stated in this Agreement, Licensee shall have
no right to sell, exploit, or in any way deal with or in any
Licensed Products covered by this Agreement or any related
advertising, marketing, promotional, and display materials,
including without limitation cartons, containers, packing, and
wrapping materials, except with and under the special consent and
instructions of Licensor in writing, which they shall be obligated
to follow. Licensee shall immediately return any and all
Confidential Information of Licensor to Licensor, as well as
marketing and advertising materials bearing the Licensed Marks.
Upon expiration or termination of this Agreement, Licensee shall
have the right to dispose of all stocks of Licensed Products
bearing the Licensed Marks in its possession or in the course of
manufacture or production as of the date of expiration or
termination for a period of ninety days after the date of
expiration or termination (the "Sell-Off Period"), in each case, in
accordance with the terms and conditions of this Agreement. Any
royalty payment accruing during the Sell-Off shall be paid to
Licensor within thirty (30) business days after the expiration of
the Sell-Off Period.
95.
Upon the natural
expiration or termination of this Agreement, neither Party shall
make any publicly disparaging comments regarding the other or its
business, whether written, oral, or electronic. This provision
shall survive the expiration or termination of this Agreement.
However, nothing herein shall limit either Party’s right to
arbitration or other judicial remedies as set out in this
Agreement.
96.
Licensee
acknowledges that a failure (except as otherwise expressly provided
herein) to cease the manufacture, sale, transmission, broadcast or
distribution of the Licensed Products upon the terminations or
expiration of this Agreement, except for the continuation of the
foregoing during the Sell-Off Period, will result in immediate and
irreparable damage to Licensor. Licensee further acknowledges that
there is no adequate remedy at law for such failure to cease
manufacture, sale or distribution, and in the event of such
failure, Licensor shall be entitled to equitable relief and such
further relief as a court or agency with jurisdiction may deem just
and proper.
97.
Upon termination or
expiration of this Agreement, all of the rights granted hereunder
to Licensee, and all rights, title and interest in and to the
Licensed Marks, including but not limited to, patent, industrial
design, copyright, trademark, service mark, trade dress and all
improvements, additions and changes thereto, trade secret rights,
and goodwill relating to the Licensed Marks, shall revert to
Licensor. Licensee agrees to promptly execute all documents that
may be reasonably necessary to effect the foregoing. This right and
obligation shall survive the terminations or expiration of this
Agreement.
98.
The rights and
obligations of the parties set forth in Section 16 (Warranties and
Indemnification), Section 25 (Governing Law), Section 26
(Confidentiality), Section 30 (Attorney's Fees) and Section 32
(Equitable Relief) and any right, obligation, or required
performance of the parties in this Agreement which, by its express
terms or nature and context is intended to survive termination or
expiration of this Agreement, will survive any such termination or
expiration.
99. FORCE MAJEURE
The
Parties shall be released from their obligations hereunder, and
this Agreement shall terminate in the event that governmental
regulations or other causes arising out of a state or national
emergency or war or causes beyond the control of the Parties render
performance impossible, and one Party so informs the other in
writing of such causes and its desire to be so released. In such
event, all royalties on sales and all other monies due, theretofore
made shall become immediately due and payable to
Licensor.
100. NOTICES
Any
notice, communication, statement, payment, or legal service of
process required or permitted under this Agreement shall be in
writing and shall be effective when hand delivered; or on the date
when the notice, communication, statement, payment, or legal
service of process is transmitted by confirmed electronic facsimile
(with a confirmation copy sent by mail); or the day after the
notice, communication, statement, payment, or legal service of
process is sent by reputable overnight air courier service (e.g.,
Federal Express). All such communications shall be sent to the
Parties at the notice addresses listed below or to such other
persons and the Parties to each other may designate notice
addresses as in writing.
If to Licensor:
|
I|M1, LLC
4521 Sharon Road, Suite 450
Charlotte, NC 28211
704.490.7705 – C
704.362.6270 - O
Attention: Paul Porter - Secretary
and Mark Elliott - CFO
Email: pporter@sstreetllc.com
and mark@levelbrands.com
|
With a copy to:
|
Erik Sterling
POB #1410
Rancho Mirage, CA 92270
Email: esterling@sterlingwinters.com
|
If to Licensee:
|
André Phillipe, Inc.
3708 Old Orchard Ct.
Celina Texas, 75009
Attention: André P. van den Broeck
Email: andrepv@andrephillipe.com
|
With a copy to:
|
Ferguson Braswell Fraser Kubasta PC
2500 Dallas Parkway, Suite 600
Plano, Texas 75093
Email: kferguson@dallasbusinesslaw.com
Attention: L. Kyle Ferguson
|
101. NEGATION OF AGENCY
Licensee is an
independent contractor with respect to Licensor. Nothing contained
herein shall be deemed to create an agency, joint venture,
franchise, or partnership relation between the Parties, and neither
Party shall so hold itself out. Licensee shall have no right to
obligate or bind Licensor in any manner whatsoever, and nothing
contained in this Agreement shall give, or is intended to give, any
rights of any kind to any third person(s).
102. ASSIGNABILITY
103.
This Agreement
shall inure to the benefit of Licensor, its successors, and
assigns, but will be personal to Licensee, and shall be assignable
by Licensee only with the prior written consent of Licensor.
Licensee shall not mortgage, assign, sub-license, or otherwise
encumber this Agreement without the prior written consent of
Licensor. Licensor shall be entitled to assign this Agreement to
any third party with notice to Licensee, including any such
assignment in connection with the sale or transfer of
Licensor’s business, provided, however, that Licensor shall
have the option to terminate this Agreement in lieu of assignment
to any successor of Licensor’s business in connection with
any such sale or transfer.
104.
Notwithstanding the
Sell-Off Period, in the event Licensor terminates this Agreement in
connection with a sale of its business, Licensee shall have a
period of six (6) months from the effective date of termination in
which to sell off its inventory of Licensed Products, subject to
the terms and conditions of this Agreement, including paying
royalties.
105. MODIFICATION AND WAIVER
106.
Except as otherwise
provided herein, no agreement or understanding purporting to add to
or to modify the terms and conditions of this Agreement shall be
binding unless agreed to by the Parties in writing. Any terms and
conditions set forth in any forms used by the Parties, which are in
conflict with the terms and conditions of this Agreement, shall be
void and have no effect. The Parties further agree that the
Exhibits to this Agreement may be modified, amended, altered,
and/or supplemented from time to time in writing signed by
authorized representatives of the Parties.
107.
It is agreed that
no waiver by either Party hereto or any breach or default of any of
the provisions set forth herein shall be deemed a waiver as to any
subsequent and/or similar breach or default.
108. GOVERNING LAW
109.
This Agreement
shall be construed in accordance with and the laws of the State of
California which shall govern all disputes relating hereto without
giving effect to any conflicts of law provisions. The Parties agree
that any and all disputes, controversies or claims arising out of,
regarding, or in any way relating to the interpretation,
application, or enforcement of this Agreement, or any matter
reasonably related thereto, shall be handled by way or arbitration
and administered by and in accordance with the JAMS streamlined
Arbitration Rules and Regulations (the ''JAMS Rules '') of the
Judicial Arbitration and Mediation Service in effect at the time of
any such proceedings. Such arbitration shall be the sole,
exclusive, and final remedy for resolving any such claims and
disputes. Judgment on the final award rendered by the arbitrator
may be entered into in any court of competent jurisdiction and
shall be final and binding upon the Parties.
110.
Notwithstanding the
foregoing, the Parties may seek provisional relief, including a
preliminary injunction or temporary restraining order, in any
federal or state court of competent jurisdiction located in Los
Angeles, California, without prejudice to the above described
arbitration procedures, if in that Parties sole judgment such
provisional relief is necessary to avoid an irreparable injury or
to preserve the status quo. Never the less, the arbitration
procedure set forth in this Section 25 is intended to be the sole
and exclusive method of resolving any claims arising out of,
relating to, or regarding this Agreement.
111. CONFIDENTIALITY
112.
The Parties agree
that the terms, conditions, and subject matter of this Agreement
constitute confidential and proprietary information belonging to
Licensor. Licensee agrees not to divulge any confidential and
proprietary information pertaining to Licensor or this Agreement to
any third party without prior written consent of Licensor;
provided, however Licensee may share the existence of this
Agreement. Licensor agrees not to divulge any confidential and
proprietary information pertaining to Licensee or this Agreement to
any third party without prior written consent of Licensee;
provided, however Licensor may share the existence of this
Agreement. Each Party shall take commercially reasonable measures
to prevent the unauthorized use and/or disclosure of such
confidential information, and to prevent unauthorized persons or
entities from obtaining or using such information. Each Party
further agrees to refrain from directly or indirectly taking any
action, which would constitute or facilitate the unauthorized use
or disclosure of such confidential information. Each Party may
disclose such confidential and proprietary information to its
officers, directors, employees, agents, and authorized
representatives to the extent necessary to enable such Party to
perform its obligations under this Agreement, provided that said
officers, directors, employees, agents, and/or authorized
representatives execute an appropriate confidentiality agreement
approved by the other Party, which by its terms shall be
enforceable by injunctive relief. The receiving Party of
confidential information shall be liable for any unauthorized use
and disclosure of such confidential information by its officers,
directors, employees, agents, and authorized representatives,
including without limitation its attorneys and accountants. The
Parties further agree that any breach or threatened breach of this
Section 26.1 would cause irreparable harm to Licensor, that a
remedy at law or in damages would be inadequate, and that the
provisions of this Section 26.1 may be enforced by way of
injunctive relief in addition to any other rights available to
Licensor in law or in equity.
113.
For purposes of
this Agreement, “confidential and proprietary
information” includes, but is not limited to, the terms,
conditions, and subject matter of this Agreement, and
Licensor’s business, including any financial, cost, pricing,
and royalty information; product development, business, marketing,
promotion, distribution, sales, sales plans, and strategies;
information concerning Licensor’s product development and
intellectual property; information concerning manufacturing
processes relating to the Licensed Products, or trade secrets. The
foregoing confidentiality obligations shall not apply to
information that: (1) was previously known to the recipient
free of any obligation to keep it confidential; (2) was
independently developed by recipient; or (3) is or becomes
publicly available by means other than the unauthorized disclosure
by recipient.
114.
In the event that
any judicial or regulatory authority requests or requires
disclosure of any Confidential Information of the other party, the
receiving party shall promptly notify the disclosing party of the
requested or required disclosure and shall cooperate with the
disclosing party in any effort to avoid or limit such
disclosure.
115. ENTIRE AGREEMENT AND ADMISSIBILITY
This
Agreement constitutes the complete understanding between the
Parties and supersedes any and makes void any and all prior
agreements, promises, representations, or inducements, no matter
their form, concerning the subject matter of this Agreement. The
Parties desire that this Agreement represent a single and
completely integrated contract expressing the entire agreement of
the Parties with respect to the subject matter of this Agreement.
No promises, agreements, or modifications to this Agreement made
subsequent to the execution of this Agreement by the Parties shall
be binding unless reduced to writing and signed by authorized
representatives of the Parties. The Parties to this Agreement agree
that this Agreement may be used as evidence in any subsequent
proceeding in which any Party alleges a breach of this Agreement or
seeks to enforce its terms, provisions, or
obligations.
116. SEVERABILITY
Whenever possible,
each provision of this Agreement shall be interpreted in such a
manner to be effective and valid under applicable law. Should any
of the provisions or terms of this Agreement be determined illegal,
invalid, or unenforceable by any court of competent jurisdiction,
validity of the remaining parts, terms, or provisions shall not be
affected thereby, and said illegal, invalid, or unenforceable part,
term, or provision shall be deemed not to be a part of this
Agreement.
117. RECITALS AND HEADINGS
The
terms of this Agreement are contractual, not a mere recital, and
are the result of joint negotiations between, and joint drafting
by, the Parties, and are therefore not to be construed in favor of
or against either Party. All recitals are incorporated by reference
into this Agreement. Caption and Section headings are used for
convenience and reference only, are no part of this Agreement, and
shall not be used in interpreting, construing, defining, limiting,
extending, or describing the scope of this Agreement, or any
provision hereof, in any way.
118. ATTORNEY FEES AND COSTS
Should
any action be necessary to enforce the terms of this Agreement, the
prevailing Party will be entitled to recover reasonable
attorneys’ fees and costs.
119. EXECUTION OF COUNTERPARTS
This
Agreement may be executed in two or more duplicate bond or
facsimile counterparts, each of which shall be considered an
original, but all of which together shall constitute one and the
same instrument, and in pleading or proving any provision of the
Agreement, it shall not be necessary to produce more than one such
counterpart.
120. EQUITABLE RELIEF
The
Parties acknowledge that the subject matter of this Agreement
(including, without limitation, the Confidentiality section)
relates to services and rights, which are extraordinary and unique
and which cannot be replaced or adequately compensated in money
damages, and any breach by Licensee of this Agreement will cause
irreparable injury to Licensor.
[signature page
follows]
IN
WITNESS WHEREOF, the Parties hereto have caused this instrument to
be duly executed as of the day and year first above
written.
Licensor:
I|M1, LLC
/s/
Stephen Roseberry
Name:
Stephen Roseberry
Title:
President
Licensee:
André Phillipe, Inc.
/s/
André P. van den Broeck 3.29.2017
Name:
André P. van den Broeck
Title:
Chief Executive Officer
EXHIBIT A
LICENSED MARK
1.
Only for the Licensed Products specified in
Exhibit B
to this Agreement and only as shown in
the following specimen(s):
2.
Examples
on Brand Partner Resource link; upon your signature a password will
be provided.
3.
Licensed
Products to include styles with each of the following supporting
categories will be provided by Licensor upon further discussion
with Licensee.
Licensor may designate other supporting brands or categories, in
writing from time to time.
EXHIBIT B
LICENSED PRODUCTS AND CHANNELS OF DISTRIBUTION
●
The
following list sets forth the Licensed Products:
Men’s
Suits
●
Licensee may only use those channels of
distribution approved, in advance, by Licensor. Licensor
anticipates the channels of distribution to be approved to include
Macy’s and above. Except for Home Love Affair (which is
pre-approved), any mass market and low tier department stores
(i.e., Wal-Mart, K-Mart, Target, and Sears), as well as club stores
(i.e. Sam’s), are specifically excluded from
the approved Channels of Distribution under this
Agreement.
●
Licensor
shall have prior approval rights relating to any internet retailers
not belonging to retailers in the approved Channels of Distribution
set forth above, which will be reviewed on an individual basis by
Licensor.
EXHIBIT C
CODE OF CONDUCT
行为守则
1.
PURPOSE:
Licensee is committed to using only manufacturers to strive to
conduct business in a highly professional and ethical manner. This
document outlines those commitments each facility makes in respect
to its compliance with applicable law and tis personal practices
and policies.
目的:[被许可人]承诺只使用了力争在一个高度专业和道德的方式开展业务的厂家。本文概述了这些各设施使得在尊重其遵守适用的法律和个人的做法和政策的承诺。
2.
CHILD
LABOR: The facility agrees not to use child labor in the
manufacturing, or distribution of the Goods. The term
“child” refers to a person younger than the local legal
minimum age for employment or the age for completing compulsory
education; provided, however, in no event shall the Facility use
any person below the age of (15) fifteen. The Facility also agrees
to comply with all other laws applicable to employees, regardless
of the age of an employee.
童工:该中心同意不使用童工在制造,或货物配送。
“童工”是指一个人年龄低于当地法定最低就业年龄或年龄在完成义务教育;
提供的,但是,在任何情况下,基金使用任何人(15)15岁以下。该基金还同意遵守适用于所有员工的其他法律,不论雇员的年龄。
3.
FORCED
LABOR: The Facility agrees to employ only persons whose presence is
voluntary. The Facility agrees not to use any forced or involuntary
labor, whether prison, bonded, indentured or
otherwise.
强迫劳动:该基金同意只雇用人员,其存在是自愿的。该基金同意不使用任何强迫或非自愿劳动,无论是监狱,保税,契约或其他方面。
4.
ABUSE
OF LABOR: The Facility agrees to treat each employee with dignity
and respect and not to use corporal punishment, threats of
violence, or other forms of physical, sexual, psychological or
verbal harassment or abuse.
滥用劳动:该基金同意把每个员工的尊严和尊重,不使用体罚,暴力威胁或其他形式的身体,性,心理或言语上的骚扰或虐待。
5.
NON-DISCRIMINATION:
The Facility agrees not to discriminate in hiring and employment
practices, including salary, benefits, advancement, discipline,
termination, or retirement on the basis of race, religion, age,
nationality, social or ethnic origin, sexual orientation, gender,
political opinion or disability.
不歧视:该基金同意不会在雇佣和招聘活动,包括工资,福利,晋升,纪律,终止或退休种族,宗教,年龄,国籍,社会或民族,性取向,性别的基础上歧视,政治观点或残疾。
6.
ASSOCIATION:
The Facility agrees to follow employees to organize and bargain
collectively without penalty or interference in accordance with
local laws.
关联关系:该基金同意遵守雇员组织和集体谈判不受处罚或干预按照当地的法律。
7.
WAGES,
DENEFITS AND WORKING HOURS: The facility recognizes that wages are
essential to meeting employee’s basic needs. The Facility
agrees to comply, at a minimum, with all applicable wages and hour
Laws, including minimum wage, overtime hours, maximum hours, piece
rates and other elements of compensation and shall provide legally
mandated benefits.
工资,福利和工作时间:该厂认识到,工资是必要的,以满足员工的基本需求。该基金同意遵守,至少,所有适用的工资和工时的法律,包括最低工资,加班,最长工时,计件工资和补偿等内容,并应提供法定福利。
8.
HEALTH
AND SAFETY: The Facility agrees to provide employees with a safe
and healthy workplace environment in accordance with all applicable
laws, ensuring at a minimum, reasonable access to potable water and
sanitary facilities, fine safety and adequate lighting and
ventilation. The Facility also agrees to ensure that the same
standards of health and safety are applied to any housing it
provides for employees.
健康和安全:该基金同意为员工提供一个安全和健康的工作环境符合所有适用法律,确保在最低限度,合理获得饮用水和卫生设施,精美的安全性和足够的照明和通风。该基金也同意,以确保健康和安全的相同标准适用于它提供了雇员的住房
9.
COMPLIANCE:
The Facility agrees to take appropriate steps to ensure that the
provisions of the COC are communicated to its employees, including
by prominent posting a copy of this COC in the local language on
one or more bulletin boards in places readily accessible to
employees at all times.
合规性:本基金同意采取适当措施,以确保奥委会的规定传达给员工,其中包括由著名张贴在当地语言的一个或多个电子公告板的名额该行为准则的副本容易获得员工的所有次。
10.
ENVIRONMENT:
Business partners should share our concern for the environment and
adhere to their local and national laws regarding the protection
and preservation of the environment.
环境:业务合作伙伴应该分享我们对环境的关注,并坚持对环境的保护和维护当地和国家法律。
11.
LEGAL
REQUIREMENTS: Business partners should be in compliance with all
legal requirements involved in conducting the
business.
法律要求:业务合作伙伴应符合参与开展业务的所有法律要求。
12.
Our Business
Partners are required to provide full access to their facilities
and those of their manufacturers, vendors and subcontractors, and
to release records relating to employment practices. We may conduct
on-site inspections of facilities to monitor the standards and
assure the quality of our products.
我们的业务合作伙伴必须提供完全访问他们的设备和那些他们的制造商,供应商和分包商,并发布有关用工行为记录。我们可以进行现场视察设施,以监控标准,确保了产品的质量。
Please report Violations Anonymously by emailing to:
esterling@sterlingwinters.com
esterling@sterlingwinters.com;
请通过电子邮件以匿名方式举报违规行为
EXHIBIT D
Approved Royalty Report Form
●
Example
Royalty Reports are set forth on the Brand Partner Resource link,
upon your signature a password will be provided
EXHIBIT E
REQUIRED INSURANCE CERTIFICATE
Under Description of Operations state the
following:
“Certificate Holder I|M1, LLC, I|M1 Holdings, LLC, Level
Brands, Inc., Encore Endeavor 1, LLC, Tommy
Meharey, Kathy Ireland, kathy ireland
Worldwide, Inc., kathy ireland LLC, The Sterling/Winters Company,
and their partners, owners, subsidiaries, affiliates,
directors, officers, managers and employees are named additional
insured with regards to liability arising out of operations of the
named insured.”
The Certificate Holder should be listed as:
I|M1, LLC
4521 Sharon Road, Ste 450
Charlotte, NC 28211
Send copies of Certificate to:
I|M1, LLC
Erik Sterling
FinancialCommittee@sterlingwinters.com;
I|M1, LLC
Mark Elliott
mark@levelbrands.com;
and
Mitchka Lyonnais
mlyonnais@mmibi.com
Momentous Insurance Brokerage, Inc.
EXHIBIT F
Millennium Development Goals
1. We
must eradicate extreme poverty and hunger!
2.
Achieve universal primary education.
3.
Promote gender equality and empower women.
4.
Reduce child mortality.
5.
Improve maternal health.
6.
Combat HIV/AIDS, Malaria, and other diseases.
7.
Ensure environmental sustainability.
8. Build global
partnerships for development.
9.
Bring opportunities of financial stability and healthcare to
American Veterans and their families.
10.
Stop Human Trafficking.
- END OF CONTRACT-
Exhibit
6.36
Exhibit 6.37
FORM OF NOTE CONVERSION AGREEMENT
(Bridge Holders)
THIS NOTE CONVERSION AGREEMENT, dated as
of June __, 2017 (this “Agreement”), by and among
Level Brands, Inc. (the “Company”) and each of the
parties executing below (each a “Noteholder”, and
collectively, the “Noteholders”).
Capitalized terms used herein and not otherwise defined shall have
the meanings ascribed to such terms in the Note (as defined
herein).
WHEREAS, the Company has previously
issued and sold 8% Convertible Promissory Notes due September 30,
2017 (together, the “Notes”) to the
Noteholders in an aggregate principal amount of
$2,125,000;
WHEREAS, each Noteholder beneficially
owns the aggregate principal amount of Notes set forth opposite its
name in Schedule A
attached hereto;
WHEREAS, pursuant to the original terms
of the Notes, such Notes, together with accrued but unpaid interest
thereon, are convertible into shares of the Company's common stock
at a conversion price of $5.00 per share, subject to
adjustment;
WHEREAS, on May 17, 2017 the Company
reduced the conversion price to $3.95 per share until June 30, 2017
(the "Reduced Conversion
Price"); and
WHEREAS, the Noteholders are desirous of
converting the principal and accrued but unpaid interest due under
the Notes into shares of the Company's common stock at the Reduced
Conversion Price subject to the terms of this
Agreement.
NOW, THEREFORE, in consideration of the
premises and the representations, warranties and agreements
contained herein, the parties hereto agree as follows:
1. Conversion; Lockup
Agreement.
(a)
Contemporaneously with the execution and delivery of this
Agreement, each Noteholder hereby converts the principal and
accrued interest due under the Note through June 30, 2017 into
shares of the Company’s common stock (the “Shares”) at the Reduced
Conversion Price, with all amounts due thereunder being cancelled
and deemed to have been paid in full, including any accrued but
unpaid interest (the “Conversion”). Immediately
following the execution of this Agreement by the parties hereto,
each Noteholder shall tender the original Note to the Company for
cancellation and the Company shall issue the certificate
representing the Shares to the Noteholder. Notwithstanding the
foregoing or anything to the contrary contained herein, upon the
execution of this Agreement by a Noteholder, the full amount of the
principal amount of the Note and the accrued but unpaid interest
due thereunder to such Noteholder shall automatically convert into
the Shares, without any further action required by the Noteholder,
with the delivery of the original Note for cancellation being only
for a matter of administrative maintenance.
(b)
In accordance with the terms and conditions of the Subscription
Agreement by and between the Company and the Noteholder pursuant to
which the Noteholder purchased the Note, as a condition of the
conversion of the Note by the Noteholder, the Noteholder shall
execute and deliver to the Company to be held by it pending the
effectiveness of its registration statement for an initial public
offering of its securities an irrevocable lockup agreement for the
benefit of Joseph A. Gunnar & Co. in the form attached hereto
as Exhibit A and
incorporated herein by such reference, to be dated and released by
the Company at such time as it deems appropriate without any
further action or consent of the Noteholder.
(c)
The parties intend that the issuance of the Shares pursuant to the
terms of this Agreement is an exempt issuance under the Securities
Act of 1933, as amended (the "Securities Act") in reliance on
exemptions provided by Section 3(a)(9) and 4(a)(2) of such act. The
certificate representing the Shares shall bear the following
legends:
"THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED ("1933
ACT"), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD OR
OTHERWISE TRANSFERRED OR DISPOSED OF EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT AND ANY
APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL
SATISFACTORY TO COUNSEL TO LEVEL BRANDS, INC. THAT AN EXEMPTION
FROM REGISTRATION UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES
LAWS IS AVAILABLE."
"THE
SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP
AGREEMENT FOR THE BENEFIT OF LEVEL BRANDS, INC. AND JOSEPH A.
GUNNAR & CO., LLC AND CANNOT BE SOLD, ASSIGNED, TRANSFERRED,
PLEDGED OR OTHERWISE HYPOTHECATED EXCEPT PURSUANT TO THE TERMS OF
SUCH LOCK-UP AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL
OFFICES OF LEVEL BRANDS, INC."
2. Representations
and Warranties of the Company. The Company represents and
warrants to the Noteholders as of the date hereof as
follows:
(a)
Due Organization.
The Company is duly organized, validly existing and in good
standing under the laws of the jurisdiction of its
organization.
(b)
Due Authorization; Binding
Agreement; No Conflicts. The Company has full right, power
and authority to execute and deliver this Agreement and to
consummate the transactions contemplated hereby. This Agreement has
been duly and validly authorized, executed and delivered by the
Company and (assuming due authorization, execution and delivery by
the Noteholders) constitutes the valid and binding obligation of
the Company enforceable against the Company in accordance with its
terms, subject to the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar laws
relating to or affecting creditors’ rights generally, and
general equitable principles (whether considered in a proceeding in
equity or at law). Neither this Agreement nor the consummation of
the Conversion will violate, conflict with or result in a breach of
or default under (i) the articles of incorporation or bylaws
of the Company, (ii) any agreement or instrument to which the
Company is a party or by which the Company or any of its assets are
bound, or (iii) any laws, regulations or governmental or
judicial decrees, injunctions or orders applicable to the
Company.
(c)
Validity of Shares.
The Shares issued pursuant to this Agreement, will be duly and
validly issued, fully paid and non-assessable.
3. Representations
and Warranties of the Noteholders. Each Noteholder hereby,
severally and not jointly, represents and warrants to the Company
as of the date hereof as follows:
(a)
Due Organization.
If such Noteholder is a legal entity, it is duly organized and
validly existing under the laws of the jurisdiction of its
organization.
(b)
Due Authorization; Binding
Agreement. Such Noteholder has full right, power and
authority to execute and deliver this Agreement and to consummate
the transactions contemplated hereby. This Agreement has been duly
and validly authorized, executed and delivered by such Noteholder
and (assuming due authorization, execution and delivery by the
Company) constitutes the valid and binding obligation of such
Noteholder enforceable against such Noteholder in accordance with
its terms, subject to the effects of bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other similar
laws relating to or affecting creditors’ rights generally,
and general equitable principles (whether considered in a
proceeding in equity or at law).
(c)
Ownership of the
Notes. Such Noteholder is, and at all times since the
purchase the Note has been, the beneficial owner of its Note, free
and clear of all claims, mortgages, pledges, liens, encumbrances,
options, charges or other security interest that would prevent such
Noteholder’s compliance with its obligations hereunder. Such
Noteholder does not own, beneficially or of record, any Notes of
the Company or securities convertible or exchangeable for Notes of
the Company other than as set forth in Schedule A hereto. Such
Noteholder has the sole right and power to vote and dispose of the
Note, and none of such Note is subject to any voting trust or other
agreement, arrangement or restriction with respect to the voting or
transfer of any of the Note, except for this
Agreement.
(d)
Investment Intent.
The Shares to be acquired by such Noteholder pursuant to this
Agreement shall be acquired for such Noteholder’s own account
and not with a view to, or intention of, distribution thereof in
violation of the Securities Act or any applicable state securities
laws, and such Shares shall not be disposed of in contravention of
the Securities Act or any applicable state securities
laws.
(e)
Accredited
Investor. Such Noteholder is an “accredited
investor” or “institutional accredited investor”
as defined in Rule 501 under Regulation D of the Securities Act.
Such Noteholder is able to bear the economic risk of its investment
in the Shares for an indefinite period of time and acknowledges
that no public market exists for the Shares and that there is no
assurance that a public market will ever develop for the Shares.
The Shares have not been registered under the Securities Act and,
therefore, cannot be sold unless subsequently registered under the
Securities Act or an exemption from such registration is available.
Such Noteholder understands that the tax consequences of the
Conversion may be complex, and accordingly such Noteholder
represents and warrants that it has consulted with its own
independent tax advisor concerning the Conversion and is not
relying on the Company or any of its respective affiliates or
agents, including its counsel and accountants, for any tax advice
regarding the tax consequences of the Conversion or any other
transactions contemplated by this Agreement.
(f)
Information. Such
Noteholder has reviewed, or has had the opportunity to review, with
the assistance of professional and legal advisors of its choosing,
sufficient information and has had sufficient access to the Company
necessary for such Noteholder to decide to convert the Notes for
Shares in accordance with this Agreement.
4. Release.
The Noteholder agrees to release
and discharge the Company, its officers, directors, employees,
affiliates, agents, attorneys, assigns and successors, of and from
any and all actions, causes of action, suits, debts, losses,
accounts, covenants, contracts, agreements, liabilities, damages,
costs, expenses, judgments, claims and other obligations of
whatever kind or nature, known or unknown, arising from, connected
or related to, or caused by any event, occurrence, cause or thing,
of any type whatsoever, arising or existing, or occurring, in whole
or in part, at any time from the beginning of the world through the
date of this Agreement.
5. General
Provisions.
(a)
Closing. The
closing of the transactions contemplated by this Agreement shall
occur simultaneously with the execution and delivery of this
Agreement.
(b)
Amendments, Etc. No
amendment, modification, termination, or waiver of any provision of
this Agreement, and no consent to any departure by any of the
Noteholders or the Company from any provision of this Agreement,
shall be effective unless it shall be in writing and signed and
delivered by the party sought to be bound, and then it shall be
effective only in the specific instance and for the specific
purpose for which it is given.
(c)
Disclosure. Nothing
contained in this Agreement shall be construed to limit the Company
or any Noteholder from making such disclosures as may be required
by law.
(d)
Notice. All notices
and other communications hereunder shall be in writing and shall be
deemed given if delivered personally, telecopied (with
confirmation), mailed by registered or certified mail (return
receipt requested) or delivered by an express courier (with
confirmation) to the Company at 4521 Sharon Road, Suite 407,
Charlotte, NC 28211, Attention: CFO, and to each Noteholder at
their last known address (or at such other address for a party as
shall be specified by like notice).
(e)
Severability. Any
term or provision of this Agreement which is invalid or
unenforceable in any jurisdiction shall, as to that jurisdiction,
be ineffective to the extent of such invalidity or unenforceability
without rendering invalid or unenforceable the remaining terms and
provisions of this Agreement or affecting the validity or
enforceability of any of the terms or provisions of this Agreement
in any other jurisdiction.
(f)
Governing Law. This
Agreement shall be governed by, and construed in accordance with,
the laws of the State of North Carolina.
(g)
Entire Agreement.
This Agreement embodies the entire agreement and understanding of
the Noteholders and the Company with respect to the subject matter
hereof and thereof, and supersedes all prior agreements or
understandings, with respect to the subject matter of this
Agreement.
(h)
Specific Performance;
Enforcement. Each of the parties hereto recognizes and
acknowledges that a breach by it of any covenants or agreements
contained in this Agreement will cause the other party to sustain
damages for which it would not have an adequate remedy at law for
money damages, and therefore, each of the parties hereto agrees
that in the event of any such breach the aggrieved party shall be
entitled to the remedy of specific performance of such covenants
and agreements and injunctive and other equitable relief in
addition to any other remedy to which it may be entitled at law or
in equity. The parties agree that they shall be entitled to enforce
specifically the terms and provisions of this Agreement in addition
to any other remedy to which they may entitled at law or in
equity.
(i) Counterparts;
Facsimile. This Agreement may be executed in counterparts,
all of which shall be considered one and the same agreement, and
shall become effective when counterparts have been signed by each
of the parties and delivered to the other parties, it being
understood that all parties need not sign the same counterpart.
This Agreement may be executed by facsimile signatures of the
parties hereto.
(j) Expenses.
All fees and expenses with respect to the negotiation of this
Agreement and the consummation of the transactions contemplated
hereby shall be borne by the party incurring such fees and
expenses. Neither the Company nor any Noteholder is a party to any
agreement, whether written or oral, which provides for the payment
of any brokerage or finder’s fees or commissions to any
broker, financial advisor or consultant, finder, placement agent,
investment banker, bank or other person with respect to the
transactions contemplated by this Agreement.
IN WITNESS WHEREOF, the Company and each
Noteholder has caused this Agreement to be executed on its behalf
as of the date first written above.
Level
Brands, Inc.
By:
________________________
Name:
Mark Elliott
Title:
Chief Operating Officer
and
Chief Financial Officer
Noteholder:
Name:
Title:
Tax ID
____________
Conversion
Details:
Principal Amount:
$_______
Accrued
Interest: $_______
Total
Conversion: $______
Shares
After Conversion: ________
Exhibit
A
LOCK-UP
LETTER AGREEMENT
Joseph
Gunnar & Co., LLC
30
Broad Street, 11th Floor
New
York, NY 10004
As
Representative of the several Underwriters named on Schedule 1 to
the Underwriting Agreement referenced below
Ladies
and Gentlemen:
The
undersigned understands that you (the “Representative”)
and certain other firms (the “Underwriters”)
propose to enter into an Underwriting Agreement (the
“Underwriting
Agreement”) providing for the purchase by the
Underwriters of shares (the “Stock”) of
Common Stock, par value $0.001 per share (the “Common
Stock”), of Level Brands, Inc., a North Carolina
corporation (the “Company”), and
that the Underwriters propose to reoffer the Stock to the public
(the “Offering”).
In
consideration of the execution of the Underwriting Agreement by the
Underwriters, and for other good and valuable consideration, the
undersigned hereby irrevocably agrees that, without the prior
written consent of the Representative, on behalf of the
Underwriters, the undersigned will not, directly or indirectly, (1)
offer for sale, sell, pledge, or otherwise transfer or dispose of
(or enter into any transaction or device that is designed to, or
could be expected to, result in the transfer or disposition by any
person at any time in the future of) any shares of Common Stock
(including, without limitation, shares of Common Stock that may be
deemed to be beneficially owned by the undersigned in accordance
with the rules and regulations of the Securities and Exchange
Commission and shares of Common Stock that may be issued upon
exercise of any options or warrants) or securities convertible into
or exercisable or exchangeable for Common Stock, (2) enter into any
swap or other derivatives transaction that transfers to another, in
whole or in part, any of the economic benefits or risks of
ownership of shares of Common Stock, whether any such transaction
described in clause (1) or (2) above is to be settled by delivery
of Common Stock or other securities, in cash or
otherwise, (3) except as
provided for below, make any demand for or exercise any right or
cause to be filed a registration statement, including any
amendments thereto, with respect to the registration of any shares
of Common Stock or securities convertible into or exercisable or
exchangeable for Common Stock or any other securities of the
Company, or (4) publicly disclose the intention to do any of the
foregoing for a period commencing on the date hereof and ending on
the 180th day after the date of the Prospectus relating to the
Offering (such 180-day period, the “Lock-Up
Period”).
The
foregoing paragraph shall not apply to (a) transactions relating to
shares of Common Stock or other securities acquired in the open
market after the completion of the Offering, provided that no filing under Section
16(a) of the Securities Exchange Act of 1934, as amended (the
“Exchange
Act”), shall be required or shall be voluntarily made
in connection with such transfers; (b) bona fide gifts of shares of any class of
the Company’s capital stock or any security convertible into
Common Stock, in each case that are made exclusively between and
among the undersigned or members of the undersigned’s family,
or affiliates of the undersigned, including its partners (if a
partnership) or members (if a limited liability company); (c) any
transfer of shares of Common Stock or any security convertible into
Common Stock by will or intestate succession upon the death of the
undersigned; (d) transfer of shares of Common Stock or any
security convertible into Common Stock to an immediate family
member (for purposes of this Lock-Up Letter Agreement,
“immediate family” shall mean any relationship by
blood, marriage or adoption, not more remote than first cousin) or
any trust, limited partnership, limited liability company or other
entity for the direct or indirect benefit of the undersigned or any
immediate family member of the undersigned; provided that, in the case of clauses (b) - (d) above,
it shall be a condition to any such transfer that (i) the
transferee/donee agrees to be bound by the terms of this Lock-Up
Letter Agreement (including, without limitation, the restrictions
set forth in the preceding sentence) to the same extent as if the
transferee/donee were a party hereto, (ii) each party (donor,
donee, transferor or transferee) shall not be required by law
(including without limitation the disclosure requirements of the
Securities Act of 1933, as amended, (the “Securities
Act”) and the Exchange
Act) to make, and shall agree to not voluntarily make, any filing
or public announcement of the transfer or disposition prior to the
expiration of the 180-day period referred to above, and
(iii) the undersigned notifies the Representative at least two
business days prior to the proposed transfer or disposition; (e)
the transfer of shares to the Company to satisfy withholding
obligations for any equity award granted pursuant to the terms of
the Company’s stock option/incentive plans, such as upon
exercise, vesting, lapse of substantial risk of forfeiture, or
other similar taxable event, in each case on a
“cashless” or “net exercise” basis (which,
for the avoidance of doubt shall not include “cashless”
exercise programs involving a broker or other third party),
provided
that as a condition of any transfer
pursuant to this clause (e), that if the undersigned is required to
file a report under Section 16(a) of the Exchange Act, reporting a
reduction in beneficial ownership of shares of Common Stock or any
securities convertible into or exercisable or exchangeable for
Common Stock during the Lock-Up Period, the undersigned shall
include a statement in such report, and if applicable an
appropriate disposition transaction code, to the effect that such
transfer is being made as a share delivery or forfeiture in
connection with a net value exercise, or as a forfeiture or sale of
shares solely to cover required tax withholding, as the case may
be; (f) transfers of shares of Common Stock or any
security convertible into or exercisable or exchangeable for Common
Stock pursuant to a bona fide third party tender offer made to all
holders of the Common Stock, merger, consolidation or other similar
transaction involving a change of control (as defined below) of the
Company, including voting in favor of any such transaction or
taking any other action in connection with such transaction,
provided that in the event
that such merger, tender offer or other transaction is not
completed, the Common Stock and any security convertible into or
exercisable or exchangeable for Common Stock shall remain subject
to the restrictions set forth herein;
(g) the exercise of warrants or the exercise of stock
options granted pursuant to the Company’s stock
option/incentive plans or otherwise outstanding on the date hereof;
provided, that the
restrictions shall apply to shares of Common Stock issued upon such
exercise or conversion; (h) the establishment of any contract,
instruction or plan that satisfies all of the requirements of Rule
10b5-1 (a “Rule 10b5-1
Plan”) under the Exchange Act; provided, however, that no sales of Common Stock
or securities convertible into, or exchangeable or exercisable for,
Common Stock, shall be made pursuant to a Rule 10b5-1 Plan prior to
the expiration of the Lock-Up Period; provided further, that the Company is not
required to report the establishment of such Rule 10b5-1 Plan in
any public report or filing with the Commission under the Exchange
Act during the lock-up period and does not otherwise voluntarily
effect any such public filing or report regarding such Rule 10b5-1
Plan; and (i) any demands or requests for, exercise any right with
respect to, or take any action in preparation of, the registration
by the Company under the Securities Act of the undersigned’s
shares of Common Stock, provided that no transfer of the
undersigned’s shares of Common Stock registered pursuant to
the exercise of any such right and no registration statement shall
be filed under the Securities Act with respect to any of the
undersigned’s shares of Common Stock during the Lock-Up
Period. For purposes of clause (f) above, “change of
control” shall mean the consummation of any bona fide third
party tender offer, merger, purchase, consolidation or other
similar transaction the result of which is that any
“person” (as defined in Section 13(d)(3) of the
Exchange Act), or group of persons, becomes the beneficial owner
(as defined in Rules 13d-3 and 13d-5 of the Exchange Act) of a
majority of total voting power of the voting stock of the
Company.
The
undersigned also agrees and consents to the entry of stop transfer
instructions with the Company’s transfer agent and registrar
against the transfer of the undersigned’s securities subject
to this Lock-Up Letter Agreement except in compliance with this
Lock-Up Letter Agreement.
If (i)
during the last 17 days of the Lock-Up Period, the Company issues
an earnings release or material news or a material event relating
to the Company occurs, or (ii) prior to the expiration of the
Lock-Up Period, the Company announces that it will release earnings
results or becomes aware that material news or a material event
will occur during the 16-day period beginning on the last day of
the Lock-Up Period, the restrictions imposed by this Lock-Up Letter
Agreement shall continue to apply until the expiration of the
18-day period beginning on the issuance of the earnings release or
the occurrence of such material news or material event, as
applicable, unless the Representative waives, in writing, such
extension.
The
undersigned agrees that, prior to engaging in any transaction or
taking any other action that is subject to the terms of this
Lock-Up Letter Agreement during the period from the date hereof to
and including the 34th day following the
expiration of the initial Lock-Up Period, the undersigned will give
notice thereof to the Company and will not consummate any such
transaction or take any such action unless it has received written
confirmation from the Company that the Lock-Up Period (as may have
been extended pursuant to the previous paragraph) has
expired.
If the
undersigned is an officer or director of the Company, (i) the
undersigned agrees that the foregoing restrictions shall be equally
applicable to any shares of Common Stock that the undersigned may
purchase in the Offering; (ii) the Representative agrees that, at
least three (3) business days before the effective date of any
release or waiver of the foregoing restrictions in connection with
a transfer of securities subject to this Lock-Up Letter Agreement,
the Representative will notify the Company of the impending release
or waiver; and (iii) the Company has agreed in the Underwriting
Agreement to announce the impending release or waiver by press
release through a major news service at least two (2) business days
before the effective date of the release or waiver. Any release or
waiver granted by the Representative hereunder to any such officer
or director shall only be effective two (2) business days after the
publication date of such press release. The provisions of this
paragraph will not apply if (a) the release or waiver is effected
solely to permit a transfer of securities subject to this Lock-Up
Letter Agreement not for consideration and (b) the transferee has
agreed in writing to be bound by the same terms described in this
securities subject to this Lock-Up Letter Agreement to the extent
and for the duration that such terms remain in effect at the time
of such transfer.
It is
understood that, if the Company notifies the Underwriters that it
does not intend to proceed with the Offering, if the Underwriting
Agreement does not become effective, or if the Underwriting
Agreement (other than the provisions thereof which survive
termination) shall terminate or be terminated prior to payment for
and delivery of the Stock, the undersigned will be released from
its obligations under this Lock-Up Letter Agreement.
The
undersigned understands that the Company and the Underwriters will
proceed with the Offering in reliance on this Lock-Up Letter
Agreement.
Whether
or not the Offering actually occurs depends on a number of factors,
including market conditions. Any Offering will only be made
pursuant to an Underwriting Agreement, the terms of which are
subject to negotiation between the Company and the
Underwriters.
This
Lock-Up Letter Agreement shall automatically terminate upon the
earliest to occur, if any, of (1) the termination of the
Underwriting Agreement before the sale of any Stock to the
Underwriters or (2) December 31, 2017, in the event that the
Underwriting Agreement has not been executed by that
date.
The
undersigned hereby represents and warrants that the undersigned has
full power and authority to enter into this Lock-Up Letter
Agreement and that, upon request, the undersigned will execute any
additional documents necessary in connection with the enforcement
hereof. Any obligations of the undersigned shall be binding upon
the heirs, personal representative, successors and assigns of the
undersigned.
Very
truly yours,
By:______________________________
Name:
Title:
Dated:
_______________, 2017
Exhibit 6.38
MANAGEMENT CONSULTING AGREEMENT
THIS
MANAGEMENT CONSULTING AGREEMENT is made this 1st day of July, 2017
(the “Effective Date”), by and between Market
Development Consulting Group, Inc. d/b/a MDC Group
(“Consultant”), a Wisconsin corporation with mailing
address 7845 N. Links Circle, Fox Point, WI, 53217, and Level
Brands, Inc., (“Company”), a Delaware corporation with
principal executive offices located at 4521 Sharon Road Suite 407,
Charlotte, NC 28211.
WHEREAS, Consultant
provides management consulting services; and
WHEREAS, Company
wishes to retain Consultant to provide such services to Company in
preparation for its Initial Public Offering (the
“IPO”), on the terms and conditions set forth
herein.
NOW
THEREFORE, for the mutual promises and other consideration
described herein, the parties hereto agree as follows:
1. Information
to be furnished by Company. Company shall furnish Consultant
with current public information about Company, including any
filings with the Securities and Exchange Commission related to an
IPO, its most recent Annual Report to Shareholders, its most recent
Proxy Statement, and shall also provide any other public
information reasonably requested by Consultant (“Company
Information”). Consultant acknowledges that Company will,
from time to time in the course of consulting with Consultant on
press releases and other communications to the public and to
broker/dealer and institutional investor networks, provide to
Consultant nonpublic information. For so long as such information
remains nonpublic or unless and until Company advises Consultant
that such information no longer is material, Consultant shall
refrain from trading in any securities of Company or advising
others to do so and shall refrain from disclosing or disseminating
such information to any other party except as directed and approved
by Company.
Company
shall be responsible to assure Company Information accurately and
fairly presents the financial condition and results of operations
of Company as of the dates indicated thereon. Consultant shall have
no liability for any misstatement or omission in Company
Information, and Company shall be obligated to indemnify and defend
Consultant against any claim, action or proceeding brought by any
party against Consultant asserting such third party has been
injured as a result of any such misstatement or
omission.
2. Management
Consulting Services. Consultant shall assist Company’s
management in developing and executing its investor and corporate
communications presentations.
Consultant is an
independent contractor and is not an officer, employee, servant,
agent, partner or joint venturer of Company. In the performance of
services under this Agreement, Consultant’s Staff shall not
be, and shall not hold themselves out to be, an officer, employee,
servant, agent, partner or joint venturer of Company and shall have
no authority to legally bind Company unless expressly authorized to
do so in writing by an authorized executive officer of
Company.
3. Term
and Termination. This Agreement shall become effective as of
the date written above, and shall remain in effect until the
completion of the Company’s IPO or no later than the close of
business on September 30, 2017 (“Expiration Date”).
Upon expiration or non-renewal of this Agreement, the parties
hereto shall have no further duty or obligations hereunder;
provided that Company shall remain obligated to defend and
indemnify Consultant as described in paragraph 1 of this Agreement
and to make any payments of retainer fees and reimbursable expenses
pursuant to paragraph 4 and paragraph 5 which remain unpaid as
of the effective date of expiration or non-renewal.
4. Compensation
for Services.
(a) Consulting Fee. For the term of
this Agreement, Company shall pay to Consultant a fee of US
$20,000.00 in two installments. Upon execution, Company shall remit
the first payment of $10,000.00 and shall issue to Consultant 5,000
shares of its common stock.
The
second installment shall be due and payable by Company on August 1,
2017 (the “Payment Date”). Failure by Company to pay
the second installment on the Payment Date shall entitle Consultant
to cease providing services pursuant to this Agreement unless and
until said payment (together with any applicable late payment fee
or penalty) is tendered in full, in addition to any other rights or
remedies Consultant may have under this Agreement, at law or in
equity, on account of such late payment. Payment of the second
installment shall be made on the Payment Date pursuant to this
agreement, without further notice or invoice by Federal Funds Wire
or ACH Transfer to Consultant.
Any
payment made more than thirty (30) days after the Payment Date will
be subject to an interest charge at the rate of 18% per year from
the Payment Date until the date paid or, if less, the maximum legal
rate permissible under applicable law.
Company
shall have taken all steps necessary to assure that such shares of
the Company, will constitute duly authorized, fully-paid upon
issuance, non-assessable, validly issued and outstanding shares of
common stock of Company.
5. Reimbursement
for Expenses. Company shall reimburse Consultant for
reasonable out-of-pocket expenses incurred by Consultant in
connection with performing services pursuant to this Agreement,
including without limitation travel, meals, lodging, mobile
telephone, and long distance telephone. Notwithstanding the
forgoing, any individual expenses in excess of $2,000.00, must be
pre-approved by Company in writing or such expense may be
disallowed. Company agrees to make reimbursement payments for
out-of-pocket expenses upon receipt of Consultant’s invoice.
Any reimbursement payments owed but not made within fifteen (15)
days following the Company's receipt of invoice shall accrue
interest from the invoice date at the rate of 18% per year, or, if
less, the maximum rate permitted under applicable law.
6. Consultant’s
Representations and Warranties. Consultant represents and
warrants to Company that Consultant has all requisite power and
authority and has taken all actions necessary to authorize the
execution, delivery and performance by it of this Agreement. This
Agreement constitutes the valid and binding obligations of
Consultant, enforceable against Consultant in accordance with its
terms, except as the enforceability thereof may be limited by
bankruptcy, insolvency, reorganization, moratorium or other similar
laws relating to the rights of creditors generally and for general
principles of equity.
EXCEPT
AS STATED IN THE PRECEEDING PARAGRAPH, CONSULTANT MAKES NO
REPRESENTATIONS OR WARRANTIES WITH RESPECT TO THE QUALITY OF
SERVICES TO BE PROVIDED HEREUNDER OR ANY RESULTS TO BE ACHIEVED,
AND HEREBY EXPRESSLY DISCLAIMS THE EXISTENCE OF ANY SUCH
REPRESENTATIONS AND WARRANTIES, INCLUDING WITHOUT LIMITATION THE
IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR
PURPOSE. CONSULTANT SHALL HAVE NO LIABILITY FOR ANY INDIRECT,
INCIDENTAL OR CONSEQUENTIAL DAMAGES SUFFERED BY
COMPANY.
7. Company’s
Representations and Warranties. Company represents and
warrants to Consultant that Company has all requisite corporate or
other power and authority, and has taken all corporate or other
actions necessary to authorize, the execution, delivery and
performance by it of this Agreement. This Agreement constitutes,
and upon execution will constitute, the valid and binding
obligations of Company, enforceable against Company in accordance
with their respective terms, except as the enforceability thereof
may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws relating to the rights of
creditors generally and for general principles of
equity.
8. Insurance. Company
shall include Consultant as an insured under the director and
officer insurance policy it maintains for its directors and
officers.
9. Miscellaneous.
Neither party may assign its rights or duties under this
Agreement without the express prior written consent of the other
party, except that (i) either party
may assign all of its rights hereunder together with all of its
obligations hereunder to any third party with which it may merge or
consolidate or to a purchaser of substantially all of the assets of
such party and (ii) Consultant may, without Company’s
consent, assign to any party affiliated with Consultant or to any
independent contractor who renders services to Consultant in
connection with Consultant’s performance of this Agreement
Consultant’s right to receive all or any portions of the
Consulting Fee, Common Stock and reimbursable expenses due and
owing to Consultant.
“Company”
as used in this Agreement, shall mean Level Brands, Inc. and all of
its wholly owned subsidiaries.
This
Agreement contains the entire understanding of the parties with
respect to the subject matter hereof. The terms of this Agreement
may be altered only by written agreement between the parties. The
failure of either party to object to or take affirmative action
with respect to any conduct of the other which is in violation of
the terms of this Agreement shall not be construed as a waiver of
the violation or breach, or of any future similar violation or
breach.
This
Agreement shall be construed, interpreted and enforced in
accordance with the laws of the State of Wisconsin, without regard
to its provisions governing choice of law.
IN
WITNESS WHEREOF, each of the parties hereto has caused this
Agreement to be executed by its duly authorized officer as of the
Effective Date.
Level
Brands, Inc.
|
Market Development Consulting Group, Inc.
|
|
|
By: /s/ Mark
Elliott
|
By: /s/ David E.
Castaneda
|
Mark Elliott, CFO & COO
|
David E. Castaneda,
President
|
EXHIBIT
A
ADVISORY AGREEMENT
THIS ADVISORY AGREEMENT (the
“Agreement”)
is made this 1st day of September, 2017 (the “Effective
Date”) by and between LEVEL BRANDS, INC., a North Carolina
corporation (the “Company”)
with its principal place of business located at 4521 Sharon Road,
Suite 470, Charlotte, NC 28211 and JON CARRASCO, an individual (the
“Advisor”),
with his principal offices located in care of P.O. Box 1410, Rancho
Mirage, CA 92270.
R E C I T A L S
WHEREAS, the Company is a branding and
marketing company.
WHEREAS, the Advisor is President of
kathy ireland® Worldwide ("kiWW").
WHEREAS, affiliates of kiWW are owners
of two of the Company's subsidiaries, I'M1, LLC, a California
limited liability company ("I’M1"),
and Encore Endeavor 1, LLC, a California limited liability
("EE1).
WHEREAS, the Company desires to retain
the Advisor to provide certain advisory services as hereinafter set
forth.
WHEREAS, the Advisor desires to provide
certain advisory and consulting services to the Company in
accordance with the terms and conditions contained
hereinafter.
NOW, THEREFORE, in consideration of the
mutual promises set forth herein and other good and valuable
consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows:
1. Advisory
Services. During the
Term of this Agreement, the Advisor is hereby retained by the
Company on a non-exclusive basis to provide advisory and consulting
services to the Company and in connection therewith, to serve as
Global Creative Director of I’M 1 and EE1 (the
“Services”).
As the Global Creative Director he will have responsibility to
develop and facilitate creative strategies for each of I'M1 and
EE1, under the direction of the Chief Executive Officer of the
Company. The Advisor shall provide such Services as reasonably
requested by the Company during the Term of this Agreement;
provided, however, that the
Advisor shall not be required to devote any minimum number of hours
per week to the provision of the Services hereunder. Unless
otherwise agreed to by the Advisor, all Services hereunder shall be
performed by the Advisor, in his sole discretion, at his principal
place of business. The Advisor represents and warrants to the
Company that the provision of the Services contemplated hereunder
will not conflict with any agreement or understanding to which he
is a party and that kiWW has consented to the engagement of the
Advisor by the Company as herein contemplated.
2. Term;
Termination. The Term of this Agreement shall commence on
the Effective Date as set forth above and end on February 28, 2019,
(the “Expiration
Date”). Either party may terminate this Agreement upon
30 days written notice to the other party.
3. Compensation;
Independent Contractor.
(a) For
all services rendered by the Advisor in any capacity required
hereunder during the Term, including, without limitation, services
as Global Creative Director of I'M1 and EE1, the Advisor shall be
entitled to receive $1.00 per month payable in accordance with the
customary accounts payable practices of the Company (the
"Compensation").
(b) The Advisor
acknowledges and agrees that he shall be an independent contractor
and the Advisor shall not be considered an “employee”
of the Company, I'M1 and/or EE1 for any purpose. The Advisor shall
be solely responsible for the payment of all foreign, federal,
state and local sales taxes, use taxes, value added tax,
withholding taxes, income tax, unemployment and workers’
compensation insurance premiums, and similar taxes and charges of
any kind with respect to his compensation and the Services provided
under this Agreement.
4. Expenses.
The Advisor shall be reimbursed for all out of pocket costs and
expenses incurred by him in the performance of the Services
hereunder subject to preapproval by the Company.
5. Return of
Documents. On termination of this Agreement or at any time
upon the request of Company in writing, Advisor shall return to
Company all documents, including all copies thereof, and all other
property relating to the business of Company and/or its
subsidiaries, including without limitation, the Confidential
Information (as hereinafter defined), in its possession or
control.
6. Amendment or
Assignment. No
modification, waiver, amendment, discharge or change of this
Agreement shall be valid unless the same is evidenced by a written
instrument, executed by the party against which such modification,
waiver, amendment, discharge or change is sought. This Agreement is
not assignable by the Advisor without the prior written consent of
the Company, which such consent may not be forthcoming; provided,
that for the avoidance of doubt, assignment by Advisor of one or
more advisory services to its employees or affiliates shall not
constitute a violation of this Agreement.
7. Confidentiality.
(a) In connection with
the performance of the Services contemplated by this Agreement, the
Advisor and his affiliates may gain access to Confidential
Information (as hereinafter defined) of the Company. Confidential
Information includes information communicated orally, in writing,
by electronic or magnetic media, by visual observation, or by other
means, and may be marked confidential or proprietary, or bear a
marking of like import, or which the Company states to be
confidential or proprietary, or which would logically be considered
confidential or proprietary under circumstances of its disclosure
known to Advisor. No rights or licenses to trademarks, inventions,
copyrights, patents or any other intellectual property rights are
implied or granted under this Agreement or by the conveying of
Confidential Information to Advisor.
(b) The Advisor
acknowledges and understands that: (i) Confidential Information
provides the Company with a competitive advantage (or that could be
used to the disadvantage of the Company by a competitor); (ii) the
Company has a continuing interest in maintaining the
confidentiality of Confidential Information; and (iii) the Company
has a compelling business interest in preventing unfair competition
stemming from the use or disclosure of Confidential
Information.
(c) For purposes
hereof, “Confidential
Information” includes, but is not limited to,
information pertaining to business plans, joint venture agreements,
licensing agreements, financial information, contracts, customers,
products, trade secrets, specifications, designs, plans, drawings,
software, data, prototypes, processes, methods, research,
development or other information relating to the business
activities and operations of the Company.
(d) The Advisor agrees,
and shall use reasonable efforts, to cause his controlled
affiliates to agree, to keep Confidential Information confidential
and, except as authorized by the Company, Advisor shall not,
directly or indirectly, use Confidential Information for any reason
except in a manner Advisor believes reasonable or appropriate to
perform the Services under this Agreement. The Advisor acknowledges
that such Confidential Information could be deemed to be material
non-public information that is not generally available to the
public. The Advisor further acknowledges his understanding that
federal securities laws strictly prohibit any individual or entity
who obtains inside information, and has a duty not to disclose it
such as the Advisor, from using the information in connection with
the purchase or sale of securities, and Company shall advise
Advisor whether information disclosed to him constitutes material,
nonpublic information.
(e) The restrictions in
subsection (d) of this Section shall not apply to any Confidential
Information that: (i) is or becomes available to the public through
no breach of this Agreement by Advisor; (ii) was previously known
by Advisor or his affiliates; (iii) is received from a third party
free to disclose such information without restriction; (iv) is
independently developed by Advisor or his affiliates without the
use of the Confidential Information; (v) is approved for release by
written authorization of the Company or its affiliates; (vi) is
required by law or regulation to be disclosed, but only to the
extent and for the purposes of such required disclosure; or (vii)
is disclosed in response to an order or request of a governmental
agency, provided that Advisor notifies the Company of the order or
request ten (10) days prior to disclosure and permits the Company
to seek an appropriate protective order.
8. Indemnity;
Insurance.
(a) Indemnity: The Company shall
indemnify, defend, and hold Advisor and his affiliates harmless, at
Company’s own expense, from and against any and all losses,
liability, obligations, damages, third-party claims, demands,
causes of action, costs and expenses of whatever form or nature
(each a “Claim”
and collectively, “Claims”),
including reasonable outside attorney’s fees and other costs
of legal defense, arising out of or related to: (i) the
Advisor’s rendering of Services under this Agreement; (ii) an
actual or alleged breach of any of the representations, warranties
or covenants of this Agreement by the Company; (iii)
Company’s negligence, willful misconduct, or willful
misrepresentation; or (iv) any other act or omission by or
attributable to Company in connection with this Agreement except to
extent such indemnity is prohibited by law. Company shall give
prompt written notice to the Advisor of any proposed settlement of
any Claim. Company may not, without the Advisor’s prior
written consent, which the Advisor shall not unreasonably withhold,
condition or delay, settle or compromise any claim or consent to
the entry of any judgment regarding which indemnification is being
sought hereunder unless such settlement, compromise or consent: (X)
includes an unconditional release of the Advisor from all liability
arising out of such claim; (Y) does not contain any admission or
statement suggesting any wrongdoing or liability on behalf of the
Advisor; and (Z) does not contain any equitable order, judgment or
term (other than the fact of payment or the amount of such payment)
that in any manner affects, restrains or interferes with the
business of the Advisor. Provided, however, that the indemnity
agreement contained in this Section 9(a) shall not apply to any
such losses, claims, related expenses, damages or liabilities
arising out of gross negligence, willful misconduct or fraud of the
Advisor, or a material breach of the Advisor’s
representations and warranties hereunder.
(b) Exculpation: Notwithstanding
anything to the contrary herein, the Advisor shall, to the greatest
extent permitted by law at the time this clause is construed, be
exculpated from any liability whatsoever for any alleged abuse of
discretion, tort, breach of fiduciary duty and/or breach of trust
caused by any act or omission in connection with this Agreement. As
a consequence, the Advisor shall under no circumstances ever be
held personally liable to any other person, firm or corporation for
any damages directly or indirectly arising out of any act or
omission committed in connection with this Agreement. This
exculpation shall not, however, protect the Advisor from any
liability for a breach of trust committed intentionally or in bad
faith. Even if this Section 9(b) shall not protect the Advisor due
to the foregoing sentence, in no event shall the Advisor ever be
liable for any punitive or exemplary damages for any act or
omission committed in connection with this Agreement hereunder
regardless of whether such act or omission constituted an act
committed intentionally or in bad faith.
(c) Insurance: The Company has
procured, and shall continue to maintain, policies of director and
officer insurance that provides to the same coverage to Advisor as
is provided to any officer and director of the
Company.
9. Waiver.
Unless agreed in writing, the failure of either party, at any time,
to require performance by the other of any provisions hereunder
shall not affect its right thereafter to enforce the same, nor
shall a waiver by either party of any breach of any provision
hereof be taken or held to be a waiver of any other preceding or
succeeding breach of any term or provision of this Agreement. No
extension of time for the performance of any obligation or act
shall be deemed to be an extension of time for the performance of
any other obligation or act hereunder.
10. Notices.
All notices, demands or other communications given hereunder shall
be in writing and shall be deemed to have been duly given on the
day when delivered in person or transmitted by confirmed facsimile
transmission or on the third (3rd) calendar day after being mailed
by United States registered or certified mail, return receipt
requested, postage prepaid, to the addresses hereinabove first
mentioned or to such other address as any party hereto shall
designate to the other for such purpose in the manner herein set
forth.
11. Entire
Agreement. This
Agreement contains all of the understandings and agreements of the
parties with respect to the subject matter discussed herein. All
prior agreements, whether written or oral, are merged herein and
shall be of no force or effect.
12. Survival.
Any termination of this Agreement shall not, however, affect the
ongoing provisions of this Agreement which shall survive such
termination in accordance with their terms.
13. Severability.
The invalidity, illegality or unenforceability of any provision or
provisions of this Agreement will not affect any other provision of
this Agreement, which will remain in full force and effect, nor
will the invalidity, illegality or unenforceability of a portion of
any provision of this Agreement affect the balance of such
provision. In the event that any one or more of the provisions
contained in this Agreement or any portion thereof shall for any
reason be held to be invalid, illegal or unenforceable in any
respect, this Agreement shall be reformed, construed and enforced
as if such invalid, illegal or unenforceable provision had never
been contained herein.
14. Governing
Law. This Agreement shall become valid when executed and
accepted by Company. This Agreement shall be construed in
accordance with the laws of the State of California, without an
application of the principles of conflicts of laws. Anything in
this Agreement to the contrary notwithstanding, the Advisor shall
conduct the Advisor's business in a lawful manner and faithfully
comply with applicable laws or regulations of the state, city or
other political subdivision in which the Advisor is
located.
15. Enforcement.
Any suit, action or proceeding with respect to this Agreement shall
be brought in the state or federal courts located in Los Angeles
County in the State of California. The parties hereto hereby accept
the exclusive jurisdiction and venue of those courts for the
purpose of any such suit, action or proceeding. The parties hereto
hereby irrevocably waive, to the fullest extent permitted by law,
any objection that any of them may now or hereafter have to the
laying of venue of any suit, action or proceeding arising out of or
relating to this Agreement or any judgment entered by any court in
respect thereof brought in Los Angeles County, California, and
hereby further irrevocably waive any claim that any suit, action or
proceeding brought in Los Angeles County, California has been
brought in an inconvenient form.
16. Binding Nature, No
Third Party Beneficiary. The terms and provisions of this
Agreement shall be binding upon and inure to the benefit of the
parties, and their respective successors and assigns.
17. Counterparts.
This Agreement may be executed in any number of counterparts,
including facsimile signatures which shall be deemed as original
signatures. All executed counterparts shall constitute one
agreement, notwithstanding that all signatories are not signatories
to the original or the same counterpart.
IN WITNESS WHEREOF, the parties hereto
have executed this Agreement as of the date first above
written.
|
THE
COMPANY
LEVEL
BRANDS, INC.
By:
/s/ Mark S.
Elliott
Mark S.
Elliott, Chief Financial Officer
/s/ Jon Carrasco
Jon
Carrasco
|
Exhibit
7.1
CONTRIBUTION
AGREEMENT
by and
between
Beauty
& Pinups, Inc.
and
Beauty
and Pin Ups, LLC
DATED
APRIL 13TH, 2015
This
CONTRIBUTION AGREEMENT (this “Agreement”) is entered
into by and between Beauty & Pinups, Inc., a New York
corporation (“BPU”), Priel Maman (“Maman”)
(BPU and Maman, collectively, the “Contributor”), and
Beauty and Pin Ups, LLC, a North Carolina limited liability company
(the “Company”), as of date first referenced above (the
“Contribution Date”).
RECITALS
1. BPU
conducts a business that produces, markets and sells various beauty
related products (the “Business”).
2.
Contributor wishes to contribute the Business and certain
intellectual property to the Company in exchange for a 12%
membership interest in the Company to Maman, a 10% membership
interest in the Company to Sigan Industries Group and a cash
payment of $150,000 to the Contributor.
3. In
order to accomplish the foregoing, simultaneously with the
execution of this Agreement, Contributor and the Company shall
enter into the agreements identified in Article III hereof
(collectively, the “Other Agreements”).
4. The
foregoing contribution of assets by Contributor and assumption of
liabilities by the Company are all subject to the terms and
conditions of this Agreement and the Other Agreements.
In
consideration of the foregoing and the mutual representations,
warranties, covenants, and agreements herein contained, Contributor
and the Company agree as follows:
ARTICLE
I
CONTRIBUTION OF
ASSETS BY CONTRIBUTOR
SECTION
1.1 Contribution
of the Assets.
(a) Subject
to the terms and conditions of this Agreement, on the Contribution
Date, Contributor hereby assigns, transfers, and delivers to the
Company, as a contribution, free and clear of all title defects,
objections, liens, pledges, claims, rights of first refusal,
options, charges, security interests, mortgages, or other
encumbrances of any nature whatsoever (collectively,
“Encumbrances”) other than “Permitted
Encumbrances” (as defined in Section 1.1(b) of this
Agreement), all of the assets, properties, and business of every
kind and description; wherever located; real, personal, or mixed;
tangible or intangible; owned or held; or used primarily in the
conduct of the Business by Contributor as the same shall exist on
the Contribution Date including all assets and property shown on
the financial statements of the Contributor and all assets and
property thereafter acquired by Contributor in respect of or used
in the Business immediately prior to the Contribution Date
(collectively, the “Assets”), and including, without
limitation, all right, title, and interest of Contributor in, to,
and under:
(i) The
machinery, equipment, furniture, vehicles, and other tangible
property (including, without limitation, maintenance and operating
supplies, fuel, and spare parts for such machinery and equipment)
used in connection with the Business (collectively, the
“Equipment”);
(ii) The
raw materials, finished goods, work-in-process, supplies, and
inventories, with respect to the Business carried on by Contributor
(collectively, the “Inventory”);
(iii) Those
patents, copyrights, trademarks, trade names, technology, know-how,
processes, trade secrets, inventions, proprietary data, formulae,
research and development data, computer software programs, and
other intangible property, and any applications for the same, used
primarily in the portion of the Business carried on by Contributor,
and all goodwill associated with such intangible property
(collectively, the “Intangible Property”);
(iv) All
of Contributor’s rights, claims, credits, causes of action,
or right of setoff against third parties relating to the Assets,
including, without limitation, unliquidated rights under
manufacturers’ and vendors’ warranties (collectively,
“Claims”);
(v) The
contracts, agreements, leases, licenses, and other instruments,
arrangements, and commitments being assumed by the Company with
respect to the Assets pursuant to Section 1.4 of this Agreement
(collectively, “Rights”);
(vi) All
transferable licenses, permits, registrations, authorizations, use
agreements, orders, or approvals of governmental or
quasi-governmental agencies and authorities (whether federal,
state, local, municipal, or foreign) or private parties relating to
the construction, use, operation, or enjoyment of the Assets
(collectively, “Permits”);
(vii) All
accounts receivable arising out of sales of Inventory or otherwise
in the ordinary and usual course of the operation of the Business
prior to the close of business on the Contribution Date
(collectively, “Receivables”);
(viii) Originals
or copies of all books, records, files, and papers, whether in hard
copy or computer format, used in the Business, including without
limitation, engineering information, manuals and data, sales and
advertising materials, sales and purchase correspondence, lists of
present and former suppliers, and personnel and employment records
(collectively, “Files and Records”);
(ix) All
lists of present and, to the extent available, future customers and
goodwill associated with the Assets.
(b) For
purposes of this Agreement, “Permitted Encumbrances”
shall mean (i) the “Assumed Liabilities,” as defined in
Section 1.3 of this Agreement, (ii) liens for current taxes not yet
due and payable, and (iii) Encumbrances that, individually or in
the aggregate, do not or would not have a material adverse effect
on the business or financial condition of the Business taken as a
whole or materially interfere with the present use of any Assets
subject thereto.
SECTION
1.2 Conveyance Instruments. In order to
effectuate the contribution of the Assets as contemplated by this
Article I, Contributor has, or will hereafter, execute and deliver,
or cause to be executed and delivered, all such documents or
instruments of assignment, transfer, or conveyance, in each case
dated the Contribution Date (collectively, the “Conveyance
Instruments”), as the parties and their respective counsel
shall reasonably deem necessary or appropriate to vest in or
confirm title to the Assets to the Company, including without
limitation, the Assignment of Servicemarks and Trademarks and
Assignment of Patents between the parties dated even date
herewith.
SECTION
1.3 Assumed Liabilities. Subject to the
terms and conditions of this Agreement, and in reliance on the
representations, warranties, covenants, and agreements of the
parties contained herein, the Company hereby assumes and agrees to
pay, discharge, or fulfill the following liabilities and
obligations relating to the Business: all of the liabilities and
obligations in respect of the contracts, agreements, licenses, and
other instruments, arrangements, and commitments with Sigan
Industries Group and it’s affilitates with respect to the
production of the product (collectively, the “Assumed
Liabilities”).
SECTION
1.4 Excluded Liabilities. Notwithstanding
any provision of this Agreement or any Conveyance Instrument to the
contrary, the Company is assuming only the Assumed Liabilities and
is not assuming any other liability or obligation of Contributor
(or any predecessor owner of all or part of its business and
assets) of whatever nature whether presently in existence or
arising hereafter, and all such other liabilities and obligations
shall be retained by and remain liabilities of Contributor (all of
such liabilities and obligations not being assumed hereinafter
referred to as the “Excluded Liabilities”) and,
notwithstanding anything to the contrary in this Section 1.4, none
of the following shall be “Assumed Liabilities” for
purposes of this Agreement:
(a) Any
liability for any taxes, fees or assessments by any federal, state
or local governmental authority (“Taxes”) arising from
or with respect to the Assets or the operations of the Business
incurred or attributable to any period prior to the Contribution
Date (the “Excluded Tax Liabilities”);
(b) Any
liabilities or obligations relating to employee benefits or
compensation, including, without limitation, any liabilities or
obligations under any of Contributor’s employee benefit
agreements, plans, or other arrangements; or
(c) Any
liabilities relating to the Excluded Assets (it being understood
that any Tax Liability relating to the Excluded Assets shall be an
Excluded Tax Liability for purposes of this
Agreement).
ARTICLE
II
RELATED
TRANSACTIONS
SECTION
2.1 Other Agreements. Contemporaneously with
the execution of this Agreement, the applicable parties shall enter
into the following Other Agreements:
(a) Redemption
Agreements, in form and substance reasonably satisfactory to the
Company, pursuant to which BPU will redeem all the capital stock of
Contributor from Amnon Ashtar in exchange for $100,000 and Miri Ben
Ari in exchange for $50,000;
(b) An
Assignment of Servicemarks and Trademarks for the trademarks used
in connection with the Business between Maman and the Company;
and
(c) An
Assignment of Patents for the patents used in connection with the
Business between Maman and the Company.
ARTICLE
III
REPRESENTATIONS AND
WARRANTIES OF CONTRIBUTOR
Contributor hereby
represents and warrants that as of the date hereof:
SECTION
3.1 Capitalization and Ownership. There are
200 shares of BPU’s Common Shares (“Contributor Common
Stock”) issued and outstanding. All such Contributor Common
Stock are owned legally and beneficially by the following persons
in the following amounts: (a) Maman owns 70 shares; Amnon Ashtar
owns 70 shares; Dean Gangbar owns 40 shares; and Miri Ben Ari owns
20 shares. The Contributor Common Stock has been duly authorized
and validly issued and is fully paid and nonassessable. There are
no outstanding rights, options, warrants, conversion rights,
preemptive rights, or agreements for the purchase or acquisition
from the Contributor with respect to any shares of the Contributor
Common Stock.
SECTION
3.2 Organization.
(a) BPU
is a corporation that is duly organized, validly existing, and in
good standing under the laws of its state (or jurisdiction) of
incorporation, with the corporate power and authority to own,
lease, and operate its properties and to carry on its business as
now being conducted.
(b) The
copies of the Certificate of Incorporation and all amendments
thereto of BPU, as certified by the Secretary of State (or
equivalent official) of the state (or jurisdiction) of its
incorporation, and the Bylaws, as amended to date.
SECTION
3.3 Authority. Contributor has the corporate
and personal, as applicable, power and authority to execute and
deliver this Agreement and the Other Agreements and to consummate
the transactions contemplated hereby and thereby. The execution and
delivery by Contributor of this Agreement and the Other Agreements,
as the case may be, and the consummation of the transactions
contemplated hereby and thereby, have been duly authorized by the
Board of Directors of Contributor; no other corporate proceedings
on the part of Contributor or any other person or entity, whether
pursuant to the Certificate of Incorporation or Bylaws of
Contributor or by law or otherwise, are necessary to authorize
Contributor to enter into this Agreement and the Other Agreements,
as the case may be, or to consummate the transactions contemplated
hereby and thereby; and this Agreement is the legal, valid, and
binding obligation of Contributor; and each Other Agreement will be
the legal, valid, and binding obligation of
Contributor.
SECTION
3.4 No Violations. Neither the execution or
delivery of this Agreement or the Other Agreements, nor the
consummation of the transactions contemplated hereby or
thereby
(a) Requires
any filing or registration with, or consent, authorization,
approval, or Permit of, any governmental or regulatory authority on
the part of Contributor; or
(b) (i)
violates or breaches or constitutes a default (or an event which,
with notice or lapse of time or both, would constitute a default)
under, or give rise to a right to terminate, any mortgage,
contract, agreement, deed of trust, license, lease, or other
instrument, arrangement, commitment, obligation, understanding, or
restriction of any kind to which Contributor is a party or by which
its properties may be bound, or (ii) will cause, or give any person
grounds to cause, to be accelerated (with notice or lapse of time
or both) the maturity of, or will increase, any liability or
obligation of Contributor.
SECTION
3.5 Certain Tax Matters. The
Contributor:
(a) Has
filed or will file or furnish when due in accordance with all
applicable laws all Tax returns, statements, reports, and forms
(including information returns and reports) required to be filed or
furnished with respect to any Pre-Contribution Tax Period
(collectively, the “Returns”);
(b) Has
correctly reflected in all material respects on the Returns (and,
as to any Returns not filed as of the date hereof, will correctly
reflect) the facts regarding its income, business, assets,
operations, activities, and status of any other information
required to be shown therein;
(c) Has
timely paid, withheld, or made adequate provision for all Taxes
shown as due and payable on the Returns that have been
filed;
(d) Is
not subject to any liens for Taxes on its assets;
(e) Is
not subject to any (A) claims, audits, actions, suits, proceedings,
or investigations with respect to any Tax or assessment, and (B)
requests for rulings in respect of any Tax or any proposed
transaction pending before any Taxing Authority.
SECTION
3.6 Patents,
Trademarks, and Similar Rights.
(i) Contributor
has the sole and exclusive right to use the Intangible Property,
and the consummation of the transactions contemplated by this
Agreement and the Other Agreements will not alter or impair any
such rights and will result in the Company having the sole and
exclusive right to use all such Intangible Property used primarily
in the Business and, with respect to Intangible Property subject to
the Assignment of Servicemarks and Trademarks and Assignment of
Patents between the Contributor and the Company dated even date
herewith, the right to use such Intangible Property to the same
extent it is currently used in the Business;
(ii) No
claims have been asserted by any person or entity for the use of
any such Intangible Property or challenging or questioning the
validity or effectiveness of any such license or agreement, and
Contributor have no knowledge of any valid basis for any such
claim; and
(iii) To
the knowledge of Contributor, the use of such Intangible Property
by Contributor does not infringe on the rights of any person or
entity.
SECTION
3.7 Litigation. There are no lawsuits,
litigation or claims pending or threatened by or against, or
involving Contributor or any directors, officers, or employees
thereof in their capacity as such that are connected to the
Business.
ARTICLE
IV
MISCELLANEOUS
PROVISIONS
SECTION
4.1 Release by Contributor. Contributor, for
themselves, and their affiliates, assigns, heirs and executors,
does hereby forever and unconditionally release the Company and
each other shareholder of the Company, together with their
affiliates and each of their respective past or present officers,
directors, managers, equity holders, employees, agents and
attorneys, from any and all claims, actions, causes of action,
suits, claims, counterclaims, charges, complaints, demands,
liabilities or obligations of any kind whatsoever, whether known or
unknown, arising out of any matter, cause or thing occurring before
the date hereof, including without limitation all claims relating
to or arising out of their interest as a shareholder or creditor of
the Company or any interest in any intellectual property rights
which are owned or used by the Company. Such released claims shall
include, but not limited to, all claims which Contributor has had
or now has and which could have been asserted under state or
federal statute or law, including specifically, but not limited to
(i) any and all claims and rights for additional compensation,
payments or benefits of whatever nature, and (ii) any and all
claims for breach of fiduciary duty, breach of contract, fraud,
negligent misrepresentation, negligence, impairment of economic
opportunity, any tort (whether intentional or negligent), violation
of federal or state unfair trade practices law, violation of state
or federal securities law, and violation of any and all other
federal, state and local laws and regulations. This release covers
any injuries not now known by Contributor that arise in any way out
of events occurring prior to the date of the execution of this
Agreement. This release shall not apply to any rights or duties
arising under this Agreement. Contributor agrees that the Company
and their affiliates may plead this release as a complete bar to
any action or suit before any court or administrative body with
respect to any claim released herein.
SECTION
4.2 Amendment and Modification. This
Agreement may be amended, modified, or supplemented only by written
agreement of the parties hereto.
SECTION
4.3 Waiver of Compliance; Consents. Any
failure of a party to comply with any obligation, covenant,
agreement, or condition herein may be waived by the other party;
provided, however,
that any such waiver may be made only by a written Instrument
signed by the party granting such waiver, but such waiver or
failure to insist upon strict compliance with such obligation,
covenant, agreement, or condition shall not operate as a waiver of,
or estoppel with respect to, any subsequent or other
failure.
SECTION
4.4 Assignment. This Agreement and all of
the provisions hereof shall be binding upon and inure to the
benefit of the parties hereto and their respective successors and
permitted assigns. Any party may assign any of its rights
hereunder, but no such assignment shall relieve it of its
obligations hereunder. Nothing in this Agreement, expressed or
implied, is intended or shall be construed to confer upon any
person other than the parties, any successors and permitted
assigns, any rights, remedy, or claim under or by reason of this
Agreement or any provisions herein contained.
SECTION
4.5 Further Assurances. From time to time,
at the request of Contributor or the Company and without further
consideration, each party, at its own expense, will execute and
deliver such other documents, and take such other action, as
Contributor or the Company may reasonably request in order to
consummate more effectively the transactions contemplated hereby
and to vest in the Company good and marketable title to the Assets.
Contributor hereby constitutes and appoints, effective as of the
Contribution Date, the Company and its successors and permitted
assigns as the true and lawful attorney of Contributor with full
power of substitution in the name of the Company or in the name of
Contributor, but for the benefit of the Company, to collect for the
account of the Company any items of Assets and to institute and
prosecute all proceedings which the Company may in its reasonable
discretion deem proper in order to assert or enforce any right,
title, or interest in, to, or under the Assets, and to defend or
compromise any and all action, suits, or proceedings in respect of
the Assets. The Company shall be entitled to retain for its own
account any amounts collected pursuant to the foregoing powers,
including any amounts payable as interest in respect
thereof.
SECTION
4.6 Governing Law. This Agreement shall be
governed by and construed in accordance with the Laws of the State
of North Carolina (without regard to its conflicts of law
doctrines).
SECTION
4.7 Counterparts. This Agreement may be
executed in two or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the
same instrument and shall become a binding Agreement when one or
more of the counterparts have been signed by each of the parties
and delivered to the other party.
SECTION
4.8 Headings. The article and section
headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation
of this Agreement.
SECTION
4.9 Entire Agreement. This Agreement and
other documents and instruments referred to herein and the Other
Agreements, embodies the entire agreement and understanding of the
parties hereto in respect of the subject matter contained herein.
This Agreement supersedes all prior agreements and understandings
between the parties with respect to such subject
matter.
SECTION
4.10 Severability. If any one or more
provisions contained in this Agreement shall, for any reason, be
held to be invalid, illegal, or unenforceable in any respect, such
invalidity, illegality, or unenforceability shall not affect any
other provision of this Agreement, but this Agreement shall be
construed as if such invalid, illegal, or unenforceable provision
had never been contained herein.
IN
WITNESS WHEREOF, the parties hereto have duly executed this
Agreement as of the day and year first above written.
/s/ Priel Maman
Priel
Maman
Beauty & Pinups, Inc.
By: /s/
Priel Maman
Name:
Title:
Beauty and Pin Ups, LLC
By: /s/
Kenneth Kahn
Name:
Kenneth
Kahn
Title:
Chief Executive
Officer
Exhibit
7.2
Amended and restated
membership
interests Exchange agreement
This
Membership Interests Exchange Agreement (this "Agreement"),
effective as of the 6th day of January
2017, is made and entered into by and among IM1 Holdings, LLC, a
California limited liability company, and the sole member
(the "Member")
of I|M1, LLC, a California limited liability company
(“IM1”)
and Level Brands, Inc., a North Carolina corporation (“the
“Company”).
Terms not otherwise defined herein shall have the meanings set
forth in the Amended and Restated Operating Agreement of
IM1 (the
“Operating
Agreement”).
RECITALS
A. The
parties hereto entered into a Membership Interests Exchange
Agreement dated January 6, 2017 (the “Original
Agreement”) and other than as set forth in the
Preamble and these Recitals, this Agreement shall contemplate the
original January 6, 2017 date.
B. The
parties now desire to amend and restate the Original Agreement with
respect to certain provisions included in the Original Agreement in
order to correct certain scrivener errors and
otherwise.
C. As
of January 5, 2017, the Member was the owner of one hundred percent
(100%) of the Class A Units (the “Class A
Interests”) and one hundred percent (100%) of the
Class B Units (the “Class B
Interests”, and together with the Class A Interests,
the “Interests”)
in IM1.
D. On
January 6, 2017, the Member transferred all of the Class A
Interests (the “Exchange
Interests”) in IM1 to the Company in exchange for
583,000 shares of the Company's Common Stock (the "Level Common
Stock") such that the Company became the holder of 100% of
the Class A Units, which, collectively, will represent 51% of the
Interests.
AGREEMENT
NOW, THEREFORE, in consideration of the
covenants and agreements set forth in this Agreement and other good
and valuable consideration, the receipt and adequacy of which is
hereby acknowledged by all of the parties, the parties hereto agree
as follows:
1.
Transfer and Acceptance of Exchange Interests.
1.1 Transfer
and Acceptance.
Subject to the terms and conditions of this Agreement, upon the
Closing of this Agreement (as hereinafter defined) the
Member shall assign,
transfer and contribute to the Company, and the Company shall
assume and acquire, all of the
right, title and interest in and to the Exchange
Interests.
1.2 Assumption
of Liabilities. The
Company shall not directly assume any of the debts, liabilities, or
other obligations of IM1. Rather, the Company shall merely hold the
Exchange Interests in IM1 with IM1 in accordance with the terms of
the Amended and Restated Operating Agreement of IM1 (the
“Amended Operating
Agreement”), while continuing to maintain its status
as a separate limited liability company for all legal and
accounting purposes.
1.3 The
Member and the Company acknowledge and agree that, for federal,
state and local income tax purposes, the transfer of the Exchange
Interests by the Member to the Company will be treated as (i) a
sale by the Member to the Company of an undivided portion of the
assets of IM1 in exchange for the Level Common Stock Consideration
(as defined below), followed immediately by (ii) a contribution by
the Member and the Company to a new tax partnership of their
respective undivided interests in each of such assets of IM1 in a
transfer described in Section 721(a) of the Code. The Member and
the Company agree to consistently treat the transfer of the
Exchange Interests in such manner for all federal, state and local
income tax purposes.
2.
Consideration.
As consideration for
the transfer of the Exchange Interests by the Member to the
Company, the Company shall issue 583,000 shares of Level Common Stock to
the Member (the “Level Common Stock
Consideration”) in accordance with the terms of this
Agreement. The Level Common Stock Consideration shall be paid by
the Company on the day of the Closing by delivery from the Company
to the Member of the certificates representing the Level Common
Stock Consideration in the names and amounts set forth on
Exhibit A hereto;
provided, that (a) the Member hereby directs the Company to deliver
58,300 of the 583,000 shares of the Level Common Stock
Consideration otherwise deliverable to the Member to Tom Hoberman,
Trustee of the Hoberman Family Trust, u/t/a dated March 29, 1991,
in consideration of services rendered by Mr. Hoberman to the Member
and (b) the parties understand and acknowledge that on the day of
the Closing, the Company shall send to the transfer agent the
completed documentation necessary for the issuance of the Exchange
Shares, and that it may take a few days to process before the
transfer agent issues the actual share certificates of the Company.
Upon issuance in accordance with the terms of this Agreement, the
shares representing the Level Common Stock Consideration shall be
validly issued, fully paid and non-assessable and shall have been
issued in compliance with all laws and regulations applicable
thereto.
3.1 Closing.
The closing of the transfer of the Exchange Interests shall take
place on and this Agreement shall be effective as of January 6,
2017 (the "Closing").
3.2 Deliveries.
3.2.1
By the
Member. At the
Closing, the Member shall deliver the interest
certificate(s), if any, and other applicable instruments evidencing
the transfer of the Exchange Interests to be acquired by the
Company, in form and substance reasonably acceptable to the
Company:
(a) all
consents, authorizations or waivers from parties, as may be
required to be obtained from them in connection with the
consummation of the transactions contemplated hereby;
and
(b) such
other documents, including the Operating Agreement, duly executed
by the Member and in a form and substance reasonably acceptable to
the Company as shall be reasonably necessary to consummate the
transactions contemplated by this Agreement.
3.2.2
By the Company. At
the Closing, the Company shall deliver such documents, including
the Operating Agreement, duly executed by the Company and in a form
and substance reasonably acceptable to the Member as shall be
reasonably necessary to consummate the transactions contemplated by
this Agreement.
3.2.3
Covenants. Each party hereto shall use its
reasonable best efforts to take or cause to be taken all actions,
and to do or cause to be done all other things, necessary, proper
or advisable in order for such party to fulfill and perform its
respective obligations pursuant to this Agreement and otherwise to
consummate and make effective the transactions contemplated hereby
and thereby.
4.
Representations and
Warranties of the Member.
The Member represents and warrants to the
Company as follows:
4.1 Authority.
The execution and delivery of this Agreement and each instrument
required hereby to be executed and delivered by the Member prior to
or at the Closing, the performance of the Member's obligations
hereunder and thereunder and the consummation by the Member of the
transactions contemplated hereby have been duly and validly
authorized by all necessary action on the part of the Member, and
no other proceedings on the part of the Member is necessary to
authorize this Agreement or to consummate the transactions
contemplated hereby. This Agreement has been duly and validly
executed by the Member, and, assuming this Agreement has been duly
executed by the Company, this Agreement constitutes a valid and
binding agreement of the Member, enforceable against the Member in
accordance with its terms, subject to bankruptcy, insolvency,
fraudulent transfer, and similar laws of general applicability
relating to or affecting creditors' rights and to general equity
principles.
4.2 Consents.
The execution and performance of this Agreement does not, and the
consummation of the transactions contemplated hereby and compliance
with the provisions of this Agreement will not (a) conflict with or
violate any statute, ordinance, rule, regulation, judgment, order,
writ, injunction, decree or law applicable to the Member, or by
which the Member is bound, or (b) result in a violation or breach
of or constitute a default (or an event which with or without
notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration
or cancellation of, or result in any loss of any benefit under, any
material contract, agreement or arrangement to which the Member is
a party and which relate to IM1, or the creation of liens on any of
the properties or assets of IM1. No consent, approval, order or
authorization of, or registration, declaration or filing with, any
governmental entity, is required by the Member in connection with
the execution of this Agreement by the Member or the consummation
by him, her or it of the transactions contemplated hereby, except
for such other consents, approvals, orders, authorizations,
registrations, declarations or filings, the failure of which to
obtain would not individually or in the aggregate have a material
adverse effect.
4.3 Title
to the Exchange Interests. The Member is the sole record and
beneficial owner of the Exchange Interests, free and clear of all
liens, and the Exchange Interests have not been sold, pledged,
assigned or otherwise transferred except pursuant to this
Agreement. There are no outstanding subscriptions, rights, options,
warrants or other agreements obligating the Member to sell or
transfer to any third person any of the Exchange Interests, or any
interest therein. The Member has full power and authority to
exchange, transfer and deliver to the Company the
Exchange Interests.
4.4 Litigation.
There are no actions, suits, proceedings or investigations pending
against the Member or the Exchange Interests (nor has the Member
received notice of any threat thereof) before any court or
governmental agency that questions the validity of this Agreement
or the right of the Member to enter into such agreements, or the
right of the Member to perform its obligations contemplated hereby
and thereby, or that, either individually or in the aggregate, if
determined adversely to such Member, would materially detract from
the value of the Exchange Interests or would otherwise be likely to
prevent or materially impede, interfere with, hinder or delay the
transactions contemplated hereby.
4.5 Accredited
Investor. The Member is an “accredited
investor,” as such term is defined in Regulation D
promulgated under the Securities Act of 1933, or is otherwise
experienced in investments and business matters, has made
investments of a speculative nature and has such knowledge and
experience in financial, tax and other business matters as to
enable him to evaluate the merits and risks of, and to make an
informed investment decision with respect to, this Agreement. The
Member understands that his acquisition of the shares of Level
Common Stock is a speculative, illiquid investment, and the Member
represents that he, she or it is able to bear the risk of such
investment for an indefinite period, and can afford a complete loss
thereof.
4.6 Access
to Counsel. The Member acknowledges that, in executing this
Agreement, he, she or it has had the opportunity to seek the advice
of independent legal and/or tax counsel, and has read and
understood all of the terms and provisions of this
Agreement.
5.
Representations and
Warranties of the Company.
5.1 Authority.
The Company is a corporation duly organized and validly existing
under the laws of the State of Florida and has the requisite power
and authority to execute and deliver this Agreement, to acquire the
Exchange Interests and issue the shares representing the Level
Common Stock Consideration, as applicable, and to carry out the
provisions of this Agreement.
5.2 Corporate
Action. All necessary actions on the part of the Company
necessary for the authorization, execution and delivery of this
Agreement and the other agreements and transactions contemplated
herein, the performance of all obligations of the Company hereunder
and thereunder and the authorization, issuance and delivery of the
shares representing the Level Common Stock Consideration being
transferred to the Member hereunder have been taken and this
Agreement and the other agreements contemplated herein constitute
valid and legally binding obligations of the Company, enforceable
in accordance with their terms, subject to bankruptcy, insolvency,
fraudulent transfer, and similar laws of general applicability
relating to or affecting creditors' rights and to general equity
principles.
5.3. Consents.
The execution and performance of this Agreement does not, and the
consummation of the transactions contemplated hereby and compliance
with the provisions of this Agreement will not (a) conflict with or
violate any statute, ordinance, rule, regulation, judgment, order,
writ, injunction, decree or law applicable to the Company, or by
which the Company is bound, or (b) result in a violation or breach
of or constitute a default (or an event which with or without
notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration
or cancellation of, or result in any loss of any benefit under, any
material contract, agreement or arrangement to which the Company is
a party, or the creation of liens on any of the properties or
assets of the Company. No consent, approval, order or authorization
of, or registration, declaration or filing with, any governmental
entity, is required by the Company in connection with the execution
of this Agreement by the Company or the consummation by it of the
transactions contemplated hereby, except for such other consents,
approvals, orders, authorizations, registrations, declarations or
filings, the failure of which to obtain would not individually or
in the aggregate have a material adverse effect.
5.4 Litigation.
There are no actions, suits, proceedings or investigations pending
against the Company (nor has the Company received notice of any
threat thereof) before any court or governmental agency that
questions the validity of this Agreement or the right of the
Company to enter into such agreements, or to perform its
obligations contemplated hereby and thereby, or that, either
individually or in the aggregate, if determined adversely to such
Company, would materially detract from the value of the shares
representing the Level Common Stock Consideration or would
otherwise be likely to prevent or materially impede, interfere
with, hinder or delay the transactions contemplated
hereby.
5.5 Level
Common Stock Consideration. The shares representing the
Level Common Stock Consideration, when issued, sold and delivered
in accordance with the terms hereof for the consideration expressed
herein, will be duly and validly issued, fully paid and
non-assessable and free of any liens, other than restrictions on
transfer under the applicable federal and state securities laws.
The shares representing the Level Common Stock Consideration issued
hereunder will be issued in compliance with all applicable federal
and state securities laws. The Company has retained an independent
third party to assist in preparing an appraisal. The Chief
Financial Officer of the Company has directed and maintained full
responsibility and oversight over the third party’s work,
including evaluation of the adequacy of the work for its purposes,
and has taken full responsibility for the results of the third
party’s work. Subsequently the Company determined the per
share value of the Level Common Stock is $0.85 per share (the
“Appraised
Value”). The Company represents and warrants that (a)
the Appraised Value is reasonable and (b) the Company will treat
the Appraised Value as the value of Level Common Stock
Consideration as of the date of grant for all purposes, including
all state, local and federal tax purposes, and will take no action
that may result in the Appraised Value being challenged. All
parties to this Agreement have discussed and concur on the
Appraised Value indicated above.
5.6 Purchase
for Investment. The Exchange Interests being acquired by the
Company are being acquired for investment for the Company’s
own account and not with a view to the distribution of any part
thereof (or participation therein) in violation of securities laws.
The Company is an “accredited investor,” as such term
is defined in Regulation D promulgated under the Securities Act of
1933, or is otherwise experienced in investments and business
matters, has made investments of a speculative nature and has such
knowledge and experience in financial, tax and other business
matters as to enable it to evaluate the merits and risks of, and to
make an informed investment decision with respect to, this
Agreement. The Company agrees and acknowledges that the Exchange
Interests being acquired by it are subject to restrictions on
transfer and other restrictions and limitations contained in the
Amended Operating Agreement. The Company acknowledges that it has
reviewed the Amended Operating Agreement and all other documents
relating to the Exchanged Interests and fully understands the
rights, restrictions and obligations set forth
therein.
6.
Registration
Rights. Prior to the
initiation by the Company of any public offering of its securities
or of the securities of any of its subsidiaries, the Company will
provide the Member (and, if applicable, its affiliates) with
customary registration rights pursuant to a customary registration
rights agreement on mutually agreeable terms.
7.1 Survival.
Unless otherwise set forth in this Agreement, the representations
and warranties of the parties contained in or made pursuant to this
Agreement shall survive the execution and delivery of this
Agreement and the Closing for a period of one (1) year following
the Closing; provided that the representations and warranties of
the Company set forth in Section 5.5 of this Agreement shall
survive until thirty (30) days following the expiration of the
statute of limitations (including any statute of limitations for
tax) applicable thereto (giving effect to any extension or tolling
thereof). All covenants and other agreements of the same shall
survive the execution and delivery of this Agreement and the
Closing until such time as they are fully performed.
7.2 Severability.
If any provision of this Agreement is found to be invalid or
unenforceable, then the remainder of this Agreement will have full
force and effect, and the invalid provision will be modified, or
partially enforced, to the maximum extent permitted to effectuate
its original objective.
7.3 Specific
Performance. The parties agree that irreparable harm for
which monetary damages, even if available, would not be an adequate
remedy, would occur in the event that the parties do not perform
the provisions of this Agreement (including the Company failing to
deliver the Level Common Stock and to take the other actions
required of it hereunder) in accordance with its specified terms or
otherwise breach such provisions. It is accordingly agreed that the
parties shall be entitled to specific performance and other
equitable relief to prevent breaches of this Agreement and to
enforce specifically the terms and provisions hereof (including
enforcement by the Member of the Company’s obligation to
deliver the Level Common Stock), this being in addition to any
other remedy to which they are entitled at law or in equity. Each
of the parties agrees that it will not oppose the granting of an
injunction, specific performance and other equitable relief on the
basis that the party seeking the injunction, specific performance
and other equitable relief has an adequate remedy of
law.
7.4 Waiver.
The failure by either party to insist upon or enforce strict
performance by the other party of any term of this Agreement, or to
exercise any right or remedy hereunder, will not be construed as a
wavier or relinquishment to any extent of that party's right to
assert or rely upon any such provisions, rights, or remedies in
that or any other instance; rather, the same will remain in full
force and effect.
7.5
Counterparts. This Agreement
may be executed in one or more counterparts, each of which shall be
deemed to be an original, but all of which shall constitute one
agreement.
7.6 Governing
Law; Jurisdiction; Venue. This Agreement will be governed by
and construed under the laws of the State of California without
regard to its conflict of laws principles to the contrary. The
parties irrevocably consent to the jurisdiction and venue of the
state and federal courts located in Los Angeles, California, in
connection with any action relating to this Agreement.
7.7 Attorneys'
Fees; Expenses. The prevailing party will be entitled (in
addition to any and all other remedies) to recover any and all
costs and expenses (including, without limitation, reasonable
attorneys' fees) that it may incur in connection with any legal
action relating to this Agreement.
7.8 Entire
Agreement; Amendments. This Agreement and the documents
referenced herein constitute the entire agreement, and supersede
any and all prior agreements, whether written or oral, with regard
to the Exchange Interests. No amendment, modification or waiver of
any of the provisions of this Agreement will be valid unless set
forth in a written instrument signed by the party to be
bound.
[signature page follows]
IN WITNESS WHEREOF, the parties have
executed this Agreement as March 24, 2017.
Company:
Level
Brands, Inc.,
By:
/s/ Martin A.
Sumichrast
Name:
Martin A. Sumichrast
Title:
Chief Executive Officer
IM1:
I|M1,
LLC, by
Its
Manager, Level Brands, Inc.,
By:
/s/ Martin A.
Sumichast
Name:
Martin A. Sumichrast
Title:
Chief Executive Officer
Member:
IM1
HOLDINGS, LLC, by
the
Sterling Winters Living Trust, u/t/a
dated
December 10, 1993, its Manager
By:
/s/ Erik
Sterling
Name:
Erik Sterling
Title:
Trustee
By:
/s/ Jason
Winters
Name:
Jason Winters
Title:
Trustee
Member
|
Number of Class A Units Interests Being Contributed
|
Number of Class B Units Interests Being Contributed
|
Number of Shares of Level Common Stock to be Issued
|
IM1
Holdings, LLC
|
583,000
|
0
|
583,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9
Exhibit
7.3
amended and restated
membership
interests Exchange agreement
This
Membership Interests Exchange Agreement (this "Agreement"),
effective as of the 6th day of January
2017, is made and entered into by and among EE1 Holdings, LLC, a
California limited liability company, and the sole member
(the "Member")
of Encore Endeavor 1 LLC, a California limited liability company
(“Encore”)
and Level Brands, Inc., a North Carolina corporation (“the
“Company”).
Terms not otherwise defined herein shall have the meanings set
forth in the Amended and Restated Operating Agreement of
Encore (the
“Operating
Agreement”).
RECITALS
A. The
parties hereto entered into a Membership Interests Exchange
Agreement dated January 6, 2017 (the “Original
Agreement”) and other than as set forth in the
Preamble and these Recitals, this Agreement shall contemplate the
original January 6, 2017 date.
B. The
parties now desire to amend and restate the Original Agreement with
respect to certain provisions included in the Original Agreement in
order to correct certain scrivener errors and
otherwise.
C. As
of January 5, 2017, the Member was the owner of one hundred percent
(100%) of the Class A Units (the “Class A
Interests”) and one hundred percent (100%) of the
Class B Units (the “Class B
Interests”, and together with the Class A Interests,
the “Interests”)
in Encore;
B. On
January 6, 2017, the Member transferred all of the Class A
Interests (the “Exchange
Interests”) in Encore to the Company in exchange for
283,000 shares of the Company's Common Stock (the "Level Common
Stock") such that the Company became the holder of 100% of
the Class A Units, which, collectively, will represent 51% of the
Interests.
AGREEMENT
NOW, THEREFORE, in consideration of the
covenants and agreements set forth in this Agreement and other good
and valuable consideration, the receipt and adequacy of which is
hereby acknowledged by all of the parties, the parties hereto agree
as follows:
1.
Transfer and Acceptance of Exchange Interests.
1.1 Transfer
and Acceptance.
Subject to the terms and conditions of this Agreement, upon the
Closing of this Agreement (as hereinafter defined) the
Member shall assign,
transfer and contribute to the Company, and the Company shall
assume and acquire, all of the
right, title and interest in and to the Exchange
Interests.
1.2 Assumption
of Liabilities. The
Company shall not directly assume any of the debts, liabilities, or
other obligations of Encore. Rather, the Company shall merely hold
the Exchange Interests in Encore with Encore in accordance with the
terms of the Amended and Restated Operating Agreement of Encore
(the “Amended Operating
Agreement”), while continuing to maintain its status
as a separate limited liability company for all legal and
accounting purposes.
1.3 The
Member and the Company acknowledge and agree that, for federal,
state and local income tax purposes, the transfer of the Exchange
Interests by the Member to the Company will be treated as (i) a
sale by the Member to the Company of an undivided portion of the
assets of Encore in exchange for the Level Common Stock
Consideration (as defined below), followed immediately by (ii) a
contribution by the Member and the Company to a new tax partnership
of their respective undivided interests in each of such assets of
Encore in a transfer described in Section 721(a) of the Code. The
Member and the Company agree to consistently treat the transfer of
the Exchange Interests in such manner for all federal, state and
local income tax purposes.
2.
Consideration.
As consideration for
the transfer of the Exchange Interests by the Member to the
Company, the Company shall issue 283,000 shares of Level Common
Stock to the Member (the “Level Common Stock
Consideration”) in accordance with the terms of this
Agreement. The Level Common Stock Consideration shall be paid by
the Company on the day of the Closing by delivery from the Company
to the Member of the certificates representing the Level Common
Stock Consideration in the names and amounts set forth on
Exhibit A hereto;
provided, that the parties understand and acknowledge
that on the day of the Closing, the Company shall send to the
transfer agent the completed documentation necessary for the
issuance of the Exchange Shares, and that it may take a few days to
process before the transfer agent issues the actual share
certificates of the Company. Upon issuance in accordance with the
terms of this Agreement, the shares representing the Level Common
Stock Consideration shall be validly issued, fully paid and
non-assessable and shall have been issued in compliance with all
laws and regulations applicable thereto.
3.1 Closing.
The closing of the transfer of the Exchange Interests shall take
place on and this Agreement shall be effective as of January 6,
2017 (the "Closing").
3.2 Deliveries.
3.2.1
By the
Member. At the
Closing, the Member shall deliver the interest
certificate(s), if any, and other applicable instruments evidencing
the transfer of the Exchange Interests to be acquired by the
Company, in form and substance reasonably acceptable to the
Company:
(a) all
consents, authorizations or waivers from parties, as may be
required to be obtained from them in connection with the
consummation of the transactions contemplated hereby;
and
(b)
such other documents, including the Operating Agreement, duly
executed by the Member and in a form and substance reasonably
acceptable to the Company as shall be reasonably necessary to
consummate the transactions contemplated by this
Agreement.
3.2.2
By the Company. At
the Closing, the Company shall deliver such documents, including
the Operating Agreement, duly executed by the Company and in a form
and substance reasonably acceptable to the Member as shall be
reasonably necessary to consummate the transactions contemplated by
this Agreement.
3.2.3
Covenants. Each party hereto shall use its
reasonable best efforts to take or cause to be taken all actions,
and to do or cause to be done all other things, necessary, proper
or advisable in order for such party to fulfill and perform its
respective obligations pursuant to this Agreement and otherwise to
consummate and make effective the transactions contemplated hereby
and thereby.
4.
Representations and
Warranties of the Member.
The Member represents and warrants to the
Company as follows:
4.1 Authority.
The execution and delivery of this Agreement and each instrument
required hereby to be executed and delivered by the Member prior to
or at the Closing, the performance of the Member's obligations
hereunder and thereunder and the consummation by the Member of the
transactions contemplated hereby have been duly and validly
authorized by all necessary action on the part of the Member, and
no other proceedings on the part of the Member is necessary to
authorize this Agreement or to consummate the transactions
contemplated hereby. This Agreement has been duly and validly
executed by the Member, and, assuming this Agreement has been duly
executed by the Company, this Agreement constitutes a valid and
binding agreement of the Member, enforceable against the Member in
accordance with its terms, subject to bankruptcy, insolvency,
fraudulent transfer, and similar laws of general applicability
relating to or affecting creditors' rights and to general equity
principles.
4.2 Consents.
The execution and performance of this Agreement does not, and the
consummation of the transactions contemplated hereby and compliance
with the provisions of this Agreement will not (a) conflict with or
violate any statute, ordinance, rule, regulation, judgment, order,
writ, injunction, decree or law applicable to the Member, or by
which the Member is bound, or (b) result in a violation or breach
of or constitute a default (or an event which with or without
notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration
or cancellation of, or result in any loss of any benefit under, any
material contract, agreement or arrangement to which the Member is
a party and which relate to Encore, or the creation of liens on any
of the properties or assets of Encore. No consent, approval, order
or authorization of, or registration, declaration or filing with,
any governmental entity, is required by the Member in connection
with the execution of this Agreement by the Member or the
consummation by him, her or it of the transactions contemplated
hereby, except for such other consents, approvals, orders,
authorizations, registrations, declarations or filings, the failure
of which to obtain would not individually or in the aggregate have
a material adverse effect.
4.3 Title
to the Exchange Interests. The Member is the sole record and
beneficial owner of the Exchange Interests, free and clear of all
liens, and the Exchange Interests have not been sold, pledged,
assigned or otherwise transferred except pursuant to this
Agreement. There are no outstanding subscriptions, rights, options,
warrants or other agreements obligating the Member to sell or
transfer to any third person any of the Exchange Interests, or any
interest therein. The Member has full power and authority to
exchange, transfer and deliver to the Company the
Exchange Interests.
4.4 Litigation.
There are no actions, suits, proceedings or investigations pending
against the Member or the Exchange Interests (nor has the Member
received notice of any threat thereof) before any court or
governmental agency that questions the validity of this Agreement
or the right of the Member to enter into such agreements, or the
right of the Member to perform its obligations contemplated hereby
and thereby, or that, either individually or in the aggregate, if
determined adversely to such Member, would materially detract from
the value of the Exchange Interests or would otherwise be likely to
prevent or materially impede, interfere with, hinder or delay the
transactions contemplated hereby.
4.5
Accredited
Investor. The Member is an “accredited
investor,” as such term is defined in Regulation D
promulgated under the Securities Act of 1933, or is otherwise
experienced in investments and business matters, has made
investments of a speculative nature and has such knowledge and
experience in financial, tax and other business matters as to
enable him to evaluate the merits and risks of, and to make an
informed investment decision with respect to, this Agreement. The
Member understands that his acquisition of the shares of Level
Common Stock is a speculative, illiquid investment, and the Member
represents that he, she or it is able to bear the risk of such
investment for an indefinite period, and can afford a complete loss
thereof.
4.6 Access
to Counsel. The Member acknowledges that, in executing this
Agreement, he, she or it has had the opportunity to seek the advice
of independent legal and/or tax counsel, and has read and
understood all of the terms and provisions of this
Agreement.
5.
Representations and
Warranties of the Company.
5.1 Authority.
The Company is a corporation duly organized and validly existing
under the laws of the State of Florida and has the requisite power
and authority to execute and deliver this Agreement, to acquire the
Exchange Interests and issue the shares representing the Level
Common Stock Consideration, as applicable, and to carry out the
provisions of this Agreement.
5.2 Corporate
Action. All necessary actions on the part of the Company
necessary for the authorization, execution and delivery of this
Agreement and the other agreements and transactions contemplated
herein, the performance of all obligations of the Company hereunder
and thereunder and the authorization, issuance and delivery of the
shares representing the Level Common Stock Consideration being
transferred to the Member hereunder have been taken and this
Agreement and the other agreements contemplated herein constitute
valid and legally binding obligations of the Company, enforceable
in accordance with their terms, subject to bankruptcy, insolvency,
fraudulent transfer, and similar laws of general applicability
relating to or affecting creditors' rights and to general equity
principles.
5.3. Consents.
The execution and performance of this Agreement does not, and the
consummation of the transactions contemplated hereby and compliance
with the provisions of this Agreement will not (a) conflict with or
violate any statute, ordinance, rule, regulation, judgment, order,
writ, injunction, decree or law applicable to the Company, or by
which the Company is bound, or (b) result in a violation or breach
of or constitute a default (or an event which with or without
notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration
or cancellation of, or result in any loss of any benefit under, any
material contract, agreement or arrangement to which the Company is
a party, or the creation of liens on any of the properties or
assets of the Company. No consent, approval, order or authorization
of, or registration, declaration or filing with, any governmental
entity, is required by the Company in connection with the execution
of this Agreement by the Company or the consummation by it of the
transactions contemplated hereby, except for such other consents,
approvals, orders, authorizations, registrations, declarations or
filings, the failure of which to obtain would not individually or
in the aggregate have a material adverse effect.
5.4 Litigation.
There are no actions, suits, proceedings or investigations pending
against the Company (nor has the Company received notice of any
threat thereof) before any court or governmental agency that
questions the validity of this Agreement or the right of the
Company to enter into such agreements, or to perform its
obligations contemplated hereby and thereby, or that, either
individually or in the aggregate, if determined adversely to such
Company, would materially detract from the value of the shares
representing the Level Common Stock Consideration or would
otherwise be likely to prevent or materially impede, interfere
with, hinder or delay the transactions contemplated
hereby.
5.5 Level
Common Stock Consideration. The shares representing the
Level Common Stock Consideration, when issued, sold and delivered
in accordance with the terms hereof for the consideration expressed
herein, will be duly and validly issued, fully paid and
non-assessable and free of any liens, other than restrictions on
transfer under the applicable federal and state securities laws.
The shares representing the Level Common Stock Consideration issued
hereunder will be issued in compliance with all applicable federal
and state securities laws. The Company has retained an independent
third party to assist in preparing an appraisal. The Chief
Financial Officer of the Company has directed and maintained full
responsibility and oversight over the third party’s work,
including evaluation of the adequacy of the work for its purposes,
and has taken full responsibility for the results of the third
party’s work. Subsequently the Company determined the per
share value of the Level Common Stock is $0.85 per share (the
“Appraised
Value”). The Company represents and warrants that (a)
the Appraised Value is reasonable and (b) the Company will treat
the Appraised Value as the value of Level Common Stock
Consideration as of the date of grant for all purposes, including
all state, local and federal tax purposes, and will take no action
that may result in the Appraised Value being challenged. All
parties to this Agreement have discussed and concur on the
Appraised Value indicated above.
5.6 Purchase
for Investment. The Exchange Interests being acquired by the
Company are being acquired for investment for the Company’s
own account and not with a view to the distribution of any part
thereof (or participation therein) in violation of securities laws.
The Company is an “accredited investor,” as such term
is defined in Regulation D promulgated under the Securities Act of
1933, or is otherwise experienced in investments and business
matters, has made investments of a speculative nature and has such
knowledge and experience in financial, tax and other business
matters as to enable it to evaluate the merits and risks of, and to
make an informed investment decision with respect to, this
Agreement. The Company agrees and acknowledges that the Exchange
Interests being acquired by it are subject to restrictions on
transfer and other restrictions and limitations contained in the
Amended Operating Agreement. The Company acknowledges that it has
reviewed the Amended Operating Agreement and all other documents
relating to the Exchanged Interests and fully understands the
rights, restrictions and obligations set forth
therein.
6.
Registration
Rights. Prior to the
initiation by the Company of any public offering of its securities
or of the securities of any of its subsidiaries, the Company will
provide the Member (and, if applicable, its affiliates) with
customary registration rights pursuant to a customary registration
rights agreement on mutually agreeable terms.
7.1 Survival.
Unless otherwise set forth in this Agreement, the representations
and warranties of the parties contained in or made pursuant to this
Agreement shall survive the execution and delivery of this
Agreement and the Closing for a period of one (1) year following
the Closing; provided that the representations and warranties of
the Company set forth in Section 5.5 of this Agreement shall
survive until thirty (30) days following the expiration of the
statute of limitations (including any statute of limitations for
tax) applicable thereto (giving effect to any extension or tolling
thereof). All covenants and other agreements of the same shall
survive the execution and delivery of this Agreement and the
Closing until such time as they are fully performed.
7.2 Severability.
If any provision of this Agreement is found to be invalid or
unenforceable, then the remainder of this Agreement will have full
force and effect, and the invalid provision will be modified, or
partially enforced, to the maximum extent permitted to effectuate
its original objective.
7.3 Specific
Performance. The parties agree that irreparable harm for
which monetary damages, even if available, would not be an adequate
remedy, would occur in the event that the parties do not perform
the provisions of this Agreement (including the Company failing to
deliver the Level Common Stock and to take the other actions
required of it hereunder) in accordance with its specified terms or
otherwise breach such provisions. It is accordingly agreed that the
parties shall be entitled to specific performance and other
equitable relief to prevent breaches of this Agreement and to
enforce specifically the terms and provisions hereof (including
enforcement by the Member of the Company’s obligation to
deliver the Level Common Stock), this being in addition to any
other remedy to which they are entitled at law or in equity. Each
of the parties agrees that it will not oppose the granting of an
injunction, specific performance and other equitable relief on the
basis that the party seeking the injunction, specific performance
and other equitable relief has an adequate remedy of
law.
7.4 Waiver.
The failure by either party to insist upon or enforce strict
performance by the other party of any term of this Agreement, or to
exercise any right or remedy hereunder, will not be construed as a
wavier or relinquishment to any extent of that party's right to
assert or rely upon any such provisions, rights, or remedies in
that or any other instance; rather, the same will remain in full
force and effect.
7.5
Counterparts. This
Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which shall
constitute one agreement.
7.6 Governing
Law; Jurisdiction; Venue. This Agreement will be governed by
and construed under the laws of the State of California without
regard to its conflict of laws principles to the contrary. The
parties irrevocably consent to the jurisdiction and venue of the
state and federal courts located in Los Angeles, California, in
connection with any action relating to this Agreement.
7.7 Attorneys'
Fees; Expenses. The prevailing party will be entitled (in
addition to any and all other remedies) to recover any and all
costs and expenses (including, without limitation, reasonable
attorneys' fees) that it may incur in connection with any legal
action relating to this Agreement.
7.8 Entire
Agreement; Amendments. This Agreement and the documents
referenced herein constitute the entire agreement, and supersede
any and all prior agreements, whether written or oral, with regard
to the Exchange Interests. No amendment, modification or waiver of
any of the provisions of this Agreement will be valid unless set
forth in a written instrument signed by the party to be
bound.
[signature page follows]
IN WITNESS WHEREOF, the parties have
executed this Agreement on March 24, 2017.
Company:
Level
Brands, Inc.,
By:
/s/ Martin A.
Sumichrast
Name:
Martin A. Sumichrast
Title:
Chief Executive Officer
Encore:
Encore
Endeavor 1 LLC, by
Its
Manager,
Level
Brands, Inc.,
By:
/s/ Martin A.
Sumichrast
Name:
Martin A. Sumichrast
Title:
Chief Executive Officer
Member:
EE1
HOLDINGS, LLC, by
the
Sterling Winters Living Trust, u/t/a
dated
December 10, 1993, its Manager
By:
/s/ Erik
Sterling
Name:
Erik Sterling
Title:
Trustee
By:
/s/ Jason
Winters
Name:
Jason Winters
Title:
Trustee
Exhibit A
Member
|
Number of Class A Units Interests Being Contributed
|
Number of Class B Units Interests Being Contributed
|
Number of Shares of Level Common Stock to be Issued
|
EE1
Holdings, LLC
|
283,000
|
0
|
283,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8
Exhibit
7.4
Exhibit 11.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S
CONSENT
We
consent to the inclusion in this Offering Circular of Level Brands,
Inc. and subsidiaries on Form 1-A of our report dated May 1, 2017
with respect to our audits of the consolidated financial statements
of Level Brands, Inc. and subsidiary as of September 30, 2016 and
2015 and for the year ended September 30, 2016 and for the initial
period from March 17, 2015 (inception) to September 30, 2015, which
report appears in this Offering Circular. We also consent to the
reference to our Firm under the heading “Experts” in
such Offering Circular.
/s/ Cherry Bekaert LLP
Charlotte, North Carolina
September
18, 2017
Level Brands, Inc. (the "Company")
CODE OF BUSINESS CONDUCT AND ETHICS
(Adopted by the Board of Directors on January 9, 2017)
Important Notice
This
Code of Business Conduct and Ethics (the "Code")
provides information about the standards of integrity that the
Company requires all employees, officers and members of the Board
of Directors to follow. It covers a wide range of business
practices and procedures. It does not cover every issue or set
forth every rule, nor is it a substitute for the responsibility of
each of us to exercise good judgment. All of our officers,
directors and employees must conduct themselves accordingly and
seek to avoid even the appearance of improper behavior. If a law
conflicts with a policy in this Code, you must comply with the law.
The Company may, in its sole discretion modify the terms of this
Code at any time. Any modifications will be effective immediately.
The Code does not create any contractual rights of any kind between
the Company and its employees or between the Company and any third
parties.
You
should notify the Company immediately if you suspect, observe or
learn of unethical business conduct or the commission of any
dishonest, destructive or illegal act. For information on how to
contact the Company, please see Section 16 of the Code. The Company
will investigate all reports and provide feedback when appropriate.
There will be no reprisals against those who report suspected
violations in good faith, and their identity will be protected to
the extent consistent with law and Company policy.
If you
have any questions about the Code or how it applies to you, you can
discuss the matter with your supervisor, your department head or
the CFO, the Ethics and Compliance Officer.
Introduction
The
Code identifies fundamental values at the Company. It establishes a
commitment to ethical and legal conduct and a respect for each
person's contributions to the success of the team. To ensure the
future success of the Company, these values must always guide our
actions.
We are each responsible for
following the Code. Ultimately, your conduct is your own
responsibility. None of us should ever commit dishonest,
destructive or illegal acts even if directed to do so by a
supervisor or co-worker, nor should we direct others to act
improperly.
Those
who do not comply with the guidelines in the Code and other Company
policies may be disciplined, up to an including dismissal.
Additionally, violations of these standards could result in
criminal penalties and/or civil liabilities. If you are in a
situation that you believe may violate or lead to a violation of
this Code, follow the guidelines described in Section 16 of this
Code.
The Code cannot cover
everything – the Company relies on your good judgment.
There will be times when the Code will not address the specifics of
your situation. When this occurs, you might find it helpful to
consider the following questions:
•
Other written
policies and guidelines: What
written policies and instructions should be
consulted?
•
People available to
assist you: Who should be
consulted?
•
Ethical impact:
What are the possible ethical
choices and the rationale for each?
•
Alternatives that
would not violate the Company's values: Is there any room for compromise that would
not violate the Company's standards of
integrity?
•
Consider the
possible outcomes: Who could be
hurt or helped by your decision? To what extent could they be hurt?
How might they be helped? Of the choices identified, which do the
most to reduce harm? Which do the most to provide help? Which are
most aligned with the Code? Which do the most to respect the rights
of those involved?
•
Make sure you are
comfortable with your decisions: Will my decision seem like the right one a
year from now, five years from now, 10 years from now? Would I be
comfortable telling my supervisor, my co-workers, my organization's
leadership team, the Board of Directors and the Company
stockholders? What about telling my family and friends about my
decision? Could I testify in a court of law and not expose myself
or the Company to liability? How would I feel if my decision were
made public through newspapers or television?
1.
Compliance with
Laws, Rules and Regulations.
Obeying
the law, both in letter and in spirit, is the foundation on which
our ethical standards are built. All employees must respect and
obey the laws of the cities, states and countries in which we
operate. Although not all employees are expected to know the
details of these laws, it is important to know enough about them to
determine when to seek advice from supervisors, managers or other
appropriate personnel.
To
maintain the trust of our investors, our submissions to the U.S.
Securities and Exchange Commission and other public disclosures
must always accurately describe the matters covered in those
disclosures. Anything that could be construed as deceptive or
misleading would be a serious disservice to our investors and could
be illegal. If you participate in the preparation of our Securities
and Exchange Commission submissions, you must take all reasonable
steps to ensure that those submissions provide complete, accurate,
understandable and timely disclosure about our business and
financial condition. If you believe that any of our public
disclosures do not meet those standards, you should contact your
supervisor.
2.
Conflicts of
Interest.
A
“conflict of interest” exists when a person’s
private interests interferes in any way with the interests of the
Company. A conflict situation can arise when an employee, officer
or director takes actions or has interests that may make it
difficult to perform his or her Company work objectively and
efficiently. Conflicts of interest may also arise when an employee,
officer or director, or members of his or her family, receives
improper personal benefits as a result of his or her position in
the Company.
Gifts
are generally given to create goodwill and, in some parts of the
world, declining a gift may insult the giver. On the other hand,
accepting a gift may create a conflict of interest or the
appearance of a conflict of interest. This presents a dilemma for
the recipient of a gift. If you receive such a gift, it is
important to notify your supervisor in writing as soon as possible
so he or she can determine whether you can retain the gift or if it
should become Company property. Never pay, offer or promise money,
favors, inappropriate gifts or anything else of value to influence,
direct, obtain or retain business or to secure any improper
advantage. Never allow an agent, representative or business partner
to make those types of payments, offers or promises on the
Company's behalf. These payments or favors may be considered
bribery, which violates Company policy as well as the laws of most
countries where we conduct business.
You
should not compete with the Company and should never let business
dealings on behalf of the Company be influenced, or even appear to
be influenced, by personal or family interests. It is almost always
a conflict of interest for a Company employee to work
simultaneously for a competitor, customer or supplier. You are not
allowed to work for a competitor as a consultant or board member.
The best policy is to avoid any direct or indirect business
connection with our customers, suppliers or competitors, except on
our behalf. Conflicts of interest are prohibited as a matter of
Company policy, except under guidelines approved by our Board of
Directors. Conflicts of interest may not always be clear-cut, so if
you have a question, you should consult with higher levels of
management. Any employee, officer or director who becomes aware of
a conflict or potential conflict should bring it to the attention
of a supervisor, manager or other appropriate personnel or consult
with the procedures described in Section 16 of this
Code.
Employees who have
access to confidential information are not permitted to use or
share that information for stock trading purposes or for any other
purpose except the conduct of our business. All non-public
information about the Company should be considered confidential
information. To use non-public information for personal financial
benefit or to “tip” others who might make an investment
decision on the basis of this information is not only unethical but
also illegal. Detailed information regarding the Company's insider
trading policy, including the relevant black-out periods, is
contained in the Company's Insider Trading Policy. See Section
16.
4.
Corporate
Opportunities.
Employees, officer
and directors are prohibited from taking for themselves personally
opportunities that are discovered through the use of corporate
property, information or position without the consent of the Board
of Directors. No employee may use corporate property, information
or position for improper personal gain, and no employee may compete
with the Company, directly or indirectly.
5.
Competition and
Fair Dealing.
We seek
to outperform our competition fairly and honestly. Stealing
proprietary information, possessing trade secret information that
was obtained without the owner’s consent, or inducing such
disclosures by past or present employees of other companies is
prohibited. Each officer, director and employee should respect the
rights of and deal fairly with the Company’s customers,
suppliers, competitors and employees. No employee should take
unfair advantage of anyone through manipulation, concealment, abuse
of privileged information, misrepresentation of material facts, or
any other intentional unfair-dealing practice.
The
purpose of business entertainment and gifts in a commercial setting
is to create good will and sound working relationships, not to gain
unfair advantage with customers. No gift, or entertainment should
ever be offered, given, provided or accepted by any Company
officer, director or employee, and/or family member of an employee
or agent, unless it (a) is not in cash, (b) is consistent with
customary business practices, (c) is not excessive in value, (d)
cannot be construed as a bribe or payoff and (e) does not violate
any laws or regulations. Please discuss with your supervisor any
gifts or proposed gifts that you are not certain are
appropriate.
6.
Discrimination and
Harassment.
The
diversity of the Company’s employees is a tremendous asset.
We are firmly committed to providing equal opportunity in all
respects aspects of employment and will not tolerate illegal
discrimination or harassment of any kind. Examples include
derogatory comments based on racial or ethnic characteristics and
unwelcome sexual advances.
The
Company strives to provide each employee with a safe and healthy
work environment. Each employee has responsibility for maintaining
a safe and healthy workplace for all employees by following safety
and health rules and practices and reporting accidents, injuries
and unsafe equipment, practices or conditions.
Violence and
threatening behavior are not permitted. Employees should report to
work in condition to perform their duties, free from the influence
of illegal drugs or alcohol. The use of alcohol and/or illegal
drugs in the workplace will not be tolerated.
The
Company requires honest and accurate recording and reporting of
information in order to make responsible business decisions. For
example, only the true and actual number of hours worked should be
reported.
Many
employees regularly use business expense accounts, which must be
documented and recorded accurately. If you are not sure whether a
certain expense is legitimate, ask your supervisor or the
Company’s controller or chief financial officer.
All of
the Company’s books, records, accounts and financial
statements must be maintained in reasonable detail, must
appropriately reflect the Company’s transactions and must
conform to both applicable legal requirements and to the
Company’s systems of accounting and internal controls.
Unrecorded or “off the books” funds or assets should
not be maintained unless permitted by applicable laws or
regulations.
Business records
and communications often become public, and we should avoid
exaggeration, derogatory remarks, guesswork or inappropriate
characterizations of people and companies that can be
misunderstood. This applies equally to e-mail, internal memos and
formal reports. Records should always be retained or destroyed
according to the Company’s record retention policies. In
accordance with these policies, in the event of litigation or
governmental investigation please consultant your supervisor. All
e-mail communications are the property of the Company and
employees, officers and directors should not expect that Company or
personal e-mail communications are private. All e-mails are the
property of the Company. No employee, officer or director shall use
Company computers, including to access the internet, for personal
or non-Company business.
Confidential
information includes all non-public information that might be of
use to competitors, or harmful to the Company or its customers, if
disclosed. It also includes information that suppliers and
customers have entrusted to us. Employees must maintain the
confidentiality of confidential information entrusted to them by
the Company or its customers, except when disclosure is required by
laws or regulations. Always store confidential information in a
safe place and follow security procedures for the computer systems
you use. In addition, use common sense to help prevent accidental
disclosure of confidential information. Remember, you can be
overhead in public places such as airplanes, elevators and
restaurants. Avoid communicating the Company's confidential
information over mobile phones in a manner that could be understood
by outsiders, for example in a crowded public place. Be
particularly careful about sending information by e-mail; it is
easy to mistype an e-mail address and send the information to an
unintended recipient. Do not discuss the Company's confidential
information with family or friends. The obligation to preserve
confidential information continues even after employment ends. In
connection with this obligation, employees, officers and directors
may be required to execute confidentiality agreements confirming
their agreement to be bound not to disclose confidential
information. If you are uncertain whether particular information is
confidential or non-public, please consult your
supervisor.
10.
Protection and
Proper Use of Company Assets.
All
officers, directors and employees should endeavor to protect the
Company’s assets and ensure their efficient use. Theft,
carelessness and waste have a direct impact on the Company’s
profitability. Any suspected incident of fraud or theft should be
immediately reported for investigation. Company equipment should
not be used for non-Company business.
The
obligation of officers, directors and employees to protect the
Company’s assets includes its proprietary information.
Proprietary information includes intellectual property such as
trade secrets, patents, trademarks and copyrights, as well as
business, marketing and service plans, engineering and
manufacturing ideas, designs, databases, records, salary
information and any unpublished financial data and reports.
Intellectual property developed by Company employees and related to
the Company's business is the property of the Company. In addition
to maintaining the confidentiality of the Company's intellectual
property, you may not use the Company's intellectual property for
non-Company purposes without the consent of the Board of Directors.
Unauthorized use or distribution of this information would violate
Company policy. It could also be illegal and result in civil or
even criminal penalties.
11.
Payments to
Government Personnel.
The
United States Foreign Corrupt Practices Act prohibits giving
anything of value, directly or indirectly, to officials of foreign
governments or foreign political candidates in order to obtain or
retain business. It is strictly prohibited to make illegal payments
to government officials of any country.
In
addition, the U. S. government has a number of laws and regulations
regarding business gratuities that may be accepted by U. S.
government personnel. The promise, offer or delivery to an official
or employee of the U. S. government of a gift, favor or other
gratuity in violation of these rules would not only violate Company
policy, but could also be a criminal offense. State and local
governments, as well as foreign governments, may have similar
rules.
12.
Public
Communications and Social Media.
Only
those individuals specifically authorized by the Company may speak
on behalf of the Company. Public comments made by individuals
identified as Company employees in a variety of contexts such as
tradeshows, press conferences, news media interviews and on the
Internet, including on "wikis," blogs, websites that allow you to
post audio or video, online discussion groups and social networking
websites, may be perceived by outsiders as representing "official
positions." Similarly, fax or email communications in which the
Company's name appears on the cover sheet, in the letterhead, in a
footer or in the employee's email address may be viewed by the
recipient as expressing the Company's position, whether intended or
not. As a result, you should:
•
not speak or appear
to be speaking on behalf of the Company unless you are specifically
authorized; this includes posting content on the Internet and
utilizing social media;
•
not use the
Company's logo when posting content on the Internet unless you have
permission from the Company's Chief Executive Officer or Chief
Operating Officer;
•
contact the Chief
Executive Officer or Chief Operating Officer before replying to any
media inquiries;
•
be sensitive to
situations in which your identity as a Company employee is known
and as a result you may be viewed as speaking on behalf of the
Company; in those situations, you should make it clear that the
views you express are your own and that you do not speak on behalf
of the Company; and
•
never publicly
disclose the Company's or any third party's confidential
information when participating in external forums.
The
Company expects employees to exercise personal responsibility
whenever they use social media, which includes not violating the
trust of those with whom they are engaging. Employees should never
use social media for covert advocacy, marketing or public
relations. Only those officially designated can use social media to
speak on behalf of the Company in an official capacity, though
employees may use social media to speak for themselves individually
or to exercise their legal rights under the National Labor
Relations Act. If you have not been specifically designated to
speak for the Company, you should assume you do not have that
authority. If an employee is authorized by the Chief Executive
Officer or Chief Operating Officer to use social media to
communicate on the Company's behalf, he or she should clearly
identify themselves as employees.
When
you see misrepresentations made about by media, analyst, bloggers
or other social media users, you may certainly use your blog,
social networking account, or someone else's to point that out. But
you may only do so in an official capacity with the Company's prior
consent. Different social media channels have proper and improper
business uses. For example, members of social networks are expected
to read, and when appropriate respond, to questions asked of them
from another member of their social network. It is important for
employees to understand what is recommended, expected and required
when they discuss related topics, whether at work or on their own
time. Employees are responsible for making sure that their online
activities do not interfere with their ability to fulfill their job
requirements or their commitments to their managers, co-workers or
customers.
Internet access is
provided to the Company's employees primarily for business use.
Non-business use of those resources must be governed by good
judgment and restraint. Use of those resources, whether in or out
of the office, is not private. The Company can and will monitor
individual use of network services, including visits to specific
Web sites and individual e-mail. The Company's computing and
networking resources should never be used to access or disseminate
sexually explicit content, slanderous or libelous content,
threatening or harassing messages or chain letters, or other
content that could be construed as hostile or inconsistent with
Company values. If you have a question about whether a particular
site is prohibited, talk to your supervisor.
14.
Waivers of the Code
of Business Conduct and Ethics.
We
expect that Company personnel will follow the Code and that waivers
will rarely be requested or granted. Any waiver of the provisions
of this Code may be made only by the Board of Directors. Waivers
for members of the Board of Directors and executive leadership team
can only be granted by the Board of Directors and must be promptly
disclosed to our stockholders along with the reasons for the
waiver.
15.
Reporting any
Illegal or Unethical Behavior.
Employees are
encouraged to talk with supervisors, managers or Company officials
about observed illegal or unethical behavior, and when in doubt
about the best course of action in a particular situation. It is
the Company’s policy not to allow retaliation for reports of
misconduct by others made in good faith by employees. Employees are
expected to cooperate in internal investigations of misconduct, and
the failure to do so could serve as grounds for termination. Any
employee may submit a good faith concern regarding questionable
accounting or auditing matters to the Company's Board of Directors
without fear of dismissal or retaliation of any kind.
16.
Compliance Procedures.
To
assist you with any questions regarding this Code, or to report any
violations, following you will find various contact
information:
|
|
|
|
|
|
|
|
Chief
Financial Officer and
Chief
Operating Officer
|
Mark
Elliott
mark@levelbrands.com
|
|
|
Chief
Executive Officer and
Chairman
of the Board of Directors
|
Martin
Sumichrast
marty@levelbrands.com
|
Chairman,
Audit Committee of the Board of Directors
|
To be
added
|
|
|
|
|
The
Company's Insider Trading Policy is distributed to all employees
upon hiring.
To
receive a copy please contact the Chief Operating
Officer.